PT,AU,BA,BE,GP,AF,BF,CA,TI,SO,SE,BS,LA,DT,CT,CY,CL,SP,HO,DE,ID,AB,C1,RP,EM,RI,OI,FU,FX,CR,NR,TC,Z9,U1,U2,PU,PI,PA,SN,EI,BN,J9,JI,PD,PY,VL,IS,PN,SU,SI,MA,BP,EP,AR,DI,D2,PG,WC,SC,GA,UT,PM,OA,HC,HP,DA,DC,EC,LC,CC,BC
J,"Albu, A1;  Bondor, CI;  Fodor, D",,,,"Albu, Adriana; Bondor, Cosmina I.; Fodor, Daniela",,,RISK FACTORS ASSOCIATED WITH ARTERIAL STIFFNESS IN ELDERLY NON-DIABETIC WOMEN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,arterial stiffness; cardiovascular risk; abdominal obesity; C-reactive protein; elderly,C-REACTIVE PROTEIN; AORTIC STIFFNESS; HEALTHY POPULATION; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; ABDOMINAL OBESITY; BODY-COMPOSITION; OLDER-ADULTS; FOLLOW-UP; HYPERTENSION,"Background: Elderly women have increased arterial stiffness but the precise mechanism that induces vascular alterations is not known. Classical cardiovascular risk factors and systemic inflammation may play a role in this process, but the major determinants in elderly women have not yet been established. The aim of this study was to evaluate the correlation between classical cardiovascular risk factors, C-reactive protein and aortic pulse wave velocity (PWV) in elderly non-diabetic women, without overt cardiovascular disease. Methods: Aortic PWV was measured non-invasively using an oscillometric device in 104 elderly women, mean age 69.7 +/- 6.4 years. Laboratory parameters of lipid and glucose metabolism and high sensitive C-reactive protein (hsCRP) were also evaluated. Results: Aortic PWV independently correlated with hsCRP (beta=0.22, p=0.01), systolic blood pressure (beta=0.23, p=0.009), abdominal circumference (beta=0.24, p=0.007) and age (beta=0.18, p=0.03). Aortic PWV was increased in hypertensive compared with normotensive subjects (10.3 +/- 2.3 vs. 9.0 +/- 1.6, p=0.006) and in obese compared to non-obese women (10.7 +/- 1.9 vs. 9.6 +/- 2.2, p=0.01). Conclusion: In elderly non-diabetic women, age, abdominal obesity, systolic blood pressure and hsCRP, are the most important determinants of aortic PWV. Body weight loss, efficient control of blood pressure and decrease in systemic inflammation may reduce arterial stiffness in this high cardiovascular risk population.","[Albu, Adriana; Fodor, Daniela] Iuliu Hatieganu Univ Med & Pharm, Dept Internal Med 2, 2-4 Clinicilor Str, Cluj Napoca, Romania; [Bondor, Cosmina I.] Iuliu Hatieganu Univ Med & Pharm, Med Informat & Biostat Dept, Cluj Napoca, Romania","Albu, A (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Internal Med 2, 2-4 Clinicilor Str, Cluj Napoca, Romania.",,"Bondor, Cosmina Ioana/V-8815-2019; albu, adriana/D-4480-2016",,,,"Alecu C, 2006, J HUM HYPERTENS, V20, P749, DOI 10.1038/sj.jhh.100207; Araujo F, 2004, INT J CARDIOL, V97, P433, DOI 10.1016/j.ijcard.2003.10.02; Assuncao LGS, 2012, BRAZ J MED BIOL RES, V45, P1284, DOI 10.1590/S0100-879X201200750015; Baulmann J, 2008, J HYPERTENS, V26, P523, DOI 10.1097/HJH.0b013e3282f314f; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.09903; Budimir D, 2012, MED SCI MONITOR, V18, pCR65, DOI 10.12659/MSM.88245; Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.211; Charakida M, 2012, J AM COLL CARDIOL, V60, P2643, DOI 10.1016/j.jacc.2012.08.101; Corden B, 2013, HYPERTENSION, V61, P1322, DOI 10.1161/HYPERTENSIONAHA.113.0117; Coutinho T, 2014, CAN J CARDIOL, V30, P756, DOI 10.1016/j.cjca.2014.03.02; Fantin F, 2010, J HYPERTENS, V28, P333, DOI 10.1097/HJH.0b013e328333d23; Ford LB, 2010, J HYPERTENS, V28, pE22; Genuth S, 2003, DIABETES CARE, V26, P316; Horvath IG, 2010, J HYPERTENS, V28, P2068, DOI 10.1097/HJH.0b013e32833c8a1; Jia GH, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.0023; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.5; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl25; Lavie CJ, 2009, AM J MED SCI, V338, P486, DOI 10.1097/MAJ.0b013e3181c61b6; Lechleitner M, 2008, GERONTOLOGY, V54, P253, DOI 10.1159/00016173; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-091; Mackey RH, 2002, AM J HYPERTENS, V15, P16, DOI 10.1016/S0895-7061(01)02228-; Mahmud A, 2005, HYPERTENSION, V46, P1118, DOI 10.1161/01.HYP.0000185463.27209.b; Mattace-Raso FUS, 2004, ATHEROSCLEROSIS, V176, P111, DOI 10.1016/j.atherosclerosis.2004.04.01; Park JB, 2010, 23 SCI M INT SOC HY; Park S, 2012, YONSEI MED J, V53, P258, DOI 10.3349/ymj.2012.53.2.25; Pasceri V, 2000, CIRCULATION, V102, P216; Recio-Rodriguez JI, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-; Safar ME, 2013, J AM COLL CARDIOL, V61, P12, DOI 10.1016/j.jacc.2012.01.08; Scuteri A, 2012, ATHEROSCLEROSIS, V221, P189, DOI 10.1016/j.atherosclerosis.2011.11.04; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.105; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.42; Trachet B, 2010, ANN BIOMED ENG, V38, P876, DOI 10.1007/s10439-010-9945-; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F; Vermeersch SJ, 2008, J HYPERTENS, V26, P1411, DOI 10.1097/HJH.0b013e3282ffac0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.06; Weisbrod RM, 2013, HYPERTENSION, V62, P1105, DOI 10.1161/HYPERTENSIONAHA.113.0174; Won KB, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/1758-5996-7-; Woodard GA, 2011, MENOPAUSE, V18, P1291, DOI 10.1097/gme.0b013e31821f81c; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.2",39,2,2,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,625.0,630,,10.19193/0393-6384_2018_3_96,,6,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000001,,,,,2022-07-14,0.0040289256198347105,1.1635956663480261e-20,0.007836233167315455,0.06200636718274583,0.007836233167315455
J,"Amato, A1;  Messina, G;  Contro, V;  Sacco, A;  Proia, P",,,,"Amato, Alessandra; Messina, Giuseppe; Contro, Valentina; Sacco, Alessia; Proia, Patrizia",,,TOTAL GENETIC SCORE: AN INSTRUMENT TO IMPROVE THE PERFORMANCE IN THE ELITE ATHLETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,genetics analysis; polymorphism; performance demands; basketball; soccer,ENDURANCE CAPACITY; SOCCER PLAYERS; PPARA GENE; STRENGTH; GENOTYPE; ACTN3; ASSOCIATION; GLY482SER; VARIANTS; ACE,"Introduction: The purpose of this study was to demonstrate the effectiveness of the TGS calculation method to identify genetic athletic predisposition in two groups of basketball and soccer players based on genetics analysis. Through the genetic profile we calculated, by an algorithm, the TGS (Total Genetic Score) in both groups; this idea comes from the concept that it's better to personalized workout based on athlete genetic profile. Identifying specifically performance demands (based on the metabolism system used during performance, aerobic or anaerobic) and paying attention to the performance-enhancing genes and their polymorphisms, is important focus it in order to build personalized and successful training for every single athlete. Materials and methods: We considered two groups of professional athletes: 21 basketball players and 21 soccer players both involved in professional championships. For the genetic analysis a saliva sample was taken from athletes, and the polymorphisms were analysed: ACE; ACTN3; CK-MM; PPAR alpha; PPAR gamma C1; NRF2 A/G; NRF2 C/T. Each genotype was scored from 0 to 2 depending on whether they were more related to resistance or power activity. The sum of these scores generates the total TGS for each athlete and was compared both for resistance and power. Results: Our results indicate that professional basketball players have a power-related TGS higher than the resistance-related conversely the football players, that have a resistance-related TGS greater than power-related one. Conclusion: TGS can be a useful tool to identify the genetic predisposition of the athlete starting from the genetic analysis of some PEPs, regardless of the type and number of genes analysed.","[Amato, Alessandra; Messina, Giuseppe; Contro, Valentina; Sacco, Alessia; Proia, Patrizia] Univ Palermo, Dipartimento Sci Psicol Pedag & Formaz, Palermo, Italy","Messina, G (corresponding author), Univ Palermo, Dipartimento Sci Psicol Pedag & Formaz, Palermo, Italy.",giuseppe.messina17@unipa.it,,"Proia, Patrizia/0000-0002-0326-5560",,,"Ahmetov II, 2013, J PHYSIOL SCI, V63, P79, DOI 10.1007/s12576-012-0233-; Alves Cleber Rene, 2018, J RENIN-ANGIO-ALDO S, P; Amato A., 2017, Human Movement, V18, P1; Bianco A., 2016, ASIAN J SPORTS MED, V; Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.04430; Charlier R, 2017, PHYSIOL GENOMICS, V49, P160, DOI 10.1152/physiolgenomics.00085.201; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.108456; Contro V, 2018, EUR J TRANSL MYOL, V28, P87, DOI 10.4081/ejtm.2018.718; Egorova ES, 2014, J SPORT SCI, V32, P1286, DOI 10.1080/02640414.2014.89885; Fedotovskaia O N, 2012, Fiziol Cheloveka, V38, P10; He Z, 2007, INT J SPORTS MED, V28, P717, DOI 10.1055/s-2007-96491; Hughes DC, 2011, J SPORT SCI, V29, P1425, DOI 10.1080/02640414.2011.59777; Jones N, 2016, BIOL SPORT, V33, P117, DOI 10.5604/20831862.119821; Lopez-Leon S, 2016, BIOL SPORT, V33, P3, DOI 10.5604/20831862.118017; Lucia A, 2005, J APPL PHYSIOL, V99, P344, DOI 10.1152/japplphysiol.00037.200; Ma F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.005468; Maciejewska A, 2012, J SPORT SCI, V30, P101, DOI 10.1080/02640414.2011.62370; Ostrander EA, 2009, ANNU REV GENOM HUM G, V10, P407, DOI 10.1146/annurev-genom-082908-15005; Patti A, 2016, J PHYS THER SCI, V28, P72, DOI 10.1589/jpts.28.7; Proia P, 2012, J SPORT MED PHYS FIT, V52, P10; Proia P, 2014, OPEN ACCESS J SPORTS, V5, P273, DOI 10.2147/OAJSM.S6833; Rankinen T, 2010, MED SCI SPORT EXER, V42, P835, DOI 10.1249/MSS.0b013e3181d86ce; Wang G, 2013, MED SCI SPORT EXER, V45, P892, DOI 10.1249/MSS.0b013e31827c501; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/37759",24,3,3,1,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1857.0,1862,,10.19193/0393-6384_2018_6_287,,6,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400038,,,,,2022-07-14,0.0024793388429752063,1.6327516048287155e-14,0.009681264456832931,0.08695417838182586,0.009681264456832931
J,"Ascione, A1;  Belfiore, P;  Di Palma, D",,,,"Ascione, Antonio; Belfiore, Patrizia; Di Palma, Davide",,,SPORTS PROGRAM TO PROMOTE THE WELLBEING OF PEOPLE WITH DISABILITIES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Disability; Sports Program; Psycho-physical Wellbeing; Swimming; Pedagogical Aspects,SYSTEM,"Introduction: It has investigated the possibility of achieving both an increase in athletic performance, that in the level of health and psycho-physical well-being by a group of athletes with disabilities through sports activities. Materials and methods: 8 disabled athletes have followed a pedagogical sports program characterized by the swimming trainings and socio-relational meetings for a period of 5 months with two series of evaluations at predetermined intervals. Results: It was found that there was a drop out equal to 0 and all the disabled athletes involved have recorded improvements both in the field of sports, that in social and psycho-physical. Conclusions: A suitable program of sporting activities, also meant in its socio-pedagogical meaning, is capable of generating multiple benefits in respect of disabled people.","[Ascione, Antonio; Belfiore, Patrizia; Di Palma, Davide] Parthenope Univ, Dept Sport Sci & Wellness, Naples, Italy","Belfiore, P (corresponding author), Parthenope Univ Naples, Naples, Italy.",patrizia.belfiore@uniparthenope.it,,"Di Palma, Davide/0000-0001-8224-5797",,,"Apalone G, 2005, QUESTIONARIO STATO ; Beyer R., 2009, J YOUTH SPORTS, V; Liow D.K., 1996, ADAPT PHYS ACT Q, V13, P372, DOI [10.1123/apaq.13.4.372, DOI 10.1123/APAQ.13.4.372; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P641, DOI 10.19193/0393-6384_2017_4_09; Messina G, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/63928; Muscogiuri G, 2014, ENDOCR RES, V39, P137, DOI 10.3109/07435800.2014.95201; Orio F, 2013, MINERVA ENDOCRINOL, V38, P30; Orio F, 2013, E SPEN J, V8, P20; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; ORNSTEIN LJ, 1983, MED SCI SPORT EXER, V15, P110, DOI 10.1249/00005768-198315020-0010; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Petralia MC, 2018, ACTA MEDICA MEDITERR, V34, P107, DOI 10.19193/0393-6384_2018_1_1; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Shapiro DR, 2014, J SPORT MANAGEMENT, V2; Tafuri D., 2017, SPORT SCI, V10, P7; 2011, WORLD REP DIS, P",22,13,13,0,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1261.0,1263,,10.19193/0393-6384_2018_5_194,,3,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700016,,,,,2022-07-14,0.002066115702479339,0.002732192289839494,0.010331280013508578,0.09866576970512389,0.010288352953050788
J,"Ascione, A21;   Belfiore, P;   Di Palma, D",,,,"Ascione, Antonio; Belfiore, Patrizia; Di Palma, Davide",,,SPORT AS A PSYCHO-SOCIAL SUPPORT IN DISABILITY THROUGH THE POSITIVE STIMULATION OF SELF-EFFICACY AND RESILIENCE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Self Efficacy; Resilience; Sport; Disability,,"Sport is a key element in disability, it is a context of great support that often welcomes and receives important changes in how every subject can read and understand his special condition. Therefore, given its characteristics, sport can contribute to enhancing and supporting psychological aspects that are fundamental to the life of the disabled, improving his development and enhancing what he feels he is able to achieve. Taking care of one's own physical and psychological well-being through sport allows reversing a life pattern from within, by creating new opportunities for growth through greater awareness, more intense quality of the relationships, and an important acquisition of new resources. Convincing and redefining positively, by experiencing and evaluating one's own limits as resources and qualities, supports the disabled and who revolves around his world, accepting difficulties and,facing the issues under a different light.","[Ascione, Antonio; Belfiore, Patrizia; Di Palma, Davide] Parthenope Univ, Via Medina 40, Naples, Italy","Belfiore, P (corresponding author), Parthenope Univ, Via Medina 40, Naples, Italy.",patrizia.belfiore@uniparthenope.it,,"Di Palma, Davide/0000-0001-8224-5797",,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Bandura A., 2000, AUTOEFFICACIA TEORI; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; Malaguti E., 2005, EDUCARSI RESILIENZ; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Petralia MC, 2018, ACTA MEDICA MEDITERR, V34, P107, DOI 10.19193/0393-6384_2018_1_1; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Short D., 2004, SPERANZA RESILIENZ; Tafuri D., 2017, SPORT SCI, V10, P7; Tortorella D, 2016, PREPARARSI VIA PSIC; Zimmerman J, ELSEVIER J, V25, P8",19,0,0,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1517.0,1520,,10.19193/0393-6384_2018_3s_232,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400009,,,,,2022-07-14,0.001859504132231405,0.0016405226863267224,0.01201642650946603,0.0980938579868465,0.012040771543301632
J,"Barcellona, M1;  Giustino, V;  Messina, G;  Battaglia, G;  Fischetti, F;  Palma, A;  Iovane, A",,,,"Barcellona, Matteo; Giustino, Valerio; Messina, Giuseppe; Battaglia, Giuseppe; Fischetti, Francesco; Palma, Antonio; Iovane, Angelo",,,EFFECTS OF A SPECIFIC TRAINING PROTOCOL ON POSTUROGRAPHIC PARAMETERS OF A TAEKWONDO ELITE ATHLETE AND IMPLICATIONS ON INJURY PREVENTION: A CASE STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,taekwondo; balance; postural control; training,BALANCE; STRATEGIES; POSTURE; QUIET; ANKLE,"Introduction: Taekwondo elite athletes should have excellent qualities in several aspects of fitness, as well as peculiar postural characteristics in terms of balance and postural control, to achieve the best possible results during competitions. Moreover, it is known that taekwondo shows high risk of injury. The aim of this case study is to evaluate the effects of a specific training protocol on posturographic parameters of a taekwondo elite athlete in order to prevent the risk of injury. Materials and methods: The specific training protocol provided 2 months of general strength conditioning, which included pre-conditioning in the first 2 weeks, physical training to improve explosive strength, balance and postural control and athletic training to improve the combat technique. The experimental design included three assessment times: the pre-test (T-0), the intermediate-test (T-1) and the post-test (T-2). Each test provided the same evaluations: anthropometric measurements, cervical ROM assessment and posturographic evaluation. Results: Stabilometric parameters showed a good balance and postural control both in T-0 and T-2. Baropodometric parameters showed a physiological load pressure distribution between the left and the right foot in T-0 (left foot 54% - right foot 46%) as well as in T-2 (left foot 45% - right foot 55%). The left forefoot-rearfoot ratio pressure showed no differences between T-0 and T-2 (p>0.05); we found an improvement on the right forefoot-rearfoot ratio (p<0.05). Cervical range of motion evaluation showed no significant variations from T-0 to T-2 (p>0.05) on rotation and lateral bending movements; we found an improvement on the extension movement from T-0 to T-2 (p<0.05), while the flexion movement decreased (p>0.05). Conclusion: The presented case study showed that the experimental protocol improved the postural parameters of this taekwondo elite athlete. We believe that other athletes may adopt this protocol in order to improve own sports performance and to prevent injuries.","[Barcellona, Matteo; Battaglia, Giuseppe; Palma, Antonio] Univ Palermo, Sport & Exercise Sci Res Unit, Palermo, Italy; [Giustino, Valerio; Messina, Giuseppe; Iovane, Angelo] Univ Palermo, Posturol & Biomech Lab Res Unit, Palermo, Italy; [Giustino, Valerio; Messina, Giuseppe] Posturalab Italia Res Inst, Palermo, Italy; [Messina, Giuseppe; Battaglia, Giuseppe; Palma, Antonio; Iovane, Angelo] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Battaglia, Giuseppe; Palma, Antonio] CONI Sicilia, Reg Sports Sch, Sicily, Italy; [Fischetti, Francesco] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy","Messina, G (corresponding author), Via Giovanni Pascoli 6, Palermo, Italy.",giuseppe.messina17@unipa.it,"Giustino, Valerio/AAR-6788-2021; Messina, Giuseppe/N-7298-2019; Battaglia, Giuseppe/AAV-3916-2020","Giustino, Valerio/0000-0002-4575-8021; Messina, Giuseppe/0000-0003-2774-4950; Battaglia, Giuseppe/0000-0002-7758-7175; Francesco, Fischetti/0000-0001-8616-5372",,,"Alexandrov AV, 2001, BIOL CYBERN, V84, P435, DOI 10.1007/PL0000798; Baldini A, 2013, AVIAT SPACE ENVIR MD, V84, P823, DOI 10.3357/ASEM.3541.201; Battaglia G, 2016, ACTA MEDICA MEDITERR, V32, P1589, DOI 10.19193/0393-6384_2016_5_13; Battaglia G, 2010, AGING CLIN EXP RES, V22, P406, DOI [10.3275/6713, 10.1007/BF03337736; Bellafiore M, 2011, AGING CLIN EXP RES, V23, P378, DOI [10.3275/7354, 10.1007/BF03337762; Bianco A, 2016, J SPORTS MED, V; Bianco A, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-3; Cho Kang Ok, 2013, J Lifestyle Med, V3, P5; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.07; Gorgy O, 2008, J SPORT SCI, V26, P629, DOI 10.1080/0264041070167040; GURFINKEL VS, 1995, NEUROSCIENCE, V68, P229, DOI 10.1016/0306-4522(95)00136-; Hamaoui A, 2014, GAIT POSTURE, V39, P333, DOI 10.1016/j.gaitpost.2013.07.13; Hrysomallis C, 2007, SPORTS MED, V37, P547, DOI 10.2165/00007256-200737060-0000; Ji M, 2016, J PHYS THER SCI, V28, P231, DOI 10.1589/jpts.28.154; Kazemi Mohsen, 2009, J Can Chiropr Assoc, V53, P14; Lystad RP, 2015, BIOL SPORT, V32, P213, DOI 10.5604/20831862.115030; Lystad RP, 2009, J SCI MED SPORT, V12, P614, DOI 10.1016/j.jsams.2008.09.01; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.46; Neto HP, 2015, J BODYW MOV THER, V19, P429, DOI 10.1016/j.jbmt.2014.09.00; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-; Thomas E, 2018, MEDICINE, V97, DOI 10.1097/MD.000000000001024; van Dijk GP, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.0001; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/036354650326217; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.121; Yoon SD, 2015, J PHYS THER SCI, V27, P509, DOI 10.1589/jpts.27.50",25,4,4,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1533.0,1538,,10.19193/0393-6384_2018_3s_236,,6,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400013,,,,,2022-07-14,0.0025826446280991736,3.165353961966743e-14,0.004570701845166564,0.08693543606922503,0.004560001746762869
J,"Barone, A1;  Ascione, A;  Tafuri, D",,,,"Barone, Augusto; Ascione, Antonio; Tafuri, Domenico",,,SPORT MEDICINE AND DISABILITY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Sport Medicine; Athlete; Disability; Inclusion,,"The sports medical examination of the disabled subject represents an important moment in the doctor-athlete relationship, more than in the case of a non-disabled subject; the person's expectations (together with his family's ones) are confronted, in fact, with the pathology the subject carries in a different context from the rehabilitation setting, from the perspective of the access to the sports universe which, at any level, can represent an excellent tool for growth and affirmation, as well as a stumulus to the set up of inclusive processes towards the disabled athlete.","[Ascione, Antonio; Tafuri, Domenico] Univ Naples Parthenope, Naples, Italy; [Barone, Augusto; Tafuri, Domenico] CONI Reg Sports Sch, Rome, Italy","Ascione, A (corresponding author), Univ Naples Parthenope, Naples, Italy.",antonio.ascione@uniparthenope.it,,,,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; ICD 10 Version, 2016, INT STAT CLASS DIS ; ICF. International Classification of Functioning, 2002, INT CLASS FUNCT DI; LUCKASSON R, 1992, MENTAL RETARDATION ; Nicoletti R, 2007, IL CONTROLLO MOTORI; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Petralia MC, 2018, ACTA MEDICA MEDITERR, V34, P107, DOI 10.19193/0393-6384_2018_1_1; Porciani M, 1995, SPORT HANDICA; Raimondi P, 2006, TEORIA METODOLOGIA ; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Tafuri D., 2017, SPORT SCI, V10, P7; 1996, DSM 4 DIAGNOSTIC ST",20,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1529.0,1532,,10.19193/0393-6384_2018_3s_235,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400012,,,,,2022-07-14,0.001962809917355372,5.429425317422731e-05,0.0014486015502388606,0.0827272649579954,0.0014480536271232766
J,"Belfiore, P1;  Di Palma, D;  Ascione, A",,,,"Belfiore, Patrizia; Di Palma, Davide; Ascione, Antonio",,,ADAPTED PHYSICAL ACTIVITY (APA) FOR THE TUTELAGE OF PATIENTS WITH TYPE II DIABETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Type II Diabetes; Adapted Physical Activity; Economic sustainability; Budget Impact Analysis,LIFE-STYLE; EXERCISE; GLUCOSE; PREVENTION; PREVALENCE; MELLITUS,"Introduction: Diabetes is one of the major public health problems because a great proportion of the healthcare expenditure has been spent on the treatment of its associated morbidity and mortality. Methods: A Budget Impact Analysis (BIA) was carried out from the healthcare management perspective to evaluate the economic sustainability and the aspects of tutelage deriving from the introduction of a structured program of APA for diabetics in Campania. Results: The results of the projection show at the end of the five years a possible saving of 27,205,286 euros, distributed among the three cost items. Conclusion: This study testify the importance of Adapted Physical Activity (APA) to obtain an optimal healthcare management and to tutelage effective services for the health and wellbeing of individuals.","[Belfiore, Patrizia; Di Palma, Davide; Ascione, Antonio] Parthenope Univ, Dept Sport Sci & Wellness, Naples, Italy","Di Palma, D (corresponding author), Univ Naples Parthenope, Dept Movement & Wellbeing Sci, Naples, Italy.",davide.dipalma@uniparthenope.it,,"Di Palma, Davide/0000-0001-8224-5797",,,"AMD (Associazione Medici Diabetologi) SID (Societa Italiana di Diabetologia), 2009, STAND IT CUR DIAB M; Associazione Medici Diabetologi (AMD) Societa Italiana di Diabetologia (SID), 2014, STAND IT CUR DIAB M; Belfiore P, 2015, POLITICHE SANITARIE, V16, P24; Centers for Disease Control and Prevention, 1996, JAMA-J AM MED ASSOC, V276, P522, DOI DOI 10.1001/JAMA.1996.0354007001801; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.18; Consoli A, 2013, ITALIANBAROMETERDIA; Creviston T, 2001, NURS CLIN N AM, V36, P24; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-; Eriksson JG, 1999, SPORTS MED, V27, P381, DOI 10.2165/00007256-199927060-0000; Galle F, 2015, BENEFICI ATTIVITA F; Galle F, 2017, DIABETES THER, V8, P875, DOI 10.1007/s13300-017-0283-; Grimaccia F, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-5; Herman WH, 2012, DIABETES CARE, V35, P943, DOI 10.2337/dc12-029; Istituto Nazionale di Statistica, 2014, ANN STAT IT 201; Istituto Nazionale di Statistica, 2010, ANN STAT I; Ivy J L, 1999, Exerc Sport Sci Rev, V27, P; Lauro R, 2015, ITALIAN BAROMETER DI, P3; Liguori G, 2014, EVIDENZE SCI ATTIVIT, P10; Marcellusi A, 2016, EUR J HEALTH ECON, V17, P139, DOI 10.1007/s10198-014-0660-; Marchesini G, 2014, DIABETE MA QUANTO C; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-; Tudor-Locke CE, 2000, CAN J APPL PHYSIOL, V25, P466, DOI 10.1139/h00-03; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM20010503344180; Wallberg-Henriksson H, 1998, SPORTS MED, V25, P25, DOI 10.2165/00007256-199825010-0000; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.05135",25,14,14,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1257.0,1260,,10.19193/0393-6384_2018_5_193,,4,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700015,,,,,2022-07-14,0.0025826446280991736,1.2826483827189975e-23,0.004952786086261558,0.06297696266272844,0.004952786086261558
J,"Belfiore, P21;   Di Palma, D;   Ascione, A",,,,"Belfiore, Patrizia; Di Palma, Davide; Ascione, Antonio",,,HEALTH PROMOTION. HEALTH PROTECTION AND SPORT IN THE SCHOOL,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,health promotion; health protection; sport activity; physical education,INCREASING PHYSICAL-ACTIVITY; AFTER-SCHOOL; EDUCATION; CHILDREN; STUDENTS; PROGRAM; YOUTH,"Introduction: Sport activity contributes to improve physical conditions and to promote health. However, its importance is often overlooked. It is not always adequately treated in schools. Materials and methods: An anonymous questionnaire was administered to 500 students. Demographic data and information about sport activity were also collected. Results: A total of 450 (90% response rate) questionnaires were completed. The 90 % of the sample reported current practice of sport. Sport was considered significant by 65% of the students. The relationship between sport and health promotion is important for 55% of the students. Conclusions: Sport activity is very important for health promotion. For this reason it is decisive the role it plays in the ,for/nation of students in schools. It is an important link between health promotion and health protection.","[Belfiore, Patrizia; Di Palma, Davide; Ascione, Antonio] Parthenope Univ, Via Medina 40, Naples, Italy","Di Palma, D (corresponding author), Parthenope Univ, Via Medina 40, Naples, Italy.",davide.dipalma@uniparthenope.it,,"Di Palma, Davide/0000-0001-8224-5797",,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; CDC, 2008, PHYS ACT GUID A; Dale D, 2000, RES Q EXERCISE SPORT, V71, P240, DOI 10.1080/02701367.2000.1060890; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; Dobbins M, 2013, COCHRANE DB SYST REV, V2, P136; Ford P, 2012, EUR J SPORT SCI, V12, P515, DOI 10.1080/17461391.2011.57724; Galle F, 2015, SPORT SCI HLTH, V11, P109, DOI [DOI 10.1007/S11332-014-0216-7, 10.1007/s11332-014-0216-7; Galle F, 2017, GERIATR GERONTOL INT, V17, P1421, DOI 10.1111/ggi.1287; Gidlow C, 2008, J SPORT SCI, V26, P1411, DOI 10.1080/0264041080227744; Hardman K, 2001, INT SPORT STUD, V23, P6; Hardman K., 2008, HUMAN MOVEMENT, V9, P5, DOI DOI 10.2478/V10038-008-0001-; Hobin EP, 2010, J SCHOOL HEALTH, V80, P445, DOI 10.1111/j.1746-1561.2010.00526.; Hohepa M, 2006, J ADOLESCENT HEALTH, V39, P328, DOI 10.1016/j.jadohealth.2005.12.02; Jago R, 2004, PREV MED, V39, P157, DOI 10.1016/j.ypmed.2004.01.01; Morgan CF, 2007, RES Q EXERCISE SPORT, V78, P407, DOI 10.5641/193250307X1308250515850; Morin P, 2013, J SCHOOL HEALTH, V83, P597, DOI 10.1111/josh.1207; Morton KL, 2016, OBES REV, V17, P142, DOI 10.1111/obr.1235; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Sport Science, V9, P2; Pommier J, 2011, GLOB HEALTH PROMOT, V18, P34, DOI 10.1177/175797591039358; Sacchetti R, 2013, J SCHOOL HEALTH, V83, P639, DOI 10.1111/josh.1207; School Sport Canada, 2013, SS; Tang KC, 2009, HEALTH PROMOT INT, V24, P68, DOI 10.1093/heapro/dan03; Trost SG, 2008, MED SCI SPORT EXER, V40, P622, DOI 10.1249/MSS.0b013e318161eaa; Tudor-Locke C, 2009, RES Q EXERCISE SPORT, V80, P164, DOI 10.1080/02701367.2009.1059955; US Department of Health and Human Services, 1996, PHYS ACT HLTH REP S; US National Physical Activity Plan Alliance, 2010, PUBL HLTH NAT PHYS ; World Health Organization, 2010, GLOB STRAT DIET PHY; World Health Organization, 2011, GLOBAL RECOMMENDATI",31,1,1,2,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1483.0,1486,,10.19193/0393-6384_2018_3s_225,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400002,,,,,2022-07-14,0.003202479338842975,2.075104883925108e-05,0.011008126007046894,0.08278527995621275,0.011011563033446492
J,"Belfiore, P31;   Di Palma, D;   Ascione, A",,,,"Belfiore, Patrizia; Di Palma, Davide; Ascione, Antonio",,,"SPORT, PHYSICAL ACTIVITY AND BREAST CANCER",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Sport; Physical Activity; Breast cancer,RANDOMIZED CONTROLLED-TRIAL; SURVIVORS; PROTEINS; PROGRAM; INSULIN; PEOPLE,Introduction. Breast cancer is a big problem in Italy and in the world. Many women are affected. It absorbs many economic resources because it tends to develop complications. Sport and physical activity have positive effects on the pathology and its complications. Methods: Number of cases and costs were compared in the presence and absence of physical activity. Results: Our results support the idea that physical activity protects against breast cancer. Conclusion: This study demonstrates the importance of physical activity and sport in the management of breast cancer and its complications.,"[Belfiore, Patrizia; Di Palma, Davide; Ascione, Antonio] Parthenope Univ, Dept Sport Sci & Wellness, Naples, Italy","Di Palma, D (corresponding author), Parthenope Univ, Naples, Italy.",davide.dipalma@uniparthenope.it,,"Di Palma, Davide/0000-0001-8224-5797",,,"Ancelle-Park R, 2012, J MED SCREEN, V19, P5, DOI 10.1258/jms.2012.01207; Arrospide A, 2015, REV ESP SALUD PUBLIC, V89, P93, DOI 10.4321/S1135-5727201500010001; Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Baeten SA, 2011, BREAST J, V17, P548, DOI 10.1111/j.1524-4741.2011.01135.; Belfiore P, 2016, IG SANITA PUBBL, V72, P3; Belfiore P, 2018, J SPORT MED PHYS FIT, V58, P1867, DOI 10.23736/S0022-4707.17.07749-; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp140187; Campbell Anna, 2005, Eur J Oncol Nurs, V9, P56, DOI 10.1016/j.ejon.2004.03.00; Canadian Partnership Against Cancer, 2013, REP EV IND WORK GRO; Carles M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-19; Crowley SA, 2003, EFFECT STRUCTURED EX, P12; Del Turco MR, 2010, EUR J CANCER, V46, P2344, DOI 10.1016/j.ejca.2010.06.11; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1479, DOI 10.19193/0393-6384_2018_3s_22; Fairey AS, 2003, CANCER EPIDEM BIOMAR, V12, P72; Friedenreich CM, 2008, BRIT J SPORT MED, V42, P636, DOI 10.1136/bjsm.2006.02913; Galle F, 2017, GERIATR GERONTOL INT, V17, P1421, DOI 10.1111/ggi.1287; Hoyle M, 2010, MED DECIS MAKING, V30, P426, DOI 10.1177/0272989X0935394; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj01; Liguori G, 2017, CLIN CHEM LAB MED, V55, P32, DOI 10.1515/cclm-2016-037; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Sport Science, V9, P2; Rue M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-32; Schmitz KH, 2005, CANCER EPIDEM BIOMAR, V14, P1672, DOI 10.1158/1055-9965.EPI-04-073",25,0,0,7,13,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1869.0,1872,,10.19193/0393-6384_2018_6_289,,4,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400040,,,,,2022-07-14,0.0025826446280991736,2.1853098176893646e-05,0.0038768114722670765,0.08273574987820409,0.003860363185414401
J,"Berber, I1;  Sahin, I;  Gorgel, A;  Cagin, YF;  Bag, HG;  Berber, NK",,,,"Berber, Ilhami; Sahin, Idris; Gorgel, Ahmet; Cagin, Yasir Furkan; Bag, Harika Gozukara; Berber, Nurcan Kirici",,,EFFECTS OF RENAL REPLACEMENT THERAPY ON FIBROMYALGIA SYNDROME IN PATIENTS WITH CHRONIC KIDNEY DISEASE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Chronic kidney disease; fibromyalgia; hemodialysis; continuous ambulatory peritoneal dialysis,PREVALENCE; POPULATION; TURKEY,"Introduction: Although musculoskeletal disorders are among the major complications of chronic kidney disease (CKD), there are scarce data to investigate fibromyalgia syndrome (FMS) in these patients. We aimed to investigate the prevalence of FMS in the patients with CKD. Material and methods: A total of 289 (119 predialysis (PD), 85 hemodialysis (HD), 85 continuous ambulatory peritoneal dialysis (CAPD)) patients were included. Diagnosis of FMS was based on American College of Rheumatology (ACR) 1990 FMS criteria. Results: Mean age was 52 +/- 16 years (range 18-89 years). One-hundred-sixty-four (56.7%) of them were male. A total of 46 patients (10 male/36 female) (15.9%) were diagnosed FMS. The prevalence of FMS was 28.8% in females and 6.1% in males. Compared to males, females had a significantly higher rate of FMS (p<0.001). The prevalence of FMS was 19.3% in PD group, 17.6% in the CAPD group, and 9.4% in the HD group. Although the frequency of FMS was lower in HD group compared to both the PD and the CAPD groups, the differences were not statistically significant (for HD vs PD, p=0.052; for HD vs CAPD, p=0.113). In PD group, hemoglobin (Hb) levels were significantly higher in patients with FMS than without FMS. Parathormone (PTH) levels were significantly lower in CAPD patients with FMS than without FMS. Although the prevalence of FMS was increased in PD and CAPD patients, this increase did not reach statistical significance. FMS was markedly more prevalent in female patients. While the Hb level was lower in the PD patients with FMS, PTH level was lower in the CAPD patients diagnosed with FMS. Conclusions: Our study demonstrated that the rate of FMS was higher in PD and CAPD patients compared to HD patients, although our results did not reach statistical significance. Among the entire demographic and laboratory parameters, female gender was found to be significant risk factor for development of FMS. Future multicenter studies which have large sample size are clearly needed to determine other factors related to development of FMS in patients with CKD.","[Berber, Ilhami] Malatya Educ Res Hosp, Dept Hematol, Malatya, Turkey; [Sahin, Idris] Inonu Univ, Fac Med, Dept Internal Med, Nephrol Div, Malatya, Turkey; [Gorgel, Ahmet] Gozde Acad Hosp, Dept Endocrinol, Malatya, Turkey; [Cagin, Yasir Furkan] Malatya Educ Res Hosp, Dept Gastroenterol, Malatya, Turkey; [Bag, Harika Gozukara] Inonu Univ, Fac Med, Dept Biostat, Malatya, Turkey; [Berber, Nurcan Kirici] Malatya Educ Res Hosp, Dept Chest Med, Malatya, Turkey","Berber, I (corresponding author), Malatya Educ Res Hosp, TR-44280 Malatya, Turkey.",drilhamiberber@hotmail.com,"Sahin, Idris/AAS-4390-2020; Bag, Harika Gozde Gozukara/ABG-7588-2020; BERBER, Ilhami/ABI-6231-2020; gÃ¶rgel, ahmet/Q-3139-2019; Cagin, Yasir Furkan/ABI-2709-2020","Sahin, Idris/0000-0002-8683-3737; Bag, Harika Gozde Gozukara/0000-0003-1208-4072; BERBER, Ilhami/0000-0003-3312-8476; Cagin, Yasir Furkan/0000-0002-2538-857X",,,"Avila-Diaz M, 2006, PERITON DIALYSIS INT, V26, P7; Bagis S, 2013, RHEUMATOL INT, V33, P167, DOI 10.1007/s00296-011-2334-; Bardin T, 2003, CURR OPIN RHEUMATOL, V15, P48, DOI 10.1097/00002281-200301000-0000; Couto CI, 2008, HEMODIAL INT, V12, P66, DOI 10.1111/j.1542-4758.2008.00243.; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.; Ferrari R, 1996, Curr Opin Rheumatol, V8, P7; Kart-Koseoglu H, 2005, RHEUMATOL INT, V25, P270, DOI 10.1007/s00296-003-0431-; McCarberg BH, 2012, AM J THER, V19, P357, DOI 10.1097/MJT.0b013e3181ff7be; Sahin I, 2009, RENAL FAILURE, V31, P920, DOI 10.3109/0886022090321926; Sakarya ST, 2011, CLIN RHEUMATOL, V30, P1039, DOI 10.1007/s10067-011-1697-; Suk JH, 2012, EXP CLIN ENDOCR DIAB, V120, P401, DOI 10.1055/s-0032-130900; Suleymanlar G, 2011, NEPHROL DIAL TRANSPL, V26, P1862, DOI 10.1093/ndt/gfq65; Topbas M, 2005, SCAND J RHEUMATOL, V34, P140, DOI 10.1080/0300974051002633; WOLFE F, 1995, J RHEUMATOL, V22, P15; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.178038010; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.178033020; Yanova D, 2007, HIPPOKRATIA, V11, P19; Yuceturk TE, NEPHROL DIAL TRANSPL, V2205, P248",18,2,2,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,337.0,343,,10.19193/0393-6384_2018_2_53,,7,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400007,,,,,2022-07-14,0.001859504132231405,7.086043585901157e-24,0.006187118913828097,0.06309271631090109,0.006187118913828097
J,"Bertozzi, G1;  Di Battista, B;  Cascio, O;  Albano, GD;  Montana, A;  Maglietta, F;  Cipolloni, L;  Monda, V;  Messina, A;  Salerno, M",,,,"Bertozzi, Giuseppe; Di Battista, Benedetta; Cascio, Orazio; Albano, Giuseppe Davide; Montana, Angelo; Maglietta, Francesca; Cipolloni, Luigi; Monda, Vincenzo; Messina, Antonietta; Salerno, Monica",,,A LETHAL DRIPPING FROM THE NECK: A CASE REPORT AND MINI REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,carotid blowout syndrome; head-and-neck cancers; post-actinic arteriopathy; autopsy,CAROTID BLOWOUT SYNDROME; IRRADIATION; HEAD; EXPRESSION; MANAGEMENT; MIGRAINE; INCREASE; ARTERY; STRESS; REGION,"Post-actinic arteriopathy is one of the most devastating complications associated with therapy for head-and-neck cancers. We report a case of 67-year-old man presented to local emergency ward with left side neck blood dripping who died in a few hours before any diagnoses and treatment could be realized. Autoptic dissection found a 0,4cm length interruption in left internal carotid artery wall, within a fibrotic scar, which comprise the carotid sinus and its bifurcation. An injection and pumping proof with the water to simulate blood flow was conducted and demonstrated water jar from the left wall carotid artery injury. A diagnosis of acute carotid blowout syndrome was posed as cause of death.","[Bertozzi, Giuseppe; Di Battista, Benedetta; Albano, Giuseppe Davide; Salerno, Monica] Univ Foggia, Sect Forens Pathol, Dept Clin & Expt Med, Foggia, Italy; [Cascio, Orazio; Montana, Angelo; Maglietta, Francesca] Univ Catania, Dept Adv Med Surg Sci & Technol GF Ingrassi, Catania, Italy; [Cipolloni, Luigi] Univ Roma La Sapienza, Dept Anat Histol Forens & Orthopaed Sci, Rome, Italy; [Monda, Vincenzo; Messina, Antonietta] Univ Campania Luigi Vanvitelli, Sect Human Physiol, Dept Expt Med, Naples, Italy","Salerno, M (corresponding author), Univ Foggia, Sect Forens Pathol, Dept Clin & Expt Med, Osped Colonnello Avanzo, Viale Aviatori 1, I-71100 Foggia, Italy.",monica.salerno@unifg.it,"Messina, Antonietta/AHH-2383-2022; MESSINA, ANTONIETTA/K-9366-2016; SALERNO, MONICA/AAC-1321-2019; Cipolloni, Luigi/AAS-2680-2020; Bertozzi, Giuseppe/AAS-9882-2020","Messina, Antonietta/0000-0001-8343-432X; SALERNO, MONICA/0000-0002-6410-3960; Bertozzi, Giuseppe/0000-0002-8179-1072; Maglietta, Francesca/0000-0001-7240-5902; Monda, Vincenzo/0000-0002-6083-5814",,,"Becker M, 1997, RADIOGRAPHICS, V17, P5, DOI 10.1148/radiographics.17.1.901779; Bramanti V, 2015, J NEUROSCI RES, V93, P521, DOI 10.1002/jnr.2350; Bramanti V, 2012, NEUROCHEM RES, V37, P2795, DOI 10.1007/s11064-012-0873-; Bramanti V, 2008, CLIN EXP HYPERTENS, V30, P798, DOI 10.1080/1064196080256357; Cacopardo B, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S5; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Cerretani D, 2011, PHARMACOL RES, V64, P517, DOI 10.1016/j.phrs.2011.08.00; Chaloupka JC, 1999, AM J NEURORADIOL, V20, P106; Chaloupka JC, 1996, AM J NEURORADIOL, V17, P84; Chang FC, 2008, J VASC SURG, V47, P936, DOI 10.1016/j.jvs.2007.12.03; Chen KC, 2015, HEAD NECK-J SCI SPEC, V37, P794, DOI 10.1002/hed.2367; CHUNG TS, 1994, J COMPUT ASSIST TOMO, V18, P533, DOI 10.1097/00004728-199407000-0000; Cianci P, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0857-; Conomv JP, 1975, CANCER, V35, P153; Dorresteijn LDA, 2005, EUR J CANCER, V41, P1026, DOI 10.1016/j.ejca.2005.01.02; Esposito M, 2011, MINERVA PEDIATR, V63, P9; ESPOSITO M, 2013, NEUR, V9, DOI DOI 10.2147/NDT.S4218; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Forlano I, 2011, ANN ITAL CHIR, V82, P40; Gianicolo ME, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-; Gleysteen J, 2016, OTOLARYNG CLIN N AM, V49, P829, DOI 10.1016/j.otc.2016.02.00; Loong HH, 2008, HEMATOL ONCOL CLIN N, V22, P1267, DOI 10.1016/j.hoc.2008.08.01; Luo CB, 2006, EUR ARCH OTO-RHINO-L, V263, P644, DOI 10.1007/s00405-006-0028-; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Muzaffar K, 2000, LARYNGOSCOPE, V110, P1811, DOI 10.1097/00005537-200011000-0000; Neri V, 2013, ANN ITAL CHIR, V84, P4; Neri V, 2009, ANN ITAL CHIR, V80, P36; Neri V, 2009, PANCREAS, V38, P717, DOI 10.1097/MPA.0b013e3181a8308; Okamura H, 2002, ORL J OTO-RHINO-LARY, V64, P226, DOI 10.1159/00005803; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Pomara C, 2012, CURR MED CHEM, V19, P5647, DOI 10.2174/09298671280398881; Pomara C, 2008, CLIN TOXICOL, V46, P322, DOI 10.1080/1556365070141901; Pomara C, 2016, J CELL PHYSIOL, V231, P1385, DOI 10.1002/jcp.2527; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2013, FORENSIC SCI INT, V231, P142, DOI 10.1016/j.forsciint.2013.04.00; Turillazzi E, 2008, VIRCHOWS ARCH, V453, P209, DOI 10.1007/s00428-008-0632-; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-; Woodward WA, 2008, CANCER-AM CANCER SOC, V112, P268, DOI 10.1002/cncr.2317; Zidar N, 1997, J LARYNGOL OTOL, V111, P988, DOI 10.1017/S002221510013916",57,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,1.0,,,,,203.0,207,,10.19193/0393-6384_2018_1_33,,5,"Medicine, General & Internal",General & Internal Medicine,FV9AH,WOS:000424878600033,,,,,2022-07-14,0.005578512396694215,0.041424282279519206,0.00492166816800441,0.11069815312482131,0.004887172720863938
J,"Bivona, G1;  Agnello, L;  Butera, D;  Ciaccio, M",,,,"Bivona, Giulia; Agnello, Luisa; Butera, Daniela; Ciaccio, Marcello",,,CLINICAL UTILITY OF HFABP IN ACUTE MYOCARDIAL INFARCTION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,AMI; HFABP; chest pain; diagnosis; rule-out,ACID-BINDING PROTEIN; ACUTE CORONARY SYNDROME; CARDIAC TROPONIN-T; LONG-TERM MORTALITY; EARLY-DIAGNOSIS; EMERGENCY-DEPARTMENT; PROGNOSTIC VALUE; CIRCULATING LEVELS; H-FABP; EXCLUSION,"Assessing chest pain patients presenting to the emergency area (EA) is still a clinical challenge, as acute myocardial infarction (AMI) diagnosis is not adjudicated in the majority of patients. New ,generation high sensitivity troponin assays (hs-cTn) still present some limitations, thus, novel biomarkers to early rule-in and rule- out myocardial infarction in chest pain patients presenting to the EA are sought after. Among all, heart- type fatty acid binding protein (h-FABP) has been largely investigated. Studies performed on HFABP in these patients present marked heterogeneity. However, it can be stated that HFABP is clearly not a reliable marker for AMI diagnosis, neither as a stand-alone test nor in combination with hs-cTn. More interventional trials are needed and more homogeneous studies are required to understand whether HFABP can add incremental value in rule- out AMI and risk stratify chest pain patients, however, available data may not encourage going on investigating.","[Bivona, Giulia; Agnello, Luisa; Butera, Daniela; Ciaccio, Marcello] Univ Palermo, Dept Biopathol & Med Biotechnol, Sect Clin Biochem & Clin Mol Med, Palermo, Italy; [Ciaccio, Marcello] Univ Hosp Paolo Giaccone Palermo, Dept & UOC Lab Med, Palermo, Italy","Ciaccio, M (corresponding author), Univ Palermo, Dept Med Biotechnol & Biopathol, Via Vespro,129, I-90127 Palermo, Italy.",marcello.ciaccio@unipa.it,,,,,"Abbasi Walid Ahmad, 2017, J Ayub Med Coll Abbottabad, V29, P10; Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.11240; Agnello L, 2017, SCAND J CLIN LAB INV, V77, P428, DOI 10.1080/00365513.2017.133588; Agnello L, 2017, CLIN BIOCHEM, V50, P797, DOI 10.1016/j.clinbiochem.2017.04.01; Alhadi HA, 2004, QJM-INT J MED, V97, P187, DOI 10.1093/qjmed/hch03; Bivona G, 2018, CLIN BIOCHEM, V58, P1, DOI 10.1016/j.clinbiochem.2018.04.02; Bivona G, 2016, ARCH MED RES, V47, P521, DOI 10.1016/j.arcmed.2016.12.00; Body R, 2017, EMERG MED J, V34, P349, DOI 10.1136/emermed-2016-20598; Body R, 2014, HEART, V100, P1462, DOI 10.1136/heartjnl-2014-30556; Body R, 2011, RESUSCITATION, V82, P1041, DOI 10.1016/j.resuscitation.2011.03.01; Cappellini Fabrizio, 2013, Acute Card Care, V15, P83, DOI 10.3109/17482941.2013.84194; Collinson PO, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta1715; Collinson P, 2014, HEART, V100, P140, DOI 10.1136/heartjnl-2013-30471; Cubranic Z, 2012, BIOCHEM MEDICA, V22, P22; Cullen LA, 2017, CLIN CHEM, V63, P129, DOI 10.1373/clinchem.2016.25473; Daly MJ, 2011, J ELECTROCARDIOL, V44, P432, DOI 10.1016/j.jelectrocard.2011.03.00; Dupuy AM, 2015, AM J EMERG MED, V33, P326, DOI 10.1016/j.ajem.2014.11.01; Freund Y, 2012, AM J EMERG MED, V30, P1378, DOI 10.1016/j.ajem.2011.10.00; Gami Bhakti N, 2015, J Clin Diagn Res, V9, pBC22, DOI 10.7860/JCDR/2015/11006.545; Garcia-Valdecasas S, 2011, ACTA CARDIOL, V66, P315, DOI 10.1080/AC.66.3.211413; Gerede DM, 2015, CARDIOVASC J AFR, V26, P204, DOI 10.5830/CVJA-2015-02; Haltern G, 2010, AM J CARDIOL, V105, P1, DOI 10.1016/j.amjcard.2009.08.64; Ishii J, 1997, CLIN CHEM, V43, P137; Jones JD, 2017, CURR CARDIOL REV, V13, P189, DOI 10.2174/1573403X1366617011612145; Kilcullen N, 2007, J AM COLL CARDIOL, V50, P2061, DOI 10.1016/j.jacc.2007.08.02; Kitamura M, 2013, J CARDIOL, V62, P336, DOI 10.1016/j.jjcc.2013.06.00; Laugaudin G, 2016, EUR HEART J-ACUTE CA, V5, P354, DOI 10.1177/204887261558551; Leung YK, 2017, J EMERG MED, V53, P287, DOI 10.1016/j.jemermed.2017.05.00; Li CJ, 2010, ACTA PHARMACOL SIN, V31, P307, DOI 10.1038/aps.2010.; Liou K, 2015, ANN CLIN BIOCHEM, V52, P370, DOI 10.1177/000456321455327; Martin-Reyes R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015281; McCann CJ, 2009, AM J CARDIOL, V103, P22, DOI 10.1016/j.amjcard.2008.08.02; McMahon CG, 2012, AM J EMERG MED, V30, P267, DOI 10.1016/j.ajem.2010.11.02; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu29; Niizeki T, 2007, CIRC J, V71, P1452, DOI 10.1253/circj.71.145; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM20000420342160; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa090042; Reiter M, 2013, HEART, V99, P708, DOI 10.1136/heartjnl-2012-30332; Reiter M, 2011, EUR HEART J, V32, P1379, DOI 10.1093/eurheartj/ehr03; Richards AM, 2015, AM J CARDIOL, V115, p48B, DOI 10.1016/j.amjcard.2015.01.04; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv32; Schernthaner C, 2017, MEDICINE, V96, DOI 10.1097/MD.000000000000839; Schoenenberger AW, 2016, EUR HEART J-ACUTE CA, V5, P185, DOI 10.1177/204887261557125; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e105; Viswanathan K, 2010, J AM COLL CARDIOL, V55, P2590, DOI 10.1016/j.jacc.2009.12.06; Vupputuri Anjith, 2015, Indian Heart J, V67, P538, DOI 10.1016/j.ihj.2015.06.03; Wang HL, 2018, JCPSP-J COLL PHYSICI, V28, P56, DOI 10.29271/jcpsp.2018.01.5; Wang J, 2017, J GERIATR CARDIOL, V14, P135, DOI 10.11909/j.issn.1671-5411.2017.02.00; Willemsen RTA, 2015, EUR J GEN PRACT, V21, P156, DOI 10.3109/13814788.2015.101393; Xu LQ, 2018, HEART LUNG CIRC, V27, P503, DOI 10.1016/j.hlc.2017.03.16; Young JM, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0089-; Zinellu A, 2011, CLIN CHEM LAB MED, V49, P897, DOI 10.1515/CCLM.2011.12",52,0,0,1,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1621.0,1625,,10.19193/0393-6384_2018_6_250,,5,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400001,,,,,2022-07-14,0.005371900826446281,8.565134302445812e-20,0.010509973453647199,0.07328059351224497,0.010509973453647199
J,"Cevik, C1;  Tekir, O;  Kaya, A",,,,"Cevik, Celalettin; Tekir, Ozlem; Kaya, Aysenur",,,STROKE PATIENTS 'QUALITY OF LIFE AND COMPLIANCE WITH THE TREATMENT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Stroke; quality of life; adherence; rehabilitation,RANDOMIZED CONTROLLED-TRIAL; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; CHRONIC DISEASES; REGIONAL BURDEN; ADHERENCE; MEDICATION; DEPRESSION; MORTALITY; REHABILITATION,"Objective: The aim of this study was to determirte adherence with treatment, quality of life and related factors in, patients who were hospitalized and diagnosed with stroke at least six months before their hospitalization? Material and methods: The data of this cross-sectional study were collected through face-to face interviews held with 140 patients who were diagrtosed with stroke at least six months ago, hospitalized in Balikesir Atatiirk State Hospital Neurology Department between October 2015 and October-2016 and then discharged from the hospital. Results. In the study, the Stroke-Specific Quality of Life Scale (SSQOL) was used, and the participants were asked whether they complied with the treatment regularly. The participants' mean scores were 2.29 +/- 0.83 for the SSQOL scale. The mean scores for the SSQOL scale were higher in the married participants in those krtowledgeable of stroke, in those who received rehabilitation, in non-smokers, in those who had hemiplegia and in those who were able to carry out physical activities independently(p<0.05). Of the participants, 67.1% stated that they complied with their treatment. According to the logistic regression model, compliance with the treatment was 2.03 times higher in the participants with secondary and higher education (95.0% CI: 1.10-5.34), 5.27 times higher in the participants residing in a city (95.0% Cl: 1.25-12.22), 7.30 times higher in the participants having stroke diagnosis for 6-11 months (95.0% Cl 5.38-10.43). Conclusion: It was concluded that two-thirds of the participants complied with their daily treatments regularly and the mean scores they obtained from the SSQOL were lower than the average score to be 'obtained from the scale.","[Cevik, Celalettin; Tekir, Ozlem; Kaya, Aysenur] Balikesir Univ, Sch Hlth, Dept Nursing, Publ Hlth, Balikesir, Turkey","Cevik, C (corresponding author), Balikesir Univ, Sch Hlth, Dept Nursing, Balikesir, Turkey.",celalettincevik@balikesir.edu.tr,", celalettin/J-3513-2019",", celalettin/0000-0002-1123-6196",,,"Arif H, 2007, NEUROL INDIA, V55, P13; Barak S, 2014, PHYS THER, V94, P101, DOI 10.2522/ptj.2012047; Barker-Collo S, 2015, NEUROEPIDEMIOLOGY, V45, P203, DOI 10.1159/00044110; Bashir S., 2017, PAKISTAN J NEUROLOGI, V12, P3; Bushnell CD, 2011, NEUROLOGY, V77, P1182, DOI 10.1212/WNL.0b013e31822f042; Chen CM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0314-; Durmaz B., 2006, TURKISH J PHYS MED R, V52, P4; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-; Hacihasanoglu R, 2011, J CLIN NURS, V20, P692, DOI 10.1111/j.1365-2702.2010.03534.; Hankey GJ, 2013, LANCET GLOB HEALTH, V1, pE239, DOI 10.1016/S2214-109X(13)70095-; Hashim S, 2014, P INT C SCI TECHN S; Heikinheimo T, 2015, MALAWI MED J, V27, P50, DOI 10.4314/mmj.v27i2.; Huang YH, 2013, AM J OCCUP THER, V67, P54, DOI 10.5014/ajot.2013.00482; Jaracz K, 2003, ACTA NEUROL SCAND, V107, P324, DOI 10.1034/j.1600-0404.2003.02078.; Kamal AK, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0471-; Khan SH, 2011, STROKE, V42, pE404, DOI 10.1161/STROKEAHA.111.61335; Lin EHB, 2012, ANN FAM MED, V10, P6, DOI 10.1370/afm.134; Marini S, 2017, NEUROCRIT CARE, P; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.003044; Michaelsen SM, 2013, MOTRIZ, V19, P746, DOI 10.1590/S1980-6574201300040001; Muus I, 2010, SCAND J CARING SCI, V24, P211, DOI 10.1111/j.1471-6712.2009.00705.; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-; Noto T, 2002, JAIDS-J ACQ IMM DEF, V51, P812; O'Carroll RE, 2013, ANN BEHAV MED, V46, P358, DOI 10.1007/s12160-013-9515-; Owolabi MO, 2013, ACTA NEUROL SCAND, V128, P311, DOI 10.1111/ane.1212; Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.1503036; Senocak O, 2008, J NEUROL SCI-TURK, V25, P16; Sprigg N, 2012, J STROKE CEREBROVASC, V21, P587, DOI 10.1016/j.jstrokecerebrovasdis.2011.01.00; Thrift AG, 2014, INT J STROKE, V9, P6, DOI 10.1111/ijs.1224; van Mierlo ML, 2014, INT J STROKE, V9, P341, DOI 10.1111/ijs.1214; Visser MM, 2015, ARCH PHYS MED REHAB, V96, P1492, DOI 10.1016/j.apmr.2015.04.00; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-0053; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-; Yont GH, 2012, INT NURS REV, V59, P274, DOI 10.1111/j.1466-7657.2011.00962.",35,0,0,1,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,839.0,846,,10.1919/0393-6384_2018_3_127,,8,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000032,,,,,2022-07-14,0.003615702479338843,2.9643752693111455e-14,0.01562817260508607,0.08211949744224913,0.01562817260508607
J,"Chen, S1;  Xiao, R",,,,"Chen, Sheng; Xiao, Rui",,,SURFACE MORPHOLOGY OF ISTHMIC LUMBAR SPONDYLOLISTHESIS IN BADMINTON ATHLETES AND DEGENERATIVE SPONDYLOLISTHESIS PATIENTS WITH SPINE PELVIS SAGITTAL PLANE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Lumbar vertebra; Isthmic spondylolisthesis; Degenerative spondylolisthesis; Spine pelvis sagittal morphology; Exploration,ASSOCIATION,"To research on specific clinical features of isthmic lumbar spondylolisthesis in badminton athletes and explore the morphological study of degenerative spondylolisthesis patients with spine pelvic sagittal plane. In order to further study the characteristics of morphology, 1,100 patients with isthmic lumbar spondylolisthesis and degenerative spondylolisthesis, receiving clinic treatment by a hospital from January 2009 to February 2016, were randomly selected as the research object and all of them have complete image data. Patients were divided into spondylolysis group (550) and degeneration group (550). The relative spine and pelvic sagittal index of two groups of patients were collected, mainly covering the following aspects: inclination of pelvis, pelvic incidence angle and lumbar lordosis angle and so on. At the same time, the following parts of two groups were measured: angle of lumbar spondylolisthesis, spondylolisthesis rate, spondylolisthesis distance to analyze comparatively the above patients with these indicators. The results show that the angle of lumbar lordosis, thoracic posterior lobe and spondylolysis angle of the group of patients was significantly higher than that of degeneration group, meeting P < 0.05, which has statistical significance. The patients in the degeneration group were superior to spondylolysis group in vertical distance of sagittal axial. The comparison between two groups of patients does not exist statistical significance in following aspects: namely morphological parameters of the pelvis, pelvic tilt angle, sacral inclination angle and lumbar spondylolisthesis rate and so forth. Therefore, we can draw the conclusion that the isthmic lumbar spondylolisthesis of badminton players is similar to degenerative spondylolisthesis in pelvic morphology, but the former has larger thoracic kyphosis, lumbar lordosis and spondylolisthesis angle than the latter.","[Chen, Sheng] Chengdu Univ, Sch Phys Educ, Chengdu 610106, Peoples R China; [Xiao, Rui] Sichuan Univ, Coll Literature & Journalism, Chengdu 610064, Peoples R China","Chen, S (corresponding author), Chengdu Univ, Phys Educ 1Sch, Chengdu 610106, Sichuan, Peoples R China.",787345913@qq.com,,,,,"Aldahmash BA, 2016, SAUDI J BIOL SCI, V23, P311, DOI 10.1016/j.sjbs.2015.09.02; Ali MA, 2016, SAUDI J BIOL SCI, V23, P229, DOI 10.1016/j.sjbs.2015.02.01; Bich GA, 2017, SAUDI J BIOL SCI, V24, P851, DOI 10.1016/j.sjbs.2016.05.01; Gao W, 2017, SAUDI PHARM J, V25, P580, DOI 10.1016/j.jsps.2017.04.02; Ge SB, 2017, SAUDI J BIOL SCI, V24, P127, DOI 10.1016/j.sjbs.2016.09.00; [ä½å®ç He Shouyu], 2015, [ä¸­å½ç«å½¢å¤ç§æå¿, Orthopedic Journal of China], V23, P7; [ä½å®ç He Shouyu], 2014, [ä¸­å½èæ±èé«æå¿, Chinese Journal of Spine and Spinal Cord], V24, P10; Jin Wang, 2016, CHINESE J TISSUE ENG, V22, P332; Kos M, 2015, ACTA MEDICA MEDITERR, V31, P21; Liang LI, 2013, CHINESE J REPARATIVE, V11, P133; Song HM, 2015, ACTA MEDICA MEDITERR, V31, P30; Taheri M, 2017, ACTA MEDICA MEDITERR, V33, P597, DOI 10.19193/0393-6384_2017_4_08; Turhan Iyidir O, 2017, TURK J MED SCI, V47, P1751, DOI 10.3906/sag-1610-13; Uluocak N, 2016, ACTA MEDICA MEDITERR, V32, P1029, DOI 10.19193/0393-6384_2016_4_12; Wang Y, 2015, ACTA MEDICA MEDITERR, V31, P98; Yang AM, 2017, J ALLOY COMPD, V695, P915, DOI 10.1016/j.jallcom.2016.10.18; Yang YS, 2018, IEEE INSTRU MEAS MAG, V21, P34, DOI 10.1109/MIM.2018.827880; Yong Liu, 2013, CHINESE J SPINE SPIN, V23, P30",18,0,0,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1583.0,1587,,10.19193/0393-6384_2018_3s_246,,5,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400022,,,,,2022-07-14,0.001859504132231405,1.9009854663879362e-05,0.06142496633040807,0.09603460420449021,0.05538411281460909
J,"Chisari, G1;  Rampello, L;  Borzi, AM;  Chisari, LM;  Chisari, CG",,,,"Chisari, Giuseppe; Rampello, Luigi; Borzi, Antonio Maria; Chisari, Laura Maria; Chisari, Clara Grazia",,,THE EFFECTS OF BLOOD GLUCOSE REGULATION ON THE MICROBIOTA OCULAR IN TYPE II DIABETIC SUBJECTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,type 2 diabetics; the eye surface; ocular microbiota,SOFT-TISSUE INFECTIONS; AMNIOTIC MEMBRANE USE; RISK-FACTORS; SURFACE; SKIN,"The authors studied the effects of blood glucose regulation on the microbiota ocular in type II diabetic subjects. 30 type II diabetic subjects were considered for at least 2 years and subdivided into three groups A, B and C based on the A1c (HbA1c) glycemic hemoglobin assay. The group A includes 10 subjects with HbA1c < 7.5%, in the group called B there are 10 subjects with the same ocular but with HbA1c range between 7.5 and 9.5 and 10 were included in group C, 10 diabetic subjects with HbA1c > 9.5%. All patients in the three groups were considered the following parameters: Schirmer I test, Schirmer II Test, time to break the tear film (BUT, sec) and conjunctival buffer for aerobic and anaerobic bacteria research. The cultivation examinations showed a positivity for the tests in group A of 5, group B of 7 and group C of 7 bacteriological examinations. In the group A we found a total of 4 mono microbial and 1 poly microbial finds, mono microbial group B 4 and 7 poly microbial, and mono microbial and 3 poly microbial C 3 groups. Our data show that there is a close relationship between the concentration of glucose in the blood and its modification of the ocular microbiota.","[Chisari, Giuseppe; Chisari, Laura Maria] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Rampello, Luigi; Chisari, Clara Grazia] Univ Catania, Dept Dept Med Surg Sci & Adv Technol GF Ingrassia, Catania, Italy; [Borzi, Antonio Maria] Univ Catania, Res Ctr Great Senescence, Catania, Italy","Chisari, LM (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy.",,"BorzÃ¬, Antonio Maria/X-8685-2018","BorzÃ¬, Antonio Maria/0000-0001-6984-308X; chisari, clara grazia/0000-0003-1607-543X; CHISARI, Giuseppe/0000-0002-0492-2171",,,"Aiello FC, 2017, CURR DIABETES REV, V13, P50, DOI 10.2174/157339981266615112310435; Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.39; Chisari CG, 2015, ACTA MEDICA MEDITERR, V31, P121; Chisari CG, 2014, ACTA MEDICA MEDITERR, V30, P24; Chisari EM, 2017, ACTA MEDICA MEDITERR, V10, P38; Chisari EM, 2016, ACTA MEDICA MEDITERR, V32, P157; Chisari G, 2017, CLIN TER, V168, pE181, DOI [10.7417/CT.2017.2002, 10.7417/T.2017.2002; Chisari G, 2017, CURR CLIN PHARM, V12, P157; Chisari G, 2016, ACTA MEDICA MEDITERR, V32, P46; Chisari G, 2017, ACTA MEDICA MEDITERR, V33, P431, DOI 10.19193/0393-6384_2017_3_06; Chisari G, 2015, ACTA MEDICA MEDITERR, V31, P105; Chisari G, 2013, ACTA MEDICA MEDITERR, V29, P36; Chisari G, 2011, ACTA MEDICA MEDITERR, V27, P7; Jaaskelainen IH, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.01.00; Jenkins TC, 2014, INFECT CONT HOSP EP, V35, P1241, DOI 10.1086/67805; Lipsky BA, 2010, DIABETOLOGIA, V53, P914, DOI 10.1007/s00125-010-1672-; Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.; Malaguarnera G, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1115-; Malaguarnera G, 2013, ANTI-CANCER AGENT ME, V13, P1406, DOI 10.2174/1871520611313666034; Malaguarnera M, 2015, AM J TRANSL RES, V7, P251; Malaguarnera M, 2013, ACTA MEDICA MEDITERR, V29, P79; Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-; Pannuzzo G, 2016, J NEUROSCI RES, V94, P1318, DOI 10.1002/jnr.2376; Reggio E, 2017, J NEUROL, V264, P494, DOI 10.1007/s00415-016-8364-; Ridolfo AL, 2016, J INFECT PUBLIC HEAL, V6, P2; Russo A, 2016, NAT PROD COMMUN, V11, P27; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296; Stock SJ, 2007, AM J OBSTET GYNECOL, V196, P255, DOI 10.1016/j.ajog.2006.10.90; Zervos MJ, 2012, J CLIN MICROBIOL, V50, P238, DOI 10.1128/JCM.05817-1",29,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,1.0,,,,,215.0,220,,10.19193/0393-6384_2018_1_35,,6,"Medicine, General & Internal",General & Internal Medicine,FV9AH,WOS:000424878600035,,,,,2022-07-14,0.002995867768595041,0.00015803536235041137,0.006089779959194732,0.10554665096551198,0.006059451090157041
J,"Cicek, M1;  Deveci, O;  Cengiz, Z;  Bilden, A;  Bilik, OA",,,,"Cicek, Mutalip; Deveci, Ozcan; Cengiz, ZeynepTas; Bilden, Alican; Bilik, Ozge Alkan",,,DOES NEUTROPHIL / LYMPHOCYTE RATIO CONTRIBUTE TO DIAGNOSTICS IN PATIENTS WITH FASCIOLIASIS?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Fascioliasis; neutrophil/lymphocyte ratio; contribution to diagnosis,INFLAMMATORY MARKER; INFECTION; HEPATICA; CANCER; STAGE,"Introduction: Fasciolia sp. is a trematode causes infection by settling in the liver bile ducts of domestic animal and human liver. Fascioliasis is a parasite disease that might have changes in liver parenchyma and in bile ducts. Many inflammatory reactions occur during the settlement of larvae and mature parasites into the liver. The neutrophil/lymphocyte ratio (NLR) has become a prominent marker of underlying inflammation. The objective of the present study is to investigate the relationship between the hematological parameters in patients with fascioliasis. Materials and methods: The diagnosis of fascioliasis was based on patient history, clinical and laboratory findings, radiological imaging (ultrasound), stool examination and IgG antibody titer determination by ELISA. Clinical and laboratory data were collected for 56 patients with fascioliasis, and diagnosed with serological and radiological imaging. 56 healthy volunteers were selected for the control group. Stool and blood samples were collected from patients with fascioliasis for serologic, biochemical, hematologic tests and ova examination. Total leukocyte, neutrophil, eosinophil and lymphocyte counts were recorded and NLR was calculated. ELISA antibody cut off titer value of patients with fascioliasis was 10> positive. Results: We compared neutrophil/lymphocyte ratio, eosinophil/lymphocyte ratio, the relation of eosinophilia and IgG antibody titers between two groups (patient and control groups). There was no statistically significant difference between patients and healthy controls neither based on age and gender nor NLR. According to these findings, NLR can not be considered as a diagnostic marker in fascioliasis. Conclusion: As a result, it was determined that NLR is not a crucial indicator of inflammation in parasitic fascioliasis. Extensive studies are need to be done to clarify the correlation between NLR and progression of other parasitic diseases.","[Cicek, Mutalip] Ahi Evran Univ, Fac Med, Dept Med Microbiol, Kirsehir, Turkey; [Deveci, Ozcan] Elazig Med Pk Hosp, Dept Clin Microbiol & Infect Dis, Elazig, Turkey; [Cengiz, ZeynepTas] Yuzuncu Yil Univ, Fac Med, Dept Med Parasitol, Van, Turkey; [Bilden, Alican; Bilik, Ozge Alkan] Dicle Univ, Fac Med, Dept Med Microbiol, Diyarbakir, Turkey","Deveci, O (corresponding author), Elazig Med Pk Hosp, Dept Clin Microbiol & Infect Dis, Elazig, Turkey.",,,,,,"Abakay O, 2015, INFLAMMATION, V38, P691, DOI 10.1007/s10753-014-9978-; Abdel-Razik A, 2015, ACTA GASTRO-ENT BELG, V78, P38; Ahsen A, 2013, INFLAMMATION, V36, P1357, DOI 10.1007/s10753-013-9675-; Berasain P, 2000, EXP PARASITOL, V94, P99, DOI 10.1006/expr.1999.447; Duffy BK, 2006, AM J CARDIOL, V97, P993, DOI 10.1016/j.amjcard.2005.10.03; Dusak A, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.9237; Garcia LS, 2007, DIAGNOSTIC MED PARAS, P43; Graziosi L, 2015, AM J SURG, V209, P333, DOI 10.1016/j.amjsurg.2014.06.01; Karahocagil MK, 2011, ACTA TROP, V118, P177, DOI 10.1016/j.actatropica.2008.08.01; Maguire JH, 2005, PRINCIPLES PRACTICE, P327; Marcos L, 2006, T ROY SOC TROP MED H, V100, P158, DOI 10.1016/j.trstmh.2005.05.01; Markell EK, 1986, MED PARASITOLOGY, V6th, P16; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.01; Nakano K, 2014, ANTICANCER RES, V34, P381; Olt S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/21050; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.04; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju12; Turkmen K, 2013, HEMODIAL INT, V17, P391, DOI 10.1111/hdi.1204; van Wolfswinkel ME, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-10; Yang Meng, 2015, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V27, P471, DOI 10.3760/cma.j.issn.2095-4352.2015.06.01",20,0,0,1,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,955.0,958,,10.19193/0393-6384_2018_4_145,,4,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500008,,,,,2022-07-14,0.002066115702479339,1.466604446747771e-14,0.003720740249312414,0.09288490140574773,0.0037254102345461166
J,"Cusano, P1;  Iovino, S;  Tafuri, D",,,,"Cusano, Pampilio; Iovino, Salvatore; Tafuri, Domenico",,,NEW TECHNOLOGIES IN THE ASSESSMENT OF THE EXPLOSIVE STRENGTH IN FOOTBALL,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Muscle Strength; Counter-Movement Jump; Powersprint; Assessment,SOCCER PLAYERS; RELIABILITY; TESTS; POWER; AGILITY; FITNESS; SPORTS; SPEED,"Introduction: The assessment of the athlete's conditional abilities is a key performance index in sports games. In the football field, we proposed a correlation of gender differences in strength abilities of both female and male athletes. Materials and methods: The experimentation was carried out on two groups of, footballer athletes of the same age and of different genders. The Bosco's Test, more specifically the Counter Movement Jump, was employed as a reference model, through a recently introduced tool called Chronojump, and a new test model, called Powersprint, considering both them as performance indexes for two groups of athletes, in order to study the athlete's explosive-elastic muscle strength. Results: The male gender registered a higher muscle strength expression in both tests. Discussion: The assessment of the lower limbs strength is closely linked to the sports practice of football. The Powersprint tool can be employed for analyzing athletes' motor abilities.","[Cusano, Pampilio; Iovino, Salvatore; Tafuri, Domenico] Parthenope Univ, Via Medina 40, Naples, Italy","Tafuri, D (corresponding author), Parthenope Univ, Via Medina 40, Naples, Italy.",domenicotafuri@inwind.it,,,,,"Akubat I, 2012, J SPORT SCI, V30, P1473, DOI 10.1080/02640414.2012.71271; Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Bangsbo J., 1993, ACTA PHYSL SCANDIN S, V619, P; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF0042216; Castagna C, 2006, J STRENGTH COND RES, V20, P320, DOI 10.1519/00124278-200605000-0001; de Blas X, 2012, RICYDE-REV INT CIENC, V8, P334, DOI 10.5232/ricyde2012.0300; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P174, DOI 10.1519/JSC.0b013e31815ef70; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-0000; Hopkins WG., 2004, SPORTSCIENCE, V8, P1, DOI DOI 10.1097/00005768-199804000-0002; Kawamori N, 2014, J STRENGTH COND RES, V28, P2738, DOI 10.1519/JSC.0b013e3182915ed; Lockie RG, 2013, J SPORT SCI MED, V12, P8; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Pasquarelli BN, 2010, REV ANDALUZA MED DEP, V; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Sands WA, 2004, J STRENGTH COND RES, V18, P81; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/0264041050045710; Svensson M, 2005, J SPORT SCI, V23, P601, DOI 10.1080/0264041040002129; Tafuri D., 2017, SPORT SCI, V10, P7; TIROSH E, 1990, AM J DIS CHILD, V144, P1083, DOI 10.1001/archpedi.1990.0215034002701",26,0,0,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1525.0,1528,,10.19193/0393-6384_2018_3s_234,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400011,,,,,2022-07-14,0.0025826446280991736,4.1196070136447346e-05,0.003167620033684758,0.08273574987820409,0.0031711696704590266
J,"Di Palma, D1;  Ascione, A;  Belfiore, P",,,,"Di Palma, Davide; Ascione, Antonio; Belfiore, Patrizia",,,EXPERIMENTAL APPROACH OF WATER POLO TRAINING TO IMPROVE PSYCHO-PHYSICAL CONDITIONS OF DISABLED ATHLETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Sport Disability; Psycho-physical Wellbeing; Water polo Training; Experimental Approach; Didactic-Pedagogical Aspects,SYSTEM,"Introduction: Disability is an enormous sanitary and social criticality and this study examines the possibility, through sports activities, to pursue both an increase in athletic performance, that in the level of health and well-being by a group of disabled athletes. Materials and methods: 10 disabled athletes have been subjected to a series of experimental programs of water polo training for 8 months and have carried out two series of evaluations at the beginning and at the end of this period of sporting activity. Results: There have been improvements both as regards the skills from a sporting point of view, both as regards the level of psycho-physical wellbeing for all disabled people. Conclusions: The sports activity, if managed in performant way, is able to lead to a benefit athletic and to an improvement of the quality of life for the people with disability.","[Di Palma, Davide; Ascione, Antonio; Belfiore, Patrizia] Parthenope Univ, Dept Sport Sci & Wellness, Naples, Italy","Ascione, A (corresponding author), Parthenope Univ, Naples, Italy.",antonio.ascione@uniparthenope.it,,,,,"Alexander M, 2010, RES REV, V1; Apalone G, 2005, QUESTIONARIO STATO ; Bampouras TM, 2009, J STRENGTH COND RES, V23, P336, DOI 10.1519/JSC.0b013e3181876ad; Beyer R., 2009, J YOUTH SPORTS, V; Kung SP, 2014, SPORT MANAG REV, V17, P8, DOI 10.1016/j.smr.2013.08.00; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P641, DOI 10.19193/0393-6384_2017_4_09; Messina G, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/63928; Muscogiuri G, 2014, ENDOCR RES, V39, P137, DOI 10.3109/07435800.2014.95201; Orio F, 2013, MINERVA ENDOCRINOL, V38, P30; Orio F, 2013, E SPEN J, V8, P20; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Petralia MC, 2018, ACTA MEDICA MEDITERR, V34, P107, DOI 10.19193/0393-6384_2018_1_1; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Shapiro DR, 2014, J SPORT MANAGEMENT, V2; Tafuri D., 2017, SPORT SCI, V10, P7; Well B, 2008, WATER POLO TRAININ; 2011, WORLD REP DIS, P",24,12,12,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1253.0,1256,,10.19193/0393-6384_2018_5_192,,4,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700014,,,,,2022-07-14,0.0022727272727272726,0.0027355702945132954,0.01074435372937456,0.09866979256918608,0.010701426668916875
J,"Di Palma, D21;   Ascione, A;   Belfiore, P",,,,"Di Palma, Davide; Ascione, Antonio; Belfiore, Patrizia",,,EDUCATIONAL SPORT FOR THE HEALTH WELLBEING OF PEOPLE WITH AUTISM,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Autism; Educational Sport; Wellness; Inclusion; Health,,"Objective: For a person with autism, motor activity represents an important opportunity for the development of functional skills as it supports those areas that are most affected by the disorder; in this case, we speak of the communication, social interaction, emotional and educational area. Through sport we can redefine those that, by definition, are described as deficits or limitations of persons with autism, channeling them towards a path that is useful and constructive for their health and well-being state. Different types of sports lead .specifically to significant support and aid for the different aspects of this disorder, contributing at the same time to enhancing the residual skills of these subjects.","[Di Palma, Davide; Ascione, Antonio; Belfiore, Patrizia] Parthenope Univ, Via Medina 40, Naples, Italy","Ascione, A (corresponding author), Parthenope Univ, Via Medina 40, Naples, Italy.",antonio.ascione@uniparthenope.it,,"Di Palma, Davide/0000-0001-8224-5797",,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Bahrami F, 2016, J AUTISM DEV DISORD, V46, P978, DOI 10.1007/s10803-015-2643-; Bahrami F, 2012, RES DEV DISABIL, V33, P1183, DOI 10.1016/j.ridd.2012.01.01; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Caputo G, 2015, TERAPIA MULTISISTEM; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina G, NEUROLOGY RESERARCH, V2013, P1, DOI [10.1155/2013/639280, DOI 10.1155/2013/639280.; Muscogiuri G, 2014, ENDOCR RES, V39, P137, DOI 10.3109/07435800.2014.95201; Oriel KN, 2011, PEDIATR PHYS THER, V23, P187, DOI 10.1097/PEP.0b013e318218f14; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Petralia MC, 2018, ACTA MEDICA MEDITERR, V34, P107, DOI 10.19193/0393-6384_2018_1_1; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Schultheis S.F., 2000, FOCUS AUTISM OTHER D, V15, P159, DOI [10.1177/108835760001500306, DOI 10.1177/108835760001500306; Tafuri D., 2017, SPORT SCI, V10, P7",21,2,2,5,17,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1479.0,1482,,10.19193/0393-6384_2018_3s_224,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400001,,,,,2022-07-14,0.002066115702479339,0.0016459377697806638,0.012283591663541479,0.09809783434842972,0.012300398137463931
J,"Di Palma, D31;   Belfiore, P;   Ascione, A",,,,"Di Palma, Davide; Belfiore, Patrizia; Ascione, Antonio",,,PROMOTE EDUCATIONAL DEVELOPMENT OF STUDENTS WITH SLD IN THE SCHOOL AND UNIVERSITY: THE ROLE OF SPORT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Sport; Specific Learning Disorders (SLD); Didactic-Educational Contexts School; University,LEARNING-DISABILITIES; CHILDREN; PEOPLE,"This research work aims to identify and analyze a performing educational and social strategy able to deal with the critical aspects relating to Specific Learning Disorders (SLD) in the main scholastic contexts such as School and University. In this regard, a set of key determinants has been suggested to define and develop operational management solutions at different educational levels and identifies in the sporting activity a tool of universal support able to achieve multiple benefits for supporting students with SLD.","[Di Palma, Davide; Belfiore, Patrizia; Ascione, Antonio] Parthenope Univ, Dept Sport Sci & Wellness, Naples, Italy","Belfiore, P (corresponding author), Parthenope Univ, Naples, Italy.",patrizia.belfiore@uniparthenope.it,,"Di Palma, Davide/0000-0001-8224-5797",,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Bollani A, 2017, PSICOL CLIN SVILUPP, V21, P329, DOI 10.1449/8754; Capuano A., 2013, BES DSA SCUOLA QUAL; Cornoldi C., 2007, DIFFICOLTA DISTURB; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1479, DOI 10.19193/0393-6384_2018_3s_22; Ghidoni E., 2015, GIOVANI ADULTI CON ; KAVALE KA, 1991, LEARN DISABILITY Q, V14, P257, DOI 10.2307/151066; Morlini I., 2017, STUDIO INCIDENZA DIS, P; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Polloway E. A., 2015, TEACHING STUDENTS S; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Razuk M, 2014, RES DEV DISABIL, V35, P1988, DOI 10.1016/j.ridd.2014.03.04; Tafuri D., 2017, SPORT SCI, V10, P7; Tressoldi P. E., 1996, DIAGNOSI DISTURBI A; Turnbull A., 1995, EXCEPTIONAL LIVES S; Vuijk PJ, 2011, J LEARN DISABIL-US, V44, P276, DOI 10.1177/002221941037844; Westendorp M, 2011, RES DEV DISABIL, V32, P2773, DOI 10.1016/j.ridd.2011.05.03",24,0,0,1,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1873.0,1877,,10.19193/0393-6384_2018_6_290,,5,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400041,,,,,2022-07-14,0.0023760330578512395,4.892736774205964e-05,0.002480158688495315,0.08273292137808433,0.0024795141127200975
J,"Dispenza, F1;  Lorusso, F;  Gallina, S;  Martines, F",,,,"Dispenza, Francesco; Lorusso, Francesco; Gallina, Salvatore; Martines, Francesco",,,LARYNGEAL INVOLVEMENT IN RELAPSING POLYCHONDRITIS: CASE REPORT AND REVIEW OF LITERATURE,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,dyspnoea; tracheotomy; laryngo-tracheal malacia; relapsing polychondritis; autoimmune disease,COMPLICATIONS; MANIFESTATIONS,"Relapsing polychondritis is a rare multisystem autoimmune disease of unknown origin characterised by recurrent episodes of inflammation and progressive destruction of the cartilaginous structures and connective tissue of the whole body. The diagnosis of relapsing polychondritis is difficult. We present a review of the literature and describe a case of 49-year old woman. Her symptoms began in June 2004 with sore throat, dysphonia, pain in the thoracic wall and some joints, a slightly raised temperature and cough. The objective picture was immediately apparent after carrying out a high definition neck-thorax computed tomography and a laryngoscopy with fiber optics, which showed considerable laryngo-tracheal damage. As can be seen the diagnosis of RP today remains very difficult. The delay in diagnosis of our patient was considerable as described in literature and now estimated to be about 2.9 years. Perhaps an ENT examination would have hastened the diagnosis.","[Dispenza, Francesco] Ist Euro Mediterraneo Sci & Tecnol, Palermo, Italy; [Lorusso, Francesco] AUOP Paolo Giaccone, UO Otorinolaringoiatria, Palermo, Italy; [Gallina, Salvatore; Martines, Francesco] Univ Palermo, Bio Ne C Dept, Palermo, Italy","Lorusso, F (corresponding author), Via Isidoro La Lumia n 80, I-90139 Palermo, Italy.",,,"Dispenza, Francesco/0000-0002-5844-9762; MARTINES, Francesco/0000-0002-8616-4481",,,"Cabibi D, 2013, PATHOLOGICA, V105, P1; CASSELMAN JW, 1988, AM J ROENTGENOL, V150, P355, DOI 10.2214/ajr.150.2.35; Chang Shu-Jen, 2005, J Chin Med Assoc, V68, P27; DAHLQVIST A, 1983, ACTA OTO-LARYNGOL, V96, P355, DOI 10.3109/0001648830913290; DALY JF, 1966, ARCHIV OTOLARYNGOL, V84, P57; DAMIANI JM, 1979, LARYNGOSCOPE, V89, P92; Daniel L, 2001, NEPHRON, V87, P190, DOI 10.1159/00004591; De Stefano A, 2010, OTORINOLARINGOLOGIA, V60, P15; Ernst A, 2009, CHEST, V135, P1024, DOI 10.1378/chest.08-118; Frances C, 2001, MEDICINE, V80, P173, DOI 10.1097/00005792-200105000-0000; GAFFNEY RJ, 1992, J LARYNGOL OTOL, V106, P63, DOI 10.1017/S002221510011864; Gallina S, 2015, ACTA OTORHINOLARYNGO, V35, P1; GIBSON GJ, 1974, THORAX, V29, P726, DOI 10.1136/thx.29.6.72; Gungor F, 1997, CLIN NUCL MED, V22, P26; HANSLIK T, 1994, CLIN EXP RHEUMATOL, V12, P53; Jaksch-Wartenhorst R., 1923, POLYCHONDROPATHIA WI, V6, P9; Lee CC, 2006, AM J EMERG MED, V24, P750, DOI 10.1016/j.ajem.2006.02.01; LUTHRA HS, 2003, RHEUMATOLOGY, P174; Martines F, 2003, ACTA MEDICA MEDITERR, V19, P18; MCADAM LP, 1976, MEDICINE, V55, P193, DOI 10.1097/00005792-197605000-0000; MICHET CJ, 1986, ANN INTERN MED, V104, P74, DOI 10.7326/0003-4819-104-1-7; Narozny W, 2001, Acta Otorhinolaryngol Belg, V55, P22; OHANLAN M, 1976, ARTHRITIS RHEUM, V19, P191, DOI 10.1002/art.178019021; PORT JL, 1993, COMPUT MED IMAG GRAP, V17, P119, DOI 10.1016/0895-6111(93)90053-; Sato M, 2010, ANN NUCL ME; Spraggs PDR, 1997, LARYNGOSCOPE, V107, P936, DOI 10.1097/00005537-199707000-0002; TERATO K, 1990, ARTHRITIS RHEUM, V33, P1493, DOI 10.1002/art.178033100; Trentham DE, 1998, ANN INTERN MED, V129, P114, DOI 10.7326/0003-4819-129-2-199807150-0001; YANG CL, 1993, ARCH DERMATOL RES, V285, P245, DOI 10.1007/BF0037159",29,1,1,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,295.0,300,,10.19193/0393-6384_2018_2_47,,6,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400001,,,,,2022-07-14,0.002995867768595041,3.741360735918343e-14,0.005777055036933499,0.08513857005901651,0.005777055036933499
J,"Egin, S1;  Gokcek, B;  Yesiltas, M;  Hot, S;  Kamali, S;  Isil, RG;  Tok, H;  Karahan, SR",,,,"Egin, Seracettin; Gokcek, Berk; Yesiltas, Metin; Hot, Semih; Kamali, Sedat; Isil, Riza Gurhan; Tok, Hasan; Karahan, Servet Rustu",,,THE FACTORS AFFECTING SURVIVAL IN OPEN ABDOMEN DUE TO SURGICAL ABDOMINAL SEPSIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Abdominal sepsis; Open abdomen; Vacuum-assisted closure; Negative pressure therapy,COMPARTMENT SYNDROME; MANAGEMENT; GUIDELINES; SOCIETY; CLOSURE,"Introduction: In the literature, there are studies comparing open abdomen technique and primary closure technique in terms of survival and other results in patients with surgical abdominal sepsis. There are no studies investigating the factors affecting survival in patients treated with open abdominal technique alone. These factors should be investigated retrospectively in open abdomen patients. We aimed to investigate the factors of survival in patients with severe intraabdominal sepsis treated with vacuum-assisted closure systems for open abdomen. We hypothesized that use of open abdomen with vacuum-assisted closure systems was reduced mortality in patients with severe intraabdominal sepsis. Materials and methods: We retrospectively reviewed 40 open abdomen patients performed vacuum-assisted closure for severe intraabdominal sepsis. Alive and mortal groups were evaluated in terms of age, gender, body mass index, etiology of surgical abdominal sepsis, Apache II score, Mannheim peritonitis index score, Bjorck classification, fascia score, abdominal defect size, stoma and fistula presence, and vacuum-assisted closure treatment duration. It was evaluated whether any of these parameters was effective on survival. Results: Mean age and body mass index were significantly elevated in the mortal group compared with the alive group. A significant difference with regard to Bjorck classification was detected between the alive and mortal groups. In Bjorck 1 and 2, mortality rates were 36.8% and 31.3%, respectively, while in Bjorck 4, mortality was 100%. The presence and ope of fistula were statistically significant for mortality. None of the other parameters were statistically significant for mortality. Discussion: The studies of the last twelve years showed that the open abdomen technique with the temporary abdominal wall closure using negative pressure dressing methods gave positive results. The 42.5% mortality rate in our study is much lower than the mortality rate for abdominal sepsis patients in the literature. Our study indicated that the management of open abdomen and negative pressure therapy was possible to increase the survival in patients with surgical abdominal sepsis.","[Egin, Seracettin; Gokcek, Berk; Yesiltas, Metin; Hot, Semih; Kamali, Sedat; Isil, Riza Gurhan; Tok, Hasan; Karahan, Servet Rustu] Saglik Bilimleri Univ, Okmeydani Educ & Res Hosp, Darulaceze Cad 25, TR-34384 Istanbul, Turkey","Egin, S (corresponding author), Saglik Bilimleri Univ, Okmeydani Educ & Res Hosp, Darulaceze Cad 25, TR-34384 Istanbul, Turkey.",seracettin_egin@hotmail.com,"Hot, Semih/ADG-3811-2022; YeÅiltaÅ, Metin/Q-8190-2019; YeÅiltaÅ, Metin/R-3639-2018; eÄin, seracettin/AAR-8417-2020","Hot, Semih/0000-0001-9623-356X; YeÅiltaÅ, Metin/0000-0002-2080-1572; YeÅiltaÅ, Metin/0000-0002-2080-1572; eÄin, seracettin/0000-0002-4090-5205",,,"Adkins AL, 2004, AM SURGEON, V70, P13; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-0000; Balogh Z, 2003, J TRAUMA, V54, P848, DOI 10.1097/01.TA.0000070166.29649.F; Bjorck M, 2009, WORLD J SURG, V33, P1154, DOI 10.1007/s00268-009-9996-; CHRISTOU NV, 1993, ARCH SURG-CHICAGO, V128, P19; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8; Dellinger RP, 2008, INTENS CARE MED, V34, P783, DOI [10.1007/s00134-008-1040-9, 10.1007/s00134-007-0934-2; Demetriades D, 2012, INT WOUND J, V9, P17, DOI 10.1111/j.1742-481X.2012.01018.; Diaz JJ, 2010, J TRAUMA, V68, P1425, DOI 10.1097/TA.0b013e3181da0da; Hanisch Ernst, 2011, J Intensive Care Med, V26, P27, DOI 10.1177/088506661038405; Kaplan M, 2005, WOUNDS S1, V17, pS; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-; Kubiak BD, 2010, SHOCK, V34, P525, DOI 10.1097/SHK.0b013e3181e14cd; Moore LJ, 2011, J TRAUMA, V70, P672, DOI 10.1097/TA.0b013e31820e780; Plaudis Haralds, 2012, Ann Intensive Care, V2 Suppl 1, pS23, DOI 10.1186/2110-5820-2-S1-S2; Rausei Stefano, 2014, Surg Technol Int, V25, P6; Robledo Felipe A, 2007, Surg Infect (Larchmt), V8, P63, DOI 10.1089/sur.2006.8.01; Sartelli M, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0032-; Sartelli M, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-2; Terzi C, 2014, INT WOUND J, V11, P17, DOI 10.1111/iwj.1228; van Hensbroek PB, 2009, WORLD J SURG, V33, P199, DOI 10.1007/s00268-008-9867-; Vargo D, 2009, AM SURGEON, V75, pS; Verdam FJ, 2011, WORLD J SURG, V35, P2348, DOI 10.1007/s00268-011-1210-",23,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,2031.0,2036,,,,6,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400068,,,,,2022-07-14,0.0023760330578512395,1.4570141417182275e-14,0.02364722051534582,0.09396872239426092,0.025045717860933205
J,"Ergonul, E1;  Baskurt, F;  Yilmaz, ND;  Baskurt, Z;  Asci, H;  Koc, S;  Temel, UB",,,,"Ergonul, Esin; Baskurt, Ferdi; Yilmaz, Nilufer Demiral; Baskurt, Zeliha; Asci, Halil; Koc, Sukran; Temel, Ugur Burak",,,RELIABILITY AND VALIDITY OF THE READINESS FOR INTERPROFESSIONAL LEARNING SCALE (RIPLS) IN TURKISH SPEAKING HEALTH CARE STUDENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Interprofessional education; RIPLS; Turkish; Psychometrics; Evaluation,EDUCATION; VERSION,"Objectives: The purpose of the study was to provide psychometric evaluation of the Turkish version of the Readiness for Interprofessional Learning Scale (RIPLS). Material and methods: This cross-sectional study was carried out with 213 students at the Faculty of Medicine, Faculty of Dentistry and Faculty of Health Sciences. The construct validity of the Turkish version of the scale was analyzed with confirmatory factor analysis (CFA). To determine the reliability of the scale, the Cronbach's alpha coefficient was calculated. In addition, for the assessment of the discrimination of each item on the scale, the top and bottom 27 % from the groups that received the lowest and highest scores from the scale were compared. Results: Standardized coefficients determined with the CFA in the Turkish version of the scale ranged between 0.34 and 0.85 in the students (Except for Item 18). The explained variance values for the items other than item 18 ranged from 0.11 to 0.72. t-values of all the factor loadings were significant. According to the reliability studies of the RIPLS, the internal consistency of Cronbach's Alpha was 0.85 for the overall scale. The t-test results showed that all the items significantly discriminated between students of high and low performance (t: 99.57; p=0.01). Conclusion: As a result, it can be said that the validity and reliability study of the RIPLS administered to Turkish healthcare students indicated that the scale was capable of measuring the Turkish-speaking students' readiness for interprofessional education.","[Ergonul, Esin] Dokuz Eylul Univ, Fac Med, Dept Med Educ, Izmir, Turkey; [Ergonul, Esin] Dokuz Eylul Univ, Vocat Sch Hlth Serv, Izmir, Turkey; [Baskurt, Ferdi; Baskurt, Zeliha] Suleyman Demirel Univ, Fac Hlth Sci, Dept Phys Therapy & Rehabil, Isparta, Turkey; [Yilmaz, Nilufer Demiral] Ege Univ, Dept Med Educ, Fac Med, Izmir, Turkey; [Asci, Halil] Suleyman Demirel Univ, Dept Pharmacol, Fac Med, Isparta, Turkey; [Koc, Sukran] Suleyman Demirel Univ, Dept Midwifery, Fac Hlth Sci, Isparta, Turkey; [Temel, Ugur Burak] Suleyman Demirel Univ, Fac Dent, Isparta, Turkey","Baskurt, F (corresponding author), Suleyman Demirel Univ, Fac Hlth Sci, Dept Phys Therapy & Rehabil, Isparta, Turkey.",,"Ergonul, Esin/Q-2657-2019",,,,"Accreditation Council for Graduate Medical Education, ACGME COMM PROGR RE; Artino AR, 2014, MED TEACH, V36, P463, DOI 10.3109/0142159X.2014.88981; Baumgartner H., 1996, INT J RES MARK, V13, P139, DOI [https://doi.org/10.1016/0167-8116(95)00038-0, DOI 10.1016/0167-8116(95)00038-0; Byrne BM, 1999, J CROSS CULT PSYCHOL, V30, P555, DOI 10.1177/002202219903000500; CHIC Working Group, 2012, INV QUANT TOOLS MEA; Frye AW, 2012, MED TEACH, V34, pE288, DOI 10.3109/0142159X.2012.66863; Gjersing L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Guitard, 2010, JPHYSICAL THERAPY ED, V24, P19, DOI [10.1097/00001416-201010000-00005, DOI 10.1097/00001416-201010000-00005; Hall P, 2005, J INTERPROFESSION S1, V19, P188, DOI DOI 10.1080/1356182050008174; Hean S, 2012, MED TEACH, V34, pE78, DOI 10.3109/0142159X.2012.65074; Hooper D, 2008, STRUCTURAL EQUATIO; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/1070551990954011; Interprofessional Education Collaborative, 2016, COR COMP INT COLL P; Kenny Gerard, 2002, Nurs Stand, V17, P3; Kline R.B, 2011, PRINCIPLES PRACTIC; Lauffs M, 2008, MED EDUC, V42, P405, DOI 10.1111/j.1365-2923.2008.03017.; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.20; Mahler C, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-14; McFadyen A K, 2005, J Interprof Care, V19, P59; National Medical Education Accreditation Board, 2018, UND MED ED STAN; National Nurse Education Accreditation Board, 2013, UND NURS ED STAN; Norgaard B, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0591-; Parsell G, 1999, MED EDUC, V33, P95, DOI 10.1046/j.1365-2923.1999.00298.; Reeves S, 2016, MED TEACH, V38, P656, DOI 10.3109/0142159X.2016.117366; Simin D, 2010, SRP ARK CELOK LEK, V138, P480, DOI 10.2298/SARH1008480; Tyastuti D, 2014, J INTERPROF CARE, V28, P426, DOI 10.3109/13561820.2014.90777; Walsh Claire L, 2005, Nurse Educ Pract, V5, P230, DOI 10.1016/j.nepr.2004.12.00; World Health Organization (WHO), 2010, FRAM ACT INT ED COL",28,3,3,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,797.0,803,,10.19193/0393-6384_2018_3_122,,7,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000042,,,,,2022-07-14,0.002892561983471074,2.502401221847604e-18,0.00557101981882904,0.06210901158127747,0.00557101981882904
J,"Etemad, Z1;  Nikbakht, H;  Azarbayjani, MA;  Gholami, M",,,,"Etemad, Zaher; Nikbakht, Hojatollah; Azarbayjani, Mohammad Ali; Gholami, Mandana",,,EFFECT OF DIFFERENT REST INTERVAL LENGTHS OF RESISTANCE EXERCISE ON SOME ATHEROSCLEROSIS MARKERS AND INFLAMMATORY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Resistance training; Rest interval; CRP; Homocysteine,ADIPOSE-TISSUE,"The purpose of this study was to determine the effects of two resistance exercise (RE) protocols with different rest intervals between sets on homocysteine and CRP In Sedentary Men. For this purpose, 30 untrained males voluntarily participated in the research and were randomly assigned to one of two resistance exercise groups: a) a shorter inter-set rest interval of 90 second (RI-90; n=10); or b) a longer rest interval of 180 second (RI-180; n=10) and control group (10 people). Resistance exercise in both groups consisted of bench press; pull down curls with pulleys, biceps and triceps workout with a barbell, squat using (hack squat machine), lat pull down and sit-ups, which were performed with 50% of one repetition maximum in the first session and with 85% of one repetition maximum on the last session and in 8-12 repetitions in 3 sets. Before and after 8 weeks training period blood sampling were collected from the antecubital vein preexercise. Indndent and paired T Tests were used to analyze data in a meaningful level (p<0.05). Results showed thepeat there is statistically significant reduction in CRP, homocysteine levels after 8 weeks of resistance training with different rest intervals in the experimental group compared to the control group (p<0.05). In general, we can say that the difference between rest periods in resistance training can be an important factor in changes in serum levels of homocysteine and CRP are important. These exercises might probably decrease the risk of cardiovascular disease.","[Etemad, Zaher; Nikbakht, Hojatollah] Islamic Azad Univ, Sci & Res Branch, Exercise Physiol, Tehran, Iran; [Azarbayjani, Mohammad Ali] Islamic Azad Univ, Dept Exercise Physiol, Tehran Cent Branch, Tehran, Iran; [Gholami, Mandana] Islamic Azad Univ, Dept Exercise Physiol, Sci & Res Branch, Tehran, Iran","Nikbakht, H (corresponding author), Islamic Azad Univ, Sci & Res Branch, Exercise Physiol, Tehran, Iran.",hojnik1937@yahoo.com,"etemad, zaher/ABB-1926-2021","Azarbayjani, Mohammad Ali/0000-0002-3502-7487",,,"Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.128; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.200; Brzycki M., 1993, J PHYS EDUC RECREAT, V64, P88, DOI [DOI 10.1080/07303084.1993.10606684, 10.1080/07303084.1993.10606684; de Salles BF, 2009, SPORTS MED, V39, P765, DOI 10.2165/11315230-000000000-0000; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.02; Fleck S. J., 2014, DESIGNING RESISTANCE, p4; Hammouda Omar, 2012, Asian J Sports Med, V3, P239, DOI 10.5812/asjsm.3454; Hudson MB, 2008, MED SCI SPORT EXER, V40, P542, DOI [10.1249/MSS.0b013e31815daf89, 10.1249/mss.0b013e31815daf89; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN1978015; Joubert L. M., 2008, PROQUES; Mann DL, 2014, BRAUNWALDS HEART DI; Mayhew DL, 2005, J STRENGTH COND RES, V19, P1; Neuman JC, 2013, NUTR RES, V33, P487, DOI 10.1016/j.nutres.2013.04.00; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.008313; Paziraei M., INTERACTIVE EFFECT ; Siri W.E., 1961, TECHNIQUES MEASURING, P22; Stefani GP, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-1; Swift DL, 2012, MED SCI SPORT EXER, V44, P1028, DOI 10.1249/MSS.0b013e31824526c; Talebi-Garakani E, 2013, ENDOCRINE, V43, P564, DOI 10.1007/s12020-012-9786-",19,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,2.0,,555.0,559,,10.19193/0393-6384_2018_2s_88,,5,"Medicine, General & Internal",General & Internal Medicine,GB7SD,WOS:000429274400002,,,,,2022-07-14,0.001962809917355372,1.3632154083579759e-11,0.003715742268983118,0.08696511512995356,0.003715742268983118
J,"Fazeli, A1;  Aminkhandaghi, M;  Rezvani, MS;  Karami, M",,,,"Fazeli, Ahmadreza; Aminkhandaghi, Maghsoud; Rezvani, Mahmood Saeedy; Karami, Morteza",,,THE NATURE OF IDEOLOGY AND EXPLANATION OF ITS IMPLICATIONS FOR CURRICULUM,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,nature; ideology; curriculum; curriculum ideology,,"Ideology is as major influence on the social implications of the social sciences, particularly education system and curriculum in each country. The aim of this study was to determine the nature of ideology and its semantics implies that the curriculum is. Definitions of ideology is discussed, examined and analyzed their nature and in terms of genus and three general categories, picked up the scientific or epistemological, social withdrawal or sociological and cultural perceptions were divided. the basic principles of curriculum and originally known books such as efficiency, control and predict the exact purpose of the center is, the accurate prediction purposes, logically organize content and other elements of the curriculum is effective. Based on the social conception of ideology, an important source of design and curriculum development is community and community needs and curriculum are designed around social issues. The basic objective of the curriculum preparing students for life in society, labor market and interact constructively with others. Based on the cultural perception of the nature of ideology, culture and customs curriculum according to design and develop the culture of each region and environment, in other words, context-based and position-based curriculum is being completely that not all of the objectives, content and other elements of the curriculum was designed and developed. The curriculum and its elements can not be determined in advance but only a general framework curriculum is determined and this type of curriculum requires teachers with academic and professional qualifications high level that they can play a role in programming.","[Fazeli, Ahmadreza] Ferdowsi Univ Mashhad, Curriculum Studies, Mashhad, Iran; [Aminkhandaghi, Maghsoud; Rezvani, Mahmood Saeedy; Karami, Morteza] Ferdowsi Univ Mashhad, Fac Educ & Psychol, Curriculum Studies, Mashhad, Iran","Aminkhandaghi, M (corresponding author), Ferdowsi Univ Mashhad, Fac Educ & Psychol, Curriculum Studies, Mashhad, Iran.",aminkhandaghi@ferdowsi.um.ac.ir,"Rahimian, Yaser/ABC-9678-2021; Rezvani, Mahmood Saeedy/AAA-5189-2021","Rezvani, Mahmood Saeedy/0000-0001-9553-9380",,,"Akarsu B., 2012, EUROPEAN J PHYS ED, V3, P3; Alexander HA, 2005, J MORAL EDUC, V34, P1, DOI 10.1080/0305724050004921; Alipour M., 2002, ANAL CONCEPT IDEOLO; Duncan G., 1987, UNDERSTANDING IDEOLO, P65; Eisner E.W., 1994, ED IMAGINATIO; Ferreira S., 2008, 5 INT BAS BERNST S ; Larrain J., 1979, CONCEPT IDEOLOG; Littledyke M., 1996, CURRICULUM STUDIES, V4, P119, DOI DOI 10.1080/096597596004010; MCCARTHY ED, 1994, SOCIOL QUART, V35, P415, DOI 10.1111/j.1533-8525.1994.tb01736.; Mehrmohammadi M., 2009, CURRICULUM PERSPECT; Musgrave P. W., 1972, MELBOURNE STUDIES ED, P12; Musgrove F., 1987, CURRICULUM STUDIES, V2, P9; SARGENT LT, 2009, CONT POLITICAL IDEO; Ssentamu P. N., 2014, TUNING J HIGHER ED, V2, P12; Tohidfam M., 2002, ROTATION IDEOLOG; Van Dijk T.A., 1998, IDEOLOGY MULTIDISCI; Walton D., 2009, STUDIES LOGIC GRAMMA, V16, P24; Yerli A. H., 2008, THESI; [No title captured",19,0,0,6,9,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,2.0,,549.0,553,,10.19193/0393-6384_2018_2s_87,,5,"Medicine, General & Internal",General & Internal Medicine,GB7SD,WOS:000429274400001,,,,,2022-07-14,0.001962809917355372,1.2119858623047464e-11,0.003715742268983118,0.10339118825100134,0.003715742268983118
J,"Gallai, B1;  Tripi, G;  Lavano, F;  Salerno, M;  Lavano, SM;  Romano, P;  Cerroni, F;  Russo, D;  Cerron, F;  D'Oro, L;  Franco, S;  Picciocchi, E;  Geraci, D;  Chisari, MG;  Polito, AN;  Sorrentino, M;  Magliulo, RM;  Di Folco, A;  Parisi, L;  Testa, D;  Murabito, P;  Marotta, R",,,,"Gallai, Beatrice; Tripi, Gabriele; Lavano, Francesco; Salerno, Margherita; Lavano, Serena Marianna; Romano, Palmira; Cerroni, Francesco; Russo, Daniela; Cerronia, Francesco; D'Oro, Lucrezia; Franco, Sabrina; Picciocchi, Elisabetta; Geraci, Diego; Chisari, Mario Giuseppe; Polito, Anna Nunzia; Sorrentino, Michele; Magliulo, Rosaria Martina; Di Folco, Annabella; Parisi, Lucia; Testa, Davide; Murabito, Paolo; Marotta, Rosa",,,EATING AND FEEDING DISORDERS IN PEDIATRIC AGE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,anorexia nervosa; feeding troubles; eating disorders,SLEEP-APNEA SYNDROME; MONOSYMPTOMATIC NOCTURNAL ENURESIS; AUTISM SPECTRUM DISORDERS; WEIGHT-LOSS PROGRAM; QUALITY-OF-LIFE; CHILDHOOD MIGRAINE; KETOGENIC DIET; PARENTAL STRESS; OBESE CHILDREN; OREXIN SYSTEM,Eating and feeding disorders are common in pediatric. age and may be important to discover and recover the early symptoms in order to optimize the treatment and management.,"[Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Lavano, Francesco; Lavano, Serena Marianna; Marotta, Rosa] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Cerroni, Francesco; Cerronia, Francesco] Ctr Manzoni Srl, Naples, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Di Folco, Annabella; Parisi, Lucia; Testa, Davide] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [D'Oro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Franco, Sabrina; Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, I-95123 Catania, Italy; [Picciocchi, Elisabetta] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Chisari, Mario Giuseppe] INPS, Catania, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Sorrentino, Michele] NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy; [Sorrentino, Michele] Pineta Grande Hosp, Castel Volturno, CE, Italy; [Magliulo, Rosaria Martina] Ctr Studi Scoliosi SRL, Naples, Italy","Parisi, L (corresponding author), Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Cerroni, Francesco/0000-0003-3024-5482; Murabito, Paolo/0000-0002-2662-1898; Marotta, Rosa/0000-0003-0515-5952",,,"Albenzio M, 2018, J DAIRY SCI, V101, P4842, DOI 10.3168/jds.2017-1310; Albenzio M, 2016, J DAIRY SCI, V99, P5032, DOI 10.3168/jds.2015-1070; Albenzio M, 2017, NUTRIENTS IN DAIRY AND THEIR IMPLICATIONS FOR HEALTH AND DISEASE, P435, DOI 10.1016/B978-0-12-809762-5.00034-; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; BRYANTWAUGH R, 1995, J CHILD PSYCHOL PSYC, V36, P191, DOI 10.1111/j.1469-7610.1995.tb01820.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0018; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2017, EUR J PHYS REHAB MED, V53, P643, DOI 10.23736/S1973-9087.16.04037-; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Gallelli Luca, 2017, Microrna, V6, P152, DOI 10.2174/221153660666617091315282; Gigante E, 2018, ACTA MEDICA MEDITERR, V34, P1295, DOI 10.19193/0393-6384_2018_5_19; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P769, DOI 10.19193/0393-6384_2017_5_11; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P729, DOI 10.19193/0393-6384_2017_5_10; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P737, DOI 10.19193/0393-6384_2017_5_10; Matricardi S, 2018, ACTA NEUROL SCAND, V137, P575, DOI 10.1111/ane.1290; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Smirni D, 2018, J NERV MENT DIS, V206, P628, DOI 10.1097/NMD.000000000000085; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P1271, DOI 10.19193/0393-6384_2018_5_19; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2018, ACTA NEUROL SCAND, V138, P523, DOI 10.1111/ane.1300; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",91,0,0,2,9,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2125.0,2133,,10.19193/0393-6384_2018_4s_327,,9,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900007,,,,,2022-07-14,0.007851239669421488,0.11543390431801631,0.00640374797380921,0.11272985594335558,0.007139395406776785
J,"Gigante, E1;  Picciocchi, E;  Valenzano, A;  Cibelli, G;  Ruberto, V;  Cantone, D;  Moretto, E;  Di Sarno, AD;  Longobardi, T;  Iennaco, D;  Messina, M;  Nascivera, N;  Pisanelli, D;  Polito, AN;  Marsala, G;  Costa, V;  Mosca, L;  Dell'Orco, S",,,,"Gigante, Elena; Picciocchi, Elisabetta; Valenzano, Anna; Cibelli, Giuseppe; Ruberto, Valentina; Cantone, Daniela; Moretto, Enrico; Di Sarno, Alfonso Davide; Longobardi, Teresa; Iennaco, Daniela; Messina, Martina; Nascivera, Nicole; Pisanelli, Daniela; Polito, Anna Nunzia; Marsala, Gabriella; Costa, Vania; Mosca, Luciana; Dell'Orco, Sivia",,,THE EFFECTS OF THE ENDOCRINE DISRUPTORS AND OF THE HALOGENS ON THE FEMALE REPRODUCTIVE SYSTEM AND ON EPIGENETICS: A BRIEF REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,Bisphenol A; embryonic development; endocrine disruptors; epigenetic; female reproductive system; halogens; Metal; Polybrominated Diphenyl Ethers; Phthalates; Pesticide,BISPHENOL-A; POLYCHLORINATED-BIPHENYLS; HYPERTHERMIC REACTIONS; INHIBITOR DEVELOPMENT; CHILDHOOD MIGRAINE; CEREBRAL INJECTION; OXIDATIVE STRESS; ITALIAN PATIENTS; EXPOSURE; CHILDREN,"Introduction: An endocrine-disrupting chemical (EDC) is defined as an exogenous chemical or a mixture of chemicals that interfere with any aspect of the hormonal action. Endocrine systems are a physiological interface with the environment and genetic-environmental interactions are disrupted by EDCs. Today, there are almost 1000 chemicals reported to have endocrine effects: the prevalence of EDC in our environment and in our bodies represents a major global health challenge. This review gathers the studies that have investigated the correlations between exposure to EDC and pathologies of the female reproductive system and fetal development. Methods: A PubMed research was conducted using the keywords, their variants, and their combinations (BPA, DES, MXC, pesticides, phthalates, plasticizers, PCBs, dioxins, ovaries, oocytes, ovaries, fallopian tubes, follicles, vagina, uterus, fibroids, fertility, infertility, puberty, polycystic ovary syndrome, premature ovarian failure, birth, preterm birth, birth outcome, steroid, hormone, female, girl and menopause). Results: The endocrine system plays a central role in all vertebrates and regulates critical biological functions such as metabolism, development, reproduction, and behavior. Epidemiological studies link EDCs with reproductive effects, neuro-behavioral and neurodevelopment alterations, metabolic syndrome, bone disorders, immune disorders, and cancers in humans. Human investigations confirm the results of the studies carried out on animal showing associations with many additional effects on health, including asthma, learning and behavior problems, premature puberty, infertility, breast and prostate cancer, Parkinson's disease, obesity and other diseases. Conclusions: It is important to undertake research with follow-up methodologies and/or longitudinal studies to detect the extent of exposure of pregnant women to EDCs and halogenated substances and the effects of such exposure on brain development. A future research hypothesis may consider the effect that these substances have on neuro-development and, more specifically, how EDCs are involved in pathogenic disorders such as autism spectrum disorders (ASD). In addition, a scientific study could be performed on the correlations between this type of substance and the inconveniences found in the field of executive frontal functions.","[Gigante, Elena; Moretto, Enrico; Di Sarno, Alfonso Davide; Longobardi, Teresa; Iennaco, Daniela; Messina, Martina; Nascivera, Nicole; Costa, Vania; Mosca, Luciana; Dell'Orco, Sivia] SiPGI Postgrad Sch Integrated Gestalt Psychothera, DM 12-10-2007,Via V Veneto 240, I-80058 Naples, Italy; [Picciocchi, Elisabetta; Valenzano, Anna; Cibelli, Giuseppe; Ruberto, Valentina; Pisanelli, Daniela] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa dei Fiori Acerra, Naples, Italy; [Cantone, Daniela] Univ Campania Luigi Vanvitelli, Dept Psychol, Naples, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Marsala, Gabriella] Osped Riuniti Foggia, Azienda Osped Univ, Foggia, Italy","Gigante, E (corresponding author), SiPGI Postgrad Sch Integrated Gestalt Psychothera, DM 12-10-2007,Via V Veneto 240, I-80058 Naples, Italy.",gigantelena@gmail.com,"Moretto, Enrico/AFV-4935-2022; Cibelli, Giuseppe/AAC-2635-2019","MORETTO, ENRICO/0000-0002-1726-7866; CIBELLI, GIUSEPPE/0000-0002-5371-2584; MOSCA, LUCIA LUCIANA/0000-0001-9090-094X",,,"Albenzio M, 2013, J DAIRY SCI, V96, P2781, DOI 10.3168/jds.2012-621; Bafunno V, 2012, HAEMOPHILIA, V18, P1003, DOI 10.1111/j.1365-2516.2012.02882.; Bafunno V, 2010, HAEMOPHILIA, V16, P469, DOI 10.1111/j.1365-2516.2009.02150.; Bafunno V, 2014, THROMB RES, V134, P1135, DOI 10.1016/j.thromres.2014.08.02; Bafunno V, 2013, J ALLERGY CLIN IMMUN, V132, P748, DOI 10.1016/j.jaci.2013.04.00; Bertozzi G, 2018, MOL NEUROBIOL, V55, P5548, DOI 10.1007/s12035-017-0774-; Boucher O, 2012, ENVIRON HEALTH PERSP, V120, P608, DOI 10.1289/ehp.110382; Bramanti V, 2016, J NEUROSCI RES, V94, P90, DOI 10.1002/jnr.2367; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-133; Braun JM, 2014, ENVIRON HEALTH PERSP, V122, P513, DOI 10.1289/ehp.130726; Brieno-Enriquez MA, 2016, FERTIL STERIL, V106, P871, DOI 10.1016/j.fertnstert.2016.07.110; Bukvic N, 2010, AM J MED GENET A, V152A, P1730, DOI 10.1002/ajmg.a.3343; Canestraro M, 2010, CANCER GENET CYTOGEN, V199, P110, DOI 10.1016/j.cancergencyto.2010.02.01; Cantone D, 2012, REV LATINOAM PSICOPA, V15, P42, DOI 10.1590/S1415-4714201200010000; Cantone D, 2012, RIV PSICHIATR, V47, P246, DOI 10.1708/1128.1244; Caroprese M, 2012, SMALL RUMINANT RES, V102, P177, DOI 10.1016/j.smallrumres.2011.07.01; Caroprese M, 2010, J DAIRY SCI, V93, P2395, DOI 10.3168/jds.2009-260; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Caserta D, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-3; Cerretani D, 2011, PHARMACOL RES, V64, P517, DOI 10.1016/j.phrs.2011.08.00; Chieffi S, 2017, FRONT PHYSL, V; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Cordier S, 2015, ENVIRON RES, V138, P271, DOI 10.1016/j.envres.2015.02.02; Csaba G, 2015, ORVOSI HETILAP, V156, P1120, DOI 10.1556/650.2015.3018; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Eladak S, 2015, FERTIL STERIL, V103, P11, DOI 10.1016/j.fertnstert.2014.11.00; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2014, CHEMOSPHERE, V94, P62, DOI 10.1016/j.chemosphere.2013.09.01; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Galimberti S, 2007, J CHEMOTHERAPY, V19, P315, DOI 10.1179/joc.2007.19.3.31; Giesbrecht GF, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0259-; Goodyer CG, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP522, 10.1289/ehp522; Lin XG, 2017, BIOSENS BIOELECTRON, V91, P104, DOI 10.1016/j.bios.2016.12.02; Macejova Dana, 2016, Endocr Regul, V50, P154, DOI 10.1515/enr-2016-001; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maldonato NM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.0044; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina G, 2015, AFRICAN J PSYCHIAT S, V1; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.01; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda V, 2017, FRONT PHYSL, V; Monteagudo C, 2016, CHEMOSPHERE, V156, P135, DOI 10.1016/j.chemosphere.2016.04.10; Moscatelli F, 2015, BIOL MED, V; Moscatelli F, 2016, PLOS ONE, V1; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Perez-Albaladejo E, 2017, TOXICOL IN VITRO, V38, P41, DOI 10.1016/j.tiv.2016.11.00; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Petito A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015660; Piacentino D, 2015, CURR NEUROPHARMACOL, V13, P101, DOI 10.2174/1570159X1366614121022272; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Pomara C, 2012, CURR MED CHEM, V19, P5647, DOI 10.2174/09298671280398881; Pomara C, 2009, RADIOL MED, V114, P1367, DOI 10.1007/s11547-009-0435-; Pomara C, 2008, CLIN TOXICOL, V46, P322, DOI 10.1080/1556365070141901; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santacroce R, 2008, BLOOD COAGUL FIBRIN, V19, P197, DOI 10.1097/MBC.0b013e3282f234a; Santacroce R, 2009, GENET TEST MOL BIOMA, V13, P573, DOI 10.1089/gtmb.2009.001; Santillo A, 2009, INT DAIRY J, V19, P655, DOI 10.1016/j.idairyj.2009.06.01; Santillo A, 2009, J DAIRY SCI, V92, P1330, DOI 10.3168/jds.2008-159; Sen A, 2016, ENDOCRINOLOGY, V157, P3366, DOI 10.1210/en.2016-145; Sevi A, 2003, APPL ANIM BEHAV SCI, V83, P41, DOI 10.1016/S0168-1591(03)00088-; Sheikh IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015144; Shelton JF, 2014, ENVIRON HEALTH PERSP, V122, P1103, DOI 10.1289/ehp.130704; Simon V, 2017, ENDOCRINOLOGY, V158, P3200, DOI 10.1210/en.2017-0037; Sperandeo R, 2016, SMART INNOV SYST TEC, V54, P293, DOI 10.1007/978-3-319-33747-0_2; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Sperandeo R, 2016, INT CONF COGN INFO, P43, DOI 10.1109/CogInfoCom.2016.780452; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.; Tassinari R, 2015, J PEDIATR ENDOCR MET, V28, P1369, DOI 10.1515/jpem-2015-011; Trasande L, 2015, J CLIN ENDOCR METAB, V100, P1245, DOI 10.1210/jc.2014-432; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2008, INT J LEGAL MED, V122, P173, DOI 10.1007/s00414-007-0208-; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Turillazzi E, 2013, FORENSIC SCI INT, V231, P142, DOI 10.1016/j.forsciint.2013.04.00; Turillazzi E, 2008, VIRCHOWS ARCH, V453, P209, DOI 10.1007/s00428-008-0632-; Uzumcu M, 2012, REPROD DOMEST ANIM, V47, P338, DOI 10.1111/j.1439-0531.2012.02096.; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Won H, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.0001; Ziv-Gal A, 2016, FERTIL STERIL, V106, P827, DOI 10.1016/j.fertnstert.2016.06.02",101,5,5,1,36,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1295.0,1303,,10.19193/0393-6384_2018_5_199,,9,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700021,,,,,2022-07-14,0.00981404958677686,0.05533096150138116,0.007276932048466872,0.1113398741675389,0.007077404612730348
J,"Gokmen, S1;  Avdal, EU;  Uran, BNO",,,,"Gokmen, Sibel; Avdal, Elif Unsal; Uran, Berna Nilgun Ozgursoy",,,INVESTIGATION OF THE EFFECT OF DIABETIC NEUROPATHIC PAIN ON DEPRESSION AND QUALITY OF LIFE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,diabetetes; neuropathic pain; depression; life quality,LEEDS ASSESSMENT; SYMPTOMS; SCALE; TURKEY; RISK,"Introduction and aim: One of the most common and long-lasting complications in uncontrolled diabetes is diabetic neuropathy. The aim of this study was to investigate the effect of diabetic neuropathic pain on depression and quality of life. Material and methods: The study was designed as cross-sectional and descriptive study and was conducted between February and April of 2016 with 40 diabetic individuals diagnosed with diabetic neuropathy. Data were collected using the Diabetes Individual Identification Form, Leeds Assessment of Neuropathic Symptom and Signs Scale, Beck's Depression Inventory and the EORTC QLQ-C30 Quality of Life Questionnaire. Verbal and written consent was obtained and the data were analyzed with the SPSS program. Results: 25 women and 15 men participated in this study. It was determined that 50% of the individuals participating in the study had had diabetes for 6-10 years, 55% had received insulin treatment and 25% had only received oral anti-diabetic (OAD) treatment. The mean score for the LANSS pain scale of diabetic subjects was 9.83, the mean score for the BECK's Depression Inventory was 18.03 and the mean score for the EORTC Quality of Life Questionnaire was 612. The correlation coefficient between the LANSS pain scale and the EORTC Quality of Life Questionnaire was significant for individuals with diabetic neuropathic pain. There was a positive correlation between the two scales (r=0.671, p=0.000 <alpha=0.05.). There was a positive but weak relationship between the LANSS Pain Scale and the BECK Depression Inventory, while no significant relationship was found between the BECK Depression Inventory and the EORTC Quality of Life Questionnaire for individuals with neuropathic pain (r=0.097, p=0.551>alpha=0.05.) rs=0.312, p=0.050 =alpha=0.05). Conclusion: Diabetic neuropathic pain seriously affects the quality of life and increases susceptibility to psychological problems such as depression. When using a patient-specific treatment approach for diabetes, taking into account the data on depression and quality of life will increase the patient's participation in the treatment process and the success of the treatment.","[Gokmen, Sibel] Izmir Katip Celebi Univ, Ataturk Res Hosp, Izmir, Turkey; [Avdal, Elif Unsal; Uran, Berna Nilgun Ozgursoy] Izmir Katip Celebi Univ, Fac Hlth Sci, Izmir, Turkey","Avdal, EU (corresponding author), Izmir Katip Celebi Univ, Fac Hlth Sci, Izmir, Turkey.",,"AVDAL, ELÄ°F UNSAL/ABE-9593-2021",,,,"AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.36; American Diabetes Association (ADA), 2015, DIABETES CARE, V38, P; Bahar A., 2006, ANADOLU PSIKIYATR DE, V7, P1; Bai JW, 2017, J DIABETES COMPLICAT, V31, P1318, DOI 10.1016/j.jdiacomp.2017.05.00; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.0171012003100; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-; Beser N, 2003, CU NURS SCH J, V7, P4; Blackburn-Munro G, 2001, J NEUROENDOCRINOL, V13, P1009, DOI 10.1046/j.0007-1331.2001.00727.; Cragg JJ, 2015, NEUROEPIDEMIOLOGY, V44, P130, DOI 10.1159/00037772; Dziemidok P, 2016, PSYCHIATR POL, V50, P407, DOI 10.12740/PP/OnlineFirst/4235; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-0000; Grundy Scott M., 2002, Circulation, V105, P2231, DOI 10.1161/01.CIR.0000013952.86046.D; Gul HL, 2015, THESIS, P3; Gulseren L, 2001, TURKISH J PSYCHIAT, V12, P8; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.5; HIBBARD JH, 1983, SOC SCI MED, V17, P129, DOI 10.1016/0277-9536(83)90246-; Hisli N., 1989, GUVENIRLIGI, V7, P; International Diabetes Federation (IDF) , 2013, DIABETES ATLAS, V6t; Irem A., 2007, THESIS, P3; Kayahan M, 2007, DAHILI VE CERRAHI KL, P4; Marks JB, 2000, J DIABETES COMPLICAT, V14, P108, DOI 10.1016/S1056-8727(00)00065-; Noh JH, 2005, DIABETES RES CLIN PR, V69, P243, DOI 10.1016/j.diabres.2004.10.00; Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.155; Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-; Sonmez B, 2013, TURK AILE HEK DERG, P11; T. C. Saglik Bakanligi Turkiye Halk Sagligi Kurumu, 2014, TURK DIYAB PROGR 20; Turhan H., 2007, THESIS, P4; Turkiye Endokrin ve Metabolizma Dernegi (TEMD), 2014, DIAB MELL VE KOMPL ; Yucel A, 2004, J PAIN, V5, P427, DOI 10.1016/j.jpain.2004.07.00; Yuksel S., 2007, THESIS, P4",30,0,0,1,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,643.0,650,,10.19193/0393-6384_2018_3_99,,8,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000004,,,,,2022-07-14,0.0030991735537190084,1.0172517029278934e-08,0.03340302213448387,0.09799058561522499,0.03340302213448387
J,"Grieco, M1;  Salerno, M;  Tripi, G;  Lavano, F;  Romano, P;  Russo, D;  Lavano, SM;  Testa, D;  Cerroni, F;  Marotta, R;  Ro, LD;  Sorrentino, M;  Di Folco, A;  Magliulo, RM;  Gallai, B;  Marsala, G;  Montana, A;  Franco, S;  Geraci, D;  Chisari, MG;  Picciocchi, E;  Cibelli, G;  Valenzano, A;  Polito, AN;  Murabito, P;  Giugliano, P;  Parisi, L",,,,"Grieco, Maria; Salerno, Margherita; Tripi, Gabriele; Lavano, Francesco; Romano, Palmira; Russo, Daniela; Lavano, Serena Marianna; Testa, Davide; Cerroni, Francesco; Marotta, Rosa; Ro, Lucrezia D'Oro; Sorrentino, Michele; Di Folco, Annabella; Magliulo, Rosaria Martina; Gallai, Beatrice; Marsala, Gabriella; Montana, Angelo; Franco, Sabrina; Geraci, Diego; Chisari, Mario Giuseppe; Picciocchi, Elisabetta; Cibelli, Giuseppe; Valenzano, Anna; Polito, Anna Nunzia; Murabito, Paolo; Giugliano, Pasquale; Parisi, Lucia",,,A BRIEF REVIEW ABOUT ANXIETY AND AGGRESSIVE BEHAVIOR IN PEDIATRIC AGE,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,pediatric anxiety; aggressive behaviour; pediatric age,MONOSYMPTOMATIC NOCTURNAL ENURESIS; CHILDHOOD ABSENCE EPILEPSY; SLEEP-APNEA SYNDROME; QUALITY-OF-LIFE; HYPERTHERMIC REACTIONS; OXIDATIVE STRESS; HEME OXYGENASE-1; OBESE CHILDREN; OPEN-LABEL; MIGRAINE,"Anxiety can be considered a normal experience of the human being and as such also of the child. It manifests itself in different ways according to the level of development: in the smaller the child, the more anxiety is expressed with manifestations that involve the whole organism, becoming evident either with motor excitement or with physical discomfort. As the psychic apparatus is structured, anxiety is experienced as an inner phenomenon and is experienced as an unpleasant state. Fortunately, we are all a bit anxious, even if there are some people who are more, others less.","[Grieco, Maria] Presidio Riabilitaz Diocleziano, Naples, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorder, St Benoit La Foret, France; [Lavano, Francesco; Lavano, Serena Marianna; Marotta, Rosa] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Testa, Davide; Di Folco, Annabella; Parisi, Lucia] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy; [Ro, Lucrezia D'Oro] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Sorrentino, Michele] NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, Italy; [Sorrentino, Michele] Pineta Grande Hosp Castel Volturno CE, Castel Volturno, Italy; [Magliulo, Rosaria Martina] Ctr Scoliosi SRL, Naples, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marsala, Gabriella] Azienda Osped Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy; [Montana, Angelo; Franco, Sabrina; Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, Catania, Italy; [Cibelli, Giuseppe] INPS, Catania, Italy; [Picciocchi, Elisabetta; Cibelli, Giuseppe; Valenzano, Anna] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Murabito, Paolo] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy; [Giugliano, Pasquale] UOC Med Legale, Syracuse, Italy; [Giugliano, Pasquale] Azienda Osped St Anna & San Sebastiano Caserta, Caserta, Italy","Parisi, L (corresponding author), Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy.",,"Cibelli, Giuseppe/AAC-2635-2019; Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; CIBELLI, GIUSEPPE/0000-0002-5371-2584; Cerroni, Francesco/0000-0003-3024-5482; Murabito, Paolo/0000-0002-2662-1898",,,"Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSL, V; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2017, EUR J PHYS REHAB MED, V53, P643, DOI 10.23736/S1973-9087.16.04037-; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Gallelli Luca, 2017, Microrna, V6, P152, DOI 10.2174/221153660666617091315282; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Li Volti G, 2004, BIOCHEM BIOPH RES CO, V315, P517, DOI 10.1016/j.bbrc.2004.01.09; Matricardi S, 2018, ACTA NEUROL SCAND, V137, P575, DOI 10.1111/ane.1290; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Moscatelli F, 2016, PLOS ONE, V2; Moscatelli F, 2015, BIOL MED, V; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Rizzo M, 2015, J CLIN ENDOCR METAB, V100, P603, DOI 10.1210/jc.2014-229; Santillo A, 2009, INT DAIRY J, V19, P655, DOI 10.1016/j.idairyj.2009.06.01; Santillo A, 2009, J DAIRY SCI, V92, P1330, DOI 10.3168/jds.2008-159; Smirni D, 2018, J NERV MENT DIS, V206, P628, DOI 10.1097/NMD.000000000000085; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2018, ACTA NEUROL SCAND, V138, P523, DOI 10.1111/ane.1300; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",98,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2071.0,2079,,,,9,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900001,,,,,2022-07-14,0.00878099173553719,0.1226584995238157,0.0019340110444991117,0.11135780597512855,0.0027299159414364547
J,"Grieco, M21;   Salerno, M;   Tripi, G;   Lavano, F;   Romano, P;   Russo, D;   Lavano, SM;   Cerroni, F;   Marotta, R;   D'oro, L;   Franco, S;   Picciocchi, E;   Geraci, D;   Chisari, MG;   Marsala, G;   Polito, AN;   Sorrentino, M;   Magliulo, RM;   Di Folco, A;   Parisi, L;   Testa, D;   Murabito, P;   Giugliano, P;   Gallai, B",,,,"Grieco, Maria; Salerno, Margherita; Tripi, Gabriele; Lavano, Francesco; Romano, Palmira; Russo, Daniela; Lavano, Serena Marianna; Cerroni, Francesco; Marotta, Rosa; D'oro, Lucrezia; Franco, Sabrina; Picciocchi, Elisabetta; Geraci, Diego; Chisari, Mario Giuseppe; Marsala, Gabriella; Polito, Anna Nunzia; Sorrentino, Michele; Magliulo, Rosaria Martina; Di Folco, Annabella; Parisi, Lucia; Testa, Davide; Murabito, Paolo; Giugliano, Pasquale; Gallai, Beatrice",,,PSYCHOPATHOLOGICAL AND PSYCHODYNAMIC HYPOTHESES FOR PEDIATRIC STUTTERING,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,pediatric stuttering; psychodynamic hypotheses; anxiety disorders,AUTISM SPECTRUM DISORDERS; MONOSYMPTOMATIC NOCTURNAL ENURESIS; PRIMARY CILIARY DYSKINESIA; SLEEP-APNEA SYNDROME; WEIGHT-LOSS PROGRAM; QUALITY-OF-LIFE; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; SOCIAL ANXIETY; OREXIN SYSTEM,"Stuttering is a common language alteration in pediatric age consisting in repetitions and blocks, which entail a break in the rhythm and melody of the speech. According to the WHO it is a disorder of the rhythm?! of the word, the subject knows precisely what he would like to .ray, but at the same time he is not able to say it. It is a great inconvenience for those affected, also because the slowing down of speaking is not about thought or cognitive skills.","[Grieco, Maria] Univ Palermo, Presidio Riabilitaz Diocleziano, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Lavano, Francesco; Lavano, Serena Marianna; Marotta, Rosa] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Romano, Palmira; Cerroni, Francesco] Ctr Riabilitaz LARS, Sarno, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Di Folco, Annabella; Parisi, Lucia; Testa, Davide] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [D'oro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Franco, Sabrina; Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, I-95123 Catania, Italy; [Picciocchi, Elisabetta] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Chisari, Mario Giuseppe] INPS, Catania, Italy; [Marsala, Gabriella] Azienda Osped Univ, Struttura Complessa Farm, Osped Riuniti Foggia, Foggia, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Sorrentino, Michele] Pineta Grande Hosp Castel Volturno CE, NICU, Preterm & High Risk Newborn Neurodev Follow Serv, Castel Volturno, Italy; [Magliulo, Rosaria Martina] Ctr Scoliosi SRL, Naples, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy; [Giugliano, Pasquale] Azienda Osped St Anna & San Sebastiano Caserta, UOC Med Legale, Caserta, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy","Parisi, L (corresponding author), Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; Murabito, Paolo/0000-0002-2662-1898; Cerroni, Francesco/0000-0003-3024-5482",,,"Albenzio M, 2018, J DAIRY SCI, V101, P4842, DOI 10.3168/jds.2017-1310; Albenzio M, 2016, J DAIRY SCI, V99, P5032, DOI 10.3168/jds.2015-1070; Albenzio M, 2017, NUTRIENTS IN DAIRY AND THEIR IMPLICATIONS FOR HEALTH AND DISEASE, P435, DOI 10.1016/B978-0-12-809762-5.00034-; Alm PA, 2014, J FLUENCY DISORD, V40, P5, DOI 10.1016/j.jfludis.2014.01.00; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0018; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Craig A, 2014, J FLUENCY DISORD, V40, P35, DOI 10.1016/j.jfludis.2014.01.00; Craig-McQuaide A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.0088; Cruz C, 2018, REV NEUROLOGIA, V66, P59, DOI 10.33588/rn.6602.201715; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Garcia-Barrera MA, 2015, J FLUENCY DISORD, V44, P1, DOI 10.1016/j.jfludis.2015.03.00; Gigante E, 2018, ACTA MEDICA MEDITERR, V34, P1295, DOI 10.19193/0393-6384_2018_5_19; Iverach L, 2017, AM J SPEECH-LANG PAT, V26, P540, DOI 10.1044/2016_AJSLP-16-003; Iverach L, 2014, J FLUENCY DISORD, V40, P69, DOI 10.1016/j.jfludis.2013.08.00; Jones R, 2014, SEMIN SPEECH LANG, V35, DOI 10.1055/s-0034-137175; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Mawson AR, 2016, EUR NEUROL, V76, P244, DOI 10.1159/00045221; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Neef NE, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0579-; Neumann K, 2017, DTSCH ARZTEBL INT, V114, P383, DOI 10.3238/arztebl.2017.038; Nippold MA, 2018, LANG SPEECH HEAR SER, V49, P4, DOI 10.1044/2017_LSHSS-17-006; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perez HR, 2016, CAN FAM PHYSICIAN, V62, P47; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Sasisekaran J, 2014, SEMIN SPEECH LANG, V35, DOI 10.1055/s-0034-137175; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Smith KA, 2014, J FLUENCY DISORD, V40, P22, DOI 10.1016/j.jfludis.2014.01.00; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P1271, DOI 10.19193/0393-6384_2018_5_19; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Ward D, 2013, J FLUENCY DISORD, V38, P134, DOI 10.1016/j.jfludis.2013.02.00; Yairi E, 2013, J FLUENCY DISORD, V38, P66, DOI 10.1016/j.jfludis.2012.11.00",98,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2171.0,2178,,10.19193/0393-6384_2018_4s_332,,8,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900012,,,,,2022-07-14,0.008884297520661158,0.11562807593606715,0.004936231118868401,0.11136036813344838,0.00525752312472346
J,"Hu, J1",,,,"Hu, Jiang",,,TRACE ANALYSIS OF THERAPEUTIC EFFECT OF NON-SURGICAL REHABILITATION METHOD IN TREATING SIMPLE POSTERIOR CRUCIATE LIGAMENT RUPTURE OF BASKETBALL PLAYER,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Female gymnasts; Special sports injury; Psychological stress; Treatment effect,DRUGS,"Introduction: During basketball training period, simple Posterior Cruciate Ligament (PCL) rupture is not often occurred, however the therapeutic methods for such injury have long been a controversial topic. In this research, non-surgical rehabilitation treatment was applied for basketball player with PLC rupture, and followed investigations of therapeutic effects were performed. Method: In this work, 50 basketball players with simple PCL rupture, who had been treated in our hospital from Apr 2012 to Apr 2016, were selected as research objects, and all the selected basketball players were injured due to basketball reason. For all the selected players, a 5-stage non-surgical rehabilitation scheme with gradually increased load was applied. The ,first stage began from the 1st day to the 5th day since got injured; the second stage started from the 6th day to the 20th day since got injured; the third stage started from the 21st day to the 25th day since got injured; the fourth stage began from the 26th day to the 30th day since got injured; and the last stage started from one month later since gut injured, during which injured players were allowed to train with their team, in the hope of maintaing their physical strengths by gradually increasing exercise amount. From the 38th to the 78th day since ,got injured, KT2 test was performed to test the stress levels of quadriceps femoris of their both legs. Results: Through rehabilitation treatment, injured players can return to basketball training after averagely 38 days since get injured, morevoer the quadriceps,femoris strength of injured leg can recover to around 102% level of that of the non-injured leg. At the first test, the ratio between injured knee strength and non-injured knee strength was 0.52:1, can then increased to 0.96:1 at the 14th day since got injured. After returing to basketball training, knee joint injuries did not reappear, the therapeutic effect was ideal and the satisfaction degree on the treatment was high. Conclusion: Regarding simple PCL rupture of basketball player, non-surgical rehabilitation treatment can achieve ideal therapeutic effect, promote the function recovery of knee joint , significantly reduce and eliminate symptoms of knee joint, and accelerate the recovery as soon as possible.","[Hu, Jiang] Shihezi Univ, Sch Phys Educ, Shihezi 832000, Peoples R China","Hu, J (corresponding author), Shihezi Univ, Sch Phys Educ, Shihezi 832000, Peoples R China.",214099889@qq.com,,,,,"Ahmad Z, 2016, SAUDI J BIOL SCI, V23, P741, DOI 10.1016/j.sjbs.2016.07.00; Attari Z, 2016, SAUDI PHARM J, V24, P57, DOI 10.1016/j.jsps.2015.03.00; Duzer S, 2017, ACTA MEDICA MEDITERR, V33, P637, DOI 10.19193/0393-6384_2017_4_09; Gao Shijun, 2011, CHINESE J ORTHOPAEDI, V3; Gao Shijun, 2010, J HEBEI MED ; Gao W, 2017, SAUDI PHARM J, V25, P548, DOI 10.1016/j.jsps.2017.04.02; Hazra M, 2015, SAUDI PHARM J, V23, P429, DOI 10.1016/j.jsps.2015.01.00; Ibrahim S, 2016, SAUDI J BIOL SCI, V23, pS56, DOI 10.1016/j.sjbs.2015.10.02; Jiang Bole, 2006, CHINESE J CLIN REHAB, V10, P1; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P667, DOI 10.19193/03936384_2017_4_10; Moty SGA, 2016, SAUDI PHARM J, V24, P119, DOI 10.1016/j.jsps.2013.12.01; Ofori-Kwakye K, 2016, SAUDI PHARM J, V24, P82, DOI 10.1016/j.jsps.2015.03.00; Peng WX, 2017, SAUDI J BIOL SCI, V24, P103, DOI 10.1016/j.sjbs.2016.08.01; Teixeira MC, 2017, SAUDI PHARM J, V25, P231, DOI 10.1016/j.jsps.2016.06.00; Turhan Iyidir O, 2017, TURK J MED SCI, V47, P1751, DOI 10.3906/sag-1610-13; Wroblewska K, 2015, SAUDI PHARM J, V23, P407, DOI 10.1016/j.jsps.2014.11.00; Yang AM, 2017, J ALLOY COMPD, V695, P915, DOI 10.1016/j.jallcom.2016.10.18; çæç¨, 2012, [ä¸­å½èå¹´å­¦æå¿, Chinese Journal of Gerontology], V32, P43",18,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1561.0,1564,,,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400017,,,,,2022-07-14,0.001859504132231405,0.0009455466432205191,0.03144312571631762,0.10036600412661877,0.04003788161080833
J,"Huzmeli, C1;  Candan, F;  Bagci, G;  Bagci, B;  Akkaya, L;  Seker, A;  Kayatas, M",,,,"Huzmeli, Can; Candan, Ferhan; Bagci, Gokhan; Bagci, Binnur; Akkaya, Lale; Seker, Ayse; Kayatas, Mansur",,,VITAMIN D RECEPTOR TAQI POLYMORPHISM IS ASSOCIATED WITH HIGHER IMMUNE RESPONSE TO HEPATITIS B VACCINATION IN TURKISH DIALYSIS PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Hemodialysis; peritoneal dialysis; vitamin D receptor; chronic kidney disease; vitamin D; polymorphism,RENAL-FAILURE PATIENTS; HEMODIALYSIS-PATIENTS; INFECTIOUS-DISEASES; VIRUS INFECTION; CHRONIC KIDNEY; D DEFICIENCY; SCHEDULES; ALPHA; GENE,"Introduction: We aimed to investigate the possible role of vitamin D receptor (VDR) gene TaqI, ApaI and FokI polymorphisms in immune response to Hepatitis B virus (HBV) vaccination in dialysis patients. Methods: A total of 200 patients included in the study. Genotyping was done by using PCR-RFLP method. Results: TaqI TC genotype was 2.15 times higher in responders compared to non-responders (OR: 2.15 95% CI: 1.12-4.15, p: 0.021). TaqI CC genotype was found to be 2.80 times higher in responders compared to non-responders (OR: 2.80, 95% CI: 1.09-7.16, p: 0.031). When TC and CC genotype were evaluated together, they were found to be 2.31 times higher in responders (OR: 2.31, 95% CI: 1.26-4.24, p: 0.006). Carrying the C allele was found 1.92 times higher in responders compared to non-responders (OR: 1.92, 95% CI: 1.21-3.03, p: 0.005). No statistical significance was found between responders and non-responders in terms of FokI and ApaI genotype and allele frequencies (p > 0.05). Conclusion: Results of the present study demonstrate that carrying TC and CC genotype and C allele of VDR TaqI polymorphism have showed higher vaccination response while carrying TT genotype and T allele showed lower vaccination response in dialysis patients.","[Huzmeli, Can; Candan, Ferhan; Akkaya, Lale; Seker, Ayse; Kayatas, Mansur] Cumhuriyet Univ, Dept Nephrol, Fac Med, Sivas, Turkey; [Bagci, Gokhan] Cumhuriyet Univ, Dept Med Genet, Fac Med, Sivas, Turkey; [Bagci, Binnur] Cumhuriyet Univ, Dept Nutr & Dietet, Fac Hlth Sci, Sivas, Turkey","Huzmeli, C (corresponding author), Cumhuriyet Univ, Div Nephrol, Dept Internal Med, Fac Med, TR-58140 Sivas, Turkey.",,"Bagci, Gokhan/AAE-3124-2021; Ertan, Asli/AAE-6201-2021","Bagci, Gokhan/0000-0003-4554-2391; bagci, binnur/0000-0003-1323-3359",Scientific Research Project Fund of Cumhuriyet University [T-594],This work was supported by the Scientific Research Project Fund of Cumhuriyet University under the project number 'T-594',"Ahmadi F, 2012, HEPAT MON, V12, P344, DOI 10.5812/hepatmon.643; Al Saran K, 2014, SAUDI J KIDNEY DIS T, V25, P185, DOI 10.4103/1319-2442.12457; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/31461; Brown CM, 2011, RENAL FAILURE, V33, P276, DOI 10.3109/0886022X.2011.55930; Cordova E, 2017, ANN IG MED PREV COMU, V29, P27, DOI 10.7416/ai.2017.212; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433re; Fabrizi F, 2006, ALIMENT PHARM THER, V23, P1105, DOI 10.1111/j.1365-2036.2006.02877.; Fabrizi F, 2012, DIGEST DIS SCI, V57, P1366, DOI 10.1007/s10620-011-1987-; Fernandez E, 1996, NEPHROL DIAL TRANSPL, V11, P1559, DOI 10.1093/oxfordjournals.ndt.a02761; Grzegorzewska AE, 2014, EXPERT REV VACCINES, V13, P1395, DOI 10.1586/14760584.2014.96252; Hashemi B, 2011, HEPAT MON, V11, P816, DOI 10.5812/kowsar.1735143X.75; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra07055; Jhorawat R, 2016, INDIAN J GASTROENTER, V35, P67, DOI 10.1007/s12664-016-0621-; Kazemi Arababadi M, 2009, J BABOL U MED SCI, V11, P1; Lin SY, 2011, VACCINE, V29, P3738, DOI 10.1016/j.vaccine.2011.03.04; McNulty CAM, 2005, VACCINE, V23, P4142, DOI 10.1016/j.vaccine.2005.03.02; Hoan NX, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1836-; Roozbeh J, 2005, ASAIO J, V51, P242, DOI 10.1097/01.MAT.0000161935.66158.9; Sadarangani SP, 2015, EXPERT REV VACCINES, V14, P1427, DOI 10.1586/14760584.2015.108242; Suneetha PV, 2006, J HEPATOL, V44, P856, DOI 10.1016/j.jhep.2006.01.02; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-0; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.OR; Zitt E, 2012, VACCINE, V30, P931, DOI 10.1016/j.vaccine.2011.11.08",24,2,2,1,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,791.0,796,,10.19193/0393-6384_2018_3_121,,6,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000026,,,,,2022-07-14,0.0024793388429752063,1.1413166419400984e-20,0.0047466654826543615,0.07211019152407273,0.0047466654826543615
J,"Iorio, S1;  Badino, P;  Aliverti, M;  Gorini, I",,,,"Iorio, Silvia; Badino, Paola; aliverti, Massimo; Gorini, Ilaria",,,A CRITICAL NOTE BY ABELE DE BLASIO (1902) ON THE ARCHAEO ANTHROPOLOGICAL CONJECTURES OF LUIGI PALMIERI (1872),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Archaeo-anthropology; ancient tombs; craniometric measurements; 1872 / 1902,,"This paper offers a description and explanation of a criticism written by Abel De Blasio in 1902 on the archaeological and anthropological conjectures that Luigi Palmieri had made in the past. In a note presented in 1872 at the Academy of Sciences of Naples, regarding some ancient tombs discovered by chance near the Observatory on Mount Vesuvius, Palmieri presented interpretative observations that were unacceptable for specialists in anthropological studies and funerary archaeology.","[Iorio, Silvia] Sapienza Univ Rome, Unit Hist Med, Dept Mol Med, Rome, Italy; [Badino, Paola; Gorini, Ilaria] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [aliverti, Massimo] Univ Insubria, Varese, Italy","Gorini, I (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.",ilaria.gorini@uninsubria.it,,"iorio, silvia/0000-0001-9741-7838",,,"[Anonymous], 1902, RIV MENS PSICH FOR A, P39; Badino Paola, 2017, Acta Biomed, V88, P97, DOI 10.23750/abm.v88i1.537; Borgo M, 2017, ACTA MEDICA MEDITERR, V33, P95, DOI 10.19193/0393-6384_2017_1_01; Caldarini C, 2015, BONES ORTHOPAEDIC PA, P; Lazzati AMB, 2015, INT J OSTEOARCHAEOL; Licata M, 2015, SKELETAL RADIOL, P32; Licata M, 2017, J FORENSIC LEG MED, V51, P74, DOI 10.1016/j.jflm.2017.07.02; Licata M, 2016, ACTA MEDICA MEDITERR, V32, P1569, DOI 10.19193/0393-6384_2016_5_13; Licata M, 2014, ACTA MEDICA MEDITERR, V30, P55; Riva E, 2014, ROMA, V80, P61",10,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,390.0,391,,10.19193/0393-6384_2018_2_61,,2,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400015,,,,,2022-07-14,0.0010330578512396695,7.22211903114938e-05,0.004847100180248796,0.09632511717234037,0.004847100180248796
J,"Isiklar, A1;  Karsidag, K",,,,"Isiklar, A.; Karsidag, K.",,,ASSOCIATION BETWEEN THALASSEMIA TRAIT AND INSULIN RESISTANCE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Insulin resistance; thalassemia minor; thalassemia trait,ALPHA-THALASSEMIA; BETA-THALASSEMIA; IRON-DEFICIENCY; SERUM FERRITIN; DIFFERENTIATION; METABOLISM; CODAM,"Introduction: One of the subjects discussed in the patients with thalassemia major and thalassemia intermedia is whether excess iron deposition in the liver causes insulin resistance or not. As well, patient group with thalassemia trait (minor) is considered as iron deficiency anemia erroneously in daily practice and this group is subjected to excess iron treatment unnecessarily. In this study, if unnecessary iron load in the patients with thalassemia minor had any effect on insulin resistance was assessed. Materials and methods: A two-hour oral glucose tolerance test (OGTT) was performed in 30 thalassemia carrier patients and 30 gender-age-history matched healthy individuals. Glucose and insulin levels were measured at time zero, 30, 60, 90 and 120 minutes. Homeostasis model assessment of insulin resistance (HOMA-IR), whole-body insulin sensitivity index (WBISI), were calculated and the association between acute phase reactant C-reactive protein (CRP) and insulin resistance was investigated. Results: There was no significant difference between study group and control group with respect to age, gender and body mass index (BMI) parameters. Insulin resistance (IR) parameters were compared within two groups and no statistical significance was determined. Groups were classified in two subgroups according to BMI value: Subgroups with BMI > 25 kg/m(2) and subgroups with BMI < 25 kg/m(2). When considered with respect to same BMI values, there was no difference between patient and control groups regarding glucose metabolism parameters and CRP levels. Insulin resistance was more evident inherently regarding BMI difference. Conclusion: It was concluded that glucose metabolisms in patients with thalassemia trait did not show difference compared to BMI-matched healthy individuals. Detecting insulin resistance to be increased in both groups as BMI increased was suggestive of main factor causing disturbances in glucose metabolism in the patients thalassemia trait was obesity.","[Isiklar, A.] Univ Hlth Sci, Fatih Sultan Mehmet Training & Res Hosp, Istanbul, Turkey; [Karsidag, K.] Istanbul Univ, Istanbul Sch Med, Istanbul, Turkey","Isiklar, A (corresponding author), E5 Highway, TR-34752 Atasehir, Turkey.",aysunisiklar@gmail.com,"KarÅÄ±daÄ, Kubilay/AAD-7442-2020","Isiklar, Aysun/0000-0003-2690-3067",,,"[Anonymous], 2009, TURKIYE ENDOKRINOLO; Apostol T, 2007, EUROPEAN J HEMATOLOG, P160; BESSMAN JD, 1979, BLOOD, V53, P288, DOI 10.1182/blood.V53.2.288.28; Bolu SE, 2006, TURKIYE KLIN J INT M, V2, P; Bonora E, 1998, DIABETES CARE, V21, P221, DOI 10.2337/diacare.21.2.22; DORMER P, 1978, BRIT J HAEMATOL, V38, P; ENGLAND JM, 1973, LANCET, V1, P449, DOI 10.1016/S0140-6736(73)91878-; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.6; FINCH CA, 1970, MEDICINE, V49, P17, DOI 10.1097/00005792-197001000-0000; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.197; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.248; James M, 1999, METHODS MOL MED, P8; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.71; Karaaslan T., 1997, THESI; KATTAMIS C, 1972, J MED GENET, V9, P154, DOI 10.1136/jmg.9.2.15; Krentz AJ, 1996, BMJ-BRIT MED J, V313, P1385, DOI 10.1136/bmj.313.7069.138; Leila JN., 2011, AM J HE; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.146; Medici F, 1999, DIABETOLOGIA, V42, P146, DOI 10.1007/s00125005113; MELIS MA, 1983, BLOOD, V62, P22; MENTZER WC, 1973, LANCET, V1, P88; MERKEL PA, 1988, NEW ENGL J MED, V318, P809, DOI 10.1056/NEJM19880331318130; MOI P, 1988, BLOOD, V72, P53; Nathan DG., 1976, CIBA FDN ; Reaven G, 2003, TIP 2 DIYABET SORULA, P5; Tong PCY, 2002, DIABETES CARE, V25, P1480, DOI 10.2337/diacare.25.8.148; Van Campenhout A, 2006, DIABETES-METAB RES, V22, P444, DOI 10.1002/dmrr.63; WALFORD DM, 1977, BRIT J HAEMATOL, V35, P347, DOI 10.1111/j.1365-2141.1977.tb00593.; WICKRAMASINGHE S N, 1970, British Journal of Haematology, V19, P719, DOI 10.1111/j.1365-2141.1970.tb07017.; Wickramsinghe SN, 1973, BRIT J HAEMATOL, V25, P1; Wlazlo N, 2015, ACTA DIABETOL, V52, P337, DOI 10.1007/s00592-014-0646-; Wlazlo N, 2013, DIABETES CARE, V36, P309, DOI 10.2337/dc12-050",32,1,1,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,321.0,327,,10.19193/0393-6384_2018_2_51,,7,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400005,,,,,2022-07-14,0.003305785123966942,1.1649926873107479e-11,0.00639503261299277,0.10193229084399516,0.00639503261299277
J,"Isler, Y1;  Ozdinc, S;  Kaya, H",,,,"Isler, Yesim; Ozdinc, Serife; Kaya, Halil",,,CAN NGAL BE USED AS AN EARLY MARKER OF CONTRAST-INDUCED NEPHROPATHY IN EMERGENCY DEPARTMENT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,acute renal failure; computerized tomography; contrast-induced nephropathy; Neutrophil Gelatinase-Associated Lipocalin (NGAL),GELATINASE-ASSOCIATED LIPOCALIN; ACUTE KIDNEY INJURY; ANGIOPLASTY; RISK,"Aim: The objective of this study was to indicate the importance of the level of Neutrophil Gelatinase-Associated Lipocalin (NGAL) against Serum Creatinine (SCr) for the early diagnosis of acute renal failure (ARF) related to contrast agent. Methods: 60 voluntary patients admitted to the emergency department for various reasons who had underwent contrast-enhanced computerized tomography scans were included in the study. Blood samples for NGAL, creatinine were taken . from the peripheral veins of the patients; pre exposure (0 hours) and post exposure to contrast agent on the 4th and 24th hours were examined for contrast computed tomography. Results: NGAL value was measured 4 hours after the administration of the contrast agent in our study and was significantly increased (p<0.05), however the creatinine value did not show a statistically significant change (p>0.05). When NGAL values were considered in relation to age, a significant increase was observed in patients over sixty years of age (p<0.05). There was no statistically significant difference between the groups based on the creatinine values (p>0.05). Conclusion: It was determined in the present study that NGAL indicates more significant results in comparison with creatinine with regard to the early diagnosis of contrast-induced nephropathy which can develop in patients who underwent a contrast-enhanced tomography scan. It is believed that NGAL can be the reagent which replaces creatinine in future studies for the early diagnosis of contrast-induced nephropathy particularly for patients aged 60 and above. Further investigations are required for clarifying the role of NGAL values in the early diagnosis of Contrast-Induced Nephropathy after contrast-enhanced computed tomography in Emergency Department.","[Isler, Yesim; Kaya, Halil] Saglik Bilimleri Univ, Bursa Training & Res Hosp, Dept Emergency Med, Bursa, Turkey; [Ozdinc, Serife] Afyon Kocatepe Univ, Med Fac, Dept Emergency Med, Afyon, Turkey","Kaya, H (corresponding author), Saglik Bilimleri Univ, Yuksek Ihtisas Training & Res Hosp, Dept Emergency Med, Fac Med, Bursa, Turkey.",drhalilkaya@gmail.com,"Kaya, Halil/ABH-5489-2020","Kaya, Halil/0000-0003-2005-6100",,,"Alharazy SM, 2014, ANGIOLOGY, V65, P216, DOI 10.1177/000331971247494; Andreoli SP, 2009, PEDIATR NEPHROL, V24, P253, DOI 10.1007/s00467-008-1074-; Bachorzewska-Gajewska H, 2007, KIDNEY BLOOD PRESS R, V30, P408, DOI 10.1159/00010910; Bachorzewska-Gajewska H, 2007, NEPHROL DIAL TRANSPL, V22, P295, DOI 10.1093/ndt/gfl40; Borregaard N, 2006, BIOMETALS, V19, P211, DOI 10.1007/s10534-005-3251-; Cruz DN, 2010, INTENS CARE MED, V36, P444, DOI 10.1007/s00134-009-1711-; Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/0036551080215015; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.02; Hawkins R, 2011, KOREAN J LAB MED, V31, P72, DOI 10.3343/kjlm.2011.31.2.7; Iakovou Ioannis, 2003, J Invasive Cardiol, V15, P1; McCullough PA, 2008, NEPHRON PHYSIOL, V109, pP61, DOI 10.1159/00014293; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.32; Sadat U., 2013, ISRN RADIOL, V2013, DOI DOI 10.5402/2013/49643; Schillinger M, 2001, J ENDOVASC THER, V8, P609, DOI 10.1583/1545-1550(2001)008<0609:PRFABA>2.0.CO;; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.5; Solomon R, 2008, CLIN J AM SOC NEPHRO, V3, P1242, DOI 10.2215/CJN.0347070; Solomon R, 2007, NEPHROL DIAL TRANSPL, V22, P1812, DOI 10.1093/ndt/gfm20; Soni SS, 2010, INT UROL NEPHROL, V42, P141, DOI 10.1007/s11255-009-9608-; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.59509; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-0001; Yildiz Alaattin, 2003, Anadolu Kardiyol Derg, V3, P10",21,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1889.0,1894,,10.19193/0393-6384_2018_6_293,,6,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400044,,,,,2022-07-14,0.0022727272727272726,2.8451189377495506e-05,0.004334360236312917,0.11576039511605936,0.004334360236312917
J,"Karaca, F1;  Afsar, CU",,,,"Karaca, Feryal; Afsar, Cigdem Usul",,,THE EFFECT OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO AND PLATELET/LYMPHOCYTE RATIO ON PATHOLOGICAL RESPONSE AND SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,rectal cancer; locally advanced; survival; NLR; PLR,TO-LYMPHOCYTE RATIO; COLORECTAL-CANCER; ULCERATIVE-COLITIS; INFLAMMATION; NEUTROPHILS; TUMOR,"Introduction: Rectal carcinoma is one of the leading causes of cancer death today. In our study, we retrospectively reviewed 357 patients with locally advanced rectal cancer who applied to our hospital between 2009 and 2016. Materials and methods: Chemoradiotherapy (CRT) was applied to the patients before surgery. The ratio of neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) were examined at the diagnosis in relation to pathological response and surveillance. The Kaplan-Meier method was used for estimating the survival function from lifetime data. In addition, Cox regression model was also used to explore the relationship between the survival of a patient and several explanatory variables. Results: As the tumor diameter increases, the NLR increases, p value is < 0.01 and statistically significant. NLRs were not different between the tumors of T1 and T2, but for T3 and T4 tumors it was higher and more different than others (T3 = 7.0186, T4 = 12.4391). NLR was higher in patients with surgical border continuity, p = 0.01 and statistically significant. A decrease of 1 unit of NLR would increase the likelihood of a pathological good response (1/0.962) by 1.04 fold. PLR, however, is not statistically significant; it has been observed that a decrease in the 1-unit PLR tends to increase the likelihood of a good response (1/0.996) in the pathological stage by 1.004 fold. While the patients who received partial response to the treatment were living at 59 months, the patients who received good response were living at 71 months. Although p value was 0.383, a 12-month median difference in life expectancy was significant. Conclusion: It has been shown that high NLR in colorectal cancer and many other cancers is a negative prognostic factor. However, there are few articles evaluating the NLR and PLR only for rectum cancer. As in other cancers, a high PLR is associated with a pathological response in rectal cancer and poor prognosis.","[Karaca, Feryal] Hlth Sci Univ, Adana Numune Educ & Res Hosp, Dept Radiat Oncol, Adana, Turkey; [Afsar, Cigdem Usul] Acibadem Mehmet Ali Aydinlar Univ, Dept Internal Med & Med Oncol, Istanbul, Turkey","Afsar, CU (corresponding author), Acibadem Mehmet Ali Aydinlar Univ, Acibadem Bakirkoy Hosp, Dept Internal Med & Med Oncol, Zeytinlik Mah Halit Ziya Usakligil Cad 1, TR-34140 Istanbul, Turkey.",cigdemusul@yahoo.com,"Afsar, Cigdem Usul/C-3436-2015; Afsar, Cigdem Usul/AAA-6103-2021","Afsar, Cigdem Usul/0000-0002-3764-7639; Afsar, Cigdem Usul/0000-0002-3764-7639",,,"Alexandrakis MG, 2003, AM J CLIN ONCOL-CANC, V26, P135, DOI 10.1097/00000421-200304000-0000; Azab B, 2014, CANCER BIOMARK, V14, P303, DOI 10.3233/CBM-14041; Buttner S, 2017, ACTA CHIR BELG, V117, P181, DOI 10.1080/00015458.2017.127987; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature0132; de Martino M, 2013, J UROLOGY, V190, P1999, DOI 10.1016/j.juro.2013.06.08; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs12; Graziosi L, 2015, AM J SURG, V209, P333, DOI 10.1016/j.amjsurg.2014.06.01; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.01; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-026; Marmol I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms1801019; Moody GA, 1996, EUR J GASTROEN HEPAT, V8, P1179, DOI 10.1097/00042737-199612000-0000; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.02; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.9; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.35; Shibutani M, 2013, ANTICANCER RES, V33, P329; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju12",17,0,0,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1383.0,1390,,10.19193/0393-6384_2018_5_211,,8,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700033,,,,,2022-07-14,0.001756198347107438,1.17299693739569e-11,0.06286308884566773,0.11308014906019649,0.06378421193800152
J,"Koseoglu, H1;  Alisik, M;  Solakoglu, T;  Tahtaci, M;  Erel, O;  Ersoy, O",,,,"Koseoglu, Huseyin; Alisik, Murat; Solakoglu, Tevfik; Tahtaci, Mustafa; Erel, Ozcan; Ersoy, Osman",,,COPEPTIN MAY NOT INCREASE IN MILD ACUTE PANCREATITIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Acute pancreatitis; Arginine vasopressin; Copeptin,PLASMA COPEPTIN; ATLANTA CLASSIFICATION; VASOPRESSIN PRECURSOR; PROGNOSIS; SEVERITY; MORTALITY; PEPTIDE; SEPSIS; RULE,"Introduction: Arginine vasopressin (AVP), a hormone of the hypothalamic-pituitary-adrenal axis, is stimulated by endogenous stress. Copeptin is a glycopeptide derived from a pre-pro-hormone, which directly mirrors AVP levels. Copeptin has been shown to be elevated in various infectious and noninfectious diseases, and in acute pancreatitis. The present study aimed to examine copeptin in mild acute pancreatitis patients and to investigate it as a severity index. Materials and methods: This prospective study included 32 patients admitted to the hospital with mild acute pancreatitis, and 30 healthy volunteers. Independent sample t test and Pearson's correlation test were used for statistical evaluation. Results: Serum copeptin level was 0.539 +/- 0.076 ng/mL in mild acute pancreatitis patients and was not statistically significantly different than the control group (0.544 +/- 0.061 ng/mL). On correlation analysis serum copeptin level was not associated with the known prognosis factors. Conclusion: Previous studies have found that copeptin may be used as a prognostic factor, but our study could not find an increase in mild acute pancreatitis patients or a correlation between copeptin level and other known prognostic factors. Further studies are needed to use copeptin in diagnosis or prognosis prediction in acute pancreatitis.","[Koseoglu, Huseyin] Ankara Ataturk Educ & Res Hosp, Dept Gastroenterol, Bilkent, Turkey; [Alisik, Murat] Ankara Ataturk Educ & Res Hosp, Dept Clin Biochem, Bilkent, Turkey; [Solakoglu, Tevfik] Corlu State Hosp, Dept Gastroenterol, Corlu, Turkey; [Tahtaci, Mustafa; Ersoy, Osman] Yildirim Beyazit Univ, Dept Gastroenterol, Fac Med, Ankara, Turkey; [Erel, Ozcan] Yildirim Beyazit Univ, Dept Clin Biochem, Fac Med, Ankara, Turkey","Koseoglu, H (corresponding author), Univ Mh Bilkent, Ataturk Egitim & Arastirma Hastanesi, Ankara Ataturk Educ & Res Hosp, Dept Gastroenterol, Cad 1, Bilkent, Turkey.",huseyinko@yahoo.com,"Ertan, Asli/AAE-6201-2021; Alisik, Murat/O-6114-2019; EREL, Ozcan/U-1008-2019; koseogÂlu, huseyin/A-2449-2017","Alisik, Murat/0000-0003-0434-3206; EREL, Ozcan/0000-0002-2996-3236; ",,,"Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-30277; Chen YH, 2015, MEDICINE, V94, DOI 10.1097/MD.000000000000063; Choi KS, 2015, SCI REP-UK, V5, DOI 10.1038/srep1166; Dobsa L, 2013, BIOCHEM MEDICA, V23, P172, DOI 10.11613/BM.2013.02; Hamada T, 2013, J GASTROENTEROL, V48, P1384, DOI 10.1007/s00535-013-0765-; Isman FK, 2013, AM J EMERG MED, V31, P690, DOI 10.1016/j.ajem.2012.12.01; Jochberger S, 2009, CRIT CARE MED, V37, P476, DOI 10.1097/CCM.0b013e318195753; Katan M, 2008, CRIT CARE, V12, DOI 10.1186/cc679; Kruger S, 2007, INTENS CARE MED, V33, P2069, DOI 10.1007/s00134-007-0895-; Moreno JP, 2013, LIVER INT, V33, P843, DOI 10.1111/liv.1217; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.00; Ray P, 2012, AM J EMERG MED, V30, P440, DOI 10.1016/j.ajem.2011.12.00; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.07; Sang G, 2014, PEPTIDES, V51, P4, DOI 10.1016/j.peptides.2013.10.01; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.01; Szinnai G, 2007, J CLIN ENDOCR METAB, V92, P3973, DOI 10.1210/jc.2007-023; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.21; Vege SS, 2009, AM J GASTROENTEROL, V104, P710, DOI 10.1038/ajg.2008.7; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-3",20,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1327.0,1330,,10.19193/0393-6384_2018_5_203,,4,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700025,,,,,2022-07-14,0.002066115702479339,8.386625898495028e-30,0.009677763651220713,0.05156204224039204,0.009677763651220713
J,"La Mantia, I1;  Grillo, C;  Andaloro, C",,,,"La Mantia, Ignazio; Grillo, Calogero; Andaloro, Claudio",,,SHORT-TERM USE OF OCCLUSAL SPLINT IN PATIENTS WITH SLEEP BRUXISM: A CASE-CONTROLLED STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,sleep bruxism; occlusal splint; migraine; masticatory muscle,ELECTROMYOGRAPHIC RECORDING DEVICE; MANDIBULAR ADVANCEMENT APPLIANCE; OF-THE-LITERATURE; TEMPOROMANDIBULAR DISORDERS; NOCTURNAL BRUXISM; HEADACHES; SYMPTOMS; ASSOCIATION; PREVALENCE; ADULTS,"Objectives: The efficacy of the occlusal splint to reduce sleep bruxism (SB), remains a controversial issue. This study aimed to investigate the effect of a short-term occlusal splint therapy in patients with SB, evaluating both the nocturnal electromyographic (EMG) activity of the temporalis muscle through a portable EMG recording device and the migraine SB-related severity and discomfort. Materials and methods: Sixty patients with SB were randomized into 2 equal groups, a group treated with an occlusal splint and an untreated control group for a study period of two weeks. EMG activity during sleep was recorded from the right side of anterior temporalis muscle with a portable electromyographic recording device. Outcomes of interest were the differences in bruxism activity (number of EMG events/hour) Bruxism length (Second/event) and migraine disability score (MIDAS) between the two groups. Results: After the 2-weeks study period the bruxism activity and length decreased significantly (p = 0.006 and p = 0.037, respectively) as well as the MIDAS grading (p < 0.05) in the treatment group compared with control group. Conclusion: Our results suggest that the short-term use of occlusal splint therapy is effective in reducing both SB activity and migraine SB-related discomfort, with a positive and rapid relaxing action of the masticatory muscles.","[La Mantia, Ignazio; Grillo, Calogero] GF Ingrassia Univ Catania, Dept Med Sci Surg & Adv Technol, Via Santa Sofia 78, I-95123 Catania, Italy; [Andaloro, Claudio] Santa Marta & Santa Venera Hosp, ENT Unit, Catania, Italy","La Mantia, I (corresponding author), GF Ingrassia Univ Catania, Dept Med Sci Surg & Adv Technol, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Andaloro, Claudio/J-7079-2019","Andaloro, Claudio/0000-0003-0274-6247",,,"American Academy of Sleep Medicine, 2014, AM ACAD SLEEP ME; Andaloro C, 2017, MINERVA GASTROENTERO, V63, P307, DOI 10.23736/S1121-421X.17.02403-; Balasubramaniam R., 2014, J DENT SLEEP MED, V1, DOI [10.15331/jdsm.3736, DOI 10.15331/JDSM.3736, DOI 10.15331/jdsm.3736; Carra MC, 2013, SLEEP MED, V14, P656, DOI 10.1016/j.sleep.2013.03.00; Daif ET, 2012, ACTA ODONTOL SCAND, V70, P72, DOI 10.3109/00016357.2011.59777; Dube C, 2004, J DENT RES, V83, P398, DOI 10.1177/15440591040830050; Fernandes G, 2013, J OROFAC PAIN, V27, P14, DOI 10.11607/jop.92; Frati F, 2014, J INVEST ALLERG CLIN, V24, P35; Goncalves DAG, 2010, HEADACHE, V50, P231, DOI 10.1111/j.1526-4610.2009.01511.; Grillo C, 2004, ACTA MEDICA MEDITERR, V20, P15; Harada T, 2006, J ORAL REHABIL, V33, P482, DOI 10.1111/j.1365-2842.2005.01576.; HOLMGREN K, 1993, J PROSTHET DENT, V69, P293, DOI 10.1016/0022-3913(93)90109-; Hosoya H, 2014, SLEEP BREATH, V18, P837, DOI 10.1007/s11325-014-0953-; Jagger Robert, 2008, Evid Based Dent, V9, P23, DOI 10.1038/sj.ebd.640056; Koyano K, 2005, INT J PROSTHODONT, V18, P29; La Mantia I, 2017, EMBJ, V12, P14; La Mantia I, 2017, AM J RHINOL ALLERG; Landry-Schonbeck A, 2009, INT J PROSTHODONT, V22, P25; Lavigne GJ, 2001, J SLEEP RES, V10, P237, DOI 10.1046/j.1365-2869.2001.00261.; Lobbezoo F, 2006, J ORAL REHABIL, V33, P293, DOI 10.1111/j.1365-2842.2006.01609.; Macedo CR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005514.pub; Manfredini D, 2013, J ORAL REHABIL, V40, P631, DOI 10.1111/joor.1206; Manfredini D, 2015, J ORAL REHABIL, V42, P862, DOI 10.1111/joor.1232; Manfredini D, 2013, J OROFAC PAIN, V27, P99, DOI 10.11607/jop.92; Matsumoto H, 2015, J ORAL REHABIL, V42, P251, DOI 10.1111/joor.1225; Mitrirattanakul S, 2002, J DENT RES, V81, pA13; Miyawaki S, 2003, SLEEP, V26, P888, DOI 10.1093/sleep/26.7.88; Savabi O, 2007, QUINTESSENCE INT, V38, P12; Shetty Shilpa, 2010, J Indian Prosthodont Soc, V10, P141, DOI 10.1007/s13191-011-0041-; Stapelmann Henrike, 2008, BMC Oral Health, V8, P22, DOI 10.1186/1472-6831-8-2; Stuginski-Barbosa J, 2016, SLEEP BREATH, V20, P695, DOI 10.1007/s11325-015-1283-; Troeltzsch M, 2011, J PROSTHET DENT, V105, P410, DOI 10.1016/S0022-3913(11)60084-; Yap Adrian U, 2016, J Conserv Dent, V19, P383, DOI 10.4103/0972-0707.19000; Yap AUJ, 1998, J ORAL REHABIL, V25, P6",34,1,1,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,301.0,305,,10.19193/0393-6384_2018_2_48,,5,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400002,,,,,2022-07-14,0.003512396694214876,3.450575285451635e-05,0.018065146007786588,0.09263955747384943,0.018065146007786588
J,"La Mantia, I21;   Cupido, F;   Andaloro, C",,,,"La Mantia, Ignazio; Cupido, Francesco; Andaloro, Claudio",,,VOCAL FUNCTION EXERCISES AND VOCAL HYGIENE COMBINED TREATMENT APPROACH AS A METHOD OF IMPROVING VOICE QUALITY IN IRRADIATED PATIENTS FOR LARYNGEAL CANCERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,voice therapy; laryngeal cancer; radiotherapy,RANDOMIZED CLINICAL-TRIAL; EARLY GLOTTIC CANCER; RADIATION-THERAPY; CARCINOMA; RADIOTHERAPY; DISORDERS; TEACHERS; EFFICACY; REHABILITATION; OUTCOMES,"Introduction: Despite the negative effects of radiation therapy on voice quality is well documented in literature few studies have focused on the efficacy of voice therapy in the irradiated laryngeal cancers population. The purpose of this study was to investigate the efficacy of an evidence-based voice therapy, known as Vocal Function Exercises (VFE) in a combined approach with Vocal Hygiene (VH) in improving vocal function in patients who have been irradiated for laryngeal cancers and compared to the results of VH alone treatment. Materials and methods: A prospective, randomized and controlled study involved patients with primary laryngeal cancer treated with curatively intended radiotherapy. Study group (10 patients) was treated with VFE+VH approach and control group (9 patients) was treated with a VH alone therapy; both interventions started one month following radiotherapy completion and lasted for 6 weeks. Voice Handicap Index (VHI) scores, laryngeal stroboscopy, high-speed laryngeal imaging, acoustic analysis, aerodynamic analysis, auditory-perceptual measures through the Grade, Roughness, Breathiness, Asthenia, Strain (GRBAS) rating scale and impact on Health-Related Quality of Life (HRQL) through the EORTC Quality of Life Questionnaire Head and Neck module (EORTC QLQ-H&N35) were evaluated at baseline and post-intervention. Results: VFE+VH combined approach shows better and statistically significant improvement after vocal intervention when compared to VH alone group for VHI (p=0.023), GRBAS (p=0.038), MPT (p<0.001), jitter (p=0.015), NMWA (p=0.011), NGG (p=0.026) and EORTC QLQ-H& N35 (p=0.047). Conclusions: The current investigation demonstrated that the VFE+VH combined approach was effective in improving the vocal function in irradiated patients with laryngeal cancers.","[La Mantia, Ignazio] Univ Catania, Dept Med Sci Surg & Adv Technol, Catania, Italy; [Cupido, Francesco] Univ Palermo, Dept Surg & Oncol Disciplines, Palermo, Italy; [Andaloro, Claudio] Santa Marta & Santa Venera Hosp, Ear Nose & Throat Unit, Catania, Italy","La Mantia, I (corresponding author), Dept Med Sci Surg & Adv Technol, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Andaloro, Claudio/J-7079-2019","Andaloro, Claudio/0000-0003-0274-6247",,,"Angadi V, 2017, ANN OTO RHINOL LARYN, V126, P483, DOI 10.1177/000348941770292; Bergstrom L, 2016, LARYNGOSCOPE, V126, P2029, DOI 10.1002/lary.2591; Frati F, 2014, J INVEST ALLERG CLIN, V24, P35; Grillo C., 2017, OTORINOLARINGOL, V67, P7; Grillo C, 2004, ACTA MEDICA MEDITERR, V20, P15; Hirano M, 1981, PSYCHOACOUSTIC EVAL; Hocevar-Boltezar I, 2009, RADIOTHER ONCOL, V93, P524, DOI 10.1016/j.radonc.2009.09.01; HONG WK, 1993, CANCER RES, V53, P511; Jacobson BH, 1997, AM J SPEECH-LANG PAT, V6, P66, DOI [10.1044/1058-0360.0603.66, DOI 10.1044/1058-0360.0603.66; Kobayashi T, 2017, AURIS NASUS LARYNX, V44, P86, DOI 10.1016/j.anl.2016.04.00; La Mantia I, 2017, EGYPTIAN J EAR NOSE, V18, P24; Lazarus CL, 2009, CURR OPIN OTOLARYNGO, V17, P172, DOI 10.1097/MOO.0b013e32832af12; Lim H. J., 2009, PHONETICS SPEECH SCI, V1, P37, DOI DOI 10.1016/j.jvoice.2017.08.03; MCGUIRT WF, 1994, ARCH OTOLARYNGOL, V120, P95; McMullen CA, 2011, J SPEECH LANG HEAR R, V54, P845, DOI 10.1044/1092-4388(2010/10-0127; Metcalfe CW, 2013, J CRANIOMAXILLOFAC S, V41, P64; Pasa G, 2007, LOGOP PHONIATR VOCO, V32, P128, DOI 10.1080/1401543070120777; Remmelts AJ, 2013, EUR ARCH OTO-RHINO-L, V270, P2079, DOI 10.1007/s00405-013-2460-; Roy N, 2003, J SPEECH LANG HEAR R, V46, P670, DOI 10.1044/1092-4388(2003/053; Roy N, 2001, J SPEECH LANG HEAR R, V44, P286, DOI 10.1044/1092-4388(2001/023; Ruotsalainen JH, 2007, COCHRANE DB SYST RE; Sauder C, 2010, ANN OTO RHINOL LARYN, V119, P460, DOI 10.1177/00034894101190070; STEMPLE JC, 1994, J VOICE, V8, P271, DOI 10.1016/S0892-1997(05)80299-; Tae K, 2011, CLIN EXP OTORHINOLAR, V4, P101, DOI 10.3342/ceo.2011.4.2.10; Tamura E, 2003, LARYNGOSCOPE, V113, P910, DOI 10.1097/00005537-200305000-0002; Tuomi L, 2014, INT J RADIAT ONCOL, V89, P964, DOI 10.1016/j.ijrobp.2014.04.03; van Gogh CDL, 2006, CANCER-AM CANCER SOC, V106, P95, DOI 10.1002/cncr.2157; van Gogh CDL, 2012, J VOICE, V26, P398, DOI 10.1016/j.jvoice.2011.06.00; Zotti P, 2000, QUAL LIFE RES, V9, P1147, DOI 10.1023/A:101667450715",29,2,2,2,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,517.0,523,,10.19193/0393-6384_2018_2_83,,7,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400036,,,,,2022-07-14,0.002995867768595041,4.338600176607099e-08,0.005571026934287602,0.07826459578115019,0.005571026934287602
J,"La Mantia, I31;   Cupido, F;   Castro, V;   Andaloro, C",,,,"La Mantia, Ignazio; Cupido, Francesco; Castro, Veronica; Andaloro, Claudio",,,OLFACTORY FUNCTION IN CHRONIC RHINITIS SUBTYPES: ANY DIFFERENCES?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Olfaction disorders; Rhinitis; Allergic; Rhinitis; Vasomotor,ALLERGIC RHINITIS; DYSFUNCTION; IMPACT; SMELL; SENSE,"Introduction: Olfactory dysfunction is a common problem in rhinological disease, but it has been few evaluated among patients with different chronic rhinitis subtypes. The aim of this study was to assess olfactory function in patients with allergic rhinitis (AR), non-allergic rhinitis (NAR) and mixed rhinitis (MR). Materials and methods: A total of 122 patients with AR, NAR, and MR were included in the study. Sniffin' Sticks test was applied to all groups. The study groups were compared in terms of odor scores and an association between olfactory dysfunction and rhinitis grading, according to ARIA (Allergic Rhinitis and its Impact on Asthma) criteria, was also investigated. Results: A significant difference was observed between NAR patients and the two other study groups with respect to all odor scores. TDI (Threshold, Discrimination, Identification) score, for overall olfactory function, resulted significantly lower in NAR patients than that in the other two groups (P=0.038). Conversely, no significant difference was observed between patients with AR and MR. Consistent with ARIA classification, NAR patients suffered mostly from persistent symptoms, whereas, AR patients generally suffered by intermittent symptoms, as well as MR patients, but this last with a significative higher presence of patients with persistent symptoms, when compared to AR group (P<0.05). A significative association was also observed between lower TDI scores and presence of persistent rhinitis symptomatology (P<0.001). Conclusions: Impaired olfaction is a feature more evident in NAR patients when compared to the other rhinitis subtype and it was much more affected by longer duration of rhinitis symptomatology rather than severity.","[La Mantia, Ignazio; Castro, Veronica] Univ Catania, Dept Med Sci Surg & Adv Technol, Catania, Italy; [Cupido, Francesco] Univ Palermo, Dept Surg & Oncol Disciplines, Palermo, Italy; [Andaloro, Claudio] Santa Marta & Santa Venera Hosp, Ear Nose & Throat Unit, Catania, Italy","La Mantia, I (corresponding author), Dept Med Sci Surg & Adv Technol, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Andaloro, Claudio/J-7079-2019","Andaloro, Claudio/0000-0003-0274-6247",,,"Apter AJ, 1999, ARCH OTOLARYNGOL, V125, P1005, DOI 10.1001/archotol.125.9.100; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-; Becker S, 2012, ACTA OTO-LARYNGOL, V132, P763, DOI 10.3109/00016489.2012.65676; Bernstein JA, 2010, ALLERGY ASTHMA PROC, V31, P365, DOI 10.2500/aap.2010.31.338; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.11889; Bramerson A, 2004, LARYNGOSCOPE, V114, P73; Ciprandi G, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0185-; Dinc ME, 2017, ACTA OTO-LARYNGOL, V137, P71, DOI 10.1080/00016489.2016.121131; Doty RL, 2001, LARYNGOSCOPE, V111, P409, DOI 10.1097/00005537-200103000-0000; Frati F, 2014, J INVEST ALLERG CLIN, V24, P35; Greiwe J, 2016, IMMUNOL ALLERGY CLIN, V36, P289, DOI 10.1016/j.iac.2015.12.00; Grillo C, 2004, ACTA MEDICA MEDITERR, V20, P15; Guilemany JM, 2009, LARYNGOSCOPE, V119, P233, DOI 10.1002/lary.2007; Guss J, 2009, ORL-J OTO-RHIN-LARYN, V71, P268, DOI 10.1159/00024242; Higo R, 1996, Nihon Jibiinkoka Gakkai Kaiho, V99, P164; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/0001648041002278; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.3; La Mantia I, 2017, EMBJ, V12, P14; La Mantia I, 2017, AM J RHINOL ALLERGY, V31, P364, DOI 10.2500/ajra.2017.31.448; La Mantia I, 2017, EURASIAN J MED, V49, P220, DOI 10.5152/eurasianjmed.2017.1725; La Mantia I, 2017, INT J PEDIATR OTORHI, V98, P103, DOI 10.1016/j.ijporl.2017.04.04; Lee CH, 2008, CLIN EXP OTORHINOLAR, V1, P196, DOI 10.3342/ceo.2008.1.4.19; Mann S. S., 2002, Indian Journal of Physiology and Pharmacology, V46, P18; Rezvani M, 2007, ANN ALLERG ASTHMA IM, V99, P571, DOI 10.1016/S1081-1206(10)60389-; Rydzewski B, 2000, ACTA OTO-LARYNGOL, V120, P32; Simola M, 1998, ALLERGY, V53, P190, DOI 10.1111/j.1398-9995.1998.tb03869.; SnowJr JB, 1997, TASTE SMELL DISORDER, P; Stuck BA, 2015, J ALLERGY CLIN IMMUN, V136, P1460, DOI 10.1016/j.jaci.2015.08.00; Tran NP, 2011, ALLERGY ASTHMA IMMUN, V3, P148, DOI 10.4168/aair.2011.3.3.14",29,6,6,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,525.0,529,,10.19193/0393-6384_2018_2_84,,5,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400037,,,,,2022-07-14,0.002995867768595041,6.501106922414101e-08,0.005365290565442722,0.07826459578115019,0.005365290565442722
J,"Latino, F1;  D'Andria, A;  Tafuri, D",,,,"Latino, Francesca; D'Andria, Antonio; Tafuri, Domenico",,,BADMINTON PLAYER REATHLETIZATION AFTER ACHILLES TENDON RUPTURE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Training Program; Achilles Tendon rupture; Badminton,MUSCLE FUNCTION; MANAGEMENT,"Introduction: The purpose of this study is to introduce an example of a criteria-driven progression through the return-to-sport phase of rehabilitation,following Achilles Tendon reconstruction. Case presentation: In this study the Authors present the case of a 28-years-old man, professional Badminton players, who had Achilles Tendon rupture during practice. So, the Authors describe recovery program necessary to get back to competitive sport. Conclusion: To ensure a successful return to sport following Achilles Tendon re-constructionis necessary to formulate an accurate training program. The training program should be personalised, gradual and editable.","[Latino, Francesca; D'Andria, Antonio; Tafuri, Domenico] Parthenope Univ, Via Medina 40, Naples, Italy","Tafuri, D (corresponding author), Parthenope Univ Naples, Naples, Italy.",domenicotafuri@inwind.it,,"Latino, Francesca/0000-0003-0302-6145",,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Carbonetto G, 2008, DA OLIMPIA A PECHIN; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; Doral MN, 2010, OPEN ACCESS J SPORTS, V1, P233, DOI 10.2147/OAJSM.S1067; GILLIES H, 1970, J BONE JOINT SURG AM, VA 52, P337, DOI 10.2106/00004623-197052020-0001; Gulati V, 2015, WORLD J ORTHOP, V6, P380, DOI 10.5312/wjo.v6.i4.38; HAGGMARK T, 1986, ORTHOPEDICS, V9, P16; Jafari A., 2014, International Journal of Basic Sciences and Applied Research, V3, P4; Jafari A, 2014, INT J BASIC SCI APPL, V3, P4; KENDAL FP, 2005, MUSCLES TESTING FUN; Lanzetta A, 1996, MALATTIE ORTOPEDICH; Leppilahti J, 1996, INT J SPORTS MED, V17, P619, DOI 10.1055/s-2007-97290; LIPSCOMB P R, 1956, Minn Med, V39, P73; Mahmudieh B, 2013, GLOBAL J SCI ENG TE; Martini F, 2012, HUMAN ANATOM; Moller M, 2002, SCAND J MED SCI SPOR, V12, P9, DOI 10.1034/j.1600-0838.2002.120103.; Myerson M S, 1999, Instr Course Lect, V48, P21; Ooi CH, 2009, J SPORT SCI, V27, P1591, DOI 10.1080/0264041090335290; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Perrone V, 2009, GIOT, V35, P12; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Tafuri D., 2017, SPORT SCI, V10, P7; WREDMARK T, 1992, Scandinavian Journal of Medicine and Science in Sports, V2, P13; Yung Patrick Shu-Hang, 2007, Res Sports Med, V15, P133, DOI 10.1080/1543862070140526",31,0,0,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1493.0,1497,,10.19193/0393-6384_2018_3s_227,,5,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400004,,,,,2022-07-14,0.0030991735537190084,4.920923667840425e-05,0.003706505142461316,0.08274282197471557,0.0037057357053367356
J,"Latino, F21;   Cassese, FP;   Tafuri, D",,,,"Latino, Francesca; Cassese, Francesco Peluso; Tafuri, Domenico",,,BADMINTON: FROM COMPETITIVE MOTOR ACTIVITY TO INCLUSIVE DIDACTICS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Badminton; Para-Badminton; Competitiveness; Inclusion,,"The purpose of this article is to examine how disabled sport, expecially Badminton, could be a means of integration and cooperation, and the way the disabled could have the equal possibilities for training in a professional context. According to researchers, Badminton is associated with emotional and psychophysical benefits, as well as with an educative function. Furthermore, participation in Badminton activities facilitates skills and behaviour across various setting. In conclusion, this study investigates how Badminton is an important activity to improve physical and mental conditions. In fact, it increases self-confidence and removes depression associated with disability.","[Latino, Francesca; Tafuri, Domenico] Parthenope Univ, Via Medina 40, Naples, Italy; [Cassese, Francesco Peluso] Cusano Univ Telemat Rome, Rome, Italy","Tafuri, D (corresponding author), Parthenope Univ, Via Medina 40, Naples, Italy.",domenicotafuri@inwind.it,"CASSESE, FRANCESCO PELUSO/A-4303-2016","CASSESE, FRANCESCO PELUSO/0000-0002-6798-3668; Latino, Francesca/0000-0003-0302-6145",,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Badminton England, 2012, DIS STRAT STRAT VI; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Bernardi M, 1996, 3 PAR C WORLD C DI; Brasile F. M., 1990, ADAPTED PHYSICAL ACT, V7, P3, DOI DOI 10.1123/APAQ.7.1.; Canevaro A., 2003, DIVERSABILITA STORI; Carbonetto G, 2008, DA OLIMPIA A PECHIN; CHIN MK, 1995, BRIT J SPORT MED, V29, P153, DOI 10.1136/bjsm.29.3.15; DE ANNA L., 2007, INTEGRAZIONE SCOLAS; De Pauw KP, 2005, ENCICLOPEDYA WORLD S, V2, P46; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; Dias R, 1995, SCI SPORTS RACKE; Fitzgerald H, 2009, INT STUD PHYS EDUC Y, P; GARDNER H., 2005, EDUCAZIONE SVILUPP; Ghirlanda S., 2003, SPORT TUTTI SPAZIO ; Gosh AK, 2003, INDIAN J MED RES, V98, P23; Ooi CH, 2009, J SPORT SCI, V27, P1591, DOI 10.1080/0264041090335290; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Petralia MC, 2018, ACTA MEDICA MEDITERR, V34, P107, DOI 10.19193/0393-6384_2018_1_1; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Reilly T, 1995, SCI RACKET SPOR; Schmidt R. A., 2000, APPRENDIMENTO MOTOR; Sherrill C., ADAPTED PHYS ACTIVIT, V16, P20; Tafuri D., 2017, SPORT SCI, V10, P7; Tweedy SM, 2011, BRIT J SPORTS MED, V4; WEISS MR, 1992, J SPORT EXERCISE PSY, V14, P177, DOI 10.1123/jsep.14.2.17",32,0,0,1,11,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1521.0,1524,,10.19193/0393-6384_2018_3s_233,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400010,,,,,2022-07-14,0.003202479338842975,5.4761908645889155e-05,0.003729216674832759,0.08274423653910264,0.003728775034682386
J,"Lavan, F1;  Testa, D;  Lavan, SM;  Marotta, R;  Tripi, G;  Salerno, M;  Romano, P;  Di Folco, A;  Gallai, B;  Russo, D;  D'Oro, L;  Sorrentno, M;  Magliulo, RM;  Cerroni, F;  Marsala, G;  Montana, A;  Franco, S;  Geraci, D;  Chisari, MG;  Picciocchi, E;  Polito, AN;  Murabito, P;  Parisi, L",,,,"Lavan, Francesco; Testa, Davide; Lavan, Serena Marianna; Marotta, Rosa; Tripi, Gabriele; Salerno, Margherita; Romano, Palmira; Di Folco, Annabella; Gallai, Beatrice; Russo, Daniela; D'Oro, Lucrezia; Sorrentno, Michele; Magliulo, Rosaria Martina; Cerroni, Francesco; Marsala, Gabriella; Montana, Angelo; Franco, Sabrina; Geraci, Diego; Chisari, Mario Giuseppe; Picciocchi, Elisabetta; Polito, Anna Nunzia; Murabito, Paolo; Parisi, Lucia",,,VISUOSPATIAL SKILLS IN CHILDREN AFFECTED BY PRIMARY NOCTURNAL ENURESIS: REHABILITATIVE PROPOSALS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,nocturnal enuresis; rehabilitation; visuospatial skills,SLEEP-APNEA SYNDROME; CHILDHOOD ABSENCE EPILEPSY; WEIGHT-LOSS PROGRAM; QUALITY-OF-LIFE; HYPERTHERMIC REACTIONS; OBESE CHILDREN; SELF-CONCEPT; OREXIN-A; MIGRAINE; ADOLESCENTS,"The sphincterial control problems in childhood are very common, with relevant comorbidities (i.e.: difficulty in academic performance, sleep disturbances, minor neurological signs) involved in the complex process of maturation and learning, such as to cause a great deal of discomfort and related disorders in affected subjects. Enuresis is characterized by the involuntary urination in the absence of a physical disorder, socially unacceptable in places and at one stage of life where such control is acquired by the majority of subjects (about 5 years). The present study aims to evaluate the visuospatial skills in children affected by primary monosymptomatic nocturnal enuresis (PMNE). 31 PMNE children (16 males and 15 females) (mean age 10.87, SD +/- 1.68) and 61 healthy children (32 males, 29 females) (mean age 11.03, SD +/- 1.85, p = 0687) were evaluated for visuomotor skills with the Visual-Motor Integration Scale (VMI). PMNE subjects show a worse performance on average to VMI, especially in the total visual-motor integration test. This finding emphasizes the importance of a framework for global and more complex than is commonly implemented, across the border but framing the subject of enuretic symptoms in a more global perspective.","[Lavan, Francesco; Lavan, Serena Marianna; Marotta, Rosa] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Testa, Davide; Di Folco, Annabella; Parisi, Lucia] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [D'Oro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Sorrentno, Michele] Pineta Grande Hosp, NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy; [Magliulo, Rosaria Martina] Ctr Scoliosi SRL, Naples, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy; [Marsala, Gabriella] Osped Riuniti Foggia, Azienda Ospedal Univ, Struttura Complessa Farm, Foggia, Italy; [Montana, Angelo; Franco, Sabrina; Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GE Ingrassia, Catania, Italy; [Chisari, Mario Giuseppe] INPS, Catania, Italy; [Picciocchi, Elisabetta] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy","Parisi, L (corresponding author), Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Cerroni, Francesco/0000-0003-3024-5482; Murabito, Paolo/0000-0002-2662-1898; Marotta, Rosa/0000-0003-0515-5952",,,"American Psychiatric Association American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5t; Beery K.E., 1989, DEV TEST VISUAL MOT; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Bosson S, 2002, ARCH DIS CHILD, V87, P188, DOI 10.1136/adc.87.3.18; Butler RJ, 1998, J CHILD PSYCHOL PSYC, V39, P453, DOI 10.1017/S002196309800222; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Dai Xiao-Mei, 2007, Zhongguo Dang Dai Er Ke Za Zhi, V9, P43; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, PRIMARY NOCTURNAL E; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Gallelli Luca, 2017, Microrna, V6, P152, DOI 10.2174/221153660666617091315282; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; MacPhersona SE, 2017, NEUROPSYCHOLOGIA, V96, P19, DOI 10.1016/j.neuropsychologia.2016.12.02; Matricardi S, 2018, ACTA NEUROL SCAND, V137, P575, DOI 10.1111/ane.1290; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSIOL, P; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Moscatelli F, 2016, PLOS ONE, V2; Moscatelli F, 2015, BIOL MED, V; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Sarici S. Umit, 2003, International Urology and Nephrology, V35, P38; Smirni D, 2018, J NERV MENT DIS, V206, P628, DOI 10.1097/NMD.000000000000085; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Smirni D, 2017, NEUROPSYCHOLOGIA, V102, P109, DOI 10.1016/j.neuropsychologia.2017.06.00; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Testa D, 2017, AGING CLIN EXP RES, V29, pS191, DOI 10.1007/s40520-016-0647-; Testa D, 2016, OPEN MED-WARSAW, V11, P208, DOI 10.1515/med-2016-004; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Touchette E, 2005, ARCH PEDIAT ADOL MED, V159, P1129, DOI 10.1001/archpedi.159.12.112; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2018, ACTA NEUROL SCAND, V138, P523, DOI 10.1111/ane.1300; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; von Gontard A, 2006, DEV MED CHILD NEUROL, V48, P744, DOI 10.1017/S001216220600159; Yu B, 2011, J PAEDIATR CHILD H, V47, P429, DOI 10.1111/j.1440-1754.2010.02000.",100,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2161.0,2170,,10.19193/0393-6384_2018_4s_331,,10,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900011,,,,,2022-07-14,0.009297520661157025,0.11442016005569441,0.003844120262093424,0.1113706179458564,0.0044948656794621174
J,"Li, F1;  Wang, JZ;  Cao, F;  Chen, H;  Wang, WB",,,,"Li, Feng; Wang, Jingzhong; Cao, Feng; Chen, Hui; Wang, Wanbi",,,QUALITY CONTROL OF LOWER LIMB ARTERY IMAGING BY 320-SLICE SPIRAL CT AND ITS EFFECT IN ARTERIAL STENOSIS ASSESSMENT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,320-slice spiral CT; Lower limb artery imaging; Arterial stenosis assessment; Quality control,WATER; SYSTEM,"Objective: This study aims to evaluate specific effect of 320-slice spiral CT in assessment of lower limb arterial stenosis, analyze the specific factors affecting imaging quality of lower limb artery by 320-slice spiral CT and propose effective countermeasures. Methods: The 400 patients receiving 320-slice spiral CT of lower limb arterial imaging examination in our hospital from March 2014 to March 2016 were included in the study. The differences in relevant parameters of general data, clinical manifestation and scanning were analyzed, the specific factors affecting lower limb artery imaging quality were analyzed; According to the standard of spiral CT imaging, arterial stenosis of the patients was divided into 4 levels by considering ,general data, respectively less than 50%, 50%-75%, 76% -99%, occlusion. The specific of feet of lower limb artery imaging by 320 - slice spiral CT under different grades of arterial stenosis was analyzed. Results: As can be seen from the imaging results, the higher the level of arterial stenosis is, the higher the sensitivity and specificity of 320-slice spiral CT in evaluation of lower limb artery imaging is, especially sensitivity. There are significant differences between the different levels (P <0.05); The imaging quality of lower limb artery by 320 - slice spiral CT is affected by such factors as contrast agent velocity, contrast agent concentration, contrast agent dose, delay time, scanning parameters, vascular calcification, patient age and reconstruction technique (P <0.05). Conclusion: Lower limb artery imaging by 320 - slice spiral CT has a high sensitivity and specificity, which enjoys great value in clinical application.","[Li, Feng; Wang, Jingzhong; Cao, Feng; Chen, Hui; Wang, Wanbi] Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Radiol Dept, Xiangyang 441021, Peoples R China","Cao, F (corresponding author), Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Radiol Dept, Xiangyang 441021, Peoples R China.",caof77210@163.com,,,Research project of Heilongjiang Provincial Health Bureau [2014-007],Research project of Heilongjiang Provincial Health Bureau; Application of 640 slice CT low dose scanning technique in abdominal and lower extremity arterial imaging (No. 2014-007).,"Balkhair KS, 2016, SAUDI J BIOL SCI, V23, pS32, DOI 10.1016/j.sjbs.2015.09.02; Ganeshpurkar A, 2017, SAUDI PHARM J, V25, P149, DOI 10.1016/j.jsps.2016.04.02; Gao W, 2017, SAUDI PHARM J, V25, P580, DOI 10.1016/j.jsps.2017.04.02; Guowei Ye, COMP ANAL 4 IMAGIN; Huang HQ, 2015, J COASTAL RES, P698, DOI 10.2112/SI73-120.; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P667, DOI 10.19193/03936384_2017_4_10; Mohammed MJ, 2017, SAUDI J BIOL SCI, V24, P737, DOI 10.1016/j.sjbs.2017.01.05; Obeidat HR, 2015, SAUDI PHARM J, V23, P455, DOI 10.1016/j.jsps.2014.11.00; Peng WX, 2016, SAUDI J BIOL SCI, V23, P348, DOI 10.1016/j.sjbs.2015.10.02; Wang L.-L., 2010, CHINESE MED EQUIPMEN, V31, P1; Wei Li, 2009, J HAINAN MED U, V15, P101; Wei Xia, 2014, CHINESE J MED IMAGIN, V10, P84; Wu K, 2015, J COASTAL RES, P521, DOI 10.2112/SI73-091.; Zhang J, 2015, J COASTAL RES, P652, DOI 10.2112/SI73-113.; Zhang M, 2015, J COASTAL RES, P304, DOI 10.2112/SI73-053.; Zhang XY, 2015, J COASTAL RES, P9, DOI 10.2112/SI73-003.; Zhao N, 2015, J COASTAL RES, P220, DOI 10.2112/SI73-039.; [å¨æ·ç´ Zhou Shuqin], 2013, [ä¸­åæ¾å°å»å­¦ä¸é²æ¤æå¿, Chinese Journal of Radiological Medicine and Protection], V33, P31",18,0,0,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1937.0,1941,,10.19193/0393-6384_2018_6_301,,5,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400052,,,,,2022-07-14,0.001859504132231405,0.0009454975010808015,0.020285195292435432,0.10018525993314083,0.02613938901357729
J,"Li, H1;  Cao, YD;  Hou, R;  Liu, ZY",,,,"Li, Huan; Cao, Yingdong; Hou, Rui; Liu, Zhiyan",,,CLINICAL NURSING ANALYSIS OF PATIENTS ACCEPTINGRADICAL ESOPHAGECTOMY FOLLOWED BY LEAVING A DUODENAL FEEDING TUBE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,radical esophagectomy; duodenal feeding tube; comprehensive nursing mode,,"Purpose: to observe and analyze the nursing strategy of radical esophagectomy followed by leaving a duodenal feeding tube. Method: 160 patients who had been treated with radical esophagectomy in our hospital were selected as research objects, and randomly divided into control group and research group, each containing 80 patients. All selected patients had a duodenal feeding tube left in their body after radical esophagectomy. The patients in control group were applied with conventional nursing mode, while patients in research group were applied with comprehensive nursing mode. The nursing effect of two groups were observed and compared. Result: the adverse reaction rate in research group was lower than that in control group, P<0. 05; the quality of life and overall nursing satisfactory in research group were significantly higher than that in control group, p<0. 05. Conclusion: The application of radical esophagectomy followed by leaving a duodenal feeding tube can significantly improve overall treatment effect and increase the quality of life of patients.","[Li, Huan; Cao, Yingdong; Hou, Rui] Zhengzhou Univ, Sias Int Univ, Nursing Sch, Xinzheng 451150, Peoples R China; [Liu, Zhiyan] Zhengzhou Univ, Canc Hosp, Zhengzhou 450008, Henan, Peoples R China","Liu, ZY (corresponding author), Zhengzhou Univ, Canc Hosp, Zhengzhou 450008, Henan, Peoples R China.",Zhanghaiyu0805@163.com,,,,,"Akay G, 2017, TURK J MED SCI, V47, P1715, DOI 10.3906/sag-1607-12; Ammar MH, 2017, SAUDI J BIOL SCI, V24, P80, DOI 10.1016/j.sjbs.2016.05.01; Jiao Wenjie, 2016, BMC CANCER, V8, P12; Kumar PKP, 2016, PAK J PHARM SCI, V29, P127; Lv Jin, 2017, WORLD J GASTROENTERO, V16, P22; Lv MX, 2017, INDIAN J PHARM SCI, V79, P893, DOI 10.4172/pharmaceutical-sciences.100030; Peng WX, 2016, SAUDI J BIOL SCI, V23, P348, DOI 10.1016/j.sjbs.2015.10.02; Pouliquen X, 2016, FRENCH ASS SURG RES, V10, P56; Qin Miaomiao, 2016, WORLD LATEST MED INF, V16, P31; Wang M, 2018, J CLEAN PROD, V179, P12, DOI 10.1016/j.jclepro.2018.01.09; Xiang Yunlian, 2016, HLTH PEOPLE, V10, P27; Yang Xiaoning, 2017, E JURNAL CLIN NURSIN, V2, P14; Zhong Jian, 2014, CONT MED FORUM, V12, P8; Zhou Yong, 2013, WORLD J GASTROENTERO, V19, P22; å­å½ç, 2016, [ä¸­å½å¾ªè¯å¿ç§æå¿, Chinese Journal of Evidence Based Pediatrics], V11, P23",15,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1971.0,1974,,10.19193/0393-6384_2018_6_307,,4,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400058,,,,,2022-07-14,0.0015495867768595042,5.885752579838313e-07,0.003331719779298423,0.08420393357631852,0.0029104411567869373
J,"Li, J21;   Wang, ST",,,,"Li, Jing; Wang, Shitao",,,STRENGTH TRAINING ON EXERCISE-INDUCED SKELETAL MUSCLE INJURY IN TRACK AND FIELD SPORTS AND MECHANISM ANALYSIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Strength training; Exercise-induced muscle injury in track and field sports; Eccentric exercise; Biomechanical property,,"This paper mainly observed the influence of eccentric contraction strength training on the structure, serum ck, and biomechanical property of muscle of track and field athlete under different tensions, analyzed the internal relation between exercise-induced muscle injury and mechanical factors. In this paper, the research method was to establish a dynamic and quantitative test model for testing muscle strength training and the biomechanical property of an alive rat, and conducted cyclical eccentric strength training for ankle joint dorsal muscle group of SD male rats under two groups of different applied loads. According to the research results, it can be seen that after eccentric movement, the difference in terms of structure, serum ck, biomechanical property of rat muscle between high tension group and low tension group was not of statistic significance, P>0.05. It can conclude that the high tension, which was resulted by eccentric contraction, was the primary factor to cause exercise-induced muscle injury.","[Li, Jing] Jilin Sport Univ, Sch Sports Human Sci, Changchun 130022, Peoples R China; [Wang, Shitao] Jilin Sport Univ, Sch Sports & Arts, Changchun 130022, Peoples R China","Wang, ST (corresponding author), Jilin Sport Univ, Sch Sports & Arts, Changchun 130022, Peoples R China.",wst-0223@163.com,,,Jilin Social Science Fund Project - Research on the health industry of the elderly [2017M16],Jilin Social Science Fund Project - Research on the health industry of the elderly (No. 2017M16).,"Alanazi K, 2016, SAUDI J BIOL SCI, V23, P87, DOI 10.1016/j.sjbs.2015.09.00; Amr AEGE, 2017, PAK J PHARM SCI, V30, P83; Bassi P, 2017, SAUDI PHARM J, V25, P32, DOI 10.1016/j.jsps.2015.06.00; Cahill T., 2015, ASIAN PAC J SURG ONC, V1, P4; Ge SB, 2017, SAUDI J BIOL SCI, V24, P1355, DOI 10.1016/j.sjbs.2016.09.01; Jin QG, 2010, CHIN SPORTS SCI, V30, P7; Kos M, 2015, ACTA MEDICA MEDITERR, V31, P21; [èµæ¡å Lai Guihua], 2015, [ä¸­å½ä¸´åºè§£åå­¦æå¿, Chinese Journal of Clinical Anatomy], V33, P54; Lee R., 2015, ASIAN PAC J SURG ONC, V1, P3; Shahid B, 2015, PAK J PHARM SCI, V28, P9; Sharma M, 2015, SAUDI PHARM J, V23, P675, DOI 10.1016/j.jsps.2015.02.01; Song HM, 2015, ACTA MEDICA MEDITERR, V31, P30; Wang Dapeng, 2016, CHINESE J TISSUE ENG, V20, P27; Wang M, 2018, J CLEAN PROD, V179, P12, DOI 10.1016/j.jclepro.2018.01.09; Wang YM, 2017, SAUDI J BIOL SCI, V24, P837, DOI 10.1016/j.sjbs.2016.12.00; Zhang M, 2015, J COASTAL RES, P304, DOI 10.2112/SI73-053.; Zhang Yipeng, 2013, RES INTEGRATED TRADI, V5, P22; Zhen-Ying Zhang, 2007, Shengli Xuebao, V59, P64",18,0,0,2,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1565.0,1569,,10.19193/0393-6384_2018_3s_242,,5,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400018,,,,,2022-07-14,0.001859504132231405,7.121812571858015e-07,0.0047335239075686885,0.08589098588300015,0.004249954361615776
J,"Li, W1;  Feng, CC;  He, XL;  Wu, Y;  Wu, J;  Hu, XK;  Zhao, SZ",,,,"Li, Wei; Feng, Chenchen; He, Xiaoli; Wu, Yan; Wu, Juan; Hu, Xiaokun; Zhao, Shuzhen",,,APPLICATION OF THE ICF CHECKLIST IN THE CHINESE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A CROSS-SECTIONAL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,ICF; systemic lupus erythematosus; function,QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; DISEASE-ACTIVITY; SOCIAL SUPPORT; RHEUMATOID-ARTHRITIS; RELEVANT CONCEPTS; REPORTED FATIGUE; SLEEP DISORDERS; LINKING RULES; HEALTH,"Systemic lupus erythematosus (SLE) has wide damages on people's function. Thorough explore of problems will benefit SLE patient's needs determination, resources allocation, rehabilitation and outcomes assessment. Therefore, there was a need for an instrument that can conduct a comprehensive investigation of SLE people's experienced problems. To identify SLE patients' function, disability and health problems and to provide references for the future development of SLE core sets. A cross-sectional study was conducted in the rheumatology outpatient in one general hospital in China. 100 SLE patients' function, disability and health problems were collected using expanded ICF checklist. Descriptive analysis was performed to summarize the data. Of the 150 categories, 55 categories were relevant to at least 20% of the patients, 28 from body functions and structures component, 14 from activities and participation component and 13 from environmental factors component. The mostly referred problems were fatiguability (96%) in body functions, joints (76%) in body structures. The most restricted activity was remunerative employment (71%), and patients' mostly important facilitator was immediate family (47%), mostly referred barrier was light (96%). In conclusion, a large variety of problems were identified, reflecting the complexity of the lived experiences of SLE patients, and intervention should be taken based on those relevant categories. And this study also can serve as a reference for future development of SLE core set.","[Li, Wei; Feng, Chenchen; He, Xiaoli; Wu, Yan; Wu, Juan; Hu, Xiaokun; Zhao, Shuzhen] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China","Zhao, SZ (corresponding author), Sichuan Univ, West China Hosp, Outpatient Dept, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China.",ssszszzsz@126.com,,,,,"Anic F, 2014, CROAT MED J, V55, P514, DOI 10.3325/cmj.2014.55.51; Askanase A, 2012, SOC WORK HEALTH CARE, V51, P576, DOI 10.1080/00981389.2012.68336; Barbasio C, 2015, COMPR PSYCHIAT, V63, P88, DOI 10.1016/j.comppsych.2015.09.00; Bauernfeind B, 2009, ARTHRIT RHEUM-ARTHR, V61, P21, DOI 10.1002/art.2416; Bickenbach J., 2012, ICF CORE SETS MANUA; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.178035060; Brennan KAM, 2016, QUAL LIFE RES, V25, P1227, DOI 10.1007/s11136-015-1151-; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-; Chen HH, 2017, CLIN RHEUMATOL, V36, P133, DOI 10.1007/s10067-016-3471-; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/1650197051004026; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/16501970276027918; Cieza A, 2019, DISABIL REHABIL, V41, P574, DOI 10.3109/09638288.2016.114525; Cleanthous S, 2012, LUPUS, V21, P465, DOI 10.1177/096120331243686; Garcia-Carrasco M, 2012, LUPUS, V21, P1219, DOI 10.1177/096120331245674; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.178039030; Gradinger F, 2011, J SLEEP RES, V20, P445, DOI 10.1111/j.1365-2869.2010.00888.; Kasitanon N, 2013, LUPUS, V22, P1353, DOI 10.1177/096120331350735; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.0052046011502; Kuhn A, 2015, DTSCH ARZTEBL INT, V112, P423, DOI 10.3238/arztebl.2015.042; Leong KP, 2005, RHEUMATOLOGY, V44, P1267, DOI 10.1093/rheumatology/keh60; Leuchten N, 2014, ARTHRIT CARE RES, V66, P1895, DOI 10.1002/acr.2237; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.178032090; Mazzoni D, 2011, LUPUS, V20, P1117, DOI 10.1177/096120331141299; Mazzoni D, 2016, ANXIETY STRESS COPIN, V29, P542, DOI 10.1080/10615806.2015.113478; McElhone K, 2007, ARTHRIT RHEUM-ARTHR, V57, P972, DOI 10.1002/art.2288; Mirbagher L., 2014, INT J RHEUM DIS, V19, P305, DOI 10.1111/1756-185x.1241; Nowicka-Sauer K, 2007, CLIN RHEUMATOL, V26, P1523, DOI 10.1007/s10067-007-0619-; Oner FC, 2015, SPINE, V40, P1371, DOI 10.1097/BRS.000000000000100; Palagini L, 2014, LUPUS, V23, P115, DOI 10.1177/096120331351862; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.00; Schmeding A, 2013, BEST PRACT RES CL RH, V27, P363, DOI 10.1016/j.berh.2013.07.00; Selb M, 2015, EUR J PHYS REHAB MED, V51, P10; Shariati-Sarabi Z, 2013, CLIN EXP RHEUMATOL, V31, P6; Stamm TA, 2007, ARTHRIT RHEUM-ARTHR, V57, P1287, DOI 10.1002/art.2301; Sterling KL, 2014, LUPUS, V23, P124, DOI 10.1177/096120331351155; Stucki G, 2004, ANN RHEUM DIS, V63, P40, DOI 10.1136/ard.2004.02823; Stucki G, 2004, J REHABIL MED, V36, P5, DOI 10.1080/1650196041002230; SYMMONS DPM, 1988, Q J MED, V69, P92; Tsutsui H, 2015, CLIN EXP NEPHROL, V19, P254, DOI 10.1007/s10157-014-0983-; Ustun B, 2004, J REHABIL MED, V36, P7, DOI 10.1080/1650196041001534; Vina ER, 2013, JCR-J CLIN RHEUMATOL, V19, P7, DOI 10.1097/RHU.0b013e31827cd20; W. World Health Organisation, 2001, INT CLASS FUNCT DI; Weigl M, 2004, J REHABIL MED, V36, P12, DOI 10.1080/1650196041001544; World Health Organization, 2001, ICF CHECKL VERS 2 1; Yilmaz-Oner S, 2016, CLIN RHEUMATOL, V35, P617, DOI 10.1007/s10067-015-2930-; Zheng Y, 2009, CLIN RHEUMATOL, V28, P265, DOI 10.1007/s10067-008-1033-; Zochling J, 2006, CLIN EXP RHEUMATOL, V24, P23; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P37; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.0172031006500",49,0,0,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1281.0,1288,,10.19193/0393-6384_2018_5_197,,8,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700019,,,,,2022-07-14,0.00506198347107438,1.393382847921201e-11,0.009893276660128982,0.08329962911012245,0.009893276660128982
J,"Li, X1;  Yang, YJ;  Zheng, J;  Li, Y;  Lin, DN;  Cai, YP",,,,"Li, Xia; Yang, Yujie; Zheng, Jing; Li, Ye; Lin, Denan; Cai, Yunpeng",,,ASSESSMENT OF APPROPRIATENESS OF DRUG USAGE IN CHINESE HYPERTENSIVE PATIENTS AND HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,hypertension; type 2 diabetes; drug; SBP; DBP,BLOOD-PRESSURE; AMERICAN SOCIETY; PREVALENCE; AWARENESS; MANAGEMENT; STATEMENT; ADULTS; AGE; COMMUNITY; COUNTRIES,"Background: Hypertension remains a major global public health problem. The objective of this study was to evaluate the appropriateness of drug usage in Chinese hypertensive patients. Methodology: Patients data with drug usage were collected from Shenzhen in China. Student' t test was used to compare the diastolic blood pressure (DBP) and systolic blood pressure (SBP) differences. Results: A total of 58,971 hypertensive patients and 12,732 hypertensive patients with type 2 diabetes were studied. The abnormal DBP (mean: 81 mmHg) and SBP (mean: above 130 mmHg) observed in two groups indicated both populations were correctly diagnosed with hypertension. Those hypertensive patients with type 2 diabetes got significant higher SBP (mean: 133 mmHg), suggesting they were more severe. After a period of at least 3 years follow up investigations, the SBP of patients with only hypertension dropped to a mean value of 129 mmHg. Hypertensive patients with type 2 diabetes also showed significant SBP decreasing changes, with the mean of SBP around 130 mmHg. The DBP of two groups decreased to the normal range after 3 years (mean: around 79 mmHg). Significance: These results supported the reasonability of current drug usage and had extensive applicability for other hypertensive patients' treatment.","[Li, Xia; Yang, Yujie; Li, Ye; Cai, Yunpeng] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr Biomed Informat Technol, Shenzhen, Peoples R China; [Zheng, Jing; Lin, Denan] Shenzhen Hlth Informat Ctr, Shenzhen, Peoples R China","Cai, YP (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr Biomed Informat Technol, Shenzhen, Peoples R China.;Lin, DN (corresponding author), Shenzhen Hlth Informat Ctr, Shenzhen, Peoples R China.",ldn308@163.com; yp.cai@siat.ac.cn,"Li, Xia/X-3897-2019; Cai, Yunpeng/O-8823-2018","Li, Xia/0000-0002-6068-5182; ",National High-tech R&D Program (863 Program) of China [SS2015AA020109]; Science and Technology Planning Project of Guangdong Province [2015B010129012]; National Natural Science Foundation of China [31501065],"This work was supported by National High-tech R&D Program (863 Program) of China (SS2015AA020109), Science and Technology Planning Project of Guangdong Province (2015B010129012), and the National Natural Science Foundation of China (31501065).","Ahmed H, 2012, JACC-CARDIOVASC INTE, V5, P758, DOI 10.1016/j.jcin.2012.01.02; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS60, DOI 10.2337/dc16-S01; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa080136; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c; DANNENBERG AL, 1987, JAMA-J AM MED ASSOC, V257, P1477, DOI 10.1001/jama.257.11.147; Dubey RK, 2002, CARDIOVASC RES, V53, P688, DOI 10.1016/S0008-6363(01)00527-; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.1857; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa150135; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.19; Holman RR, 2014, LANCET, V383, P2008, DOI 10.1016/S0140-6736(14)60794-; Huri HZ, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-; Larsen RN, 2014, NUTR METAB CARDIOVAS, V24, P976, DOI 10.1016/j.numecd.2014.04.01; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt21; Munger MA, 2010, DRUG AGING, V27, P871, DOI 10.2165/11538650-000000000-0000; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-; Rosendorff C, 2015, HYPERTENSION, V65, P1372, DOI 10.1161/HYP.000000000000001; Salehi N, 2016, ACTA MEDICA MEDITERR, V32, P92; Sorlie PD, 2014, AM J HYPERTENS, V27, P793, DOI 10.1093/ajh/hpu00; Tikkanen I, 2015, DIABETES CARE, V38, P420, DOI 10.2337/dc14-109; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.100; Vijan S, 2003, ANN INTERN MED, V138, P593, DOI 10.7326/0003-4819-138-7-200304010-0001; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu05; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.212; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.1; Wolz M, 2000, AM J HYPERTENS, V13, P103, DOI 10.1016/S0895-7061(99)00241-; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.78816; Xue BJ, 2005, AM J PHYSIOL-HEART C, V288, pH2177, DOI 10.1152/ajpheart.00969.200",30,0,0,2,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,1.0,,,,,153.0,158,,10.19193/0393-6384_2018_1_25,,6,"Medicine, General & Internal",General & Internal Medicine,FV9AH,WOS:000424878600025,,,,,2022-07-14,0.0030991735537190084,0.00011340616409824398,0.06497751754727574,0.11367239334405863,0.06421515017170254
J,"Liu, K1",,,,"Liu, Kun",,,EFFECT OF BUSHEN JIANPI HUOXUE RECIPE ON TIBIAL STRESS INJURIES IN RABBITS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Bushen Jianpi Huoxue Recipe; tibial stress injury in rabbit running,,"The study was aimed to study the preventive effect of Bushen Jianpi Huoxue recipe on tibial stress injury in rabbits. In this research, seventy mature male rabbits were divided randomly and equally into 7 groups with each group containing 10 rabbits. All the mature male rabbits were participated in the passive running and jumping before they undergone the radio nuclide bone imaging and tibial X-ray findings. The histological and electron microscopic changes were observed, and each of the parathyroid hormone (PTH), osteocalcin (BGP) and testosterone concentration (T) was measured. After 2 weeks of continuous stimulation, the trends of stress injury in osteocytes, serum parathyroid hormone and osteocalcin have increased, while serum testosterone is showing an obvious decreasing trend. After three to four weeks, the X-ray, radionuclide bone imaging, histology, and blood biochemistry were carried out on the rabbits. The results showed stress injuries have occurred in the rabbits. In the two medication groups, the X-ray and nuclide bone showed the formation of new bone in the cortex; osteoblastic phase existed in bone cells; serum parathyroid hormone decreased significantly; while serum osteocalcin and blood testosterone level of the rabbits were higher as compared to exercise group in the same week. It can be concluded that Bushen Jianpi Huoxue recipe can be used to treat the tibial stress injury in rabbits effectively by stimulating the new bone formation and enhance the blood testosterone level.","[Liu, Kun] Soochow Univ, Sch Phys Educ, Suzhou 215021, Peoples R China; [Liu, Kun] Jiangxi Univ Tradit Chinese Med, PE Dept, Nanchang 330004, Jiangxi, Peoples R China","Liu, K (corresponding author), Soochow Univ, Sch Phys Educ, Suzhou 215021, Peoples R China.;Liu, K (corresponding author), Jiangxi Univ Tradit Chinese Med, PE Dept, Nanchang 330004, Jiangxi, Peoples R China.",liuk0791@163.com,,,,,"Attari Z, 2016, SAUDI PHARM J, V24, P57, DOI 10.1016/j.jsps.2015.03.00; Balkhair KS, 2016, SAUDI J BIOL SCI, V23, pS83, DOI 10.1016/j.sjbs.2015.10.02; Cankilic MY, 2017, BIOMED RES-INDIA, V28, P310; Chen You-xue, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P738, DOI 10.3736/jcim2008071; Ding X. Q., 2012, EFFECTS JUMPING BON; El-Jakee JK, 2016, SAUDI J BIOL SCI, V23, P48, DOI 10.1016/j.sjbs.2015.06.01; Gao W, 2017, SAUDI PHARM J, V25, P548, DOI 10.1016/j.jsps.2017.04.02; Gao W, 2017, SAUDI J BIOL SCI, V24, P132, DOI 10.1016/j.sjbs.2016.09.00; Hazra M, 2015, SAUDI PHARM J, V23, P429, DOI 10.1016/j.jsps.2015.01.00; Moty SGA, 2016, SAUDI PHARM J, V24, P119, DOI 10.1016/j.jsps.2013.12.01; Ofori-Kwakye K, 2016, SAUDI PHARM J, V24, P82, DOI 10.1016/j.jsps.2015.03.00; Oliveira MTA, 2016, SAUDI J BIOL SCI, V23, P34, DOI 10.1016/j.sjbs.2015.02.00; Sharma V, 2017, ARAB J CHEM, V10, P509, DOI 10.1016/j.arabjc.2014.08.01; Sui Y. H., 2014, EFFECT BUSHEN YIQI ; Sun LX, 2016, SAUDI J BIOL SCI, V23, P66, DOI 10.1016/j.sjbs.2015.10.00; Wroblewska K, 2015, SAUDI PHARM J, V23, P407, DOI 10.1016/j.jsps.2014.11.00; Xia J. Y., 2014, CLIN OBSERVATION BU; Yu X. M., 2014, EFFECT YIQI BUSHEN ",18,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,1.0,,233.0,237,,10.19193/0393-6384_2018_1s_38,,5,"Medicine, General & Internal",General & Internal Medicine,FV9AM,WOS:000424879100003,,,,,2022-07-14,0.001859504132231405,4.647863021578567e-06,0.0023509192073738784,0.08560235583342914,0.002414566270251476
J,"Liu, M1;  Gao, BH;  Lv, BQ;  Qin, CL;  Kou, GN",,,,"Liu, Meng; Gao, Bing-Hong; Lv, Bing-Qiang; Qin, Chun-Li; Kou, Guang-Ning",,,CITRUS FRUIT INTAKE DECREASES THE RISK OF INCIDENT TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,Citrus fruits; TypeIIdiabetes; Risk; Meta-analysis; women,CORONARY-HEART-DISEASE; VEGETABLE CONSUMPTION; DIETARY FIBER; INSULIN-RESISTANCE; NUTRITIONAL EPIDEMIOLOGY; OXIDATIVE STRESS; MELLITUS; HEALTH; COHORT; WOMEN,"Objective: Increasing total fruit consumption is often used in the management of typeII diabetes. However, so far we are not know the orange whether effective reduce the incidence of typeIIdiabetes so the target of this study was to review and conduct quantitative analyses of the results from expected cohort researches which assessed the correlation between the citrus ingestion and the risk of typeII diabetes. Materials and methods: The research team identified the pertinent studies by a systematical search in PubMed, Embase, Science Direct and Cochrane Library up to May 2017. Furthermore, the reseachers also used the random-effect model to combine the study-specific results and the subgroup analyses. Sensitivity analyses were also carried out. Researchers used the funnel plot of beg for estimating publication bias. Publication bias was estimated by using Begg's funnel plot. Results: This study selected a total 13 prospective studies that included 415462 participants from eight publications. The combined relative risk (RR) of type II diabetes for the highest versus the lowest category of the citrus fruit intake were 0.85 (95% CI, 0.78-0.92; p = 0.0001) for the incidence of all typeII diabetes events, and the correlation of subgroup analysis with sex, region, duration of follow-up, amount of cases and study quality was highly consistent with the overall data. For female subjects, there are exsit significant protective associations that between the citrus intake and the type II diabetes risk (RR, 0.83; 95% CI, 0.73-0.93; p = 0.000). The studies with follow-up were longer than 10 years (RR, 0.81; 95% CI, 0.73-0.89; p = 0.001). No publication bias was found. Conclusions: These results indicate that the consumption of citrusis inversely correlated with the risk of typeIIdiabetes, especially for female.","[Kou, Guang-Ning] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Liu, Meng; Lv, Bing-Qiang; Qin, Chun-Li] Chongqing Adm Sport, Chongqing Inst Sport Sci, Chongqing, Peoples R China; [Kou, Guang-Ning] Chongqing Southwest Inst Fruit Nutr, Chongqing, Peoples R China; [Liu, Meng; Lv, Bing-Qiang; Qin, Chun-Li; Kou, Guang-Ning] Lab Phys Fitness Evaluat & Performance Monitoring, Chongqing, Peoples R China; [Gao, Bing-Hong; Kou, Guang-Ning] Shanghai Sport Univ, Shanghai, Peoples R China","Kou, GN (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China.;Kou, GN (corresponding author), Chongqing Southwest Inst Fruit Nutr, Chongqing, Peoples R China.;Kou, GN (corresponding author), Lab Phys Fitness Evaluat & Performance Monitoring, Chongqing, Peoples R China.",kouguangning@sina.com,,,Chongqing program for production of late maturing Citrus fruits [20184-4]; Chongqing sports bureau RD project [A2017014]; Fundamental Research Funds for the Central Universities [XDJK2017D087],This work was financially supported by Chongqing program for production of late maturing Citrus fruits (20184-4); Chongqing sports bureau R&D project (A2017014); Fundamental Research Funds for the Central Universities (XDJK2017D087).,"Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P; Boeing H, 2013, EUR J CLIN NUTR, V67, P424, DOI 10.1038/ejcn.2013.4; Carter Patrice, 2010, BMJ, V341, pc4229, DOI 10.1136/bmj.c422; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.7; Chen LW, 2012, DIABETES CARE, V35, P1079, DOI 10.2337/dc11-210; Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.8; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.258; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.62; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.5; Gordon MH, 1996, NAT PROD REP, V13, P265, DOI 10.1039/np996130026; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.00; Hamer M, 2007, J HYPERTENS, V25, P2361, DOI 10.1097/HJH.0b013e3282efc21; Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.149; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-; Holt EM, 2009, J AM DIET ASSOC, V109, P414, DOI 10.1016/j.jada.2008.11.03; Keogh RH, 2013, STAT MED, V32, P3838, DOI 10.1002/sim.580; Kurotani K, 2013, BRIT J NUTR, V109, P709, DOI 10.1017/S000711451200170; Lattimer JM, 2010, NUTRIENTS, V2, P1266, DOI 10.3390/nu212126; Li J, 2014, EUR REV MED PHARMACO, V18, P177; Li S, 2017, EUR REV MED PHARMACO, V21, P349; Li SS, 2015, ENDOCRINE, V48, P454, DOI 10.1007/s12020-014-0351-; Liese AD, 2003, AM J CLIN NUTR, V78, P965, DOI 10.1093/ajcn/78.5.96; Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.299; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.92; Meyer KA, 2000, AM J CLIN NUTR, V71, P92; Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.160209; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f500; Mursu J, 2014, AM J CLIN NUTR, V99, P328, DOI 10.3945/ajcn.113.06964; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM19930610328230; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.37; Roza JM, 2007, ALTERN THER HEALTH M, V13, P4; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.10; Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.57; Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.20140067",35,1,1,1,14,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1743.0,1749,,10.19193/0393-6384_2018_6_267,,7,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400018,,,,,2022-07-14,0.003615702479338843,1.2907248384742419e-23,0.018487124720042283,0.06303109230017906,0.018487124720042283
J,"Maltese, A1;  Salerno, M;  Cerroni, F;  Romano, P;  Di Folco, A;  Di Filippo, T;  Tripi, G",,,,"Maltese, Agata; Salerno, Margherita; Cerroni, Francesco; Romano, Palmira; Di Folco, Annabella; Di Filippo, Teresa; Tripi, Gabriele",,,THE TRANSCRANIAL STIMULATION WITH DIRECT CURRENTS (TDCS): AN HISTORICAL AND CONCEPTUAL MINIREVIEW,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,Transcranial Stimulation with Direct Currents; non invasive brain stimulation; tDCS,HUMAN MOTOR CORTEX; MAGNETIC STIMULATION; CHILDHOOD MIGRAINE; PREFRONTAL CORTEX; HEALTHY-SUBJECTS; PARIETAL CORTEX; VISUAL-SEARCH; CHILDREN; SLEEP; AURA,"Transcranial Stimulation with Direct Currents (tDCS) is a method for non invasive brain stimulation created to induce functional changes in cerebral cortex. tDCS consists of application on the scalp of electrodes providing a low intensity direct current influencing neuronal functions. tDCS is not the only neurostimulation method for neuroscience clinical practice and research and can be used for treat many different clinical conditions such as migraine prevention, autism spectrum disorders (ASD), cerebral palsy rehabilitation, post-traumatic brain injury neuropsychological disorders.","[Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira] Univ Campania Luigi Vanvitelli, Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Caserta, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325; Cerroni, Francesco/0000-0003-3024-5482",,,"Andrade SM, 2017, J NEUROL SCI, V378, P225, DOI 10.1016/j.jns.2017.05.00; Bracco M, 2017, NEUROPSYCHOLOGIA, V101, P30, DOI 10.1016/j.neuropsychologia.2017.05.00; Bracco M, 2017, NEUROSCI LETT, V641, P45, DOI 10.1016/j.neulet.2017.01.02; Cambiaghi M, 2018, J NEUROL, V265, P2466, DOI 10.1007/s00415-018-8739-; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Duarte NDC, 2018, PEDIATR PHYS THER, V30, P67, DOI 10.1097/PEP.000000000000046; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Havrda M, 2015, EARLY SCI MED, V20, P265, DOI 10.1163/15733823-00203P0; Kim HJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/137294; Lewis PM, 2016, NEUROSCIENTIST, V22, P406, DOI 10.1177/107385841664670; MacPhersona SE, 2017, NEUROPSYCHOLOGIA, V96, P19, DOI 10.1016/j.neuropsychologia.2016.12.02; Mangano GR, 2015, NEUROPSYCHOLOGIA, V70, P196, DOI 10.1016/j.neuropsychologia.2015.03.00; Mangano GR, 2014, VISION RES, V97, P74, DOI 10.1016/j.visres.2014.02.00; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Muszkat D, 2016, J CHILD ADOL PSYCHOP, V26, P590, DOI 10.1089/cap.2015.017; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.; de Amorim RLO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0016; Oliveri M, 2010, NEUROPSYCHOLOGIA, V48, P1003, DOI 10.1016/j.neuropsychologia.2009.11.02; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-0002; Przeklasa-Muszynska A, 2017, PHARMACOL REP, V69, P714, DOI 10.1016/j.pharep.2017.02.01; Rosenkranz K, 2000, NEUROSCI LETT, V296, P61, DOI 10.1016/S0304-3940(00)01621-; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Sanchez-Kuhn A, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0361-; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Smirni D, 2017, NEUROPSYCHOLOGIA, V102, P109, DOI 10.1016/j.neuropsychologia.2017.06.00; Smirni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.014483; Steinberg H, 2013, PSYCHOL MED, V43, P669, DOI 10.1017/S003329171200292; Turriziani P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.0006; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.00; Turriziani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.000531; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07",52,1,1,1,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,697.0,702,,10.19193/0393-6384_2018_3_107,,6,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000012,,,,,2022-07-14,0.004855371900826446,0.05142548720862088,0.003501811388594589,0.11068043311723208,0.003380842188695361
J,"Maltese, A21;   Cerroni, F;   Romano, P;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Cerroni, Francesco; Romano, Palmira; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,RETRACTED: THE COMPLEX COGNITIVE SYSTEM OF EXECUTIVE FUNCTIONING: A CONCEPTUAL REVIEW (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Review; Retracted Publication,,,,,,SAS; executive functioning; cognition,TRANSCRANIAL MAGNETIC STIMULATION; AUTISM SPECTRUM DISORDER; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; HEALTHY-SUBJECTS; CHILDREN; ADOLESCENTS; THERAPY; CORTEX; AURA,"Every day we are faced with a variety of situations that require the use of cognitive processes different, such as recognizing and memorizing stimuli, understanding and producing statements, solving problems. In recent decades, cognitive psychology and neuropsychology have made considerable advances in description of these processes and how they can be disrupted as a result of an injury to the nervous system central. However, it is clear that our adaptation to the environment is not limited to perceiving, reading, and speaking. A fundamental aspect of mental life is represented by the need to continuously modulate the use of these cognitive resources to contingent needs according to our goals and goals. It is this type of problem that refers to the expression executive functions (EFs). During developmental age Efs change consistently and since age of 8 years many Efs are similar to adults.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Cerroni, Francesco/0000-0003-3024-5482; TRIPI, Gabriele/0000-0001-7088-9325; Marotta, Rosa/0000-0003-0515-5952",,,"Auvin S, 2012, EUR J PEDIATR, V171, P1695, DOI 10.1007/s00431-012-1813-; Boccia G, 2006, CEPHALALGIA, V26, P1214, DOI 10.1111/j.1468-2982.2006.01196.; Bracco M, 2017, NEUROPSYCHOLOGIA, V101, P30, DOI 10.1016/j.neuropsychologia.2017.05.00; Bracco M, 2017, NEUROSCI LETT, V641, P45, DOI 10.1016/j.neulet.2017.01.02; Carey CE, 2018, J AM ACAD CHILD PSY, V57, P146, DOI 10.1016/j.jaac.2018.01.00; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Cirino PT, 2018, NEUROPSYCHOLOGY, V32, P176, DOI 10.1037/neu000042; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Ishihara T, 2018, EUR J SPORT SCI, V18, P741, DOI 10.1080/17461391.2018.144479; Kouklari EC, 2018, RES DEV DISABIL, V76, P12, DOI 10.1016/j.ridd.2018.02.01; MacPhersona SE, 2017, NEUROPSYCHOLOGIA, V96, P19, DOI 10.1016/j.neuropsychologia.2016.12.02; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Mangano GR, 2015, NEUROPSYCHOLOGIA, V70, P196, DOI 10.1016/j.neuropsychologia.2015.03.00; Mangano GR, 2014, VISION RES, V97, P74, DOI 10.1016/j.visres.2014.02.00; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Oliveri M, 2010, NEUROPSYCHOLOGIA, V48, P1003, DOI 10.1016/j.neuropsychologia.2009.11.02; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Smirni D, 2017, NEUROPSYCHOLOGIA, V102, P109, DOI 10.1016/j.neuropsychologia.2017.06.00; Smirni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.014483; Sonney J, 2019, J ASTHMA, V56, P179, DOI 10.1080/02770903.2018.144187; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Turriziani P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.0006; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.00; Turriziani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.000531; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Zelazo PD, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.0020",52,0,0,4,14,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,915.0,920,,10.19193/0393-6384_2018_4_139,,6,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500002,,,,,2022-07-14,0.0046487603305785125,0.04601114920496983,0.003762311500567755,0.11268523800100112,0.0030753898720414573
J,"Maltese, A31;   Cerroni, F;   Romano, P;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Cerroni, Francesco; Romano, Palmira; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,"RETRACTED: TECHNOLOGY, EDUCATIONAL CHALLENGES: SERIOUS GAME AND REHABILITATION (Retracted Article)",ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,Serious games; virtual reality; electronic devices,TRANSCRANIAL MAGNETIC STIMULATION; AUTISM SPECTRUM DISORDERS; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; HEALTHY-SUBJECTS; CHILDREN; ADOLESCENTS; STRESS; SLEEP; BRAIN,"During child neurodevelopment, parenting plays the key role for accompanying children trough the evolutionary path, taking into account the various risks and dangers that may occur. Actually, certain delays or developmental disturbances may be considered as the consequence of incorrect parenting behavior. In this perspective the use of electronic devices may be observed seriously.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","TRIPI, Gabriele/0000-0001-7088-9325; Cerroni, Francesco/0000-0003-3024-5482; Marotta, Rosa/0000-0003-0515-5952",,,"Auvin S, 2012, EUR J PEDIATR, V171, P1695, DOI 10.1007/s00431-012-1813-; Boccia G, 2006, CEPHALALGIA, V26, P1214, DOI 10.1111/j.1468-2982.2006.01196.; Bracco M, 2017, NEUROPSYCHOLOGIA, V101, P30, DOI 10.1016/j.neuropsychologia.2017.05.00; Bracco M, 2017, NEUROSCI LETT, V641, P45, DOI 10.1016/j.neulet.2017.01.02; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.0029; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Fisher Paul G, 2017, J Pediatr, V191, P1, DOI 10.1016/j.jpeds.2017.10.02; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1189, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Horowitz-Kraus T, 2018, ACTA PAEDIATR, V107, P685, DOI 10.1111/apa.1417; Kenney EL, 2017, J PEDIATR-US, V182, P144, DOI 10.1016/j.jpeds.2016.11.01; MacPhersona SE, 2017, NEUROPSYCHOLOGIA, V96, P19, DOI 10.1016/j.neuropsychologia.2016.12.02; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Mangano GR, 2015, NEUROPSYCHOLOGIA, V70, P196, DOI 10.1016/j.neuropsychologia.2015.03.00; Mangano GR, 2014, VISION RES, V97, P74, DOI 10.1016/j.visres.2014.02.00; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Monda V, 2018, MOL NEUROBIOL, V55, P6362, DOI 10.1007/s12035-017-0865-; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Nelissen S, 2018, INFORM COMMUN SOC, V21, P375, DOI 10.1080/1369118X.2017.128199; Ogelman HG, 2018, EARLY CHILD DEV CARE, V188, P168, DOI 10.1080/03004430.2016.120819; Oliveri M, 2010, NEUROPSYCHOLOGIA, V48, P1003, DOI 10.1016/j.neuropsychologia.2009.11.02; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2018, CLIN DRUG INVEST, V38, P457, DOI 10.1007/s40261-018-0627-; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Smirni D, 2017, NEUROPSYCHOLOGIA, V102, P109, DOI 10.1016/j.neuropsychologia.2017.06.00; Smirni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.014483; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Turriziani P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.0006; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.00; Turriziani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.000531; Vecchio D, 2011, MINERVA PEDIATR, V63, P34",68,0,0,3,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,921.0,927,,10.19193/0393-6384_2018_4_140,,7,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500003,,,,,2022-07-14,0.005991735537190082,0.06465465032640802,0.00455681075041156,0.11273248162856511,0.004792654031897899
J,"Maltese, A41;   Cerroni, F;   Romano, P;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Cerroni, Francesco; Romano, Palmira; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,RETRACTED: THE CEREBRAL LOCALIZATION OF EXECUTIVE FUNCTIONS (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,Executive Functions; frontal lobes; cortical areas; neuropsychology,AUTISM SPECTRUM DISORDERS; BEHAVIORAL-DISORDERS; MATERNAL STRESS; DEVELOPMENTAL DYSLEXIA; CHILDHOOD MIGRAINE; PARENTAL STRESS; OREXIN SYSTEM; CHILDREN; ADOLESCENTS; THERAPY,"Executive Functions (EFs) are a complex neuropsychological tool that can lead all action of daily-life indipendently from age. The attempt to associate specific regions of the central nervous system (CNS) with specific sensory functions, motor and cognitive skills is one of the most recurring themes in the history of neuroscience. The concept of cerebral localization of mental activities started from the formulations of beginning phrenologists in Nineteenth century, passing through the holistic conceptions and antilocalization that marked some periods of the Twentieth century, until the beginning of the new millennium, characterized by the enormous popularity of the techniques of functional neuroimaging and the success of research programs aiming to create a real functional cartography of the human cerebral cortex.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Cerroni, Francesco/0000-0003-3024-5482; Marotta, Rosa/0000-0003-0515-5952; TRIPI, Gabriele/0000-0001-7088-9325",,,"[Anonymous], 2013, CURRENT TOPICS TOXIC, V9, P2; Burgess PW, 2017, J INT NEUROPSYCH SOC, V23, P755, DOI 10.1017/S135561771700070; Capovilla G, 2004, EPILEPSIA, V45, P887, DOI 10.1111/j.0013-9580.2004.457erratum.; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.0029; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Craik FIM, 2018, CAN J EXP PSYCHOL, V72, P141, DOI 10.1037/cep000014; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2018, ACTA MEDICA MEDITERR, V34, P697, DOI 10.19193/0393-6384_2018_3_10; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Matricardi S, 2018, ACTA NEUROL SCAND, V137, P575, DOI 10.1111/ane.1290; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0025; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Monda V, 2018, MOL NEUROBIOL, DOI [10.1007/s12035-017-0865-zM, DOI 10.1007/S12035-017-0865-ZM; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Monda V, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0069; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2018, CLIN DRUG INVEST, V38, P457, DOI 10.1007/s40261-018-0627-; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Salmon DP, 2013, NEUROLOGY, V80, P2174, DOI 10.1212/WNL.0b013e318296ea3; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Smirni D, 2018, NEUROL SCI, V39, P1391, DOI 10.1007/s10072-018-3433-; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.209; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S135561771100069; Tafuri D, 2015, BIOL MED, V; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",69,0,0,2,11,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,929.0,935,,10.19193/0393-6384_2018_4_141,,7,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500004,,,,,2022-07-14,0.005888429752066116,0.0740097760420664,0.005049245777192502,0.11272985594335558,0.005120091744711687
J,"Maltese, A51;   Cerroni, F;   Romano, P;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Cerroni, Francesco; Romano, Palmira; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,RETRACTED: ANXIETY DISORDERS IN DEVELOPMENTAL AGE (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,social phobia; Separation anxiety,TRANSCRANIAL MAGNETIC STIMULATION; AUTISM SPECTRUM DISORDERS; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; HEALTHY-SUBJECTS; CHILDREN; ADOLESCENTS; THERAPY; AURA; STRESS,"Anxiety disorders represent the more common psychiatric disorder in developmental age and it is estimated that a third of adolescents satisfy the criteria for an anxiety disorder at the age of 18. Many researches show that the disorders of anxiety in childhood are associated with anxiety disorders in adulthood, depressive disorders and use of psychoactive substances. Suffering from anxiety disorders, such as specific phobia, agoraphobia, social anxiety or panic disorder, represents a strong predictor for the development of other psychiatric disorders consequential. In the literature the debate on the weight of environmental factors and genetic factors in determining the development of anxiety disorders is ongoing.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","TRIPI, Gabriele/0000-0001-7088-9325; Marotta, Rosa/0000-0003-0515-5952; Cerroni, Francesco/0000-0003-3024-5482",,,"Bracco M, 2017, NEUROPSYCHOLOGIA, V101, P30, DOI 10.1016/j.neuropsychologia.2017.05.00; Bracco M, 2017, NEUROSCI LETT, V641, P45, DOI 10.1016/j.neulet.2017.01.02; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; de Lijster JM, 2018, J AFFECT DISORDERS, V230, P108, DOI 10.1016/j.jad.2018.01.00; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1189, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Kaliebe K, 2018, CHILD ADOL PSYCH CL, V27, pXIII, DOI 10.1016/j.chc.2017.12.00; MacPhersona SE, 2017, NEUROPSYCHOLOGIA, V96, P19, DOI 10.1016/j.neuropsychologia.2016.12.02; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Mangano GR, 2015, NEUROPSYCHOLOGIA, V70, P196, DOI 10.1016/j.neuropsychologia.2015.03.00; Mangano GR, 2014, VISION RES, V97, P74, DOI 10.1016/j.visres.2014.02.00; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Oliveri M, 2010, NEUROPSYCHOLOGIA, V48, P1003, DOI 10.1016/j.neuropsychologia.2009.11.02; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Pearcey S, 2018, J AFFECT DISORDERS, V229, P469, DOI 10.1016/j.jad.2017.12.07; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Smirni D, 2017, NEUROPSYCHOLOGIA, V102, P109, DOI 10.1016/j.neuropsychologia.2017.06.00; Smirni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.014483; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Suveg C, 2018, J ABNORM CHILD PSYCH, V46, P569, DOI 10.1007/s10802-017-0319-; Turriziani P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.0006; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.00; Turriziani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.000531; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Wissemann K, 2018, CHILD PSYCHIAT HUM D, V49, P814, DOI 10.1007/s10578-018-0797-",60,0,0,0,11,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,937.0,943,,10.19193/0393-6384_2018_4_142,,7,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500005,,,,,2022-07-14,0.005268595041322314,0.06438992641509893,0.004223544859213694,0.1127141044002748,0.004800093214625977
J,"Maltese, A61;   Cerroni, F;   Romano, P;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Cerroni, Francesco; Romano, Palmira; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,RETRACTED: DIGITAL NATIVES: LUCKY OR JELLIED? (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,digital natives; Millennial Generation; media devices,TRANSCRANIAL MAGNETIC STIMULATION; AUTISM SPECTRUM DISORDERS; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; CHILDREN; ADOLESCENTS; AURA; THERAPY; STRESS; CORTEX,"The technology now seems to have involved not only the world of adults, but also and especially that of children, becoming a form of communication and rapid interaction and widespread dissemination. Some parents start to worry about a possible technological dependency, given the hours spent by the youngest, called digital children, in front of computer, smartphones and tablets. A decade ago, the sociologist Mark Prensky spoke of digital natives, that is the first generation of children grew up with consoles, videogames and computers while today we are witnessing an evolution of this concept in the third generation of digital, appeared approximately with the arrival of iPad and tablet and is constantly evolving in a technology with wi-fi, app (programs designed for smartphones) and touchscreen.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; TRIPI, Gabriele/0000-0001-7088-9325; Cerroni, Francesco/0000-0003-3024-5482",,,"Bracco M, 2017, NEUROPSYCHOLOGIA, V101, P30, DOI 10.1016/j.neuropsychologia.2017.05.00; Bracco M, 2017, NEUROSCI LETT, V641, P45, DOI 10.1016/j.neulet.2017.01.02; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; de Wet C, 2015, SCOT MED J, V60, P152, DOI 10.1177/003693301559717; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1189, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Katz VS, 2017, PEDIATRICS, V140, pS132, DOI 10.1542/peds.2016-1758; MacPhersona SE, 2017, NEUROPSYCHOLOGIA, V96, P19, DOI 10.1016/j.neuropsychologia.2016.12.02; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Mangano GR, 2015, NEUROPSYCHOLOGIA, V70, P196, DOI 10.1016/j.neuropsychologia.2015.03.00; Mangano GR, 2014, VISION RES, V97, P74, DOI 10.1016/j.visres.2014.02.00; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Oliveri M, 2010, NEUROPSYCHOLOGIA, V48, P1003, DOI 10.1016/j.neuropsychologia.2009.11.02; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Paudel S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-01458; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Prensky M, 2001, DIGITAL NATIVES DIGI, V; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Smirni D, 2017, NEUROPSYCHOLOGIA, V102, P109, DOI 10.1016/j.neuropsychologia.2017.06.00; Smirni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.014483; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Turriziani P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.0006; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.00; Turriziani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.000531; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Velasco HF, 2015, J PEDIAT-BRAZIL, V91, P183, DOI 10.1016/j.jped.2014.07.00",60,0,0,1,9,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,945.0,950,,10.19193/0393-6384_2018_4_143,,6,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500006,,,,,2022-07-14,0.005268595041322314,0.06236018672566688,0.004073889535363308,0.1127141044002748,0.004309061832346659
J,"Maltese, A71;   Cerroni, F;   Romano, P;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Cerroni, Francesco; Romano, Palmira; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,RETRACTED: A MINIREVIEW ABOUT PRETERM BIRTH AND MAIN SPECIFIC NEURODEVELOPMENTAL DISORDERS (Retracted article),ACTA MEDICA MEDITERRANEA,,,English,Review; Retracted Publication,,,,,,neurodevelopmental disorders; specific learning disorders; sensorial disability; very low birth weight,AUTISM SPECTRUM DISORDER; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; CHILDREN; ADOLESCENTS; THERAPY; AURA; STRESS; SLEEP,"The preterm birth interrupts the physiological processes that allow the development of the Nervous System and of the body apparatus. Preterm children present a multi-organ dysfunction inversely proportional to the gestational age, leading to respiratory, cardiovascular, haematological, metabolic, infectious, and neurological problems.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] Childhood Psychiat Serv Neurodev Disorders, Ch Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; Cerroni, Francesco/0000-0003-3024-5482",,,"Arpino Carla, 2005, Ann Ist Super Sanita, V41, P22; Arpino C, 2010, CHILD NERV SYST, V26, P1139, DOI 10.1007/s00381-010-1125-; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.0029; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Ferreira C, 2017, CODAS, V29, DOI 10.1590/2317-1782/2017201528; Fumagalli M, 2015, J MATERN-FETAL NEO M, V28, P2280, DOI 10.3109/14767058.2013.79616; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Plomgaard AM, 2016, PEDIATR RES, V79, P466, DOI 10.1038/pr.2015.23; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Sirgiovanni I, 2014, PEDIATR RADIOL, V44, P289, DOI 10.1007/s00247-013-2826-; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Vecchio D, 2011, MINERVA PEDIATR, V63, P34",41,0,0,3,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1171.0,1176,,10.19193/0393-6384_2018_5_179,,6,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700001,,,,,2022-07-14,0.003512396694214876,0.048457828396376475,0.002545893028474885,0.11265638638347396,0.0019442956183590339
J,"Maltese, A81;   Cerroni, F;   Romano, P;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Cerroni, Francesco; Romano, Palmira; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,RETRACTED: AUGMENTATIVE AND ALTERNATIVE COMMUNICATION (AAC) IN NEURODEVELOPMENTAL DISORDERS: A MINIREVIEW (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Review; Retracted Publication,,,,,,augmentative and alternative communication; devices with voice output; Functional Communication training,TRANSCRANIAL MAGNETIC STIMULATION; AUTISM SPECTRUM DISORDER; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; CHILDREN; ADOLESCENTS; THERAPY; STRESS; SYSTEM; CORTEX,"Children with neurodevelopmental disorders such as Autism Spectrum Disorders (ASD), cerebral palsy or severe motor speech disorders may beneficiate of augmentative and alternative communication (AAC) systems that may improve the developing language and the communication abilities. The term AAC tend to include each form of communication supplementing or replacing the natural speech production.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] Childhood Psychiat Serv Neurodev Disorders, Ch Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; Cerroni, Francesco/0000-0003-3024-5482",,,"An SN, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0165-; Borg S, 2015, STUD HEALTH TECHNOL, V217, P811, DOI 10.3233/978-1-61499-566-1-81; Bracco M, 2017, NEUROPSYCHOLOGIA, V101, P30, DOI 10.1016/j.neuropsychologia.2017.05.00; Bracco M, 2017, NEUROSCI LETT, V641, P45, DOI 10.1016/j.neulet.2017.01.02; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.0029; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Ferreira C, 2017, CODAS, V29, DOI 10.1590/2317-1782/2017201528; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Ganz JB, 2017, AUGMENT ALTERN COMM, V33, P224, DOI 10.1080/07434618.2017.137385; MacPhersona SE, 2017, NEUROPSYCHOLOGIA, V96, P19, DOI 10.1016/j.neuropsychologia.2016.12.02; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Mandak K, 2018, AUGMENT ALTERN COMM, V34, P130, DOI 10.1080/07434618.2018.143851; Mangano GR, 2015, NEUROPSYCHOLOGIA, V70, P196, DOI 10.1016/j.neuropsychologia.2015.03.00; Mangano GR, 2014, VISION RES, V97, P74, DOI 10.1016/j.visres.2014.02.00; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Mohan V, 2019, DISABIL REHABIL-ASSI, V14, P75, DOI 10.1080/17483107.2017.141314; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; O'Neill T, 2017, SEMIN SPEECH LANG, V38, P313, DOI 10.1055/s-0037-160427; Oliveri M, 2010, NEUROPSYCHOLOGIA, V48, P1003, DOI 10.1016/j.neuropsychologia.2009.11.02; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Romski M A, 1999, ASHA, V41, P3; ROMSKI MA, 1994, AM J MENT RETARD, V98, P52; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Smirni D, 2017, NEUROPSYCHOLOGIA, V102, P109, DOI 10.1016/j.neuropsychologia.2017.06.00; Smirni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.014483; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Thiemann-Bourque K, 2016, J SPEECH LANG HEAR R, V59, P1133, DOI 10.1044/2016_JSLHR-L-15-031; Turriziani P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.0006; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.00; Turriziani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.000531; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Zink AG, 2018, PEDIATR DENT, V40, P1",59,0,0,8,22,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1181.0,1187,,10.19193/0393-6384_2018_5_181,,7,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700003,,,,,2022-07-14,0.005371900826446281,0.05235773709852321,0.004584728830947054,0.11270360581681006,0.003964643756267671
J,"Maltese, A91;   Romano, P;   Cerroni, F;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Romano, Palmira; Cerroni, Francesco; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,RETRACTED: EXECUTIVE FUNCTIONS REHABILITATION PROPOSAL: A TAILORED INTERVENTION (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,Executive Functions; tailored-chid rehabilitation; cognitive-behavioral training,AUTISM SPECTRUM DISORDER; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; CHILDREN; ADOLESCENTS; THERAPY; AURA; PRETERM; STRESS; SLEEP,"Executive functions (EFs) are cognitive processes that allow the development of intentional behaviors e requiring the ability to formulate goals and objectives, capacity for initiative, to anticipate the consequences of actions, to organize behavior and monitor it and adapt it based on the context. Patients with EFs deficiencies exhibit specific disorders of planning, regulation and correction intentional conduct and cognitive activity, while they have no problem in the execution of usual action sequences.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Romano, Palmira; Cerroni, Francesco; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] Childhood Psychiat Serv Neurodev Disorders, Ch Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; Cerroni, Francesco/0000-0003-3024-5482",,,"Arpino Carla, 2005, Ann Ist Super Sanita, V41, P22; Arpino C, 2010, CHILD NERV SYST, V26, P1139, DOI 10.1007/s00381-010-1125-; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.0029; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Fumagalli M, 2015, J MATERN-FETAL NEO M, V28, P2280, DOI 10.3109/14767058.2013.79616; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Plomgaard AM, 2016, PEDIATR RES, V79, P466, DOI 10.1038/pr.2015.23; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Sirgiovanni I, 2014, PEDIATR RADIOL, V44, P289, DOI 10.1007/s00247-013-2826-; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Vecchio D, 2011, MINERVA PEDIATR, V63, P34",39,1,1,3,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1189.0,1194,,10.19193/0393-6384_2018_5_182,,6,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700004,,,,,2022-07-14,0.003409090909090909,0.048395697692097506,0.002443018484734565,0.11265376424174008,0.0018414732029517352
J,"Maltese, A101;   Cerroni, F;   Romano, P;   Russo, D;   Salerno, M;   Gallai, B;   Marotta, R;   Lavano, SM;   Lavano, F;   Tripi, G",,,,"Maltese, Agata; Cerroni, Francesco; Romano, Palmira; Russo, Daniela; Salerno, Margherita; Gallai, Beatrice; Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco; Tripi, Gabriele",,,THE MAIN SEQUELAE OF PRETERM BIRTH: FOCUS ON NEURODEVELOPMENTAL DISORDERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,preterm birth; periventricular leukomalacia; Neonatal Intensive Care Unit,AUTISM SPECTRUM DISORDERS; BEHAVIORAL-DISORDERS; CHILDHOOD MIGRAINE; CHILDREN; ADOLESCENTS; THERAPY; STRESS; AURA; HEMORRHAGE; SLEEP,"Preterm birth is a traumatic event that interrupts the physiological processes that allow the development of the Nervous System and the body systems, resulting in a multi-organ dysfunction, of an entity in inverse proportion to the gestational age, which causes respiratory, cardiovascular, metabolic, infectious endocrine problems. and neurological. In particular, at a neurological level, in the most serious cases, for macroscopic lesions of the Central Nervous System, there is the risk of incurring in evolutionary Disabilities (Infantile Cerebral Palsy etc.); but in the absence of severe damage, since the birth occurs at a critical moment of the cerebral development in which the cortex is being organized, it is possible to establish minor deficits, arising from alterations in neural connectivity.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Cerroni, Francesco; Romano, Palmira; Russo, Daniela] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Serena Marianna; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] Childhood Psychiat Serv Neurodev Disorders, Ch Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; Cerroni, Francesco/0000-0003-3024-5482",,,"Arpino Carla, 2005, Ann Ist Super Sanita, V41, P22; Arpino C, 2010, CHILD NERV SYST, V26, P1139, DOI 10.1007/s00381-010-1125-; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.0029; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Fumagalli M, 2015, J MATERN-FETAL NEO M, V28, P2280, DOI 10.3109/14767058.2013.79616; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1257, DOI 10.19193/0393-6384_2017_2s_19; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Plomgaard AM, 2016, PEDIATR RES, V79, P466, DOI 10.1038/pr.2015.23; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Sirgiovanni I, 2014, PEDIATR RADIOL, V44, P289, DOI 10.1007/s00247-013-2826-; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Vecchio D, 2011, MINERVA PEDIATR, V63, P34",39,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1195.0,1200,,10.19193/0393-6384_2018_5_183,,6,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700005,,,,,2022-07-14,0.003409090909090909,0.048395697692097506,0.002443018484734565,0.11265376424174008,0.0018414732029517352
J,"Maltese, A141;   Gallai, B;   Romano, P;   D'Oro, L;   Marotta, R;   Lavano, F;   Lavano, SM;   Tripi, G;   Salerno, M",,,,"Maltese, Agata; Gallai, Beatrice; Romano, Palmira; D'Oro, Lucrezia; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Tripi, Gabriele; Salerno, Margherita",,,"RETRACTION: MOTION SICKNESS IN CHILDHOOD MIGRAINE (Retraction of Vol 33, Pg 1241, 2017)",ACTA MEDICA MEDITERRANEA,,,English,Retraction,,,,,,,,,"[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Romano, Palmira] Ctr LARS, Sarno, Italy; [D'Oro, Lucrezia] Ctr Relax, Benevento, Italy; [Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Maltese, A (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020",,,,"Al-Twaijri WA, 2002, PEDIATR NEUROL, V26, P365, DOI 10.1016/S0887-8994(01)00416-; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P1241, DOI 10.19193/0393-6384_2017_2s_19",2,0,0,2,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,,,1241.0,,,7,"Medicine, General & Internal",General & Internal Medicine,HF1IM,WOS:000453919900002,,,,,2022-07-14,0.00020661157024793388,0.0009726136158351347,2.2875216851957114e-05,0.09859341420437763,9.100238016170838e-06
J,"Maniaci, G1;  La Cascia, C;  Ferraro, L;  Picone, F;  Sideli, L;  Seminerio, F;  Scaglione, A;  La Barbera, D;  Cannizzaro, C",,,,"Maniaci, Giuseppe; La Cascia, Caterina; Ferraro, Laura; Picone, Francesca; Sideli, Lucia; Seminerio, Fabio; Scaglione, Alessandra; La Barbera, Daniele; Cannizzaro, Carla",,,THE EFFICACY OF A FUNCTIONAL THERAPY PROGRAM FOR GAMBLING DISORDER: A PILOT STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Gambling disorder treatment; Functional Therapy; body-oriented therapy; treatment outcome,,"Background: Despite the great progress achieved by treatment approaches for Gambling Disorder (GD) the relevance of studying efficacious therapies still remains high. This pilot study aims at the evaluation of the efficacy of a standardized protocol based on Functional theory for GD. Functional Therapy (FT) is an integrated body-mind therapy. Methods: Twenty-eight pathological gamblers completed the FT protocol consisted in 16 sessions, two times a week for a total duration of two months, in an individual setting. No one of the patients was taking any psychopharmacological therapy. Psychological assessment both at baseline (T0) and at the end of the treament (T1) includes the South Oaks Gambling Screen, the PG-Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS), State-Trait Anxiety Inventory (STAI), the Beck Depression Inventory II version (BDI-II), the Barrat Impulsiveness Scale 11th version (BIS-11) and the Measurement of Psychological Stress (MSP). Results: a significant reduction of GD (gambling frequency, duration, money inserted, and expenditure) in pathological gamblers was revealed together with a significant reduction of depression, anxiety, impulsivity and perceived stress. Conclusions: the structured FT program for GD highlights a strong improvement in gambling behavior, in reducing impulsivity, depression, anxiety and perceived stress, thus obtaining a good compliance and a few dropout.","[Maniaci, Giuseppe; La Cascia, Caterina; Ferraro, Laura; Sideli, Lucia; Seminerio, Fabio; Scaglione, Alessandra; La Barbera, Daniele] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Picone, Francesca] ASP Palermo, Dept Pathol Addict, Palermo, Italy; [Cannizzaro, Carla] Giuseppe DAlessandro Univ Palermo, Dept Sci Hlth Promot & Mother & Child Care, Palermo, Italy","Maniaci, G (corresponding author), Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy.",giuseppemaniaci@icloud.com,"Ferraro, Laura/AAG-3724-2020; La Cascia, Caterina/U-7743-2017; La Barbera, Daniele/AAX-5591-2020","Ferraro, Laura/0000-0002-1205-2356; La Cascia, Caterina/0000-0002-2078-0214; La Barbera, Daniele/0000-0002-9506-4546",,,"Achab S, 2011, CURR PHARM DESIGN, V17, P1389, DOI 10.2174/13816121179615077; American Psychiatric Association American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5t; Beck A.T., 1996, BECK DEPRESSION INV; BERGER BG, 1988, RES Q EXERCISE SPORT, V59, P148, DOI 10.1080/02701367.1988.1060549; Cavallaro A, 2016, ACTA MEDICA MEDITERR, V32, P903, DOI 10.19193/0393-6384_2016_4_10; Chambless DL, 2001, ANNU REV PSYCHOL, V52, P685, DOI 10.1146/annurev.psych.52.1.68; Cowlishaw S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008937.pub; Di Nuovo S, 2000, MISURARE STRESS LIN; Dunn K., 2012, J GAMBL STUD, V12, P; Gambling Serpelloni G., 2013, GIOCO AZZARDO PROBL; Hodgins DC, 2004, PSYCHOL ADDICT BEHAV, V18, P293, DOI 10.1037/0893-164X.18.3.29; Ledgerwood DM, 2006, CLIN PSYCHOL REV, V26, P216, DOI 10.1016/j.cpr.2005.11.00; Leeman RF, 2012, PSYCHOPHARMACOLOGY, V219, P469, DOI 10.1007/s00213-011-2550-; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P118; Lupi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/53730; Lushene, MANUAL STATE TRAIT ; Malathi A., 1999, Indian Journal of Physiology and Pharmacology, V43, P21; Maniaci G, 2018, J GAMBL STUD, V34, P147, DOI 10.1007/s10899-017-9685-; Maniaci G, 2017, PSYCHIAT RES, V257, P540, DOI 10.1016/j.psychres.2017.08.00; Maniaci G, 2017, J GAMBL STUD, V33, P633, DOI 10.1007/s10899-016-9636-; Maniaci G, 2015, INT J MENT HEALTH AD, V13, P728, DOI 10.1007/s11469-015-9550-; Murugesan R., 2000, Indian Journal of Physiology and Pharmacology, V44, P20; Netz Y, 2003, J PSYCHOL, V137, P405, DOI 10.1080/0022398030960062; Nower L, 2013, ADDICTION, V108, P789, DOI 10.1111/add.1201; Pallanti S, 2005, J GAMBL STUD, V2; Perciavalle V, 2017, NEUROL SCI, V38, P451, DOI 10.1007/s10072-016-2790-; Perrella R, 2017, MEDITERR J CLIN PSYC, V5, DOI 10.6092/2282-1619/2017.5.166; Petry NM, 2014, J GAMBL STUD, V30, P493, DOI 10.1007/s10899-013-9370-; Plescia F, 2015, ACTA MEDICA MEDITERR, V31, P81; Raju P S, 1997, J Altern Complement Med, V3, P291, DOI 10.1089/acm.1997.3.29; Rash CJ, 2014, PSYCHOL RES BEHAV MA, V7, P285, DOI 10.2147/PRBM.S4088; Rispoli L, 2008, BASIC EXPERIENCE DE; Rispoli L., 2016, CORPO PSICOTERAPIA ; Rosenberg O, 2013, PSYCHIAT RES, V206, P111, DOI 10.1016/j.psychres.2012.09.04; Rosenthal R J, 1994, J Gambl Stud, V10, P21, DOI 10.1007/BF0210977; Smith DP, 2015, BEHAV RES THER, V69, P100, DOI 10.1016/j.brat.2015.04.00; Stinchfield R, 2002, ADDICT BEHAV, V27, P1, DOI 10.1016/S0306-4603(00)00158-; Telles S, 1993, Indian J Med Sci, V47, P23; Toneatto T, 2008, AM J ADDICTION, V17, P298, DOI 10.1080/1055049080213883; Viets VCL, 1997, CLIN PSYCHOL REV, V17, P689, DOI 10.1016/S0272-7358(97)00031-",40,5,5,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1447.0,1452,,10.19193/0393-6384_2018_5_220,,6,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700042,,,,,2022-07-14,0.004132231404958678,1.14972429273498e-11,0.05839320280166911,0.07095889808454958,0.05839320280166911
J,"Merdin, A1",,,,"Merdin, Alparslan",,,SUGGESTION OF NEW FORMULAE TO BE USED IN DISTINGUISHING BETA THALASEMIA TRAIT FROM IRON DEFICIENCY ANEMIA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Thalasemia trait; iron deficiency anemia; discrimination index,DIFFERENTIATION; INDEXES,"Introduction: Clinical findings of thalasemia trait is similar with iron deficiency anemia. It is important to discriminate both from each other. Because treatment approaches are different for the each entities. But, it is not always possible to reach enough laboratory sufficiency for discriminating the two entities everywhere. Some pratical and easy formulae could help for the discrimination in such insufficient technical possibilities. Materials and method: 40 patients included in the study. The formula (RDW(Red blood cell distribution width) X RBC(Red blood cell count) X HGB(Hemoglobin))/MCV(Mean corpuscular volume) was evaluated for the discrimination of the two entities. The formula log(10) (MCH(Mean corpuscular hemoglobin) X MCHC(Mean corpuscular hemoglobin concentration) X RDW / RBC) was also evaluated for the differentiation of these two entities. The latter formula was identified as Alparslan index''. These formulae were compared with the well known indices such as Mentzer index. Youden Index was calculated for each index for comparing the reliability and validity of the indices. Results: The study showed no difference between the compared indices according to the sensitivity. Youden Index were found 94,73 for the Alparslan Index and 89,96 for the Mentzer Index. Discussion: There are many formulae and indices to help have an opinion for the discrimination of beta thalasemia trait from IDA(Iron deficiency anemia). Simply calculable valid formulae could be more commonly and easily used according to the complex calculation formulae. RDWI(Red Blood Cell Distribution Width Index) was found to provide more reliability than Mentzer Index in the study. In the study, Alparslan Index and RDWI were also found to provide same reliability according to Youden Index.","[Merdin, Alparslan] Univ Hlth Sci Ankara, Dr Abdurrahman Yurtaslan Oncol Training & Res Hos, Hematol Clin, Ankara, Turkey; [Merdin, Alparslan] Univ Hlth Sci Ankara, Dr Abdurrahman Yurtaslan Oncol Training & Res Hos, Bone Marrow Transplantat Unit, Ankara, Turkey","Merdin, A (corresponding author), Zerdalilik Mahallesi, Muratpasa Antalya, Turkey.",Alparslanmerdin@yahoo.com,,,,,"Demir A, 2002, PEDIATR INT, V44, P612, DOI 10.1046/j.1442-200X.2002.01636.; GREEN R, 1989, BLOOD CELLS, V15, P48; Jayabose S, 1999, J PEDIAT HEMATOL ONC, V21, P31; MENTZER WC, 1973, LANCET, V1, P88; Ntaios G, 2007, ANN HEMATOL, V86, P487, DOI 10.1007/s00277-007-0302-; Sirdah M, 2008, INT J LAB HEMATOL, V30, P324, DOI 10.1111/j.1751-553X.2007.00966.; SRIVASTAVA PC, 1973, LANCET, V2, P15; Vehapoglu A, 2014, ANEMIA, V2014, DOI 10.1155/2014/57673; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-",9,2,2,1,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,393.0,395,,10.19193/0393-6384_2018_2_62,,3,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400016,,,,,2022-07-14,0.0010330578512396695,1.85308020870256e-08,0.00844229946574291,0.12781746398531685,0.00844229946574291
J,"Messina, A1;  Picciocchi, E;  Monda, V;  Valenzano, A;  Cibelli, G;  Ruberto, V;  Pisanelli, D;  Polito, AN;  Marsala, G;  Di Palma, A;  Barone, AV;  Monda, M;  Ruberto, M;  Gallai, B;  Tripi, G;  Lavan, F;  Salerno, M;  Lavano, SM;  Romano, P;  Cerroni, F;  Russo, D;  Doro, L;  Sorrentino, M;  Magliulo, RM;  Di Folco, A;  Parisi, L;  Testa, D;  Marotta, R;  Messina, G",,,,"Messina, Antonietta; Picciocchi, Elisabetta; Monda, Vincenzo; Valenzano, Anna; Cibelli, Giuseppe; Ruberto, Valentina; Pisanelli, Daniela; Polito, Anna Nunzia; Marsala, Gabriella; Di Palma, Antonella; Barone, Antonia Vanessa; Monda, Marcellino; Ruberto, Maria; Gallai, Beatrice; Tripi, Gabriele; Lavan, Francesco; Salerno, Margherita; Lavano, Serena Marianna; Romano, Palmira; Cerroni, Francesco; Russo, Daniela; Doro, Lucrezia; Sorrentino, Michele; Magliulo, Rosaria Martina; Di Folco, Annabella; Parisi, Lucia; Testa, Davide; Marotta, Rosa; Messina, Giovanni",,,BENEFICIAL EFFECTS OF PASTA DURING PREGNANCY: THE POSITIVE EFFECTS OF MEDITERRANEAN DIET,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Pregnancy; Diet; Mediterranean diet; Pasta; Nutrition,SLEEP-APNEA SYNDROME; CARDIOVASCULAR-DISEASE; HYPERTHERMIC REACTIONS; CEREBRAL INJECTION; OXIDATIVE STRESS; ITALIAN PATIENTS; CHILDREN; MUTATION; GENE; MIGRAINE,"Pregnancy is a physiological state during which the woman's body undergoes profound modifications. During this time, every woman must be nourished in such a way as to maintain herself in good health and at the same time allovt , the fetal tissues to form and develop in the best way. Proper nutrition is one of the fundamental prerequisites for the normal evolution of both pregnancy and fetal growth: the quantity and quality of food and drinks must be scrupulously controlled. Contrariwise, it is important to avoid the excess calories and macronutrients. In filet, during pregnancy, it may be just as harmful as their shortage, e.specially in overweight and obese women, jar which the risk of miscarriage, gestational diabetes, fetal growth disorders and preeclampsia increases. The pasta constitutes the foundation of the Mediterranean diet food. The dough can be seen, therefore, so it represents an excellent ally of the diet from a nutritional point of view. The nutritional values of the pasta change depending on the type, based on the fact that the dough is traditional or integral semolina. It also contains vitamin B and has an abundance of minerals, among which potassium. The pasta is an easily digestible food, ensuring energy ready to use (such as all carbohydrates); moreover, it possesses a great satiating power. In case of overweight, however, it is possible to reduce the number of carbohydrates in the diet, taking care not to make them ever miss. In conclusion, the consumption of pasta is very important during pregnancy: a diet without carbohydrates can be dangerous for all physiological pathways.","[Messina, Antonietta; Monda, Vincenzo; Monda, Marcellino] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy; [Picciocchi, Elisabetta; Valenzano, Anna; Cibelli, Giuseppe; Ruberto, Valentina; Pisanelli, Daniela; Di Palma, Antonella; Barone, Antonia Vanessa; Messina, Giovanni] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Marsala, Gabriella] Azienda Ospedaliero Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy; [Ruberto, Maria] CDR Santa Maria Pozzo, Somma Vesuviana, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Lavan, Francesco; Lavano, Serena Marianna; Marotta, Rosa] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Di Folco, Annabella; Parisi, Lucia; Testa, Davide] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Doro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Sorrentino, Michele] NICU Preterm & High Risk Newborn Neurodev Follow, Volturno, CE, Italy; [Sorrentino, Michele] Pineta Grande Hosp Castel, Volturno, CE, Italy; [Magliulo, Rosaria Martina] Ctr Studi Scoliosi SRL, Naples, Italy","Monda, V (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.",vincenzo.monda@unicampania.it,"Messina, Antonietta/AHH-2383-2022; Cibelli, Giuseppe/AAC-2635-2019; Marotta, Rosa/AAG-1453-2020; Messina, Giovanni/AAE-8668-2022; MESSINA, ANTONIETTA/K-9366-2016","Messina, Antonietta/0000-0001-8343-432X; Messina, Giovanni/0000-0002-0011-867X; Monda, Marcellino/0000-0002-7184-218X; Monda, Vincenzo/0000-0002-6083-5814; CIBELLI, GIUSEPPE/0000-0002-5371-2584; Cerroni, Francesco/0000-0003-3024-5482; Marotta, Rosa/0000-0003-0515-5952",Pastificio Di Martino Gaetano F. lli Spa,Thanks to Pastificio Di Martino Gaetano & F. lli Spa for non-conditioned financial support for research projects in Nutrition Physiology,"Albenzio M, 2013, J DAIRY SCI, V96, P2781, DOI 10.3168/jds.2012-621; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S136898001100251; Bafunno V, 2010, HAEMOPHILIA, V16, P469, DOI 10.1111/j.1365-2516.2009.02150.; Bafunno V, 2014, THROMB RES, V134, P1135, DOI 10.1016/j.thromres.2014.08.02; Bafunno V, 2013, J ALLERGY CLIN IMMUN, V132, P748, DOI 10.1016/j.jaci.2013.04.00; Bertozzi G, 2018, MOL NEUROBIOL, V55, P5548, DOI 10.1007/s12035-017-0774-; Bramanti V, 2016, J NEUROSCI RES, V94, P90, DOI 10.1002/jnr.2367; Bruce KD, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0446-; Bukvic N, 2010, AM J MED GENET A, V152A, P1730, DOI 10.1002/ajmg.a.3343; Canestraro M, 2010, CANCER GENET CYTOGEN, V199, P110, DOI 10.1016/j.cancergencyto.2010.02.01; Caroprese M, 2012, SMALL RUMINANT RES, V102, P177, DOI 10.1016/j.smallrumres.2011.07.01; Caroprese M, 2010, J DAIRY SCI, V93, P2395, DOI 10.3168/jds.2009-260; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Catalano P, 2015, INT J OBESITY, V39, P642, DOI 10.1038/ijo.2015.1; Cerretani D, 2011, PHARMACOL RES, V64, P517, DOI 10.1016/j.phrs.2011.08.00; Chatzi L, 2017, PEDIATR OBES, V12, P47, DOI 10.1111/ijpo.1219; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Cleveland LE, 2000, J AM COLL NUTR, V19, p331S, DOI 10.1080/07315724.2000.1071896; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Dominguez LJ, 2017, CURR OPIN CLIN NUTR, V20, P61, DOI 10.1097/MCO.000000000000033; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Esposito M, 2014, CHEMOSPHERE, V94, P62, DOI 10.1016/j.chemosphere.2013.09.01; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Galimberti S, 2007, J CHEMOTHERAPY, V19, P315, DOI 10.1179/joc.2007.19.3.31; Gabarra AG, 2017, NUTR HOSP, V34, P490, DOI 10.20960/nh.93; Gutierrez-Bedmar M, 2017, CIRC J, V81, P1183, DOI 10.1253/circj.CJ-17-003; Muros JJ, 2017, NUTRITION, V35, P87, DOI 10.1016/j.nut.2016.11.00; Koutelidakis AE, 2018, INT J FOOD SCI NUTR, V69, P84, DOI 10.1080/09637486.2017.133040; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina G., 2015, BIOL MED ALIGARH, V7, P1, DOI [10.4172/0974-8369.1000240, DOI 10.4172/0974-8369.1000240; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.01; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda V, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0069; Moscatelli F, 2015, BIOL MED, V; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015984; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parlapani E, 2019, J MATERN-FETAL NEO M, V32, P1084, DOI 10.1080/14767058.2017.139912; Pellegrino PL, 2007, AM J CARDIOL, V99, P1737, DOI 10.1016/j.amjcard.2007.01.05; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Petito A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015660; Piacentino D, 2015, CURR NEUROPHARMACOL, V13, P101, DOI 10.2174/1570159X1366614121022272; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Pomara C, 2012, CURR MED CHEM, V19, P5647, DOI 10.2174/09298671280398881; Pomara C, 2009, RADIOL MED, V114, P1367, DOI 10.1007/s11547-009-0435-; Pomara C, 2008, CLIN TOXICOL, V46, P322, DOI 10.1080/1556365070141901; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Santacroce R, 2008, BLOOD COAGUL FIBRIN, V19, P197, DOI 10.1097/MBC.0b013e3282f234a; Santacroce R, 2009, GENET TEST MOL BIOMA, V13, P573, DOI 10.1089/gtmb.2009.001; Santillo A, 2009, INT DAIRY J, V19, P655, DOI 10.1016/j.idairyj.2009.06.01; Santillo A, 2009, J DAIRY SCI, V92, P1330, DOI 10.3168/jds.2008-159; Sevi A, 2003, APPL ANIM BEHAV SCI, V83, P41, DOI 10.1016/S0168-1591(03)00088-; Smirni D, 2018, NEUROL SCI, V39, P1391, DOI 10.1007/s10072-018-3433-; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Tong TYN, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0677-; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2008, INT J LEGAL MED, V122, P173, DOI 10.1007/s00414-007-0208-; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Turillazzi E, 2013, FORENSIC SCI INT, V231, P142, DOI 10.1016/j.forsciint.2013.04.00; Turillazzi E, 2008, VIRCHOWS ARCH, V453, P209, DOI 10.1007/s00428-008-0632-; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",97,0,0,5,11,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2107.0,2114,,10.19193/0393-6384_2018_4s_325,,8,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900005,,,,,2022-07-14,0.009194214876033058,0.0786170744114441,0.005305272237306258,0.11132450864260003,0.0053291430771285585
J,"Mi, Z1",,,,"Mi, Zhan",,,CLINICAL EFFICACY OBSERVATION OF MASSAGE MANIPULATION FOR GYMNASTS' ANKLE SPRAIN AND CONTUSION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Massage; Ankle joint; Skeletal injury; Ligament injury; Clinical efficacy,,"To fully define clinical effects of massage manipulation for gymnasts' ankle sprain and contusion, and find new method for gymnasts injury, this paper makes retrospective analysis of treatment materials of 1,200 Gymnasts' ankle sprain and contusion. According to different treatment methods, they are divided into observation group and control group, respectively 800 cases, 400 cases. Injury patients in observation group were treated with traditional Chinese massage manipulation, while injury patients in control group received conventional western way of treatment. Used drugs are Voltaren, to be administered in external application. Half a month after treatment, ankle injury symptoms and recovery of ankle function before and after treatment were compared and effect evaluation was done from such dimensions as ankle injury pain, joint swelling, joint tenderness, joint dysfunction. The results show that after massage manipulation, ankle symptoms and functional activity index scores of injury patients in observation group are significantly reduced. Compared with the situation before treatment, improved difference significantly P<0.05, statistically significant. In comparison of indexes of the two groups, ankle junction recovery of observation group patients is obviously better than that of control group patients, differences between the two groups P <0.05, with statistically significant differences. Therefore, the results of this study Ally confirm that treatment of Gymnasts' ankle sprain and contusion with massage manipulation can effectively improve patients' ankle function, and help patients relieve pain, with good therapeutic effect and high clinical value.","[Mi, Zhan] Changan Univ, Dept Phys Educ, Xian 710064, Shaanxi, Peoples R China","Mi, Z (corresponding author), Changan Univ, Dept Phys Educ, Xian 710064, Shaanxi, Peoples R China.",345035663@qq.com,,,,,"Banjar A, 2017, TURK J MED SCI, V47, P211, DOI 10.3906/sag-1510-10; Bich GA, 2017, SAUDI J BIOL SCI, V24, P851, DOI 10.1016/j.sjbs.2016.05.01; Bo Chen, 2012, CHINESE J TRADITIONA, V; Bo Chen, 2012, SHANGHAI J TRADITION, V12, P5; Dilci A, 2017, TURK J MED SCI, V47, P1757, DOI 10.3906/sag-1705-10; Feiyue Li, 2014, CHINESE J TRADITIONA, V1; Fu HL, 2017, WATER-SUI, V9, DOI 10.3390/w911084; Ge SB, 2017, SAUDI J BIOL SCI, V24, P1355, DOI 10.1016/j.sjbs.2016.09.01; Jianbang Tang, 2011, J GUANGZHOU U TRADIT, V17, P23; Kumar R, 2016, SAUDI J BIOL SCI, V23, P243, DOI 10.1016/j.sjbs.2015.03.00; Li S, 2013, ACTA OCEANOL SIN, V32, P8, DOI 10.1007/s13131-013-0326-; Pinhui Xie, 2011, JIANGXI J TRADITIONA, V21, P6; Shi Yanpeng, 2014, J OPT, V16, P; Valiee S, 2016, ACTA MEDICA MEDITERR, V32, P102; Xiangyang Zhai, 2011, J CHINESE MED, V8, P37; Yang AM, 2017, J ALLOY COMPD, V695, P915, DOI 10.1016/j.jallcom.2016.10.18; Yingzhi Li, 2014, J LIAONING U TRADITI, V23, P8; Zhongsheng Gou, 2013, CHINESE MED HERALD, V8, P208",18,0,0,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1589.0,1592,,10.19193/0393-6384_2018_3s_247,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400023,,,,,2022-07-14,0.001859504132231405,3.8554944463586776e-05,0.010585115276515716,0.09918134407114827,0.008198730245191103
J,"Mnedla, S1;  Bragazzi, NL;  Chiorri, C;  Elloumi, A;  Briki, W",,,,"Mnedla, Sofiene; Bragazzi, Nicola Luigi; Chiorri, Carlo; Elloumi, Ali; Briki, Walid",,,VALIDATION OF THE ARABIC-TUNISIAN VERSION OF THE FRENCH COMPETITIVE STATE ANXIETY INVENTORY-2 REVISED (CSAI-2R): INSIGHTS FROM AN EXPLORATORY FACTOR ANALYSIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,competitive anxiety; sport psychology; Arabic language; scale validation; parallel analysis (PA); exploratory factor analysis (EFA); item analysis,DIMENSIONS; INTENSITY,"Aim: The Competitive State Anxiety Inventory-2 Revised (CSAI-2R) is one of the most frequently used instruments when quantitatively investigating competitive state anxiety in the field of sport psychology research. The purpose of the present study was to validate the Arabic-Tunisian version of the French CSAI-2R questionnaire and to evaluate its validity and reliability. Materials and methods: Out of an initial list of 490 subjects, participants of the present validation study were 304 Tunisian football players (81 males [26.6%]; mean age 21.58 years (SD = 2.40 years, range 16-31) of different levels (international level: 34 [11.2%]; national level: 238 [78.3%]; regional level: 32 [10.5%]) that volunteered to participate in the study. Data were collected and analyzed in terms of reliability and validity using correlations, reliability, parallel analysis and exploratory factor analysis. Results: The 2-factor solution accounted for 48%, 47% and 56% of variance for the Direction, Frequency, and Intensity scales, respectively. The 3-factor solution accounted for 60%, 57% and 64% of variance for the Direction, Frequency, and Intensity scales, respectively. Although the 3-factor solution explained an additional, substantial proportion of variance with respect to the 2-factor solution, the factor structure did not replicate well across scales. Conversely, in 2-factor solution, if items 1, 2, 15, and 16 were excluded, the pattern of loadings was exactly the same for all scales. Hence, we concluded that the 2-factor solution should be retained, as it provided a measurement model for the Arabic-Tunisian CSAI-2R items that was constant across scales. Conclusion: The Arabic-Tunisian version of the French CSAI-2R in its original version has failed to demonstrate robust and sound psychometric properties. Its reduced version represents a first attempt that can be henceforth used in the Arab world, even if further investigations should enable to improve its psychometric properties.","[Mnedla, Sofiene] Mannouba Univ, Dept Educ Sci, Higher Inst Sport & Phys Educ Ksar Said, Manouba, Tunisia; [Bragazzi, Nicola Luigi] Univ Genoa, Dept Hlth Sci DISSAL, Sch Publ Hlth, I-16132 Genoa, Italy; [Bragazzi, Nicola Luigi] Univ Genoa, IRCCS San Martino IST, Dept Neurosci DINOGMI, Sect Psychiat, Largo Rosanna Benzi 10, I-16132 Genoa, Italy; [Chiorri, Carlo] Univ Genoa, Dept Educ Sci, Genoa, Italy; [Elloumi, Ali] Univ Paris 05, Lab Tech & Enjeux Corps, Paris, France; [Briki, Walid] Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar","Mnedla, S (corresponding author), Mannouba Univ, Dept Educ Sci, Higher Inst Sport & Phys Educ Ksar Said, Manouba, Tunisia.;Mnedla, S (corresponding author), Tunis Univ, Fac Humanities & Social Sci, Dept Educ Sci, Tunis, Tunisia.",,"Bragazzi, Nicola Luigi/G-1672-2011","Bragazzi, Nicola Luigi/0000-0001-8409-868X; Briki, Walid/0000-0002-6298-811X",,,"Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/1070551090300820; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/1076998602500106; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_; Gaudreau P, 2002, PSYCHOL SPORT EXERC, V3, P1, DOI 10.1016/S1469-0292(01)00017-; Genz A., 2016, PACKAGE MVTNOR; Hambleton RK., 2009, ADAPTING ED PSYCHO; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF0228944; JONES G, 1992, PERCEPT MOTOR SKILL, V74, P467, DOI 10.2466/PMS.74.2.467-47; Martens R., 1990, COMPETITIVE ANXIETY, P12; Martinent G, 2010, PSYCHOL SPORT EXERC, V11, P51, DOI 10.1016/j.psychsport.2009.05.00; MORRIS LW, 1981, J EDUC PSYCHOL, V73, P541, DOI 10.1037/0022-0663.73.4.54; Muthen B., 1998, MPLUS USERS GUID; Nunnally J, 1994, PSYCHOMETRIC THEOR; SWAIN A, 1993, J SPORT SCI, V11, P533, DOI 10.1080/0264041930873002; VALLERAND RJ, 1989, CAN PSYCHOL, V30, P662, DOI 10.1037/h007985; Woodman T, 2005, J SPORT EXERCISE PSY, V27, P382, DOI 10.1123/jsep.27.3.38; Woodman T, 2003, J SPORT SCI, V21, P443, DOI 10.1080/026404103100010180; Woodman T., 2001, HDB SPORT PSYCHOL, V2nd, P29",18,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,377.0,382,,10.19193/0393-6384_2018_2_59,,6,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400013,,,,,2022-07-14,0.001859504132231405,2.5923121446639495e-11,0.0035094935871218167,0.10348182119453085,0.0035094935871218167
J,"Moshtaghie, M1;  Kaboli, M;  Salehi, M",,,,"Moshtaghie, Minoo; Kaboli, Mohammad; Salehi, Mansour",,,GEOMETRIC MORPHOMETRIC ANALYSIS OF HEAD SHAPE IN A SPOTTED WHIP SNAKE (HEMORRHOIS RAVERGIERI) IN DIFFERENT HABITATS OF IRAN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,geometric morphometric; Hemorrhois ravergieri; head shape; habitat,LIZARD ANOLIS-CAROLINENSIS; SEXUAL SIZE DIMORPHISM; BODY-SIZE; MORPHOLOGICAL VARIATION; CRANIAL DESIGN; BITE-FORCE; EVOLUTION; PERFORMANCE; PATTERNS; CONSEQUENCES,"Morphological patterns of existing variation and investigative concept related to diversity can be very important in understanding the evolution of morphology. It is known that phylogenetic history, size and ecology can all promote the evolution of morphological variation; however, some methods have been recently developed to analyze these aspects for particular body structures. Spotted whip snake Hemorrhois ravergieri appears to have the widest distribution of the Hemorrhois snake genus, especially in Iran. Morphological difference resulting from habitat can occur in several populations of H. ravergieri. Some studies have studied the relation between morphology and habitat use, revealing that motion is the main facilitator of this evolutionary relationship. Now, we consider intraspecific ecomorphological in three habitat types. Geometric morphometric analyses can provide a more detailed image of head shape in three directions (dorsal, lateral and ventral) on three types of habitat: north-west of Iran, north-east of Iran and central Zagros of Iran. Adult specimens were selected and characteristics of head were analyzed, along with body and head size for understanding the proximate mechanisms, which might be involved. The morphological variation between H. ravergieri indicated that variation in size and head dimensions between species and sexes are highly significant in habitat. Males and females differed in head characters and body size; especially, males were found to exhibit a disproportionate increase in head size and dimensions. H. ravergieri from north-east and central Zagros are smaller, than those living in north-west are. The results revealed that considering the previous findings on the populations, the morphological differences were probably not caused by competition between the populations; instead, these traits could be attributed to the natural selection.","[Moshtaghie, Minoo] Islamic Azad Univ, Dept Environm & Energy, Sci & Res Branch, Tehran, Iran; [Kaboli, Mohammad] Univ Tehran, Fac Nat Resources, Dept Environm, Tehran, Iran; [Salehi, Mansour] Isfahan Univ Med Sci, Sch Med, Dept Genet & Mol Biol, Esfahan, Iran","Kaboli, M (corresponding author), Univ Tehran, Fac Nat Resources, Dept Environm, Tehran, Iran.",mkaboli@ut.ac.ir,,,,,"Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/1125000040935654; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-628; ANDREWS RM, 1994, COPEIA, P613, DOI 10.2307/144717; Barros FC, 2011, J EVOLUTION BIOL, V24, P2423, DOI 10.1111/j.1420-9101.2011.02372.; Bookstein, BIOMETRICS 1978 INT, P15; Brown JH, 2000, SFI S SCI C, P; Bruner E, 2005, ACTA ZOOL-STOCKHOLM, V86, P245, DOI 10.1111/j.1463-6395.2005.00206.; Cardini A, 2009, ZOOL J LINN SOC-LOND, V157, P197, DOI 10.1111/j.1096-3642.2009.00508.; CARPENTER GC, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P8; Claude J, 2003, BIOL J LINN SOC, V79, P485, DOI 10.1046/j.1095-8312.2003.00198.; Collar DC, 2011, EVOLUTION, V65, P2664, DOI 10.1111/j.1558-5646.2011.01335.; COOPER WE, 1989, AM NAT, V133, P729, DOI 10.1086/28494; DRYDEN IL, 1998, STAT SHAPE ANAL VOL; Fathnia B, 2011, IRANIAN J ANIMAL BIO, V; Ghazikhanloo A, 2013, J ANIMAL ENV, V4, P5; Goodman RM, 2013, INTEGR ZOOL, V8, P184, DOI 10.1111/1749-4877.1204; Gvozdik L, 2003, J ZOOL, V259, P7, DOI 10.1017/S095283690200330; Herrel A, 2001, J EXP ZOOL, V290, P101, DOI 10.1002/jez.103; Herrel A, 2007, INTEGR COMP BIOL, V47, P107, DOI 10.1093/icb/icm01; Husak JF, 2006, COPEIA, P301, DOI 10.1643/0045-8511(2006)6[301:BPPDIM]2.0.CO;; Huyghe K, 2009, BIOL J LINN SOC, V96, P13, DOI 10.1111/j.1095-8312.2008.01103.; Kaliontzopoulou A, 2008, BIOL J LINN SOC, V93, P11; Kaliontzopoulou A, 2007, J MORPHOL, V268, P152, DOI 10.1002/jmor.1049; Kikukawa Nobuto, 2012, Current Herpetology, V31, P97, DOI 10.5358/hsj.31.9; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-9; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.; Rohlf F. J, 2004, TPSDIG DIGITIZE LAN; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/299220; Rohlf FJ., 2003, TPSSMALL THIN PLAT; Schaerlaeken V, 2012, J EXP ZOOL PART A, V317A, P371, DOI 10.1002/jez.173; Schaetti Beat, 2010, Bulletin of Zoological Nomenclature, V67, P4; Schatti B, 1985, NEUES KONZEPT COLUB; Schweiger M, 1991, HERPETOFAUNA, V13, P7; Shirai LT, 2010, J EXP ZOOL PART B, V314B, P663, DOI 10.1002/jez.b.2136; Thompson GG, 2008, AUST J ZOOL, V56, P351, DOI 10.1071/ZO0803; Tollis M, 2014, GENETICA, V142, P59, DOI 10.1007/s10709-013-9754-; Wallach V., 2014, SNAKES WORLD CATALO; Watkins GG, 1996, ECOLOGY, V77, P1473, DOI 10.2307/226554; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P",41,0,0,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,2.0,,583.0,589,,10.19193/0393-6384_2018_2s_92,,7,"Medicine, General & Internal",General & Internal Medicine,GB7SD,WOS:000429274400006,,,,,2022-07-14,0.0043388429752066115,2.8810958318928106e-05,0.008453570352104197,0.11581579545590505,0.008453570352104197
J,"Pajaujiene, S1;  Dabasinskiene, L;  Santos-Rocha, R",,,,"Pajaujiene, Simona; Dabasinskiene, Laura; Santos-Rocha, Rita",,,HEALTH PROMOTION PROGRAM FOR IMPROVING WOMEN'S BODY COMPOSITION AND ACTIVE LIFESTYLE IN POSTPARTUM: A PILOT STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,postpartum care; preventive healthcare; lifestyle; exercise; physical activity; body composition,PHYSICAL-ACTIVITY; MATERNAL OBESITY; PREGNANCY; WEIGHT; IMPACT,"Introduction: The purpose was to design a healthy lifestyle promotion program for postpartum women aiming at improving women's body composition and active lifestyle, and to analyze its feasibility regarding the methods and acceptability. It is important to understand which interventions focused on the reduction of weight gained during pregnancy are the safest, and the most effective. Methods: A pilot study was carried out in a Hospital setting. Twenty-nine women were involved in the study. A healthy lifestyle promotion program for postpartum women including, visual materials of an exercise program, and physical activity and healthy diet recommendations after delivery, was designed. Women after 2 days after delivery were invited to participate in the study by following recommendations on lifestyle. After two and six month's postpartum, women were asked to come back to the Obstetrics Department for individual control (health variables), lifestyle (diet and exercise) and anthropometric measurements (body composition). Data analysis consisted of the qualitative analysis regarding the feasibility of the program, and on the quantitative analysis regarding the changes of the outcome variables from 2 to 6 months postpartum. Results: The pilot study was feasible and most of the participants were satisfied with it. The materials were built by health and exercise professionals, and were easily put in practice. The setting was appropriate, and the intervention was combined with the usual care of postpartum women in a hospital setting, supervised by a midwife. The pilot intervention resulted in positive changes in body composition (i.e., 71.1 +/- 10.8 to 62.6 +/- 10.1 kg; and significant reduction of most girths and skin folds' measurements), and physical activity level of women (12.1 +/- 1.6 to 23.5 +/- 2.5 metabolic equivalent) within 6 months after delivery. Discussion: This pilot study supports the research hypothesis that a healthy lifestyle promotion program may positively affect the changes in the body composition and physical activity level of women after childbirth. A protocol study for a randomised control study will be developed in first place.","[Pajaujiene, Simona] Lithuanian Sports Univ, Dept Coaching Sci, Kaunas, Lithuania; [Dabasinskiene, Laura] Vilnius Univ Hosp Santaros Clin, Obstet Dept, Vilnius, Lithuania; [Santos-Rocha, Rita] Polytech Inst Santarem, Sport Sci Sch Rio Maior, Santarem, Portugal; [Santos-Rocha, Rita] Univ Lisbon, Fac Human Kinet, Interdisciplinary Ctr Study Human Performance, Lisbon, Portugal","Santos-Rocha, R (corresponding author), Escola Super Desporto Rio Maior, Av Dr Mario Soares 110, P-2040413 Rio Maior, Portugal.",ritasantosrocha@esdrm.ipsantarem.pt,"Santos-Rocha, Rita/AAF-3774-2020; Santos-Rocha, Rita A/L-4317-2014","Santos-Rocha, Rita/0000-0001-7188-8383; Santos-Rocha, Rita A/0000-0001-7188-8383",,,"Adegboye ARA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005627.pub; American College of Sports Medicine, 2017, ACSMS GUIDELINES EX; Blum JW, 2004, MATERN CHILD HEALT J, V8, P163, DOI 10.1023/B:MACI.0000037649.24025.2; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0; Chasan-Taber L, 2011, MED SCI SPORT EXER, V43, P195, DOI 10.1249/MSS.0b013e318202a02; Choi SK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.000000000000121; Cramp AG, 2010, MATERN CHILD HLTH J, V14, P343, DOI 10.1007/s10995-009-0462-; EuropeActive, 2016, EUROPEACTIVE STAND ; Fell DB, 2009, MATERN CHILD HLTH J, V13, P597, DOI 10.1007/s10995-008-0404-; Godin G., 1997, MED SCI SPORT EXER, V29, pS36, DOI DOI 10.1097/00005768-199706001-0000; Jones G, 2017, PILOT FEASIBILITY ST, V4, P; Kernot J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-51; Kinnunen TI, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-2; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P17; Lietuvos statistikos departamentas, 2015, LIET GYV SVEIK 201; Medairos R, 2016, J PHYS ACT HEALTH, V6, P; Mottola MF, 2013, NUTR REV, V71, pS31, DOI 10.1111/nure.1206; Myatt L., 2010, MATERNAL FETAL NUT; Norton K, 2004, ANTHROPOMETRICA TXB, P2; Paoli A, 2015, CLIN PHYSIOL FUNCT I, V35, P1, DOI 10.1111/cpf.1213; Paoli A, 2012, AM J CARDIOL, V109, P305, DOI 10.1016/j.amjcard.2011.10.01; Ruager-Martin R, 2010, EARLY HUM DEV, V86, P715, DOI 10.1016/j.earlhumdev.2010.08.00; Saligheh M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0908-; Schmitt NM, 2007, INT J OBESITY, V31, P1642, DOI 10.1038/sj.ijo.080365; Siri W.E., 1961, TECHNIQUES MEASURING, P22; Tenenbaum-Gavish K, 2013, FETAL DIAGN THER, V34, P1, DOI 10.1159/00035017; The American College of Nurse-Midwives, 2014, J MIDWIFERY WOM HEAL, V59, P47; Torris C, 2013, BREASTFEED MED, V8, P8, DOI 10.1089/bfm.2012.004; Tripette J, 2014, MED SCI SPORT EXER, V46, P472, DOI 10.1249/MSS.000000000000013; Walker LO, 2007, JOGNN-J OBST GYN NEO, V36, P490, DOI 10.1111/J.1552-6909.2007.00179.; WHO, 2014, OB O; WILMORE JH, 1970, AM J CLIN NUTR, V23, P26",33,0,0,0,11,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1365.0,1375,,10.19193/0393-6384_2018_5_209,,11,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700031,,,,,2022-07-14,0.003409090909090909,2.1861023583513504e-08,0.01636697139491075,0.10518880738929638,0.0156293230122512
J,"Pennacchio, S1;  Tripi, G;  Salerno, M;  Russo, DA;  Lavano, SM;  Cerroni, F;  Marotta, R;  Romano, P;  Gallai, B;  Giugliano, P;  Murabito, P;  Sorrentino, M;  Magliulo, RM;  D'oro, L;  Di Folco, A;  Testa, D;  Marsala, G;  Geraci, D;  Chisari, MG;  Picciocchi, E;  Lavano, F;  Marotta, R;  Parisi, L;  Ruberto, M",,,,"Pennacchio, Stefano; Tripi, Gabriele; Salerno, Margherita; Russo, Daniel A.; Lavano, Serena Marianna; Cerroni, Francesco; Marotta, Rosa; Romano, Palmira; Gallai, Beatrice; Giugliano, Pasquale; Murabito, Paolo; Sorrentino, Michele; Magliulo, Rosaria Martina; D'oro, Lucrezia; Di Folco, Annabella; Testa, Davide; Marsala, Gabriella; Geraci, Diego; Chisari, Mario Giuseppe; Picciocchi, Elisabetta; Lavano, Francesco; Marotta, Rosa; Parisi, Lucia; Ruberto, Maria",,,ANIMALS-ASSISTED THERAPY: A BRIEF REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,animals-assisted therapy; neurodevelopmental disorders; dogs,MONOSYMPTOMATIC NOCTURNAL ENURESIS; CHILDHOOD ABSENCE EPILEPSY; SLEEP-APNEA SYNDROME; QUALITY-OF-LIFE; HYPERTHERMIC REACTIONS; CHILDREN; MIGRAINE; ADOLESCENTS; DISORDERS; WEIGHT,"In rehabilitative setting, the presence of animals can be considered as an important stimulus for verbal and social communication, and for mood regulation. Interaction with an animal is beneficial for children's development and numerous psychological tests have revealed that growing up with pets has a beneficial effect on children's self-esteem and self-confidence, can improve empathy, a sense of responsibility and cognitive development, as well as social status within the peer group.","[Pennacchio, Stefano] Medh Ctr Srl, Campania, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disor, St Benoit La Foret, France; [Salerno, Margherita; Di Folco, Annabella; Testa, Davide; Parisi, Lucia] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Russo, Daniel A.] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Lavano, Serena Marianna; Marotta, Rosa] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy; [Romano, Palmira; Lavano, Francesco; Marotta, Rosa] Ctr Riabilitaz LARS, Sarno, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Giugliano, Pasquale] UOC Med Legale, Azienda Osped St Anna & San Sebastiano di Caser, Viterbo, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy; [Sorrentino, Michele] Pineta Grande Hosp, NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy; [Magliulo, Rosaria Martina] Ctr Scoliosi SRL, Naples, Italy; [D'oro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Marsala, Gabriella; Chisari, Mario Giuseppe] Azienda Osped Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy; [Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, I-95123 Catania, Italy; INPS, Catania, Italy; [Picciocchi, Elisabetta; Lavano, Francesco] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Ruberto, Maria] CDR Santa Maria del Pozzo, Somma Vesuviana, Italy","Parisi, L (corresponding author), Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Cerroni, Francesco/0000-0003-3024-5482; Murabito, Paolo/0000-0002-2662-1898; Marotta, Rosa/0000-0003-0515-5952",,,"Bachi K, 2017, CLIN CHILD PSYCHOL P, V22, P3, DOI 10.1177/135910451667254; Ballarini G., 2005, ANIMALI AMICI SALUT; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Braun Carie, 2009, Complement Ther Clin Pract, V15, P105, DOI 10.1016/j.ctcp.2009.02.00; Butler RJ, 1998, J CHILD PSYCHOL PSYC, V39, P453, DOI 10.1017/S002196309800222; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSL, V; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Charry-Sanchez JD, 2018, J DEV BEHAV PEDIATR, V39, P580, DOI 10.1097/DBP.000000000000059; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Dimitrijevic I, 2009, PSYCHIAT DANUB, V21, P23; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Gallelli Luca, 2017, Microrna, V6, P152, DOI 10.2174/221153660666617091315282; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Marchesini R., 2015, PET THERAPY MANUAL; Martin F, 2002, WESTERN J NURS RES, V24, P657, DOI 10.1177/01939450232055540; Matricardi S, 2018, ACTA NEUROL SCAND, V137, P575, DOI 10.1111/ane.1290; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Moscatelli F, 2016, PLOS ONE, V2; Moscatelli F, 2015, BIOL MED, V; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P481, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Smirni D, 2018, J NERV MENT DIS, V206, P628, DOI 10.1097/NMD.000000000000085; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Smirni D, 2017, NEUROPSYCHOLOGIA, V102, P109, DOI 10.1016/j.neuropsychologia.2017.06.00; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Testa D, 2017, AGING CLIN EXP RES, V29, pS191, DOI 10.1007/s40520-016-0647-; Testa D, 2016, OPEN MED-WARSAW, V11, P208, DOI 10.1515/med-2016-004; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2018, ACTA NEUROL SCAND, V138, P523, DOI 10.1111/ane.1300; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Yap E, 2017, COMPLEMENT THER CLIN, V26, P47, DOI 10.1016/j.ctcp.2016.11.00",96,0,0,5,15,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2089.0,2095,,10.19193/0393-6384_2018_4s_323,,7,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900003,,,,,2022-07-14,0.008987603305785123,0.11262102289254121,0.0033089432374345884,0.11136293040967293,0.0038752219801147293
J,"Provenzano, S1;  Santangelo, OE;  Catalano, R;  Marchese, V;  Bonanno, V;  La Placa, S;  Cernigliaro, A;  Mattina, F;  Firenze, A",,,,"Provenzano, Sandro; Santangelo, Omar Enzo; Catalano, Rosanna; Marchese, Valentina; Bonanno, Valentina; La Placa, Simona; Cernigliaro, Achille; Mattina, Francesca; Firenze, Alberto",,,DETERMINANTS ASSOCIATED WITH OBESITY AND PHYSICAL ACTIVITY IN THE PUBLIC AND PRIVATE SCHOOLS OF THE CITY OF PALERMO,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Surveys and Questionnaires; Students; Adolescent Behavior; Sicily; Body Weight; Physical Activity,QUALITY-OF-LIFE; SEDENTARY BEHAVIOR; AGED CHILDREN; ADOLESCENTS; OVERWEIGHT; HEALTH; TELEVISION; EXERCISE; FAMILY; EAT,"Introduction: Obesity is a medical condition associated with premature death and it is a risk factor for many chronic diseases. In this context, performing a regular physical activity promotes a healthy lifestyle, with significant health benefits. The aim of the study was to investigate behaviors that increase the risk of obesity and the determinants that encourage physical activity among adolescents. Materials and methods: The HBSC (Health Behavior in School-aged Children) questionnaire was administered to students in Palermo's private and public schools. For the sampling of public schools the protocol of the HBSC Surveillance System was followed; for the private ones it was opportunistic. Results: Private school students are more likely to exercise more than 3 days per week (OR 1.58) and are more likely to exercise more than 2 times a week (OR 2.08). Obese students in private schools in Palermo are more likely to perform physical activity for less than 3 days a week (OR 3.52) and a higher risk of not having breakfast (OR 10.11) and a snack between main meals (OR 3.82) every day. For all the schools examined, it emerged that obese subjects are more likely not to consume fruit (OR 3.13), to stay more than 6 hours a day in front of PCs and video games (OR 3.24) and more than 2 hours a day in front of TV (OR 3.79). Male students are more likely to perform physical activity for more than 3 days per week (OR 1.48) and intense physical activity at least 2 times per week (OR 1.76) Conclusions: It is necessary to intervene early with training on school and family in order to promote correct and responsible food choices and increase the level of physical activity among students. Therefore prevention interventions must be an integral part of coherent strategies based on tests of agreed effectiveness in order to minimize the risk linked to the development of diseases.","[Provenzano, Sandro; Santangelo, Omar Enzo; Catalano, Rosanna; Marchese, Valentina; Bonanno, Valentina; La Placa, Simona; Firenze, Alberto] Univ Study Palermo, Dept Sci Hlth Promot & Mother & Child Care GD Ale, Palermo, Italy; [La Placa, Simona] Polyclin Univ Hosp P Giaccone, Palermo, Italy; [Cernigliaro, Achille] Reg Hlth Author, Dept Hlth Serv & Epidemiol Observ, Palermo, Sicilian Region, Italy; [Mattina, Francesca] Local Hlth Unit Palermo, Dept Prevent Food Hyg Surveillance & Nutr Prevent, Palermo, Italy","Firenze, A (corresponding author), Dipartimento Sci Promoz Salute & Materno Infantil, Via Vespro 129, I-90127 Palermo, Italy.",alberto.firenze@unipa.it,"Santangelo, Omar Enzo/T-9659-2019; Cernigliaro, Achille/AAP-8092-2020","Santangelo, Omar Enzo/0000-0003-2017-3665; Provenzano, Sandro/0000-0001-7179-7246",,,"Alfermann D, 2000, INT J SPORT PSYCHOL, V31, P4; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P; [Anonymous], 2014, CALCULATE YOUR BM; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.42; Boreham C, 2001, J SPORT SCI, V19, P915, DOI 10.1080/02640410131710842; Centers for Disease Control SHAPE America, 2017, PHYS ACTIVIT; Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.36; Fox KR, 2000, INT J SPORT PSYCHOL, V31, P22; Friedlander SL, 2003, ARCH PEDIAT ADOL MED, V157, P1206, DOI 10.1001/archpedi.157.12.120; Haines J, 2007, OBESITY, V15, P2748, DOI 10.1038/oby.2007.32; HBSC Italia, 2014, HLTH BEH SCH AG CHI; Mainvil LA, 2009, AM J HEALTH PROMOT, V23, P210, DOI 10.4278/ajhp.06122115; Ministero della Salute Repubblica Italiana, 2012, DOSS ALC GUAD SA; Mond J, 2011, J ADOLESCENT HEALTH, V48, P373, DOI 10.1016/j.jadohealth.2010.07.02; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-092; Pearson N, 2009, PUBLIC HEALTH NUTR, V12, P267, DOI 10.1017/S136898000800258; Provincia autonoma di Bolzano-Alto Adige, 2010, IND SPORT SCO; Santangelo OE, 2018, RIV PSICHIA IN PRESS, V5; Schor EL, 2003, PEDIATRICS, V111, P154; Sjoberg RL, 2005, PEDIATRICS, V116, pE389, DOI 10.1542/peds.2005-017; Sonneville KR, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-8; StataCorp, 2015, STAT REL 14 STAT SO; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.74; Swallen KC, 2005, PEDIATRICS, V115, P340, DOI 10.1542/peds.2004-067; Troiano RP, 2001, J NUTR, V131, p451S, DOI 10.1093/jn/131.2.451; Vieno A, 2005, EPIDEMIOL PSICHIAT S, V14, P100, DOI 10.1017/S1121189X0000630; Who, 2000, IS BIRDT; World Health Organization, 2004, GLOB STRAT DIE; World Health Organization, 2011, GLOBAL RECOMMENDATI",29,2,2,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,443.0,448,,10.19193/0393-6384_2018_2_70,,6,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400024,,,,,2022-07-14,0.002995867768595041,1.302119102102506e-08,0.005777055036933499,0.07108604495751727,0.005777055036933499
J,"Rampello, L1;  Rampello, L;  Malaguarnera, G;  Chisari, EM;  Arcidiacono, A;  Zappia, M",,,,"Rampello, Luigi; Rampello, Liborio; Malaguarnera, Giulia; Chisari, Eleonora Margherita; Arcidiacono, Antonio; Zappia, Mario",,,DIFFERENTIAL DIAGNOSIS OF THE MAIN TRANSIENT GLOBAL AMNESIAS ATYPICAL CASE REPORT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,transient epileptic amnesia; transient global amnesia; transient ischemic attack,OF-THE-LITERATURE; VASCULAR DEMENTIA; EPILEPTIC AMNESIA; FOLLOW-UP; DEPRESSION; PROGNOSIS; EVOLUTION; ANATOMY; ATTACK,"Objective: Memory is one of man's most important cognitive functions. Various diseases can affect memory function and yield specific memory impairments. One of these conditions, transient global amnesia, is a peculiar type of memory loss with hallmark characteristics. However, the pathophysiological explanation for transient global amnesia remains controversial Methods: Starting with the most significant data from the literature, we describe the most important features needed for diagnosing the three main clinical conditions that could mimic transient global amnesia. Then, we describe a retrospective series of cases of transient global amnesia. Results: Among the cases observed, we focus on a case of transient global amnesia with features that distinguish it from the cases reported in the literature. Conclusion: This paper describes the key features of transient global amnesia, discusses the main differential diagnoses from similar conditions and proposes a pathogenetic interpretation consistent with all of the hallmarks of the disorder (amnesia duration, lack of specific neuroradiological and electroencephalo-graphic correlates or impaired sensitivity or motility, reversibility and benign prognosis of the amnesic episodes, and rare recurrence).","[Rampello, Luigi; Rampello, Liborio; Zappia, Mario] Univ Catania, Neurosci Sect, GF Ingrassia Dept, Via Santa Sofia 78, I-95123 Catania, Italy; [Malaguarnera, Giulia] Univ Catania, Res Ctr, Great Senescence, I-95123 Catania, Italy; [Chisari, Eleonora Margherita] Univ Catania, Dept Educ, I-95123 Catania, Italy; [Arcidiacono, Antonio] Univ Catania, Biometec Dept, Via Santa Sofia 78, I-95123 Catania, Italy","Rampello, L (corresponding author), Univ Catania, Dipartimento GF Ingrassia, Sez Neurosci, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Zappia, Mario/AAB-7800-2019",,University of Catania [21040104],Financial support was provided by the University of Catania (code 21040104),"Bartolomei F, 2004, NEUROLOGY, V63, P858, DOI 10.1212/01.WNL.0000137037.56916.3; Bartsch T, 2007, ANN NEUROL, V62, P475, DOI 10.1002/ana.2118; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-; Bettermann K, 2006, ARCH NEUROL-CHICAGO, V63, P1336, DOI 10.1001/archneur.63.9.133; Butler CR, 2008, BRAIN, V131, P2243, DOI 10.1093/brain/awn12; Caplan L., 1985, HDB CLIN NEUROLOGY, V1, P20; Cataudella E, 2012, ACTA MEDICA MEDITERR, V28, P24; Di Filippo M, 2007, NEUROLOGY, V69, P493, DOI 10.1212/01.wnl.0000271085.87627.7; Dohring J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.0028; FISHER CM, 1964, ACTA NEUROL SCAND, V40, P; GANDOLFO C, 1992, EUR NEUROL, V32, P52, DOI 10.1159/00011678; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.83; HODGES JR, 1990, BRAIN, V113, P639, DOI 10.1093/brain/113.3.63; Malaguarnera M, 2008, DIGEST DIS SCI, V53, P3018, DOI 10.1007/s10620-008-0238-; Malaguarnera M, 2011, SCAND J GASTROENTERO, V46, P750, DOI 10.3109/00365521.2011.56506; Malaguarnera M, 2011, METAB BRAIN DIS, V26, P281, DOI 10.1007/s11011-011-9260-; Manahan-Vaughan D, 2003, NEUROPHARMACOLOGY, V44, P17, DOI 10.1016/S0028-3908(02)00342-; MERRIAM AE, 1992, PSYCHOSOMATICS, V33, P109, DOI 10.1016/S0033-3182(92)72029-; MILLER JW, 1987, NEUROLOGY, V37, P733, DOI 10.1212/WNL.37.5.73; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl10; Rampello L, 2005, J NEUROL, V252, P1045, DOI 10.1007/s00415-005-0811-; Rampello L, 2004, PSYCHOPHARMACOLOGY, V173, P73, DOI 10.1007/s00213-003-1698-; Rampello L, 2000, CNS DRUGS, V13, P35, DOI 10.2165/00023210-200013010-0000; Rampello L, 2016, J NEUROL SCI, V369, P354, DOI 10.1016/j.jns.2016.08.04; Ricceri R, 2013, ACTA MEDICA MEDITERR, V29, P9; Schmidtke K, 1998, EUR NEUROL, V40, P9, DOI 10.1159/00000794; Schreiber SJ, 2005, J NEUROL NEUROSUR PS, V76, P509, DOI 10.1136/jnnp.2004.04384; STILLHARD G, 1990, J NEUROL NEUROSUR PS, V53, P339, DOI 10.1136/jnnp.53.4.33; Vuilleumier P, 1996, NEUROLOGY, V46, P1036, DOI 10.1212/WNL.46.4.103; Weon YC, 2008, AM J NEURORADIOL, V29, P1324, DOI 10.3174/ajnr.A110; Winbeck K, 2005, J NEUROL NEUROSUR PS, V76, P438, DOI 10.1136/jnnp.2004.04243; Zelante G, 2012, ACTA MEDICA MEDITERR, V28, P4; Zeman AZJ, 1998, J NEUROL NEUROSUR PS, V64, P435, DOI 10.1136/jnnp.64.4.43; ZORZON M, 1995, STROKE, V26, P1536, DOI 10.1161/01.STR.26.9.153",34,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,685.0,690,,10.19193/0393-6384_2018_3_105,,6,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000010,,,,,2022-07-14,0.003512396694214876,8.997429532752046e-10,0.00680691093182053,0.10543398939124941,0.00680691093182053
J,"Rampello, L21;   Rampello, L;   Chisari, CG;   Malaguarnera, M;   Arcidiacono, A;   Vecchio, I;   Scuderi, R;   Zappia, M",,,,"Rampello, Luigi; Rampello, Liborio; Chisari, Clara Grazia; Malaguarnera, Michele; Arcidiacono, Antonio; Vecchio, Ignazio; Scuderi, Rosario; Zappia, Mario",,,AFTER THE SWEET COMES THE BITTER. TIME TO HALT THE DIABETIC NEUROPATHY EPIDEMIC,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,diabetes; diabetic neuropathy; diabetic complications; diabetic prevention; diabetic therapy,DISCOID LUPUS-ERYTHEMATOSUS; OCULAR SURFACE; POPULATION; PREVALENCE; DIAGNOSIS; RISK,"Diabetes is the leading cause of neuropathy in industrialized countries and possibly worldwide. The most common form is distal symmetrical polyneuropathy. Diabetes affects the nerves even before being recognized. The disease continues to expand in parallel with the incorrect lifestyle habits typical of modern society. The cardinal symptoms of peripheral nervous system diseases may be indicative of motor, sensory, autonomic and trophic lesions. Diabetic neuropathy also has significant economic costs to society. The high rate of diabetic neuropathy causes substantial morbidity from recurrent infections of the lower limbs, ulceration and amputation. Electromyographic examination of the distal muscles of the lower extremities may reveal acute and chronic denervation. Some alterations of the paraspinal muscles, such as spontaneous activity, are similar to those of disease in the spinal nerve roots.","[Rampello, Luigi; Rampello, Liborio; Chisari, Clara Grazia; Zappia, Mario] Univ Catania, GF Ingrassia Dept, Neurosci Sect, Via Santa Sofia 78, I-95123 Catania, Italy; [Malaguarnera, Michele] Univ Catania, Res Ctr Great Senescence, Catania, Italy; [Arcidiacono, Antonio] Univ Catania, Biometec Dept, Via Santa Sofia 78, I-95123 Catania, Italy; [Vecchio, Ignazio; Scuderi, Rosario] Univ Catania, Dept Clin & Expt Med, Catania, Italy","Rampello, L (corresponding author), Univ Catania, GF Ingrassia Dept, Neurosci Sect, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Zappia, Mario/AAB-7800-2019; Malaguarnera, Michele/A-1376-2019","Malaguarnera, Michele/0000-0002-7145-6377; chisari, clara grazia/0000-0003-1607-543X","University of Catania, Department.  G.F. Ingrassia [21040104/2014]","This work was supported by the University of Catania, trough financing No 21040104/2014, Department.  G.F. Ingrassia.","Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-110; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-; Bischoff C, 1996, ELECTROMYOGR MOTOR C, V101, P528, DOI 10.1016/S0013-4694(96)96553-; Boulton AJM, 2004, NEW ENGL J MED, V351, P48, DOI 10.1056/NEJMcp03296; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-; Chisari CG, 2015, ACTA MEDICA MEDITERR, V31, P121; Chisari CG, 2014, ACTA MEDICA MEDITERR, V30, P24; Chisari G, 2015, ACTA MEDICA MEDITERR, V31, P105; Chisari G, 2013, ACTA MEDICA MEDITERR, V29, P36; Gregg EW, 2004, DIABETES CARE, V27, P1591, DOI 10.2337/diacare.27.7.159; Johannsen L, 2001, J Clin Neuromuscul Dis, V3, P47, DOI 10.1097/00131402-200112000-0000; Miralles-Garcia Jose M, 2010, Endocrinol Nutr, V57, P414, DOI 10.1016/j.endonu.2010.05.00; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-204; Rampello L., 2011, 20 WORLD C NEUR FREE, P13; Rampello L, 2016, J NEUROL SCI, V369, P354, DOI 10.1016/j.jns.2016.08.04; Rampello L, 2012, ACTA MEDICA MEDITERR, V28, P13; Rampello L, 2012, ACTA MEDICA MEDITERR, V28, P12; Rampello L, 2012, ACTA MEDICA MEDITERR, V28, P13; Steven S, 2016, DIABETES CARE, V39, P808, DOI 10.2337/dc15-194; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.00; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-001; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.13; Vinik AI, 2016, NEW ENGL J MED, V374, P1455, DOI 10.1056/NEJMcp150394; Warren B, 2017, LANCET DIABETES ENDO, V5, P34, DOI 10.1016/S2213-8587(16)30321-; WATKINS PJ, 1997, TXB DIABETE",25,1,1,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,691.0,696,,10.19193/0393-6384_2018_3_106,,6,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000011,,,,,2022-07-14,0.0023760330578512395,1.4097547132264168e-06,0.03709335629010193,0.11232695498798984,0.03740222692299595
J,"Rampello, L31;   Patti, F;   Rampello, L;   Arcidiacono, A;   Zappia, M",,,,"Rampello, Luigi; Patti, Francesco; Rampello, Liborio; Arcidiacono, Antonio; Zappia, Mario",,,A CASE OF MULTIPLE AUTOIMMUNITY COMPLICATED BY SIADH,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Autoimmunity; Vasculitis- CNS Vasculitides-Multiorgan dysimmune syndrome-SIADH-Immunosuppressors,CENTRAL-NERVOUS-SYSTEM; PRIMARY ANGIITIS; VASCULITIS,"Central nervous system (CNS) vasculitides are rare, often severe diseases, difficult to diagnose for the lack of specific symptoms and with a poor outcome. We report a case of CNS vasculitis in a 57-year-old patient suffering from multiorgan dysimmune syndrome characterised by celiac disease, ulcerative colitis and diabetes mellitus. Cognitive deterioration, gait impairment and balance loss were the main clinical findings, and the patient was able to walk in 3 years. Moreover, inappropriate secretion of adiuretin syndrome occurred, making the patient's treatment more complex. Methylprednisolone and monthly intravenous pulse of cyclophosphamide boosters were administered; plasma-exchange, intravenous immunoglobulins and rituximab were sequentially used with no benefit.","Univ Catania, GF Ingrassia Dept, Neurosci Sect, Via Santa Sofia 78, I-95123 Catania, Italy; Univ Catania, Biometec Dept, Via Santa Sofia 78, I-95123 Catania, Italy","Rampello, L (corresponding author), Univ Catania, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Zappia, Mario/AAB-7800-2019","patti, francesco/0000-0002-6923-0846","University of Catania, GF Ingrassia Department [21040104]","The authors have contributed equally to the elaboration and writing of the manuscript with a financing of the University of Catania No 21040104, GF Ingrassia Department","Benseler SM, 2006, ARTHRITIS RHEUM-US, V54, P1291, DOI 10.1002/art.2176; Calabrese LH, 1997, ARTHRITIS RHEUM, V40, P1189, DOI 10.1002/1529-0131(199707)40:7<1189::AID-ART2>3.0.CO;2-; CALABRESE LH, 1988, MEDICINE, V67, P20, DOI 10.1097/00005792-198801000-0000; Campi A, 2001, NEURORADIOLOGY, V43, P599, DOI 10.1007/s00234010056; Crowley Rachel K, 2006, Expert Rev Endocrinol Metab, V1, P537, DOI 10.1586/17446651.1.4.53; Cuesta M, 2016, BEST PRACT RES CL EN, V30, P175, DOI 10.1016/j.beem.2016.02.00; CUPPS TR, 1983, AM J MED, V74, P97, DOI 10.1016/0002-9343(83)91125-; Holle JU, 2011, CURR OPIN RHEUMATOL, V23, P7, DOI 10.1097/BOR.0b013e32834115f; Kadkhodayan Y, 2004, RADIOLOGY, V233, P878, DOI 10.1148/radiol.233303162; Pistone G, 2002, ARCH GERONTOL GERIAT, P27; Polizzi A, 2001, CLIN NEUROL NEUROSUR, V103, P151, DOI 10.1016/S0303-8467(01)00132-; Rampello L, 2016, J NEUROL SCI, V369, P354, DOI 10.1016/j.jns.2016.08.04; Rampello L, 2012, CLIN NEUROL NEUROSUR, V114, P751, DOI 10.1016/j.clineuro.2011.12.02; Runkle I, 2013, MED CLIN-BARCELONA, V14; Runkle I, 2014, NEFROLOGIA, V34, P439, DOI 10.3265/Nefrologia.pre2014.Apr.1222; Salvarani C, 2007, ANN NEUROL, V62, P442, DOI 10.1002/ana.2122; Salvarani C, 2012, LANCET, V380, P767, DOI 10.1016/S0140-6736(12)60069-; Twilt M, 2012, NAT REV RHEUMATOL, V8, P97, DOI 10.1038/nrrheum.2011.19; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.00",19,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,1131.0,1135,,10.19193/0393-6384_2018_4_174,,5,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500037,,,,,2022-07-14,0.002066115702479339,1.961002858646314e-08,0.038706565345099066,0.12870800037229588,0.038231160958702
J,"Rampello, L41;   Patti, F;   Rampello, L;   Arcidiacono, A;   D'Amico, E;   Zappia, M",,,,"Rampello, Luigi; Patti, Francesco; Rampello, Liborio; Arcidiacono, Antonio; D'Amico, Emanuele; Zappia, Mario",,,PRIMARY CEREBRAL VASCULITIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,primary CNS vasculitis; PACNS; CNS primary angiitis; CNS vasculitides; vasculitis,CENTRAL-NERVOUS-SYSTEM; NONINFECTIOUS GRANULOMATOUS-ANGIITIS; ZOSTER-VIRUS VASCULOPATHIES; CHURG-STRAUSS-SYNDROME; LUPUS-ERYTHEMATOSUS; VASOCONSTRICTION SYNDROMES; NEUROLOGICAL INVOLVEMENT; WEGENERS-GRANULOMATOSIS; INFECTION; MANIFESTATIONS,"Vasculitides are rare conditions affecting vessels of different type and caliber. They are characterized by inflammation of the blood vessel walls and vascular damage causing alterations in blood flow. The resulting clinical syndromes mostly result from tissue ischemia, vascular damage and inflammation affecting one or more organs or systems. Primary isolated vasculitic involvement of the central nervous system (primary CNS vasculitis) is a rare form characterized by inflammation of the blood vessels in the brain and medulla without evidence of vasculitis symptoms outside the CNS.","Univ Catania, GF Ingrassia Dept, Neurosci Sect, Via Santa Sofia 78, I-95123 Catania, Italy; Univ Catania, Biometec Dept, Via Santa Sofia 78, I-95123 Catania, Italy","Rampello, L (corresponding author), Univ Catania, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Zappia, Mario/AAB-7800-2019; D'Amico, Emanuele/N-5568-2019","D'Amico, Emanuele/0000-0001-7494-9057; patti, francesco/0000-0002-6923-0846","University of Catania, Department. G.F. Ingrassia [21040104]","This work was supported by the University of Catania, trough financing No 21040104, Department. G.F. Ingrassia.","Al-Araji A, 2009, LANCET NEUROL, V8, P192, DOI 10.1016/S1474-4422(09)70015-; Alrawi A, 1999, NEUROLOGY, V53, P858, DOI 10.1212/WNL.53.4.85; Appenzeller S, 2008, CLIN REV ALLERG IMMU, V34, P361, DOI 10.1007/s12016-007-8060-; Barinagarrementeria F, 1998, STROKE, V29, P123, DOI 10.1161/01.STR.29.1.12; Benseler SM, 2006, ARTHRITIS RHEUM-US, V54, P1291, DOI 10.1002/art.2176; Bilge I, 2005, PEDIATR NEPHROL, V20, P529, DOI 10.1007/s00467-004-1736-; Birnbaum J, 2009, ARCH NEUROL-CHICAGO, V66, P704, DOI 10.1001/archneurol.2009.7; Bleck TP, 1999, NEUROL CLIN, V17, P801, DOI 10.1016/S0733-8619(05)70167-; Bley TA, 2007, AM J NEURORADIOL, V28, P1722, DOI 10.3174/ajnr.A063; Cacoub P, 2005, AIDS, V19, pS128, DOI 10.1097/01.aids.0000192081.33938.2; Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-0000; Calabrese LH, 1997, ARTHRITIS RHEUM, V40, P1189, DOI 10.1002/1529-0131(199707)40:7<1189::AID-ART2>3.0.CO;2-; CALABRESE LH, 1988, MEDICINE, V67, P20, DOI 10.1097/00005792-198801000-0000; Chitravas N, 2011, ANN NEUROL, V70, P437, DOI 10.1002/ana.2245; CRAVIOTO H, 1959, NEUROLOGY, V9, P599, DOI 10.1212/WNL.9.9.59; CUPPS TR, 1983, AM J MED, V74, P97, DOI 10.1016/0002-9343(83)91125-; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm25; Ducros Anne, 2009, Pract Neurol, V9, P256, DOI 10.1136/jnnp.2009.18785; ELLIS SG, 1979, SEMIN ARTHRITIS RHEU, V8, P212, DOI 10.1016/S0049-0172(79)80009-; Engelter ST, 2002, ARCH NEUROL-CHICAGO, V59, P1480, DOI 10.1001/archneur.59.9.148; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-66; Gan C, 2015, J CLIN NEUROSCI, V22, P1528, DOI 10.1016/j.jocn.2015.03.03; Garge SS, 2014, ANN INDIAN ACAD NEUR, V17, P444, DOI 10.4103/0972-2327.14403; Ghinoi A, 2010, CLIN EXP RHEUMATOL, V28, P75; Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-; GOLDEN MP, 1994, MEDICINE, V73, P246, DOI 10.1097/00005792-199409000-0000; Goncalves C, 2004, An Pediatr (Barc), V60, P18; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-0000; Hajj-Ali RA, 2014, J AUTOIMMUN, V48-49, P149, DOI 10.1016/j.jaut.2014.01.00; HANLY JG, 1992, J RHEUMATOL, V19, P73; Harbitz F, 1922, AM J MED SCI, V163, P250, DOI 10.1097/00000441-192202000-0001; HARRISON PE, 1976, J NEUROL SCI, V29, P335, DOI 10.1016/0022-510X(76)90182-; Heinrich A, 2003, EUR NEUROL, V50, P109, DOI 10.1159/00007251; Holle JU, 2011, CURR OPIN RHEUMATOL, V23, P7, DOI 10.1097/BOR.0b013e32834115f; Lie J T, 1991, Curr Opin Rheumatol, V3, P36, DOI 10.1097/00002281-199102000-0000; MARRA CM, 1995, CURR OPIN NEUROL, V8, P16; Melica G, 2009, J MED VIROL, V81, P578, DOI 10.1002/jmv.2146; Miller DV, 2009, AM J SURG PATHOL, V33, P35, DOI 10.1097/PAS.0b013e318181e09; Nagashima T, 2000, NEUROPATHOLOGY, V20, P309, DOI 10.1046/j.1440-1789.2000.00352.; Nagel MA, 2008, NEUROLOGY, V70, P853, DOI 10.1212/01.wnl.0000304747.38502.e; NEWMAN W, 1952, T AM NEUROL ASSOC, P11; NISHINO H, 1993, ANN NEUROL, V33, P4, DOI 10.1002/ana.41033010; Oran I, 1999, NEURORADIOLOGY, V41, P436, DOI 10.1007/s00234005077; Ovetchkine P, 2002, SCAND J INFECT DIS, V34, P307, DOI 10.1080/0036554011007745; PARISI JE, 1994, SEMIN NEUROL, V14, P341, DOI 10.1055/s-2008-104109; Ramos-Casals M, 2008, MEDICINE, V87, P210, DOI 10.1097/MD.0b013e318181e6a; Ringleb PA, 2005, RHEUMATOLOGY, V44, P1012, DOI 10.1093/rheumatology/keh66; Saliou G, 2008, RHEUMATOLOGY, V47, P107, DOI 10.1093/rheumatology/kem26; Salvarani C, 2008, ARTHRIT RHEUM-ARTHR, V59, P291, DOI 10.1002/art.2333; Salvarani C, 2007, ANN NEUROL, V62, P442, DOI 10.1002/ana.2122; Salvarani C, 2012, LANCET, V380, P767, DOI 10.1016/S0140-6736(12)60069-; SANDHU R, 1979, ARCH NEUROL-CHICAGO, V36, P433, DOI 10.1001/archneur.1979.0050043006300; Sangha Kim M. D., 2015, GEN HOSP PSYCHIAT, V3; SEHGAL M, 1995, MAYO CLIN PROC, V70, P337, DOI 10.4065/70.4.33; Sen ES, 2010, RHEUMATOLOGY, V49, P806, DOI 10.1093/rheumatology/kep45; Singhal AB, 2011, ARCH NEUROL-CHICAGO, V68, P1005, DOI 10.1001/archneurol.2011.6; Starke J R, 1999, Semin Pediatr Neurol, V6, P318, DOI 10.1016/S1071-9091(99)80029-; Tabarki B, 2001, PEDIATR NEUROL, V25, P239, DOI 10.1016/S0887-8994(01)00290-; Twilt M, 2012, NAT REV RHEUMATOL, V8, P97, DOI 10.1038/nrrheum.2011.19; VOLLMER TL, 1993, ARCH NEUROL-CHICAGO, V50, P925, DOI 10.1001/archneur.1993.0054009003200; Younger DS, 2004, CURR OPIN NEUROL, V17, P317, DOI 10.1097/00019052-200406000-0001; Zeller V, 2004, PRESSE MED, V33, P1385, DOI 10.1016/S0755-4982(04)98937-",62,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,1137.0,1142,,10.19193/0393-6384_2018_4_175,,6,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500038,,,,,2022-07-14,0.006508264462809917,1.9248067680252067e-08,0.012026605259051753,0.1278883883156518,0.012014075563994468
J,"Rosa, R1;  D'Andria, A;  Napolitano, F",,,,"Rosa, Roberta; D'Andria, Antonio; Napolitano, Felicia",,,INNOVATIVE STRATEGIES IN THE AUTISM SPECTRUM SYNDROME,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Biodanza SRT; Autism Spectrum Syndrome; Inclusion; Special Didactics,,"Introduction: Recent evidence suggests that systemic-relational approaches to corporeal mediation such as Biodanza SRT turn out to be innovative strategies in educational-didactic proposals for people with Autism Spectrum Syndrome. Case presentation: Through the enhancement of corporeity and the integration of music, emotions and movement lived in groups, the Biodanza SRT system induces motor, relational and emotional experiences, by stimulating the possible communication and relationship, the emotional self regulation and the autonomy capabilities, healthy lifestyles and behavioral skills that can be spent in everyday life. Conclusion: Biodanza SRT is an important opportunity for the development of functional skills in areas that are most undermined by the autistic disorder: that of communication, social interaction, interests and behavior in general; it represents an innovative and effective strategy that determines the increase of psychological, motor, emotional and relational well-being by improving the Quality of Life (QoL).","[Rosa, Roberta; D'Andria, Antonio; Napolitano, Felicia] Parthenope Univ, Via Medina 40, Naples, Italy","Rosa, R (corresponding author), Parthenope Univ, Via Medina 40, Naples, Italy.",roberta.rosa@uniparthenope.it,,,,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; Gallese V, 2016, EMPATIA SEMPRE INCA; Garaudy R, 1985, DANZARE LA VIT; Ghedin E., 2016, J SPECIAL ED INCLUSI, V2, P20; Giannelli M. T, 2015, HLTH EFFECTS DERIVE; Montesano P, 2016, VALORIZZAZIONE CORPO, pXI; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; R. Rosa R, 2016, OFFICIAL J ITALIAN S, V3; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Riva D, 2000, GIORNALE NEUROPSICHI, V20, P17; Salvitti C, 2000, PRATICA ATTIVITA MO; Stueck M, 2012, BIOPSYCHOLOGICAL BAS, P; Tafuri D., 2017, SPORT SCI, V10, P7; Toro Araneda R, 2012, CIMEB TEXTX, V; Toro Araneda R, 2012, CIMEB TESTI, V; Toro Araneda R., 2007, BIODANZA MUSICA MOV; Toro R., 1997, ALFABETO VITA POETI",24,0,0,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1487.0,1491,,10.19193/0393-6384_2018_3s_226,,5,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400003,,,,,2022-07-14,0.0023760330578512395,4.337475739649889e-05,0.0024671414952078573,0.08273292137808433,0.002466274786758109
J,"Rosa, R21;   de Vita, T;   Napolitano, F",,,,"Rosa, Roberta; de Vita, Tiziana; Napolitano, Felicia",,,THE BIODANZA SRT PROPOSAL IN NEURODEGENERATIVE DISEASES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Autism; Pet-Therapy; Motor Disorder,PREMOTOR CORTEX; RECOGNITION,"Introduction: Recent evidence suggests that therapeutic dance may be an appropriate form of physical activity for some individuals with Neurodegenerative Diseases. Rolando Toro's Biodanza System (SRT) is a therapeutic strategy of human development and growth that integrates movement, music and emotions to induce motor, relational and emotional experiences. Case presentation: By drawing on Neuroscientific research, the authors describe therapeutic aspects and the use of Biodanza SRT in clinical cases of Neurodegenerative Diseases. By involving people on a physical, mental, emotional, and social level, the aim is to create new movement patterns integrating the individual's emotional and motor components, in order to generate adaptive responses aimed at strengthening the self-esteem and self-efficacy of the communication-relational skills. Conclusion: Biodanza SRT represents an innovative and effective strategy that, in short terms, allows for the increase of psychological, general motor, and emotional-relational well-being, and the consequent improvement of Quality of Life (QoL).","[Rosa, Roberta; de Vita, Tiziana; Napolitano, Felicia] Parthenope Univ, Via Medina 40, Naples, Italy","Rosa, R (corresponding author), Parthenope Univ, Via Medina 40, Naples, Italy.",roberta.rosa@uniparthenope.it,,,,,"Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.59; Ghedin E., 2016, J SPECIAL ED INCLUSI, V2, P20; Kiepe MS, 2012, ART PSYCHOTHER, V39, P404, DOI 10.1016/j.aip.2012.06.00; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-; Rogers C, 2007, RELAZIONE EFFICACE ; Rosa R., OFFICIAL J ITALIAN N, V3; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-; Stueck M., 2012, BIOPSYCHOLOGICAL BAS, P; Tafuri D., 2017, SPORT SCI, V10, P7; Toro Acuna GC, 2013, IBF RETE CIMEB RET; Toro Araneda R, 2012, TEORIA BIODANZA RACC, V; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/3504455",23,0,0,5,12,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1507.0,1511,,10.19193/0393-6384_2018_3s_230,,5,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400007,,,,,2022-07-14,0.0022727272727272726,4.895083590044667e-05,0.0020797114128284036,0.08273150720054699,0.002079160572732498
J,"Ruberto, M1;  Gallai, B;  Tripi, G;  Lavano, F;  Salerno, M;  Lavano, SM;  Romano, P;  Russo, D;  Marotta, R;  Franco, S;  Picciocchi, E;  Geraci, D;  Chisari, MG;  Marsala, G;  Polito, AN;  Sorrentino, M;  Russo, D;  Magliulo, RM;  D'oro, L;  Di Folco, A;  Parisi, L;  Testa, D;  Murabito, P;  Giugliano, P;  Cerroni, F",,,,"Ruberto, Maria; Gallai, Beatrice; Tripi, Gabriele; Lavano, Francesco; Salerno, Margherita; Lavano, Serena Marianna; Romano, Palmira; Russo, Daniela; Marotta, Rosa; Franco, Sabrina; Picciocchi, Elisabetta; Geraci, Diego; Chisari, Mario Giuseppe; Marsala, Gabriella; Polito, Anna Nunzia; Sorrentino, Michele; Russo, Daniela; Magliulo, Rosaria Martina; D'oro, Lucrezia; Di Folco, Annabella; Parisi, Lucia; Testa, Davide; Murabito, Paolo; Giugliano, Pasquale; Cerroni, Francesco",,,RETRACTED: CORPUS CALLOSUM AGENESIA A MINIREVIEW (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Review; Retracted Publication,,,,,,corpus callosum; agenesia; cerebral abnormalities,MONOSYMPTOMATIC NOCTURNAL ENURESIS; SLEEP-APNEA SYNDROME; BEHAVIORAL-DISORDERS; KETOGENIC DIET; HYPERTHERMIC REACTIONS; CHILDHOOD MIGRAINE; PARENTAL STRESS; MATERNAL STRESS; OREXIN SYSTEM; CHILDREN,"The corpus callosum (CC) is the largest of the fiber bundles present in the human brain, and its name derives from its hard consistency caused by the presence of myelinated fibers. It represents the largest and most voluminous brain commissure and a white matter station. CC alterations may be identified in many neurodevelopmental disorders.","[Ruberto, Maria] CDR Santa Maria del Pozzo, Somma Vesuviana, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Lavano, Francesco; Lavano, Serena Marianna; Marotta, Rosa] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Russo, Daniela; Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Di Folco, Annabella; Parisi, Lucia; Testa, Davide] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Franco, Sabrina; Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, I-95123 Catania, Italy; [Picciocchi, Elisabetta] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Chisari, Mario Giuseppe] INPS, Catania, Italy; [Marsala, Gabriella] Azienda Osped Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Sorrentino, Michele] Pineta Grande Hosp, NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy; [Magliulo, Rosaria Martina] Ctr Scoliosi SRL, Bari, Italy; [D'oro, Lucrezia; Di Folco, Annabella] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy; [Giugliano, Pasquale] UOC Med Legale, Azienda Osped St Anna San & Sebastiano di Caserta, Viterbo, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy","Parisi, L (corresponding author), Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Murabito, Paolo/0000-0002-2662-1898; Cerroni, Francesco/0000-0003-3024-5482; Marotta, Rosa/0000-0003-0515-5952",,,"AIELLO I, 1994, ITAL J NEUROL SCI, V15, P497, DOI 10.1007/BF0233461; Anderson NG, 2006, PEDIATRICS, V118, P951, DOI 10.1542/peds.2006-055; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.0029; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0018; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Delcan J, 2004, PRENATAL DIAG, V24, P635, DOI 10.1002/pd.95; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1181, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1197, DOI 10.19193/0393-6384_2017_2s_18; Gallai B, 2017, ACTA MEDICA MEDITERR, V33, P1205, DOI 10.19193/0393-6384_2017_2s_18; Jarre A, 2017, RADIOLOGIA-MADRID, V59, P226, DOI 10.1016/j.rx.2017.01.00; Labadi B, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.0009; Maldonato MN, 2018, ACTA MEDICA MEDITERR, V34, P357, DOI 10.19193/0393-6384_2018_2_5; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P769, DOI 10.19193/0393-6384_2017_5_11; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P729, DOI 10.19193/0393-6384_2017_5_10; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P737, DOI 10.19193/0393-6384_2017_5_10; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P1279, DOI 10.19193/0393-6384_2017_2s_19; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Pacheco Sheila Cristina da Silva, 2014, Rev. paul. pediatr., V32, P252, DOI 10.1590/0103-058220143231; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Pascoe L, 2015, J INT NEUROPSYCH SOC, V21, P610, DOI 10.1017/S135561771500071; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P349, DOI 10.19193/0393-6384_2018_2_5; Testa D, 2017, AGING CLIN EXP RES, V29, pS191, DOI 10.1007/s40520-016-0647-; Testa D, 2016, OPEN MED-WARSAW, V11, P208, DOI 10.1515/med-2016-004; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",94,0,0,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2115.0,2123,,10.19193/0393-6384_2018_4s_326,,9,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900006,,,,,2022-07-14,0.008057851239669421,0.11890542915027981,0.006741518994195412,0.11213957206241819,0.007298914709532651
J,"Ruberto, M21;   Gallai, B;   Tripi, G;   Lavano, F;   Salerno, M;   Lavano, SM;   Romano, P;   Russo, D;   Marotta, R;   Franco, S;   Picciocchi, E;   Geraci, D;   Chisari, MG;   Marsala, G;   Polito, AN;   Sorrentino, M;   Magliulo, RM;   D'oro, L;   Di Folco, A;   Parisi, L;   Testa, D;   Murabito, P;   Cerroni, F",,,,"Ruberto, Maria; Gallai, Beatrice; Tripi, Gabriele; Lavano, Francesco; Salerno, Margherita; Lavano, Serena Marianna; Romano, Palmira; Russo, Daniela; Marotta, Rosa; Franco, Sabrina; Picciocchi, Elisabetta; Geraci, Diego; Chisari, Mario Giuseppe; Marsala, Gabriella; Polito, Anna Nunzia; Sorrentino, Michele; Magliulo, Rosaria Martina; D'oro, Lucrezia; Di Folco, Annabella; Parisi, Lucia; Testa, Davide; Murabito, Paolo; Cerroni, Francesco",,,NEUROPSYCHOMOTRICITY IN WATER: A NEW REHABILITATIVE TOOL FOR NERUODEVELOPMENTAL DISORDERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,neuropsychomotricity; pediatric rehabilitation; water,CHILDHOOD ABSENCE EPILEPSY; PRIMARY NOCTURNAL ENURESIS; HYPERTHERMIC REACTIONS; OXIDATIVE STRESS; HEME OXYGENASE-1; OBESE CHILDREN; OPEN-LABEL; MIGRAINE; SLEEP; ADOLESCENTS,"Neuropsychomotricity in water is a rehabilitative practice that avails itself just of the liquid element, as a mediator of relationships: in water yes they upset all dynamics, be they relational, of equilibrium, of movement and perception, due to the fact that proprioceptive sensations, created by bodily contact with water, they are different than those generated by contact with air.","[Ruberto, Maria] CDR Santa Maria del Pozzo, Somma Vesuviana, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, Italy; [Lavano, Francesco; Lavano, Serena Marianna; Marotta, Rosa] Magna Graecia Univ Catanzaro, Dept Hlth Sci 5, Catanzaro, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Di Folco, Annabella; Parisi, Lucia; Testa, Davide] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Franco, Sabrina; Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, I-95123 Catania, Italy; [Picciocchi, Elisabetta] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa dei Fiori Acerra, Naples, Italy; [Chisari, Mario Giuseppe] INPS, Catania, Italy; [Marsala, Gabriella] Azienda Osped Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Sorrentino, Michele] Pineta Grande Hosp, NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy; [Magliulo, Rosaria Martina] Ctr Studi Scoliosi SRL, Naples, Italy; [D'oro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy","Parisi, L (corresponding author), Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Cerroni, Francesco/0000-0003-3024-5482; Marotta, Rosa/0000-0003-0515-5952; Murabito, Paolo/0000-0002-2662-1898",,,"Albenzio M, 2013, J DAIRY SCI, V96, P2781, DOI 10.3168/jds.2012-621; Albenzio M, 2017, NUTRIENTS IN DAIRY AND THEIR IMPLICATIONS FOR HEALTH AND DISEASE, P435, DOI 10.1016/B978-0-12-809762-5.00034-; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Berges J, 1966, Rev Neuropsychiatr Infant, V14, P23; Buhr M, 1992, Kinderarztl Prax, V60, P16; Cappellini A C, 2008, Minerva Pediatr, V60, P27; Caroprese M, 2012, SMALL RUMINANT RES, V102, P177, DOI 10.1016/j.smallrumres.2011.07.01; Caroprese M, 2010, J DAIRY SCI, V93, P2395, DOI 10.3168/jds.2009-260; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; DE FRANCO F, 1960, G Psichiatr Neuropatol, V88, P104; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2017, EUR J PHYS REHAB MED, V53, P643, DOI 10.23736/S1973-9087.16.04037-; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Gallelli Luca, 2017, Microrna, V6, P152, DOI 10.2174/221153660666617091315282; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Li Volti G, 2004, BIOCHEM BIOPH RES CO, V315, P517, DOI 10.1016/j.bbrc.2004.01.09; Loranger N, 1992, Pediatr Nurs, V18, P57; Matricardi S, 2018, ACTA NEUROL SCAND, V137, P575, DOI 10.1111/ane.1290; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Rizzo M, 2015, J CLIN ENDOCR METAB, V100, P603, DOI 10.1210/jc.2014-229; Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.386; Santillo A, 2009, INT DAIRY J, V19, P655, DOI 10.1016/j.idairyj.2009.06.01; Santillo A, 2009, J DAIRY SCI, V92, P1330, DOI 10.3168/jds.2008-159; Smirni D, 2018, J NERV MENT DIS, V206, P628, DOI 10.1097/NMD.000000000000085; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Testa D, 2017, AGING CLIN EXP RES, V29, pS191, DOI 10.1007/s40520-016-0647-; Testa D, 2016, OPEN MED-WARSAW, V11, P208, DOI 10.1515/med-2016-004; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2018, ACTA NEUROL SCAND, V138, P523, DOI 10.1111/ane.1300; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Viggiano E, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.0015; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",99,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2151.0,2159,,10.19193/0393-6384_2018_4s_330,,9,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900010,,,,,2022-07-14,0.00909090909090909,0.11672989414363687,0.0029529775303429036,0.11136549280381036,0.003316154504710874
J,"Rui, L1;  Zhang, GJ;  Bie, FJ;  Min, M;  Yi, M",,,,"Rui, Liao; Zhang Guijuan; Bie Fengjie; Min, Ma; Yi, Ma",,,EUGENOL SUPPRESSES THE DEVELOPMENT OF ESTROGEN RECEPTOR-POSITIVE PRECANCEROUS BREAST LESIONS AND REGULATES ESTROGEN RECEPTOR-RELATED PROTEINS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Eugenol; estrogen receptor-positive; precancerous lesions of breast cancer; antitumor therapy; prevention,GLYCOGEN-SYNTHASE KINASE-3; CANCER-CELLS; GPER; TAMOXIFEN; PATHWAY; DISEASE; ACTIVATION,"Introdution: The breast precancerous lesions is a necessary stage of breast cancer, and most of drugs for the treatment o breast precancerous lesions have a lot of adverse reactions, so finding a new drug effects on precancerous lesions of breast cancer has important significance. Eugenol has therapeutic effect on tumor, However, the mechanism of the treatment is not clear, the purpose of this study is to evaluate eugenol anti-tumor effect on ER positive precancerous lesions of breast cancer. Material and methods: 40 female SD rats were randomized into 5 groups, 8 in each. The groups were named Blank control group, Model group, Tamoxifen group, The low dose of Eugenol cream group (0.5mg) and The high dose of Eugenol cream group (1mg) respectively. The rats with breast precancerous lesions were induced by 7,12-dimethylbenz(a)anthracene (DMBA) combined with estrogen and progesterone injection. Drug interventions by tamoxifen(TAM) ointment and Eugenol cream were also launched during the model formation. The rats were executed after 70d. In MCF-10AT cell lines, we use 180 mu M eugenol to treat the cell lines, then observed 24 hours. And then the correlated indexes are detected by Western-blot and elisa. Results: 1mg eugenol significantly delayed the pathology process of rat breast tissue models in precancerous lesions of breast cancer, meanwhile, 1mg eugenol reduced the level of serum estradiol(E2) and the reduce rate was 36%, increased progesterone(P) and the increase rate was 26%, in addition, the protein levels of ER alpha, GPER, p-AKT, GSK3-alpha, GSK3-beta, p70s6k were decreased in the rat models and the decreased rates were respectively 31%, 53%, 57%, 58%, 56%, 93%, as well as MCF-10AT cell lines were treated with 180 mu M eugenol, the decreased rates were respectively 35%, 60%, 63%, 57%, 42%, 68% (P < 0.01). However, in rat models the expressions of PTEN and ER beta protein were increased and the increase rates were 76%, 58% (P < 0.05), in MCF-10AT cell lines the increase rates of the expressions of PTEN and ER beta protein were 46%, 177%. Discussion: eugenol is effective in the treatment of ER positive precancerous lesions of breast cancer, indicating that eugenol may be a new effective drug in treating ER positive precancerous lesions of breast cancer.","[Rui, Liao; Zhang Guijuan] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China; [Bie Fengjie; Min, Ma] Jinan Univ, Sch Tradit Chinese Med, Guangzhou 510632, Guangdong, Peoples R China; [Rui, Liao] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Yi, Ma] Jinan Univ, Bioengn Inst, Guangzhou 510632, Guangdong, Peoples R China","Min, M (corresponding author), Jinan Univ, Sch Tradit Chinese Med, Guangzhou 510632, Guangdong, Peoples R China.",1019312292@qq.com,,,"National Natural Science Foundation Project of China [81173265, 81473688, 81373314, 81673979]; Science and Technology Planning Project of Guangdong Province, China [2014A020210015, 2013B090500105, 2014A020212672]; Education Program of China for New Century Excellent Talents [NCET-13-0827]; Traditional Chinese Medicine Administration Project of Guangdong Province, China [20141070]; Natural Science Foundation of Guangdong Province [2015A030313333, 2015A030313345, 2016A030313114]; Science and Technology Support Program of Guangzhou, China [2014J4100104, 201707010245]; Fundamental Research Funds for the Central Universities [21615412, 21615464]; Guangzhou Municipal Enterprise Research and Development Institutions Construction Project [201503010064]; Cooperation Ombudsman Workstation Project in Industry, Education and Research of Guangdong Province, China [2013B090900010]","The current work was supported by National Natural Science Foundation Project of China (no. 81173265, 81473688, 81373314 and 81673979); The Science and Technology Planning Project of Guangdong Province, China (no. 2014A020210015, 2013B090500105 and 2014A020212672); Education Program of China for New Century Excellent Talents (no. NCET-13-0827); Traditional Chinese Medicine Administration Project of Guangdong Province, China (no. 20141070); The Natural Science Foundation of Guangdong Province (no. 2015A030313333, 2015A030313345 and 2016A030313114); Science and Technology Support Program of Guangzhou, China (no. 2014J4100104 and 201707010245); The Fundamental Research Funds for the Central Universities (no. 21615412 and 21615464). Guangzhou Municipal Enterprise Research and Development Institutions Construction Project (No. 201503010064), the Cooperation Ombudsman Workstation Project in Industry, Education and Research of Guangdong Province, China (No. 2013B090900010).","Al-Sharif I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-60; Ali S, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.0004; Azoulay-Alfaguter I, 2015, ONCOGENE, V34, P4613, DOI 10.1038/onc.2014.39; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.20040906; Barough MS, 2015, IRAN J CANCER PREV, V8, DOI 10.17795/ijcp-419; Bartella V, 2016, CELL SIGNAL, V28, P61, DOI 10.1016/j.cellsig.2015.11.01; Baxi SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.004840; Bocker W, 2002, VERH DEUT G, V86, P11; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.2133; Chen ZJ, 2016, MOL ONCOLOG; Chiang KC, 2015, DRUG DES DEV THER, V9, P4631, DOI 10.2147/DDDT.S8618; Dembowy J, 2015, ONCOGENE, V34, P3514, DOI 10.1038/onc.2014.27; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM19850117312030; Fox EM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr344; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-129; Jones ME, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr320; Kesharwani RK, 2015, APPL BIOCHEM BIOTECH, V176, P1996, DOI 10.1007/s12010-015-1696-; Kim H. S., 2013, PLOS ONE, V; Li DH, 2012, ADV MATER RES-SWITZ, V554-556, P1725, DOI 10.4028/www.scientific.net/AMR.554-556.172; Lim J, 2015, J NEUROCHEM, V133, P544, DOI 10.1111/jnc.1308; Lin YL, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0163-; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.12; Prossnitz ER, 2009, PROSTAG OTH LIPID M, V89, P89, DOI 10.1016/j.prostaglandins.2009.05.00; Pupo M, 2016, METHODS MOL BIOL, V1366, P471, DOI 10.1007/978-1-4939-3127-9_3; Rigiracciolo DC, 2016, ONCOTARGET, V7, P94, DOI 10.18632/oncotarget.647; Sarwa KK, 2014, CURR DRUG DELIV, V11, P332, DOI 10.2174/156720181166614011511312; Segatto I, 2013, MOL CANCER RES, V11, DOI 10.1158/1557-3125.ADVBC-B05; Segatto I, 2014, MOL ONCOL, V8, P766, DOI 10.1016/j.molonc.2014.02.00; Tokunaga E, 2006, INT J CANCER, V118, P284, DOI 10.1002/ijc.2135; Wang C, 2012, AM J TRANSL RES, V4, P39; Wang S, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0668-; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-; Wu JJ, 2014, EXP CELL RES, V328, P351, DOI 10.1016/j.yexcr.2014.08.03; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra05077; Yarla NS, 2016, SEMINARS CANC BIO; Zhang GJ, 2012, ADV MATER RES-SWITZ, V554-556, P1789, DOI 10.4028/www.scientific.net/AMR.554-556.178; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-011",37,0,0,0,11,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1821.0,1827,,10.19193/0393-6384_2018_6_280,,7,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400031,,,,,2022-07-14,0.003822314049586777,2.3696420711496494e-11,0.007424568312244537,0.1021323288914211,0.007424568312244537
J,"Sahin, N1;  Gurses, VV;  Baydil, B;  Akgul, MS;  Feka, K;  Iovane, A;  Messina, G",,,,"Sahin, Nese; Gurses, Veli Volkan; Baydil, Bilgehan; Akgul, Mustafa Sakir; Feka, Kaltrina; Iovane, Angelo; Messina, Giuseppe",,,THE EFFECT OF COMPREHENSIVE WARM UP (FIFA 11+PROGRAM) ON MOTOR ABILITIES IN YOUNG BASKETBALL PLAYERS: A PILOT STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,physical fitness; performance; agility; FIFA 11+; injury prevention,INJURY SURVEILLANCE SYSTEM; 11 TRAINING-PROGRAM; FOOTBALL PLAYERS; DESCRIPTIVE EPIDEMIOLOGY; PREVENTING INJURIES; STRATEGIES; PERFORMANCE; MECHANISMS; STRENGTH; IMPACT,"Aim: Recent findings indicated that dedicated warm up activities may significantly affect performance and prevent injuries. Furthermore, since it is known that comprehensive warm up program helps in prevention injuries, the purpose of this study was to investigate the effects of a comprehensive warm-up program (F-MARC The 11+) on performance and injuries in young basketball players. While knowing the specifics and possible injuries of basketball game, the prevention of injuries must be considered as an important issue. Methods: Twenty children (mean +/- SD: age 10,7 +/- 0,3 yr; height 149,20 +/- 7.51, weight 47,61 +/- 12,30 kg, percentage of body fat: 14,44 +/- 7,68 %) were recruited from two local basketball clubs to participate in this study. Players were randomly selected and assigned to either group: experimental (Exp. n = 10) or a control (Con. n = 10), respectively. They were trained 3 days per week (2,1 +/- 0,6 years of experience), for 10 weeks in a row. The experimental group followed the F-MARC 11+ program for 20 minutes during warm up phase in each training season for ten weeks while control group performed their regular warm up routine. Both groups performed vertical jumps and pro agility tests at the beginning and at the end of the tenth-week training sessions. Moreover, nonparametric Wilcoxon signed rank tests were performed to compare the pre and post test scores. Results: The agility pre-test result was found 6,358 +/- 0, 27 seconds and post-test was found 6,121 +/- 0, 34 seconds. A significant difference was found between agility test values (p<0,05) Discussion: Comprehensive warm-up program leads to a significant change in agility in the present study. Therefore, this is a desirable result since basketball is characterized by many quick movements such as sudden speed-ups, stops and turns. Eventually, previous studies indicated that the FIFA 11+ program resulted to be an important way to warm up properly before training sessions. Conclusion: Based on the results of this study we may conclude that The F-MARC 11+ comprehensive warm-up is an appropriate and effective tool for improving basketball-specific performance such as agility in young basketball players.","[Sahin, Nese] Ankara Univ, Fac Sport Sci, Ankara, Turkey; [Gurses, Veli Volkan; Baydil, Bilgehan; Akgul, Mustafa Sakir] Kastamonu Univ, Sch Phys Educ & Sport, Kastamonu, Turkey; [Feka, Kaltrina] Univ Palermo, PhD Program Hlth Promot & Cognit Sci, Sport & Exercise Sci Res Unit, Palermo, Italy; [Iovane, Angelo; Messina, Giuseppe] Univ Palermo, Dept Psychol Pedag & Educ Sci, Sport & Exercise Sci Res Unit, Palermo, Italy","Messina, G (corresponding author), Via Giovanni Pascoli 6, I-90144 Palermo, Italy.",giuseppe.messina17@unipa.it,"AKGÃL, Mustafa Åakir/AAT-8696-2020; Messina, Giuseppe/N-7298-2019","AKGÃL, Mustafa Åakir/0000-0002-9696-6541; Messina, Giuseppe/0000-0003-2774-4950; Feka, Kaltrina/0000-0003-1293-7995",,,"Adirim TA, 2006, CURR PAEDIAT, V16, P205, DOI DOI 10.1016/j.cupe.2006.03.00; Agel J, 2007, J ATHL TRAINING, V42, P20; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.01834; Battaglia G, 2016, ACTA MEDICA MEDITERR, V32, P1589, DOI 10.19193/0393-6384_2016_5_13; Bianco A, 2014, CANCER MED-US, V3, P385, DOI 10.1002/cam4.19; Brito J, 2010, ISOKINET EXERC SCI, V18, P211, DOI 10.3233/IES-2010-038; Chimera NJ, 2004, J ATHL TRAINING, V39, P2; Condello G, 2016, INT J SPORT PHYSIOL, V11, P96, DOI 10.1123/ijspp.2014-045; Cowley HR, 2006, J ATHL TRAINING, V41, P6; Dick R, 2007, J ATHL TRAINING, V42, P19; Enoksen E, 2009, J SPORT SCI, V27, P77, DOI 10.1080/0264041080244872; Neto MG, 2017, CLIN REHABIL, V31, P651, DOI 10.1177/026921551667590; Kilding AE, 2008, J SPORT SCI MED, V7, P32; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/036354650629389; Lockie RG, 2016, SPORTS, V4, DOI 10.3390/sports403004; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/036354651243876; Meeuwisse WH, 2003, AM J SPORT MED, V31, P379, DOI 10.1177/0363546503031003090; Pasanen K, 2009, BRIT J SPORT MED, V43, P1073, DOI 10.1136/bjsm.2009.06174; Patti A, 2016, J PHYS THER SCI, V28, P72, DOI 10.1589/jpts.28.7; Sahin N, 2015, J PHYS THER SCI, V27, P437, DOI 10.1589/jpts.27.43; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18; Steffen K, 2013, BRIT J SPORT MED, V47, P480, DOI 10.1136/bjsports-2012-09188; Vanderlei Franciele Marques, 2013, Int Arch Med, V6, P5, DOI 10.1186/1755-7682-6-",24,1,1,2,12,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,703.0,707,,10.19193/0393-6384_2018_3_108,,5,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000013,,,,,2022-07-14,0.0024793388429752063,1.3856468475869627e-11,0.007384205948576642,0.09225109834081444,0.0072675878260307575
J,"Savran, Y1;  Mengi, T;  Yilmaz, B;  Tokur, ME;  Ergan, B;  Yaka, E;  Comert, B",,,,"Savran, Yusuf; Mengi, Tugce; Yilmaz, Baris; Tokur, Murat E.; Ergan, Begum; Yaka, Erdem; Comert, Bilgin",,,CAN NEUTROPHIL-LYMPHOCYTE RATIO PREDICT DISEASE SEVERITY AND MORTALITY IN SEPSIS AND SEPTIC SHOCK PATIENTS?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,critical care; mortality; rteutrophil-lymphocyte ratio; sepsis; septic shock; severity,COUNT RATIO; ASSOCIATION; DIAGNOSIS,"Introduction: Sepsis and septic shock are the most serious clinical conditions in intensive care units with increased mortality rates. Efforts on improving treatment modalities and survival is still the most hot topic worldwide. One of the key points is finding out a reliable and cost-effective marker that can predict prognosis. The neutrophil-lymphocyte ratio (NLR) has been shown to be associated with prognosis in various clinical situations. The aim of this study was to investigate the relationship of NLR at admission and disease severity and 28-day mortality in sepsis and septic shock patients. Materials and methods: Patients over 18 years of age admitted to Medical Intensive Care Unit (ICU) with the diagnosis of sepsis and septic shock between January 1st ,2010 and January 1st ,2016 were enrolled retrospectively. NLR at ICU admission of each patient was calculated from whole blood test results. Results: A total of 314 patients, 159 men and 155 women, were included in the study. 185 patients (58.9%) were diagnosed as sepsis and 129 patients (41.1%) as septic shock. NLR was significantly higher in the septic shock group (sepsis: 14.7, septic shock: 21.5) (p<0.05). 118 patients (37.6%) survived, and 196 (62.4%) died. While APACHE II scores (survivors: 21; non-survivors: 25) and expected mortality rates (survivors: 38%; non-survivors: 53%) were significantly different between two groups (p<0,05), no significant relationship between NLR and mortality could be detected (p>0.05). Conclusion: In our study, there was no significant relationship between NLR and mortality but, NLR was related to severity of sepsis. We suggest NLR should be used in detecting severity of sepsis besides APACHE and SOFA scores which will increase physicians' awareness during the management of therapy.","[Savran, Yusuf] Dokuz Eylul Univ, Fac Med, Dept Internal Med, Izmir, Turkey; [Mengi, Tugce; Yaka, Erdem] Dokuz Eylul Univ, Fac Med, Dept Neurol, Izmir, Turkey; [Yilmaz, Baris] Dokuz Eylul Univ, Fac Med, Dept Pulmonol, Izmir, Turkey; [Tokur, Murat E.] Dokuz Eylul Univ, Fac Med, Dept Anesthesiol, Izmir, Turkey; [Ergan, Begum] Dokuz Eylul Univ, Fac Med, Dept Pulmonol & Intens Care, Izmir, Turkey; [Comert, Bilgin] Dokuz Eylul Univ, Fac Med, Dept Internal Med & Intens Care, Izmir, Turkey","Savran, Y (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Internal Med, Izmir, Turkey.",yusuf.savran@deu.edu.tr,"Mengi, TuÄÃ§e/AAA-4505-2022; CÃ¶mert, Bilgin/P-3030-2019; Savran, Yusuf/AAI-1796-2019; Ergan, Begum/U-8276-2017","CÃ¶mert, Bilgin/0000-0002-2148-5356; Ergan, Begum/0000-0003-2920-9214",,,"Benites-Zapata VA, 2015, AM J CARDIOL, V115, P57, DOI 10.1016/j.amjcard.2014.10.00; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc930; Gurol G, 2015, J MICROBIOL BIOTECHN, V25, P521, DOI 10.4014/jmb.1408.0806; Hwang SY, 2017, AM J EMERG MED, V35, P234, DOI 10.1016/j.ajem.2016.10.05; Korkmaz P, 2017, J CLIN ANAL MED, V8, P211, DOI 10.4328/JCAM.481; Liu X, 2016, MEDIAT INFLAMM, V2016, DOI DOI 10.1155/2016/819125; Lowsby R, 2015, EMERG MED J, V32, P531, DOI 10.1136/emermed-2014-20407; OKASHAH AS, 2014, RES OPIN ANESTH INTE, V0002, P0003; Park JJ, 2013, AM J CARDIOL, V111, P636, DOI 10.1016/j.amjcard.2012.11.01; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-; Riche F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1144-; Salciccioli JD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0731-; Sandquist M, 2014, EXPERT REV CLIN IMMU, V10, P1349, DOI 10.1586/1744666X.2014.94967; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.028; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.004286; Vincent JL, 2013, EXPERT REV ANTI-INFE, V11, P265, DOI [10.1586/eri.13.9, 10.1586/ERI.13.9; Yodying H, 2016, ANN SURG ONCOL, V23, P646, DOI 10.1245/s10434-015-4869-; Zhang HB, 2016, EXP THER MED, V12, P2215, DOI 10.3892/etm.2016.358",18,2,2,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,877.0,882,,10.19193/0393-6384_2018_3_134,,6,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000038,,,,,2022-07-14,0.001859504132231405,3.239138941046981e-17,0.0035094935871218167,0.08295554850928537,0.0035094935871218167
J,"Scoppa, F1;  Pirino, A;  Belloni, G;  Gallamini, M;  Messina, G;  Iovane, A",,,,"Scoppa, Fabio; Pirino, Alessio; Belloni, Gabriele; Gallamini, Michele; Messina, Giuseppe; Iovane, Angelo",,,POSTURAL AND AUTONOMIC MODIFICATIONS FOLLOWING OSTEOPATHIC MANIPULATIVE TREATMENT (OMT): COMPARISON BETWEEN TWO TECHNIQUES. A PILOT STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,static baropodometry; balance; posture; Osteopathic Manipulative Treatment (OMT),SWAY-DENSITY; BALANCE; FALLS; STABILIZATION,Objective: With reference to OMT principles consistent mention is made of the capability of stimulating Autonomic Responses through both Ortho-and Para-Sympathetic channels. Several studies have been performed to demonstrate this kind of interaction. The purpose of this pilot study was twofold: 1) Compare different OMTs that supposedly interact either with Ortho-or Para-Sympathetic branches of the Autonomic System; 2) Ascertain whether there is a relationship between Autonomic Balance and Quiet Upright Stance Balance. Results: A Sample of 51 young healthy students underwent to a series of four assessment tests for both functions over a 5 hr period. Conclusion: The time plot of the main parameters afforded by the Heart Rate Variability (HRV) Instrumental Assessment and by the Romberg Test performed on a Force Platform actually confirmed that different OMTs challenge different Autonomic components and can achieve different responses in quiet upright stance balance control.,"[Scoppa, Fabio; Belloni, Gabriele] Sapienza Univ Rome, Fac Med & Dent Surg, Posturol, Rome, Italy; [Scoppa, Fabio; Belloni, Gabriele] Chinesis IFOP Osteopathy Sch, Rome, Italy; [Pirino, Alessio] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Messina, Giuseppe; Iovane, Angelo] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy","Messina, G (corresponding author), Via Giovanni Pascoli 6, I-90144 Palermo, Italy.",17@unipa.it,"Messina, Giuseppe/N-7298-2019; PIRINO, ALESSIO/ABG-2384-2020","Messina, Giuseppe/0000-0003-2774-4950; PIRINO, ALESSIO/0000-0001-5369-7284",,,"AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.616604; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.24; Bianco A, 2014, AGING CLIN EXP RES, V26, P147, DOI 10.1007/s40520-013-0144-; Burns L, 2000, J OSTEOPATH MED, V100, P249, DOI 10.7556/jaoa.2000.100.4.24; Camm AJ, 1996, EUR HEART J, V17, P35; Fornari M, 2017, J AM OSTEOPATH ASSOC, V117, P559, DOI 10.7556/jaoa.2017.11; Giles PD, 2013, J ALTERN COMPLEM MED, V19, P92, DOI 10.1089/acm.2011.003; Gurfinkel V, 2006, J NEUROPHYSIOL, V96, P2678, DOI 10.1152/jn.00406.200; Gurfinkel Victor S, 2011, J Vis Exp, DOI 10.3791/367; Henley Charles E, 2008, Osteopath Med Prim Care, V2, P7, DOI 10.1186/1750-4732-2-; Jacono M, 2004, MOTOR CONTROL, V8, P292, DOI 10.1123/mcj.8.3.29; Jakel A, 2011, J AM OSTEOPATH ASSOC, V111, P68; Kang HG, 2013, GAIT POSTURE, V38, P757, DOI 10.1016/j.gaitpost.2013.03.02; Kapteyn T S, 1983, Agressologie, V24, P32; Lopez D, 2011, J AM OSTEOPATH ASSOC, V111, P382, DOI 10.7556/jaoa.2011.111.6.38; Martines F, 2016, EUR ARCH OTO-RHINO-L, V273, P1419, DOI 10.1007/s00405-015-3714-; Martines F, 2015, ACTA MEDICA MEDITERR, V31, P90; Messina Giuseppe, 2017, Eur J Transl Myol, V27, P6363, DOI 10.4081/ejtm.2017.636; Milnes K, 2007, INT J OSTEOPATH MED, V10, P8, DOI 10.1016/j.ijosm.2007.01.00; Noll DR, 2013, J AM OSTEOPATH ASSOC, V113, P1; Northup GW, 1945, J AM OSTEOPATH ASSOC, V100, P64; Pagani M, 1984, J HYPERTENS        S, V2, pS38; Parvan K, 2013, MED BALTIM, V2, P295, DOI DOI 10.1097/MD.000000000000241; Patti A., 2015, J BIOLOGICAL RES, V88, P11; Patti A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph1407080; Patti A, 2017, WORK, V57, P23, DOI 10.3233/WOR-17253; Ruffini N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.0027; Salvago P, 2017, INT J AUDIOL, V56, P148, DOI 10.1080/14992027.2016.123641; Scoppa F, 2017 ACTA MED MEDIT; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.00; Waitley DD, 1948, J AM OSTEOPATH ASSOC, V100, P65; Younes M, 2017, CHIROPR MAN THER, V25, DOI 10.1186/s12998-017-0167-",32,1,1,2,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,431.0,436,,10.19193/0393-6384_2018_2_68,,6,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400022,,,,,2022-07-14,0.003305785123966942,1.2242231500565467e-11,0.0058694620243054125,0.10333600213504136,0.005864695189873937
J,"Sessa, F1;  Franco, S;  Picciocchi, E;  Geraci, D;  Chisari, MG;  Marsala, G;  Polito, AN;  Sorrentino, M;  Tripi, G;  Salerno, M;  Russo, D;  Lavano, SM;  Cerroni, F;  Romano, P;  Gallai, B;  Marotta, R;  Lavano, F;  Magliulo, RM;  D'oro, L;  Di Folco, A;  Parisi, L;  Testa, D;  Murabito, P;  Montana, A;  Giugliano, P;  Salerno, M",,,,"Sessa, Francesco; Franco, Sabrina; Picciocchi, Elisabetta; Geraci, Diego; Chisari, Mario Giuseppe; Marsala, Gabriella; Polito, Anna Nunzia; Sorrentino, Michele; Tripi, Gabriele; Salerno, Margherita; Russo, Daniela; Lavano, Serena Marianna; Cerroni, Francesco; Romano, Palmira; Gallai, Beatrice; Marotta, Rosa; Lavano, Francesco; Magliulo, Rosaria Martina; D'oro, Lucrezia; Di Folco, Annabella; Parisi, Lucia; Testa, Davide; Murabito, Paolo; Montana, Angelo; Giugliano, Pasquale; Salerno, Monica",,,ADDICTIONS SUBSTANCE FREE DURING LIFESPAN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Digital Natives; addiction; techonology,MONOSYMPTOMATIC NOCTURNAL ENURESIS; CHILDHOOD ABSENCE EPILEPSY; SLEEP-APNEA SYNDROME; QUALITY-OF-LIFE; HYPERTHERMIC REACTIONS; HEME OXYGENASE-1; CHILDREN; MIGRAINE; ADOLESCENTS; WEIGHT,"The addictions substance free is an umbrella definition comprises internet addiction, sexual addiction, gambling pathological, workholism, videogames and computer addiction. Actually, the technological addictions is frequent in young adolescents. The term Digital Natives indicates the children born in an information system of learning and communication different from that of the generations previous. This temporal range was strongly characterized by growing presence of technological communication tools in daily life. The effects of hyper-exposition to technological tools tend to create a relational virtuality without a body is born, therefore, already within the family ties and during adolescence he moved to the digital socialization network. The technological object it interacts between the adolescent and the world of peers and adults, becoming the facilitator object that as the psychotropic substance, it conveys new modes of communication","[Sessa, Francesco; Salerno, Monica] Univ Foggia, Dept Clin & Expt Med, Viale Pinto 1, I-71122 Foggia, Italy; [Franco, Sabrina; Geraci, Diego; Montana, Angelo] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, I-95123 Catania, Italy; [Picciocchi, Elisabetta] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Chisari, Mario Giuseppe] INPS, Catania, Italy; [Marsala, Gabriella] Azienda Ospedaliero Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Sorrentino, Michele] NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy; [Sorrentino, Michele] Pineta Grande Hosp, Castel Volturno, CE, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Di Folco, Annabella; Parisi, Lucia; Testa, Davide] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Lavano, Serena Marianna; Marotta, Rosa; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Magliulo, Rosaria Martina] Ctr Studi Scoliosi SRL, Naples, Italy; [D'oro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy; [Giugliano, Pasquale] UOC Med Legale, Syracuse, Italy; [Giugliano, Pasquale] Azienda Osped St Anna & San Sebastiano Caserta, Caserta, Italy","Salerno, M (corresponding author), Univ Foggia, Dept Clin & Expt Med, Viale Pinto 1, I-71122 Foggia, Italy.",,"Marotta, Rosa/AAG-1453-2020; SALERNO, MONICA/AAC-1321-2019; Sessa, Francesco/G-1754-2018","SALERNO, MONICA/0000-0002-6410-3960; Sessa, Francesco/0000-0003-0357-8791; Murabito, Paolo/0000-0002-2662-1898; Marotta, Rosa/0000-0003-0515-5952",,,"Albenzio M, 2018, J DAIRY SCI, V101, P4842, DOI 10.3168/jds.2017-1310; Albenzio M, 2016, J DAIRY SCI, V99, P5032, DOI 10.3168/jds.2015-1070; Albenzio M, 2017, NUTRIENTS IN DAIRY AND THEIR IMPLICATIONS FOR HEALTH AND DISEASE, P435, DOI 10.1016/B978-0-12-809762-5.00034-; Carey SE, 2015, DRUG ALCOHOL DEPEN, V155, P175, DOI 10.1016/j.drugalcdep.2015.07.67; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSL, V; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Crocq Marc-Antoine, 2007, Dialogues Clin Neurosci, V9, P35; De Luca V, 2008, PSYCHIAT INVEST, V; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Gigante E, 2018, ACTA MEDICA MEDITERR, V34, P1295, DOI 10.19193/0393-6384_2018_5_19; Jouroukhin Y, 2019, BIOL PSYCHIAT, V85, P891, DOI 10.1016/j.biopsych.2018.07.02; Kang SH, 2018, IRAN J PUBLIC HEALTH, V47, P104; King DL, 2013, AUST NZ J PSYCHIAT, V47, P875, DOI 10.1177/000486741349592; Larkin M, 2002, ADDICT RES THEORY, V10, P281, DOI 10.1080/1606635021186; Li Volti G, 2004, BIOCHEM BIOPH RES CO, V315, P517, DOI 10.1016/j.bbrc.2004.01.09; Lupica CR, 2018, LEARN MEMORY, V25, P435, DOI 10.1101/lm.046748.11; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Moscatelli F, 2016, PLOS ONE, V2; Moscatelli F, 2015, BIOL MED, V; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Rizzo M, 2015, J CLIN ENDOCR METAB, V100, P603, DOI 10.1210/jc.2014-229; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.386; Salgado-Mendialdua V, 2018, BIOCHEM PHARMACOL, V157, P159, DOI 10.1016/j.bcp.2018.08.02; Sami H, 2018, PSYCHIAT RES, V267, P327, DOI 10.1016/j.psychres.2018.03.06; Shaffer HJ, 2004, HARVARD REV PSYCHIAT, V12, P367, DOI 10.1080/1067322049090570; Singer M, 2012, ADDICTION, V107, P1747, DOI 10.1111/j.1360-0443.2012.03879.; Smirni D, 2018, J NERV MENT DIS, V206, P628, DOI 10.1097/NMD.000000000000085; Smirni D, 2018, NEUROL SCI, V39, P885, DOI 10.1007/s10072-018-3297-; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P1271, DOI 10.19193/0393-6384_2018_5_19; Throuvala MA, 2018, CURR NEUROPHARMACO; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Viggiano E, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.0015",99,6,6,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2081.0,2087,,10.19193/0393-6384_2018_4s_322,,7,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900002,,,,,2022-07-14,0.008987603305785123,0.11276235092770114,0.004118856920913495,0.11136293040967293,0.004752421744283471
J,"Sessa, F21;   Franco, S;   Picciocchi, E;   Geraci, D;   Chisari, MG;   Marsala, G;   Polito, AN;   Sorrentino, M;   Tripi, G;   Salerno, M;   Russo, D;   Lavano, SM;   Cerroni, F;   Romano, P;   Gallai, B;   Marotta, R;   Lavano, F;   Magliulo, RM;   D'Oro, L;   Di Folco, A;   Parisi, L;   Testa, D;   Murabito, P;   Salerno, M",,,,"Sessa, Francesco; Franco, Sabrina; Picciocchi, Elisabetta; Geraci, Diego; Chisari, Mario Giuseppe; Marsala, Gabriella; Polito, Anna Nunzia; Sorrentino, Michele; Tripi, Gabriele; Salerno, Margherita; Russo, Daniela; Lavano, Serena Marianna; Cerroni, Francesco; Romano, Palmira; Gallai, Beatrice; Marotta, Rosa; Lavano, Francesco; Magliulo, Rosaria Martina; D'Oro, Lucrezia; Di Folco, Annabella; Parisi, Lucia; Testa, Davide; Murabito, Paolo; Salerno, Monica",,,FORENSIC CONSIDERATIONS ON VIOLENT PARASOMNIAS DURING LIFESPAN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,NREM parasomnias; sleep; consciousness; guiltiness,HYPERTHERMIC REACTIONS; NOCTURNAL ENURESIS; HEME OXYGENASE-1; SLEEP; BEHAVIOR; CHILDREN; SYSTEM; SLEEPWALKING; DISORDERS; EVENTS,"Nocturnal parasomnias are a group of sleep complex manifestation that don't alter the sleep macrostructure, but when persistent during adulthood may be assume violent aspects with relevant forensic implications about the guiltiness.","[Sessa, Francesco; Picciocchi, Elisabetta; Salerno, Monica] Univ Foggia, Dept Clin & Expt Med, Viale Pinto 1, I-71122 Foggia, Italy; [Franco, Sabrina; Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, I-95123 Catania, Italy; [Picciocchi, Elisabetta] Casa Cura Villa dei Fiori Acerra, Naples, Italy; [Chisari, Mario Giuseppe] INPS, Catania, Italy; [Marsala, Gabriella] Azienda Osped Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Sorrentino, Michele] Pineta Grande Hosp Castel Volturno, NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Di Folco, Annabella; Parisi, Lucia; Testa, Davide] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Lavano, Serena Marianna; Marotta, Rosa; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Magliulo, Rosaria Martina] Ctr Studi Scoliosi SRL, Naples, Italy; [D'Oro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy","Salerno, M (corresponding author), Univ Foggia, Dept Clin & Expt Med, Viale Pinto 1, I-71122 Foggia, Italy.",,"Sessa, Francesco/G-1754-2018; SALERNO, MONICA/AAC-1321-2019; Marotta, Rosa/AAG-1453-2020","Sessa, Francesco/0000-0003-0357-8791; SALERNO, MONICA/0000-0002-6410-3960; Murabito, Paolo/0000-0002-2662-1898; Marotta, Rosa/0000-0003-0515-5952; Cerroni, Francesco/0000-0003-3024-5482",,,"Albenzio M, 2018, J DAIRY SCI, V101, P4842, DOI 10.3168/jds.2017-1310; Albenzio M, 2016, J DAIRY SCI, V99, P5032, DOI 10.3168/jds.2015-1070; Albenzio M, 2013, J DAIRY SCI, V96, P2781, DOI 10.3168/jds.2012-621; Albenzio M, 2017, NUTRIENTS IN DAIRY AND THEIR IMPLICATIONS FOR HEALTH AND DISEASE, P435, DOI 10.1016/B978-0-12-809762-5.00034-; Bisulli F, 2011, SLEEP MED, V12, pS27, DOI 10.1016/j.sleep.2011.10.00; Bugalho P, 2017, J NEURAL TRANSM, V124, P1183, DOI 10.1007/s00702-017-1759-; Caroprese M, 2010, J DAIRY SCI, V93, P2395, DOI 10.3168/jds.2009-260; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Carpprese M, 2012, SMALL RUMINANT RE; Chieffi S, 2017, FRONT PHYSL, V; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Fantini ML, 2012, CURR TREAT OPTION NE, V14, P438, DOI 10.1007/s11940-012-0187-; Ferini-Strambi L, 2016, PARKINSONISM RELAT D, V22, pS69, DOI 10.1016/j.parkreldis.2015.09.00; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Geddes MR, 2016, CORTEX, V74, P96, DOI 10.1016/j.cortex.2015.10.01; Gigante E, 2018, ACTA MEDICA MEDITERR, V34, P1295, DOI 10.19193/0393-6384_2018_5_19; Jiang HY, 2017, MOL NEUROBIOL, V54, P2997, DOI 10.1007/s12035-016-9831-; Kotagal S, 2015, SLEEP MED CLIN, V10, P163, DOI 10.1016/j.jsmc.2015.02.00; Li Volti G, 2004, BIOCHEM BIOPH RES CO, V315, P517, DOI 10.1016/j.bbrc.2004.01.09; Mahowald Mark W, 2011, Handb Clin Neurol, V99, P1149, DOI 10.1016/B978-0-444-52007-4.00026-; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; McKenna D, 2017, MOVEMENT DISORD, V32, P636, DOI 10.1002/mds.2700; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Moscatelli F, 2016, PLOS ONE, V2; Moscatelli F, 2015, BIOL MED, V; Ohayon MM, 2010, SLEEP MED, V11, P941, DOI 10.1016/j.sleep.2010.02.01; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Rizzo M, 2015, J CLIN ENDOCR METAB, V100, P603, DOI 10.1210/jc.2014-229; Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.386; Santillo A, 2009, INT DAIRY J, V19, P655, DOI 10.1016/j.idairyj.2009.06.01; Santillo A, 2009, J DAIRY SCI, V92, P1330, DOI 10.3168/jds.2008-159; Smirni D, 2019, NEUROL SCI, V40, P97, DOI 10.1007/s10072-018-3587-; Sperandeo R, 2018, ACTA MEDICA MEDITERR, V34, P1271, DOI 10.19193/0393-6384_2018_5_19; Stallman Helen M, 2017, Aust Fam Physician, V46, P59; Szucs A, 2014, MED HYPOTHESES, V83, P47, DOI 10.1016/j.mehy.2014.04.01; Tassinari CA, 2009, REV NEUROL-FRANCE, V165, P762, DOI 10.1016/j.neurol.2009.08.00; Testa D, 2017, AGING CLIN EXP RES, V29, pS191, DOI 10.1007/s40520-016-0647-; Testa D, 2016, OPEN MED-WARSAW, V11, P208, DOI 10.1515/med-2016-004; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Turillazzi E, 2013, FORENSIC SCI INT, V231, P142, DOI 10.1016/j.forsciint.2013.04.00; Umanath S, 2011, J HIST NEUROSCI, V20, P253, DOI 10.1080/0964704X.2010.51347; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; van Gastel A, 2014, Tijdschr Psychiatr, V56, P12; Viana BD, 2009, REV BRAS PSIQUIATR, V31, P28; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano E, NEUROPSYCHIATR DIS, V1; Viggiano E, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.0015",82,6,6,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2135.0,2142,,10.19193/0393-6384_2018_4s_328,,8,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900008,,,,,2022-07-14,0.008057851239669421,0.0708320370950641,0.005491882028341155,0.1113398741675389,0.005657265218404849
J,"Shen, L1;  Xu, YM;  Zhu, YL;  Zhong, CJ",,,,"Shen, Liang; Xu, Yi-Ming; Zhu, Yu-Ling; Zhong, Chong-Jun",,,MIR-222 ENHANCES HUMAN ESOPHAGEAL SQUAMOUS CELL CARCINOMA CELL LINE TE11 GROWTH VIA REGULATING,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,microRNA-222; proliferation; ESCC; p27,CANCER CELLS; MICRORNAS; EXPRESSION; PROLIFERATION,"Increasing evidence suggests that the abnormal expression of microRNAs involved in human esophageal carcinogenesis. It is still unknown whether and how miRNA-222 played a part in esophageal cancer. Herein, we aimed to investigate the roles of miR-222 in esophageal cancer cells, particularly in regulating response to proliferation. Esophageal squamous cell carcinoma cell line, TE11 cells, was transfected with miR-222 mimic, inhibitor or their negative controls. Cell Counting Kit-8 (CCK-8) and EdU incorporation assay were used to analyze Cell proliferation. MiR-222 and expression levels of its putative target genes (p27 and p57) were detected using qRT-PCR and Western blot. Our results showed that overexpression of miR-222 enhanced TE11 cell proliferation, and expression level of p27Kip1 was negatively moderated by miR-222 up-regulation at post-transcriptional level. Finally, we transfected miR-222 inhibitor and p27 si-RNA into TE11 cells, and found that proliferation-suppressing effects of miR-222 inhibitor on TE11 cells could be partially reversed by silencing p27, indicating that p27 is a target gene of miR-222 during TE11 cell proliferation. Our data suggests that miR-222 overexpression controls TE11 cell growth by down-regulating p27. Inhibition of miR-222 might be a potential therapeutic strategy for esophageal cancer.","[Shen, Liang; Xu, Yi-Ming; Zhu, Yu-Ling; Zhong, Chong-Jun] Nantong Univ, Affiliated Hosp 2, Dept Thorac & Cardiovasc Surg, 6 Haierxiang Bei Rd, Nantong 226001, Peoples R China","Zhong, CJ (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Thorac & Cardiovasc Surg, 6 Haierxiang Bei Rd, Nantong 226001, Peoples R China.",zhongcjnt001@126.com,,,The Science and Technology Guiding Program of Nantong [YYZ17035],This work was supported by the grants from The Science and Technology Guiding Program of Nantong (Project No: YYZ17035 to L. Shen).,"Akao Y, 2011, CANCER LETT, V300, P197, DOI 10.1016/j.canlet.2010.10.00; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.00; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.0; Chen WX, 2013, TUMOR BIOL, V34, P1361, DOI 10.1007/s13277-013-0750-; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.17; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M70180520; Garofalo M, 2012, CURRENT MOL MED, V12, P18; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.01; Han Li-Hui, 2015, Asian Pac J Cancer Prev, V16, P224; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.050960310; Hiyama T, 2010, INT J CANCER, V121, P164; Hwang MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.006650; Liu JG, 2012, EUR J CARDIO-THORAC, V41, pE7, DOI 10.1093/ejcts/ezr24; Matsuzaki J, 2015, J CLIN MED, V4, P1566, DOI 10.3390/jcm408156; Matsuzaki J, 2013, GASTROENTEROLOGY, V145, P1300, DOI 10.1053/j.gastro.2013.08.00; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.0120; Quintavalle C, 2012, ONCOGENE, V31, P858, DOI 10.1038/onc.2011.28; Sage CL, 2014, EMBO J, V26, P369; Shibuya H, 2010, ONCOLOGY-BASEL, V79, P313, DOI 10.1159/00032328; Tili E, 2011, P NATL ACAD SCI USA, V108, P4908, DOI 10.1073/pnas.110179510; Yamashita R, 2015, CANCER MED-US, V4, P551, DOI 10.1002/cam4.41; Yang ZH, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-3; Zhang S, 2015, AER ADV ENG RES, V15, P; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-; Zhao YY, 2015, J CANCER, V6, P1230, DOI 10.7150/jca.1254; Zhong CJ, 2015, INT J CLIN EXP MED, V8, P553; Zhou JF, 2010, ONCOL REP, V23, P121, DOI 10.3892/or_0000061",27,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1311.0,1316,,10.19193/0393-6384_2018_5_201,,6,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700023,,,,,2022-07-14,0.0027892561983471073,2.9183578846546356e-21,0.0053649632543488965,0.06484936590986742,0.0053649632543488965
J,"Sorrentino, M1;  Tripi, G;  Salerno, M;  Russo, D;  Lavano, SM;  Cerroni, F;  Romano, P;  Gallai, B;  Marotta, R;  Lavano, F;  Magliulo, RM;  D'Oro, L;  Di Folco, A;  Testa, D;  Marsala, G;  Montana, A;  Franco, S;  Geraci, D;  Chisari, MG;  Picciocchi, E;  Polito, AN;  Murabito, P;  Ruberto, M;  Parisi, L",,,,"Sorrentino, Michele; Tripi, Gabriele; Salerno, Margherita; Russo, Daniela; Lavano, Serena Marianna; Cerroni, Francesco; Romano, Palmira; Gallai, Beatrice; Marotta, Rosa; Lavano, Francesco; Magliulo, Rosaria Martina; D'Oro, Lucrezia; Di Folco, Annabella; Testa, Davide; Marsala, Gabriella; Montana, Angelo; Franco, Sabrina; Geraci, Diego; Chisari, Mario Giuseppe; Picciocchi, Elisabetta; Polito, Anna Nunzia; Murabito, Paolo; Ruberto, Maria; Parisi, Lucia",,,BEHAVIORAL ASPECTS IN CHILDREN'S BROTHERS AFFECTED BY AUTISM SPECTRUM DISORDERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Autism spectrum disorders; siblings; behavior,MONOSYMPTOMATIC NOCTURNAL ENURESIS; CHILDHOOD ABSENCE EPILEPSY; SLEEP-APNEA SYNDROME; QUALITY-OF-LIFE; HYPERTHERMIC REACTIONS; DEPRESSIVE SYMPTOMS; OBESE CHILDREN; OPEN-LABEL; MIGRAINE; WEIGHT,"Introduction: Autistic Spectrum Disorder (ASD) is a permanent and complex disability arising within the first three years of life characterized by a socio-communicative disorder and by fixed interests and repetitive behaviors. The present pilot study aims to evaluate behavioral aspects in a small population of siblings of ASD children. Material and methods: Population: 5 school-aged children (2 males, 3 females) (mean age 9.235 +/- 2.041) were enrolled, as siblings of ASD children, and for comparison, 12 healthy (7 males, 5 females) children (average age 9,528 +/- 3,351). All subjects underwent evaluation of the behavioral with Child Behavior Checklist (CBCL) scale. Results: The two groups were statistically comparable by age (p = 0.86) and gender distribution (p = 0.87). From the behavioral point of view evaluated with the CBCL scale, siblings of ASD have a higher degree of overall problem (Total problems) compared to control children (p=0.003), in addition they have significantly higher scores in the subscales of behavior examined (Anxious/Depressed, Withdrawn, Somatic Complaints, Social, Thought, Attention, Delinquent, Aggressive) as well as a greater share of disturbances both internalizing (p=0.004) and externalizing (p = 0.007) (Table 1). Conclusions: The present preliminary data confirm the need for a global management of the entire family structure for the correct management of Autistic Disorders.","[Sorrentino, Michele] Pineta Grande Hosp, NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy; [Tripi, Gabriele; Ruberto, Maria] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Russo, Daniela] Ctr Riabilitaz La Filanda LARS, Sarno, Italy; [Di Folco, Annabella; Testa, Davide; Parisi, Lucia] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy; [Lavano, Serena Marianna; Marotta, Rosa; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Cerroni, Francesco] Ctr Manzoni Srl, Naples, Italy; [Romano, Palmira] Ctr Riabilitaz LARS, Sarno, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Magliulo, Rosaria Martina] Ctr Scoliosi SRL, Naples, Italy; [D'Oro, Lucrezia] Ctr Ambulatoriale Santo Stefano, Pesaro, Italy; [Marsala, Gabriella] Osped Riuniti Foggia, Azienda Osped Univ, Struttura Complessa Farm, Foggia, Italy; [Montana, Angelo; Franco, Sabrina; Geraci, Diego] Univ Catania, Dept Med Surg & Adv Technol Sci GF Ingrassia, Catania, Italy; [Chisari, Mario Giuseppe] INPS, Catania, Italy; [Picciocchi, Elisabetta] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Polito, Anna Nunzia] Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy; [Murabito, Paolo] Univ Catania, Catania, Italy; CRD Santa Maria Pozzo, Somma Vesuviana, Italy","Sorrentino, M (corresponding author), Pineta Grande Hosp, NICU Preterm & High Risk Newborn Neurodev Follow, Castel Volturno, CE, Italy.",,"Marotta, Rosa/AAG-1453-2020","Cerroni, Francesco/0000-0003-3024-5482; Marotta, Rosa/0000-0003-0515-5952; Murabito, Paolo/0000-0002-2662-1898",,,"Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-26; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Bontinck C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.019336; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSL, V; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2017, EUR J PHYS REHAB MED, V53, P643, DOI 10.23736/S1973-9087.16.04037-; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Filliter JH, 2015, J ABNORM CHILD PSYCH, V43, P567, DOI 10.1007/s10802-014-9921-; Finan LJ, 2018, DEV PSYCHOL, V54, P1555, DOI 10.1037/dev000054; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Gallelli Luca, 2017, Microrna, V6, P152, DOI 10.2174/221153660666617091315282; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Matricardi S, 2018, ACTA NEUROL SCAND, V137, P575, DOI 10.1111/ane.1290; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.0026; Messina A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.0009; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, FRONT PHYSL, V; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Moscatelli F, 2016, PLOS ONE, V2; Moscatelli F, 2015, BIOL MED, V; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisula E, 2015, INT J MOL SCI, V16, P13217, DOI 10.3390/ijms16061321; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Sin J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010540.pub; Smirni D, 2018, J NERV MENT DIS, V206, P628, DOI 10.1097/NMD.000000000000085; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2018, ACTA NEUROL SCAND, V138, P523, DOI 10.1111/ane.1300; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",99,0,0,2,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,4.0,,2097.0,2105,,10.19193/0393-6384_2018_4s_324,,9,"Medicine, General & Internal",General & Internal Medicine,HA4LD,WOS:000450232900004,,,,,2022-07-14,0.008884297520661158,0.12240016870489293,0.0028381829130895565,0.11136036813344838,0.003563165962903111
J,"Sperandeo, R1;  Maldonato, MN;  Messina, A;  Cozzolino, P;  Monda, M;  Cerroni, F;  Romano, P;  Salerno, M;  Maltese, A;  Roccella, M;  Parisi, L;  Tripi, G;  Moscatelli, F;  Sessa, F;  Salerno, M;  Cibelli, G;  Messina, G;  Monda, V;  Chieffi, S;  Villano, I;  Monda, E;  Ruberto, M;  Marsala, G;  Marotta, RR;  Velenzano, A",,,,"Sperandeo, Raffaele; Maldonato, Mauro N.; Messina, Antonietta; Cozzolino, Pasquale; Monda, Marcellino; Cerroni, Francesco; Romano, Palmira; Salerno, Margherita; Maltese, Agata; Roccella, Michele; Parisi, Lucia; Tripi, Gabriele; Moscatelli, Fiorenzo; Sessa, Francesco; Salerno, Monica; Cibelli, Giuseppe; Messina, Giovanni; Monda, Vincenzo; Chieffi, Sergio; Villano, Ines; Monda, Emanuele; Ruberto, Maria; Marsala, Gabriella; Marotta, Rosa R.; Velenzano, Anna",,,OREXIN SYSTEM: NETWORK MULTI-TASKING,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Orexin; Obesity; emotional stress; narcolepsy,RESTING ENERGY-EXPENDITURE; SLEEP-APNEA SYNDROME; HYPOCRETIN/OREXIN NEURONS; CHILDHOOD MIGRAINE; RAT-BRAIN; CHILDREN; RECEPTOR; EXPRESSION; NARCOLEPSY; AURA,"Orexin system regulates sleep/wake states and its deficiency result in narcolepsy thus indicating the crucial role of orexins in maintaining wakefulness. There are two types of orexin peptides: the orexin-A (OXA or hypocretin 1) and orexin-B (OXB or hypocretin 2). The Majority of the central nervous system orexin peptides are synthesized in neurons located in the lateral and back hypothalamus and send projections throughout the brain regions Orexin neurons are multi-tasking hence regulating also energy homeostasis, reward systems and feeding behaviour through connection with hypothalamic nuclei and through responsiveness to leptine and glucose. It has recently been found a connection with lymbic system suggesting a further possible role of orexins in regulating emotions. All the studies conducted confirm that orexin system regulates vigilance states, energy homeostasis, reward system, and emotions. These crucial role might be the target to develope treatments of narcolepsy, obesity, emotional stress, and drug addiction.","[Sperandeo, Raffaele] Univ Campania, Dept Expt Med, Sect Human Physiol, Naples, Italy; [Sperandeo, Raffaele] Univ Campania, Unit Dietet & Sport Med, Naples, Italy; [Maldonato, Mauro N.; Messina, Antonietta; Monda, Marcellino] Univ Basilicata, Dept Human Sci, Potenza, Italy; [Cozzolino, Pasquale] SiPGI Postgrad Sch Integrated Gestalt Psychothera, DM 12 10 2007, Naples, Italy; [Cerroni, Francesco; Romano, Palmira] Univ Campania Luigi Vanvitelli, Dept Mental Hlth Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Naples, Italy; [Marotta, Rosa R.] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Salerno, Margherita; Maltese, Agata; Roccella, Michele; Parisi, Lucia; Tripi, Gabriele] Univ Palermo, Dept Psychol & Pedag Sci, Child Neuropsychiat, Palermo, Italy; [Moscatelli, Fiorenzo; Sessa, Francesco; Salerno, Monica; Cibelli, Giuseppe; Messina, Giovanni; Velenzano, Anna] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Monda, Vincenzo; Chieffi, Sergio; Villano, Ines; Monda, Emanuele] Univ Campania Luigi Vanvitelli, Dept Expt Med, Sect Human Physiol, Naples, Italy; [Monda, Vincenzo; Chieffi, Sergio; Villano, Ines; Monda, Emanuele] Univ Campania Luigi Vanvitelli, Unit Dietet & Sports Med, Naples, Italy; [Ruberto, Maria] Ctr CRD, Naples, Italy; [Marsala, Gabriella] Azienda Osped Univ, Struttura Complessa Farm, Foggia, Italy","Velenzano, A (corresponding author), Univ Foggia, Dept Clin & Expt Med, Foggia, Italy.",anna.valenzano@unifg.it,"Monda, Emanuele/AAQ-6457-2020; MESSINA, ANTONIETTA/K-9366-2016; Messina, Antonietta/AHH-2383-2022; Moscatelli, Fiorenzo/ABC-9536-2020; Sessa, Francesco/G-1754-2018; Cibelli, Giuseppe/AAC-2635-2019; Messina, Giovanni/AAE-8668-2022; Marotta, Rosa/AAG-1453-2020; SALERNO, MONICA/AAC-1321-2019; MALDONATO, NELSON MAURO/AAG-3791-2021","Monda, Emanuele/0000-0001-9304-988X; Messina, Antonietta/0000-0001-8343-432X; Sessa, Francesco/0000-0003-0357-8791; Messina, Giovanni/0000-0002-0011-867X; SALERNO, MONICA/0000-0002-6410-3960; MALDONATO, NELSON MAURO/0000-0002-6401-2305; Moscatelli, Fiorenzo/0000-0003-1274-0332; Sperandeo, Raffaele/0000-0002-8892-179X; VILLANO, INES/0000-0002-1755-358X; Monda, Marcellino/0000-0002-7184-218X; Marotta, Rosa/0000-0003-0515-5952; Monda, Vincenzo/0000-0002-6083-5814; TRIPI, Gabriele/0000-0001-7088-9325; Cerroni, Francesco/0000-0003-3024-5482; CIBELLI, GIUSEPPE/0000-0002-5371-2584",,,"Avola R, 2004, CLIN EXP HYPERTENS, V26, P323, DOI 10.1081/CEH-12003413; Bramanti V, 2012, NEUROCHEM RES, V37, P2795, DOI 10.1007/s11064-012-0873-; Capovilla G, 2004, EPILEPSIA, V45, P887, DOI 10.1111/j.0013-9580.2004.457erratum.; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2017, FRONT PSYCHIATRY, P; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Cerretani D, 2011, PHARMACOL RES, V64, P517, DOI 10.1016/j.phrs.2011.08.00; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0023; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Cianci P, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0857-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito T, 2016, DRUG DES DEV THER, V10, P2939, DOI 10.2147/DDDT.S10644; Fiorelli A, 2017, ANN THORAC SURG, V103, P216, DOI 10.1016/j.athoracsur.2016.10.05; Forlano I, 2011, ANN ITAL CHIR, V82, P40; Liu ZW, 2007, J NEUROPHYSIOL, V97, P837, DOI 10.1152/jn.00873.200; Maldonato M., 2015, ARCHIPELAGO CONSCIO; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/63928; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G, 2015, BIOL ME; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Asian J Sports Med, V7, pe26841, DOI 10.5812/asjsm.2684; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S1; Monda M, 2008, CLIN NUTR, V27, P657, DOI 10.1016/j.clnu.2008.04.00; Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.01; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-; Neri V, PANCREAS, V3; Neri V, 2013, ANN ITAL CHIR, V84, P4; Neri V, 2009, ANN ITAL CHIR, V80, P36; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perez-Leighton CE, 2012, AM J PHYSIOL-ENDOC M, V303, pE865, DOI 10.1152/ajpendo.00119.201; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pomara C, 2012, CURR MED CHEM, V19, P5647, DOI 10.2174/09298671280398881; Pomara C, 2008, CLIN TOXICOL, V46, P322, DOI 10.1080/1556365070141901; Pomara C, 2016, J CELL PHYSIOL, V231, P1385, DOI 10.1002/jcp.2527; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Precenzano F, 2017, ACTA MEDICA MEDITERR, P3; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Rainero Innocenzo, 2008, Expert Rev Neurother, V8, P409, DOI 10.1586/14737175.8.3.40; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-; Salomone F, 2014, TRANSL RES, V163, P593, DOI 10.1016/j.trsl.2013.12.00; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.01; Sperandeo R, 7 IEEE INT C COGN I; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-; Tsunematsu T, 2008, J NEUROSCI, V28, P228, DOI 10.1523/JNEUROSCI.3490-07.200; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2013, FORENSIC SCI INT, V231, P142, DOI 10.1016/j.forsciint.2013.04.00; Turillazzi E, 2010, HISTOL HISTOPATHOL, V25, P1539, DOI 10.14670/HH-25.153; Turillazzi E, 2008, VIRCHOWS ARCH, V453, P209, DOI 10.1007/s00428-008-0632-; Vacchiano G, 2012, J ROY ARMY MED CORPS, V158, P338, DOI 10.1136/jramc-158-04-1; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Vyshka G, 2014, BMJ CASE RE; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.070267610; Xie XM, 2006, J PHYSIOL-LONDON, V574, P399, DOI 10.1113/jphysiol.2006.10826; Yang LY, 2013, J NEUROSCI, V33, P5275, DOI 10.1523/JNEUROSCI.3200-12.201; Zhao X, 2014, PEPTIDES, V54, P140, DOI 10.1016/j.peptides.2013.11.01",86,22,23,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,349.0,356,,10.19193/0393-6384_2018_2_55,,8,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400009,,,,,2022-07-14,0.008574380165289256,0.06969839079716968,0.006316884659475705,0.11130914735813258,0.006025529188361952
J,"Sperandeo, R21;   Picciocchi, E;   Valenzano, A;   Cibelli, G;   Ruberto, V;   Moretto, E;   Monda, V;   Messina, A;   Dell'Orco, S;   Di Sarno, AD;   Marsala, G;   Polito, AN;   Longobardi, T;   Maldonato, NM",,,,"Sperandeo, Raffaele; Picciocchi, Elisabetta; Valenzano, Anna; Cibelli, Giuseppe; Ruberto, Valentina; Moretto, Enrico; Monda, Vincenzo; Messina, Antonietta; Dell'Orco, Silvia; Di Sarno, Alfonso Davide; Marsala, Gabriella; Polito, Anna Nunzia; Longobardi, Teresa; Maldonato, Nelson Mauro",,,EXPLORING THE RELATIONSHIPS BETWEEN EXECUTIVE FUNCTIONS AND PERSONALITY DIMENSIONS IN THE LIGHT OF EMBODIED COGNITION THEORY: A STUDY ON A SAMPLE OF 130 SUBJECTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Executive Functions; personality; prefrontal cortical areas,HYPERTHERMIC REACTIONS; INHIBITOR DEVELOPMENT; CHILDHOOD MIGRAINE; CEREBRAL INJECTION; ITALIAN PATIENTS; STRESS; MUTATION; GENE; MICROSCOPY; SYMPTOMS,"The Executive Functions and the dimensions of the personality seem to have numerous points of convergence both on the psychological and neurobiological sides. Current studies interpret this relationship as a linear concatenation that starts from a damage of the prefrontal cortical areas, produces a deficit of the executive functions and finally evolves towards the development of pathological character traits. In an enacted cognition perspective, the relationship between executive functions and personality should be interpreted according to a circular causality model that appears ecologically more realistic and adequate to empirical data. The present study evaluates executive functions and personality dimensions in a sample of 130 subjects using the Frontal Assessment Battery, the Temperament and Character Inventory, respectively. The results show that subjects with low empathic and emotional propensities, detected through 9 items of Temperament and Character Inventory, while not presenting any kind of disturbances, show Executive Functions that are not efficient or even inadequate. These data are not easily explained according to the classic linear model and seem to confirm the circular perspective proposed by the embodied cognition theory. However, an expansion of the sample is essential to obtain confirmation of the data that emerged.","[Sperandeo, Raffaele; Moretto, Enrico; Di Sarno, Alfonso Davide; Longobardi, Teresa] SiPGI Postgrad Sch Integrated Gestalt Psychothera, DM 12-10-2007,Via V Veneto 240, I-80058 Naples, Italy; [Picciocchi, Elisabetta; Valenzano, Anna; Cibelli, Giuseppe; Ruberto, Valentina] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Picciocchi, Elisabetta] Casa Cura Villa Fiori Acerra, Naples, Italy; [Monda, Vincenzo; Messina, Antonietta] Univ Campania, Dept Expt Med, Sect Human Physiol, Naples, Italy; [Monda, Vincenzo; Messina, Antonietta] Univ Campania, Unit Dietet & Sport Med, Naples, Italy; [Dell'Orco, Silvia; Maldonato, Nelson Mauro] Univ Basilicata, Dept Human Sci, Potenza, Italy; [Marsala, Gabriella] Osped Riuniti Foggia, Azienda Osped Univ, Foggia, Italy; [Polito, Anna Nunzia] Osped Riuniti Foggia, Complex Struct Neuropsychiat Childhood Adolescenc, Foggia, Italy","Sperandeo, R (corresponding author), SiPGI Postgrad Sch Integrated Gestalt Psychothera, DM 12-10-2007,Via V Veneto 240, I-80058 Naples, Italy.",raffaele.sperandeo@gmail.com,"Messina, Antonietta/AHH-2383-2022; MESSINA, ANTONIETTA/K-9366-2016; Cibelli, Giuseppe/AAC-2635-2019; MALDONATO, NELSON MAURO/AAG-3791-2021; Moretto, Enrico/AFV-4935-2022","Messina, Antonietta/0000-0001-8343-432X; MALDONATO, NELSON MAURO/0000-0002-6401-2305; MORETTO, ENRICO/0000-0002-1726-7866; Sperandeo, Raffaele/0000-0002-8892-179X; CIBELLI, GIUSEPPE/0000-0002-5371-2584; Monda, Vincenzo/0000-0002-6083-5814",,,"Albenzio M, 2013, J DAIRY SCI, V96, P2781, DOI 10.3168/jds.2012-621; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-; Bafunno V, 2012, HAEMOPHILIA, V18, P1003, DOI 10.1111/j.1365-2516.2012.02882.; Bafunno V, 2010, HAEMOPHILIA, V16, P469, DOI 10.1111/j.1365-2516.2009.02150.; Bafunno V, 2014, THROMB RES, V134, P1135, DOI 10.1016/j.thromres.2014.08.02; Bafunno V, 2013, J ALLERGY CLIN IMMUN, V132, P748, DOI 10.1016/j.jaci.2013.04.00; Bramanti V, 2016, J NEUROSCI RES, V94, P90, DOI 10.1002/jnr.2367; Bukvic N, 2010, AM J MED GENET A, V152A, P1730, DOI 10.1002/ajmg.a.3343; Burgess P., 2003, HDB CLIN NEUROPSYCHO, P30; Canestraro M, 2010, CANCER GENET CYTOGEN, V199, P110, DOI 10.1016/j.cancergencyto.2010.02.01; Cantone D, 2012, REV LATINOAM PSICOPA, V15, P42, DOI 10.1590/S1415-4714201200010000; Caroprese M, 2012, SMALL RUMINANT RES, V102, P177, DOI 10.1016/j.smallrumres.2011.07.01; Caroprese M, 2010, J DAIRY SCI, V93, P2395, DOI 10.3168/jds.2009-260; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Caruana F., 2016, CERVELLO AZIONE INT; Cerretani D, 2011, PHARMACOL RES, V64, P517, DOI 10.1016/j.phrs.2011.08.00; Chieffi S, 2017, FRONT PHYSIOL, P; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Cloninger C.R., 1994, TEMPERAMENT CHARACT; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2014, CHEMOSPHERE, V94, P62, DOI 10.1016/j.chemosphere.2013.09.01; Fineschi V, 2006, INT J LEGAL MED, V120, P293, DOI 10.1007/s00414-006-0104-; Fossati A, 2007, COMPR PSYCHIAT, V48, P380, DOI 10.1016/j.comppsych.2007.02.00; Galimberti S, 2007, J CHEMOTHERAPY, V19, P315, DOI 10.1179/joc.2007.19.3.31; Hart Susan, 2008, BRAIN ATTACHMENT PE; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X0003402; Kagan J., 2011, TRAMA VITA COME GEN; Le Doux J, 2002, IL SE SINAPTIC; Maldonato M., 2011, WORLD FUTURE, V67, P569, DOI [10.1080/02604027.2011.615591, DOI 10.1080/02604027.2011.615591; Maldonato M, 2018, SMART INNOV SYST TEC, V69, P369, DOI 10.1007/978-3-319-56904-8_3; Maldonato M, 2016, INTEL SYST REF LIBR, V106, P13, DOI 10.1007/978-3-319-31053-4_; Maldonato NM, 2017, WORLD FUTURES, P; Mandolesi L., 2012, NEUROSCIENZE ATTIVI; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Meares Russell., 2012, DISSOCIATION MODEL ; Messina G, 2015, AFRICAN J PSYCHIAT S, V1; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BIOL MED, V; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.01; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda V, 2017, FRONT PHYSIOL, P; Moscatelli F, 2015, BIOL MED, V; Moscatelli F, 2016, PLOS ONE, V1; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Pellegrino PL, 2007, AM J CARDIOL, V99, P1737, DOI 10.1016/j.amjcard.2007.01.05; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Petito A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015660; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.163; Piacentino D, 2015, CURR NEUROPHARMACOL, V13, P101, DOI 10.2174/1570159X1366614121022272; Pomara C, 2005, INT J LEGAL MED, V119, P153, DOI 10.1007/s00414-004-0513-; Pomara C, 2009, RADIOL MED, V114, P1367, DOI 10.1007/s11547-009-0435-; Pomara C, 2008, CLIN TOXICOL, V46, P322, DOI 10.1080/1556365070141901; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santacroce R, 2008, BLOOD COAGUL FIBRIN, V19, P197, DOI 10.1097/MBC.0b013e3282f234a; Santacroce R, 2009, GENET TEST MOL BIOMA, V13, P573, DOI 10.1089/gtmb.2009.001; Santillo A, 2009, INT DAIRY J, V19, P655, DOI 10.1016/j.idairyj.2009.06.01; Santillo A, 2009, J DAIRY SCI, V92, P1330, DOI 10.3168/jds.2008-159; Sevi A, 2003, APPL ANIM BEHAV SCI, V83, P41, DOI 10.1016/S0168-1591(03)00088-; Sperandeo R, 2017, 27 IT WORKSH NEUR N; Sperandeo R, 2016, SMART INNOV SYST TEC, V54, P293, DOI 10.1007/978-3-319-33747-0_2; Sperandeo R, 2017, INT CONF COGN INFO, P63, DOI 10.1109/CogInfoCom.2017.826821; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; Sperandeo R, 2016, INT CONF COGN INFO, P43, DOI 10.1109/CogInfoCom.2016.780452; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2005, INT J CARDIOL, V104, P152, DOI 10.1016/j.ijcard.2004.10.05; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2008, INT J LEGAL MED, V122, P173, DOI 10.1007/s00414-007-0208-; Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.1274; Turillazzi E, 2013, FORENSIC SCI INT, V231, P142, DOI 10.1016/j.forsciint.2013.04.00; Turillazzi E, 2008, VIRCHOWS ARCH, V453, P209, DOI 10.1007/s00428-008-0632-; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",91,16,16,1,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1271.0,1279,,10.19193/0393-6384_2018_5_196,,9,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700018,,,,,2022-07-14,0.00878099173553719,0.0557387469290813,0.005593289331982393,0.11131426731523326,0.005422188641112182
J,"Spinato, G1;  Cazzato, G;  Ferlito, S;  Tirelli, G;  Rizzo, PB;  Da Mosto, MC;  Galletti, B;  Tonoli, G;  Politi, D;  Conti, A;  Campione, G;  Di Luca, M;  Gatto, A;  Piovesana, M;  Serra, A",,,,"Spinato, Giacomo; Cazzato, Giorgio; Ferlito, Salvatore; Tirelli, Giancarlo; Rizzo, Paolo Boscolo; Da Mosto, Maria Cristina; Galletti, Bruno; Tonoli, Giovanni; Politi, Doriano; Conti, Angelo; Campione, Gianluca; Di Luca, Milena; Gatto, Annalisa; Piovesana, Marco; Serra, Agostino",,,THERAPEUTICAL INNOVATIONS AND MEDICAL RESPONSIBILITY: WHAT'S NEW IN OTO-LARYNGOLOGY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,law Gelli Bianco; legally valid consent; therapeutical innovation; molecular biology; new technologies; professional responsibility,VOICE REHABILITATION; HEAD,"On one hand the incessant and constant technological and instrumental progress in the medical field has allowed to increase knowledge and to reach new objectives. On the other hand, however, it has also raised the risk linked to professional responsibility, regarding informed consent and law 24/2017 of the Italian Republic, better known as Gelli Bianco. In this work an analysis of relevant literature will be presented, followed by a study on the role of new devices on responsibility profiles in otolaryngology. According to the analysis of the Italian law and considering the weaknesses of the above mentioned guidelines, pending legal administrative clarifications, we believe an operational protocol can be proposed in case of application of therapeutical innovations, especially about experimental introductions. Consequently, in our opinion, the risk of incrimination persists in case of use of innovative procedures in the absence of a formal shared opinion expressed in guidelines or in good practices, which still need a satisfactory definition.","[Spinato, Giacomo; Tonoli, Giovanni] Rovigo Prov Hosp, Ear Nose & Throat Dept, I-45100 Rovigo, Italy; [Cazzato, Giorgio; Politi, Doriano] Mestre Hosp, Prov Ear Nose & Throat Dept Venice, I-30174 Venice, Italy; [Ferlito, Salvatore; Conti, Angelo; Campione, Gianluca; Di Luca, Milena; Serra, Agostino] Univ Catania, Ear Nose & Throat Dept, I-95125 Catania, Italy; [Tirelli, Giancarlo; Gatto, Annalisa; Piovesana, Marco] Univ Trieste, Cattinara Hosp, Ear Nose & Throat Dept, I-34149 Trieste, Italy; [Rizzo, Paolo Boscolo; Da Mosto, Maria Cristina] Univ Padua, Treviso Prov Hosp, Dept Neurosci, Ear Nose & Throat Clin, I-35122 Padua, Italy; [Rizzo, Paolo Boscolo; Da Mosto, Maria Cristina] Univ Padua, Treviso Prov Hosp, Reg Ctr Head & Neck Canc, I-35122 Padua, Italy; [Galletti, Bruno] Univ Messina, Dept Otolaryngol, Messina, Italy","Spinato, G (corresponding author), Rovigo Prov Hosp, Ear Nose & Throat Dept, I-45100 Rovigo, Italy.",giacomo.spinato@aulss5.veneto.it,"salvatore, ferlito/AAB-5788-2021; tirelli, giancarlo/G-3118-2012","salvatore, ferlito/0000-0001-7136-9698; tirelli, giancarlo/0000-0002-7871-2011; Cocuzza, Salvatore/0000-0002-6135-0958; BOSCOLO RIZZO, PAOLO/0000-0002-4635-7959; Spinato, Giacomo/0000-0001-5295-5077",,,"[Anonymous], 1997, EUR TREAT SER, V16; Ausoni S, 2016, CANCER METAST REV, V35, P413, DOI 10.1007/s10555-016-9625-; Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp100660; Boscolo-Rizzo P, 2015, EUR ARCH OTO-RHINO-L, V272, P3491, DOI 10.1007/s00405-014-3369-; Boscolo-Rizzo P, 2015, ORAL ONCOL, V51, P500, DOI 10.1016/j.oraloncology.2015.02.10; Caltabiano R, 2012, EUR REV MED PHARMACO, V16, P189; Caltabiano R, 2008, PATHOLOGICA, V100, P18; Cherry J, 2000, J LARYNGOL OTOL, V114, P73; Cocuzza S, 2014, J VOICE, V28, P245, DOI 10.1016/j.jvoice.2013.08.00; Cocuzza S, 2013, EUR ARCH OTO-RHINO-L, V270, P1879, DOI 10.1007/s00405-013-2430-; Da Mosto MC, 2013, ANN SURG ONCOL, V20, P250, DOI 10.1245/s10434-012-2520-; Dawes PJD, 1999, CLIN OTOLARYNGOL, V24, P198, DOI 10.1046/j.1365-2273.1999.00244.; De Nicola E, 1947, CONSTITUTION ITALIA; Ferri E, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/36934; Gallina S, 2015, ACTA OTORHINOLARYNGO, V35, P1; Germonpre P, 2016, B-ENT, V12, P8; Giacomarra V, 2013, EUR ARCH OTO-RHINO-L, V270, P2975, DOI 10.1007/s00405-013-2625-; Institute of Medicine, 2011, CLIN PRACT GUID WE ; Jouanneau E., 2011, ADV ENDOSCOPIC SUR; Karpishchenko S. A., 2016, Vestnik Otorinolaringologii, P14, DOI 10.17116/otorino201681414-1; Mallardi V, 2005, Acta Otorhinolaryngol Ital, V25, P31; Manna A., 2005, CARDIOLOGIA AMBULATO, V3, P15; McCloy R, 2001, BRIT MED J, V323, P912, DOI 10.1136/bmj.323.7318.91; Meisel A, 1996, ARCH INTERN MED, V156, P2521, DOI 10.1001/archinte.156.22.252; Mercante G, 2013, ACTA OTORHINOLARYNGO, V33, P23; Montevecchi F, 2017, INT J MED ROBOT COMP, V13, DOI 10.1002/rcs.176; Mosher HP, 1913, LARYNGOSCOPE, V23, P88; National Federations of Medical Doctors, 2014, COD MED ET; Petrie K J, 2002, BMJ, V32; Serra A, 2017, ACTA OTORHINOLARYNGO, V37, P175, DOI 10.14639/0392-100X-129; Serra A, 2015, ACTA OTORHINOLARYNGO, V35, P412, DOI 10.14639/0392-100X-68; Serra A, 2017, ONCOTARGET, V8, P38962, DOI 10.18632/oncotarget.1716; Serra A, 2017, INT J PEDIATR OTORHI, V97, P245, DOI 10.1016/j.ijporl.2017.04.02; Serra A, 2016, PROG NUTR, V18, P33; Serra A, 2016, EUR ARCH OTO-RHINO-L, V273, P4359, DOI 10.1007/s00405-016-4177-; Sokol AJ, 2002, J LEGAL MED, V23, P449, DOI 10.1080/0194764029005030; Tahir A., 2015, INT J OTOLARYNGOLOGY, V4, P13; Thiagarajan Balasubramanian, 2014, OTOLARYNGOLOGY ONLIN, V; Tirelli G., 2013, AM J RHINOLOGY ALLE; Umani Ronchi G, 2004, CONSENT PROFESSIONA",40,7,7,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,307.0,312,,10.19193/0393-6384_2018_2_49,,6,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400003,,,,,2022-07-14,0.004132231404958678,5.96237004978565e-11,0.01304895051255494,0.1024848337268271,0.013103365981903021
J,"Tafuri, D1;  Di Palma, D;  Molisso, V",,,,"Tafuri, Domenico; Di Palma, Davide; Molisso, Vittoria",,,DOPING: EDUCATION AND PREVENTION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Doping; Addiction; Education; Knowledge; Prevention,,"Education and prevention represent, in the complex world of doping, a fundamental aspect for it allow us identifying its characteristics and, at the same time, acting on the origins of this phenomenon, by working on aspects that are facilitators, co-responsible and involved in it. Doping refers to the use of substances or drugs that an athlete takes to improve his performance. Being it a phenomenon of great complexity, it requires a deep and exhaustive analysis, which cannot ignore the convergence and confluence of different aspects that, on the one hand, show and explain the reason why this phenomenon exists and, on the other, are elements that support the education and prevention of this large and extended field.","[Tafuri, Domenico; Di Palma, Davide; Molisso, Vittoria] Parthenope Univ, Via Medina 40, Naples, Italy","Di Palma, D (corresponding author), Parthenope Univ Naples, Naples, Italy.",davide.dipalma@uniparthenope.it,,"Di Palma, Davide/0000-0001-8224-5797",,,"Andolfi M, 2009, MANUALE PSICOLOGIA ; Ascione A, 2018, ACTA MEDICA MEDITERR, V34, P1261, DOI 10.19193/0393-6384_2018_5_19; Aurilio R, 2015, TERAPIA SISTEMICO R; Bateson G., 1984, MENTE E NATUR; Bateson Gregory, 1976, VERSO UNECOLOGIA ME; Belfiore P, 2018, ACTA MEDICA MEDITERR, V34, P1257, DOI 10.19193/0393-6384_2018_5_19; Cisotto L., 2015, PSICOPEDAGOGIA DIDA; Di Palma D, 2018, ACTA MEDICA MEDITERR, V34, P1253, DOI 10.19193/0393-6384_2018_5_19; LEVY P, 1996, INTELLIGENZA COLLET; Levy P., 1990, TECNOLOGIE INTELLIG; Malagoli Togliatti M, 2014, DALLINDIVIDUO SISTE; Murgia M, 2014, MIGLIORARE PRESTAZI; Orio F, 2016, MINERVA ENDOCRINOL, V41, P50; Palma D. di, 2018, Journal of Physical Education and Sport, V18, P47; Palma D. di, 2017, Sport Science, V10, P3; Palma D. di, 2017, Sport Science, V10, P1; Palma D. di, 2016, Journal of Physical Education and Sport, V16, P78; Palma D. di, 2016, Sport Science, V9, P2; Petralia MC, 2018, ACTA MEDICA MEDITERR, V34, P107, DOI 10.19193/0393-6384_2018_1_1; Pontecorvo C., 1995, CONTESTI SOCIALI APP, P15; Prokop L, 1970, J Sports Med Phys Fitness, V10, P4; Raiola G, 2017, SPORT SCI, V10, P5; Raiola G., 2016, SPORT SCI, V9, P4; Reale G, 2001, IL PENSIERO ANTICO, P8; Tafuri D., 2017, SPORT SCI, V10, P7",25,0,0,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,3.0,,1499.0,1502,,10.19193/0393-6384_2018_3s_228,,4,"Medicine, General & Internal",General & Internal Medicine,GP7NG,WOS:000441088400005,,,,,2022-07-14,0.0024793388429752063,5.2295097071981224e-05,0.0025664422460613835,0.0827343356039692,0.002573224501893938
J,"Taheri, M31;   Irandoust, K;   Sadeghi, A;   Yari, S",,,,"Taheri, Morteza; Irandoust, Khadijeh; Sadeghi, Abbas; Yari, Shokoofe",,,THE EFFECT OF OMEGA-3 FATTY ACID SUPPLEMENT AND AEROBIC EXERCISE ON LIPID PROFILE AND DEPRESSION IN OBESE WOMEN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Omega 3; Lipid profiles; Exercise; Depression,BODY-COMPOSITION; RISK-FACTORS; CHOLESTEROL; CHILDREN; ADULTS; TRIAL; ACID; MEN,"Background: Elevated blood lipids and its associated psychological concerns, including depression, are some of the most harmful aspects of obesity, which has made the need for its prevention and treatment more obvious to researchers and authorities. Objectives: This study sought to evaluate the effect of 8 weeks of omeg-3 supplementation combined with aerobic exercise on blood lipid profile and depression in obese women. Materials and methods: 32 inactive obese women with mild to moderate depression with the age range of 25-40 years were selected and then randomly divided into four groups of (n=8): aerobic exercise + omega-3 supplement; omega-3 supplement, aerobic exercise, and control. The aerobic exercise protocol included warming up; main program and cooling down phases lasted for 8 consecutive weeks (5 days/week). The daily intake of omega-3 supplement was 2,000 milligrams. Lipid profiles and the Depression were measured before and after 8 weeks of exercise intervention and supplementation. Results: There was a significant decrease in total cholesterol and LDL in aerobic exercise, aerobic exercise + omega-3, and omega-3 groups and there was a significant increase in HDL in the three groups (p=0.05). Compared to the omega-3 supplement group, aerobic exercise group and aerobic exercise+omega-3 supplement group had lower total cholesterol and LDL levels and higher HDL after intervention (p=0.05). In addition, in all three experimental groups, depression showed a significant improvement (p=0.05). The aerobic exercise group and the aerobic+omega-3 supplement group showed a more significant improvement compared to the omega-3 supplement group in terms of depression (p=0.05). Conclusion: Given the findings of this study, aerobic exercise and omega-3 supplement simultaneously improve the blood lipids and depression in women. Since blood lipids are improved in the prevention of obesity and related diseases, including depression, omega-3 consumption and aerobic exercise in interaction are recommended for women.","[Taheri, Morteza; Irandoust, Khadijeh; Sadeghi, Abbas] Imam Khomeini Int Univ, Dept Sport Sci, Fac Social Sci, Qazvin, Iran; [Yari, Shokoofe] Imam Khomeini Int Univ, Dept Sport Sci, Fac Social Sci, Exercise Physiol, Qazvin, Iran","Taheri, M (corresponding author), Imam Khomeini Int Univ, Dept Sport Sci, Fac Social Sci, Qazvin, Iran.",taheri_morteza@yahoo.com,"Taheri, Morteza/N-5170-2016; irandoust, khadijeh/ABH-3519-2021","Taheri, Morteza/0000-0001-8031-3792; ",,,"Altena TS, 2006, MED SCI SPORT EXER, V38, P367, DOI 10.1249/01.mss.0000185088.33669.f; Amini M, 2018, INT J SPORT STUD HL; Bianco A, 2010, J SPORT MED PHYS FIT, V50, P15; Budania S, 2014, MED J DY PATIL U, V7, P54; Colussi Gianluca, 2007, Recent Pat Cardiovasc Drug Discov, V2, P13, DOI 10.2174/15748900777960615; Dangardt F, 2010, ATHEROSCLEROSIS, V212, P580, DOI 10.1016/j.atherosclerosis.2010.06.04; Dunn AL, 2002, CONTROL CLIN TRIALS, V23, P584, DOI 10.1016/S0197-2456(02)00226-; Hesar KM, 2013, IRANIAN J ENDOCRINOL, V14, P47; Irandoost K, 2015, SALMAND, V10, P4; Irandoust K, 2017, PHYS PHYSL LITERAC; Irandoust K, 2017, ASIAN J SPORTS MED, V; Irandoust K, 2015, J PHYS THER SCI, V27, P433, DOI 10.1589/jpts.27.43; Jafari M, 2017, INT J SPORT STUD HL; Jee SH, 2011, EUR HEART J, V32, P2773, DOI 10.1093/eurheartj/ehr22; Jensky-Squires NE, 2008, BRIT J NUTR, V100, P859, DOI 10.1017/S000711450892546; Kannan U, 2014, J CLIN DIAGN RES, V8, pBC8, DOI 10.7860/JCDR/2014/8519.461; Kong A, 2012, J ACAD NUTR DIET, V112, P1428, DOI 10.1016/j.jand.2012.05.01; Lee HC, 2014, J PHYS THER SCI, V26, P1675, DOI 10.1589/jpts.26.167; Liperoti R, 2009, CURR PHARM DESIGN, V15, P4165, DOI 10.2174/13816120978990968; Maes M, 1997, ACTA PSYCHIAT SCAND, V95, P212, DOI 10.1111/j.1600-0447.1997.tb09622.; Mann S, 2014, SPORTS MED, V44, P211, DOI 10.1007/s40279-013-0110-; Mohammadpour A, 2015, J PHARM CARE, V1, P2; Noorian F., 2017, ACTA MED MEDITERRANE, V3; Olusi SO, 1996, BIOL PSYCHIAT, V40, P1128, DOI 10.1016/S0006-3223(95)00599-; Paoli A, 2015, MAR DRUGS, V13, P996, DOI 10.3390/md1302099; Paoli A, 2012, AM J CARDIOL, V109, P305, DOI 10.1016/j.amjcard.2011.10.01; Rahman A., 2015, INVESTIGATION PREVAL, V2015, P1; Rogers PJ, 2008, BRIT J NUTR, V99, P421, DOI 10.1017/S000711450780109; Ruljancic N, 2011, PROG NEURO-PSYCHOPH, V35, P1261, DOI 10.1016/j.pnpbp.2011.02.00; Sarshar N, 2006, OFOGH E DANESH J GON, V12, P3; Sayyah M, 2011, BIOSCI BIOTECH RES A, V8, P367, DOI DOI 10.13005/bbra/87; Schachter H M, 2005, Evid Rep Technol Assess (Summ), P; Shibata H, 1999, J Epidemiol, V9, P26; Simopoulos Artemis P, 2007, Curr Sports Med Rep, V6, P230, DOI 10.1007/s11932-007-0037-; Sneddon AA, 2008, OBESITY, V16, P1019, DOI 10.1038/oby.2008.4; Surette ME, 2008, CAN MED ASSOC J, V178, P177, DOI 10.1503/cmaj.07135; Zorba E, 2011, J SPORT MED PHYS FIT, V51, P66",37,1,1,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,865.0,870,,10.19193/0393-6384_2018_3_132,,6,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000036,,,,,2022-07-14,0.003822314049586777,2.1857493499624227e-08,0.010712593251642177,0.10046391913069651,0.010712593251642177
J,"Tan, R1;  Tang, NN;  Zhang, Y;  Mei, YJ;  Sun, LD",,,,"Tan, Rui; Tang, Nina; Zhang, Yuan; Mei, Yijie; Sun, Ledong",,,EFFECT OF IMIQUIMOD IN THE TREATMENT OF BASAL CELL CARCINOMA AND ON EXPRESSION OF VEGF MRNA IN THE PERIPHERAL BLOOD,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Imiquimod; Basal cell carcinoma; VEGF,ENDOTHELIAL GROWTH-FACTORS; MICROVESSEL DENSITY; ANGIOGENESIS; INHIBITOR; PATHWAY; BIOLOGY,"Objective: Study the clinical efficacy of imiquimod for basal cell carcinoma and the effect on expression of VEGF mRNA to explore the underlying mechanism of imiquimod for basal cell carcinoma. Materials and methods: Use 5% imiquimod cream for 8 weeks regularly, and detect the expression of VEGF in peripheral blood of VEGF mRNA by real-time fluorescence quantitative PCR in before and after treatment groups. Results: The clinical efficacy of imiquimod for basal cell carcinoma was significant; the expression levels of VEGF mRNA in before/after treatment group were significantly higher than those of normal group (p<0.05); In the meantime, the expression level in after treatment group were obvious lower than that in before group(p<0.05). Conclusion: The therapeutic effect of imiquimod for basal cell carcinoma may be related to the decreased expression of VEGF mRNA in the peripheral blood.","[Tan, Rui; Tang, Nina; Zhang, Yuan; Mei, Yijie; Sun, Ledong] Southern Med Univ, Zhujiang Hosp, Dept Dermatol, 253 Ind Rd, Guangzhou 510282, Guangdong, Peoples R China","Sun, LD (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Dermatol, 253 Ind Rd, Guangzhou 510282, Guangdong, Peoples R China.",sunledong126@126.com,,,,,"Anwar U, 2006, PLAST RECONSTR SURG, V117, p6E, DOI 10.1097/01.prs.0000194908.32762.e; Carbone A, 2011, EUR J DERMATOL, V21, P608, DOI 10.1684/ejd.2011.131; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/1073968080209596; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-; Hesling C, 2004, BRIT J DERMATOL, V150, P761, DOI 10.1111/j.0007-0963.2004.05898.; Imai Y, 2015, J IMMUNOL, V195, P421, DOI 10.4049/jimmunol.150044; Jiang HH, 2012, MED RECAPITULATE, V18, P29; Jimeno A, 2013, CLIN CANCER RES, V19, P2766, DOI 10.1158/1078-0432.CCR-12-365; Leng FF, 2017, ACTA MEDICA MEDITERR, V33, P1085, DOI 10.19193/0393-6384_2017_6_17; Li Vincent W, 2008, J Drugs Dermatol, V7, ps1; Majewski S, 2005, INT J DERMATOL, V44, P14, DOI 10.1111/j.1365-4632.2004.02318.; Nagarajan S, 2002, CANCER RES, V62, P286; Oh CK, 2003, J DERMATOL, V30, P306, DOI 10.1111/j.1346-8138.2003.tb00392.; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa111371; Sobjanek M, 2014, ARCH DERMATOL RES, V306, P539, DOI 10.1007/s00403-014-1471-; Sterry W, 2002, BRIT J DERMATOL, V147, P1227, DOI 10.1046/j.1365-2133.2002.05069.; Tang S, 2016, AUSTRALAS J DERMATO; Tokluoglu S, 2017, ACTA MEDICA MEDITERR, V33, P145, DOI 10.19193/0393-6384_2017_1_02; Vuletic MS, 2014, J BUON, V19, P78; Wang XY, 2011, CLIN EXP DERMATOL, V36, P69, DOI 10.1111/j.1365-2230.2010.03860.; Wu CS, 2014, DNA CELL BIOL, V33, P652, DOI 10.1089/dna.2014.236; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.05; Zhong CG, 2014, EXPRESSION CYCLIND; å½­å, 2007, [ä¸­åç®è¤ç§æå¿, Chinese Journa of Dermatology], V40, P16",24,0,0,1,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1351.0,1355,,10.19193/0393-6384_2018_5_207,,5,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700029,,,,,2022-07-14,0.0024793388429752063,8.129199087463593e-05,0.0047466654826543615,0.09216853130207094,0.0047466654826543615
J,"Tartaglia, N1;  Iadarola, R;  Di Lascia, A;  Fersini, A;  Ambrosi, A",,,,"Tartaglia, Nicola; Iadarola, Roberta; Di Lascia, Alessandra; Fersini, Alberto; Ambrosi, Antonio",,,UNUSUAL COMPLICATION IN THYROID SURGERY. CASE REPORT AND LITERATURE REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,Total thyroidectomy; Tracheal injury; Tracheal surgery; Tracheal lesion-Tracheostomy-Tracheal laceration,ASTROGLIAL CELL-PROLIFERATION; ACUTE BILIARY PANCREATITIS; TRACHEAL NECROSIS; CHILDREN; EXPRESSION; RUPTURE; DIFFERENTIATION; POPULATION; LEUKEMIA; EFFICACY,"Background and Objective: Complication rates from total thyroidectomy are low, at present mortality for this procedure is around 0% and overall complication rate is less than 3%. Major complication includes wound infection, hematoma, recurrent laryngeal nerve palsy, hypoparathyroidism. Tracheal injury associated with thyroidectomy is rare, but when it occurs it can be very dangerous. Tracheal perforation is generally not considered a complication as such, but rather atechnical occurrence during surgery that requires expeditious attention. Tracheal perforation, if encountered, needs to be managed appropriately incenters of expertise for high volume of thyroidectomy.","[Tartaglia, Nicola; Iadarola, Roberta; Di Lascia, Alessandra; Fersini, Alberto; Ambrosi, Antonio] Univ Foggia, Dept Med & Surg Sci, Luigi Pinto St 1, I-71122 Foggia, Italy","Tartaglia, N (corresponding author), Univ Foggia, Dept Med & Surg Sci, Luigi Pinto St 1, I-71122 Foggia, Italy.",nicola.tartaglia@unifg.it,"Tartaglia, Nicola/AAJ-9264-2020; tartaglia, nicola/AAD-7321-2019","Tartaglia, Nicola/0000-0001-6845-7080; tartaglia, nicola/0000-0001-6845-7080",,,"Albano GD, 2017, ACTA MEDICA MEDITERR, V33, P93; Albenzio M, 2009, J DAIRY SCI, V92, P79, DOI 10.3168/jds.2008-143; Albenzio M, 2013, J DAIRY SCI, V96, P2781, DOI 10.3168/jds.2012-621; Avola R, 2004, CLIN EXP HYPERTENS, V26, P323, DOI 10.1081/CEH-12003413; Bertolaccini L, 2012, INTERACT CARDIOV TH, V14, P500, DOI 10.1093/icvts/ivr12; Bonaventure A, 2017, LANCET HAEMATOL, V4, pE202, DOI 10.1016/S2352-3026(17)30052-; Bramanti V, 2012, NEUROCHEM RES, V37, P2795, DOI 10.1007/s11064-012-0873-; Bramanti V, 2016, J NEUROSCI RES, V94, P90, DOI 10.1002/jnr.2367; Caroprese M, 2010, J DAIRY SCI, V93, P2395, DOI 10.3168/jds.2009-260; Caroprese M, 2009, J DAIRY SCI, V92, P2796, DOI 10.3168/jds.2008-180; Carotenuto M, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.0029; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carter YM, 2012, ENDOCR PRACT, V18, P720, DOI [10.4158/EP12014.OR, 10.4158/EP11344.CR; Cerame Giuseppe, 2008, Ig Sanita Pubbl, V64, P46; Chauhan A, 2009, J POSTGRAD MED, V55, P193, DOI 10.4103/0022-3859.5740; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Cianci P, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0857-; Conzo G, 2012, ANN ITAL CHIR, V83, P25; Conzo G, 2012, ANN ITAL CHIR, V83, P5; Damrose EJ, 2009, AURIS NASUS LARYNX, V36, P113, DOI 10.1016/j.anl.2008.03.00; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Escott Alistair B, 2016, Ear Nose Throat J, V95, pE1; Esposito M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0068; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Forlano I, 2011, ANN ITAL CHIR, V82, P40; Giallongo C, 2011, ACTA HAEMATOL-BASEL, V126, P205, DOI 10.1159/00032991; Golger A, 2002, CAN J SURG, V45, P46; Gosnell JE, 2006, BRIT J SURG, V93, P55, DOI 10.1002/bjs.513; Han XW, 2016, J VASC INTERV RADIOL, V27, P1758, DOI 10.1016/j.jvir.2016.04.01; Heavrin BS, 2012, J EMERG MED, V43, pE259, DOI 10.1016/j.jemermed.2011.03.03; Jacqmin Sebastien, 2005, J Anesth, V19, P347, DOI 10.1007/s00540-005-0330-; Lombardi C P, 2007, Minerva Chir, V62, P39; Maglietta F, 2017, ACTA MEDICA MEDITERR, V33, P947, DOI 10.19193/0393-6384_2017_6_14; Mazzucco W, 2012, ARCH ENVIRON OCCUP H, V67, P91, DOI 10.1080/19338244.2011.57868; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BENEFICIAL EFFECTS C, DOI [10.4172/0974-8369.1000, DOI 10.4172/0974-8369.1000; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Asian J Sports Med, V7, pe26841, DOI 10.5812/asjsm.2684; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2018, MOL NEUROBIOL, V55, P6362, DOI 10.1007/s12035-017-0865-; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S14839; Neri V, 2013, ANN ITAL CHIR, V84, P4; Neri V, 2009, ANN ITAL CHIR, V80, P36; Neri V, 2009, PANCREAS, V38, P717, DOI 10.1097/MPA.0b013e3181a8308; Nishihara E, 2005, THYROID, V15, P1183, DOI 10.1089/thy.2005.15.118; Palmieri Giovanni Messina Filomena, 2015, BIOL ME; Pieri M, 2016, J FORENSIC LEG MED, V38, P93, DOI 10.1016/j.jflm.2015.12.00; Pomara C, 2008, CLIN TOXICOL, V46, P322, DOI 10.1080/1556365070141901; Pomara C, 2016, J CELL PHYSIOL, V231, P1385, DOI 10.1002/jcp.2527; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Precenzano F, 2017, ACTA MEDICA MEDITERR, P3; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Rosato L, 2012, MINERVA CHIR, V67, P27; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Salomone F, 2014, TRANSL RES, V163, P593, DOI 10.1016/j.trsl.2013.12.00; Sanna S, 2014, G CHIR, V35, P65, DOI 10.11138/gchir/2014.35.3.06; Sperandeo R, 2018, NEUROPSYCH DIS TREAT, V14, P11, DOI 10.2147/NDT.S14625; To Edward W H, 2002, Ear Nose Throat J, V81, P73; Tramuto F, 2012, J COMMUN HEALTH, V37, P547, DOI 10.1007/s10900-011-9477-; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Vacchiano G, 2012, J ROY ARMY MED CORPS, V158, P338, DOI 10.1136/jramc-158-04-1; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",76,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,423.0,429,,10.19193/0393-6384_2018_2_66,,7,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400021,,,,,2022-07-14,0.00743801652892562,0.050705545767255715,0.014569810596424853,0.11084265610149889,0.014468721153992592
J,"Vanne, D1;  Vanni, P;  Mannelli, I;  Vanne, S",,,,"Vanne, Duccio; Vanni, Paolo; Mannelli, Iacopo; Vanne, Simone",,,"ELENA, DUCHESS OF AOSTA, INSPECTOR GENERAL OF THE RED CROSS VOLUNTEER NURSES IN THE GREAT WAR - WORLD WAR 1",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Italian Red Cross; Word War 1; Elena of France; San Giorgio of Nogaro; Accanto agli Eroi. Italian volunteer nurses,,"It is our conviction that the history of the Red Cross is part of the history of medicine. The nursing activity of H.R.H. Elena of France during the Great War is a fine example of the medical emergency history. In May 1915, the Duchess of Aosta became Inspector General of the volunteer nurses of the Italian Red Cross. Her diary Accanto agli eroi (Side by Side with the Heros) is an exhaustive text that accurately describes those dramatic events. For her activity in the Great War we can refer to her as our Florence Nightingale.","[Vanne, Duccio] Univ Florence, Hist Med, Hlth Sci Dept, Florence, Italy; [Vanni, Paolo] Univ Florence, Med Chem, Italian Red Cross Silver Medal, Florence, Italy; [Vanne, Simone] Empoli Hosp Florence, Emergency Dept, Florence, Italy","Vanni, P (corresponding author), Reg Toscana, Ufficio Storico CRI, Via Massoni 21, I-50139 Florence, Italy.",,,"Vanni, Simone/0000-0002-1201-5715",,,"[Anonymous], 1919, P MED C HELD INV CO; Baldo D., 2010, STUDENTI AL FRONTE, P5; Bartoloni S., 2003, ITALIANE GUERRA LASS, P; D'Aosta Elena, 1930, ACCANTO EROI CROCE R, P; Diana E., 2011, ATT CONV NAZ FIR 9 ; Dunant H., 2005, MEMOIRES TEXT ESTABL, V107; Dunant H., 2010, PUBLIC GENEVA LIB, V1-1; Dunant H., 2008, SOUVENIR SOLFERIN; Gaspari P., 2008, CROCEROSSINE NELLA G, P21; Guthrie D., 1958, HIST ME; Major RH, 1959, HIST ME; Ottaviani R, 2011, J MED BIOGR, V19, P117, DOI 10.1258/jmb.2010.01003; Ottaviani R., 2011, MENSCHENLIEBE HEILT, P5; Ottaviani Raimonda, 2003, Vesalius, V9, P2; Pazzini A., 1974, STORIA ARTE SANITARI, VI-I; Premuda L., 1960, STORIA ME; Vanni D, 2008, J Med Biogr, V16, P195, DOI 10.1258/jmb.2008.00802; Vanni D., 2014, MED STORIA ANNO 14, V6, P6; Vanni D., 2017, ATT CONV NAZ STOR S; Vanni D., INTERNAL EMERGENCY ; Vanni P., 2013, STORIA CROCE ROSSA I, P80; Walker K., 1957, STORY ME; Zanobio B., 1997, STORIA ME; [No title captured",24,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,713.0,718,,10.19193/0393-6384_2018_3_110,,6,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000015,,,,,2022-07-14,0.0024793388429752063,1.2157978299981646e-11,0.009066627588568247,0.10344864437391128,0.009066627588568247
J,"Vanni, D1;  Guerin, E;  Mannelli, I",,,,"Vanni, Duccio; Guerin, Elisabeth; Mannelli, Iacopo",,,"A POSSIBLE (IF NOT PROBABLE) DIFFERENT INTERPRETATION OF KUHN'S PROFILE OF HENRY DUNANT (1828-1910), THE REAL FOUNDER OF THE INTERNATIONAL RED CROSS",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,International Red Cross; Henry Dunant; Roland Kuhn; historical psychiatric reading,,"In 1985, the famous Swiss psychiatrist, Roland Kuhn (1912-2005), explained his psychiatric reading of Henry Dunant (1828-1910), the real founder of the International Red Cross, in a specific paper. Our historical analysis obout his article shows at least five criticism that can be made against Kuhn's interpretation of Dunant profile. All reasons of our historical criticism are described and discussed.","[Vanni, Duccio] Univ Florence, Hlth Sci Dept, Hist Med, Florence, Italy; [Guerin, Elisabeth] Univ Florence, SCIFOPSI LILSI, Florence, Italy; [Mannelli, Iacopo] IOT, Cent Emergency Headquarters 118, Nursing Sci, Florence, Italy","Vanni, D (corresponding author), Univ Florence, Hlth Sci Dept, Hist Med, Florence, Italy.",duccio.vanni@unifi.it,,,,,"Baccolo M.G., 2007, ATT FOND G RONCH ANN, P78; Dunant H., 2010, QUADERNI H DUNANT, V1-1; DUNANT H., 2008, SOUVENIR SOLFERINO ; Dunant H., 2010, QUADERNI H DUNANT, V1; Dunant H., 1994, L AVENIR SANGLAN; Dunant H., 2005, MEMOIRES, P107; Durand R., 1989, SOURCES IDEE CROIX ; Kuhn R., 1988, ACT C H DUN GEN 3 4, P11; Kuhn R., 1993, PSICHIATRIA TERRITOR, V10, P; Ottaviani R, 2011, J MED BIOGR, V19, P117, DOI 10.1258/jmb.2010.01003; Ottaviani R., 2011, MENSCHENLIEBE HEILT, P5; Ottaviani Raimonda, 2003, Vesalius, V9, P2; Vanni D, 2008, J Med Biogr, V16, P195, DOI 10.1258/jmb.2008.00802; Vanni D., 2014, MED STORIA ANNO 14, V6, P6; Vanni D., 2017, GENESI CROCE ROSSA M, P54; Vanni D., INTERNAL EMERGENCY ; Vanni P., 2013, STORIA CROCE ROSSA I, P80",17,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1345.0,1349,,10.19193/0393-6384_2018_5_206,,5,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700028,,,,,2022-07-14,0.001652892561983471,5.2971430463036495e-14,0.0018589597996514563,0.0857540241493254,0.0018589597996514563
J,"Vanni, D21;   Vanni, P;   Vanni, S",,,,"Vanni, Duccio; Vanni, Paolo; Vanni, Simone",,,GREAT WAR: MILITARY MEDICAL CARE AND ITALIAN RED CROSS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Battles of the Isonzo; Military Healthcar; Italian Red Cross; Diseases of war; causes of death,,"After a brief description of the great war the authors deal with medical assistance, military health activities and the Red Cross. The tragic aspects of a vast medical assistance, yet always insufficient compared to the magnitude of the tragedy, are described.","[Vanni, Duccio] Univ Florence, Hist Med, Florence, Italy; [Vanni, Paolo] Florence Univ, Florence, Italy; [Vanni, Simone] Empolis Hosp, Emergency Dept, Empoli Firenze, Italy","Vanni, P (corresponding author), Florence Univ, Florence, Italy.",paolo.vanni@unifi.it,"Vanni, Simone/GLR-6148-2022","Vanni, Simone/0000-0002-1201-5715",,,"Baldo D., 2010, STUDENTI AL FRONTE, P5; Barbero A., 2017, CAPORETT; Belogi R., 1990, CRI BERGAMO, V1-; Bocchetti F., 1924, LIBRO ORO MEDICI IT; Gadda C.-E., 2002, GIORNALE GUERRA PRI; Gaspari P., 2008, CROCEROSSINE NELLA G, P21; Losi A., 2015, ALBO ONORE CADUTI G; Lusssu E., 1996, ANNO SULL ALTIPIAN; Santoro A., 2017, CONV NAZ STOR SAN MI, P43; Vanne D, 2018, ACTA MEDICA MEDITERR, V34, P713, DOI 10.19193/0393-6384_2018_3_11; Vanni D, 2018, INTERN EMERG MED, V13, P301, DOI 10.1007/s11739-017-1775-",11,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1863.0,1867,,10.19193/0393-6384_2018_6_288,,5,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400039,,,,,2022-07-14,0.0011363636363636363,7.543869998333977e-15,0.002065155115573547,0.08574794709847726,0.002065155115573547
J,"Wan, L1;  Liu, J;  Huang, CB;  Wang, Y;  Shen, X;  Zhang, WD;  Wang, GZ;  Fan, HX;  Ge, Y;  Chen, RL;  Cao, YX;  Zong, RK;  Liu, TY",,,,Wan Lei; Liu Jian; Huang Chuan-Bing; Wang Yuan; Shen Xi; Zhang Wan-Dong; Wang Gui-Zheng; Fan Hai-Xia; Ge Yao; Chen Rui-Lian; Cao Yun-Xiang; Zong Rui-Kai; Liu Tian-Yang,,,EFFECTS OF XINFENG CAPSULE ON LIPOPROTEIN METABOLISM IN ADJUVANT ARTHRITIS RATS BASED ON VASCULAR STRESS IMBALANCE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,adjuvant arthritis; Xinfeng capsules; lipoprotein; metabolism; vascular stress,HIGH-DENSITY-LIPOPROTEIN; RHEUMATOID-ARTHRITIS; NONRHEUMATOID ARTHRITIS; PULMONARY-FUNCTION; CHOLESTEROL; SERUM,"Objective: To observe the effect of Xinfeng Capsule (XFC) on protein metabolism and cytokines in adjuvant arthritis (AA). Methods: 60 rats were randomly divided into normal control group (NC) group, model control group (MC) group, methotrexate (MTX), tripterygium wilfordii polyglycoside (TPT) group and XFC group. To the rats except the NC group, the right hind foot plantar intradermal injection of 0.1 ml inflammation. / G), apolipoprotein A1 (Apo-A1), Apolipoprotein B (Apo-B), apolipoprotein A1 / B (APOA1 / B), cytokines, GMP-140, CD40L were observed after 30 days of administration. Results: Compared with NC group, the levels of PA, ALB, A / G, APOA1, APOA1 / B and IL-10 were decreased in MC group, and the levels of GLO, IL-1 beta, ANCA, VEGF and E IL-1 beta, ANCA, VEGF, E-selectin, PAF, GMP-140 and CD40L in MTX, TPT and XFC groups were significantly lower than those in MC group (P <0.05), While the XFC group in the rise of PA, ALB, APOA1, APOA1 / B and other aspects was significantly better than other treatment groups. (P < 0.05 or P < 0.01). Compared with TPT and MTX group, the body weight of XFC group increased (P < 0.05), and the arthritis index of XFC group was significantly lower than that before treatment, VEGF, E-selectin, PAF decreased, IL-10 was significantly increased (P < 0.05). Conclusion: Xinfeng Capsule can reduce the arthritis of adjuvant arthritis rats and improve the body weight and regulate protein metabolism. The mechanism is that by down-regulating the expression of cytokines IL-1 beta, ANCA, VEGF, E-selectin, GMP-140, CD40L, Upregulates the expression of cytokines IL-10, inhibits inflammatory effects, enhances anti-inflammatory effects, inhibits vasculitis formation, improves microvascular circulation, regulates protein metabolism in vivo.","[Wan Lei; Liu Jian; Huang Chuan-Bing; Wang Yuan; Shen Xi; Zhang Wan-Dong; Wang Gui-Zheng; Fan Hai-Xia; Ge Yao; Chen Rui-Lian; Cao Yun-Xiang; Zong Rui-Kai; Liu Tian-Yang] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Rheumatol, Hefei 230031, Anhui, Peoples R China","Liu, J (corresponding author), Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Rheumatol, Hefei 230031, Anhui, Peoples R China.",,,,National Natural Science Foundation [81403388]; Anhui Provincial Natural Science Foundation of China [1508085QH159]; Anhui Provincial Key Laboratory of Modern Traditional Chinese Medicine Internal Medicine Application Foundation and Development Research [1606c08238]; Anhui University Natural Science Research Project [KJ2017A281],"This paper belongs to the project of the National Natural Science Foundation Project (81403388). Anhui Provincial Natural Science Foundation of China (1508085QH159), Anhui Provincial Key Laboratory of Modern Traditional Chinese Medicine Internal Medicine Application Foundation and Development Research (1606c08238), Anhui University Natural Science Research Project (KJ2017A281).","An J, 2016, J RHEUMATOL, V43, P1989, DOI 10.3899/jrheum.16011; Cao YX, 2011, CHIN J INTEGR MED, V17, P738, DOI 10.1007/s11655-011-0873-; Charles-Schoeman C, 2017, ARTHRITIS RHEUMATOL, V69, P46, DOI 10.1002/art.3983; Govindan KPS, 2015, J PHARM BIOALLIED SC, V7, pS22, DOI 10.4103/0975-7406.15576; Jamnitski A, 2013, J RHEUMATOL, V40, P825, DOI 10.3899/jrheum.12135; Kahraman C, 2016, ACTA MEDICA MEDITERR, V32, P981, DOI 10.19193/0393-6384_2016_4_11; Kim JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.016456; Kremer JM, 2017, ARTHRITIS RHEUMATOL, V69, P943, DOI 10.1002/art.4003; Lee JS, 2016, PROTEOM CLIN APPL, V10, P183, DOI 10.1002/prca.20150003; Liao KP, 2017, HEART, V103, P734, DOI 10.1136/heartjnl-2016-31076; Liao KP, 2014, ANN RHEUM DIS, V73, P1170, DOI 10.1136/annrheumdis-2012-20320; Liao KP, 2013, ARTHRIT CARE RES, V65, P2046, DOI 10.1002/acr.2209; Liu J, 2014, J TRADIT CHIN MED, V34, P532, DOI 10.1016/S0254-6272(15)30058-; Liu J, 2011, CHIN J INTEGR MED, V17, P735, DOI 10.1007/s11655-011-0872-; O'Neill F, 2017, HEART, V103, P766, DOI 10.1136/heartjnl-2015-30895; Ormseth MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2099, DOI 10.1002/art.3967; Ormseth MJ, 2016, CURR OPIN LIPIDOL, V27, P67, DOI 10.1097/MOL.000000000000025; Russo C, 2012, ACTA MEDICA MEDITERR, V28, P20; Schroeder LL, 2015, RHEUMATOL INT, V35, P1059, DOI 10.1007/s00296-014-3194-; Sodergren A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/67301; Tian Zhang Jun, 1998, MODERN PHARM EXPT ME, P138; Wagan AA, 2016, PAK J MED SCI, V32, P534, DOI 10.12669/pjms.323.977; Wan L, 2014, J TRADIT CHIN MED, V34, P76, DOI 10.1016/S0254-6272(14)60058-; Wan L, 2013, J CHIN MED ASSOC, V76, P715, DOI 10.1016/j.jcma.2013.08.00; Wang YL, 2015, J TRADIT CHIN MED, V35, P62; Wu JJ, 2015, INT J DERMATOL, V54, pE442, DOI 10.1111/ijd.1292; Xu SY, 2002, PHARM EXPT METHODOLO, P91",27,1,1,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,1.0,,,,,51.0,57,,10.19193/0393-6384_2018_1_9,,7,"Medicine, General & Internal",General & Internal Medicine,FV9AH,WOS:000424878600009,,,,,2022-07-14,0.0027892561983471073,1.0014593526001552e-07,0.011526135648532778,0.08743959170769161,0.011526135648532778
J,"Wang, Y1;  Zhang, HY;  Wang, YS",,,,"Wang, Yang; Zhang, Haiyu; Wang, Yongsheng",,,RELEVANCE BETWEEN FGFR-2 GENE POLYMORPHISM AND BREAST CANCER,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Breast cancer; fibroblast growth factor receptor 2; Gene polymorphism,SUSCEPTIBILITY; ASSOCIATION,"Objective: To investigate the relevance between the second intron single nucleotide polymorphism of fibroblast growth factor receptor 2 (FGFR2) gene and the onset of breast cancer in women. Methods: The 132 cases of female breast cancer (breast cancer group) and 145 normal women (control group) were detected by combining polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method with agarose gel electrophoresis. The polymorphism distribution of two single nucleotide polymorphisms (rs2981579) and (rs2981582) of the second intron of FGFR2 gene was analyzed statistically. Results: For FGFR2 gene single nucleotide polymorphism rs2981579, the frequencies of genotype (CC, CT, TT) in breast cancer group and the control group were 31.06%, 43.18%,25.76% and 26.90%, 45.52%,27.58% respectively. The frequencies of C allele in breast cancer group and control group were 68.94% and 75.17% respectively, and the frequencies of T allele in the two groups were 31.06% and 24.83% respectively. There was no statistically significant difference in genotype and allele frequency distribution between the two groups. For FGFR2 gene single nucleotide polymorphism s2981582, the frequencies of genotype (CC, CT, TT) in breast cancer group and the control group were 37.12%, 46.97%, 15.91% and 35.86% .45.52% .18.62% respectively. The frequencies of C allele in breast cancer group and control group were 72.73% and 71.72% respectively, and the frequencies of T allele were 27.27% and 31.72% respectively. The distribution of genotype frequency and allele frequency were compared between the two groups and there was no statistically significant difference (p>0. 05). Conclusion: There is no significant correlation between the 2 polymorphism sites of FGFR2 intron and breast cancer.","[Wang, Yang; Wang, Yongsheng] Shandong Univ, Shandong Canc Hosp, Jiyan Rd 440, Jinan 250117, Shandong, Peoples R China; [Wang, Yang] Weifang Peoples Hosp, Dept Galactophore Surg, Guangwen St 151, Weifang 261041, Shandong, Peoples R China; [Zhang, Haiyu] Weifang Peoples Hosp, Dept Antenatal Diag, Guangwen St 151, Weifang 261041, Shandong, Peoples R China; [Wang, Yongsheng] Shandong Acad Med Sci, Jinan 250062, Shandong, Peoples R China","Wang, YS (corresponding author), Shandong Acad Med Sci, Jinan 250062, Shandong, Peoples R China.;Wang, YS (corresponding author), Shandong Univ, Shandong Canc Hosp, Breast Canc Ctr, Jiyan Rd 440, Jinan, Shandong, Peoples R China.",,,,,,"Bai AL, 2010, CANCER RES, V70, P7630, DOI 10.1158/0008-5472.CAN-10-148; Basse C, 2015, INT J CANCER, V137, P2785, DOI 10.1002/ijc.2934; Boyarskikh UA, 2009, EUR J HUM GENET, V17, P1688, DOI 10.1038/ejhg.2009.9; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature0588; Garcia-Closas Montserrat, 2008, PLoS Genetics, V4, pe1000054, DOI 10.1371/journal.pgen.100005; Hunter DJ, NATURE GENETICS, V20, P87; Ingersoll RG, 2001, CYTOGENET CELL GENET, V94, P121, DOI 10.1159/00004880; Katoh M, 2010, EXPERT REV ANTICANC, V10, P1375, DOI 10.1586/ERA.10.12; Liang J, 2008, CARCINOGENESIS, V29, P2341, DOI 10.1093/carcin/bgn23; MichailldouI K, NATURE GENETICS, V20, P37; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.7; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.121052; Reintjes N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.006026; Tapper W, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr221; [èµµæ´ªç Zhao Hongmeng], 2010, [ä¸­å½è¿ç¤ä¸´åº, Chinese Journal of Clinical Oncology], V37, P62",15,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1717.0,1720,,10.19193/0393-6384_2018_6_262,,4,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400013,,,,,2022-07-14,0.0015495867768595042,7.296334841207755e-15,0.002890619463283807,0.08925360748697617,0.002890619463283807
J,"Xiao, W1;  Zhang, XB;  Wang, Z;  Guo, XL;  He, L;  Wang, Y",,,,Xiao Wei; Zhang Xianbao; Wang Zhen; Guo Xiaoli; He Ling; Wang Yan,,,MECHANISMS OF ACUPUNCTURE INTERVENTION IN RATS OF POST-STROKE DEPRESSION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,post-stroke depression; acupuncture; neurotransmitter; neurotransmitter receptor,FILIFORM NEEDLE ACUPUNCTURE; HIPPOCAMPAL; STRESS; MODEL; NEUROINFLAMMATION; 5-HTTLPR; UPDATE; STROKE; LESION; PSD,"Objective: To observe the effect of Jieyuanshen acupuncture on brain neurotransmitters in post-stroke depression (PSD) rats, and to explore the mechanism by which acupuncture improves PSD. Methods: Rats were randomly divided into normal, model, drug, and acupuncture groups. A post-stroke depression model was made by middle cerebral artery occlusion and chronic unpredictable mild stress. The acupuncture group was treated at Baihui, Fengfu, Shenmen and Taichong points for 20 min. The rats in the treatment group were treated with fluoxetine (2 mg/kg) once a day for 7 days. 3 courses, each course of rest between 1 day. Pathological changes in the hippocampal CA1 region were observed by light microscopy. Ultrastructural changes of the hippocampus were observed by electron microscopy. Levels of seretonin (5-HT), norepinephrine (NE), acetylcholine (Ach), gamma-aminobutyric acid (gamma-GABA) and glutamate (Glu) were measured in the cerebral cortex. 5-HT transporter (5-HTT), 5-HT1A receptor (5-HT1A R), NE alpha 2 receptor (NE alpha 2R) mRNAs and proteins were detected by RT-PCR and immunoblotting, respectively, in the hippocampus and raphe nucleus. Results: Compared with the model group, the acupuncture group had a lower Zea Longa score, higher sugar consumption, higher exercise level and greater number of vertical movements in the open field test (P <0.01 or P <0.05). The ultrastructural changes of hippocampal neurons were obvious and the damage to neurons was severe. There were fewer ultrastructural changes in hippocampal neurons in the acupuncture and drug groups compared with those in the model group. After treatment, levels of 5-HTT and 5HT1A R mRNA and protein in the brain tissue of PSD model rats were decreased, and levels of Ach, gamma-GABA, and Glu, and 5-HTT and 5-HT1A R mRNA and protein were significantly higher in the cortex of the acupuncture group compared with those in the untreated group (P <0.01). The mRNA and protein levels of NE alpha 2R mRNA and protein in the hippocampus, (P <0.01). The mRNA and protein levels of Ach, gamma-GABA, Glu and NE alpha 2R were decreased (P <0.01 or P <0.05). Conclusion: Jieyuanshen acupuncture can significantly improve the behavioral changes of post-stroke depression rats, and may up-regulate the levels of 5-HT and NE in the cerebral cortex, down-regulate the expression of Ach, gamma-GABA and Glu, and promote hippocampus, 5-HTT, 5-HT1A R, NE alpha 2R, inhibit the expression of NE alpha 2R, reduce the organic damage of hippocampus, and provide neuroprotective effect.","[Xiao Wei; Zhang Xianbao; Wang Zhen; Guo Xiaoli] Anhui Univ Chinese Med, Affiliated Hosp 2, Hefei 230001, Anhui, Peoples R China; [He Ling] Anhui Univ Chinese Med, Hefei 230001, Anhui, Peoples R China; [Wang Yan] Anqing Municipal Hosp, Anqing 246000, Peoples R China","Xiao, W (corresponding author), Care of Jian L, Dept Rheumatol, Anhui Univ Chinese Med, Affiliated Hosp 1, Hefei 230031, Anhui, Peoples R China.",liujianahzy@126.com,,,National Natural Science Foundation Project: Study on the Mechanism of Acupuncture Intervention on Post-stroke Depression by Using Neurotransmitter Receptor PCR Chip Technology [81273857],Fund Project: National Natural Science Foundation Project: Study on the Mechanism of Acupuncture Intervention on Post-stroke Depression by Using Neurotransmitter Receptor PCR Chip Technology (81273857),"[Anonymous], 2014, J ACUPUNCTURE MOXIBU, V39, P13; Carnes-Vendrell A, 2016, REV NEUROLOGIA, V62, P460, DOI 10.33588/rn.6210.201547; Das SK, 2016, NEUROSCI LETT, V612, P231, DOI 10.1016/j.neulet.2015.12.03; Ding XH, 2016, METAB BRAIN DIS, V31, P279, DOI 10.1007/s11011-015-9748-; Llorca GE, 2015, NEUROLOGIA, V30, P23, DOI 10.1016/j.nrl.2012.06.00; Fan WT, 2012, NEURAL REGEN RES, V7, P187, DOI 10.3969/j.issn.1673-5374.2012.03.00; Feng C, 2014, J SCI WORLD, V2014, P521; Finkelmeyer A, 2016, PSYCHOL MED, V46, P2157, DOI 10.1017/S003329171600070; Ji XW, 2014, EXP THER MED, V8, P159, DOI 10.3892/etm.2014.167; Koizumi J., 1986, JPN J STROKE, V8, P; Le JJ, 2016, NEUROSCI LETT, V615, P66, DOI 10.1016/j.neulet.2016.01.00; Li JF, 2016, J AFFECT DISORDERS, V197, P215, DOI 10.1016/j.jad.2016.03.03; Li Y, 2015, CHINESE MED J-PEKING, V128, P2926, DOI 10.4103/0366-6999.16805; Liu Dan, 2010, ZHONGGUO JING BAO JI, V13, P38; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.8; Loubinoux I, 2012, J CELL MOL MED, V16, P1961, DOI 10.1111/j.1582-4934.2012.01555.; Manning KJ, 2016, BIOL PSYCHIAT, V80, pE1, DOI 10.1016/j.biopsych.2016.05.00; Nabavi SF, 2015, CURR MED CHEM, V22, P34; Qian XL, 2015, J ALTERN COMPLEM MED, V21, P748, DOI 10.1089/acm.2015.008; Queirazza F, 2014, J NEUROL NEUROSUR PS, V85, P241, DOI 10.1136/jnnp-2012-30414; Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.1503036; Sun Yi, 2007, CHINESE J STROKE, V2, P89; Tanahashi N, 2016, NEUROSCI LETT, V618, P99, DOI 10.1016/j.neulet.2016.02.05; Tang MM, 2016, PHYSIOL BEHAV, V161, P166, DOI 10.1016/j.physbeh.2016.04.03; Terroni L, 2015, NEUROPSYCH DIS TREAT, V11, P233, DOI 10.2147/NDT.S7372; Wei CJ, 2016, INT J NEUROSCI, V126, P623, DOI 10.3109/00207454.2015.105104; Werheid K, 2016, GERONTOLOGY, V62, P33, DOI 10.1159/00038187; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P35; Wiwanitkit V, 2014, NEURAL REGEN RES, V9, P1248, DOI 10.4103/1673-5374.13532; Xu Shuyun, 1994, PHARM EXPT METHOD, P64; Young KD, 2016, BRAIN BEHAV IMMUN, V56, P335, DOI 10.1016/j.bbi.2016.04.00; Zhang C, 2015, EVID-BASED COMPL ALT, V2015, P49; Zhang JP, 2014, NEURAL REGEN RES, V9, P773, DOI 10.4103/1673-5374.13159; Zhao Q, 2016, MOL NEUROBIOL, V53, P1699, DOI 10.1007/s12035-015-9120-",34,0,0,6,21,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,2.0,,,,,507.0,515,,10.19193/0393-6384_2018_2_82,,9,"Medicine, General & Internal",General & Internal Medicine,GB7TQ,WOS:000429278400035,,,,,2022-07-14,0.003512396694214876,1.8659868131651142e-17,0.00680691093182053,0.07060488253185608,0.00680691093182053
J,"Xue-Mei, X1;  Dian-Ming, L;  Jun-Feng, H;  Yong, Z;  Shan, G",,,,"Xue-Mei, Xia; Dian-Ming, Li; Jun-Feng, Hu; Yong, Zhang; Shan, Gao",,,MECHANISMS INVOLVED IN THE EFFECT OF DOWN-REGULATED CX43 ON ACQUIRED RESISTANCE OF NON-SMALL CELL LUNG CANCER CELLS TO GEFITINIB (R),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Non-small cell lung cancer; CX43; Gifitinib (R); Acquired resistance,TYROSINE KINASE EXPRESSION; BREAST-CANCER; AXL; NEK2,"Objective: To study the effect of down-regulated Cx43 on acquired resistance of non-small lung cancer (NSCLC) cells to Gefitinib (R), and explore its mechanisms. Methods: Gefitinib (R) - resistant cells strain HCC827 GR were exposed gradually to increasing concentrations of Gefitinib (R), and the IC50 value of the drug was determined by MTT assay. The Cx43 mRNA expression was measured using RT-PCR, while the protein and phosphorylated Akt (p-Akt) levels were determined with Western blot. Immunofluorescence technique was used for the analysis of the Cx43 cells. Results: The IC50 values of Gefitinib (R) for HCC827 and HCC827 GR were 0.075 +/- 0.013 and 10.67 +/- 0.027 mu mol/L, respectively, and differed significantly (p < 0.05). The expression levels of mRNA and protein of Cx43 in HCC827 GR were significantly lower than those of HCC827 (p < 0.05), while the protein level of p-Akt was significantly increased (p < 0.05). When LT294002, the specific inhibitor of PI3K was added to HCC827 GR, the protein expression level of p-Akt was significantly reduced (p < 0.05), while that of Cx43 was significantly increased (p < 0.01). Conclusion: The down-regulation of Cx43 in the cytoplasm of patients with NSCLC is associated with acquired resistance of NSCLC cells to Gefitinib (R), most likely due to the activation of PI3K / Akt signal pathway of Cx43 non-GJIC-dependent. Thus, measurement of levels of Cx43 is a useful guide during the treatment of NSCLC.","[Xue-Mei, Xia; Dian-Ming, Li; Jun-Feng, Hu; Yong, Zhang; Shan, Gao] Bengbu Med Coll, Affiliated Hosp 1, Dept Resp & Crit Care Med, Bengbu, Anhui, Peoples R China","Dian-Ming, L (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Dept Resp & Crit Care Med, Bengbu, Anhui, Peoples R China.",yxogy6@163.com,,,,,"Cichon MA, 2014, ONCOGENE, V33, P4185, DOI 10.1038/onc.2013.38; D'Alfonso TM, 2014, J CLIN PATHOL, V67, P690, DOI 10.1136/jclinpath-2013-20216; Lee CH, 2014, ANN SURG ONCOL, V21, P1031, DOI 10.1245/s10434-013-3400-; Liu X, 2014, ONCOL REP, V31, P745, DOI 10.3892/or.2013.291; Neal CP, 2014, J SURG ONCOL, V110, P828, DOI 10.1002/jso.2371; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.2126; WANG Junjie, 2016, ORAL MEDCINE, V36, P33; Wang W.J., 2017, MOBILE INFORM SYSTEM, V2017, P1, DOI DOI 10.1080/09540105.2017.136025; Yue CH, 2016, MOL MED REP, V14, P1636, DOI 10.3892/mmr.2016.542",9,0,0,1,12,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,1037.0,1040,,10.19193/0393-6384_2018_4_158,,4,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500021,,,,,2022-07-14,0.0009297520661157025,1.1635333645714892e-11,0.0016522948634643119,0.10479252595455382,0.0016522948634643119
J,"Yang, L21;   Zhou, XK;   Wang, L;   Shi, HX;   Liu, XF;   Wang, YG",,,,"Yang, Lin; Zhou, Xiao-Kai; Wang, Lei; Shi, Hong-Xia; Liu, Xiao-Feng; Wang, Yong-Gang",,,ISOLATION OF ENDOPHYTIC FUNGI FROM THERMOPSIS LANCEOLATA AND THEIR ANTIOXIDANT ACTIVITY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Endophytic fungi; Thermopsis lanceolata; Antioxidant activity,,"Introduction: Plant endophytic fungi resources is nearly a decade of research hot spots, endogenous fungal resources development and utilization will be fruitful. Aim: Aim of this study is isolation of endophytic fungi strains from healthy tissues of Thermopsis lanceolata and evaluation of antioxidant activity of fermented extracts of these isolated endophytic fungi strains. Materials and methods: Root, stem and leaf of Thermopsis lanceolata were used to isolate endophytic fungi strains. Reducing power and DPPH free radical scavenging assays were used to evaluate the antioxidant activity of fermented extracts from isolated endophytic fungi strains from Thermopsis lanceolata. Meanwhile, Total phenolic content (TPC) of fungal extracts was tested by Folin-Ciocalteau reagent based assay. Results: 16 endophytic fungi strains were isolated by tissue culture from healthy root, stem and leaf of Thermopsis lanceolata; Results of antioxidant activity evaluate indicates that there are 4 samples showed a good reduction force, especially ethyl acetate extract of Tlc-R-7 has the highest reducing power, it's absorbance value reached 0.528 (ascorbic acid, 0.588). Moreover, ethyl acetate extracts had generally higher antioxidant activity than extracts of n-butanol and methanol; Result of DPPH free radical scavenging activity showed there are 3 extracts samples showed inhibition rate of more than 90%. 2 extracts showed inhibition rate of more than 85%, among them, Tlc-R-7 ethyl acetate extract has the highest inhibition rate of 93%; The results indicate that the higher the phenol content in the sample, the stronger the antioxidant capacity of the sample; Most of the higher activity extracts of the fungal was concentrated in the roots. Conclusion: There are abundant endophytic fungi resources in Thermopsis lanceolata, and the endophytic fermentation product has a good prospect of antioxidant drug development.","[Yang, Lin; Zhou, Xiao-Kai; Wang, Lei; Liu, Xiao-Feng; Wang, Yong-Gang] Lanzhou Univ Technol, Sch Life Sci & Engn, Gansu Educ Dept, Key Lab Screening Evaluat & Adv Proc TCM & Tibeta, Lanzhou 730050, Gansu, Peoples R China; [Shi, Hong-Xia] Lanzhou Inspect & Quarantine Co Ltd, 1 Yingmen Village Anning Dist, Lanzhou, Gansu, Peoples R China","Yang, L (corresponding author), Lanzhou Univ Technol, Sch Life Sci & Engn, Gansu Educ Dept, Key Lab Screening Evaluat & Adv Proc TCM & Tibeta, Lanzhou 730050, Gansu, Peoples R China.",yanglin-401@163.com,,,,,"Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.04; CARROLL G, 1988, ECOLOGY, V69, P2, DOI 10.2307/194315; Chen J. S, 1987, POISONOUS PLANTS CHI, P34; Cui JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.011820; Ebadi A. G., MEASUREMENT SOME CH; Faeth SH, 1997, ECOLOGY, V78, P810, DOI 10.1890/0012-9658(1997)078[0810:FEIOTL]2.0.CO;; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/3504168; Goddemir G., 2017, ACTA MEDICA MEDITERR, P15; Gulcin I, 2007, AMINO ACIDS, V32, P431, DOI 10.1007/s00726-006-0379-; Halliwel B, 1989, FREE READICALS BIO; Halliwell B, 1995, BIOCHEM SOC SYMP, P73, DOI 10.1042/bss061007; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-; Kelecom A, 2002, AN ACAD BRAS CIENC, V74, P151, DOI 10.1590/S0001-3765200200010001; Lachance PA, 2001, NUTRITION, V17, P835, DOI 10.1016/S0899-9007(01)00636-; Liu CH, 2001, J BIOTECHNOL, V88, P277, DOI 10.1016/S0168-1656(01)00285-; Manila Y, 2014, ASIAN PAC J TROP MED, pS256, DOI [10.1016/S1995-7645(14)60242-X, DOI 10.1016/S1995-7645(14)60242-X; Mirzaei A, 2016, ACTA MEDICA MEDITERR, V32, P132; Ovchinnikov A. Yu, 2013, Vestnik Otorinolaringologii, P8; Pan JH, 2008, BOT MAR, V51, P179, DOI 10.1515/BOT.2008.03; Petrini Orlando, 1992, Natural Toxins, V1, P185, DOI 10.1002/nt.262001030; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.; Sadananda TS, 2011, J MED PLANTS RES, V5, P364; Schulz B, 2002, MYCOL RES, V106, P996, DOI 10.1017/S095375620200634; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-; Zheng Xiu-Fang, 2013, Zhong Yao Cai, V36, P155",25,2,2,3,11,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,1.0,,,,,27.0,31,,10.19193/0393-6384_2018_1_4,,5,"Medicine, General & Internal",General & Internal Medicine,FV9AH,WOS:000424878600004,,,,,2022-07-14,0.0026859504132231405,2.8522422563557403e-05,0.005158885343493069,0.11577147094351357,0.005158885343493069
J,"Yildiz, Y1;  Cakmak, S;  Calapoglu, T;  Hocoglu, ZI;  Karadeniz, EG;  Ozkasap, S",,,,"Yildiz, Yasin; Cakmak, Semiha; Calapoglu, Tugba; Hocoglu, Zeynep I.; Karadeniz, Elif G.; Ozkasap, Serdar",,,MEAN PLATELET VOLUME CAN BE USED AS A HOSPITALIZATION CRITERIA IN PEDIATRIC PATIENTS DIAGNOSED WITH ACUTE BRONCHIOLITIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Mean platelet volume; Acute bronchiolitis; C-reactive protein; White blood cells,INFLAMMATION,"Introduction: Acute bronchiolitis is a disease generally seen in children tinder the age of 2 years and progressing with pronounced wheezing, cough, tachypnea and prolonged expirium resulting from inflammation of the bronchioles frequently caused by viral infection. Mean platelet volume (MPV) is a marker of platelet activation and function. Method: 204 children were included in this study in three ,groups; healthy children aged 3 - 48 months (control, group, Group 2), patients diagnosed with acute bronchiolitis in our clinic and then hospitalized (severe cases, group 1b) and patients diagnosed but not hospitalized (mild cases, Group 1a). Patients with a history of asthma, chronic disease or congenital anomaly were excluded. The clinical severity of acute bronchiolitis and the relations with WBC, CRP and MPV were compared between the groups. Results: Mean MPV values were 7.4 +/- 1.5 fL (4.6-10.3) in Group 2; 7.8 +/- 0.7 fL (6.5-10.1) in Group la and 8.3 +/- 1.0 fL (6.311.2) in Group 1b.While no difference was observed in terms of MPV between Group 2 and Group 1a(p=0.23), a significant difference was determined between Group 2 and Group 1b (<0.001). Discussion: MPV values in our study differed only in the severe patient group. In addition, no difference was observed between the mild and severe case groups in terms of other parameters apart from MPV. This finding shows that MPV values are correlated with severity of disease, that they rise significantly in moderate-severe cases and that they can therefore be used as a finding to assist clinicians in assessing the severity of the disease.","[Yildiz, Yasin; Cakmak, Semiha; Calapoglu, Tugba] Recep Tayyip Erdogan Univ, Sch Med, Dept Pediat, Rize, Turkey; [Hocoglu, Zeynep I.; Karadeniz, Elif G.] Rize Publ Hosp, Dept Pediat, Rize, Turkey","Yildiz, Y (corresponding author), Rize Training & Res Hosp, Rize, Turkey.",yasinyildizmd@gmail.com,"yildiz, yasin/AAE-2806-2019; Yildiz, Yasin/AAG-7802-2021","Yildiz, Yasin/0000-0002-0602-7795",,,"Anmolsingh R, 2016, W INDIAN MED J, DOI [10.7727/wimj.2015.364, DOI 10.7727/WIMJ.2015.364; Aslan A, 2004, J CHILD HLTH DIS, V47, P20; Canpolat FE, 2009, PEDIATR INT, V51, P314, DOI 10.1111/j.1442-200X.2009.02820.; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.42; Fitzgerald DA, 2004, MED J AUSTRALIA, V180, P399, DOI 10.5694/j.1326-5377.2004.tb05993.; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P4; Gunes A, 2015, INT J CLIN EXP MED, V8, P1133; Kara TT, 2015, TURKISH J PED DIS, DOI [10.12956/tjpd.2015.187, DOI 10.12956/TJPD.2015.187; Karadag-Oncel E, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-1; Kutlug S, 2021, W INDIAN MED J, V69, P395, DOI 10.7727/wimj.2015.26; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-222; Makay B, 2009, CLIN RHEUMATOL, V28, P975, DOI 10.1007/s10067-009-1148-; Mannaioni PF, 1997, INFLAMM RES, V46, P4, DOI 10.1007/PL0000015; Martinez FD, 1999, J ALLERGY CLIN IMMUN, V104, pS169, DOI 10.1016/S0091-6749(99)70058-; Mochizuki H, 2000, PEDIATRICS, V106, P1442, DOI 10.1542/peds.106.6.144; OMalley T, 1996, BLOOD COAGUL FIBRIN, V7, P431, DOI 10.1097/00001721-199606000-0000; Park Y, 2002, PLATELETS, V13, P301, DOI 10.1080/09537100222014833; Schoene NW, 1997, AM J CLIN NUTR, V65, P166; Steiner RWP, 2004, AM FAM PHYSICIAN, V69, P32; Turkish Thoracic Society, 2009, TURKISH THORACIC ; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/51612",21,0,0,2,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,6.0,,,,,1997.0,2000,,10.19193/0393-6384_2018_6_311,,4,"Medicine, General & Internal",General & Internal Medicine,GX5TR,WOS:000447814400062,,,,,2022-07-14,0.0021694214876033058,2.713111155936179e-17,0.055519732705308716,0.0859611576339369,0.05478301509294946
J,"Yin, M1;  Wang, ZY;  Xiao, W",,,,"Yin, Ming; Wang, Zhongyang; Xiao, Wei",,,THE SIGNIFICANCE OF ULTRASOUND-GUIDED LAUROMACROGOL INJECTION TO HEPATOCELLULAR CARCINOMA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Lauromacrogol; HCC; ultrasound-guided,ETHANOL INJECTION; CIRRHOSIS; ABLATION; LESIONS,"Introduction: Ultrasound-guided lauromacrogol injection (UGLI) has been widely utilized in patients with various ailments such as cystic lesions, piles, varicose veins, and so on. Herein, we utilized HepG2-bearing mice model to explore the efficacy and feasibility of UGLI on hepatocellular carcinoma (HCC). Material and methods: 26 BALB/c mice were inoculated subcutaneously with hepatoma HepG2 cells in right armpit. When subcutaneous tumor nodules developed, animals were respectively administered with intratumoral injection of lauromacrogol, ethanol or saline under ultrasound guidance. Ten days after treatment, tumor weight, histopathological as well as inflammatory infiltration extent and liver function variance were investigated. Results: Our datum demonstrated that lauromacrogol and ethanol nearly played equivalent tissue ablation effect on the hepatoma nodules as compared with saline. However, mice pretreated with lauromacrogol exhibited with less tissue inflammatory infiltration, liver injury. Conclusion: These results revealed that on the basis of nearly equivalent antitumor effect, lauromacrogol harbored less tissue impairment and side-effects, deserving further clinic promotion.","[Yin, Ming; Wang, Zhongyang; Xiao, Wei] Jiangsu Taizhou Peoples Hosp, Ultrason Unit, Taizhou 225300, Peoples R China","Wang, ZY (corresponding author), Jiangsu Taizhou Peoples Hosp, Ultrason Unit, Taizhou 225300, Peoples R China.",zhongyangwangdoc@163.com,,,,,"Acharya SK, 2014, J CLIN EXP HEPATOL, V4, pS27, DOI 10.1016/j.jceh.2014.05.01; Alazawi W, 2010, ALIMENT PHARM THER, V32, P344, DOI 10.1111/j.1365-2036.2010.04370.; CASTELLS A, 1993, HEPATOLOGY, V18, P112; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-0001; Huang H, 2015, INT J HYPERTHER, V31, P40, DOI 10.3109/02656736.2014.99901; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115; Kang TW, 2015, LIVER CANCER, V4, P176, DOI 10.1159/00036774; Kosugi C, 2004, WORLD J SURG, V28, P29, DOI 10.1007/s00268-003-7003-; Kukura V, 2010, COLLEGIUM ANTROPOL, V34, P3; Liccioni A, 2014, DIGEST DIS, V32, P554, DOI 10.1159/00036050; LIVRAGHI T, 1995, RADIOLOGY, V197, P101, DOI 10.1148/radiology.197.1.756880; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.00; Mancuso A, 2015, DIGEST LIVER DIS, V47, P324, DOI 10.1016/j.dld.2015.01.00; Mohandas KM, 2007, J GASTROENTEROL, V26, P26; Nakaji S, 2015, ENDOSCOPY, V47, pE558, DOI 10.1055/s-0034-139339; Sato D, 2012, EUR J VASC ENDOVASC, V44, P73, DOI 10.1016/j.ejvs.2012.04.00; Szary N, 2015, BIOMOLECULES, V5, P3295, DOI 10.3390/biom504329; Wang ZK, 2015, GASTROINTEST ENDOSC, V81, P1274, DOI 10.1016/j.gie.2014.08.01; Xue J, 2015, PAK J PHARM SCI, V28, P69; Zhong JH, 2015, MEDICINE, V94, DOI 10.1097/MD.000000000000039; Zimmet Steven E, 2003, Tech Vasc Interv Radiol, V6, P116, DOI 10.1053/S1089-2516(03)00044-",21,1,1,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,5.0,,,,,1331.0,1335,,10.19193/0393-6384_2018_5_204,,5,"Medicine, General & Internal",General & Internal Medicine,GL3JV,WOS:000437030700026,,,,,2022-07-14,0.0021694214876033058,7.355972890105728e-15,0.004128175593578668,0.08705427402311255,0.004128175593578668
J,"Zhang, W1;  Ji, Y;  Huang, CH;  Ying, J;  Ye, ZQ;  Qin, GY;  Zhao, NQ",,,,"Zhang, Wei; Ji, Yuan; Huang, Caihong; Ying, Jun; Ye, Zhengqiang; Qin, Guoyou; Zhao, Naiqing",,,EVALUATION OF THE ASSOCIATION BETWEEN THE PATHOGENESIS OF TYPE 2 DIABETES AND GENOME-WIDE COPY NUMBER VARIATIONS USING THE LASSO METHOD,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Type 2 diabetes; copy number variation; Genome-wide association; LASSO,ARRAY; GENE; VARIANTS; IDENTIFICATION; INSIGHTS; DATABASE; GLUCOSE; OBESITY,"Objective: Type 2 diabetes (T2D) is a complex disease caused by the combination of genetic factors and environmental factors. To date, although many loci, including genes and single nucleotide polymorphisms (SNPs), have been identified as risk variants of T2D, only approximately 10% of its heritability can be explained. In the current study, we proposed a data processing and analysis procedure to more accurately evaluate the association of the pathogenesis of T2D with copy number variations (CNVs). Methods: The data in our study came from the WTCCC (Wellcome Trust Case Control Consortium) genome-wide CNV database. Individual CNVs were identified by SW-ARRAY and CBS algorithms and genotyped with a global threshold method. Overlapped CNVs among all samples were split into smaller but more accurate CNV segments (CNVSegs) after the CNV call; then, LASSO-based logistic regression models with 10-fold cross-validations were performed 100 times to examine the association of CNVSegs with T2D. The AUC (area under the curve) in every model was summarized to preliminarily verify the classification ability of the models. Results: After quality control, 1,813 T2D cases and 2,777 controls were enrolled in the study. A total of 65,163 CNVs were identified, of which 25,512 were identified in the T2D group and 39,651 were identified in the healthy control group. A total of 22,279 CNVSegs were constructed after pre-processing the raw CNV data. By means of fitting 1,000 logistic regression models with the LASSO method, 26 CNVSegs were identified as T2D-associated CNVSegs according to pre-defined criteria (Frequency > 85% & Length > = 50 bp). Twenty-seven protein-coding genes were found to be overlapped with the CNVSegs, of which 11 were verified to be relevant to T2D, obesity or metabolic syndrome based on current published evidence. The average AUC of all models was 0.611 with the maximum being 0.683. Conclusions: Our study explored T2D-associated CNVSegs by LASSO-logistic regression models from the perspective of the whole genome for a more complete understanding of the genetic mechanisms of T2D. Further studies are necessary to verify the influence of the susceptibility loci on the pathogenesis or progression of T2D among different populations.","[Zhang, Wei; Qin, Guoyou; Zhao, Naiqing] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200032, Peoples R China; [Zhang, Wei; Ying, Jun] Fudan Univ, Fudan Univ Lib, Shanghai 200032, Peoples R China; [Ji, Yuan] Northshore Univ HealthSyst, Evanston, IL 60201 USA; [Ji, Yuan] Univ Chicago, Med & Biol Sci, Chicago, IL 60637 USA; [Huang, Caihong] Xuhui Cent Hosp, Shanghai 200032, Peoples R China; [Ye, Zhengqiang] Fudan Univ, Eye & ENT Hosp, Shanghai 200032, Peoples R China","Qin, GY; Zhao, NQ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200032, Peoples R China.",gyqin@fudan.edu.cn; nqzhao@fudan.edu.cn,,,NIH [2R01 CA132897],YJ's research is partly supported by NIH 2R01 CA132897.,"Aerts E, 2016, OBESITY, V24, P970, DOI 10.1002/oby.2143; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/7555; Bae JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.001909; Baeza-Raja B, 2012, P NATL ACAD SCI USA, V109, P5838, DOI 10.1073/pnas.110363810; Bao MX, 2006, CHIN J CLIN REHABIL, V10, P14; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature0591; Crespo-Facorro B., 2014, INT J NEUROPSYCHOPHA, V1; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i0; Fukuda T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.016413; Grarup N, 2014, DIABETOLOGIA, V57, P1528, DOI 10.1007/s00125-014-3270-; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.; Jeon JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-42; Kato N, 2013, J DIABETES INVEST, V4, P233, DOI 10.1111/jdi.1206; Lee HS, 2014, GENOMICS, V104, P113, DOI 10.1016/j.ygeno.2014.05.00; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt95; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.220; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.238; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh00; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.185; Plengvidhya N, 2012, GENE, V506, P383, DOI 10.1016/j.gene.2012.06.09; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki64; Pundir S, 2017, METHODS MOL BIOL, V1558, P41, DOI 10.1007/978-1-4939-6783-4_; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature0532; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-7; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.100019; Sedova L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015270; Slattery ML, 2011, MUTAT RES-FUND MOL M, V706, P13, DOI 10.1016/j.mrfmmm.2010.10.00; Smushkin G, 2010, CURR OPIN CLIN NUTR, V13, P471, DOI 10.1097/MCO.0b013e32833a558; Tews D, 2014, MOL CELL ENDOCRINOL, V395, P41, DOI 10.1016/j.mce.2014.07.01; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw113; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.009250; World Health Organization, 1999, DEF DIAGN CLASS DI ; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv115; Zhao XN, 2013, P NATL ACAD SCI USA, V110, P11023, DOI 10.1073/pnas.121772711",37,0,0,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,4.0,,,,,1143.0,1149,,10.19193/0393-6384_2018_4_176,,7,"Medicine, General & Internal",General & Internal Medicine,GJ1AT,WOS:000434986500039,,,,,2022-07-14,0.003822314049586777,2.047915498211353e-20,0.031015131164940028,0.07190129912574557,0.031015131164940028
J,"Zhu, Q1;  Ma, JD;  Dong, X;  Zhang, L",,,,"Zhu, Qiao; Ma, Jiede; Dong, Xian; Zhang, Lei",,,THE PROTECTIVE EFFECT OF THE COMBINATION OF XIAOXIANXIONG DECOCTION AND GUIZHI FULING PILLS ON RAT VASCULAR ENDOTHELIUM POST-MYOCARDIAL INFARCTION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Xiaoxianxiong decoction; Guizhi Fuling Pills; Myocardial infarction; serum lipid; endothelium function,ACUTE MYOCARDIAL-INFARCTION; TRADITIONAL CHINESE MEDICINE; CARDIOVASCULAR-DISEASE; RISK,"The study aims to explore the potential benefit of Traditional Chinese Medicines on myocardial infarction in well-established rat model. The myocardial infarction rat was established by ligating the left anterior descending coronary arteries. The infarction was evaluated by TTC staining. Traditional Chinese Medicines Xiaoxianxiong decoction and Guizhi Fuling Pills were administrated by gavage. The left ventricular ejection fraction (LVEF) was monitored at week 2, 4 by M-Mode Sonography. The total cholesterol and triglyceride in serum were measured by biochemical auto-analyzer. The change in serous content of C-Reactive Protein (CRP), Homocysteine (Hcy), nitric oxide (NO), endothelin (ET) were determined by ELISA and endothelial nitric oxide synthase (NOS) in myocardial tissue were detected by Western Blot. We found that treatment with the combination of Xiaoxianxiong decoction and Guizhi Fuling Pills could increase the expression level of myocardial eNOS and serous NO concentration, lower the level of CRP, Hcy and ET simultaneously. A significant protective effect was observed in endothelial injury and myocardial infarction. Our results suggested combinational treatment with Xiaoxianxiong decoction and Guizhi Fuling Pills might conserve the vascular endothelium function by promotion the release of relaxing factors, inhibition of the release of contracting factors and reduction of coronary spasm and contraction.","[Zhu, Qiao; Zhang, Lei] Yantai Hosp Tradit Chinese Med, Dept Cardiol, 39 Xingfu Rd, Yantai 264013, Shandong, Peoples R China; [Ma, Jiede; Dong, Xian] Yantai Hosp Tradit Chinese Med, Dept Heart Dis, Yantai, Shandong, Peoples R China","Zhang, L (corresponding author), Yantai Hosp Tradit Chinese Med, Dept Cardiol, 39 Xingfu Rd, Yantai 264013, Shandong, Peoples R China.",zhanglei19811981@163.com,,,,,"Abrams Jonathan, 1996, American Journal of Cardiology, V77, p31C, DOI 10.1016/S0002-9149(96)00186-; Al-Azzam SI, 2012, ACTA CARDIOL, V67, P445, DOI 10.1080/AC.67.4.217068; [Anonymous], 2008, Harv Heart Lett, V18, P; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.84; Bhatraju P, 2015, NITRIC OXIDE-BIOL CH, V50, P114, DOI 10.1016/j.niox.2015.08.00; Cavallari Ilaria, 2017, Interv Cardiol Clin, V6, P119, DOI 10.1016/j.iccl.2016.08.00; Chen LL, 2017, CARDIOVASC DRUG THER, V31, P9, DOI 10.1007/s10557-016-6704-; Dong-mei X, 2013, INT J CLIN PRACT, V67, P1254, DOI 10.1111/ijcp.1217; Erdmann J, 2013, NATURE, V504, P432, DOI 10.1038/nature1272; Frangogiannis NG, 2012, CARDIOVASC RES, V96, P4, DOI 10.1093/cvr/cvs26; Gaeta R, 2014, LANCET, V383, P410, DOI 10.1016/S0140-6736(14)60148-; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.22392; HOLMBOM B, 1993, HISTOCHEMISTRY, V99, P265, DOI 10.1007/BF0026909; Ke Zhi-peng, 2015, Zhongguo Zhong Yao Za Zhi, V40, P99; Kolettis TM, 2013, CARDIOL REV, V21, P249, DOI 10.1097/CRD.0b013e318283f65; Mehta PK, 2015, TRENDS CARDIOVAS MED, V25, P140, DOI 10.1016/j.tcm.2014.10.00; Moran AE, 2014, GLOB HEART, V9, P3, DOI 10.1016/j.gheart.2014.03.122; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.18; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra110523; Oliver MF, 2014, LANCET, V383, P409, DOI 10.1016/S0140-6736(14)60147-; RAPAPORT E, 1979, CIRCULATION, V59, P60; Reddy K, 2015, WORLD J CARDIOL, V7, P243, DOI 10.4330/wjc.v7.i5.24; Reed GW, 2017, LANCET, V389, P197, DOI 10.1016/S0140-6736(16)30677-; Rogers EJ, 2011, LANCET, V377, P2175, DOI 10.1016/S0140-6736(11)60952-; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-; Wu Y., 2011, JOVE-J VIS EXP, V48, pe246; Zhang Zhen-zhen, 2015, Zhongguo Zhong Yao Za Zhi, V40, P99",27,1,1,5,14,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,3.0,,,,,765.0,771,,10.19193/0393-6384_2018_3_117,,7,"Medicine, General & Internal",General & Internal Medicine,GJ0YH,WOS:000434980000022,,,,,2022-07-14,0.0027892561983471073,2.949512843996616e-14,0.019900393541782115,0.0821780581189035,0.019900393541782115
J,"Zhuang, X1;  Yang, J;  Sun, LZ",,,,"Zhuang, Xin; Yang, Jie; Sun, Lingzhi",,,EFFECT OF ADD-SUBSTRACT OF GUIPI DECOCTION ON BLOOD PRESSURE PATIENT AND THE QUALITY OF LIFE UPON TREATMENT ON SENILE HYPERTENSION WITH DEPRESSION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,elderly hypertension with depression; addition and subtractation Guipi decoction; blood pressure improvement; quality of life,,"Objective: This paper aims to observe and analyze the effect of addition and subtraction ofGuipi decoction on blood pressure and the quality of life for hypertension elderly patients complicated with depression. Methods: Total of 120 elderly patients diagnosed with hypertension and depression were selected as the study subjects. According to different treatment regimens, the patients were randomly divided into two groups. The analysis of clinical trials involves observation and comparison between patients with addition and subtraction of Guipi Decoction (referred as study group) and reference group that received western drug therapy. Results: The scores of 17 Hamilton Depression Scale (HAMD17), Health Status Questionnaire (SF-36), Hamilton Anxiety Scale (HAMA) and Treatment Drug Side Effects Scale (TESS) were measured to evaluate therapeutic effect of the two groups. The results showed that the indicators of study group were significantly better than the reference group (P < 0.05). At the same time, changes of blood pressure before and after treatment were not significantly different between both the groups (P> 0.05). Nevertheless after treatment, study group showed more significant advantages (P> 0.05). Conclusion: Application of addition and subtraction ofGuipi decoction for the elderly patients with hypertension complicated with depression can give full play to curative effect, significantly improve the patients' blood pressure levels, while improving their quality of life by alleviating depression symptoms, so it is worthy of promotion in treatment.","[Zhuang, Xin; Yang, Jie; Sun, Lingzhi] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China","Zhuang, X (corresponding author), Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China.",zhuangxin1972@126.com,,,,,"Cai Meiyun, TREATMENT LIVER QI ; Dung DTM, 2017, ARAB J CHEM, V10, P465, DOI 10.1016/j.arabjc.2015.10.00; Gao W, 2017, SAUDI PHARM J, V25, P548, DOI 10.1016/j.jsps.2017.04.02; Gao W, 2017, SAUDI J BIOL SCI, V24, P132, DOI 10.1016/j.sjbs.2016.09.00; Ge SB, 2017, SAUDI J BIOL SCI, V24, P1370, DOI 10.1016/j.sjbs.2016.12.01; Guo Jingyin, 2016, REVELATION HYPERTEN; Haidar AM, 2016, SAUDI J BIOL SCI, V23, P293, DOI 10.1016/j.sjbs.2015.06.01; Kumar R, 2016, SAUDI J BIOL SCI, V23, P243, DOI 10.1016/j.sjbs.2015.03.00; Li Haicong, 2016, CHINES J INTEGRATED, V22, P17; Li Qiubing, 2016, CHINA J TRAD CHIN ME, V10, P307; Lungu M, 2017, ACTA MEDICA MEDITERR, V33, P369, DOI 10.19193/0393-6384_2017_3_05; Nidhi, 2016, SAUDI PHARM J, V24, P458, DOI 10.1016/j.jsps.2014.10.00; Qin HP, 2016, SAUDI PHARM J, V24, P265, DOI 10.1016/j.jsps.2016.04.01; Selim SA, 2016, SAUDI J BIOL SCI, V23, P282, DOI 10.1016/j.sjbs.2015.11.00; Vinoth R, 2017, BIOMED RES-INDIA, V28, P319; Wang C, 2016, PAK J PHARM SCI, V29, P215; Zhang Zhifang, 2013, REVELATION HYPERTEN",17,1,1,0,17,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2018,34,,,,1.0,,273.0,277,,10.19193/0393-6384_2018_1s_45,,5,"Medicine, General & Internal",General & Internal Medicine,FV9AM,WOS:000424879100010,,,,,2022-07-14,0.001756198347107438,2.3767594695561556e-06,0.0026213996011838535,0.08560992650635442,0.0026570527845146707
J,"Aktas, T1;  Aktas, F;  Ozmen, C;  Ozmen, Z;  Kaya, T;  Demir, O",,,,"Aktas, Turan; Aktas, Fatma; Ozmen, Cansel; Ozmen, Zafer; Kaya, Turan; Demir, Osman",,,MEAN PLATELET VOLUME (MPV): A NEW PREDICTOR OF PULMONARY FINDINGS AND SURVIVAL IN CCHF PATIENTS?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Crimean-Congo Hemorrhagic Fever; Mean Platelet Volume; Chest X-ray; Paranchymal Infiltration; Pleural Effusion,CONGO HEMORRHAGIC-FEVER,"Background: Crimean-Congo Hemorrhagic Fever (CCHF) is a viral zoonotic disease caused by infection with Nairoviruses in the Bunyaviridae family. The virus is transmitted to people by vectors such as ticks. Despite how little is known about the disease's pathophysiology, management of the clinical period, and developments in treatment, it is known that proinflammatory parameters and cytokines are important in the pathophysiology and clinical follow-up of viral hemorrhagic diseases with fever. Among these, the number of platelets, neutrophils, and lymphocytes is important in diagnosis and clinical follow-up. There is a lot of information concerning how low platelet number is directly related to mortality and survival. Mean platelet volume (MPV) is a parameter showing platelet activation and function; therefore, it is a significant finding showing platelet maturation. For that reason, it can be claimed that platelet activation plays an important role in CCHF. Materials and methods: A total of 209 patients who were diagnosed as CCHF between May 2010 and September 2015 and whose lungs were examined during admission were retrospectively involved in the study. The patients' demographic features, clinical findings and follow-ups, laboratory findings, radiological examinations of lung, and surveys were retrospectively examined. Results: The 209 cases involved in the study consisted of 127 male (60.8%) and 82 female (39.2%) patients. Mean age was as 52 +/- 18 years. Ferritin, procalcitonin, and CRP, which are related to inflammation, were high compared to the normal reference range, too. Mean platelets and leukocytes in hemogram were 56.200/mu L +/- 44.800 and 3.070/mu L +/- 2.930, respectively. Average MPV values in nonsurvival and survival groups were 11.50 fL +/- 2.74 fL and 10.44 fL +/- 2.40 fL, respectively. Conclusions: The comparison of MPV between the survival and nonsurvival groups was found to be statistically significant (p<0.05) in CCHF. MPV can be used as a new and important clinical follow-up parameter for clinical observation of patients diagnosed with CCHF in terms of both survival and radiological findings.","[Aktas, Turan] Gaziosmanpasa Univ, Sch Med, Pulmonar Med Dept, Tokat, Turkey; [Aktas, Fatma; Ozmen, Zafer] Gaziosmanpasa Univ, Sch Med, Dept Radiol, Tokat, Turkey; [Ozmen, Cansel] Gaziosmanpasa Univ, Sch Med, Dept Clin Biochem, Tokat, Turkey; [Kaya, Turan] Tokat State Hosp, Infect & Clin Microbiol Dept, Tokat, Turkey; [Demir, Osman] Gaziosmanpasa Univ, Sch Med, Dept Stat, Tokat, Turkey","Aktas, T (corresponding author), Gaziosmanpasa Univ, Sch Med, Dept Pulm Med, Tokat, Turkey.",,,,,,"Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.; Bancroft AJ, 2000, PLATELETS, V11, P37; Ekiz F, 2013, CLIN APPL THROMB-HEM, V19, P441, DOI 10.1177/107602961244003; Ergonul O, 2006, CLIN MICROBIOL INFEC, V12, P551, DOI 10.1111/j.1469-0691.2006.01445.; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P4; Gozutok F., 2015, ACTA MED ANAT, V3, P; Inci A, 2015, J CLIN ANAL MED, V6, P1, DOI 10.4328/JCAM.227; Mardani M, 2007, ARCH IRAN MED, V10, P20; Oncu Serkan, 2013, Virologica Sinica, V28, P193, DOI 10.1007/s12250-013-3327-; Park Y, 2002, PLATELETS, V13, P301, DOI 10.1080/09537100222014833; Parlak E., 2015, JMID, V5, P5; SWANEPOEL R, 1989, REV INFECT DIS, V11, pS79; Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/51428",14,2,2,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,183.0,190,,10.19193/0393-6384_2017_2_026,,8,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700001,,,,,2022-07-14,0.001446280991735537,6.792787550842174e-20,0.005109159016926122,0.07503236158157056,0.005864770831272409
J,"Akyol, M1;  Kara, M;  Alacacioglu, A;  Demir, L;  Ellidokuz, H;  Kucukzeybek, Y;  Yildiz, Y;  Bayoglu, V;  Yildiz, I;  Salman, T;  Varol, U;  Kucukzeybek, B;  Oflazoglu, U;  Taskaynatan, H;  Gumus, Z;  Tarhan, MO",,,,"Akyol, Murat; Kara, Mete; Alacacioglu, Ahmet; Demir, Leyla; Ellidokuz, Hulya; Kucukzeybek, Yuksel; Yildiz, Yasar; Bayoglu, Vedat; Yildiz, Ibrahim; Salman, Tarik; Varol, Umut; Kucukzeybek, Betul; Oflazoglu, Utku; Taskaynatan, Halil; Gumus, Zehra; Tarhan, Mustafa Oktay",,,THE EFFECTS OF ADJUVANT CHEMOTHERAPY ON SERUM ADMA AND ENDOTHELIN-1 LEVELS IN EARLY STAGE BREAST CANCER PATIENTS ( IZMIR ONCOLOGY GROUP (IZOG) STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,ADMA; Endothelin-1; early stage breast cancer; adjuvant chemotherapy,NITRIC-OXIDE SYNTHASE; BODY-COMPOSITION CHANGE; WEIGHT-GAIN; ASYMMETRIC DIMETHYLARGININE; ENERGY-BALANCE; WOMEN; DIMETHYLAMINOHYDROLASE; SURVIVAL; DYSFUNCTION; DOXORUBICIN,"Objective: We aimed to investigate changes in body composition, serum asymmetric dimethyl arginine (ADMA) and endothelin-1(ET-1) levels before and after adjuvant chemotherapy in early breast cancer patients. Methods: Seventy-two patients with early breast cancer who admitted to our outpatient clinic were included in the study. Before and after chemotherapy, the anthropometric measurements and bioelectrical impedance analysis with TANITA device, body compositions, serum ADMA and ET-1 levels were recorded. Results: There was a statistically significant increase of serum ADMA levels (112.10 +/- 52.24 ng/ml vs. 206.34 +/- 128.02 ng/ml, p<0.001) after chemotherapy. On the other hand, the decrease of serum ET-1 levels was not statistically significant (2.19 +/- 6.65 vs. 1.68 +/- 3.71, p=0.57). ADMA levels was similar in both of the groups treated with anthracycline or anthracycline plus taxane regimens. There was no relationship between serum ADMA levels and disease stage/grade, hormone or nodal status. The changes in body composition and antropometric measurements were not statistically significant. Conclusion: The increased serum levels of ADMA could be caused by the oxidative stress, apoptosis and endothelial dysfunction secondary to chemotherapy and the decreased estrogen levels. The decrease in serum ET-1 levels might be due to the inhibition of cell proliferation and angiogenesis due to adjuvant chemotherapy.","[Akyol, Murat] Manisa State Hosp, Dept Med Oncol, Manisa, Turkey; [Kara, Mete; Alacacioglu, Ahmet; Kucukzeybek, Yuksel; Yildiz, Yasar; Bayoglu, Vedat; Yildiz, Ibrahim; Salman, Tarik; Varol, Umut; Oflazoglu, Utku; Taskaynatan, Halil; Gumus, Zehra] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Med Oncol, Izmir, Turkey; [Demir, Leyla] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Biochem, Izmir, Turkey; [Ellidokuz, Hulya; Tarhan, Mustafa Oktay] Dokuz Eylul Univ, Inst Oncol, Izmir, Turkey; [Kucukzeybek, Betul] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Pathol, Izmir, Turkey","Alacacioglu, A (corresponding author), Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Med Oncol Clin, TR-35360 Izmir, Turkey.",,"akyol, murat/AAV-5418-2021; DEMÄ°R, LEYLA/ABH-5523-2020; Yildiz, Ibrahim/AAF-9885-2019; Ellidokuz, HÃ¼lya/Q-4049-2019; yildiz, ibrahim/C-9144-2014","akyol, murat/0000-0003-0886-3559; Ellidokuz, HÃ¼lya/0000-0001-8503-061X; ",,,"Abe O, 2005, LANCET, V366, P208; Alacacioglu A, 2010, J BUON, V15, P57; Aslani A, 1999, BREAST CANCER RES TR, V57, P285, DOI 10.1023/A:100622051059; Bagnato Anna, 2004, J Transl Med, V2, P16, DOI 10.1186/1479-5876-2-1; Bhalla A, 2009, EUR J CLIN INVEST, V39, P74, DOI 10.1111/j.1365-2362.2009.02123.; BRISTOW MR, 1978, AM J MED, V65, P823, DOI 10.1016/0002-9343(78)90802-; CAMORIANO JK, 1990, J CLIN ONCOL, V8, P1327, DOI 10.1200/JCO.1990.8.8.132; CHLEBOWSKI RT, 1986, BREAST CANCER RES TR, V7, P23, DOI 10.1007/BF0188673; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.15490; COBBS CS, 1995, CANCER RES, V55, P72; Conklin KA, 2000, NUTR CANCER, V37, P1, DOI 10.1207/S15327914NC3701_; Demark-Wahnefried W, 2001, J CLIN ONCOL, V19, P2381, DOI 10.1200/JCO.2001.19.9.238; Demark-Wahnefried W, 2008, CLIN BREAST CANCER, V8, P70, DOI 10.3816/CBC.2008.n.00; DEMARKWAHNEFRIED W, 1993, J CLIN ONCOL, V11, P1418, DOI 10.1200/JCO.1993.11.7.141; DemarkWahnefried W, 1997, J AM DIET ASSOC, V97, P519, DOI 10.1016/S0002-8223(97)00133-; Dirican A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0905-; Fleming I, 2005, CARDIOVASC RES, V65, P897, DOI 10.1016/j.cardiores.2004.11.00; Freedman RJ, 2004, J CLIN ENDOCR METAB, V89, P2248, DOI 10.1210/jc.2003-03187; Gallo O, 1998, J NATL CANCER I, V90, P587, DOI 10.1093/jnci/90.8.58; Goodwin PJ, 1999, J CLIN ONCOL, V17, P120, DOI 10.1200/JCO.1999.17.1.12; Grant K, 2003, BRIT J CANCER, V88, P163, DOI 10.1038/sj.bjc.670075; HEASMAN KZ, 1985, BREAST CANCER RES TR, V5, P195, DOI 10.1007/BF0180599; Holden DP, 2003, CIRCULATION, V108, P1575, DOI 10.1161/01.CIR.0000091083.61609.D; Hung CH, 2015, TOXICOL SCI, V145, P59, DOI 10.1093/toxsci/kfv01; Ingram C, 2004, CANCER NURS, V27, P48; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.286; KAYE DM, 1994, CLIN EXP PHARMACOL P, V21, P709, DOI 10.1111/j.1440-1681.1994.tb02574.; Kostourou V, 2002, BRIT J CANCER, V87, P673, DOI 10.1038/sj.bjc.660051; Kroenke CH, 2005, J CLIN ONCOL, V23, P1370, DOI 10.1200/JCO.2005.01.07; Krzyzanowska K, 2004, J CLIN ENDOCR METAB, V89, P6277, DOI 10.1210/jc.2004-067; Kutynec CL, 1999, J AM DIET ASSOC, V99, P1222, DOI 10.1016/S0002-8223(99)00301-; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.21226979; Levine MN, 2006, NEW ENGL J MED, V355, P1920, DOI 10.1056/NEJMe06820; Li H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.34; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM19910321324120; MUKHOPADHYAY M G, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P25; Murata T, 2001, LIFE SCI, V69, P2685, DOI 10.1016/S0024-3205(01)01352-; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr290; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI [10.3322/caac.21254, 10.1001/jamaoto.2014.2530, 10.3322/caac.21208, 10.1136/bmj.g1502; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI11870; Szuba A, 2008, LEUKEMIA LYMPHOMA, V49, P2316, DOI 10.1080/1042819080251032; THOMSEN LL, 1994, CANCER RES, V54, P135; Tsai KL, 2011, MOL NUTR FOOD RES, V55, pS227, DOI 10.1002/mnfr.20110014; Tsuda K, 2004, CIRCULATION, V109, pE35, DOI 10.1161/01.CIR.0000115213.34702.5; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.2; VALLANCE P, 1992, J CARDIOVASC PHARM, V20, pS60, DOI 10.1097/00005344-199204002-0001; Vassilakopoulou M, 2010, VASC PHARMACOL, V53, P115, DOI 10.1016/j.vph.2010.05.00; Villela Nivaldo Ribeiro, 2006, Clinics, V61, P53, DOI 10.1590/S1807-5932200600010001; Wulfing P, 2004, BRIT J CANCER, V91, P434, DOI 10.1038/sj.bjc.660188; Wulfing P, 2003, CLIN CANCER RES, V9, P412",50,1,1,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,557.0,564,,10.19193/0393-6384_2017_4_081,,8,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700002,,,,,2022-07-14,0.005165289256198347,4.766397831238713e-18,0.010098863604344073,0.07462859169371439,0.010098863604344073
J,"Aliverti, M21;   Gorini, I;   Borgo, M;   Licata, M;   Martini, M;   Vecchio, I;   Tornali, C",,,,"Aliverti, Massimo; Gorini, Ilaria; Borgo, Melania; Licata, Marta; Martini, Mariano; Vecchio, Ignazio; Tornali, Cristina",,,ON TWO ITALIAN PUBLICATIONS BY THE CUBAN ANTHROPOLOGIST FERNANDO ORTIZ (1881-1969),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Fernando Ortiz; criminal anthropology; criminal superstitions,,"Fernando Ortiz was a Cuban anthropologist as well as one of the most prominent figures in 20th-century Latin-American culture. His interests spanned from law to criminology, from anthropology to sociology, from psychology to ethnomedicine, and from folklore to musicology. In this paper, we will focus on two essays that he wrote in Italian, Criminality of the Black in Cuba and Criminal superstitions in Cuba. Noteworthy is the relationship between Ortiz and the Italian school of criminology. He spent several years in Genoa where he met Cesare Lombroso, one of the leading figures of the positive school. Ortiz drew inspiration from Cesare Lombroso and contextualised these ideas in Cuban society.","[Aliverti, Massimo] Univ Insubria, Varese, Italy; [Gorini, Ilaria; Borgo, Melania; Licata, Marta] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Vecchio, Ignazio] Univ Catania, Dept Clin & Expt Med, Catania, Italy; [Tornali, Cristina] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Licata, Marta] Univ Genoa, Sect Hist Med & Eth, Dept Hlth Sci DISSAL, Genoa, Italy","Vecchio, I (corresponding author), Univ Catania, Policlin, Via Santa Sofia 78, Catania, Italy.",,"; Tornali, Cristina/M-5187-2017","Vecchio, Ignazio/0000-0001-5942-1908; Tornali, Cristina/0000-0002-1722-5498",,,"Aliverti M., 2001, RIV ITALIANA SCI TRA, V1, P; Borgo M, 2017, ACTA MEDICA MEDITERR, V33, P95, DOI 10.19193/0393-6384_2017_1_01; Iznaga Diana, 1989, TRANSCULTURACION FE; Licata M, 2016, ACTA MEDICA MEDITERR, V32, P1569, DOI 10.19193/0393-6384_2016_5_13; Matos Arevalos Jose, 1999, HIST FERNANDO ORTI; Ortiz F, 1998, MISCELANEA 2 STUDIE; Riva V, 1982, ESTATE VARADERO ORT",7,2,2,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,471.0,474,,10.19193/0393-6384_2017_3_069,,4,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200017,,,,,2022-07-14,0.0007231404958677686,7.208716907836619e-05,0.0011358406501593722,0.09629062260641208,0.0011358406501593722
J,"Atalay, H1;  Boyuk, B;  Guzel, S;  Altay, M;  Kiziler, AR;  Aydemir, B",,,,"Atalay, Hande; Boyuk, Banu; Guzel, Savas; Altay, Murat; Kiziler, Ali Riza; Aydemir, Birsen",,,SERUM TRACE ELEMENTS IN TYPE 2 DIABETES MELLITUS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Diabetes; trace elements; HbA1C,MAGNESIUM-DEFICIENCY; INSULIN-RESISTANCE; OXIDATIVE STRESS; ZINC; COPPER; HYPOMAGNESEMIA; PATHOGENESIS; METABOLISM; MANGANESE; FERRITIN,"Studies suggested that imbalances of several trace elements may play an important role in normal glucose and insulin metabolism. The aim of the present study was to evaluate changes in serum levels of copper, zinc, iron, and magnesium in patients with type 2 diabetes mellitus (T2DM) and their effect on glycemic control. Sixty female patients with T2DM and seventeen healthy subjects were enrolled in this study. Fasting plasma samples were obtained from the patient and control groups. Trace elements were studied using an atomic absorption spectrometer. Correlation analyses of trace elements with metabolic parameters were analyzed using Spearman's Rho correlation coefficient. T2DM patients had a significantly high fasting plasma glucose, glycated hemoglobin (HbA1C), and microalbuminuria levels (p< 0.05). Serum magnesium levels were significantly lower in patients with T2DM compared with the healthy controls (2.0 +/- 0.2 ng/mL vs. 2.3 +/- 0.2 ng/mL, p< 0.05). Serum copper levels showed a negative correlation with diabetes duration (r= -0.338, p= 0.011), and iron levels were negatively correlated with body mass index and C-reactive protein (r= -0.407, p= 0.009; r= -0.390, p= 0.017). Serum magnesium levels indicated a correlation with HbA1C and creatinine clearance (r= -0.371, p= 0.049; r= -0.462, p= 0.023), but no significant correlation was found with any of the other variables and zinc levels. The present study found low levels of magnesium, iron, copper, and zinc in women with T2DM, which supports a close relationship of the above trace elements with glucose metabolism. Low magnesium levels has been linked to poor glycemic control in T2DM; therefore, magnesium deficiency should be prevented in patients with diabetes.","[Atalay, Hande] Gebze Fatih Govt Hosp, Internal Med Dept, Kocaeli, Turkey; [Boyuk, Banu; Altay, Murat] Gaziosmanpasa Taksim Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey; [Guzel, Savas] Namik Kemal Univ, Dept Biochem, Tekirdag, Turkey; [Kiziler, Ali Riza] Namik Kemal Univ, Dept Biophys, Tekirdag, Turkey; [Aydemir, Birsen] Sakarya Univ, Dept Biophys, Med Fac, Adapazari, Turkey","Atalay, H (corresponding author), Gebze Fatih Govt Hosp, Internal Med Dept, Kocaeli, Turkey.",,"erman, hande/AAP-6507-2021; erman, hande/AAZ-7697-2021; Boyuk, Banu/GLN-8251-2022; BOYUK, BANU/ABA-7026-2021","erman, hande/0000-0001-7213-9624; erman, hande/0000-0001-7213-9624; Boyuk, Banu/0000-0001-7794-4411; ",,,"Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.2883; Barbagallo M, 2007, ARCH BIOCHEM BIOPHYS, V458, P40, DOI 10.1016/j.abb.2006.05.00; BENNETT PH, 1994, JOSLINS DIABETES MEL, P19; Canturk Z, 2003, ENDOCR RES, V29, P299, DOI 10.1081/ERC-12002503; Chutia Happy, 2015, J Lab Physicians, V7, P75, DOI 10.4103/0974-2727.16313; Cohen A M, 1986, Pancreas, V1, P309, DOI 10.1097/00006676-198607000-0000; Friederich M, 2009, CURR DIABETES REV, V5, P120, DOI 10.2174/15733990978816680; Hadjistavri LS, 2010, MED SCI MONITOR, V16, pCR30; Jansen J, 2009, J NUTR BIOCHEM, V20, P399, DOI 10.1016/j.jnutbio.2009.01.00; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.00023; Khan AR, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-1; Kisters K, 2000, TRACE ELEM ELECTROLY, V17, P6; MA J, 1995, J CLIN EPIDEMIOL, V48, P927, DOI 10.1016/0895-4356(94)00200-; Makhlough A, 2015, NEPHROUROL MON, V7, DOI DOI 10.5812/NUMONTH-LY.2857; Fernandez-Real JM, 2015, DIABETES CARE, V38, P2169, DOI 10.2337/dc14-308; MCNAIR P, 1978, DIABETES, V27, P1075, DOI 10.2337/diabetes.27.11.107; Miao X, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/42585; Miller JM, 2005, CLIN NEPHROL, V64, P24; MOORADIAN AD, 1994, DIABETES CARE, V17, P464, DOI 10.2337/diacare.17.5.46; NADLER JL, 1993, HYPERTENSION, V21, P1024, DOI 10.1161/01.HYP.21.6.102; NOTO R, 1983, ACTA DIABETOL LAT, V20, P81, DOI 10.1007/BF0262913; PAOLISSO G, 1986, DIABETOLOGIA, V29, P644, DOI 10.1007/BF0086926; Pham PCT, 2005, CLIN NEPHROL, V63, P42; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.0296090; PIDDUCK HG, 1970, DIABETES, V19, P234, DOI 10.2337/diab.19.4.23; Prabodh S, 2011, BIOL TRACE ELEM RES, V142, P29, DOI 10.1007/s12011-010-8750-; Ranasinghe P, 2015, DARU, V23, DOI 10.1186/s40199-015-0127-; Sales CH, 2011, CLIN NUTR, V30, P359, DOI 10.1016/j.clnu.2010.12.01; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.95; Sheu WHH, 2003, CLIN ENDOCRINOL, V58, P380, DOI 10.1046/j.1365-2265.2003.01729.; Tilbrook Louise, 2004, Ann Clin Biochem, V41, P25; Viktorinova A, 2009, METABOLISM, V58, P1477, DOI 10.1016/j.metabol.2009.04.03; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-001; WALTER RM, 1991, DIABETES CARE, V14, P1050, DOI 10.2337/diacare.14.11.105; Walti MK, 2003, AM J CLIN NUTR, V78, P44; Zargar AH, 1998, POSTGRAD MED J, V74, P665, DOI 10.1136/pgmj.74.877.66",37,4,4,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,795.0,800,,10.19193/0393-6384_2017_5_117,,6,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000011,,,,,2022-07-14,0.003822314049586777,8.890783154956202e-10,0.013376065931269793,0.09195140254386215,0.013376065931269793
J,"Aykas, F1;  Avci, D;  Arik, F;  Cetinkaya, A;  Kolagasi, O;  Ozen, M;  Oguz, A;  Unal, A;  Uslu, E;  Arik, BE",,,,"Aykas, Fatma; Avci, Deniz; Arik, Ferhat; Cetinkaya, Ali; Kolagasi, Oykun; Ozen, Mustafa; Oguz, Arzu; Unal, Aydin; Uslu, Emine; Arik, Bade Erturk",,,THERE IS A RELATION BETWEEN BLOOD SUBGROUPS AND INSULIN RESISTANCE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,insulin resistance; ABO blood subgroups; Rh system; HOMA-IR,DIABETES-MELLITUS; ADIPOSE-TISSUE; GROUP-AB; OBESITY; RISK; DISEASE; CANCER,"Objective: Effects of concomitance of genetic factors with diabetes mellitus have been researched for a long time. We investigated relationship between insulin resistance and ABO/Rh blood group systems, which has not been investigated before. Material and method: In the present study, medical files of patients who applied to outpatient clinics of Endocrinology and Metabolism, Internal Medicine and Diabetes at Kayseri Training and Research Hospital between dates September 2010 and March 2015, and who had been studied for, but not diagnosed with diabetes mellitus, were retrospectively evaluated. Among patients, those with HOMA-IR >= 2.5 were accepted as having insulin resistance, and enrolled in the study. Patient whose blood groups were recorded in the hospital records or blood groups were determined later during control visits. The control group composed of healthy individuals who applied to the same hospital. Results: When compared with the control group, blood type A was significantly higher in patients with insulin resistance (p=0.022). The adjusted p value was 0.264 when Bonferroni correction was used. Blood type O group was also determined less significantly higher in patients with insulin resistance (p=0.055). The adjusted p value was 0.060. No significant difference was determined in blood types B and AB (p=0.49 and 0.12, respectively). Blood type A Rh (+) was 45.2% in patients with IR whereas 37.2% in the control group (p=0.030, adj. p=0.360). Blood type 0 Rh (+) was significantly higher in the control group (p< 0.001, adj. p< 0.001). Conclusion: These data suggest that individuals with blood type A are more directly related with insulin resistance, while those with type O are less directly related with insulin resistance in Turkish population.","[Aykas, Fatma; Kolagasi, Oykun] Antalya Training & Res Hosp, Dept Hematol, Antalya, Turkey; [Avci, Deniz; Arik, Ferhat; Cetinkaya, Ali; Ozen, Mustafa; Oguz, Arzu; Uslu, Emine] Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey; [Unal, Aydin] Univ Erciyes, Dept Nephrol, Kayseri, Turkey; [Arik, Bade Erturk] Univ Erciyes, Dept Family Practice, Kayseri, Turkey","Arik, F (corresponding author), Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey.",,"Oguz, Arzu/W-8004-2019","Oguz, Arzu/0000-0001-6512-6534",,,"Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-26185; Bener A, 2014, NIGER J CLIN PRACT, V17, P565, DOI 10.4103/1119-3077.14141; Fagherazzi G, 2015, DIABETOLOGIA, V58, P519, DOI 10.1007/s00125-014-3472-; Franchini M, 2014, THROMB HAEMOSTASIS, V112, P1103, DOI 10.1160/TH14-05-045; Gates MA, 2011, INT J CANCER, V128, P482, DOI 10.1002/ijc.2533; Hiltunen LM, 2009, THROMB RES, V124, P167, DOI 10.1016/j.thromres.2008.11.01; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI11793; Jassim W. E., 2012, Eastern Mediterranean Health Journal, V18, P88; KANAZAWA Y, 1983, Tohoku Journal of Experimental Medicine, V141, P29; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M70676220; Ohno Y, 2015, INT J CLIN EXP MED, V8, P264; Okon U A, 2008, Niger J Physiol Sci, V23, P; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/61619; Pourafkari L, 2015, PERFUSIO; Qureshi MA, J COL; Sahi MD, 2011, S AFR FAM PRACT, V53, P568, DOI 10.1080/20786204.2011.1087415; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.00; Tahir, 2012, ANN PAK I MED SCI, V8, P13; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-159; Wang DS, 2012, INT J CANCER, V131, P461, DOI 10.1002/ijc.2637; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI20031924; Zhang CP, 2015, DIABETES-METAB RES, V31, P627, DOI 10.1002/dmrr.265",22,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,987.0,990,,10.19193/0393-6384_2017_6_156,,4,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500015,,,,,2022-07-14,0.0022727272727272726,2.980821184625724e-11,0.004224751889288059,0.10557427826674956,0.004220599756215785
J,"Bacarea, A1;  Romila, A;  Petrisor, DV;  Costea, GC;  Bui, L;  Bacarea, V",,,,"Bacarea, Anca; Romila, Aurelia; Petrisor, Dana Valentina; Costea, George Claudiu; Bui, Lucia; Bacarea, Vladimir",,,"OCCUPATIONAL WORK EXPOSURE TO HEPATITIS B VIRUS INFECTION IN THE EMERGENCY COUNTY CLINICAL HOSPITAL, TIRGU MURES, ROMANIA",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,hepatitis B viral infection; HBsAg; HBsAb; health care workers; occupational work exposure,HEALTH-CARE WORKERS; BODY-FLUIDS; BLOOD; RISKS,"Introduction: One of the ways of transmission of hepatitis B viral infection is occupational exposure and health care workers (HCWs) are exposed to the risk of acquiring HBV infection. The aim of our study is to assess the occupational exposure to HBV infection, in the HCWs of the Emergency County Clinical Hospital Tirgu Mures, Romania. Materials and methods: The study was conducted retrospectively on a sample of 524 HCWs, between January 2010 and December 2014, who accidentally came into contact with blood or other body fluids from patients admitted in the Emergency County Clinical Hospital Tirgu Mures, Romania. We persuaded the source patients for the following markers: HBsAg, HCVAb and the HCWs for the following markers: HBsAg, HBsAb, HCVAb, HIVAb. Depending on the tests results and after subjects has given their consent for vaccination and counseling, vaccination was planned at 1 month, 3 months and 6 months. Results: The annual rate of HBV infections occurring in health care workers ranged from 0.78% to 2.88%. The highest proportion of occupational work exposure occurred among physicians (41.6%) and nurses (32.44%). The HCWs working in surgical departments, reported the highest occupational work exposure (44.85%). The adherence to follow-up decreased significantly from the 1 month scheduled serological testing, to the 3 and 6 months testing (p< 0.0001). Conclusion: Educational programs, implementation and adherence to more safety precautions for HCWs will help to decrease the frequency of occupational work exposure. Administration of hepatitis B vaccine to HCWs early in their careers can prevent HBV infection associated with occupational work exposure.","[Bacarea, Anca; Costea, George Claudiu] Univ Med & Pharm, Dept Pathophysiol, Targu Mures, Romania; [Romila, Aurelia] Univ Dunarea de Jos, Fac Med, Dept Clin Med, 1 Vadu Sacalelor St,Bl Pescarus,Ap 8, Galati, Romania; [Romila, Aurelia] Galati Cty Hosp, Clin Geriatr Dept, Targu Mures, Romania; [Petrisor, Dana Valentina; Bacarea, Vladimir] Univ Med & Pharm, Med Res Methodol Dept, Targu Mures, Romania; [Bui, Lucia] Emergency Cty Hosp, Surveillance & Control Nosocomial Infect Dept, Targu Mures, Romania","Romila, A (corresponding author), Univ Dunarea de Jos, Fac Med, Dept Clin Med, 1 Vadu Sacalelor St,Bl Pescarus,Ap 8, Galati, Romania.",,"Bacarea, Anca/AAW-9459-2020",,,,"[Anonymous], 2011, COUNTRY MISSION ROM; Batra V, 2015, ANN GASTROENTEROL, V28, P27; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.00; Butsashvili M, 2012, OCCUP MED-OXFORD, V62, P620, DOI 10.1093/occmed/kqs12; Coppola N, 2016, WORLD J HEPATOL, V8, P273, DOI 10.4254/wjh.v8.i5.27; Dement JM, 2004, AM J IND MED, V46, P637, DOI 10.1002/ajim.2010; Gheorghe L, 2013, EUR J GASTROEN HEPAT, V25, P56, DOI 10.1097/MEG.0b013e328358b0b; Homoud AHA, 2014, J INFECT PUBLIC HEAL, V7, P257, DOI 10.1016/j.jiph.2013.08.00; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.2151; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.00; Markovc-Denic L, 2013, SRP ARK CELOK LEK, V141, P789, DOI 10.2298/SARH1312789; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-91564; Minuk G Y, 2005, HPB (Oxford), V7, P56, DOI 10.1080/1365182041001663; Nardone A, 2009, EPIDEMIOL INFECT, V137, P961, DOI 10.1017/S095026880800167; Rice BD, 2015, OCCUP MED-OXFORD, V65, P210, DOI 10.1093/occmed/kqu20; Schillie S, 2013, MMWR RECOMM REP, V62, P; Vieira D, 2015, ANN OCCUP HYG, V59, P566, DOI 10.1093/annhyg/meu11",18,1,1,1,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,1.0,,,,,17.0,21,,10.19193/0393-6384_2017_1_002,,5,"Medicine, General & Internal",General & Internal Medicine,EP2PY,WOS:000397226800002,,,,,2022-07-14,0.001859504132231405,1.1671425118699838e-11,0.00559743417987367,0.10344864437391128,0.005575929485236409
J,"Balkan, A1;  Guelsen, MT;  Kaya, B",,,,"Balkan, Ayhan; Guelsen, Murat Taner; Kaya, Buenyamin",,,"SERUM MICRORNA-26, MICRORNA-122 AND MICRORNA-192 EXPRESSIONS IN HEPATOCELLULAR CARCINOMA",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Hepatocellular carcinoma; microRNA-26; microRNA-122; microRNA-192,HEPATITIS-B-VIRUS; CIRCULATING MICRORNAS; ALPHA-FETOPROTEIN; CANCER; IDENTIFICATION; METASTASIS; BIOMARKERS; DIAGNOSE; PLASMA,"Introduction: There is not yet an ideal biomarker to detect hepatocellular carcinoma (HCC) in early stage. MicroRNA (miRNA) dysregulation in HCC results in inhibition of cellular apoptosis, increased angiogenesis, invasion and development of metastasis. The aim of the present study was to evaluate the efficacy of serum miRNA-26, miRNA-122 and miRNA-192 levels in diagnosis of HCC compared to other prognostic criteria. Materials and methods: The study included newly diagnosed HCC patients (n=42) and patients with non-alcoholic fatty liver disease (NAFLD) as controls (n=45). We measured serum miRNA-26, miRNA-122 and miRNA-192 levels for each patient. Results: Serum levels of miRNA-26 were significantly lower in HCC patients (29.03) than those in control group (30.34) (p<0.001). There was no significant difference in serum levels of miRNA-122 between the two groups (p=0.181). MiRNA-192 was not expressed as assessed by the real-time PCR method. For diagnosis of HCC, cut-off value was set at 29.38 for miR-26. With this cut-off value, sensitivity was 71.4%, and specificity was 82.2%, while positive and negative predictive values were 78.9% and 75.5%, respectively (p<0.0001). We also compared the miRNA-26 and miRNA-122 levels of patients with other diagnostic, clinical and prognostic data, which are significant for HCC. No statistically significant correlation was found between alpha-fetoprotein (AFP) and miRNA122 and miRNA-26 gene expressions. Conclusions: Serum levels of miRNA-26 may contribute to early diagnosis of HCC when used together with other diagnostic, clinical and prognostic markers.","[Balkan, Ayhan; Guelsen, Murat Taner] Gazi Univ, Fac Med, Dept Gastroenterol, Gaziantep TR-27310, Turkey; [Kaya, Buenyamin] Gazi Univ, Fac Med, Dept Internal Med, Gaziantep TR-27310, Turkey","Balkan, A (corresponding author), Gazi Univ, Fac Med, Dept Gastroenterol, Gaziantep TR-27310, Turkey.",,,,Scientific Research Fund by Gaziantep University [BAP- TF.UT.16.07],All authors thank to Scientific Research Fund by Gaziantep University for their financial support (Project no. BAP- TF.UT.16.07).,"Badvie S, 2000, POSTGRAD MED J, V76, P4, DOI 10.1136/pmj.76.891.; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.03; Carr BI, 2007, DIGEST DIS SCI, V52, P776, DOI 10.1007/s10620-006-9541-; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ; Dienstag JL, 2012, HARRISONS PRINCIPLES, V18; Durand F, 2001, J HEPATOL, V35, P254, DOI 10.1016/S0168-8278(01)00108-; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.02; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.01; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms134; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.02; Liu SP, 2012, J HEPATOL, V56, P389, DOI 10.1016/j.jhep.2011.08.00; Liu Z, 2008, INT J MOL SCI, V9, P978, DOI 10.3390/ijms906097; Okuda K, 1992, PRIMARY LIVER CANC J, P; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.144; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.01; Piluso A, 2015, HEPATOL INT, V9, P586, DOI 10.1007/s12072-015-9658-; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.002848; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-1; Sun J, 2013, SCI WORLD J, DOI 10.1155/2013/92420; Takizawa D, 2007, DIGEST DIS SCI, V52, P3290, DOI 10.1007/s10620-007-9808-; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.2280; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.081337110; Wang Y, 2016, TUMOUR BIO; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.2245; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.2071; Yuen MF, 2004, HEPATOLOGY, V39, P1694, DOI 10.1002/hep.2024; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.269; Zinkin NT, 2008, CLIN CANCER RES, V14, P470, DOI 10.1158/1078-0432.CCR-07-058",29,2,2,1,13,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,1.0,,,,,165.0,172,,10.19193/0393-6384_2017_1_025,,8,"Medicine, General & Internal",General & Internal Medicine,EP2PY,WOS:000397226800025,,,,,2022-07-14,0.002995867768595041,1.1759319671270689e-11,0.07850902396685676,0.1045232207837082,0.07850902396685676
J,"Bovand, T1;  Vatanpour, H;  Mousavi, Z",,,,"Bovand, Tannaz; Vatanpour, Hossein; Mousavi, Zahra",,,THE PROTECTIVE EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR (GCSF) ON PHENOBARBITAL TOXICITY IN MOUSE FETUS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,GCSF; Phenobarbital; prevention; mice fetuswith language disorders,ANTIEPILEPTIC DRUGS; TERATOGENICITY; PREGNANCY; MICE; PHENYTOIN; THERAPY; TUMOR; TRIAL; CSF,"Introduction: GCSF is a drug That is prescribed for growing the stimulation either in some of immune system diseases or anticoncern drug users. In this study, the researchers reflected on the GCSF's effects on different organs in pregnant mice. Then, using safe doses for mother and fetus, it was applied either as a growing stimulator or a neutralizer factor for negative effects of such teratogenicity drugs as Phenobarbital. Using Phenobarbital during pregnancy can increase the possibility of abnormalities in infants like cleft palate, heart abnormalities and weight reduction in birthday. The purpose of this research is Studying the possible protective effect of GCSF against teratogenic effects of Phenobarbital in mice fetus. Method: 120 mg/kg of Phenobarbital within GCSF in different doses was injected to the mice on 9th day of gestation. Their fetuses were then brought out of uterus on 15th day of gestation and were examined by microscopic and macroscopic methods. Findings: Although it was observed that 1.63 mu g/mL of GCSF amended the cleft palate in mice fetus (P<0.05), other doses of GCSF (3.25, 7.75, 12, 15 mu g/mL) yielded no difference in the cleft palate occurrence or its amendment in mice fetus. Results: The results of the present study showed that GCSF may have the teratogenicity effects of Phenobarbital in cleft palate and will prevent its occurrence.","[Bovand, Tannaz; Mousavi, Zahra] Islamic Azad Univ, Pharmaceut Sci Branch, Fac Pharm, Dept Pharmacol & Toxicol,IAUPS, Tehran, Iran; [Vatanpour, Hossein] Med Sci Univ Shahid Beheshti, Sch Pharm, Toxicol & Pharmacol Dept, Tehran, Iran","Vatanpour, H (corresponding author), Med Sci Univ Shahid Beheshti, Sch Pharm, Toxicol & Pharmacol Dept, Tehran, Iran.",,"Mousavi, Zahra/AAO-3117-2021","Mousavi, Zahra/0000-0001-6524-491X","Toxicology and Pharmacology Lab., School of Pharmacy, Medical Science University of Shahid Beheshti, Tehran, Iran","The authors thank the Toxicology and Pharmacology Lab., School of Pharmacy, Medical Science University of Shahid Beheshti, Tehran, Iran for supporting this project. Thanks to Akbar Shirini, Baharak Mohammad Zadeh Asl, Saba Vatanpour for their many helpful comments on this paper.","Afshar M., 2002, RAZI J MED SCI, V8, P52; Andermann E., 1982, EPILEPSY PREGNANCY C, P23; CHAOUAT G, 1990, J REPROD FERTIL, V89, P44; Clark DA, 1999, AM J REPROD IMMUNOL, V41, P23; Finnell RH, 1995, TERATOLOGY, V52, P324, DOI 10.1002/tera.142052060; Finnell RH, 1997, DRUG TOXICITY EMBRYO, P12; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.210; Gorivodsky M, 1999, CLIN EXP IMMUNOL, V117, P54; Heidari M., 2000, CLONING EXPRESSION ; HERNANDEZDIAZ S, 2001, OBSTET GYNECOLOGICAL, V56, P25; HOLDER M, 1990, MONATSSCHR KINDERH, V138, P3; LAWRENCE A, 1963, BRIT MED J, P126; Liles WC, 1997, TRANSFUSION, V37, P182, DOI 10.1046/j.1537-2995.1997.37297203521.; Marino VJ, 2001, CYTOKINE, V16, P41, DOI 10.1006/cyto.2001.094; NAU H, 1995, LIFE SCI, V57, P53, DOI 10.1016/0024-3205(95)00242-; NETA R, 1988, J IMMUNOL, V140, P10; Neta R, 1989, PROGR CLIN BIOL RES, V352, P47; OSTER W, 1989, BLOOD, V73, P6; REYNOLDS EH, 1973, LANCET, V1, P137; RUEDY J, 1984, CAN FAM PHYSICIAN, V30, P213; Saddler TW, 2004, LANGMANS MED EMBRYOL, P9; Savion S, 1999, TERATOGEN CARCIN MUT, V19, P171, DOI 10.1002/(SICI)1520-6866(1999)19:3<171::AID-TCM1>3.0.CO;2-; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.05132; SULLIVAN FM, 1975, TOXICOL APPL PHARM, V34, P271, DOI 10.1016/0041-008X(75)90032-; THAKKER J C, 1991, Indian Pediatrics, V28, P7; Tiboni GM, 2005, PEDIATR RES, V58, P94, DOI 10.1203/01.PDR.0000166754.24957.7; TORCHINSKY A, 1994, CLIN EXP IMMUNOL, V98, P51; Wegmann T, 1989, TRANSPLANTATION ; WEGMANN TG, 1990, CURR OPIN IMMUNOL, V2, P765, DOI 10.1016/0952-7915(90)90048-; Winn LM, 1999, FREE RADICAL BIO MED, V26, P266, DOI 10.1016/S0891-5849(98)00193-; Yamano T, 2007, JPN J CLIN ONCOL, V37, P793, DOI 10.1093/jjco/hym09; Yerby M., 2001, NEW ANTIEPILEPTIC D; Yerby MS, 2008, INT REV NEUROBIOL, V83, P181, DOI 10.1016/S0074-7742(08)00010-; Zhang XM, 2012, NUTR NEUROSCI, V15, P55, DOI 10.1179/1476830511Y.000000002",34,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,3.0,,1351.0,1359,,10.19193/0393-6384_2017_3s_211,,9,"Medicine, General & Internal",General & Internal Medicine,FV9AC,WOS:000424878100013,,,,,2022-07-14,0.003615702479338843,1.8822409589838496e-08,0.007012818071670883,0.1277938400200668,0.007012818071670883
J,"Bulgan, C21",,,,"Bulgan, Cigdem",,,ANGULAR KINEMATICS OF THE DEEP SQUAT TEST IN FUNCTIONAL MOVEMENT SCREEN (TM) ACCORDING TO THE SCORING SYSTEM,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Angular Kinematics; Deep Squat; FMS; Screening,INTERRATER RELIABILITY; BIOMECHANICAL ANALYSIS; PERFORMANCE; PLAYERS; SCORES; ASSOCIATION; OVERWEIGHT; STABILITY; CHILDREN,"The aim of this study was to determine to angular kinematic differences of the Functional Movement Screen (FMS) TM deep squat test according to the classifications. 23 university students (age 22.43 +/- 1.53yrs; height 177.26 +/- 6.09cm and weight 70.21 +/- 12.40kg) participated to this study voluntarily. Participants performed a deep squat test three times according to Cook's guidelines for Functional Movement Screening. They get scored by a clinician as 1, 2 or 3. During the test performance, 3D angular kinematic data was collected by 8 high speed Oqus 7+ cameras which were connected directly to the computer. Left and right knee, hip and shoulder angles; trunk flexion angle; hip, calf segmental angles, dowel angle in frontal axis; and also thigh segmental angle in horizontal axis were assessed to examine differences between the three scoring groups by using Qualisys Track Manager (QTM) Version 2.12. SPSS 18.0 (SPSS Inc., Chicago, IL, USA) program was used for the differences by Kruskal Wallis test. As a result of the study, the significant difference were found at right and left knee angle between groups (p<0.05). Also in horizontal plane, right and left thigh were significantly difference between groups (p<0.05) too. There were no significant differences found in other parameters. (p>0.05). As a conclusion, in squat movement, as the limitation of motion increases, the hip and knee angles were getting higher and because there was a knee excursion in the horizantal plane, the mechanics of movement distorted.","[Bulgan, Cigdem] Halic Univ, Sch Phys Educ & Sports, TSYD Campus,Levent Cad 51, TR-34350 Istanbul, Turkey","Bulgan, C (corresponding author), Halic Univ, Sch Phys Educ & Sports, TSYD Campus,Levent Cad 51, TR-34350 Istanbul, Turkey.",,"Bulgan, Cigdem/AAH-3432-2020",,,,"Beach TAC, 2014, APPL ERGON, V45, P482, DOI 10.1016/j.apergo.2013.06.00; Bushman TT, 2015, J STRENGTH COND RES, V29, pS65, DOI 10.1519/JSC.000000000000104; Butler RJ, 2010, SPORT BIOMECH, V9, P270, DOI 10.1080/14763141.2010.53962; Chorba Rita S, 2010, N Am J Sports Phys Ther, V5, P4; Clifton DR, 2013, J STRENGTH COND RES, V27, P966, DOI 10.1519/JSC.0b013e318260b72; Conlon JK, 2013, THESI; Cook G, FUNCTIONAL MOVEMEN; Cook G., 2010, MOVEMENT FUNCTIONAL, VFirs; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P6; Duncan MJ, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-1; El-Tohamy AM, 2016, TRENDS APPL SCI RES, V11, P19, DOI DOI 10.3923/tasr.2016.19.2; Escamilla RF, 2001, MED SCI SPORT EXER, V33, P984, DOI 10.1097/00005768-200106000-0001; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI 10.1111/j.1553-2712.2007.tb01851.; Fox D, 2014, PHYS THER SPORT, V15, P194, DOI 10.1016/j.ptsp.2013.11.00; Frost DM, 2012, J STRENGTH COND RES, V26, P1620, DOI 10.1519/JSC.0b013e318234ec5; Hemmerich A, 2006, J ORTHOP RES, V24, P770, DOI 10.1002/jor.2011; Kiesel K, 2011, SCAND J MED SCI SPOR, V21, P287, DOI 10.1111/j.1600-0838.2009.01038.; Koehle MS, 2016, J STRENGTH COND RES, V30, P540, DOI 10.1519/JSC.000000000000109; Krause DA, 2015, INT J SPORTS PHYS TH, V10, P3; Liao T, 2017, APPL FUNCTIONAL MOVE, P18; Lockie RG, 2015, BIOL SPORT, V32, P41, DOI 10.5604/20831862.112728; McCunn R, 2016, SPORTS MED, V46, P763, DOI 10.1007/s40279-015-0453-; McMillian DJ, 2016, J STRENGTH COND RES, V30, P973, DOI 10.1519/JSC.000000000000119; Mills JD, 2005, PHYS THER SPORT, V6, P60, DOI 10.1016/j.ptsp.2005.02.00; Minick KI, 2010, J STRENGTH COND RES, V24, P479, DOI 10.1519/JSC.0b013e3181c09c0; Okada T, 2011, J STRENGTH COND RES, V25, P252, DOI 10.1519/JSC.0b013e3181b22b3; Paoli A, 2015, CLIN PHYSIOL FUNCT I, V35, P1, DOI 10.1111/cpf.1213; Parenteau E, 2014, PHYS THER SPORT, V15, P169, DOI 10.1016/j.ptsp.2013.10.00; Shultz R, 2013, J ATHL TRAINING, V48, P331, DOI 10.4085/1062-6050-48.2.1; Waldron M, 2016, J STRENGTH COND RES, V30, P910, DOI 10.1519/JSC.000000000000027",30,1,1,1,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,651.0,656,,10.19193/0393-6384_2017_4_097,,6,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700018,,,,,2022-07-14,0.0030991735537190084,7.210303698028254e-11,0.005983068908662273,0.1002537413909171,0.005983068908662273
J,"Bursa, D1;  Paciorek, M;  Porowski, D;  Bednarska, A",,,,"Bursa, Dominik; Paciorek, Marcin; Porowski, Dawid; Bednarska, Agnieszka",,,PATIENT WITH UNDETERMINED FULMINANT SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: CLINICAL IMPLICATIONS FROM CASE REPORT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,sepsis; systemic inflammatory response syndrome; hemophagocytic limphohistiocytosis; macrophage activation syndrome; adult-onset Still's disease; red man syndrome,MACROPHAGE ACTIVATION SYNDROME; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SEPTIC SHOCK,"Introduction: Severe systemic inflammatory response syndrome (SIRS) is commonly related to sepsis but rare autoimmunological or hematological diseases can provide similar conditions: adult-onset Still's disease (AOSD), systemic lupus erythematous (SLE), hemophagocytic limphohistiocytosis (HLH), macrophage activation syndrome (MAS). These diseases cause cytokine storm and trigger extreme hyperferritinemia, thus they are called hyperferritinemic syndromes. Case presentation: We present a case of a 55-year-old female who had fever, rash and arthralgia. She was admitted to the Hospital of Infectious Diseases in Warsaw with SIRS initially attributed to bacterial infection and suspicion of sepsis. During diagnostic management the patient developed overwhelming SIRS with hyperferritinemia. Broad-spectral antibiotics with short course of steroids were administered for the suspected autoimmunological syndrome. The response to treatment was quick. None syndromes met diagnostic criteria. After vancomycin infusion the second exacerbation appeared with acute kidney injury. Methylprednisolone pulses provided improvement. The patient met HLH criteria a few days after the second exacerbation. Slow, complete remission was achieved with immunosuppressive therapy (steroids and methotrexate). MAS was recognized due to AOSD. Conclusion: The clinical presentation of patients with SIRS is nonspecific. They require thorough assessment because similar symptoms may occur in other several non-infectious conditions, such as autoimmune or hematological disorders.","[Bursa, Dominik; Paciorek, Marcin; Porowski, Dawid; Bednarska, Agnieszka] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland; [Bursa, Dominik; Paciorek, Marcin; Porowski, Dawid; Bednarska, Agnieszka] Hosp Infect Dis, Warsaw, Poland","Bursa, D (corresponding author), 7-6 Lecha St, PL-05400 Otwock, Poland.",,,,"Research Development Foundation in Hospital for Infectious Diseases, Warsaw, Poland","Paper is partially supported by Research Development Foundation in Hospital for Infectious Diseases, Warsaw, Poland","Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.00; Deane S, 2010, INT ARCH ALLERGY IMM, V153, P109, DOI 10.1159/00031262; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8; Efthimiou P, 2014, CLIN RHEUMATOL, V33, P305, DOI 10.1007/s10067-014-2487-; Gerfaud-Valentin M, 2014, AUTOIMMUN REV, V13, P708, DOI 10.1016/j.autrev.2014.01.05; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.2103; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-13420; Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.00; Olgar S, 2007, J RHEUMATOL, V34, P249; Raschke RA, 2011, CHEST, V140, P933, DOI 10.1378/chest.11-061; Rosado FGN, 2013, AM J CLIN PATHOL, V139, P713, DOI 10.1309/AJCP4ZDKJ4ICOUA; Rosario C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; YAMAGUCHI M, 1992, J RHEUMATOL, V19, P42",13,1,1,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,569.0,573,,10.19193/0393-6384_2017_4_083,,5,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700004,,,,,2022-07-14,0.0013429752066115702,1.812061143085346e-17,0.0024779299821800454,0.08133291882672224,0.0024779299821800454
J,"Cakmur, H1;  Anuk, T",,,,"Cakmur, Hulya; Anuk, Turgut",,,FREQUENCY AWARENESS AND MANAGEMENT OF OBESITY AMONG HEALTHCARE PROVIDERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,awareness; education; health personnel; obesity,RISK-FACTORS; BODY-MASS; OVERWEIGHT; WEIGHT; PREVALENCE; NURSES; ADULTS,"Introduction: Obesity is a growing public health problem all over the world. To create a healthy generation and for health promotion, obesity must be more emphasised among healthcare providers and policy makers. The aim of this study was to evaluate the frequency, awareness and self-management of obesity among healthcare providers. This study also evaluated whether sociodemographic factors influence obesity and obesity awareness and management among the participants. Material and methods: The study was cross-sectional; the research was conducted with 493 healthcare providers. The study group ranged in age from 18-57 years. The survey questions were prepared using the World Health Organisation (WHO) STEP wise approach to noncommunicable disease risk factor surveillance. Results: The frequency of obesity among healthcare providers was 14.9%. Obesity risks were 3.361 fold (95% CI, 1.996-5.727) higher in older age groups than younger. There was no significant relationship identified between obesity and gender. A relatively low educational level meant a 2.688-fold (95% CI, 1.590-4.546) increase in the risk of obesity. The obesity rate was significantly higher in married participants and significantly lower in childless participants. The frequency of obesity by occupation was 16% for doctors, 1% for nurses, 13% for permanent medical staff, and 22% for medical information technology staff. A higher rate of eating a regular balanced diet was observed in doctors. It was observed that cigarette smoking increased the risk of obesity 1.852-fold (95% CI, 1.282.2.973). Conclusion: Although obesity awareness was low among all healthcare providers, the frequency of obesity was lower than the general population in this study group.","[Cakmur, Hulya] Kafkas Univ, Sch Med, Dept Family Med, Kars, Turkey; [Anuk, Turgut] Kafkas Univ, Dept Gen Surg, Sch Med, Kars, Turkey","Cakmur, H (corresponding author), Kafkas Univ, Sch Med, Dept Family Med, Kars, Turkey.",,,,,,"[Anonymous], 2016, WHO STEP WISE APPRO; Cakmur H., 2017, ADIPOSITY EPIDEMIOLO, P1; Dombrowski SU, 2010, OBESITY FACTS, V3, P377, DOI 10.1159/00032307; Florez KR, 2015, J ACAD NUTR DIET, V115, P1102, DOI 10.1016/j.jand.2015.01.00; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.11; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-; Iwuala SO, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.1.558; Katz Sara, 2005, BMC Med Educ, V5, P4, DOI 10.1186/1472-6920-5-; Kyle RG, 2016, INT J NURS STUD, V53, P126, DOI 10.1016/j.ijnurstu.2015.10.01; Makowske M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-; Metcalf B, 2005, OBES SURG, V15, P183, DOI 10.1381/096089205326838; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.7; Oguz A, 2008, TURK KARDIYOL DERN A, V36, P30; Paoli A, 2015, CLIN PHYSIOL FUNCT I, V35, P1, DOI 10.1111/cpf.1213; Rurik I, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-15; Satman I, 2002, TURDEP GROUP D CARE, V25, P155; Thaikruea L, 2016, PREVALENCE NORMAL W; TurkStat, 2016, STAT DE; While AE, 2015, LONDON J PRIM CARE, V7, P112, DOI 10.1080/17571472.2015.111371; Willis LH, 2012, J APPL PHYSIOL, V113, P1831, DOI 10.1152/japplphysiol.01370.201; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.; Wolf AM, 2008, DIABETES OBES METAB, V10, P1248, DOI 10.1111/j.1463-1326.2008.00895.; Wolin KY, 2009, OBESIT; World Health Organization, GLOB STRAT DIET PHY; World Health Organization Expert Committee on Physical Status, 1995, WHO TECHN SUPP SER, V85; Zhu DQ, 2011, OBES REV, V12, P459, DOI 10.1111/j.1467-789X.2010.00821.",26,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,1073.0,1079,,10.19193/0393-6384_2017_6_170,,7,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500029,,,,,2022-07-14,0.0026859504132231405,2.1710797547791434e-08,0.006461247256522966,0.10483338206786012,0.006198847530169745
J,"Cetinkaya, G1;  Sahin, FN;  Tyariz, K",,,,"Cetinkaya, Guney; Sahin, F. Nese; Tyariz, Kisme",,,LEISURE SATISFACTION LEVEL OF ACTIVE AND PASSIVE PARTICIPATION IN OUTDOOR RECREATION ACTIVITIES AND ITS RELATIONSHIP WITH PUBLIC HEALTH,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Outdoor recreation; leisure satisfaction; participation in outdoor recreation activities,PHYSICAL-ACTIVITY; RISK,"Introduction: The aim of this study was to determine the leisure satisfaction scores according to participation in outdoor recreation activities. Material and methods: Participants of this study consisted of 101 men and 97 women with the total of 198 people (X age = 29.68 +/- 9.79) who volunteered for the study. Leisure satisfaction was measured with Leisure Satisfaction Scale (LSS) developed by Beard and Raghed (1980) and the Turkish validity and reliability of the scale was measured by Karli et al. (2008). Additionally a  personal information form was adopted in order to collect data concerning the demographic information and outdoor recreation participation of the sample. Independent samples t test was used to determine the differences of leisure satisfaction levels of participants according to their active or passive participation in these activities. Results: According to the findings, significant differences were obtained in leisure satisfaction scores (total(3.723)= 196, p= 0.000) and in four sub-dimensions of the scale which were Psychological (t1(4.191)= 196, p= 0.000), Educational (t2(2,373)= 159.7, p= 0.019), Relaxing (t3(2.852)= 196, p= 0.005) and Physiological (t4(4.442)= 196, p= 0.000) according to active or passive participation in outdoor recreation activities. Conclusion: In conclusion, the findings of this study present that leisure satisfaction scores are affected by active and passive participation in outdoor recreation activities. As a result, the findings of this study demonstrate that leisure satisfaction differs according to active/passive participation in outdoor activities. Participating in outdoor activities in an active manner may enhance individuals' levels of leisure satisfaction.","[Cetinkaya, Guney; Sahin, F. Nese; Tyariz, Kisme] Ankara Univ, Fac Sport Sci, Ankara, Turkey","Sahin, FN (corresponding author), Ankara Univ, Fac Sport Sci, Ankara, Turkey.",,"Rajendran, Renuchitra/AAO-4033-2020; Ãetinkaya, GÃ¼ney/AAG-8657-2019; SAHIN, FATMA NESE/AAG-9096-2020; Ãetinkaya, GÃ¼ney/B-9050-2016","Ãetinkaya, GÃ¼ney/0000-0002-1757-5105; SAHIN, FATMA NESE/0000-0002-8777-5807; ",,,"Aksoy Y., 2011, ISTANBUL TICARET UNI, V10, P8; Aras D, 2016, ACTA MEDICA MEDITERR, V32, P22; Ardahan F., 2010, SPOR BILIMLERI DERGI, V21, P12; Aydin I., 2014, ANATOLIA TURIZM ARAS, V25, P11; Baker DA, 2006, SOC INDIC RES, V75, P395, DOI 10.1007/s11205-004-5298-; BEARD JG, 1980, J LEISURE RES, V12, P20, DOI 10.1080/00222216.1980.1196941; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.02; Bell S, 2008, DESIGN OUTDOOR RECRE, DOI [DOI 10.4324/9780203928110, 10.4324/9780203928110; Bianco A, 2014, CANCER MED-US, V3, P385, DOI 10.1002/cam4.19; Bodin M, 2003, PSYCHOL SPORT EXERC, V4, P141, DOI 10.1016/S1469-0292(01)00038-; BROWN BA, 1993, SOCIOL SPORT J, V10, P1, DOI 10.1123/ssj.10.1.; Chick G, 2008 M SOC CROSS CU; Chick G, 1994, EXPRESSIVE VALUES R; Chick G, 2015, LEISURE SCI, V37, P232, DOI 10.1080/01490400.2014.96789; Collins S, 2007, J FOREST, V105, P37; Coon JT, 2011, ENVIRON SCI TECHNOL, V45, P1761, DOI 10.1021/es102947; Cordell H. K., 2008, Forest History Today, P; Dahmann N, 2010, HEALTH PLACE, V16, P431, DOI 10.1016/j.healthplace.2009.11.00; Dobbs R., 2014, OVERCOMING OBESITY ; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.230; Godbey GC, 2005, AM J PREV MED, V28, P150, DOI 10.1016/j.amepre.2004.10.02; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649; Henderson K. A., 2002, Journal of Park and Recreation Administration, V20, P13; Ho J.T.S., 1996, INT J EDUC MANAG, V10, P41, DOI [https://doi.org/10.1108/09513549610105353, DOI 10.1108/09513549610105353; Hug SM, 2009, HEALTH PLACE, V15, P971, DOI 10.1016/j.healthplace.2009.03.00; Iwasaki Y, 2001, CAN J PUBLIC HEALTH, V92, P214, DOI 10.1007/BF0340430; Karakucuk S., 2008, REKREASYON BOS ZAMA; Karli U., 2008, HACET J SPORT SCI, V19, P8; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM19990909341110; Librett J., 2007, J PHYS ACT HLTH S1, V4, P; Librett John, 2007, J Phys Act Health, V4 Suppl 1, pS; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai03; Mannell R. C., 2007, World Leisure Journal, V49, P11; Mieczkowski Z., 1990, WORLD TREND TOURIS; Mitchell R, 2013, SOC SCI MED, V91, P130, DOI 10.1016/j.socscimed.2012.04.01; Onder S., 2003, ZIRAAT FAKULTESI DER, V17, P3; Onsekiz D, 2008, SOSYAL BILIMLER ENST, V24, P6; Outdoor Industry Association, 2012, OUTD RECR E; Overholt J., 2012, ILLUMINARE STUDENT J, V10, P; Paoli A, 2015, IRAN J PUBLIC HEALTH, V44, P60; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/0960312050015596; Reconomics, 2014, EC IMP OUTD REC; Rocha CA, 2017, EXPOS HEALTH, V9, P169, DOI 10.1007/s12403-016-0230-; Rosenberger RS, 2009, J PARK RECREAT ADM, V27, P; Spangler KJ, 2007, J PHYS ACT HEALTH, V4, P6; Talay I, 2010, COGRAFI BILIMLER DER, V8, P14; The UK's Faculty of Public Health, 2016, WHY PUBL MENT HLTH ; Wenger N K, 1995, Clin Pract Guidel Quick Ref Guide Clin, P",48,3,3,1,21,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,191.0,196,,10.19193/0393-6384_2017_2_027,,6,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700002,,,,,2022-07-14,0.004958677685950413,2.2114676201634336e-08,0.014550384008728958,0.11138343286501663,0.015097164499045372
J,"Chelouti, H1;  Bouzid, K;  Khelil, M",,,,"Chelouti, Hiba; Bouzid, Kamel; Khelil, Malika",,,"NO ASSOCIATION BETWEEN NAT1*15 AND BREAST CANCER, AND INTERACTION WITH RED MEAT",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Genetic polymorphism; N-acetyltransferase 1; Red meat; Risk factor,CIGARETTE-SMOKING; HUMAN N-ACETYLTRANSFERASE-1; HETEROCYCLIC AMINES; COOKED FOODS; RISK; ACETYLTRANSFERASE; NAT1; CARCINOGENESIS; POLYMORPHISMS; ACETYLATION,"Introduction: Breast cancer is a complex disease characterized by the accumulation and combination of multiple genetic and environmental factors. Indeed, many studies have suggested that among powerful pre-carcinogens involved in breast carcinogenesis derived from aromatic and heterocyclic amines. These are either directly detoxified or converted into carcinogens by N-acetyltransferases-1 and 2. Both highly polymorphic isoenzymes are involved in the increased susceptibility to breast cancer. The objective of our work was to examine the effects of N-acetyltransferase 1*15 (NAT1*15) polymorphism and its relationship with red meat consumption and cigarettes smoking, on breast cancer risk. Materiel and methods: The C and T alleles were identified by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism analysis for 60 Algerian patients with BC and 60 women controls. Results: There was no association between NAT1*15 polymorphisms and Breast cancer. However, the red meat intake increased susceptibility to the disease (p=0.017, OR=5.537). Conclusion: Our results suggest that NAT1* 15 polymorphisms would not be involved in the pathogenesis of breast cancer. However, the red meat intake would be a risk factor for breast cancer in our population. This risk can be attributed to the high fat contained in the red meat.","[Chelouti, Hiba; Khelil, Malika] Univ Sci & Technol Houari Boumed, Fac Sci Biol, Dept Biol Cellulaire & Mol, BP 32 El Alia, Algiers 16111, Algeria; [Bouzid, Kamel] CHU Mustapha Bacha, Ctr Pierre & Marie Curie, Serv Oncol, Algiers, Algeria","Khelil, M (corresponding author), Univ Sci & Technol Houari Boumed, Fac Sci Biol, Dept Biol Cellulaire & Mol, BP 32 El Alia, Algiers 16111, Algeria.",,,,,,"Boukouvala S, 2005, DRUG METAB REV, V37, P511, DOI 10.1080/0360253050025120; Bruhn C, 1999, BIOCHEM PHARMACOL, V58, P1759, DOI 10.1016/S0006-2952(99)00269-; Cho EY, 2006, ARCH INTERN MED, V166, P2253, DOI 10.1001/archinte.166.20.225; Deitz AC, 1997, ANAL BIOCHEM, V253, P219, DOI 10.1006/abio.1997.237; Felton JS, 2002, ENVIRON MOL MUTAGEN, V39, P112, DOI 10.1002/em.1007; Gammon MD, 2004, ENVIRON RES, V96, P176, DOI 10.1016/j.envres.2003.08.00; Gaudet MM, 2013, JNCI-J NATL CANCER I, V105, P515, DOI 10.1093/jnci/djt02; GOODMAN MT, 1992, CANCER EPIDEM BIOMAR, V1, P26; Grant DM, 1997, MUTAT RES-FUND MOL M, V376, P61, DOI 10.1016/S0027-5107(97)00026-; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-; Hein DW, 2006, MOL CARCINOGEN, V45, P230, DOI 10.1002/mc.2016; HEIN DW, 1988, BIOCHIM BIOPHYS ACTA, V948, P37, DOI 10.1016/0304-419X(88)90004-; Hirvonen A, 1999, IARC Sci Publ, P25; Hughes NC, 1998, PHARMACOGENETICS, V8, P55, DOI 10.1097/00008571-199802000-0000; LAYTON DW, 1995, CARCINOGENESIS, V16, P39, DOI 10.1093/carcin/16.1.3; MATOS EL, 1991, NEOPLASMA, V38, P35; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.26; Miller SA, 1988, NUCLEIC ACIDS RES, V16, P883, DOI [DOI 10.1093/NAR/16.3.1215, 10.1093/nar/16.3.1215; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P37; NAGAO M, 1994, CANCER, V74, P1063, DOI 10.1002/1097-0142(19940801)74:3+<1063::AID-CNCR2820741514>3.0.CO;2-; PALMER JR, 1993, EPIDEMIOL REV, V15, P145, DOI 10.1093/oxfordjournals.epirev.a03609; Shirai T, 1995, Princess Takamatsu Symp, V23, P23; VATSIS KP, 1993, ARCH BIOCHEM BIOPHYS, V301, P71, DOI 10.1006/abbi.1993.111; VATSIS KP, 1995, PHARMACOGENETICS, V5, P1, DOI 10.1097/00008571-199502000-0000; WEBER WW, 1985, PHARMACOL REV, V37, P2; Xue F, 2011, ARCH INTERN MED, V171, P125, DOI 10.1001/archinternmed.2010.50; Zheng W, 1998, JNCI-J NATL CANCER I, V90, P1724, DOI 10.1093/jnci/90.22.172; Zheng W, 1999, CANCER EPIDEM BIOMAR, V8, P23; Zhu Y, 2008, PHARMACOGENOMICS J, V8, P339, DOI 10.1038/sj.tpj.650048",29,1,1,1,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,1.0,,,,,89.0,93,,10.19193/0393-6384_2017_1_014,,5,"Medicine, General & Internal",General & Internal Medicine,EP2PY,WOS:000397226800014,,,,,2022-07-14,0.0030991735537190084,1.876335469756682e-08,0.005983068908662273,0.1277769711049804,0.005983068908662273
J,"Chisari, G21;   Chisari, EM;   Maria, BA;   Grasso, A;   Chisari, CG",,,,"Chisari, Giuseppe; Chisari, Eleonora Margherita; Maria, Borzi Antonio; Grasso, Antonino; Chisari, Clara Grazia",,,AMNIOTIC MEMBRANE USE IN TYPE 2 DIABETES PATIENTS WITH CHRONIC ULCERS: MICROBIOLOGICAL EVALUATION AND THERAPEUTIC BENEFITS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,amniotic membrane AM; bacteria; type II diabetes,OCULAR SURFACE; PEGYLATED INTERFERON; RISK-FACTORS; TRANSPLANTATION; SUPPLEMENTATION; PROTEINS; DISEASE,"Amniotic membrane AM, as a natural biomaterial, has many advantages, such as low immunogenicity and rich extracellular matrix components, which make it a promising source for vascular tissue engineering. This study evaluated the efficacy and impact of amniotic membrane skin in patients (diabetes) with chronic ulcer lesions hard to heel. 56 patients with type II diabetes (32 F-24 M mean age 57 +/- 5 years) with chronic ulcers were admitted to our department. Patients were treated with human amniotic membrane was prepared using fresh human placenta. At 4 weeks grafting were found the following data: 57.1% scar in full and the remaining 42.9% partial resolution. Histological evaluation of the grafts explanted shown a single layer of skin cells compact enough. The results show that the amniotic membrane has a good regulatory activities and its clinical efficacy is confirmed by direct activity in wound skin and an indirect selection in the normal bacterial flora of the skin.","[Chisari, Giuseppe] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Chisari, Eleonora Margherita] Univ Catania, Dept Educ, Catania, Italy; [Maria, Borzi Antonio] Univ Catania, Res Ctr Great Senescence, Catania, Italy; [Grasso, Antonino; Chisari, Clara Grazia] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Catania, Italy","Chisari, EM (corresponding author), Univ Catania, Dept Educ, Catania, Italy.",,"BorzÃ¬, Antonio Maria/X-8685-2018","BorzÃ¬, Antonio Maria/0000-0001-6984-308X; chisari, clara grazia/0000-0003-1607-543X",,,"Agarwal N, 2015, EXPERT REV OPHTHALMO, V10, P145, DOI 10.1586/17469899.2015.100354; Akinbi HT, 2004, AM J OBSTET GYNECOL, V191, P2090, DOI 10.1016/j.ajog.2004.05.00; Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.39; Cabrera-Pastor A, 2016, SCI REP-UK, V6, DOI 10.1038/srep3312; Chisari CG, 2015, ACTA MEDICA MEDITERR, V31, P121; Chisari CG, 2014, ACTA MEDICA MEDITERR, V30, P24; Chisari EM, 2017, ACTA MEDICA MEDITERR, V10, P38; Chisari EM, 2016, ACTA MEDICA MEDITERR, V32, P157; Chisari G, 2016, ACTA MEDICA MEDITERR, V32, P865, DOI 10.19193/0393-6384_2016_4_10; Chisari G, 2015, ACTA MEDICA MEDITERR, V31, P105; Chisari G, 2013, ACTA MEDICA MEDITERR, V29, P36; Chisari G, 2011, ACTA MEDICA MEDITERR, V27, P7; Chisari G, 2008, CURR CLIN PHARMACOL, V3, P153, DOI 10.2174/15748840878574769; COLOCHO G, 1974, ARCH SURG-CHICAGO, V109, P37; Davis S., 1910, J HOPKINS MED J, V15, P30; Frazzetto P, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-S1-S1; Ghanassia E, 2008, DIABETES CARE, V31, P1288, DOI 10.2337/dc07-214; Grasso A, 2016, ACTA VULVOLOGIC; Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-0001; Khanolkar MP, 2008, QJM-INT J MED, V101, P685, DOI 10.1093/qjmed/hcn02; Lavery LA, 2006, DIABETES CARE, V29, P1288, DOI 10.2337/dc05-242; Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.; Malaguarnera G, 2016, AGING CLIN EXP RE; Malaguarnera G, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1115-; Malaguarnera G, 2015, CLIN OPHTHALMOL, V9, P1437, DOI 10.2147/OPTH.S7753; Malaguarnera G, 2014, WORLD J GASTROENTERO, V20, P16639, DOI 10.3748/wjg.v20.i44.1663; Malaguarnera G, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.1160; Malaguarnera G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/19149; Malaguarnera G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/94350; Malaguarnera M, 2015, AM J TRANSL RES, V7, P251; Malaguarnera M, 2013, ACTA MEDICA MEDITERR, V29, P79; Malaguarnera M, 2011, WORLD J GASTROENTERO, V17, P4414, DOI 10.3748/wjg.v17.i39.441; Malaguarnera M, 2011, HEPAT MON, V11, P9; Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-; Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.024; Niknejad H, 2008, EUR CELLS MATER, V15, P8; Rampello L, 2012, ACTA MEDICA MEDITERR, V28, P22; Rampello L, 2012, ACTA MEDICA MEDITERR, V28, P21; Rampello L, 2012, ACTA MEDICA MEDITERR, V28, P12; Sabella N, 1913, MED REC NY, V83, P478, DOI DOI 10.1177/00145246130240101; Stock SJ, 2007, AM J OBSTET GYNECOL, V196, P255, DOI 10.1016/j.ajog.2006.10.90; Zhang Y, 2004, EXP HEMATOL, V32, P657, DOI 10.1016/j.exphem.2004.04.00",42,9,10,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,431.0,435,,10.19193/0393-6384_2017_3_063,,5,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200011,,,,,2022-07-14,0.004132231404958678,0.0001600360770704272,0.007775587609992501,0.10557197543924704,0.00804869920663382
J,"Coco, M1;  Ramaci, T;  Sagone, E;  Sardo, MG;  Brachina, P;  Buscemi, B;  Coco, LSG;  Papotto, G;  Papotto, GMF;  Di Gregorio, G;  Petralia, MC;  Buscemi, A;  Perciavalle, V",,,,"Coco, Marinella; Ramaci, Tiziana; Sagone, Elisabetta; Sardo, Milena Galati; Brachina, Paola; Buscemi, Barbara; Coco, Lucio Salvatore Giovanni; Papotto, Giacomo; Papotto, Giulio Maria Federico; Di Gregorio, Giulia; Petralia, Maria Cristina; Buscemi, Andrea; Perciavalle, Valentina",,,BRAIN AND MEMORY: A PILOT STUDY ON THE EXPERIENCE OF REBIRTH AND THE PRESENT LIFE QUALITY OF ADULT SUBJECTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,memory; rebirth; pregnancy; adults; lifestyle,ADOLESCENTS,"It is commonly thought that you cannot remember anything about one's birth, what happened inside the maternal womb and on childbirth. Experimental investigations have, however, highlighted the existence of a fetal memory, as the fetus would seem to be able to memorize and learn prematurely. However, these are unconscious memories, which are not easily retrievable and expressible. The purpose of this study was to verify whether and how pregnancy and birth patterns affect the lifestyle of an adult subject. 50 volunteer students of the Degree Course in Psychological Sciences and Techniques of the University of Catania took part in the research. The sample was subjected to the regression technique, and then a nine-question questionnaire was given out to be filled in anonymously. Only 15 out of 50 subjects returned it completed. The results obtained have shown how the experience of rebirth influences the quality of present life. One observes how the experience of regression is significantly correlated with the perception of one's self and how subjects can retrieve memories of unconscious feelings that experience has led them to live, which may partly account for one's personality.","[Coco, Marinella; Buscemi, Barbara; Buscemi, Andrea] Horus Cooperat Social, Ragusa, Italy; [Ramaci, Tiziana] Univ Kore, Enna, Italy; [Sagone, Elisabetta; Perciavalle, Valentina] Univ Catania, Dept Educ Sci, Catania, Italy; [Sardo, Milena Galati; Brachina, Paola; Coco, Lucio Salvatore Giovanni; Papotto, Giacomo; Papotto, Giulio Maria Federico; Di Gregorio, Giulia] Univ Catania, Catania, Italy; [Petralia, Maria Cristina] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy","Coco, M (corresponding author), Horus Cooperat Social, Ragusa, Italy.",marinella.coco@gmail.com,"Coco, Marinella/AAC-8750-2020; papotto, giacomo/AAP-3068-2021; RAMACI, TIZIANA/AAD-3672-2019; Sagone, Elisabetta/AAC-1483-2022; Petralia, Maria/AAE-6337-2019","papotto, giacomo/0000-0001-8103-8075; RAMACI, TIZIANA/0000-0002-0745-2013; Petralia, Maria Cristina/0000-0002-9643-1045; SAGONE, Elisabetta/0000-0001-5283-4603",,,"Buscemi A, 2016, ACTA MEDICA MEDITERR, V32, P953, DOI 10.19193/0393-6384_2016_4_11; Caraci F, 2014, CNS NEUROL DISORD-DR, V13, P173, DOI 10.2174/1871527311312999010; Castellano S, 2015, CLIN GERONTOLOGIST, V38, P103, DOI 10.1080/07317115.2014.99059; Chamberlain D., 1998, BAMBINI RICORDANO N; Conel JL, 1939, POSTNATAL DEV HUMA; De Pasquale C, 2016, WORLD J TRANSPLANT, V24, P73; De Pasquale C, 2016, ANN GEN PSYCHIATR, P1; FALIN LI, 1961, ACTA ANAT, V44, P18; Friedhoff AJ, PRENATAL NEUROTRANSM, P51; Garcia D, 2017, PEERJ, V5, DOI 10.7717/peerj.286; HUTTUNEN MO, 1978, ARCH GEN PSYCHIAT, V35, P42; Imbasciati A., 1998, NASCITA COSTRUZION; Kershman J., 1939, ARCH NEUROL PSYCHIA; Lagercrantz H, 2002, NEWBORN BRAIN: NEUROSCIENCE AND CLINICAL APPLICATIONS, P13; Musumeci G, 2012, ACTA HISTOCHEM, V114, P805, DOI 10.1016/j.acthis.2012.02.00; Musumeci G, 2012, KNEE SURG SPORT TR A, V20, P216, DOI 10.1007/s00167-011-1630-; Pellerone M, 2017, CLIN NEUROPSYCHIATR, V14, P14; Pellerone M, 2017, PSYCHOL RES BEHAV MA, V10, P69, DOI 10.2147/PRBM.S12831; Perciavalle V, 2016, PHYSICIAN SPORTSMED, V44, P403, DOI 10.1080/00913847.2016.122285; Sagone E, 2013, PROCD SOC BEHV, V82, P131, DOI 10.1016/j.sbspro.2013.06.23; Santisi G, 2014, PROCD SOC BEHV, V116, P1227, DOI 10.1016/j.sbspro.2014.01.37; Specchiale A, 2013, ACTA MEDICA MEDITERR, V29, P40; Ulfig N, 2003, ANN NY ACAD SCI, V985, P2",23,4,4,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,901.0,904,,10.19193/0393-6384_2017_6_143,,4,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500002,,,,,2022-07-14,0.0023760330578512395,1.3504549278720877e-17,0.004335185184789882,0.05552528178506898,0.004334931903603125
J,"Cui, H1",,,,"Cui, Hao",,,CLINICAL VALUE OF EMERGENCY CT EXAMINATION IN TAEKWONDO ATHLETES' KNEE FRACTURE AND LIGAMENT INJURY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Taekwondo Athletes; Emergency CT Examination; Knee Fracture; Ligament Injury; Clinical Application,,"Knee fracture and ligament injury are very common in the competition and training of taekwondo athletes. In this study, specific causes of athletes' knee fracture and ligament injury were explored, the application of emergency CT examination in taekwondo athletes' knee fracture and ligament injury was analyzed through a specific examination method, in order to verify the practical value of emergency CT examination in the clinic. 1400 taekwondo athletes with knee fracture and ligament injury were randomly selected as subjects, clinical data were retrospectively analyzed, with patients' X-ray examination results, clinical and surgical results compared. Results showed that 1,000 out of 1,400 patients had fracture. 1200 cases (why 1200 ? only 1000 had fracture ?) of knee fracture were diagnosed by CT examination, with 10 false negative cases; 500 cases of fracture were detected by X-ray examination, 900 cases of ligament injury were diagnosed by CT examination with 50 false negative cases; 170 cases of medial collateral ligament injury were determined by X-ray with indirect signs. Based on the above findings we can conclude that CT examination had advantages when compared to X-ray examination, as it was more sensitive than X-ray examination in incomplete ligament injury diagnosis. For the diagnosis of complete laceration of ligament, X-ray examination should be combined with clinical data to obtain a more accurate diagnosis.","[Cui, Hao] DaLian Maritime Univ, Dept Phys Educ, Dalian 116026, Peoples R China","Cui, H (corresponding author), DaLian Maritime Univ, Dept Phys Educ, Dalian 116026, Peoples R China.",haocui2016@126.com,,,,,"Cantarella G, 2015, ACTA MEDICA MEDITERR, V31, P101; Gao W, 2017, SAUDI PHARM J, V25, P580, DOI 10.1016/j.jsps.2017.04.02; Ge S, 2016, SAUDI JOURNAL OF BI; Khan M, 2017, ARAB J CHEM, V10, P708, DOI 10.1016/j.arabjc.2017.01.00; Li Chengming, 2011, CONT MED, V14, P11; Olya M. H., 2014, ADV IND ENG MANAGE, V3, P35, DOI [10.7508/AIEM-V3-N4-35-44, DOI 10.7508/AIEM-V3-N4-35-44; Peng Botao, 2016, CHINESE J CT MRI, V03, P12; Qi HC, 2012, J COMPUT THEOR NANOS, V9, P1525, DOI 10.1166/jctn.2012.223; Qiu H, 2015, PAK J PHARM SCI, V28, P184; Shao Lixi, 2014, J MODERN MED HLTH, V13, P200; Wang Y, 2015, ACTA MEDICA MEDITERR, V31, P98; Yang SY, 2016, SAUDI PHARM J, V24, P245, DOI 10.1016/j.jsps.2016.04.00; Yang X, 2015, J COASTAL RES, P448, DOI 10.2112/SI73-079.; Yang ZC, 2015, J COASTAL RES, P420, DOI 10.2112/SI73-074.; Yao Yong, 2013, J MED IMAGING, V11, P177; Zhang YL, 2016, SAUDI J BIOL SCI, V23, P237, DOI 10.1016/j.sjbs.2015.02.01",16,0,0,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,3.0,,1317.0,1320,,10.19193/0393-6384_2017_3s_204,,4,"Medicine, General & Internal",General & Internal Medicine,FV9AC,WOS:000424878100006,,,,,2022-07-14,0.001652892561983471,1.823983076997282e-06,0.002372595633009184,0.08544820585249592,0.0023700871001488375
J,"Duzer, S1;  Aydemir, Y;  Sakallioglu, O;  Akyigit, A;  Polat, C;  Cetiner, H",,,,"Duzer, Sertac; Aydemir, Yavuz; Sakallioglu, Oner; Akyigit, Abdulvahap; Polat, Cahit; Cetiner, Hasan",,,SIGNIFICANCE OF PARANASAL SINUS APLASIA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Paranasal; sinus; aplasia; anomaly,SPHENOID SINUS; AGENESIS; MAXILLARY,"Introduction: Paranasal sinus aplasia is a rare condition mostly affecting the frontal and sphenoid sinuses and more rarely the maxillary sinuses. Material and methods: The present study retrospectively evaluated axial and coronal 1 mm thick CT scans of paranasal sinuses in 1502 cases. The patients without aeration of the frontal bone and ethmoidal cells above the supraorbital margin (horizontal line) and patients without aerated cells extending beyond the medial wall of the orbit (vertical line) were considered to have frontal sinus aplasia Results: Of 1502 patients with an age range between 16 and 73 years, 819 were females and 683 were males. Of these patients, 42 (0.27%) had bilateral frontal sinus aplasia and 53 (0.35%) had unilateral frontal sinus aplasia. Only two patients had sphenoid sinus aplasia and one patient had maxillary sinus aplasia. Conclusion: Paranasal sinuses represent great structural variations. Fractures, mucocele, primary ciliary dyskinesia, infections, and some syndromes may affect the development of PNSs. Aplasia of PNSs can point to clinically significant diseases and it must be kept in mind and explored during planning for surgical intervention to the sinuses in order to prevent complications. Computed tomography is a useful method in delineating a detailed anatomy of PNSs and detecting anomalies and pathological conditions.","[Duzer, Sertac; Sakallioglu, Oner; Akyigit, Abdulvahap; Polat, Cahit; Cetiner, Hasan] Elazig Training & Res Hosp, Dept Otorhinolaryngol, TR-23200 Elazig, Turkey; [Aydemir, Yavuz] Elazig Training & Res Hosp, Dept Radiol, Elazig, Turkey","Duzer, S (corresponding author), Elazig Training & Res Hosp, Dept Otorhinolaryngol, TR-23200 Elazig, Turkey.",,"CETINER, HASAN/AAQ-6824-2020; DUZER, SERTAC/AAK-1078-2020; Akyigit, Abdulvahap/W-2984-2018","DUZER, SERTAC/0000-0003-2988-6223; Akyigit, Abdulvahap/0000-0002-2192-155X; POLAT, CAHIT/0000-0001-9838-6906",,,"Anik I, 2005, CLIN ANAT, V18, P217, DOI 10.1002/ca.2009; Antoniades K, 1996, ORL J OTO-RHINO-LARY, V58, P347, DOI 10.1159/00027686; Aydinlioglu A, 2004, CLIN ANAT, V17, P618, DOI 10.1002/ca.2002; Aydmlioglu A, 2003, YONSEI MED J, V44, P21; Baykara M., 2002, TURK J MED SCI, V32, P27; Cakur Binali, 2011, Int J Med Sci, V8, P27; Choudhary S, 2015, INT J ANAT RES, V3, P1620, DOI [10.16965/ijar.2015.237, DOI 10.16965/IJAR.2015.237; Eggesbo HB, 2001, ACTA RADIOL, V42, P482, DOI 10.1080/02841850112734721; HANSON CL, 1980, AM J PHYS ANTHROPOL, V53, P251, DOI 10.1002/ajpa.133053020; Jafari-Pozve Nasim, 2014, Dent Res J (Isfahan), V11, P61; Keskin G, 2002, SURG RADIOL ANAT, V24, P324, DOI 10.1007/s00276-002-0028-; Khanduri S, 2015, INDIAN J OTOLARYNGOL, V67, P434, DOI 10.1007/s12070-015-0877-; Korkmaz H, 2013, ALLERGY RHINOL, V4, pE105, DOI 10.2500/ar.2013.4.005; Martines F, 2016, BRAZ J OTORHINOLAR, V82, P215, DOI 10.1016/j.bjorl.2015.04.00; Martines Francesco, 2014, J Med Case Rep, V8, P282, DOI 10.1186/1752-1947-8-28; Pifferi M, 2011, EUR RESPIR J, V37, P566, DOI 10.1183/09031936.0006881; Pifferi M, 2009, THORAX, V64, P1077, DOI 10.1136/thx.2008.11094; REICHS KJ, 1993, FORENSIC SCI INT, V61, P141, DOI 10.1016/0379-0738(93)90222-; Ribeiro F de A, 2000, Ear Nose Throat J, V79, P2; Som PM, 2003, ANATOMY PHYSL, P9; Sonbay D, 2010, B-ENT, V6, P16; Thiagarajan B, 2012, ONLINE J OTOLARYNGOL, V; Vitali M, 2017, J NEUROSURG SCI, DOI 10.23736/S0390-5616.17.03987-; White SC., 2009, ORAL RADIOL, V6th ed, P52",24,3,3,1,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,637.0,640,,10.19193/0393-6384_2017_4_094,,4,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700015,,,,,2022-07-14,0.0024793388429752063,6.720318133035959e-27,0.004600411679085511,0.05739323257896016,0.00459183701786009
J,"Elboga, G1;  Sahin, SK;  Sahin, AZ;  Altindag, A",,,,"Elboga, Gulcin; Sahin, Sengul Kocamer; Sahin, Ahmet Ziya; Altindag, Abdurrahman",,,SERUM LEVELS OF INFLAMMATORY BIOMARKERS IN SCHIZOAFFECTIVE DISORDERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Schizoaffective disorder; IL-2; IL-4; IL-6; TNF-alpha; hs-CRP,BIPOLAR DISORDER; SCHIZOPHRENIA; ALPHA; IL-6; POPULATION; DEPRESSION; SYMPTOMS; MARKERS; DISEASE,"Introduction: A growing body of evidence suggests that inflammatory markers elevate in schizophrenia, bipolar disorder, major depression. The purpose of this study is to evaluate the association between schizoaffective disorder and serum levels of IL-2, IL-4, IL-6, TNF-alpha, hs-CRP, including the comparison between the affective episodes of the disease. Materials and methods: The study group consisted of 40 patients with bipolar type schizoaffective disorder as defined by DSM-IV criteria and 39 healthy control subjects. IL-2, IL-4, IL-6, TNF-alpha and hsCRP serum levels were examined by ELISA. Their clinical symptoms were rated using the Hamilton Depression Rating Scale and Young Mania Rating Scale. Univariate analysis of covariance controlled for possible confounders was used to compare cytokines and hsCRP levels among the groups. Results: hsCRP levels were significantly higher in patients compared to controls and IL-4 levels were significantly lower in patients compared to controls. hsCRP levels were significantly higher during the depressive phase, and IL-4 levels were significantly lower during the manic phase in patients compared to controls. No statistically significant differences were found in IL-2, IL-6, TNF-alpha. Conclusion: The results suggest that inflammatory dysregulation is associated with the schizoaffective disorder, and these changes may be related to affective phases of the bipolar type schizoaffective disorder.","[Elboga, Gulcin; Altindag, Abdurrahman] Gaziantep Univ, Med Fac, Dept Psychiat, Sahinbey, Gaziantep, Turkey; [Sahin, Sengul Kocamer] Adana State Hosp, Dept Psychiat, Adana, Turkey; [Sahin, Ahmet Ziya] Adana Askim Tufekei State Hosp, Dept Internal Med, Adana, Turkey","Elboga, G (corresponding author), Gaziantep Univ, Med Fac, Dept Psychiat, Sahinbey, Gaziantep, Turkey.",,"Sahin, Ahmet Ziyaettin/AAI-1994-2021; Elboga, Gulcin/AAG-6587-2020; Åahin, Ahmet Ziyaettin/A-8069-2012; Åahin, ÅengÃ¼l/AAI-2398-2019; Altindag, Abdurrahman/AAG-6463-2020","Sahin, Ahmet Ziyaettin/0000-0003-1060-6746; Åahin, Ahmet Ziyaettin/0000-0003-1060-6746; Åahin, ÅengÃ¼l/0000-0002-5371-3907; Altindag, Abdurrahman/0000-0001-5531-4419",Gaziantep University Scientific Research Project Department [TF.12.32],Gaziantep University Scientific Research Project Department supports this study. (Project no: TF.12.32),"Altamura AC, 2013, PROG NEURO-PSYCHOPH, V42, P63, DOI 10.1016/j.pnpbp.2012.08.01; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th, DOI [DOI 10.1176/APPI.BOOKS.9780890420249.DSM-IV-TR, 10.1176/appi.books.9780890420249.dsm-iv-tr; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn205; Bernstein HG, 2009, EXPERT REV NEUROTHER, V9, P1059, DOI [10.1586/ern.09.59, 10.1586/ERN.09.59; Bhatia M S, 1992, Indian J Med Sci, V46, P23; Binbay T, 2012, TURK PSIKIYATR DERG, V23, P149, DOI 10.5080/u678; Brietzke E, 2009, J AFFECT DISORDERS, V116, P214, DOI 10.1016/j.jad.2008.12.00; Campbell IL, 2005, BRAIN RES REV, V48, P166, DOI 10.1016/j.brainresrev.2004.12.00; Chase Kayla A., 2016, BMC PSYCHIATRY, V16, P15; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn229; Drexhage RC, 2003, BRAIN BEHAV IMMUNOLO, V25, P120; Frydecka D, 2015, EUR ARCH PSY CLIN N, V265, P449, DOI 10.1007/s00406-014-0533-; GATTAZ WF, 1992, SCHIZOPHR RES, V6, P237, DOI 10.1016/0920-9964(92)90006-; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r0450; Hope S, 2011, J PSYCHIATR RES, V45, P1608, DOI 10.1016/j.jpsychires.2011.08.00; Hope S, 2009, BIPOLAR DISORD, V11, P726, DOI 10.1111/j.1399-5618.2009.00757.; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1; Kim YK, 2000, SCHIZOPHR RES, V44, P165, DOI 10.1016/S0920-9964(99)00171-; Kuloglu M, 2011, KLIN PSIKOFARMAKOL B, V21, P193, DOI 10.5455/bcp.2011041801185; Kunz M, 2011, REV BRAS PSIQUIATR, V33, P268, DOI 10.1590/S1516-4446201100030001; Li ZX, 2017, ACTA MEDICA MEDITERR, V33, P41, DOI 10.19193/0393-6384_2017_1_00; Lowe GDO, 2005, J THROMB HAEMOST, V3, P1618, DOI 10.1111/j.1538-7836.2005.01416.; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.02; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.01; Modabbernia A, 2013, BIOL PSYCHIAT, V15, P475; O'Brien SM, 2008, PSYCHIAT RES, V160, P256, DOI 10.1016/j.psychres.2007.11.01; Ortiz-Dominguez A, 2007, BIPOLAR DISORD, V9, P596, DOI 10.1111/j.1399-5618.2007.00493.; Padhy S, 2015, TURK PSIKIYATR DERG, V26, P13; Petitto JM, 1997, J NEUROIMMUNOL, V73, P183, DOI 10.1016/S0165-5728(96)00196-; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.0031; Suvisaari J, 2011, PSYCHIAT RES, V189, P305, DOI 10.1016/j.psychres.2011.07.00; WOODROOFE MN, 1995, NEUROLOGY, V45, pS6, DOI 10.1212/WNL.45.6_Suppl_6.S; Zhang XY, 2004, J CLIN PSYCHIAT, V65, P94",33,3,3,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,863.0,868,,10.19193/0393-6384_2017_5_128,,6,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000022,,,,,2022-07-14,0.003409090909090909,0.00012016472242794625,0.039412146184284846,0.11088328617739035,0.04176455703807789
J,"Ersan, S1;  Liv, F;  Tanrisev, M;  Colak, H;  Yilmaz, B;  Alp, A",,,,"Ersan, Sibel; Liv, Fatma; Tanrisev, Mehmet; Colak, Hulya; Yilmaz, Banu; Alp, Alper",,,HEMODIALYSIS PATIENTS' KNOWLEDGE AND AWARENESS ABOUT DIETARY SODIUM: THERE IS STILL NEED FOR AWARENESS RAISING INTERVENTIONS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,chronic kidney disease; hemodialysis patients; nutrition; salt,SALT INTAKE; NONCOMPLIANCE,"Introduction: Hemodialysis patients are particularly susceptible to the adverse effects of salt because of impaired ability to excrete sodium. The patients who restrict dietary sodium intake have better cardiovascular outcomes and quality of life. The purpose of this study was to assess dietary knowledge of patients about dietary sodium and medical complications of noncompliance. Materials and methods: An interviewer-administered questionnaire about knowledge of dietary sodium, and medical complications of dietary noncompliance was applied to hemodialysis patients. Results: Although 85.3% of patients reported that high sodium intake was associated with high blood pressure, interdialytic weight gain were more than 5.7% in 81.6% of patients. There was no statistically significant difference between genders, educational, and economic status of patients and interdialytic weight gain. Overall knowledge scores were poor, moderate, and high in 16%, 56%, and 28% of patients, respectively. The awareness score of risks of noncompliance was high in only 24% of patients. The knowledge scores showed significant weak positive correlation with educational level (spearman's rho (rs)=0.17, p=0.03). There was no correlation with knowledge levels and interdialytic weight gains (rs=-0.13, p=0.11). The awareness did not differ with educational level, and age (rs=-0.01, p=0.84, and rs=0.13, p=0.10, respectively). Conclusion: Majority of the patients have not still perceived the constituents of salt-free diet despite the implementation of the governmental salt reduction program. More impressive dietetic and psycho-educational techniques to promote dietary changes and compliance should be implemented.","[Ersan, Sibel; Liv, Fatma; Tanrisev, Mehmet; Colak, Hulya; Yilmaz, Banu; Alp, Alper] Izmir Tepecik Res & Training Hosp, Dept Nephrol, Izmir, Turkey","Ersan, S (corresponding author), Izmir Tepecik Res & Training Hosp, Dept Nephrol, Izmir, Turkey.",,"ERSAN, SÄ°BEL/ABF-1542-2021; Alp, Alper/AAK-2766-2020; Colak, Hulya/AAB-1979-2021","ERSAN, SÄ°BEL/0000-0002-9381-5262; Alp, Alper/0000-0002-2864-361X; ",,,"Agondi RD, 2011, J RENAL NUTR, V21, P160, DOI 10.1053/j.jrn.2010.03.00; Baines LS, 2000, NEPHRON, V85, P1, DOI 10.1159/00004562; CHAN CY, 1994, DIALYSIS TRANSPLANT, V23, P18; CUMMINGS KM, 1982, MED CARE, V20, P567, DOI 10.1097/00005650-198206000-0000; Durose CL, 2004, J AM DIET ASSOC, V104, P35, DOI 10.1016/j.jada.2003.10.01; Erdem Y, 2010, BLOOD PRESSURE, V19, P313, DOI 10.3109/0803705100380254; Hecking M, 2013, AM J NEPHROL, V38, P78, DOI 10.1159/00035310; Lee SH, 2002, INT J NURS STUD, V39, P695, DOI 10.1016/S0020-7489(02)00007-; Mason H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.008444; Park KA, 2008, J RENAL NUTR, V18, P415, DOI 10.1053/j.jrn.2008.04.00; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.; Shepherd R, 2002, P NUTR SOC, V61, P267, DOI 10.1079/PNS200214; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P161, DOI 10.1016/j.numecd.2011.10.00; Suckling RJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006763.pub; Topbas E, 2015, J REN CAR; Welch JL, 2005, INT J NURS STUD, V42, P597, DOI 10.1016/j.ijnurstu.2004.09.01; Wiser NA, 1997, J RENAL NUTR, V7, P187, DOI DOI 10.1016/S1051-2276(97)90017-",17,2,2,1,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,217.0,222,,10.19193/0393-6384_2017_2_032,,6,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700007,,,,,2022-07-14,0.001756198347107438,7.455772830306566e-18,0.002890651482847333,0.06208988922599309,0.002890651482847333
J,"Gallai, B21;   Valentini, V;   Barbanera, F;   Marotta, R;   Lavano, F;   Lavano, SM;   Maltese, A;   Tripi, G;   Romano, P;   Salerno, M",,,,"Gallai, Beatrice; Valentini, Vittoria; Barbanera, Francesca; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Salerno, Margherita",,,BEHAVIOURAL DISORDERS IN CHILDREN AND ADOLESCENTS: A CONCEPTUAL REVIEW ABOUT THE THERAPEUTIC ALLIANCE WITH FAMILY AND SCHOOL,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,Behavioural disorders; Family alliance; therapeutic program,AUTISM SPECTRUM DISORDERS; CHILDHOOD ABSENCE EPILEPSY; PRIMARY NOCTURNAL ENURESIS; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; SLEEP-APNEA SYNDROME; WEIGHT-LOSS PROGRAM; QUALITY-OF-LIFE; PARENTAL STRESS; MATERNAL STRESS,"Aim: In disruptive behavioral disorders, given the wide range of symptomatic manifestations and the complexity of the socio-familiar contexts in which they develop, it is now proven that more visible and more stable results can be achieved over time through multimodal and multidimensional interventions. These are accomplished through the integration of psychotherapeutic interventions for the child and parents, counseling interventions for all the various practitioners who come into contact with the child in school, sports, and social settings, through the possibility of organizing multiple settings in patient can be followed by several health professionals such as child and adolescent neuropsychiatrist, neuropsychomotricist, occupation therapist, psychologist.","[Gallai, Beatrice; Valentini, Vittoria; Barbanera, Francesca] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Romano, Palmira] Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Naples, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","TRIPI, Gabriele/0000-0001-7088-9325; Marotta, Rosa/0000-0003-0515-5952",,,"Ahmadi MRH, 2017, ACTA MEDICA MEDITERR, V33, P351, DOI 10.19193/0393-6384_2017_2_05; Balkan A, 2017, ACTA MEDICA MEDITERR, V33, P165, DOI 10.19193/0393-6384_2017_1_02; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chelouti H, 2017, ACTA MEDICA MEDITERR, V33, P89, DOI 10.19193/0393-6384_2017_1_01; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Eksi F, 2017, ACTA MEDICA MEDITERR, V33, P341, DOI 10.19193/0393-6384_2017_2_05; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Feola A, 2017, ACTA MEDICA MEDITERR, V33, P55, DOI 10.19193/0393-6384_2017_1_00; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Gokdemir GS, 2017, ACTA MEDICA MEDITERR, V33, P157, DOI 10.19193/0393-6384_2017_1_02; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Karagoz H, 2017, ACTA MEDICA MEDITERR, V33, P205, DOI 10.19193/0393-6384_2017_2_03; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2017, J CHILD ADOL PSYCHOP, V27, P844, DOI 10.1089/cap.2016.020; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shirazi SAM, 2017, ACTA MEDICA MEDITERR, V33, P267, DOI 10.19193/0393-6384_2017_2_03; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Yilmazel G, 2017, ACTA MEDICA MEDITERR, V33, P329, DOI 10.19193/0393-6384_2017_2_04",91,10,10,1,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1181.0,1188,,10.19193/0393-6384_2017_2s_184,,8,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700002,,,,,2022-07-14,0.008264462809917356,0.13022771729198196,0.013209515580605803,0.11287445049499178,0.016263542885157505
J,"Gallai, B31;   Valentini, V;   Barbanera, F;   Marotta, R;   Lavano, F;   Lavano, SM;   Maltese, A;   Tripi, G;   Romano, P;   Salerno, M;   Di Folco, A",,,,"Gallai, Beatrice; Valentini, Vittoria; Barbanera, Francesca; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Salerno, Margherita; Di Folco, Annabella",,,THE PSYCHOTERAPEUTIC INTERVENTIONS AND STRATEGIES FOR CHILDREN AND ADOLESCENTS WITH BEHAVIOURAL DISORDERS: THE INCREDIBLE YEARS TREATMENT PROGRAM,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Behavioural disorders; psychotherapeutic interventions; parents; teachers,AUTISM SPECTRUM DISORDERS; CHILDHOOD ABSENCE EPILEPSY; PRIMARY NOCTURNAL ENURESIS; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; SLEEP-APNEA SYNDROME; WEIGHT-LOSS PROGRAM; PARENTAL STRESS; MATERNAL STRESS; OBESE CHILDREN,"The psychotherapeutic interventions disposable and considered the key role in behavioral therapy are the Incredible Years, the evidence-based parenting support.","[Gallai, Beatrice; Valentini, Vittoria; Barbanera, Francesca] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Barbanera, Francesca] Univ Perugia, Azienda Sanitaria Locale Umbria 1, Perugia, Italy; [Marotta, Rosa; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Romano, Palmira] Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Naples, Italy; [Salerno, Margherita; Di Folco, Annabella] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","TRIPI, Gabriele/0000-0001-7088-9325; Marotta, Rosa/0000-0003-0515-5952",,,"Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.0098; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2017, J CHILD ADOL PSYCHOP, V27, P844, DOI 10.1089/cap.2016.020; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Sofulu F, 2017, ACTA MEDICA MEDITERR, V33, P107, DOI 10.19193/0393-6384_2017_1_01; Taravati F, 2017, ACTA MEDICA MEDITERR, V33, P271, DOI 10.19193/0393-6384_2017_2_04; Tokluoglu S, 2017, ACTA MEDICA MEDITERR, V33, P145, DOI 10.19193/0393-6384_2017_1_02; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Xu YM, 2017, ACTA MEDICA MEDITERR, V33, P231, DOI 10.19193/0393-6384_2017_2_03; Yildirim MS, 2017, ACTA MEDICA MEDITERR, V33, P83, DOI 10.19193/0393-6384_2017_1_01; Yilmazel G, 2017, ACTA MEDICA MEDITERR, V33, P329, DOI 10.19193/0393-6384_2017_2_04",90,3,3,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1189.0,1196,,10.19193/0393-6384_2017_2s_185,,8,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700003,,,,,2022-07-14,0.008161157024793388,0.12995636596187493,0.012627010078845435,0.11287181819241847,0.015676461910934702
J,"Gallai, B41;   Valentini, V;   Barbanera, F;   Marotta, R;   Lavano, F;   Lavano, SM;   Maltese, A;   Tripi, G;   Romano, P;   Salerno, M",,,,"Gallai, Beatrice; Valentini, Vittoria; Barbanera, Francesca; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Salerno, Margherita",,,REVIEW ABOUT COMORBIDITIES OF BEHAVIOURAL DISORDERS IN CHILDREN AND ADOLESCENTS: THE FOCUS ON ATTENTION-DEFICIT/HYPERACTIVITY DISORDER,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,Behavioural disorders; comorbidities; ADHD,AUTISM SPECTRUM DISORDERS; CALLOUS UNEMOTIONAL TRAITS; CHILDHOOD ABSENCE EPILEPSY; PRIMARY NOCTURNAL ENURESIS; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; SLEEP-APNEA SYNDROME; WEIGHT-LOSS PROGRAM; QUALITY-OF-LIFE; PARENTAL STRESS,"Disruptive behavior disorders (DBD) present high comorbidity rate mainly for opposite-defiant disorders that are frequent among children, adolescents and adults affected by with attention deficit and hyperactivity disorder (ADHD), probably as result of common temperamental risk factors such as attention, distraction, impulsivity. ADHD tend to manifest in about 50% of individuals diagnosed as disruptive behavioral disorders.","[Gallai, Beatrice; Valentini, Vittoria; Barbanera, Francesca] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Romano, Palmira] Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Naples, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; TRIPI, Gabriele/0000-0001-7088-9325",,,"Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chisari G, 2016, ACTA MEDICA MEDITERR, V32, P865, DOI 10.19193/0393-6384_2016_4_10; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Masi G, 2016, PSYCHIAT RES, V238, P8, DOI 10.1016/j.psychres.2016.02.01; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Muratori P, 2017, J AFFECT DISORDERS, V208, P110, DOI 10.1016/j.jad.2016.08.05; Muratori P, 2016, COMPR PSYCHIAT, V69, P202, DOI 10.1016/j.comppsych.2016.06.00; Muratori P, 2016, PSYCHIAT RES, V236, P35, DOI 10.1016/j.psychres.2016.01.00; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2017, J CHILD ADOL PSYCHOP, V27, P844, DOI 10.1089/cap.2016.020; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Wen SW, 2016, ACTA MEDICA MEDITERR, V32, P30",88,11,11,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1197.0,1203,,10.19193/0393-6384_2017_2s_186,,7,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700004,,,,,2022-07-14,0.007954545454545454,0.12920682267048786,0.013636560457811787,0.11355238307506423,0.017886111543461262
J,"Gallai, B51;   Valentini, V;   Barbanera, F;   Marotta, R;   Lavano, F;   Lavano, SM;   Maltese, A;   Tripi, G;   Romano, P;   Salerno, M;   Di Folco, A",,,,"Gallai, Beatrice; Valentini, Vittoria; Barbanera, Francesca; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Salerno, Margherita; Di Folco, Annabella",,,THE BEHAVIORAL PARENTING INTERVENTIONS (BPT) FOR SUPPORT AND MANDATORY INTEGRATIVE THERAPY FOR CHILDREN AND ADOLESCENTS AFFECTED BY DISRUPTIVE BEHAVIOURAL DISORDERS: A BRIEF REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,Behavioural disorders; therapeutic alliance; parental involving,AUTISM SPECTRUM DISORDERS; CHILDHOOD ABSENCE EPILEPSY; PRIMARY NOCTURNAL ENURESIS; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; SLEEP-APNEA SYNDROME; WEIGHT-LOSS PROGRAM; QUALITY-OF-LIFE; MATERNAL STRESS; OBESE CHILDREN,"The behavioral parenting interventions (BPT), commonly abbreviated as parent training, is a program conducted by an expert with the specific purpose of improving or modifying parental practices in order to promote the child's well-being, increasing parenting skills in the daily management of the child, problem solving and reducing the level of parenting and family stress. BPT presents many positive effects on children or adolescents affected by neurodevelopmental disorder such as ADHD, autism and cognitive dysfunction but BPT appears to improve also other proximal outcomes such as parenting competence and parenting stress","[Gallai, Beatrice; Valentini, Vittoria; Barbanera, Francesca] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Romano, Palmira] Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Naples, Italy; [Salerno, Margherita; Di Folco, Annabella] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","TRIPI, Gabriele/0000-0001-7088-9325; Marotta, Rosa/0000-0003-0515-5952",,,"Azizpour M, 2017, ACTA MEDICA MEDITERR, V33, P129, DOI 10.19193/0393-6384_2017_1_02; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Huang HT, 2017, ACTA MEDICA MEDITERR, V33, P223, DOI 10.19193/0393-6384_2017_2_03; Ibrahim S, 2017, ACTA MEDICA MEDITERR, V33, P65, DOI 10.19193/0393-6384_2017_1_01; Li ZX, 2017, ACTA MEDICA MEDITERR, V33, P41, DOI 10.19193/0393-6384_2017_1_00; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P667, DOI 10.19193/03936384_2017_4_10; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P675, DOI 10.19193/0393-6384_2017_4_10; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P641, DOI 10.19193/0393-6384_2017_4_09; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Natanzi MM, 2017, ACTA MEDICA MEDITERR, V33, P295, DOI 10.19193/0393-6384_2017_2_04; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Diaz-Narvaez VP, 2017, ACTA MEDICA MEDITERR, V33, P115, DOI 10.19193/0393-6384_2017_1_01; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2017, J CHILD ADOL PSYCHOP, V27, P844, DOI 10.1089/cap.2016.020; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Sahin N, 2017, ACTA MEDICA MEDITERR, V33, P245, DOI 10.19193/0393-6384_2017_2_03; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Taravati F, 2017, ACTA MEDICA MEDITERR, V33, P271, DOI 10.19193/0393-6384_2017_2_04; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Yildirim MS, 2017, ACTA MEDICA MEDITERR, V33, P83, DOI 10.19193/0393-6384_2017_1_01",93,11,11,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1205.0,1212,,10.19193/0393-6384_2017_2s_187,,8,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700005,,,,,2022-07-14,0.008264462809917356,0.13030827759596733,0.024548578553841707,0.11512981838509022,0.028405022602803007
J,"Gorini, I1;  Vecchio, I;  Badino, P",,,,"Gorini, Ilaria; Vecchio, Ignazio; Badino, Paola",,,THE EMERGENCY ARCHAEOLOGY AND THE OSTEOARCHAEOLOGICAL STUDIES. THE NORTHWEST LOMBARDY RESEARCH ON FUNERARY SITES,ACTA MEDICA MEDITERRANEA,,,English,Letter,,,,,,,MEDIEVAL SKELETONS,,"[Gorini, Ilaria; Badino, Paola] Univ Insubria, Dept Biotechnol & Life Sci, Ctr Res Osteoarchaeol & Paleopathol, Varese, Italy; [Vecchio, Ignazio] Univ Catania, Dept Clin & Expt Med, Catania, Italy","Badino, P (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Ctr Res Osteoarchaeol & Paleopathol, Varese, Italy.",,,"Vecchio, Ignazio/0000-0001-5942-1908",,,"Lazzati AMB, 2016, INT J OSTEOARCHAEOL, V26, P670, DOI 10.1002/oa.245; Licata M, 2016, SKELETAL RADIOL, V45, P323, DOI 10.1007/s00256-015-2266-; Licata M, 2014, ACTA MEDICA MEDITERR, V30, P55; Licata M, 2014, INJURY, V45, P457, DOI 10.1016/j.injury.2013.10.01; Ubelaker SH, 1989, HUMAN SKELETAL REMA",5,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,965.0,966,,10.19193/0393-6384_2017_6_152,,2,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500011,,,,,2022-07-14,0.0005165289256198347,4.4701378130787226e-08,0.0008263182027376301,0.08079256841911979,0.0008263182027376301
J,"Guven, R1;  Aykal, G;  Gungor, F;  Akyol, KC;  Bayar, N",,,,"Guven, Ramazan; Aykal, Guzin; Gungor, Faruk; Akyol, K. Can; Bayar, Nermin",,,WHICH PATIENTS HAVE AN ASSOCIATION BETWEEN HBA1C LEVEL AND SEVERITY OF CORONARY ARTERY DISEASE: DIABETIC OR NON-DIABETIC?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,coronary artery disease; diabetes mellitus; HbA1c; gensini,ACUTE MYOCARDIAL-INFARCTION; GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; ADMISSION GLUCOSE; HEART-DISEASE; MELLITUS; MORTALITY; COMPLICATIONS; GLYCEMIA; INSULIN,"Introduction: Diabetes mellitus (DM) has long been recognized as a major risk factor for coronary artery diseases (CAD). Although Hemoglobin A1c (HbA1c) has been widely used as a marker for predicting the severity of DM, there are controversial reports in the literature regarding its association with the severity of CAD. The aim of our study was to determine the association between HbA1c levels and severity of CAD in both diagnosed and undiagnosed diabetic patients with admission hyperglycemia. Materials and methods: The files of the patients who were admitted to the emergency department of a regional training and research hospital from 2014 to 2015 due to acute coronary syndrome and whose diagnosis was confirmed by coronary angiography and HbA1c levels were analyzed were reviewed retrospectively. Those patients whose HbA1c levels were measured were divided into two groups: diagnosed diabetes (DD) or undiagnosed diabetes (UDD). Gensini score was measured for all patients and the correlation between elevated HbA1c levels and severity of coronary artery disease was subjected to statistical analysis. Results: Out of 168 patients who met the inclusion criteria, 85.1% (n=143) were male, while 14.9% (n=25) were female. The mean age was 46.6 +/- 6.5 years. HbA1c was found to have a significantly positive correlation with the Gensini score in DD group (n=77), whereas no significant correlation was found between HbA1c and the Gensini score in UDD group (n=91) (p <0.001; correlation coefficient: 0.656, p=0.207; correlation coefficient: 0.251, respectively). Linear regression analysis revealed that HbA1c was a significant predictor for gensini score (p<0.001; a: 0.632). Conclusion: HbA1c can be used as a predictor for the evaluation of diabetic patients with CAD. Moreover, HbA1c was not found to have a significant association with the severity of CAD in undiagnosed diabetic CAD patients with admission hyperglycemia.","[Guven, Ramazan] Bitlis State Hosp, Dept Emergency Med, Bitlis, Turkey; [Aykal, Guzin] Antalya Training & Res Hosp, Dept Biochem, Antalya, Turkey; [Gungor, Faruk; Akyol, K. Can] Antalya Training & Res Hosp, Dept Emergency Med, Antalya, Turkey; [Bayar, Nermin] Antalya Training & Res Hosp, Dept Cardiol, Antalya, Turkey","Guven, R (corresponding author), Bitlis State Hosp, Dept Emergency Med, Bitlis, Turkey.",,"Aykal, GÃ¼zin/AED-4990-2022; Kucukseymen, Selcuk/Q-4135-2018","Kucukseymen, Selcuk/0000-0002-9757-3088",,,"Ayhan SS, 2012, ENDOKRYNOL POL, V63, P36; Dziewierz A, 2009, AM J CARDIOL, V103, P954, DOI 10.1016/j.amjcard.2008.12.00; Ertem AG, 2013, TURK KARDIYOL DERN A, V41, P389, DOI 10.5543/tkda.2013.9566; Garg N, 2014, MAYO CLIN PROC, V89, P908, DOI 10.1016/j.mayocp.2014.03.01; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-; Ghaffari Samad, 2015, Ther Adv Cardiovasc Dis, V9, P305, DOI 10.1177/175394471558550; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM19980723339040; Hong LF, 2014, LIPIDS HLTH DIS, V13, P; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-113; Khaw KT, 2006, CURR OPIN LIPIDOL, V17, P637, DOI 10.1097/MOL.0b013e3280106b9; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.51783; Liu Y, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-9; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi19; Marik PE, 2013, CRIT CARE MED, V41, pE93, DOI 10.1097/CCM.0b013e318283d12; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.132; Meigs JB, 2002, DIABETES CARE, V25, P1313, DOI 10.2337/diacare.25.8.131; Naito R, 2014, J CARDIOL, V63, P106, DOI 10.1016/j.jjcc.2013.07.00; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa090835; Sloan FA, 2008, ARCH INTERN MED, V168, P192, DOI 10.1001/archinternmed.2007.3; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.40; Wang W, 2011, PANCREAS, V40, P206, DOI 10.1097/MPA.0b013e31820032a; WHO, 2016, GLOB REP PSO",22,1,1,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,1.0,,,,,123.0,127,,10.19193/0393-6384_2017_1_019,,5,"Medicine, General & Internal",General & Internal Medicine,EP2PY,WOS:000397226800019,,,,,2022-07-14,0.0022727272727272726,4.405889841260527e-11,0.004867037555677191,0.09365596911675068,0.004515976746542698
J,"Jenaabadi, H21",,,,"Jenaabadi, Hossein",,,A COMPARISON OF COGNITIVE EMOTION REGULATION STRATEGIES AND EMOTIONAL SCHEMAS BETWEEN MOTHERS OF CHILDREN WITH MENTAL DISORDERS AND MOTHERS OF PHYSICALLY AND MENTALLY DISABLED CHILDREN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Cognitive Emotion Regulation; Emotional Schemas; Mental Disorders; Disabled Children; Mental and Physical Disability,PARENTS,"Introduction: This study aimed to evaluate cognitive emotion regulation strategies and emotional schemas in mothers of children with mental disorders and mothers of physically and mentally disabled children. Methods and Materials: The method of this study was descriptive followed by a casual-comparative design. The statistical population of this study included all mothers of children with mental disorders and mothers of physically and mentally disabled children in Zahedan. The statistical sample consisted of 63 mothers of children with mental disorders, including emotional disorders, disruptive behavior disorders, and developmental disorders, selected using the random sampling method. The sample was matched with 63 mothers of physically and mentally disabled children chosen among clients admitted to rehabilitation centers and clinics in Zahedan. These two groups filled out the Garnefski, Kraaij, and Spinhoven Cognitive Emotion Regulation Questionnaire and the Leahy Emotional Schemas Scale. The obtained data was analyzed using the multivariate analysis of variance (MANOVA). Results: The results indicated that compared to the mothers of disabled children, the mothers of children with mental disorders obtained higher scores on self-blame, catastrophizing, and other-blame (the subscales of maladaptive cognitive emotion regulation strategies), putting into perspective (the subscale of adaptive cognitive emotion regulation strategies), emotional self-awareness, expression of feelings, not being controlled, comprehensibility, simplistic view of emotions, and acceptance of feelings (the subscales of emotional schemas). Conclusion: It can be concluded that using these improper strategies can put these mothers at the risk of mental issues and conflicts. Therefore, through training efficient emotional schemas and adaptive cognitive emotion regulation strategies, these mothers can be aided to improve their conditions.","[Jenaabadi, Hossein] Univ Sistan & Baluchestan, Fac Educ Sci & Psychol, Dept Educ Sci, Zahedan, Iran","Jenaabadi, H (corresponding author), Univ Sistan & Baluchestan, Fac Educ Sci & Psychol, Dept Educ Sci, Zahedan, Iran.",hjenaabadi@ped.usb.ac.ir,,"Jenaabadi, Hossein/0000-0002-4373-9353",,,"Ahmadi KH, 2013, J BEHAV SCI, V6, P33; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.00; Aminzadeh A, 2011, J REHABIL, V18, P3; Bargh J.A., 2007, HDB EMOTION REGULATI, P429, DOI DOI 10.3109/00048674.2010.49635; Baxter AC, 2007, J AUTISM DEV DISORD, V37, P976, DOI 10.1007/s10803-006-0217-; BHAVNAGRI NP, 1999, EARLY EDUC DEV, V10, P55; Campbell-Sills L., 2007, HDB EMOTION REGULATI, P54; Cordova JV, 2005, J SOC CLIN PSYCHOL, V24, P218, DOI 10.1521/jscp.24.2.218.6227; Darvishi M, 2015, J ARAK U MED SCI, V18, P3; Dowdell E B, 1995, J Psychosoc Nurs Ment Health Serv, V33, P2; Garnefski N, 2004, PERS INDIV DIFFER, V36, P267, DOI 10.1016/S0191-8869(03)00083-; Garnefski N, 2003, J YOUTH ADOLESCENCE, V32, P401, DOI 10.1023/A:102599420055; Gross JJ, 2007, HDB EMOTION REGULATI, V2007, P3, DOI DOI 10.'1080/0014013060097113; Hames A, 1998, CHILD CARE HLTH DEV, V24, P15; Hankin, 2001, DRUG BENEFIT TRENDS, V13, P1; Hasani J, 2014, J CLIN PSYCHOL, V6, P9; Hasani J., 2011, J CLIN PSYCHOL, V2, P7; Jamilian H R, 2014, Glob J Health Sci, V6, P116, DOI 10.5539/gjhs.v6n7p11; Karimi HR, 2004, REHABILITATION SERV; Khanzade M., 2012, J CLIN PSYCHOL, V11, P9; KOEGEL RL, 1992, J AUTISM DEV DISORD, V22, P205, DOI 10.1007/BF0105815; Leahy R. L., 2009, COGNITIVE BEHAV THER, V2, P18; Loeb ME, 2008, ALTER, V2, P32, DOI 10.1016/j.alter.2007.06.00; Mashhadi A, 2011, JCP, V8, P2; McKay M., 2007, DIALECTICAL BEHAV T; Rosenzweig JM, 2002, SOC WORK, V47, P415, DOI 10.1093/sw/47.4.41; Roskam I, 2008, J COUNS DEV, V86, P132, DOI 10.1002/j.1556-6678.2008.tb00490.; Sanders JL, 1997, CHILD FAM BEHAV THER, V19, P15, DOI 10.1300/J019v19n04_0; Tompson NS, 2009, PARENTAL PERCEPTIO; Xie HY, 2005, PSYCHIAT SERV, V56, P1282, DOI 10.1176/appi.ps.56.10.128; Yoselyani GH, 2012, J SCH PSYCHOL, V1, P11; Zamani N, 2014, SCI J ILAM U MED SCI, V20, P4; Zamani N, 2013, J RES HLTH, V123, P2",33,0,0,0,12,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,1.0,,887.0,894,,10.19193/0393-6384_2017_1s_132,,8,"Medicine, General & Internal",General & Internal Medicine,FV8ZR,WOS:000424877000001,,,,,2022-07-14,0.003409090909090909,4.529912889754992e-18,0.006600982445594492,0.05538739707842924,0.006600982445594492
J,"Karabulut, M1;  Afsar, CU;  Karabulut, S;  Peker, KD;  Gemici, E;  Dagoglu, N;  Karaman, S;  Yasasever, CT;  Tas, F",,,,"Karabulut, Mehmet; Afsar, Cigdem Usul; Karabulut, Senem; Peker, Kivanc Derya; Gemici, Eyup; Dagoglu, Nergiz; Karaman, Sule; Yasasever, Ceren Tilgen; Tas, Faruk",,,SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,IL-32; diagnostic; pancreatic adenocancer; prognostic; serum,NF-KAPPA-B; TUMOR PROGRESSION; CARCINOMA-CELLS; CANCER; EXPRESSION; GROWTH; MIGRATION; SUSCEPTIBILITY; POLYMORPHISMS; INFLAMMATION,"Background: Pancreatic adenocarcinoma (PA) is a very lethal malignancy. Different parameters have been found to be predictive and prognostic. This study was conducted to investigate the serum levels of interleukin-32 (IL-32) in patients with PA and the relationship with tumor progression and known prognostic parameters. Materials and methods: Thirty-three patients with PA were investigated. Blood samples were obtained from patients with PA at first admission, one month after surgery and two weeks before adjuvant or palliative treatment. Age and sex matched 30 healthy controls were included in the analysis. Serum IL-32 levels were determined using enzyme-linked immunosorbent assay (ELISA). Results: The median age at diagnosis was 59 years, range 32-84 years; 20 (61%) patients were men. The tumor was located in the head of the pancreas in 21 (63%) patients. The most common metastatic site was liver in 23 patients with metastasis (n = 19, 83%). The median follow-up time was 26.0 weeks (range: 1.0-184.0 weeks). At the end of the observation period, thirty-two patients (97%) were dead. Thirty-nine percent of 23 metastatic patients who received palliative chemotherapy (CTx) were CTx-responsive. Median overall survival (OS) of the whole group was 41.3 +/- 8.3 weeks [95% confidence interval (CI) = 25-58 weeks]. The baseline serum IL-32 levels were significantly higher in patients with PA than in the control group (p=0.04). Serum IL-32 levels were significantly higher in the patients with liver metastatic disease (p=0.05). Moreover, patients with elevated serum IL-32 concentrations had significantly favorable OS compared with those with lower levels (median 47.2 vs 32.7 weeks, respectively, p = 0.05). Conclusion: Despite new therapies; the prognosis of PA is still poor. There is need to find new parameters. Serum levels of IL-32 may be a good diagnostic and prognostic marker for PA according to our data.","[Karabulut, Mehmet; Peker, Kivanc Derya; Gemici, Eyup] Istanbul Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Clin Gen Surg, Istanbul, Turkey; [Afsar, Cigdem Usul] Acibadem Bakirkoy Hosp, Clin Med Oncol, Istanbul, Turkey; [Karabulut, Senem] Istanbul Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Clin Med Oncol, Istanbul, Turkey; [Dagoglu, Nergiz; Karaman, Sule] Istanbul Univ, Inst Oncol, Dept Radiat Oncol, Istanbul, Turkey; [Yasasever, Ceren Tilgen] Istanbul Univ, Inst Oncol, Dept Basic Oncol, Istanbul, Turkey; [Tas, Faruk] Istanbul Univ, Inst Oncol, Dept Med Oncol, Istanbul, Turkey","Afsar, CU (corresponding author), Acibadem Bakirkoy Hosp, Clin Med Oncol, Istanbul, Turkey.",,"Dagoglu, Nergiz/AAE-7450-2020; Tas, Faruk/AAF-8751-2019; Karaman, Sule/AAS-5135-2020; karabulut, senem/AAT-3594-2020; Yasasever, Ceren Tilgen/A-6547-2018; Peker, Kivanc Derya Derya/D-8801-2015; Afsar, Cigdem Usul/C-3436-2015; Gemici, EyÃ¼p/ABC-5796-2020; Afsar, Cigdem Usul/AAA-6103-2021","Karaman, Sule/0000-0002-4810-4453; Yasasever, Ceren Tilgen/0000-0002-8732-4117; Peker, Kivanc Derya Derya/0000-0002-8887-3505; Afsar, Cigdem Usul/0000-0002-3764-7639; Afsar, Cigdem Usul/0000-0002-3764-7639",,,"Bellone G, 2006, CANCER IMMUNOL IMMUN, V55, P684, DOI 10.1007/s00262-005-0047-; Ben-Baruch A, 2006, SEMIN CANCER BIOL, V16, P38, DOI 10.1016/j.semcancer.2005.07.00; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-570; Erturk K, 2016, TUMOR BIOL, V37, P405, DOI 10.1007/s13277-015-3829-; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-; Hong JT, 2017, PHARMACOL THERAPEUT, V174, P127, DOI 10.1016/j.pharmthera.2017.02.02; Ishigami S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0472-; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115; Kang YH, 2012, CANCER LETT, V318, P226, DOI 10.1016/j.canlet.2011.12.02; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.00; Kollmar O, 2006, ANN SURG ONCOL, V13, P263, DOI 10.1245/ASO.2006.03.09; Leach SD, 2015, J EXP MED, V212, P284, DOI 10.1084/jem.2123insight; Lee HJ, 2012, ONCOL LETT, V3, P490, DOI 10.3892/ol.2011.51; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.00; Li YJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-8; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.00; McCawley LJ, 2001, CURR BIOL, V11, pR25, DOI 10.1016/S0960-9822(00)00038-; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-186; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.050823710; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M90036820; Okada S, 1998, JPN J CLIN ONCOL, V28, P12, DOI 10.1093/jjco/28.1.1; Paniccia A, 2015, CHINESE J CANCER RES, V27, P376, DOI 10.3978/j.issn.1000-9604.2015.05.0; Park JS, 2013, CELL ONCOL, V36, P493, DOI 10.1007/s13402-013-0154-; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.02; Seo EH, 2008, J MICROBIOL BIOTECHN, V18, P160; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI [10.3322/caac.21254, 10.1001/jamaoto.2014.2530, 10.3322/caac.21208, 10.1136/bmj.g1502; Sorrentino C, 2009, AM J RESP CRIT CARE, V180, P769, DOI 10.1164/rccm.200903-0400O; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.18; Sunaga N, 2012, INT J CANCER, V130, P1733, DOI 10.1002/ijc.2616; Tjomsland V, 2011, NEOPLASIA, V13, P664, DOI 10.1593/neo.1133; Tsai CY, 2014, CLIN CANCER RES, V20, P2276, DOI 10.1158/1078-0432.CCR-13-122; Wang SM, 2015, ONCOL LETT, V9, P305, DOI 10.3892/ol.2014.264; Wang YW, 2017, BIOMARKERS, V22, P165, DOI 10.1080/1354750X.2016.125295; Wu HH, 2015, J EXP MED, V212, P333, DOI 10.1084/jem.2014170; Yousif NG, 2013, CYTOKINE, V61, P223, DOI 10.1016/j.cyto.2012.09.02; Yu XZ, 2015, TUMOR BIOL, V36, P5265, DOI 10.1007/s13277-015-3186-; Zeng QL, 2014, CYTOKINE, V65, P24, DOI 10.1016/j.cyto.2013.09.01; Zhang Y, 2015, REV RECENT CLIN TRIA, V10, P317, DOI 10.2174/157488711066615091614253",39,1,1,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,613.0,619,,10.19193/0393-6384_2017_4_091,,7,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700012,,,,,2022-07-14,0.0040289256198347105,7.467684534604662e-15,0.03857482043428766,0.08735910186179574,0.03774973872036152
J,"Karaca, F21;   Afsar, CU;   Almali, N;   Karabulut, S;   Karabulut, M;   Keskin, S;   Akbulut, S",,,,"Karaca, Feryal; Afsar, Cigdem Usul; Almali, Necat; Karabulut, Senem; Karabulut, Mehmet; Keskin, Siddik; Akbulut, Serkan",,,THE EFFECT OF PRETREATMENT NEUTROPHIL/LEUCOCYTE RATIO ON SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL CANCER RECEIVING CHEMORADIOTHERAPY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,esophageal cancer; survival; chemotherapy; radiotherapy; neutrophil,DEFINITIVE CHEMORADIOTHERAPY; GASTRIC CANCERS; TRIAL; CHEMOTHERAPY; CARCINOMA; SURGERY; CISPLATIN; RISK,"Introduction: Esophageal cancer (EC) is a highly lethal malignancy. The majority of esophageal cancers are squamous cell or adenocarcinomas. Although the incidence of squamous cell carcinoma (SCC) is decreasing in the United States, the incidence of adenocarcinoma arising out of Barrett's esophagus is rising dramatically, although less so in the last few years. Treatment in locally advanced EC (LA-EC) must be multidisciplinary. There are only few factors which affects the prognosis. Our aim was to investigate the prognostic and predictive roles of pretreatment neutrophil/leucocyte (neu/leu) ratios in LA-EC patients receiving chemoradiotherapy (CRT). Materials and methods: Sixty patients with non-metastatic EC (youngest 31 years old) who applied to our hospital between 2011 and 2015 were included in this study. Neu/leu ratios were calculated before CRT and after CRT. The Kaplan-Meier method was used for estimating the survival function from lifetime data. In addition, Cox regression model was also used to explore the relationship between the survival of a patient and several explanatory variables. Results: There was statistical significance between neu/leu ratio before CRT and OS (p=0.047). One unit increase in neu/leu ratio, increases the probability of being alive 2.725 times (1/0.367). There was statistical significance between neu/leu ratio before CRT and progression-free survival (PFS) (p=0.046). One unit increase in neu/leu ratio, increases the probability of no relapse 3.559 (1/0.281) times. This means that the patients with higher neu/leu ratio before CRT have a lower risk of relapse. Discussion and conclusion: Multimodal therapeutic strategies combining chemotherapy, radiation therapy and surgery have been shown to be feasible and to have a positive impact on outcomes by decreasing the risk of locoregional recurrence and often by increasing overall survival. The overall survival (OS) and disease-free survival (DFS) of patients is too short in patients with LA-EC. Our study shows that patients with LA-EC who had higher pretreatment neu/leu ratios have better OS and PFS.","[Karaca, Feryal] Adana Numune Educ & Res Hosp, Dept Radiat Oncol, Adana, Turkey; [Afsar, Cigdem Usul] Acibadem Bakirkoy Hosp, Dept Med Oncol, Istanbul, Turkey; [Almali, Necat] Van YuzuncuYil Univ, Med Fac, Dept Gen Surg, Van, Turkey; [Karabulut, Senem] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Clin Med Oncol, Istanbul, Turkey; [Karabulut, Mehmet] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Gen Surg, Istanbul, Turkey; [Keskin, Siddik] Van YuzuncuYil Univ, Med Fac, Dept Biostat, Van, Turkey; [Akbulut, Serkan] Adana Numune Educ & Res Hosp, Dept Gen Surg, Adana, Turkey","Afsar, CU (corresponding author), Acibadem Bakirkoy Hosp, Dept Med Oncol, Istanbul, Turkey.",,"Afsar, Cigdem Usul/AAA-6103-2021; Akbulut, Serkan/T-5710-2018; karabulut, senem/AAT-3594-2020; Afsar, Cigdem Usul/C-3436-2015","Afsar, Cigdem Usul/0000-0002-3764-7639; Akbulut, Serkan/0000-0002-2043-2754; Afsar, Cigdem Usul/0000-0002-3764-7639",,,"Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.208; [Anonymous], 2014, ANN SURG, DOI DOI 10.1097/SLA.0000000000000666; Conroy T, 2014, LANCET ONCOL, V15, P305, DOI 10.1016/S1470-2045(14)70028-; Di Fiore F, 2007, AM J GASTROENTEROL, V102, P2557, DOI 10.1111/j.1572-0241.2007.01437.; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg04; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra03501; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-; Gholipour C, 2008, DIS ESOPHAGUS, V21, P322, DOI 10.1111/j.1442-2050.2007.00776.; Huang LJ, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-18; Kelsen DP, 2007, J CLIN ONCOL, V25, P3719, DOI 10.1200/JCO.2006.10.476; Khushalani NI, 2008, MAYO CLIN PROC, V83, P71; LEICHMAN L, 1991, SEMIN ONCOL, V18, P6; Nozoe T, 2001, AM J SURG, V182, P197, DOI 10.1016/S0002-9610(01)00684-; Shan L, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-7; Sobin L. H., 2009, UICC TNM CLASSIFICA; Staal EFWC, 2010, BRIT J SURG, V97, P1482, DOI 10.1002/bjs.717; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.2061; Wang CY, 2009, RADIOTHER ONCOL, V92, P270, DOI 10.1016/j.radonc.2009.01.00; Xu YP, 2013, ONCOL LETT, V5, P185, DOI 10.3892/ol.2012.100; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.059; Yeh HL, 2012, FORMOS J SURG, V45, P172, DOI 10.1016/j.fjs.2012.10.00; Zingg U, 2010, J GASTROINTEST SURG, V14, P462, DOI 10.1007/s11605-009-1113-",22,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,905.0,911,,10.19193/0393-6384_2017_6_144,,7,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500003,,,,,2022-07-14,0.0022727272727272726,1.1729833122389797e-11,0.004334360236312917,0.10485155056812642,0.004334360236312917
J,"Karagoz, H1;  Erden, A;  Ozer, O;  Cetinkaya, A;  Avci, D;  Gencer, V;  Arik, F;  Kalan, U;  Gorkem, H;  Karaman, H;  Karaman, A",,,,"Karagoz, Hatice; Erden, Abdulsamet; Ozer, Ozerhan; Cetinkaya, Ali; Avci, Deniz; Gencer, Vedat; Arik, Ferhat; Kalan, Ugur; Gorkem, Hasan; Karaman, Hatice; Karaman, Ahmet",,,THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,ABO; Blood Groups; Non-alcoholic Fatty Liver Disease; Non-alcoholic Steatohepatitis,PREECLAMPSIA; RISK; SEVERITY; FEATURES; FIBROSIS,"Introduction: Non-alcoholic fatty liver disease is defined as the accumulation of fat in the liver in the absence of excessive alcohol consumption or other known pathologies and is a spectrum of disease ranging from steatosis (fat infiltration into the liver) to steatohepatitis. Non-alcoholic steatohepatitis is a more severe form of Non-alcoholic fatty liver disease which is characterised by steatosis, lobular inflammation, ballooning, and fibrosis in liver biopsies. In this study, we aimed to investigate any possible relationship between the ABO/Rh blood group system and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis, in Turkey. Materials and methods: A total of 179 patients with hepatosteatosis from Kayseri Training and Research Hospital between the years 2002-2012 were included in the study. The distributions of blood groups of the patients with Non-alcoholic fatty liver disease were compared with the distribution of blood groups of 17.314 healthy donors. The patients were examined for any association between ABO/Rh blood groups and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis, and also for an association between ABO/Rh blood groups and grading. Results: Group AB was found to be higher in patients with Non-alcoholic fatty liver disease compared to the control group (p=0.04). The percentage of patients with steatohepatitis was significantly higher in group AB than non-AB blood group (p=0.024). The percentage of patients with steatohepatitis was significantly higher in group grade 3 Non-alcoholic fatty liver disease patients than other two -grade 1 and grade 2 Non-alcoholic fatty liver disease -groups (<0.001). Conclusion: To our knowledge, this is the first analysis in the literature that investigates the association between the ABO blood groups and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis. This epidemiological study can not explain the mechanism behind the blood group effect but may be a light for future studies.","[Karagoz, Hatice; Karaman, Ahmet] Acibadem Kayseri Hosp, Dept Internal Med, Kayseri, Turkey; [Erden, Abdulsamet; Ozer, Ozerhan; Cetinkaya, Ali; Avci, Deniz; Gencer, Vedat; Arik, Ferhat; Kalan, Ugur; Gorkem, Hasan] Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey; [Karaman, Hatice] Kayseri Training & Res Hosp, Dept Clin Pathol, Kayseri, Turkey","Erden, A (corresponding author), Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey.",,"Karaman, Hatice/AAX-1803-2021; Erden, Abdulsamet/W-2397-2019; ÃZER, ÃZERHAN/O-6794-2015; KARAMAN, HATÄ°CE/AAW-2604-2021; KaragÃ¶z, Hatice/AAP-8029-2020","ÃZER, ÃZERHAN/0000-0001-5855-5509; KARAMAN, HATÄ°CE/0000-0002-5250-5663; ",,,"Adams LA, 2005, DIABETIC MED, V22, P1129, DOI 10.1111/j.1464-5491.2005.01748.; ALSARRAF M, 1974, CANCER-AM CANCER SOC, V33, P574, DOI 10.1002/1097-0142(197402)33:2<574::AID-CNCR2820330237>3.0.CO;2-; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.014090; Chandra T, 2012, IRAN J PEDIATR HEMAT, V2, P14; Corrado RL, 2014, MED CLIN N AM, V98, P55, DOI 10.1016/j.mcna.2013.09.00; Farhud DD, 2013, IRAN J PUBLIC HEALTH, V42, P; Flegel WA, 2013, BLOOD TRANSFUS-ITALY, V11, P6, DOI 10.2450/2012.0250-1; HAMLYN AN, 1974, GUT, V15, P480, DOI 10.1136/gut.15.6.48; Hiltunen LM, 2009, THROMB RES, V124, P167, DOI 10.1016/j.thromres.2008.11.01; JICK H, 1969, LANCET, V1, P53; Kamil M, 2010, LIBYAN J MED, V5, DOI 10.3402/ljm.v5i0.484; Karagoz H, 2015, THER CLIN RISK MANAG, V11, P1613, DOI 10.2147/TCRM.S9229; Larsen TB, 2005, J THROMB HAEMOST, V3, P300, DOI 10.1111/j.1538-7836.2005.01195.; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-; MAY D, 1973, BMJ-BRIT MED J, V4, P738, DOI 10.1136/bmj.4.5894.73; MELENDEZ M, 1979, GUT, V20, P288, DOI 10.1136/gut.20.4.28; Morelli VM, 2005, J THROMB HAEMOST, V3, P183, DOI 10.1111/j.1538-7836.2004.01071.; Salomone F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/15327; SANKALE M, 1968, PATHOL BIOL, V16, P107; Shavakhi A, 2012, J RES MED SCI, V17, P46; SPINILLO A, 1995, J HUM HYPERTENS, V9, P62; Stal P, 2015, WORLD J GASTROENTERO, V21, P11077, DOI 10.3748/wjg.v21.i39.1107; Torres DM, 2012, CLIN GASTROENTEROL H, V10, P837, DOI 10.1016/j.cgh.2012.03.01; Yang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.013166; ZUCKERMAN A. J., 1966, J MED GENET, V3, P33, DOI 10.1136/jmg.3.1.3",25,2,2,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,205.0,210,,10.19193/0393-6384_2017_2_030,,6,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700005,,,,,2022-07-14,0.0026859504132231405,1.871639558154826e-08,0.006860764972520109,0.1278343435944165,0.006826381531147096
J,"Khodaii, Z1;  Ghaderian, SMH;  Natanzi, MM",,,,"Khodaii, Zohreh; Ghaderian, Sayyed Mohammad Hossein; Natanzi, Mahboobeh Mehrabani",,,"PROBIOTIC BACTERIA AGAINST HALITOSIS PRODUCING BACTERIA, IN THE PRESENCE OF THE HEP 2 CELLS",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Streptococcus mutans; Lactobacillus routeri; probiotic bacteria; HEp-2 cell,LACTOBACILLUS-RHAMNOSUS GG; ORAL MICROBIOME; IN-VITRO; ADHESION; CARIES,"Background and aim: Streptococcus mutans (S. mutans) is a Gram-positive, bacterium commonly found in the human oral cavity. S. mutans is a significant contributor to tooth decay. The potential application of probiotic bacteria for control and prevention of oral diseases has been the focus of the attention for various health researchers. Material and methods: In this study, primarily, we examined the antibacterial activity of Lactobacillus routeri (L. routeri) against S. mutans using the spot agar test. Secondly, the ability of L. routeri to inhibit the adhesion of pathogenic S. mutans to human epidermoid laryngeal (HEp-2) cell line was tested using coincubation assay. In co incubation experiment, both bacteria were added to HEp-2 cells simultaneously and the number of adhered pathogen was counted in the presence and absent of probiotic bacteria. Results: The result showed that, the presence of L. routeri decreased S. mutans adhesion by 4-folds. Conclusion: In conclusion, probiotic bacteria may prevent colonization of oral cavity by odours producing bacteria: S. mutans.","[Khodaii, Zohreh; Natanzi, Mahboobeh Mehrabani] Alborz Univ Med Sci, Dietary Supplements & Probiot Res Ctr, Karaj, Iran; [Khodaii, Zohreh; Natanzi, Mahboobeh Mehrabani] Alborz Univ Med Sci, Dept Biochem Genet & Nutr, Fac Med, Karaj, Iran; [Ghaderian, Sayyed Mohammad Hossein] Shahid Beheshti Univ Med Sci, Dept Med Genet, Fac Med, Tehran, Iran","Natanzi, MM (corresponding author), Eshteraki Blvd Baghestan, Karaj 9779453, Iran.",Mahboobehmehrabani@yahoo.com,"ghaderian, sayyed mohammad hossein/O-5566-2019; mehrabani natanzi, mahboobeh/O-3489-2017; Khodaii, Zohreh/S-4983-2017","ghaderian, sayyed mohammad hossein/0000-0002-2534-071X; mehrabani natanzi, mahboobeh/0000-0001-8879-5984; Khodaii, Zohreh/0000-0002-8858-1983",,,"Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/00032459; Chaiyasut C, 2012, AFR J MICROBIOL RES, V6, P1658, DOI 10.5897/AJMR10.13; Chang YC, 2001, ORAL SURG ORAL MED O, V92, P446, DOI 10.1067/moe.2001.11681; FARZIANPOUR F, 2014, AM J AGR BIOL SCI, V9, P147, DOI DOI 10.3844/AJAB-SSP.2014.147.15; Hasslof P, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-1; Jenkinson HF, 2011, ENVIRON MICROBIOL, V13, P3077, DOI 10.1111/j.1462-2920.2011.02573.; Lebeer S, 2010, BENEF MICROBES, V1, P335, DOI 10.3920/BM2010.003; Mehrabani M, 2013, INT J ENTRIC PATHOG, V1, P5; Nase L, 2001, CARIES RES, V35, P412, DOI 10.1159/00004748; Organization WH, 2001, HLTH NUTR PROP PRO; Ouwehand AC, 1999, FEMS MICROBIOL LETT, V177, P35, DOI 10.1111/j.1574-6968.1999.tb13710.; Sadoun D., 2014, INT J APPL MICROBIOL, V2, P5; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/002203451141541; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/002203451037960; Twetman S, 2012, Adv Dent Res, V24, P98, DOI 10.1177/002203451244946; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.00; Wu CC, 2015, MOL ORAL MICROBIOL, V30, P16, DOI 10.1111/omi.1206; Yanine N, 2013, CLIN ORAL INVEST, V17, P1627, DOI 10.1007/s00784-013-0990-",18,3,3,1,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,301.0,304,,10.19193/0393-6384_2017_2_045,,4,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700020,,,,,2022-07-14,0.001859504132231405,7.291934199472967e-15,0.0035094935871218167,0.08858384808968199,0.0035094935871218167
J,"Kilic, B1;  Demiroglu, M;  Ozkan, FU;  Soylemez, MS;  Turkmen, I;  Saglam, Y;  Ozkan, K",,,,"Kilic, Bulent; Demiroglu, Murat; Ozkan, Feyza Unlu; Soylemez, Mehmet Salih; Turkmen, Ismail; Saglam, Yavuz; Ozkan, Korhan",,,OSTEOARTHRITIS: CAN IT BE REVERSED? A NEW BIOLOGICAL TREATMENT TECHNIQUE FOR TREATING PATIENTS WITH MODERATE TO ADVANCED GONARTHROSIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Gonarthrosis; Subchondral drilling; Bone Marrow injection; Osteophytectomy,KNEE OSTEOARTHRITIS; SUBCHONDRAL BONE; JOINT LAVAGE; RISK-FACTORS; CARTILAGE; TKA; HIP,"Osteoarthritis of the knee is leading cause of disability in the elderly, all times. Although there are pharmacological and nonpharmacological treatment methods, these are generally insufficient to alleviate pain and the disability in advanced cases Although total knee arthroplasty improves quality of life and provides a generally high level of patient satisfaction for treatment of advanced gonarthrosis, it is not always without complications. Herein we present a new technique consisting of patellofemoral joint irrigation, simple osteophytectomy if needed, lateral patellar retinaculum release, subchondral drilling of the proximal tibia, percutaneous medial collateral ligament release, intra-articular injection of proximal tibial bone marrow, and the results of this treatment applied under local anesthesia in 20 knees of 13 patients. The mean VAS (Visual Analogue Scale) was 8.20 +/- 0.68 prior to treatment and 3.33 +/- 0.72 after treatment; the values were 18.67 +/- 3.34 and 4.10 +/- 3.15 for leg measurements, 7.80 +/- 0.77 and 1.07 +/- 0.96 for pain, 5.07 +/- 2.28 and 1.80 +/- 1.42 for walking, and 5.80 +/- 0.92 and 1.23 +/- 0.92 for daily living activities, respectively. All decreases were statistically significant (p = 0.001 for p < 0.01 in all cases). Biological treatment solutions to gonarthrosis without using foreign materials could decrease the need for prosthetic surgery and its related complications, as well as the need for further attempts at revision. In this study we presented a new biologic treatment for gonarthrosis.","[Kilic, Bulent] Istanbul Gelisim Univ, Dept Hlth Sci, Istanbul, Turkey; [Demiroglu, Murat] Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Dept Orthopaed & Traumatol, Istanbul, Turkey; [Ozkan, Feyza Unlu] Fatih Sultan Mehmet Training & Res Hosp, Dept Phys Therapy & Rehabil, Istanbul, Turkey; [Soylemez, Mehmet Salih] Bingol State Hosp, Dept Orthopaed & Traumatol, Bingol, Turkey; [Turkmen, Ismail] Beykoz State Hosp, Dept Orthopaed & Traumatol, Istanbul, Turkey; [Saglam, Yavuz] Biruni Univ, Dept Orthopaed & Traumatol, Fac Med, Istanbul, Turkey; [Ozkan, Korhan] Istanbul Medeniyet Univ, Dept Orthopaed & Traumatol, Fac Med, Istanbul, Turkey","Kilic, B (corresponding author), Istanbul Gelisim Univ, Dept Hlth Sci, Istanbul, Turkey.",,,,,,"ARNOLDI CC, 1975, J BONE JOINT SURG BR, V57, P360, DOI 10.1302/0301-620X.57B3.36; ARNOLDI CC, 1994, ACTA ORTHOP SCAND, V65, P; Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn02; Bozic KJ, 2014, J BONE JOINT SURG AM, V96A, P640, DOI 10.2106/JBJS.L.0163; Brandt KD, 2003, OSTEOARTHRITI; Davies-Tuck ML, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar291; de Rezende MU, 2015, ACTA ORTOP BRAS, V23, P162, DOI 10.1590/1413-78522015230214588; Farnworth L, 2000, ORTHOPEDICS, V23, P14; Hauser RA, 2013, CLIN MED INSIGHTS-AR, V6, P65, DOI 10.4137/CMAMD.S1095; Healy WL, 2013, CLIN ORTHOP RELAT R, V471, P215, DOI 10.1007/s11999-012-2489-; Higuera CA, 2011, CLIN ORTHOP RELAT R, V469, P1391, DOI 10.1007/s11999-011-1804-; Imhof H, 1997, SKELETAL RADIOL, V26, P398, DOI 10.1007/s00256005025; Iorio R, 2014, CLIN ORTHOP RELAT R, V472, P194, DOI 10.1007/s11999-013-2980-; Koh IJ, 2014, CLIN ORTHOP RELAT R, V472, P316, DOI 10.1007/s11999-013-3252-; LEQUESNE MG, 1987, SCAND J RHEUMATOL, P8; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar440; Lyu SR, 2008, J BONE JOINT SURG BR, V90B, P1186, DOI 10.1302/0301-620X.90B9.2058; Moskowitz RW, 2001, OSTEOARTHRITIS DIAG; Murphy L, 2012, ORTHOP NURS, V31, P85, DOI 10.1097/NOR.0b013e31824fcd4; Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.2088; Piedade SR, 2013, KNEE SURG SPORT TR A, V21, P2737, DOI 10.1007/s00167-012-2139-; Prakash D, 2002, KNEE, V9, P7, DOI 10.1016/S0968-0160(01)00133-; Ravaud P, 1999, ARTHRITIS RHEUM-US, V42, P475, DOI 10.1002/1529-0131(199904)42:3<475::AID-ANR12>3.0.CO;2-; Simkin P.A., 2004, NOVART FDN SYMP, V260, P18; Simkin PA., 2004, NOVART FDN SYMP, V260, P27; Simkin Peter A, 2004, Novartis Found Symp, V260, P17; Siow WM, 2013, CLIN ORTHOP RELAT R, V471, P1451, DOI 10.1007/s11999-012-2776-; Tanamas SK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar297; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.477013040; Wluka A, 2007, OSTEOARTHR CARTILAGE, V15, P1437, DOI 10.1016/j.joca.2007.04.01",30,3,3,2,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,335.0,340,,10.19193/0393-6384_2017_2_050,,6,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700025,,,,,2022-07-14,0.0030991735537190084,1.876335469756682e-08,0.005983068908662273,0.1277769711049804,0.005983068908662273
J,"Koca, R1;  Eyigor, M;  Osma, U;  Eyigor, H;  Yilmaz, MD;  Selcuk, OT;  Renda, L;  Gultekin, M",,,,"Koca, Rahime; Eyigor, Mete; Osma, Ustun; Eyigor, Hulya; Yilmaz, Mustafa Deniz; Selcuk, Omer Tarik; Renda, Levent; Gultekin, Meral",,,SIGNIFICANCE OF INTERLEUKIN-17A AND INTERLEUKIN-23 IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Chronic rhinosinusitis; nasal polyposis; IL-17A; IL-23; serum; nasal lavage; ELISA,EXPRESSION; IL-17; IL-23; SINUSITIS; CYTOKINE; DISTINCT; CHILDREN,"Introduction: Several previous studies have investigated the significance of interleukin 17 (IL-17) in the pathogenesis of chronic rhinosinusitis with nasal polyposis; however, the importance of IL-23 has not been studied. We investigated the significance of IL-17 and IL-23 in the pathogenesis of by chronic rhinosinusitis with nasal polyposis measuring the levels of these proinflammatory cytokines in serum and nasal lavage samples. Materials and methods: Twenty-five patients aged >18 years with chronic rhinosinusitis with nasal polyposis and a control group with 25 healthy subjects were included the study. The levels of IL-17 and IL-23 were measured in the serum and nasal lavage fluids using enzyme-linked immunosorbent assays. Results: The average serum level of IL-17 was 10.2 pg/ml in the study group, and it was 5.0 pg/ml in the control group. The average nasal lavage level of IL-17 was 16.8 pg/ml in the study group compared with 1.0 pg/ml in the control group. There were no statistically significant differences between the groups in the serum levels of IL-17 or IL-23; however, a significant difference between the two groups was found in the lavage fluid levels of IL-17 (p < 0.001). Conclusion: We found a significant difference in the nasal lavage fluid levels of IL-17, which demonstrates the importance of local inflammation. This supports the hypothesis that IL-17 is significant in the pathogenesis of nasal polyposis.","[Koca, Rahime; Osma, Ustun; Yilmaz, Mustafa Deniz; Selcuk, Omer Tarik; Renda, Levent] Antalya Educ & Res Hosp, Dept ENT Head & Neck Surg, Antalya, Turkey; [Eyigor, Mete; Eyigor, Hulya; Gultekin, Meral] Akdeniz Univ, Fac Med, Dept Med Microbiol, Antalya, Turkey","Selcuk, OT (corresponding author), Antalya Educ & Res Hosp, ENT Dept, Antalya, Turkey.",,"Selcuk, Omer/AAJ-3450-2021; Eyigor, Mete/C-1251-2016","Selcuk, Omer/0000-0002-7364-7599; ",Antalya Education and Research Hospital,The study was funded by Antalya Education and Research Hospital<SUP>1</SUP>,"Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P; Beadling C, 2006, ARCH IMMUNOL THER EX, V54, P15, DOI 10.1007/s00005-006-0002-; Bernstein JM, 1995, OTOLARYNG HEAD NECK, V113, P724, DOI 10.1016/S0194-5998(95)70012-; Ciprandi G, 2009, ALLERGY, V64, P1375, DOI 10.1111/j.1398-9995.2009.02010.; [æè¿æ¶ Du Jintao], 2010, [åå·å¤§å­¦å­¦æ¥. å»å­¦ç, Journal of Sichuan University. Medical Science Edition], V41, P23; Fokkens W, 2007, RHINOLOGY S20, V45, P; GEORGITIS JW, 1995, INT ARCH ALLERGY IMM, V106, P416, DOI 10.1159/00023687; HAMILOS DL, 1993, J ALLERGY CLIN IMMUN, V92, P39, DOI 10.1016/0091-6749(93)90035-; Hu XD, 2013, J INT MED RES, V41, P777, DOI 10.1177/030006051347808; Jacobi HH, 1999, J ALLERGY CLIN IMMUN, V103, P768, DOI 10.1016/S0091-6749(99)70418-; Jiang XD, 2011, AM J RHINOL ALLERGY, V25, pE171, DOI 10.2500/ajra.2011.25.364; Liu SJ, 2007, J LEUKOCYTE BIOL, V82, P354, DOI 10.1189/jlb.020711; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P18; Makihara S, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.01; Martines F, 2016, BRAZ J OTORHINOLAR, V82, P215, DOI 10.1016/j.bjorl.2015.04.00; Martines Francesco, 2014, J Med Case Rep, V8, P282, DOI 10.1186/1752-1947-8-28; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.169; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.02; Molet SM, 2003, LARYNGOSCOPE, V113, P1803, DOI 10.1097/00005537-200310000-0002; Mucia M, 2015, ACTA MEDICA MEDITERR, V31, P41; Ono N, 2012, ALLERGY RHINOL, V3, pE50, DOI 10.2500/ar.2012.3.003; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-; Saitoh T, 2010, INT ARCH ALLERGY IMM, V151, P8, DOI 10.1159/00023256; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.2006140; Shen Y, 2011, SCAND J IMMUNOL, V74, P176, DOI 10.1111/j.1365-3083.2011.02546.; Steinke JW, 2004, AM J RESP CELL MOL, V30, P212, DOI 10.1165/rcmb.2003-0071O; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.01; Wakashin H, 2009, INT ARCH ALLERGY IMM, V149, P108, DOI 10.1159/00021138; Wang M, 2013, CLIN EXP ALLERGY, V43, P956, DOI 10.1111/cea.1212; Wang X, 2006, ANN OTO RHINOL LARYN, V115, P450, DOI 10.1177/00034894061150060",30,2,2,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,211.0,216,,10.19193/0393-6384_2017_2_031,,6,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700006,,,,,2022-07-14,0.0030991735537190084,1.3470099608389562e-26,0.005578827255734774,0.05739731631969357,0.00560454003256678
J,"Komurcu, O1;  Avci, A;  Gulen, M;  Ozer, AI;  Kocer, M;  Ulger, H;  Satar, S",,,,"Komurcu, Ozkan; Avci, Akkan; Gulen, Muge; Ozer, Ali Ilker; Kocer, Mursel; Ulger, Huseyin; Satar, Salim",,,THE PROGNOSTIC ROLE OF MPV AND RDW IN PATIENTS WITH SPONTANEOUS INTRACEREBRAL HEMORRHAGE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,MPV; RDW; Haemorrhagic Stroke; Emergency Service,CELL DISTRIBUTION WIDTH; MORTALITY; DISEASE; STROKE; RISK; RECEPTOR,"Aim: Having serious complications and high morbidity and mortality rate, stroke, which can result from ischemic and haemorrhagic causes, is a significant emergency case that requires early diagnosis and treatment. The aim of this study is to identify whether their is a significant relationship between mean value of platelet volume obtained from complete blood cell count of the patients diagnosed with haemorrhagic stroke, corpuscular distribution volume value and bleeding volume value identified in the computed tomography scans of the head. Material and method: The sample of the study consisted of all patients aged above 18 and diagnosed with haemorrhagic stroke who applied to Emergency Unit at Adana Numune Education and Research Hospital between 1, June 2014 and 30, July 2016. Results: The sample included 86 patients with haemorrhagic stroke. The sample consisted of 58 % (n=50) male and 41,9 % (n=36) female. The mean value for the patients' ages was 60,4 +/- 16,5. Among the patients, 60,5 % (n=52) of them were observed to have applied to the emergency service with sudden clouding of consciousness. A high majority of patients these (79,5 %) were later exitus. The mean value of red cells distribution volume of the patients with exitus was significantly higher than those of surviving patients' (p<0,05). Parenchymal bleeding was observed to exist in 55,8 % (n=48) of the patients. The mortality rate for the patients with high bleeding volume was higher. Conclusion: Impaired consciousness, existence of hypertension, high corpuscular distribution and bleeding volume can be among the factors affecting mortality.","[Komurcu, Ozkan] Sehit Kamil State Hosp, Emergency Med Serv, Gaziantep, Turkey; [Avci, Akkan; Gulen, Muge; Ozer, Ali Ilker; Ulger, Huseyin; Satar, Salim] Health Sci Univ, Adana Numune Training & Res Hosp, Adana, Turkey; [Kocer, Mursel] Balikligol State Hosp, Emergency Serv, Sanliurfa, Turkey","Avci, A (corresponding author), Hlth Sci Univ, Adana Numune Training & Res Hosp, Dept Emergency Med, TR-01240 Adana, Turkey.",,,,,,"Akca ASD, 2012, TURK J GERIATR, V15, P15; Ali SS, 2000, HYPERTENSION COMPANI, P11; Altintas O, 2017, TURK NEUROSURG, V27, P368, DOI 10.5137/1019-5149.JTN.16136-15.; Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.02; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B; Cigsar G, 2015, KAFKAS J MED SCI, V5, P; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.79; Eroglu A, 2012, TURK NOROSIRURJI DER, V22, P16; FIESCHI C, 1988, STROKE, V19, P192, DOI 10.1161/01.STR.19.2.19; Fukuta H, 2009, INT HEART J, V50, P301, DOI 10.1536/ihj.50.30; Garcia JH, 1994, INTRACEREBRAL HEMORR, P4; Gul HL, 2006, THESI; Gurol ME., 2010, KLIN GELISIM DERGISI, V23, P1; Hommel M., 2014, CEREBROVASC DIS, P77; Kim JA, 1996, BIOCHEM BIOPH RES CO, V27, P5; Kiyan S, 2009, EURASIAN J EMERG MED, V8, P15, DOI 10.4170/JAEM.2009.4633; Lopez-Farre A, 2001, NEPHROL DIAL TRANSPL, V16, P45, DOI 10.1093/ndt/16.suppl_1.4; Mayda DF, 2010, J STROKE CEREBROVASC, V19, P6; Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.000000000000036; MULLEY GP, 1983, THROMB HAEMOSTASIS, V50, P52; Naidech AM, 2009, ANN NEUROL, V65, P352, DOI 10.1002/ana.2161; Nickenig G, 2002, CIRCULATION, V105, P393, DOI 10.1161/hc0302.10261; NIIZUMA H, 1988, STROKE, V19, P987, DOI 10.1161/01.STR.19.8.98; Ogihara T, 2002, HYPERTENSION, V40, P872, DOI 10.1161/01.HYP.0000040262.48405.A; Ozdemir G, 2002, INTRASEREBRAL HEMORA, P15; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp16; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.5; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793o; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM20010510344190; Serebruany VL, 1998, STROKE, V29, P235, DOI 10.1161/01.STR.29.1.23; STEINER I, 1984, STROKE, V15, P279, DOI 10.1161/01.STR.15.2.27; Takahashi O, 2006, QJM-INT J MED, V99, P743, DOI 10.1093/qjmed/hcl10; Unger T, 2002, AM J CARDIOL, V89, p3; Uyarel H, 2012, INT J CARDIOL, V154, P351, DOI 10.1016/j.ijcard.2011.10.12; Wolf PA, 2000, CIRCULATION, V102, P7; Yilmaz M, 2011, J CLIN EXP INVEST, V2, P40; Ziai Wendy C, 2003, J Stroke Cerebrovasc Dis, V12, P201, DOI 10.1016/S1052-3057(03)00075-",37,3,3,2,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,527.0,533,,10.19193/0393-6384_2017_3_078,,7,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200026,,,,,2022-07-14,0.003822314049586777,4.4942559798580474e-11,0.060333444085397946,0.10589071815347591,0.05852068357669757
J,"Kuscu, F1;  Komur, S;  Caglayik, DY;  Ulu, A;  Inal, AS;  Kurtaran, B;  Tasova, Y;  Aksu, HSZ;  Ozkul, A",,,,"Kuscu, Ferit; Komur, Suheyla; Caglayik, Dilek Yagci; Ulu, Aslihan; Inal, Ayse Seza; Kurtaran, Behice; Tasova, Yesim; Aksu, Hasan Salih Zeki; Ozkul, Aykut",,,IS CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS TOPOTYPE IMPORTANT IN THE POSSIBILITY OF NOSOCOMIAL TRANSMISSION?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Crimean-Congo hemorrhagic fever; nosocomial transmission; Phylogenetic analysis,M-RNA SEGMENT; RIBAVIRIN PROPHYLAXIS; OUTBREAK,"Introduction: Crimean-Congo hemorrhagic fever (CCHF) is a viral zoonotic disease which is mainly transmitted by tick bite. Contact with blood or body secretions of viremic humans or animals is also among the other modes of transmission. In this study, the serological states in terms of CCHF tested in healthcare workers (HCW) who had had contact with two fatal patients with a diagnosis of CCHF. The relation of the transmission possibility with the phylogenetic analysis of the virus were evaluated. Materials and methods: CCHF IgM and IgG were investigated with ELISA one month after contact with index cases in HCW. The contact levels and states of use of personal protective equipment (PPE) were evaluated. Phylogenetic analysis with sequence analysis based on partial sequences of NP coding region was performed for CCHF viruses detected in the index cases. Results: CCHF IgM and IgG were found negative in any of 20 healthcare workers some of whom had a history of high-risk contact. The sequence analysis revealed that the viruses found in both patients were identical. Phylogenetic evaluation showed that both viruses have high homology with the viruses which were determined previously in the endemic area in Turkey. Conclusion: As in our study, detection of virus topotype with sequence analysis in studies about nosocomial transmission will help to determine if there is a difference between virus subtypes in terms of transmission.","[Kuscu, Ferit; Komur, Suheyla; Ulu, Aslihan; Inal, Ayse Seza; Kurtaran, Behice; Tasova, Yesim; Aksu, Hasan Salih Zeki] Cukurova Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Adana, Turkey; [Caglayik, Dilek Yagci] Publ Hlth Inst Turkey, Natl Arbovirus & Viral Zoonoses Reference & Res L, Ankara, Turkey; [Caglayik, Dilek Yagci] Marmara Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey; [Ozkul, Aykut] Ankara Univ, Fac Vet Med, Dept Virol, Ankara, Turkey","Kuscu, F (corresponding author), Cukurova Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Adana, Turkey.",,"Kuscu, Ferit/L-2974-2016; Inal, Ayse Seza/B-7367-2016; TaÅova, YeÅim/H-5871-2018; kÃ¶mÃ¼r, sÃ¼heyla/E-9639-2018; Candevir, Aslihan/A-8016-2015; ÃaÄlayÄ±k, Dilek YaÄcÄ±/AAD-5747-2020; Ozkul, Aykut/A-1973-2016; Kurtaran, Behice/E-9577-2018","Kuscu, Ferit/0000-0001-5662-8305; Inal, Ayse Seza/0000-0002-1182-7164; Candevir, Aslihan/0000-0001-9340-516X; ÃaÄlayÄ±k, Dilek YaÄcÄ±/0000-0003-3473-8073; Ozkul, Aykut/0000-0001-5008-9443; Kurtaran, Behice/0000-0002-2081-4664",,,"Ahmed AA, 2005, J GEN VIROL, V86, P3327, DOI 10.1099/vir.0.81175-; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-1; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.94; Celikbas AK, 2014, EMERG INFECT DIS, V20, P477, DOI 10.3201/eid2003.13135; Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.; Gozel MG, 2013, INT J INFECT DIS, V17, pE1046, DOI 10.1016/j.ijid.2013.05.00; Guner R, 2014, VECTOR-BORNE ZOONOT, V14, P601, DOI 10.1089/vbz.2013.154; Haferkamp S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-4; JUKES T H, 1969, P2; Leblebicioglu H, 2016, ANTIVIR RES, V126, P21, DOI 10.1016/j.antiviral.2015.12.00; Morikawa S, 2007, COMP IMMUNOL MICROB, V30, P375, DOI 10.1016/j.cimid.2007.07.00; Oncu Serkan, 2013, Virologica Sinica, V28, P193, DOI 10.1007/s12250-013-3327-; Ozdarendeli A, 2008, ARCH VIROL, V153, P37, DOI 10.1007/s00705-007-1056-; Ozkaya E, 2010, VIRUS RES, V149, P64, DOI 10.1016/j.virusres.2009.12.01; Papa A, 2005, J MED VIROL, V75, P466, DOI 10.1002/jmv.2029; Papa A, 2011, SCAND J INFECT DIS, V43, P225, DOI 10.3109/00365548.2010.54003; Pshenichnaya NY, 2015, INT J INFECT DIS, V33, P120, DOI 10.1016/j.ijid.2014.12.04; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a04045; SULEIMAN MNEH, 1980, LANCET, V2, P93; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.040420610; TIGNOR GH, 1993, ANTIVIR RES, V22, P309, DOI 10.1016/0166-3542(93)90040-; Tutuncu EE, 2009, SCAND J INFECT DIS, V41, P377, DOI 10.1080/0036554090288243; VANEEDEN PJ, 1985, S AFR MED J, V68, P71; Vorou R, 2007, CURR OPIN INFECT DIS, V20, P495, DOI 10.1097/QCO.0b013e3282a56a0; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.00",29,3,3,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,575.0,580,,10.19193/0393-6384_2017_4_084,,6,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700005,,,,,2022-07-14,0.002995867768595041,1.7317477498566097e-20,0.00553276928159413,0.07471730153216781,0.005512506000418786
J,"La Marra, M1;  Valenzano, A;  Ruberto, M;  Perrella, R;  Iavarone, A;  Chieffi, S;  Monda, V;  Albano, GD;  Sessa, F;  Marsala, G;  Centofanti, D;  Salerno, M;  Triggiani, AI;  Messina, A;  Caviglia, G",,,,"La Marra, Marco; Valenzano, Anna; Ruberto, Maria; Perrella, Raffaella; Iavarone, Alessandro; Chieffi, Sergio; Monda, Vincenzo; Albano, Giuseppe Davide; Sessa, Francesco; Marsala, Gabriella; Centofanti, Domenico; Salerno, Monica; Triggiani, Antonio Ivano; Messina, Antonietta; Caviglia, Giorgio",,,RETRACTED: THE EFFECTS OF OVERWEIGHT AND OBESITY ON COGNITIVE FUNCTIONS AND PSYCHOLOGICAL WELL-BEING (Retracted article),ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,Obesity; cognitive decline; mood disorders,BODY-MASS INDEX; BLOOD-BRAIN-BARRIER; C-REACTIVE PROTEIN; FOLLOW-UP; ALZHEIMER-TYPE; INSULIN-RESISTANCE; RISK-FACTORS; DEMENTIA; DEPRESSION; CHILDREN,"Recent findings showed that obesity represent a risk factor to developingbrain illness such as cognitive impairments and psychopathological disorders. Weight increase additively afflicts brain structure of cognitively impaired patients but is linked with poor brain volumes even in healthysubjects. Further, several studies show that subjects with psychiatric disorders are more likely than general population to be obese. Hovewer, the process by which weight gain injures cognitive abilities and psychological well-being remain unclear. In this review we analyze the relationships between obesity andbrain illness and underline the role played by covariates to determine this link.","[La Marra, Marco; Chieffi, Sergio; Monda, Vincenzo; Messina, Antonietta] Univ Campania Luigi Vanvitelli, Sect Human Physiol, Dept Expt Med, Naples, Italy; [Valenzano, Anna; Albano, Giuseppe Davide; Sessa, Francesco; Salerno, Monica; Triggiani, Antonio Ivano] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Ruberto, Maria] Univ Campania Luigi Vanvitelli, Dept Med Surg & Dent Specialties, Naples, Italy; [Perrella, Raffaella; Caviglia, Giorgio] Univ Campania Luigi Vanvitelli, Dept Psychol, Naples, Italy; [Iavarone, Alessandro] AORN Osped Colli, CTO Hosp, Neurol & Stroke Unit, Naples, Italy; [Marsala, Gabriella] Azienda Osped Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy; [Centofanti, Domenico] Natl Assoc Nutr Sci Specialists, Rome, Italy; [Centofanti, Domenico] Italian Soc Aesthet Med, Rome, Italy","Messina, A (corresponding author), Univ Campania Luigi Vanvitelli, Sect Human Physiol, Dept Expt Med, Naples, Italy.;Triggiani, AI (corresponding author), Univ Foggia, Dept Clin & Expt Med, Foggia, Italy.",ivanotriggiani@gmail.com; ivanotriggiani@gmail.com,"Messina, Antonietta/AHH-2383-2022; Sessa, Francesco/G-1754-2018; SALERNO, MONICA/AAC-1321-2019; MESSINA, ANTONIETTA/K-9366-2016; Triggiani, Antonio Ivano/M-6252-2015","Messina, Antonietta/0000-0001-8343-432X; Sessa, Francesco/0000-0003-0357-8791; SALERNO, MONICA/0000-0002-6410-3960; la marra, marco/0000-0001-7488-8493",,,"Aksoy A, 2016, ACTA MEDICA MEDITERR, V32, P707, DOI 10.19193/0393-6384_2016_3_7; Amann B, 2009, J AFFECT DISORDERS, V118, P155, DOI 10.1016/j.jad.2009.01.02; Amieva H, 2005, BRAIN, V128, P1093, DOI 10.1093/brain/awh45; Atik D, 2016, ACTA MEDICA MEDITERR, V32, P933, DOI 10.19193/0393-6384_2016_4_11; Balkan A, 2016, ACTA MEDICA MEDITERR, V32, P669, DOI 10.19193/0393-6384_2016_3_7; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.01; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.; BLACK DW, 1992, AM J PSYCHIAT, V149, P22; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm01; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Cerretani D, 2011, PHARMACOL RES, V64, P517, DOI 10.1016/j.phrs.2011.08.00; Chieffi S, 2011, CURR TOP PEPT PROTEI, V12, P7; Chieffi S, 2011, CURR TOPICS PEPTIDE, V12, P6; Chieffi S, 2013, HORIZON NEUROSCIENCE, V1; Chieffi S., 2016, JOUNRAL PSYCHIAT, V19, P388, DOI [10.4172/2378-5756.1000388, DOI 10.4172/2378-5756.1000388; Chieffi S, 2015, J PSYCHIAT, V18, P297, DOI DOI 10.4172/2378-5756.100029; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b22; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq04; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.80; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572co; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.00; Gao JL, 2016, ACTA MEDICA MEDITERR, V32, P55; Gazdzinski S, 2008, ANN NEUROL, V63, P652, DOI 10.1002/ana.2137; Ghasemzadeh I, 2016, ACTA MEDICA MEDITERR, V32, P201; Glinski J, 2001, OBES SURG, V11, P581, DOI 10.1381/0960892016055705; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.49; Gorospe EC, 2007, AGE AGEING, V36, P23, DOI 10.1093/ageing/afl12; Grimley Evans J, 2003, COCHRANE DATABASE SY, V; Gunstad J, 2008, BRAIN RES, V1230, P233, DOI 10.1016/j.brainres.2008.07.04; Gustafson D, 2004, NEUROLOGY, V63, P1876, DOI 10.1212/01.WNL.0000141850.47773.5; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.152; Hajloo N, 2016, ACTA MEDICA MEDITERR, V32, P109; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.00; Hassing LB, 2009, INT J OBESITY, V33, P893, DOI 10.1038/ijo.2009.10; Ho AJ, 2010, NEUROBIOL AGING, V31, P1326, DOI 10.1016/j.neurobiolaging.2010.04.00; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.767818; Iavarone A, 2007, J AUTISM DEV DISORD, V37, P775, DOI 10.1007/s10803-006-0190-; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.154; Jahangiri A, 2013, OBESITY, V21, P993, DOI 10.1002/oby.2012; Jahdi F, 2016, ACTA MEDICA MEDITERR, V32, P127; Jalili Z, 2016, ACTA MEDICA MEDITERR, V32, P197; Kolotkin RL, 2003, OBES SURG, V13, P371, DOI 10.1381/09608920376588768; Lan YH, 2016, ACTA MEDICA MEDITERR, V32, P115; Lee YH, 2009, NEUROENDOCRINOLOGY, V90, P383, DOI 10.1159/00023555; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.39; Maddi SR, 2001, OBES SURG, V11, P680, DOI 10.1381/0960892016055860; Messina G, 2011, CURR TOPICS PEPTIDE, V12, P7; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.00; Mitchell NS, 2011, PSYCHIAT CLIN N AM, V34, P717, DOI 10.1016/j.psc.2011.08.00; Moroz N, 2008, J ALZHEIMERS DIS, V15, P2; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P401, DOI 10.1016/j.bbadis.2008.12.00; Moscatelli F, 2015, BIOL ME; Mrak RE, 2009, CLIN NEUROPATHOL, V28, P4; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-; Nguyen JCD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.0037; Nicosia L, 2016, ACTA MEDICA MEDITERR, V32, P1567, DOI 10.19193/0393-6384_2016_5_13; Nodari RJ, 2016, ACTA MEDICA MEDITERR, V32, P1015, DOI 10.19193/0393-6384_2016_4_12; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.123072; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg27; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri292; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.04; Papageorgiou GM, 2002, OBES SURG, V12, P534, DOI 10.1381/09608920276225230; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.32; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.2087; Ramos JM, 2016, ACTA MEDICA MEDITERR, V32, P27; Richardson LP, 2003, ARCH PEDIAT ADOL MED, V157, P739, DOI 10.1001/archpedi.157.8.73; Rosengren A, 2005, ARCH INTERN MED, V165, P321, DOI 10.1001/archinte.165.3.32; Salomone F, 2013, STEM CELL RES, V11, P1037, DOI 10.1016/j.scr.2013.07.00; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a00618; Shahrbabaki PM, 2016, ACTA MEDICA MEDITERR, V32, P87; Shen H, 2016, ACTA MEDICA MEDITERR, V32, P5; Silay K, 2016, ACTA MEDICA MEDITERR, V32, P12; Skoog I, 1998, NEUROLOGY, V50, P966, DOI 10.1212/WNL.50.4.96; Song JU, 2016, ACTA MEDICA MEDITERR, V32, P44; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.; Tibullo D, 2013, CURR PHARM DESIGN, V19, P2765, DOI 10.2174/138161281131915001; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2008, INT J LEGAL MED, V122, P173, DOI 10.1007/s00414-007-0208-; Turillazzi E, 2008, VIRCHOWS ARCH, V453, P209, DOI 10.1007/s00428-008-0632-; Uluocak N, 2016, ACTA MEDICA MEDITERR, V32, P1029, DOI 10.19193/0393-6384_2016_4_12; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Volti GL, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-6; Wang QX, 2016, ACTA MEDICA MEDITERR, V32, P50; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-2; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.e; World Health Organization, 2011, OB OV FACTSHEE; Yaffe K, 2007, CURR ALZHEIMER RES, V4, P123, DOI 10.2174/15672050778036219; Yazdanbakhsh K, 2016, ACTA MEDICA MEDITERR, V32, P200; Yu M, 2016, ACTA MEDICA MEDITERR, V32, P1767, DOI 10.19193/0393-6384_2016_6_16; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.97",100,0,0,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1225.0,1231,,10.19193/0393-6384_2017_2s_190,,7,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700007,,,,,2022-07-14,0.010330578512396695,0.02560838815641792,0.088291338345801,0.11359769049323461,0.0812689496531981
J,"Lei, W1;  Ping, LS;  Mou, XD;  Jun, L",,,,"Lei, Wei; Ping, Liao Su; Mou, Xing Dan; Jun, Liu",,,THE EFFECTS OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) ON FUNCTIONAL REGENERATION OF TRANSECTED FEMORAL NERVE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Femoral nerve injury; Glial cell line-Derived Neurotrophic Factor (GDNF); Nerve Regeneration; Functional recovery,BINDING NGF-BETA; COLLAGEN SCAFFOLDS; LARYNGEAL MUSCLES; SCHWANN-CELLS; REPAIR; CONDUIT; EXPRESSION; PROMOTION; LAMININ; RATS,"Femoral nerve injury is still a challenge because of the lack of effective treatments. In this research, a new drug delivery system is built, which contains a tube of polylactic acid-trimethylene carbonate (PA-TC) equipped with Glial cell line-Derived Neurotrophic Factor (GDNF) and examined its capability to facilitate functional recovery in femoral nerve injury. At the bottom of the transected femoral nerve in rats, a tube injected with GDNF will be installed. Assessment of functional recovery will be made at the fourth, the eight, and twelfth weeks after injury. Compared with animals remedied by antilogous nerve grafting (p < 0.05), those animals treated with the PA-TC tube loaded with GDNF showed improvement of recovery in muscle action potentials and regenerated fiber area. As a result, we can conclude that drug delivery system which induced nerve regeneration following femoral nerve transaction takes better effects than which induced by antilogous nerve grafting. It is possible to have great potential to be applied in nerve regeneration of femoral nerve transection injury.","[Lei, Wei; Ping, Liao Su; Mou, Xing Dan; Jun, Liu] Huazhong Univ Sci & Technol, Pu Ai Hosp, Dept Hand Surg, Wuhan, Hubei, Peoples R China","Lei, W (corresponding author), Huazhong Univ Sci & Technol, Pu Ai Hosp, Dept Hand Surg, Wuhan, Hubei, Peoples R China.",eeplore@163.com,,,,,"Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-; Bozkurt A, 2016, BIOMATERIALS, V75, P112, DOI 10.1016/j.biomaterials.2015.10.00; Cao JN, 2013, BIOMATERIALS, V34, P1302, DOI 10.1016/j.biomaterials.2012.10.03; Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.02; Chen PR, 2004, BIOMATERIALS, V25, P5667, DOI 10.1016/j.biomaterials.2004.01.05; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.4; Ciaramitaro P, 2010, J PERIPHER NERV SYST, V15, P120, DOI 10.1111/j.1529-8027.2010.00260.; de Boer R, 2011, MICROSURG, V31, P293, DOI 10.1002/micr.2086; Ding T, 2011, REGEN MED, V6, P437, DOI [10.2217/RME.11.39, 10.2217/rme.11.39; Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.00; Ha SW, 2009, CHEM COMMUN, P2881, DOI 10.1039/b902195; Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/10763270032074; Hernandez-Morato I, 2014, LARYNGOSCOPE, V124, P2750, DOI 10.1002/lary.2475; Immerman I, 2014, BULL HOSP JT DIS, V72, P4; Iorio JA, 2016, CURR REV MUSCULOSKE, V9, P290, DOI 10.1007/s12178-016-9350-; Li BC, 2010, J BIOMED MATER RES A, V94A, P769, DOI 10.1002/jbm.a.3272; Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.3086; Luo ZT, 2014, CHEM COMMUN, V50, P5143, DOI 10.1039/c3cc47512; Pattammattel A, 2015, RSC ADV, V5, P59364, DOI 10.1039/c5ra10306; Petis S, 2015, CAN J SURG, V58, P128, DOI 10.1503/cjs.00721; Pierucci A, 2008, TISSUE ENG PT A, V14, P595, DOI 10.1089/tea.2007.027; Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.3141; Sun WJ, 2010, J BIOMED MATER RES A, V92A, P887, DOI 10.1002/jbm.a.3244; Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.03; Sun WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.000618; Vega-Cordova X, 2010, LARYNGOSCOPE, V120, P1591, DOI 10.1002/lary.2102; Wood MD, 2013, BIOTECHNOL BIOENG, V110, P1272, DOI 10.1002/bit.2480; Xu YQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.014718; Yang XN, 2013, BIOMATERIALS, V34, P5606, DOI 10.1016/j.biomaterials.2013.04.01; Yin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.014197; Yuan JJ, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5437-",31,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,1117.0,1122,,10.19193/0393-6384_2017_6_175,,6,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500034,,,,,2022-07-14,0.003305785123966942,1.878693213057913e-08,0.00639503261299277,0.12778371813657544,0.00639503261299277
J,"Liao, J1;  Deng, YJ;  Ailijiang, ASL;  Liu, ZF;  Meng, QC;  Xiang, WY;  Yu, HC;  Fang, R",,,,"Liao, Jun; Deng, Yingjie; Ailijiang, Asila; Liu, Zhenfeng; Meng, Qingcai; Xiang, Wenyuan; Yu, Haicheng; Fang, Rui",,,SHOULDER ARTHROSCOPIC ANCHOR IMPLANTATION AND FIXATION FOR SHOULDER JOINT BANKART INJURY CAUSED BY SWIMMING,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Shoulder Arthroscopy; Anchor Implantation and Fixation; Shoulder Joint Bankart Injury; Clinical Efficacy,STRESS; WATER,"This study attempted to better understand the clinical efficacy of shoulder arthroscopic anchor implantation and fixation for shoulder joint bankart injury patients, in order to provide a scientific basis guiding the clinical treatment of related diseases. We collected the clinical data of a total of 1025 cases of patients with shoulder joint bankart injury caused by swimming and treated in twenty medical units from January 2014 to December 2015 for a retrospective analysis. All patients voluntarily accepted shoulder arthroscopic anchor implantation and fixation. To further clarify for the effect of treatment, shoulder injury pain degree and athletic ability level of patients before and after treatment were statistically compared. Also, by 6 months' follow-up, stability of the treatment effect was evaluated. The results showed that shoulder arthroscopic anchor implantation and fixation enjoyed very significant effect for shoulder joint bankart injury caused by swimming, with significant improvements in shoulder function scores and pain scores after treatment. Differences before and after treatment were statistically significant (p < 0.05); in addition, after 3 months of treatment, 991 cases of patients had a stable efficacy, without recurring injury and with effective treatment rate at 96.68%; 34 cases of patients had recurrence of shoulder injury, with a recurrence rate at 3.32%. As can be seen from the treatment results, shoulder arthroscopic anchor implantation and fixation showed a significant treatment effect for shoulder joint bankart injury caused by swimming, which can effectively help patients restore joint function, reduce pain in patients, with a high application value and good therapeutic effect.","[Liao, Jun; Deng, Yingjie; Ailijiang, Asila; Liu, Zhenfeng; Meng, Qingcai; Xiang, Wenyuan; Yu, Haicheng; Fang, Rui] Chinese Med Hosp Xinjiang, Dept Orthopaed, Uygur Autonomous Region, Urumqi, Peoples R China","Fang, R (corresponding author), Chinese Med Hosp Xinjiang, Dept Orthopaed, Uygur Autonomous Region, Urumqi, Peoples R China.",jndkhkiu@163.com,,,National Natural Science Foundation of China [81160460];  [ZYYBZ2013],National Natural Science Foundation of China (grant 81160460).; Postdoctoral Research Fund (No. ZYYBZ2013).,"Attari Z, 2016, SAUDI PHARM J, V24, P57, DOI 10.1016/j.jsps.2015.03.00; Cam R, 2015, ACTA MEDICA MEDITERR, V31, P107; Dawood KM, 2017, ARAB J CHEM, V10, P473, DOI 10.1016/j.arabjc.2013.06.00; Halici U, 2015, ACTA MEDICA MEDITERR, V31, P80; Kumar R, 2016, SAUDI J BIOL SCI, V23, P243, DOI 10.1016/j.sjbs.2015.03.00; Kuppusamy P, 2016, SAUDI PHARM J, V24, P473, DOI 10.1016/j.jsps.2014.11.01; Li M, 2015, PAK J PHARM SCI, V28, P186; Mohan D, 2016, SAUDI J BIOL SCI, V23, P122, DOI 10.1016/j.sjbs.2015.01.01; Moussa TAA, 2016, SAUDI J BIOL SCI, V23, P397, DOI 10.1016/j.sjbs.2015.04.01; Ofori-Kwakye K, 2016, SAUDI PHARM J, V24, P82, DOI 10.1016/j.jsps.2015.03.00; Sandri A. B. A., 2015, ASIAN PAC J SURG ONC, V1, P11; Smithers BM, 2015, ASIAN PAC J SURG ONC, V1, P12; Yang X, 2015, J COASTAL RES, P448, DOI 10.2112/SI73-079.; Yang ZC, 2015, J COASTAL RES, P420, DOI 10.2112/SI73-074.",14,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,3.0,,1309.0,1312,,10.19193/0393-6384_2017_3s_202,,4,"Medicine, General & Internal",General & Internal Medicine,FV9AC,WOS:000424878100004,,,,,2022-07-14,0.001446280991735537,6.681540726628961e-07,0.0013841326075713992,0.08465460396862183,0.0012362343704299548
J,"Maglietta, F1;  Sessa, F;  Albano, GD;  Bertozzi, G;  Giugliano, P;  Vacchiano, G;  Marsala, G;  Salerno, M",,,,"Maglietta, Francesca; Sessa, Francesco; Albano, Giuseppe Davide; Bertozzi, Giuseppe; Giugliano, Pasquale; Vacchiano, Giuseppe; Marsala, Gabriella; Salerno, Monica",,,ITALIAN MAFIA: A FOCUS ON APULIA MAFIA WITH A LITERATURE REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Italian mafia; Garganic Mafia; Apulia; Sacra Corona Unita; Lupara Bianca; Shotgun,LASER-SCANNING MICROSCOPY; SELF-CONCEPT; CHILDREN; MIGRAINE; INCAPRETTAMENTO; MULTICENTER; SLEEP; AURA; ABNORMALITIES; CHILDHOOD,"The goal of this paper is a systematic literary review that analyzes the differences between the main Apulia's Mafia organizations and their distinctive murder methods. In homicides committed by criminal organization, the method used intends to be an admonition to other persons. We analyze the criminal organization named Mafia of Gargano, that is a promontory of Apulia Region, in South-East of Italy. We analyze its homicidal mode, the type of weapon used in murders, the drawn body sites and the action recurrence. Previously named Faida of Gargano, the Garganic Mafia was certified by legal court as an inveterate mafia system only in 2009. In fact, in the Garganic area an archaic and violent mafia arise for theft of animals; subsequently, the most profitable activities of these clans became drug and weapons trafficking. The Garganic Mafia is an extremely traditional Mafia, like Camorra, with particularly practices of cadaver concealment. Very often, utilizing natural conformation of Gargano promontory, the criminals throw away the bodies into natural canyons. In this manner, the cadavers are discovered after many years accidentally: this method was classified as Lupara Bianca. Another kind of Apulia's Mafia is the so called Sacra Corona Unita (SCU). Originally it was founded by the Camorra's boss but it's inspired by Calabrian 'Ndrangheta: both these mafia associations was found in south of Italy, Camorra in Campania Region and 'Ndragheta in Calabria Region. In the murders committed by the SCU was frequent the recourse to deception to attract the victim, the use of the gun and the method of Lupara Bianca with the burning of the body. As previously described, the kind of the murder represents the signature of the mafia organization. These finding are very useful for investigations, helping to identify crime's motivations and the correlation with suspects.","[Maglietta, Francesca; Sessa, Francesco; Albano, Giuseppe Davide; Bertozzi, Giuseppe; Salerno, Monica] Univ Foggia, Sect Forens Pathol, Clin & Expt Med Dept, DAvanzo Hosp, Viale Aviatori 1, Foggia, Italy; [Giugliano, Pasquale] UOC, St Anna & San Sebastiano Hosp, Legal Med, Palasciano St, Caserta, Italy; [Vacchiano, Giuseppe] Sannio Univ, Dept Law Econ Math Methods, UOC, Benevento, Italy; [Marsala, Gabriella] Azienda Osped Univ, Struttura Complessa Farm, Osped Riuniti Foggia, Foggia, Italy","Salerno, M (corresponding author), Univ Foggia, Sect Forens Pathol, Clin & Expt Med Dept, Osped Colonnello DAvanzo, Viale Aviatori 1, I-71100 Foggia, Italy.",,"Sessa, Francesco/G-1754-2018; Bertozzi, Giuseppe/AAS-9882-2020; SALERNO, MONICA/AAC-1321-2019","Sessa, Francesco/0000-0003-0357-8791; Bertozzi, Giuseppe/0000-0002-8179-1072; SALERNO, MONICA/0000-0002-6410-3960; Maglietta, Francesca/0000-0001-7240-5902; Giugliano, Pasquale/0000-0002-3633-8893",,,"Baraybar JP, 2006, J FORENSIC SCI, V51, P103, DOI 10.1111/j.1556-4029.2005.00035.; Barone R, 2017, J CELL MOL MED, V21, P1636, DOI 10.1111/jcmm.1309; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0018; Council of Europe, 1999, REP ORG CRIM SIT COU, P7; D'Errico S, 2011, AM J FOREN MED PATH, V32, P44, DOI 10.1097/PAF.0b013e3181efbbf; De Donno A, 2009, J FORENSIC SCI, V54, P895, DOI 10.1111/j.1556-4029.2009.01068.; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Fenton TW, 2005, J FORENSIC SCI, V50, P27; Fineschi V, 1998, AM J FOREN MED PATH, V19, P87, DOI 10.1097/00000433-199803000-0001; Focardi M, 2014, AM J FOREN MED PATH, V35, P83, DOI 10.1097/PAF.000000000000007; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Harding BE, 2011, AM J FOREN MED PATH, V32, P208, DOI 10.1097/PAF.0b013e318221ba7; Ledda C, 2017, MOL MED REP, V15, P3350, DOI 10.3892/mmr.2017.638; Marselli R, 1997, INT REV LAW ECON, V17, P89, DOI 10.1016/S0144-8188(96)00060-; MASCIANDARO D, 1999, RIV INT SCI SOC, V107, P8; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0013; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Neri M, 2007, INT J LEGAL MED, V121, P287, DOI 10.1007/s00414-006-0110-; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pollanen MS, 2003, AM J FOREN MED PATH, V24, P51, DOI 10.1097/00000433-200303000-0001; Pomara C, 2015, RADIOL MED, V120, P802, DOI 10.1007/s11547-015-0549-; Pomara C, 2009, RADIOL MED, V114, P1367, DOI 10.1007/s11547-009-0435-; Pomara C, 2008, AM J FOREN MED PATH, V29, P72, DOI 10.1097/PAF.0b013e31816520b; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Pomara C, 2010, AM J FOREN MED PATH, V31, P264, DOI 10.1097/PAF.0b013e3181dfc9b; Porta D, 2013, AM J FOREN MED PATH, V34, P195, DOI 10.1097/PAF.0b013e318288759; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Santamaria S., 2016, BIOL MED, V8, DOI 10.4172/0974-8369.100026; Seccia D., 2011, MAFIA INNOMINABIL; Turillazzi E, 2008, INT J LEGAL MED, V122, P173, DOI 10.1007/s00414-007-0208-; Turillazzi E, 2013, FORENSIC SCI INT, V231, P142, DOI 10.1016/j.forsciint.2013.04.00; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707",47,7,7,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,947.0,952,,10.19193/0393-6384_2017_6_149,,6,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500008,,,,,2022-07-14,0.0043388429752066115,0.033118895849527354,0.004181339537658621,0.11120429193424242,0.004042526189454836
J,"Maltese, A151;   Salerno, M;   Tripi, G;   Romano, P;   Ricciardi, A;   Folco, A;   Di Filippo, T;   Parisi, L",,,,"Maltese, Agata; Salerno, Margherita; Tripi, Gabriele; Romano, Palmira; Ricciardi, Annaclaudia; Folco, AnnabellaDi; Di Filippo, Teresa; Parisi, Lucia",,,THE ANGELMAN SYNDROME: A BRIEF REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Angelman syndrome; behavioural abnormalities; mental retardation; UBE3A; EEG abnormalities,AUTISM SPECTRUM DISORDERS; PRIMARY NOCTURNAL ENURESIS; SLEEP-APNEA SYNDROME; CHILDHOOD ABSENCE EPILEPSY; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; WEIGHT-LOSS PROGRAM; QUALITY-OF-LIFE; PARENTAL STRESS; MATERNAL STRESS,"Angelman's Syndrome (AS) was described for the first time by Harry Angelman in the 1960s, based on obervation of three child patients with similar physical and behavioral features such as severe intellectual impairment, lack of language, motor disorders and happy behaviour. Many years later the typical patients' features were identified as linked to genetic abnormalities mainly characterized by neurological symptoms. Life expectancy is good although the symptoms tend to be stable and severe.","[Maltese, Agata; Folco, AnnabellaDi; Di Filippo, Teresa; Parisi, Lucia] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Romano, Palmira; Ricciardi, Annaclaudia] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, CE, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Bird LM, 2014, APPL CLIN GENET, V7, P93, DOI 10.2147/TACG.S5738; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Fairbrother LC, 2015, AM J MED GENET A, V167, P1565, DOI 10.1002/ajmg.a.3705; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P491, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P481, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",84,6,6,3,14,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,667.0,673,,10.19193/03936384_2017_4_100,,7,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700021,,,,,2022-07-14,0.007024793388429752,0.12392149475148072,0.0007201604427178477,0.11073361016735875,0.0007717244560207665
J,"Maltese, A161;   Salerno, M;   Tripi, G;   Romano, P;   Ricciardi, A;   Sessa, G;   Di Folco, A;   Di Filippo, T;   Parisi, L",,,,"Maltese, Agata; Salerno, Margherita; Tripi, Gabriele; Romano, Palmira; Ricciardi, Annaclaudia; Sessa, Giulia; Di Folco, Annabella; Di Filippo, Teresa; Parisi, Lucia",,,REHABILITATIVE TREATMENT PROPOSALS IN PEDIATRIC NON-VERBAL SYNDROME,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Nonverbal learning disability; NVLD; visuospatial abilities; rehabilitation; evidence based medicine (EBM),AUTISM SPECTRUM DISORDERS; PRIMARY NOCTURNAL ENURESIS; SLEEP-APNEA SYNDROME; QUALITY-OF-LIFE; CHILDHOOD ABSENCE EPILEPSY; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; WEIGHT-LOSS PROGRAM; PARENTAL STRESS; MATERNAL STRESS,"Nonverbal learning disability (NVLD) can be defined as a specific learning disorder peculiar for deficits in non-verbal area, such as visuospatial and visuo-constructive difficulties, fine motor coordination impairments, and poor mathematics achievement, associated with well-developed language skills. aim of the present work is suggesting rehabilitative proposal for management treatment of NVLD in pediatric age tailored on children and based on EBM.","[Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Parisi, Lucia] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Romano, Palmira; Ricciardi, Annaclaudia; Sessa, Giulia] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, CE, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; La Grutta S, 2007, Minerva Pediatr, V59, P74; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P491, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P481, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2015, MENT ILLN, V7, P32, DOI 10.4081/mi.2015.598; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Semrud-Clikeman M, 2014, J AUTISM DEV DISORD, V44, P331, DOI 10.1007/s10803-013-1871-; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",98,3,3,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,675.0,682,,10.19193/0393-6384_2017_4_101,,8,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700022,,,,,2022-07-14,0.008264462809917356,0.14014953563156507,0.0006807241709767681,0.11076402000160196,0.0007674500896252109
J,"Maltese, A171;   Salerno, M;   Tripi, G;   Romano, P;   Ricciardi, A;   Di Folco, A;   Di Filippo, T;   Parisi, L",,,,"Maltese, Agata; Salerno, Margherita; Tripi, Gabriele; Romano, Palmira; Ricciardi, Annaclaudia; Di Folco, Annabella; Di Filippo, Teresa; Parisi, Lucia",,,INTERNALIZING PROBLEMS ARE RELATED TO SLEEP PATTERNS DISORDERED IN CHILDREN AFFECTED BY PRIMARY HEADACHE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Primary headaches; internalizing problems; sleep disorders,AUTISM SPECTRUM DISORDERS; PRIMARY NOCTURNAL ENURESIS; QUALITY-OF-LIFE; CHILDHOOD ABSENCE EPILEPSY; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; WEIGHT-LOSS PROGRAM; APNEA SYNDROME; PARENTAL STRESS; MATERNAL STRESS,"Introduction: Migraine is a common disorder in children and adolescents, associated with various disorders such as emotions, behavioral problems, and sleep disturbances. Aim of the study is to verify the relationship between psychological problems of cephalalgic patients and sleep disturbances. Materials and methods: 64 subjects (27 females), aged 8-12 years (mean 9.4 years, SD +/- 1.03) with primary headache were enrolled. CBCL 6-18 scale and the SDSC scale were used for behavioral screening and for assessing sleep habits. Results: According to the ICHD-III criteria, the distribution of the headache subtype was as follows: headaches without aura (71.87%), headache episodes typical of tension (7.81%) and chronic headache (7.81%) (Figure 1). CBCL assessment (total problem element) showed an interesting relationship with sleep disorders such as DIMS, DA and SWTD (respectively r = .37, p = 0.019; r = .39, p = 0.015; r = 37, p = 0.019). Discussion: MwA children revealed a specific behavioral phenotype characterized by internalization problems. Among migraine subjects, prevalent sleep disorders include difficulty falling asleep, increased night-time awakening, decreased sleep duration, and excessive daytime sleepiness.","[Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Parisi, Lucia] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Romano, Palmira; Ricciardi, Annaclaudia] Univ Campania Luigi Vanvitelli, Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; La Grutta S, 2007, Minerva Pediatr, V59, P74; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P491, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P481, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2015, MENT ILLN, V7, P32, DOI 10.4081/mi.2015.598; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",94,4,4,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,729.0,735,,10.19193/0393-6384_2017_5_107,,7,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000001,,,,,2022-07-14,0.008161157024793388,0.14006316415400194,0.00047411260072882454,0.11076148521082442,0.0005608385193772469
J,"Maltese, A181;   Salerno, M;   Romano, P;   Ricciardi, A;   Di Filippo, T;   Tripi, G",,,,"Maltese, Agata; Salerno, Margherita; Romano, Palmira; Ricciardi, Annaclaudia; Di Filippo, Teresa; Tripi, Gabriele",,,KETOGENIC DIET AS ANTIEPILEPTIC THERAPY: ADMINISTRATION AND FORMULAS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,ketogenic diet; epilepsy; cholesterol; free fatty acids; administration; formulas,AUTISM SPECTRUM DISORDERS; PRIMARY NOCTURNAL ENURESIS; SLEEP-APNEA SYNDROME; QUALITY-OF-LIFE; CHILDHOOD ABSENCE EPILEPSY; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; WEIGHT-LOSS PROGRAM; PARENTAL STRESS; MATERNAL STRESS,"In 1921 Wilder defined classical cholesterol diet providing the patient with a daily calorie intake of less than 20% compared to age-related requirements. The main macronutrient is represented by saturated and long chain unsaturated fatty acids, in the ratio of 4:1 to carbohydrates and proteins (4 grams of lipids per gram of carbohydrates and proteins). One of the first therapeutic protocols proposed is that of John Hopkins that the onset of the diet should take place in a hospital environment to assess the patient's response in a controlled situation.","[Maltese, Agata; Di Filippo, Teresa] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Romano, Palmira; Ricciardi, Annaclaudia] Univ Campania Luigi Vanvitelli, Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; La Grutta S, 2007, Minerva Pediatr, V59, P74; La Grutta S, 2006, Minerva Pediatr, V58, P51; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P491, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P481, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2015, MENT ILLN, V7, P32, DOI 10.4081/mi.2015.598; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2017, J CHILD ADOL PSYCHOP, V27, P844, DOI 10.1089/cap.2016.020; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",95,2,2,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,737.0,744,,10.19193/0393-6384_2017_5_108,,8,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000002,,,,,2022-07-14,0.008264462809917356,0.13936330421714835,0.0005522629558876001,0.11076402000160196,0.0006377524956980398
J,"Maltese, A191;   Salerno, M;   Romano, P;   Ricciardi, A;   Di Filippo, T;   Tripi, G",,,,"Maltese, Agata; Salerno, Margherita; Romano, Palmira; Ricciardi, Annaclaudia; Di Filippo, Teresa; Tripi, Gabriele",,,KETOGENIC DIET AS ANTIEPILEPTIC THERAPY: HISTORICAL PERSPECTIVE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,ketogenic diet; epilepsy; cholesterol; free fatty acids,AUTISM SPECTRUM DISORDERS; PRIMARY NOCTURNAL ENURESIS; SLEEP-APNEA SYNDROME; QUALITY-OF-LIFE; CHILDHOOD ABSENCE EPILEPSY; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; WEIGHT-LOSS PROGRAM; PARENTAL STRESS; MATERNAL STRESS,"Ketogenic diet (KD) is a high-lipid diet, adequate for protein content but low in carbohydrates content. Caloric intake is calculated on the basis of the ideal patient's needs, reduced by about 20%, and is about 90% of lipids present in 3:1 or 4: 1 ratio with proteins and carbohydrates. KD is considered the most ancient antiepileptic therapy, actually proposed also for migraine therapy.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Romano, Palmira; Ricciardi, Annaclaudia] Univ Campania Luigi Vanvitelli, Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; La Grutta S, 2007, Minerva Pediatr, V59, P74; La Grutta S, 2006, Minerva Pediatr, V58, P51; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P491, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P481, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2015, MENT ILLN, V7, P32, DOI 10.4081/mi.2015.598; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2017, J CHILD ADOL PSYCHOP, V27, P844, DOI 10.1089/cap.2016.020; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",95,3,3,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,769.0,775,,10.19193/0393-6384_2017_5_113,,7,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000007,,,,,2022-07-14,0.008264462809917356,0.13936330421714835,0.0005522629558876001,0.11076402000160196,0.0006377524956980398
J,"Maltese, A201;   Salerno, M;   Romano, P;   Ricciardi, A;   Di Filippo, T;   Tripi, G",,,,"Maltese, Agata; Salerno, Margherita; Romano, Palmira; Ricciardi, Annaclaudia; Di Filippo, Teresa; Tripi, Gabriele",,,KETOGENIC DIET AS ANTIEPILEPTIC THERAPY: NEUROTRASMISSION EFFECTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,ketogenic diet; epilepsy; cholesterol; free fatty acids,AUTISM SPECTRUM DISORDERS; PRIMARY NOCTURNAL ENURESIS; SLEEP-APNEA SYNDROME; QUALITY-OF-LIFE; CHILDHOOD ABSENCE EPILEPSY; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; WEIGHT-LOSS PROGRAM; PARENTAL STRESS; MATERNAL STRESS,"The Ketogenic diet (KD) presents many effects on neurostrasmitters pathways. KD may act on potassium channels sensitive to ATP (KATP), inhibiting rapamycin pathway in mammalians or glutamatergic synaptic transmission or mediated by peptide hormones.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Romano, Palmira; Ricciardi, Annaclaudia] Univ Campania Luigi Vanvitelli, Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; La Grutta S, 2007, Minerva Pediatr, V59, P74; La Grutta S, 2006, Minerva Pediatr, V58, P51; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G, 2014, J ANESTH CLIN RES, V5, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395.; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P491, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P481, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2015, MENT ILLN, V7, P32, DOI 10.4081/mi.2015.598; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pisano S, 2017, J CHILD ADOL PSYCHOP, V27, P844, DOI 10.1089/cap.2016.020; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",95,19,19,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,777.0,783,,10.19193/0393-6384_2017_5_114,,7,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000008,,,,,2022-07-14,0.008264462809917356,0.13936330421714835,0.0005522629558876001,0.11076402000160196,0.0006377524956980398
J,"Maltese, A211;   Romano, P;   D'Oro, L;   Gallai, B;   Marotta, R;   Lavano, F;   Lavano, SM;   Tripi, G;   Salerno, M",,,,"Maltese, Agata; Romano, Palmira; D'Oro, Lucrezia; Gallai, Beatrice; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Tripi, Gabriele; Salerno, Margherita",,,"RETRACTED: ANGER IN CHILDREN: A MINIREVIEW (Retracted article. See vol. 34, 2018)",ACTA MEDICA MEDITERRANEA,,,English,Review; Retracted Publication,,,,,,anger; children; emotional control; drawings,MIGRAINE; SLEEP; AURA; CARE; IRAN; KERMANSHAH; HOSPITALS; SYNERGISM; ENURESIS; EFFICACY,"Aggressive behavior is a peculiar characteristic of most animal species playing an important role in species preservation and two types have been identified: interspecific and intraspecific aggression. The interspecific refers purely to the instinct of predation, while the intraspecific is the purpose for species preservation. Anger has been found in very young children between the ages of four and seven, is manifested through vocalizations, expressions and global movements affecting the entire body of the child: it is a means of communication privileged to express themselves and communicate. Anger must be considered a positive event, even if it may frighten it has a positive effect: transforming an event that could only be destructive and useless in a constructive process, and channeling the child's anger toward a specific goal.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Romano, Palmira] Ctr LARS, Sarno, Italy; [D'Oro, Lucrezia] Ctr Relax, Benevento, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","TRIPI, Gabriele/0000-0001-7088-9325; Marotta, Rosa/0000-0003-0515-5952",,,"Acar YA, 2016, ACTA MEDICA MEDITERR, V32, P7; Akdam H, 2016, ACTA MEDICA MEDITERR, V32, P685, DOI 10.19193/0393-6384_2016_3_7; Behnamipour S, 2016, ACTA MEDICA MEDITERR, V32, P154; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Chisari G, 2016, ACTA MEDICA MEDITERR, V32, P865, DOI 10.19193/0393-6384_2016_4_10; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Crittenden PM, 2017, CLIN CHILD PSYCHOL P, V22, P436, DOI 10.1177/135910451771621; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Di Serio F, 2016, ACTA MEDICA MEDITERR, V32, P1911, DOI 10.19193/0393-6384_2016_6_18; Eksi F, 2017, ACTA MEDICA MEDITERR, V33, P341, DOI 10.19193/0393-6384_2017_2_05; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Eraslan A, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_15; Es MU, 2016, ACTA MEDICA MEDITERR, V32, P911, DOI 10.19193/0393-6384_2016_4_10; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Fariba F, 2016, ACTA MEDICA MEDITERR, V32, P210; Feghhi F, 2016, ACTA MEDICA MEDITERR, V32, P101; George C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.0159; Jalili Z, 2016, ACTA MEDICA MEDITERR, V32, P91; Karakas D, 2017, ACTA MEDICA MEDITERR, V33, P811, DOI 10.19193/0393-6384_2017_5_12; Kargin NC, 2016, ACTA MEDICA MEDITERR, V32, P31; Khodaii Z, 2017, ACTA MEDICA MEDITERR, V33, P301, DOI 10.19193/0393-6384_2017_2_04; Kilic B, 2017, ACTA MEDICA MEDITERR, V33, P335, DOI 10.19193/0393-6384_2017_2_05; Kirisci O, 2016, ACTA MEDICA MEDITERR, V32, P1805, DOI 10.19193/0393-6384_2016_6_16; Li HC, 2016, ACTA MEDICA MEDITERR, V32, P51; Li Y, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Li ZX, 2017, ACTA MEDICA MEDITERR, V33, P41, DOI 10.19193/0393-6384_2017_1_00; Licata M, 2016, ACTA MEDICA MEDITERR, V32, P1569, DOI 10.19193/0393-6384_2016_5_13; Lin ZH, 2016, ACTA MEDICA MEDITERR, V32, P57; Liu TG, 2016, ACTA MEDICA MEDITERR, V32, P877, DOI 10.19193/0393-6384_2016_4_10; Ma H, 2016, ACTA MEDICA MEDITERR, V32, P115; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P667, DOI 10.19193/03936384_2017_4_10; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P675, DOI 10.19193/0393-6384_2017_4_10; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P641, DOI 10.19193/0393-6384_2017_4_09; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_09; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Mohammadnejad E, 2016, ACTA MEDICA MEDITERR, V32, P129; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Motlagh AH, 2016, ACTA MEDICA MEDITERR, V32, P206; Nankaly A, 2016, ACTA MEDICA MEDITERR, V32, P95; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Pekel NB, 2017, ACTA MEDICA MEDITERR, V33, P101, DOI 10.19193/0393-6384_2017_1_01; Perciavalle V, 2016, ACTA MEDICA MEDITERR, V32, P2; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Pirsaheb M, 2016, ACTA MEDICA MEDITERR, V32, P96; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rasouli AS, 2016, ACTA MEDICA MEDITERR, V32, P106; Refahi S, 2016, ACTA MEDICA MEDITERR, V32, P120; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salehi M, 2016, ACTA MEDICA MEDITERR, V32, P193; Salehi N, 2016, ACTA MEDICA MEDITERR, V32, P196; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Valiee S, 2016, ACTA MEDICA MEDITERR, V32, P102; van Rosmalen L, 2016, HIST PSYCHOL, V19, P22, DOI 10.1037/hop000001; Vazirinejad R, 2016, ACTA MEDICA MEDITERR, V32, P987, DOI 10.19193/0393-6384_2016_4_12; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Wang GP, 2016, ACTA MEDICA MEDITERR, V32, P59; Wang H, 2016, ACTA MEDICA MEDITERR, V32, P54; Wen SJ, 2016, ACTA MEDICA MEDITERR, V32, P48; Wen SW, 2016, ACTA MEDICA MEDITERR, V32, P30; Yoon H., 2016, ACTA MEDICA MEDITERR, V32, P1697, DOI DOI 10.19193/0393-6384_5_15; Zohreyi T, 2016, ACTA MEDICA MEDITERR, V32, P125",84,1,1,3,17,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1233.0,1240,,10.19193/0393-6384_2017_2s_191,,8,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700008,,,,,2022-07-14,0.007644628099173554,0.060709908613268686,0.08741793443112159,0.11902273481783865,0.08406435068545257
J,"Maltese, A221;   Gallai, B;   Romano, P;   D'Oro, L;   Marotta, R;   Lavano, F;   Lavano, SM;   Tripi, G;   Salerno, M",,,,"Maltese, Agata; Gallai, Beatrice; Romano, Palmira; D'Oro, Lucrezia; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Tripi, Gabriele; Salerno, Margherita",,,"RETRACTED: MOTION SICKNESS IN CHILDHOOD MIGRAINE (Retracted article. See vol. 34, 2018)",ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,childhood migraine; periodic syndromes; Abdominal Migraine; Motion Sickness; Cyclic Vomiting; Growing Pains,BENIGN PAROXYSMAL VERTIGO; RESTLESS-LEGS-SYNDROME; PEDIATRIC MIGRAINE; CHILDREN; AURA; SLEEP; ANXIETY; HEADACHE; EFFICACY; THERAPY,"Background: Migraine is a chronic, progressive, and debilitating disorder that has an impact on the lives of millions of individuals. The origins of the disability can be traced into childhood and adolescence for most adult migraine sufferers. The group of periodic syndromes consists in symptoms related to migraine, thought to be migraine equivalent or precursors. Aim of this study is to assess the role of MS as risk factors for childhood migraine. Materials and methods: 441 subjects (211 Females) aged 6-13 years (mean 9.20; SD 2.42), consecutively referred between October 2007 to March 2009 for primary headaches to pediatric Centers for Headache in Childhood. Control group consisted of 365 subjects (175 F) aged 7-13 years (mean 9.08; SD 3.02). Results: Two groups were not different for age (F=0.390; p=0.539) and sex ratio (Chi-square=0.002; p=0.966). Headache percentage distribution was the following: MoA 38.32%, MA 11.11%, FETTH 16.78%, CTTH 20.63%. Logistic regression shows a greater OR for CVS and MS associated for migraine group (MoA and MA patients), respectively 8.28 (IC95% 2.35 - 29.16) for CVS and 5.22 (IC95% 3.5 - 7.77); moreover, CVS cause a consistent increase in OR of 3.69 (IC95% 2.21 - 6.17) also for headache group (CTTH and FETTH patients). Discussion: Periodic syndromes could be considered the natural precursors of migraine almost but not only in children, as reported in some studies in adulthood.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Romano, Palmira] Ctr LARS, Sarno, Italy; [D'Oro, Lucrezia] Ctr Relax, Benevento, Italy; [Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","TRIPI, Gabriele/0000-0001-7088-9325; Marotta, Rosa/0000-0003-0515-5952",,,"Al-Twaijri WA, 2002, PEDIATR NEUROL, V26, P365, DOI 10.1016/S0887-8994(01)00416-; Ambrosini A, 2003, BRAIN, V126, P2009, DOI 10.1093/brain/awg20; Balaban CD, 1999, CURR OPIN NEUROL, V12, P29, DOI 10.1097/00019052-199902000-0000; Barlow CF, 1984, EXPRESSION CHILDHOOD, P4; BASSER LS, 1964, BRAIN, V87, P141, DOI 10.1093/brain/87.1.14; Bigal ME, 2008, CURR OPIN NEUROL, V21, P301, DOI 10.1097/WCO.0b013e328300c6f; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Chieffi S., 2015, J PSYCHIAT, V18, DOI [10.4172/1994-8220.1000228, DOI 10.4172/1994-8220.1000228; Chugani DC, 1999, NEUROLOGY, V53, P1473, DOI 10.1212/WNL.53.7.147; Cole JA, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-2; Cologno D, 2008, NEUROL SCI, V29, pS166, DOI 10.1007/s10072-008-0915-; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; d'Onofrio F, 2006, EUR J NEUROL, V13, P85, DOI 10.1111/j.1468-1331.2006.01129.; d'Onofrio F, 2008, NEUROL SCI, V29, pS169, DOI 10.1007/s10072-008-0916-; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito T, 2006, J THERM BIOL, V31, P527, DOI 10.1016/j.jtherbio.2006.07.00; FENICHEL GM, 1967, J PEDIATR-US, V71, P114, DOI 10.1016/S0022-3476(67)80239-; LANZI G, 1983, CEPHALALGIA, V3, P115, DOI 10.1046/j.1468-2982.1983.0302115.; Lewis DW, 2009, NEUROL CLIN, V27, P481, DOI 10.1016/j.ncl.2008.11.00; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Marcus DA, 2006, MED SCI MONITOR, V12, pPI; Marcus D, 2007, HEADACHE, V47, P607, DOI 10.1111/j.1526-4610.2007.00762.; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BENEFICIAL EFFECTS C, DOI [10.4172/0974-8369.1000, DOI 10.4172/0974-8369.1000; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2015, BIOL ME; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Panconesi A, 1997, CEPHALALGIA, V17, P3, DOI 10.1046/j.1468-2982.1997.1701003.; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Sabayan B, 2007, MED HYPOTHESES, V69, P64, DOI 10.1016/j.mehy.2006.10.06; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shevell M., 1998, CONT PEDIAT, V15, P7; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.; Teggi R, 2009, HEADACHE, V49, P435, DOI 10.1111/j.1526-4610.2009.01338.; Tietjen GE, 2007, HEADACHE, V47, P857, DOI 10.1111/j.1526-4610.2007.00814.; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Vendrame M, 2008, PEDIATR NEUROL, V39, P6, DOI 10.1016/j.pediatrneurol.2008.03.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Wang CT, 2009, HEADACHE, V49, P426, DOI 10.1111/j.1526-4610.2008.01283.; Yates BJ, 1998, BRAIN RES BULL, V47, P395, DOI 10.1016/S0361-9230(98)00092-",65,1,1,2,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1241.0,1247,,10.19193/0393-6384_2017_2s_192,,7,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700009,,,,,2022-07-14,0.00640495867768595,0.061039253967934866,0.010828181845612121,0.11284813299292368,0.010974694613270683
J,"Maltese, A231;   Gallai, B;   Marotta, R;   Lavano, F;   Lavano, SM;   Tripi, G;   Romano, P;   D'Oro, L;   Salerno, M",,,,"Maltese, Agata; Gallai, Beatrice; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Tripi, Gabriele; Romano, Palmira; D'Oro, Lucrezia; Salerno, Margherita",,,"RETRACTED: NEUROSCIENCES AND ATTACHMENT THEORY: A BRIEF REVIEW (Retracted article. See vol. 34, 2018)",ACTA MEDICA MEDITERRANEA,,,English,Review; Retracted Publication,,,,,,attachment theory; neurosciences; fMRI; cortisol,SLEEP-APNEA SYNDROME; CHILDREN; MIGRAINE; AURA; THERAPY; PROGNOSIS; EFFICACY; ANXIETY; DISEASE; RESISTANCE,The attachment theory was proposed and elaborated by John Bowlby. Over the last ten years the attachment theory has attracted considerable interest in the field of mental health as it emphasizes how relationships that are established in the earliest stages of development have an impact on man in an indefinable and lifelong manner.,"[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Romano, Palmira] Ctr LARS, Sarno, Italy; [D'Oro, Lucrezia] Ctr Relax, Benevento, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","TRIPI, Gabriele/0000-0001-7088-9325; Marotta, Rosa/0000-0003-0515-5952",,,"Aktas T, 2017, ACTA MEDICA MEDITERR, V33, P183, DOI 10.19193/0393-6384_2017_2_02; Ali FB, 2017, ACTA MEDICA MEDITERR, V33, P935, DOI 10.19193/0393-6384_2017_1s_14; Aliverti M, 2017, ACTA MEDICA MEDITERR, V33, P471, DOI 10.19193/0393-6384_2017_3_06; Amini M, 2017, ACTA MEDICA MEDITERR, V33, P945, DOI 10.19193/0393-6384_2017_1s_14; Atik D, 2016, ACTA MEDICA MEDITERR, V32, P933, DOI 10.19193/0393-6384_2016_4_11; Aydin B, 2016, ACTA MEDICA MEDITERR, V32, P45; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Celik M, 2016, ACTA MEDICA MEDITERR, V32, P691, DOI 10.19193/0393-6384_2016_3_7; Chisari EM, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_13; Ciftci F, 2016, ACTA MEDICA MEDITERR, V32, P967, DOI 10.19193/0393-6384_2016_4_11; Cocuzza S, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_13; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Crittenden PM, 2017, CLIN CHILD PSYCHOL P, V22, P436, DOI 10.1177/135910451771621; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Dong GZ, 2016, ACTA MEDICA MEDITERR, V32, P10; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito G, 2017, BEHAV BRAIN RES, V325, P87, DOI 10.1016/j.bbr.2017.03.02; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Farahani ZB, 2016, ACTA MEDICA MEDITERR, V32, P107; Feng Y, 2016, ACTA MEDICA MEDITERR, V32, P50; George C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.0159; Gerardo B, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_13; Gunaydin ZY, 2016, ACTA MEDICA MEDITERR, V32, P14; Jamebozorg Z, 2016, ACTA MEDICA MEDITERR, V32, P193; Jamebozorg Z, 2016, ACTA MEDICA MEDITERR, V32, P110; Jiang W, 2016, ACTA MEDICA MEDITERR, V32, P53; Karakilic E, 2016, ACTA MEDICA MEDITERR, V32, P1791, DOI 10.19193/0393-6384_2016_6_16; Kardes S, 2016, ACTA MEDICA MEDITERR, V32, P947, DOI 10.19193/0393-6384_2016_4_11; Kohan S, 2016, ACTA MEDICA MEDITERR, V32, P150; Koylu O, 2016, ACTA MEDICA MEDITERR, V32, P29; Li WM, 2016, ACTA MEDICA MEDITERR, V32, P51; Ma YS, 2016, ACTA MEDICA MEDITERR, V32, P48; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P675, DOI 10.19193/0393-6384_2017_4_10; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Mirjalili MR, 2016, ACTA MEDICA MEDITERR, V32, P120; Mirzaei N, 2016, ACTA MEDICA MEDITERR, V32, P147; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Nedeljkovic-Arsenovic O, 2016, ACTA MEDICA MEDITERR, V32, P44; Niu TL, 2016, ACTA MEDICA MEDITERR, V32, P871, DOI 10.19193/0393-6384_2016_4_10; Nobari SM, 2016, ACTA MEDICA MEDITERR, V32, P107; Obrenovic-Kircanski B, 2016, ACTA MEDICA MEDITERR, V32, P6; Oruc A, 2016, ACTA MEDICA MEDITERR, V32, P32; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Pekel NB, 2017, ACTA MEDICA MEDITERR, V33, P101, DOI 10.19193/0393-6384_2017_1_01; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Pirodda A, 2016, ACTA MEDICA MEDITERR, V32, P863, DOI 10.19193/0393-6384_2016_4_10; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Sastre-Heres AJ, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_15; Shahram S, 2016, ACTA MEDICA MEDITERR, V32, P99; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; van Rosmalen L, 2016, HIST PSYCHOL, V19, P22, DOI 10.1037/hop000001; Vecchio I, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_13; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Wan L, 2016, ACTA MEDICA MEDITERR, V32, P112; Yang SY, 2016, ACTA MEDICA MEDITERR, V32, P112; Yazdi B, 2016, ACTA MEDICA MEDITERR, V32, P102; Zadeh FH, 2016, ACTA MEDICA MEDITERR, V32, P205",78,2,2,5,25,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1249.0,1255,,10.19193/0393-6384_2017_2s_193,,7,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700010,,,,,2022-07-14,0.00743801652892562,0.05789171756284639,0.02244262336927348,0.11361102308604157,0.02138606238335295
J,"Maltese, A241;   Gallai, B;   Marotta, R;   Lavano, F;   Lavano, SM;   Tripi, G;   Romano, P;   D'Oro, L;   Salerno, M",,,,"Maltese, Agata; Gallai, Beatrice; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Tripi, Gabriele; Romano, Palmira; D'Oro, Lucrezia; Salerno, Margherita",,,THE SYNACTIVE THEORY OF DEVELOPMENT: THE KEYWORD FOR NEURODEVELOPMENTAL DISORDERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Synactive Theory of Development; autonomic nervous system; sleep,AUTISM SPECTRUM DISORDERS; SLEEP-APNEA SYNDROME; CHILDHOOD ABSENCE EPILEPSY; KETOGENIC DIET; SELF-CONCEPT; CHILDREN; MIGRAINE; AURA; DEPRESSION; THERAPY,"The synactive theory of development may be considered the keyword for neurodevelopmental disorders, considering that each one presents constantly autonomic troubles such as sleep disorders, feeding problems.","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Romano, Palmira; D'Oro, Lucrezia] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; TRIPI, Gabriele/0000-0001-7088-9325",,,"Als H, 1986, PHYS OCCUPATIONAL TH, V6, P3, DOI DOI 10.1080/J006V06N03_0; Asgary MR, 2016, ACTA MEDICA MEDITERR, V32, P124; Barghamadi Z, 2016, ACTA MEDICA MEDITERR, V32, P206; Bembich S, 2017, J PERINAT NEONAT NUR, V31, P67, DOI 10.1097/JPN.000000000000022; Bosnak V, 2016, ACTA MEDICA MEDITERR, V32, P997, DOI 10.19193/0393-6384_2016_4_12; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Chieffi S., 2015, J PSYCHIAT, V18, DOI [10.4172/1994-8220.1000228, DOI 10.4172/1994-8220.1000228; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito T, 2006, J THERM BIOL, V31, P527, DOI 10.1016/j.jtherbio.2006.07.00; Giardina S, 2016, ACTA MEDICA MEDITERR, V32, P1739, DOI 10.19193/0393-6384_2016_6_15; Gibbins Sharyn, 2008, Adv Neonatal Care, V8, P141, DOI 10.1097/01.ANC.0000324337.01970.7; Guclu A, 2016, ACTA MEDICA MEDITERR, V32, P1843, DOI 10.19193/0393-6384_2016_6_17; Hazavehei SMM, 2016, ACTA MEDICA MEDITERR, V32, P99; Kefeli A., 2016, ACTA MEDICA MEDITERR, V32, P1609, DOI 10.19193/0393-6384_2016_5_13; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_11; Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P769, DOI 10.19193/0393-6384_2017_5_11; Martini R, 2016, AM J OCCUP THER, V7; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BENEFICIAL EFFECTS C, DOI [10.4172/0974-8369.1000, DOI 10.4172/0974-8369.1000; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_08; Moscatelli F, 2015, BIOL ME; Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_06; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Ozcelik KC, 2016, ACTA MEDICA MEDITERR, V32, P20; Ozkaya I, 2016, ACTA MEDICA MEDITERR, V32, P25; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P491, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Pektas SD, 2016, ACTA MEDICA MEDITERR, V32, P1785, DOI 10.19193/0393-6384_2016_6_16; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Pickler Rita H, 2004, Neonatal Intensive Care, V17, P3; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Rezaei S, 2016, ACTA MEDICA MEDITERR, V32, P144; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Roan C, 2017, PHYS OCCUP THER PEDI, V37, P283, DOI 10.1080/01942638.2016.118550; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_09; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shahtaheri E, 2016, ACTA MEDICA MEDITERR, V32, P204; Shamansouri S, 2016, ACTA MEDICA MEDITERR, V32, P210; Ulusoy MO, 2016, ACTA MEDICA MEDITERR, V32, P925, DOI 10.19193/0393-6384_2016_4_11; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Vardar E, 2016, ACTA MEDICA MEDITERR, V32, P753, DOI 10.19193/0393-6384_2016_3_8; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707",71,9,9,3,11,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1257.0,1263,,10.19193/0393-6384_2017_2s_194,,7,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700011,,,,,2022-07-14,0.006508264462809917,0.06966791848915714,0.007883792756125777,0.11276662667023916,0.008519658251930209
J,"Maltese, A251;   Gallai, B;   Romano, P;   D'Oro, L;   Marotta, R;   Lavano, F;   Lavano, SM;   Tripi, G;   Salerno, M",,,,"Maltese, Agata; Gallai, Beatrice; Romano, Palmira; D'Oro, Lucrezia; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Tripi, Gabriele; Salerno, Margherita",,,"RETRACTED: THE DYNAMIC MATURATIVE MODEL FOR ATTACHMENT (Retracted article. See vol. 34, 2018)",ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,dynamic maturative model; attachment style; intersubjectivity,CHILDREN; MIGRAINE; PLATELET; DISEASE; SLEEP; AURA; STRATEGIES; EFFICACY; POSITION; THERAPY,"The Dynamic- Maturation Model (DMM) was developed by Patricia Crittenden (1-4), which focused its studies on attachment to different ethnic, socio-cultural and dangers as families in which episodes of Maltreatment and abuse or families with high psychosocial risk. Crittenden proposes new protocols of the Strange Situation (SS) and the Adult Attachment Interview (AAI) based on a coding and classification system derived from the model proposed by Ainsworth, but modified and enriched with that of Main, Goldwyn and Hesse. The SS procedure, adopted for children aged between 10 and 18 months, is valid until all preschool age, assuming This way the name of the Preschool Assessment of Attachment (PAA).","[Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Romano, Palmira] Ctr LARS, Sarno, Italy; [D'Oro, Lucrezia] Ctr Relax, Benevento, Italy; [Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; TRIPI, Gabriele/0000-0001-7088-9325",,,"Ariyurek SY, 2016, ACTA MEDICA MEDITERR, V32, P36; Bayhan Z, 2016, ACTA MEDICA MEDITERR, V32, P11; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Chieffi S., 2015, J PSYCHIAT, V18, DOI [10.4172/1994-8220.1000228, DOI 10.4172/1994-8220.1000228; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; Crittenden PM, 2017, CLIN CHILD PSYCHOL P, V22, P436, DOI 10.1177/135910451771621; Crittenden PM, 2017, CLIN CHILD PSYCHOL P, V22, P358, DOI 10.1177/135910451770402; Crittenden PM, 1999, MONOGR SOC RES CHILD, V64, P14; Dahaz S, 2016, ACTA MEDICA MEDITERR, V32, P103; Dogru S, 2016, ACTA MEDICA MEDITERR, V32, P791, DOI 10.19193/0393-6384_2016_3_9; Erken E, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_13; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito T, 2006, J THERM BIOL, V31, P527, DOI 10.1016/j.jtherbio.2006.07.00; Fariba F, 2016, ACTA MEDICA MEDITERR, V32, P86; Gulmez C, 2016, ACTA MEDICA MEDITERR, V32, P36; Gunduz O, 2016, ACTA MEDICA MEDITERR, V32, P805, DOI 10.19193/0393-6384_2016_3_9; Hamissi JH, 2016, ACTA MEDICA MEDITERR, V32, P133; Jamshidi F, 2016, ACTA MEDICA MEDITERR, V32, P131; Jiang S, 2016, ACTA MEDICA MEDITERR, V32, P53; Lan YH, 2016, ACTA MEDICA MEDITERR, V32, P113; Li HY, 2016, ACTA MEDICA MEDITERR, V32, P111; Mao YL, 2016, ACTA MEDICA MEDITERR, V32, P837, DOI 10.19193/0393-6384_2016_3_9; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Mehrabi S, 2016, ACTA MEDICA MEDITERR, V32, P207; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G, 2015, BENEFICIAL EFFECTS C, DOI [10.4172/0974-8369.1000, DOI 10.4172/0974-8369.1000; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Mohammadlou M, 2016, ACTA MEDICA MEDITERR, V32, P126; Moscatelli F, 2015, BIOL ME; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Murat B, 2016, ACTA MEDICA MEDITERR, V32, P843, DOI 10.19193/0393-6384_2016_3_10; Nader S, 2016, ACTA MEDICA MEDITERR, V32, P100; Norbech PCB, 2013, J PERS ASSESS, V95, P571, DOI 10.1080/00223891.2013.82344; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Piskipasa N, 2016, ACTA MEDICA MEDITERR, V32, P20; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Savran Y, 2016, ACTA MEDICA MEDITERR, V32, P1; Song R, 2016, ACTA MEDICA MEDITERR, V32, P59; Taheri B, 2016, ACTA MEDICA MEDITERR, V32, P105; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Yang J, 2016, ACTA MEDICA MEDITERR, V32, P54; Yuan SM, 2016, ACTA MEDICA MEDITERR, V32, P35",61,2,2,4,15,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1265.0,1270,,10.19193/0393-6384_2017_2s_195,,6,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700012,,,,,2022-07-14,0.005785123966942148,0.04928754287334312,0.009740198799656874,0.11132706926889857,0.009459044120864051
J,"Mamur, A1;  Kayhan, M;  Oztas, D",,,,"Mamur, Ahmet; Kayhan, Mehmet; Oztas, Dilek",,,EVALUATION OF METABOLIC PANEL AND HEPATITIS MARKERS OF TYPE 2 DIABETES MELLITUS PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Type 2 DM; Hepatitis B; Hepatitis C,VACCINATION; INFECTION; INFLUENZA; IMPACT,"Purpose: Our aim is to evaluate the hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (AntiHBs) and AntiHCV negativity and positivity rates which can be investigated in the primary care in Type 2 Diabetes Mellitus (DM) patients in this study. Material and method: The recordings of patients who were diagnosed with type 2 diabetes and whose hepatitis serology was recorded in Eskisehir Tepebasi District Yeni Family Health Center's information management system program between the dates of 01.01.2016 - 31.12.2016 were evaluated retrospectively. Age, gender, comorbid diseases of patients were noted. Hepatitis serology and routine blood test results in the last 3 months were taken from the database. SPSS 21 program was used for statistical analyze. Results: A total of 300 patients were reached. 182 (60.7%) of the patients were female and 118 (39.3%) were male. The mean age of the patients was 58.66 +/- 11.44 years. When the patients were questioned regarding treatment method of diabetes, it was found out that 205 patients (68.3%) received only oral antidiabetic (OAD), 54 patients (18.0%) received insulin with OAD, and 41 patients (13.7%) received only insulin therapy. Of the 300 patients in the study group, 16 (5.3%) were hepatitis B surface antigen (HBsAg) positive, 62 (20.7%) were hepatitis B surface antibody (AntiHBs) positive and 7 (2.3%) were AntiHCV positive. Conclusion: Vaccination rates of patients can be increased by spending more time on counseling about vaccination and by emphasizing possible problems they may face if not vaccinated.","[Mamur, Ahmet] Eskisehir Publ Hlth Management, Eskisehir, Turkey; [Kayhan, Mehmet] Yeni Family Hlth Care Ctr, Eskisehir, Turkey; [Oztas, Dilek] Yildirim Beyazit Univ, Dept Publ Hlth, Ankara, Turkey","Mamur, A (corresponding author), Eskisehir Publ Hlth Management, Eskisehir, Turkey.",,"kayhan, mehmet/W-1631-2017","kayhan, mehmet/0000-0001-7493-5165",,,"[Anonymous], 2014, DIABETES CARE, V37, pS5, DOI 10.2337/dc14-S00; Arslan E. I., 2016, AWARENESS HEPATITIS, V2; Barut HS, 2009, KLIMIK J, V22, P3; Bridges CB, 2013, MMWR-MORBID MORTAL W, V62, P; Cacoub P, 2000, MEDICINE, V79, P47, DOI 10.1097/00005792-200001000-0000; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P170; Citil R, 2010, ERCIYES MED J, V32, P11; Fabrizi F, 2011, ALIMENT PHARM THER, V33, P815, DOI 10.1111/j.1365-2036.2011.04589.; Hoerger TJ, 2013, DIABETES CARE, V36, P63, DOI 10.2337/dc12-075; Huang JF, 2007, AM J GASTROENTEROL, V102, P1237, DOI 10.1111/j.1572-0241.2007.01181.; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.2558; MCKINNEY WP, 1989, AM J PUBLIC HEALTH, V79, P1422, DOI 10.2105/AJPH.79.10.142; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.8; Noto H, 2006, J DIABETES COMPLICAT, V20, P113, DOI 10.1016/j.jdiacomp.2006.01.00; Pala T, 2004, TURKISH J ENDOCRINOL, V3, P9; Reilly Meredith L, 2012, J Diabetes Sci Technol, V6, P85; Satman I, 2013, HUM VACC IMMUNOTHER, V9, P2618, DOI 10.4161/hv.2582; Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.00; Thompson Nicola D, 2009, J Diabetes Sci Technol, V3, P28",20,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,1003.0,1006,,10.19193/0393-6384_2017_6_158,,4,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500018,,,,,2022-07-14,0.002066115702479339,1.012086763216853e-08,0.04231680257624517,0.11256730198969683,0.04113882781413754
J,"Massimino, S1;  Rinella, S;  Cicarelli, C;  Guarnera, M;  Di Corrado, D",,,,"Massimino, Simona; Rinella, Sergio; Cicarelli, Cristina; Guarnera, Maria; Di Corrado, Donatella",,,PSYCHOLOGICAL FEATURES OF YOUNG GIRLS PRACTISING WATER SPORTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,water sport; women; development; emotion; self-esteem,BLOOD LACTATE; WORKING-MEMORY; MOOD STATES; IN-VITRO; EXCITABILITY; PERFORMANCE; EXPRESSION; PROFILE; VIVO,"Introduction: This study aims to investigate the characteristics of those who practice two water sports during development, such as water polo and synchronized swimming, through assessment of emotional states, self-esteem, personological features and visual-spatial skills, such as perceptual organization and visual memory. Materials and methods: A total of 24 young female athletes (Age: mean, m = 11.47 year; +/- 0.61 Standard Deviation, SD; Height: m = 143.75 centimeters, +/- 6.13SD; Weight: m = 39.22 kilograms, +/- 3.83SD) practicing team water sports at a competitive level from at least one year participated in the research; 11 of them were part of a synchronized swimming team and 13 of a water polo squad. To carry out the present study, in order to assess personality, self-esteem, mood and visual-spatial skills of sample, the following psychological assessment tests were used: 1) Big Five Questionnaire for Children, 2) Multidimensional Self-esteem Test, 3) Profile of Mood States-Adolescent, and 4) Rey-Osterrieth Complex Figure Test. The study was performed at the sports center Torre del Grifo Village (Mascalucia, Italy). Results: The study has showed, in both groups of athletes, the presence of personological features oriented to establish friendly and cooperative relations; what it makes us conclude that within the two teams there are positive relationships between athletes, also aimed at achieving the common goal, and that the group component is crucial. It is also seen that in the synchronized swimming team the individual dimension emerges strongly, in terms of athletic competition spirit. Conclusion: The comparison between the two groups showed that the water polo seems to encourage the development of visual-spatial skills, compared to synchronized swimmers. It is due to better performance in the memory copy of Rey-Osterrieth Complex Figure, by the water polo athletes.","[Massimino, Simona; Rinella, Sergio; Cicarelli, Cristina] Univ Catania, Sect Physiol, Dept Biomed & Biotechnol Sci, Catania, Italy; [Guarnera, Maria; Di Corrado, Donatella] Kore Univ, Dept Human & Social Sci, Enna, Italy","Di Corrado, D (corresponding author), Univ KORE Enna, Dept Sport Sci, I-94100 Enna, Italy.",,"Di Corrado, Donatella/H-3726-2019; Rinella, Sergio/AAB-5946-2021; Di Corrado, Donatella/K-3757-2019; Rinella, Sergio/ADM-1130-2022","Di Corrado, Donatella/0000-0001-8223-6671; Rinella, Sergio/0000-0002-9368-7088",,,"Allport G., 1961, PATTERN GROWTH PERS; Barbaranelli C, 2003, PERS INDIV DIFFER, V34, P645, DOI 10.1016/S0191-8869(02)00051-; Barbaranelli C, 1998, BIG FIVEQUESTIONNAI; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.49; Bracken B.A, 2003, TEST TMA VALUTAZION; Cei A, 1998, PSICOLOGIA SPOR; Chatard JC, 1999, EUR J APPL PHYSIOL, V79, P479, DOI 10.1007/s00421005054; Coco M, 2016, MEDICINE, V95, DOI 10.1097/MD.000000000000297; Coco M, 2014, SOMATOSENS MOT RES, V31, P35, DOI 10.3109/08990220.2013.83481; Coco M, 2013, SOMATOSENS MOT RES, V30, P90, DOI 10.3109/08990220.2013.76994; Coco M, 2009, BRAIN RES, V1302, P205, DOI 10.1016/j.brainres.2009.09.03; Di Corrado D, 2014, MOL MED REP, V9, P2441, DOI 10.3892/mmr.2014.211; Donia M, 2012, ONCOL REP, V28, P682, DOI 10.3892/or.2012.184; Eagleton JR, 2007, PERCEPT MOTOR SKILL, V105, P265, DOI 10.2466/PMS.105.5.265-27; Fagone P, 2013, J NEUROIMMUNOL, V261, P82, DOI 10.1016/j.jneuroim.2013.04.01; Fagone P, 2013, BASIC CLIN PHARMACOL, V112, P63, DOI 10.1111/j.1742-7843.2012.00923.; Furley P, 2010, PERCEPT MOTOR SKILL, V110, P801, DOI 10.2466/PMS.110.3.801-80; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-; HOLLANDER AP, 1994, MED SPORT SCI, V39, P17; Maxwell J. P., 2007, PSYCHOL ANGER, P20; Melchiorri G, 2010, J STRENGTH COND RES, V24, P2647, DOI 10.1519/JSC.0b013e3181e3486; Mijatovic S, 2010, FREE RADICAL BIO MED, V48, P1090, DOI 10.1016/j.freeradbiomed.2010.01.02; Musumeci G, 2013, INT J MOL SCI, V14, P15767, DOI 10.3390/ijms14081576; Perciavalle V, 2015, NEUROL SCI, V36, P2129, DOI 10.1007/s10072-015-2329-; Perciavalle V, 2015, NEUROL SCI, V36, P1597, DOI 10.1007/s10072-015-2210-; Perciavalle V, 2014, PERCEPT MOTOR SKILL, V118, P940, DOI 10.2466/19.50.PMS.118k27w; Perciavalle V, 2014, PERCEPT MOTOR SKILL, V118, P733, DOI 10.2466/29.30.PMS.118k22w; Perciavalle V, 2014, SOMATOSENS MOT RES, V31, P1, DOI 10.3109/08990220.2013.79692; Perciavalle V, 2013, MOL MED REP, V7, P1733, DOI 10.3892/mmr.2013.142; PRAPAVESSIS H, 1992, AUSTR J SCI MED SPOR, V24, P1; Proios M., 2012, International Quarterly of Sport Science, P1; Rey A., 1959, NEUROL SCI, V22, P44; Slutzky CB, 2009, PSYCHOL SPORT EXERC, V10, P381, DOI 10.1016/j.psychsport.2008.09.00; Tenenbaum G, 2008, MIL PSYCHOL, V20, pS11, DOI 10.1080/0899560070180477; Terry PC, 1999, J SPORT SCI, V17, P861, DOI 10.1080/02640419936542; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-; TERRY PC, 1996, J SPORTS SCI, V14, P4; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.00; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.00; Yamamura C, 1999, INT J SPORTS MED, V20, P246, DOI 10.1055/s-2007-97112",40,0,0,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,657.0,662,,10.19193/0393-6384_2017_4_098,,6,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700019,,,,,2022-07-14,0.003925619834710744,1.0722127129542432e-16,0.005161590233470411,0.055596717036832825,0.0051617101487365985
J,"Messina, A21;   Monda, V;   Nigro, E;   Valenzano, AA;   Villano, I;   Ruberto, M;   Monda, G;   Ascione, A;   Chieffi, S;   Cibelli, G;   Messina, G;   Monda, M",,,,"Messina, Antonietta; Monda, Vincenzo; Nigro, Ersilia; Valenzano, Anna A.; Villano, Ines; Ruberto, Maria; Monda, Giuseppe; Ascione, Antonio; Chieffi, Sergio; Cibelli, Giuseppe; Messina, Giovanni; Monda, Marcellino",,,AN ALLIED HEALTH: THE PASTA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Mediterranean Diet; Pasta; Prevention; Health and Wellness,CAROTID-ARTERY OCCLUSION; PIAL MICROVASCULAR RESPONSES; MEDITERRANEAN DIET; LINE BISECTION; HEART-RATE; RAT; REPERFUSION; MICROCIRCULATION; INTERFERENCE; QUALITY,"The Mediterranean diet has been recognized historical and cultural heritage of great importance, nutritional and culinary excellence to scratch. In the Mediterranean diet 50-60% of kilocalories should come from carbohydrates, 25-30% from lipids and the remaining 10-15% from protein, the dough thus represents the main source of complex carbohydrates, ideal energy source is essential for the daily activities ensuring the good health state. The beneficial properties and the nutritional values of pasta are numerous Pasta is a ally of the diet: satiating has great power and is an excellent solution for stress. It also contains vitamins of the B group essential for the proper functioning of the nervous system, the starch paste is free glucose, which promotes the synthesis of serotonin, which gives well-being. Some studies have shown that, among the carbohydrates, the pasta has the lowest glycemic index not therefore increases the levels of C-reactive protein, which proved to be correlated with cardiovascular risk does not increase the risk of hypertension because it contains very little sodium and fiber, the latter fundamental in the prevention of cancer.","[Messina, Antonietta; Monda, Vincenzo; Villano, Ines; Monda, Giuseppe; Chieffi, Sergio; Cibelli, Giuseppe; Messina, Giovanni; Monda, Marcellino] Univ Campania, Dept Expt Med, Sect Human Physiol, Naples, Italy; [Messina, Antonietta; Monda, Vincenzo; Villano, Ines; Monda, Giuseppe; Chieffi, Sergio; Cibelli, Giuseppe; Messina, Giovanni; Monda, Marcellino] Univ Campania, Unit Dietet & Sport Med, Naples, Italy; [Nigro, Ersilia; Messina, Giovanni] CEINGE Biotecnol Avanzate Scarl, Naples, Italy; [Valenzano, Anna A.] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Ascione, Antonio] Univ Naples Parthenope, Dept Motor Sci & Wellness, Naples, Italy; [Ruberto, Maria] Univ Campania Luigi Vanvitelli, Dept Med Surg & Dent Specialties, Naples, Italy","Messina, A (corresponding author), Univ Naples 2, Dept Expt Med, Sect Human Physiol, Via Costantinopoli 16, I-80138 Naples, Italy.;Messina, A (corresponding author), Univ Naples 2, Clin Dietet Serv, Via Costantinopoli 16, I-80138 Naples, Italy.",,"Messina, Antonietta/AHH-2383-2022; Cibelli, Giuseppe/AAC-2635-2019; MESSINA, ANTONIETTA/K-9366-2016; Ascione, Antonio/I-9473-2018; Messina, Giovanni/AAE-8668-2022","Messina, Antonietta/0000-0001-8343-432X; Ascione, Antonio/0000-0003-4466-1807; Messina, Giovanni/0000-0002-0011-867X; Nigro, Ersilia/0000-0001-5637-1685; Monda, Marcellino/0000-0002-7184-218X; Monda, Vincenzo/0000-0002-6083-5814; VILLANO, INES/0000-0002-1755-358X; CIBELLI, GIUSEPPE/0000-0002-5371-2584",Pastificio Di Martino Gaetano F. lli Spa,Thanks to Pastificio Di Martino Gaetano & F. lli Spa for non-conditioned financial support for research projects in Nutrition Physiology.,"Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Esposito T, 2006, J THERM BIOL, V31, P527, DOI 10.1016/j.jtherbio.2006.07.00; Muros JJ, 2017, NUTRITION, V35, P87, DOI 10.1016/j.nut.2016.11.00; Lapi D, 2013, ARCH ITAL BIOL, V151, P11, DOI 10.4449/aib.v151i1.147; Lapi D, 2013, J VASC RES, V50, P332, DOI 10.1159/00035329; Lapi D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.0009; Lapi D, 2015, MICROCIRCULATION, V22, P79, DOI 10.1111/micc.1217; Lapi D, 2013, CLIN HEMORHEOL MICRO, V54, P415, DOI 10.3233/CH-13176; Lapi D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.0003; Lapi D, 2011, J PINEAL RES, V51, P136, DOI 10.1111/j.1600-079X.2011.00870.; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G., 2014, J ANESTH CLIN RES, V5, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0013; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/383197; Padalino L, 2016, CARBOHYD POLYM, V153, P229, DOI 10.1016/j.carbpol.2016.07.10; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Tong TYN, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0677-; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003",30,6,6,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,641.0,644,,10.19193/0393-6384_2017_4_095,,4,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700016,,,,,2022-07-14,0.0027892561983471073,0.022078175749961786,0.0010773354062471366,0.11051616070511137,0.0009046401463870239
J,"Messina, A31;   Monda, V;   Avola, R;   Moscatelli, F;   Valenzano, AA;   Villano, I;   Ruberto, M;   Monda, E;   La Marra, M;   Tafuri, D;   Chieffi, S;   Cibelli, G;   Monda, M;   Messina, G",,,,"Messina, Antonietta; Monda, Vincenzo; Avola, Roberto; Moscatelli, Fiorenzo; Valenzano, Anna A.; Villano, Ines; Ruberto, Maria; Monda, Emanuele; La Marra, Marco; Tafuri, Domenico; Chieffi, Sergio; Cibelli, Giuseppe; Monda, Marcellino; Messina, Giovanni",,,"ROLE OF THE OREXIN SYSTEM ON AROUSAL, ATTENTION, FEEDING BEHAVIOUR AND SLEEP DISORDERS",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,orexin; hypocretin; arousal; attention; sleep; narcolepsy,HYPERTHERMIC REACTIONS; HEART-RATE; CEREBRAL INJECTION; ARTERY OCCLUSION; INTERFERENCE; DISTRACTOR; BISECTION,"The orexin-A/hypocretin-1 and orexin-B/hypocretin-2 are neuropeptides synthesized by a cluster of neurons in the lateral hypothalamus. Orexins play an significant role in regulating arousal and attention. The term arousal refers to a person's general state of alertness or excitation, both physiological and psychological. Arousal levels ranges on a continuum from drowsiness through alertness to excitement. Orexin plays an important role in the regulation of feeding behaviour. The orexin stimulates food intake and reduces the metabolic rate, increasing and maintaining the body's energy reserves. Orexins play also a fundamental role in the regulation of the sleep-wake cycle by increasing arousal levels and maintaining wakefulness. Its deficit can cause narcolepsy. Key to the diagnosis of narcolepsy is the combination of a common symptom, excessive daytime sleepiness, and an uncommon symptom, cataplexy, i.e. a sudden and transient episode of muscle weakness","[Messina, Antonietta; Monda, Vincenzo; Villano, Ines; Monda, Emanuele; La Marra, Marco; Chieffi, Sergio; Cibelli, Giuseppe; Monda, Marcellino; Messina, Giovanni] Univ Campania, Dept Expt Med, Sect Human Physiol, Naples, Italy; [Messina, Antonietta; Monda, Vincenzo; Villano, Ines; Monda, Emanuele; La Marra, Marco; Chieffi, Sergio; Cibelli, Giuseppe; Monda, Marcellino; Messina, Giovanni] Univ Campania, Unit Dietet & Sport Med, Naples, Italy; [Avola, Roberto; Messina, Giovanni] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Moscatelli, Fiorenzo; Valenzano, Anna A.] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Tafuri, Domenico] Univ Naples Parthenope, Dept Motor Sci & Wellness, Naples, Italy; [Ruberto, Maria] Univ Campania Luigi Vanvitelli, Dept Med Surg & Dent Specialties, Naples, Italy","Messina, A (corresponding author), Univ Naples 2, Dept Expt Med, Sect Human Physiol, Via Costantinopoli 16, I-80138 Naples, Italy.;Messina, A (corresponding author), Univ Naples 2, Clin Dietet Serv, Via Costantinopoli 16, I-80138 Naples, Italy.",,"Messina, Antonietta/AHH-2383-2022; Cibelli, Giuseppe/AAC-2635-2019; Monda, Emanuele/AAQ-6457-2020; Moscatelli, Fiorenzo/ABC-9536-2020; Messina, Giovanni/AAE-8668-2022; MESSINA, ANTONIETTA/K-9366-2016","Messina, Antonietta/0000-0001-8343-432X; Monda, Emanuele/0000-0001-9304-988X; Messina, Giovanni/0000-0002-0011-867X; VILLANO, INES/0000-0002-1755-358X; Monda, Marcellino/0000-0002-7184-218X; Monda, Vincenzo/0000-0002-6083-5814; la marra, marco/0000-0001-7488-8493; Moscatelli, Fiorenzo/0000-0003-1274-0332; CIBELLI, GIUSEPPE/0000-0002-5371-2584",,,"Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Chieffi S, 2004, EXP BRAIN RES, V158, P421, DOI 10.1007/s00221-004-1916-; Chieffi S., 2015, J PSYCHIAT, V18, DOI [10.4172/1994-8220.1000228, DOI 10.4172/1994-8220.1000228; Chieffi S, 2008, EXP BRAIN RES, V189, P129, DOI 10.1007/s00221-008-1458-; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Chieffi S, 2012, EXP BRAIN RES, V219, P489, DOI 10.1007/s00221-012-3106-; Chieffi S, 2009, BEHAV BRAIN RES, V203, P200, DOI 10.1016/j.bbr.2009.05.00; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Esposito M, 2014, CHEMOSPHERE, V94, P62, DOI 10.1016/j.chemosphere.2013.09.01; Esposito T, 2006, J THERM BIOL, V31, P527, DOI 10.1016/j.jtherbio.2006.07.00; Franco R, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-4; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Iavarone A, 2007, J AUTISM DEV DISORD, V37, P775, DOI 10.1007/s10803-006-0190-; Lapi D, 2013, ARCH ITAL BIOL, V151, P11, DOI 10.4449/aib.v151i1.147; Lapi D, 2013, J VASC RES, V50, P332, DOI 10.1159/00035329; Lapi D, 2015, MICROCIRCULATION, V22, P79, DOI 10.1111/micc.1217; Lapi D, 2013, CLIN HEMORHEOL MICRO, V54, P415, DOI 10.3233/CH-13176; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/63928; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2008, CLIN NUTR, V27, P657, DOI 10.1016/j.clnu.2008.04.00; Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.01; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2015, BIOL ME; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707",50,20,20,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,645.0,649,,10.19193/0393-6384_2017_4_096,,5,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700017,,,,,2022-07-14,0.004958677685950413,0.036550329919816785,0.002599163851765652,0.1109926272459381,0.002253053814077251
J,"Messina, A41;   Russo, G;   Monda, V;   Valenzano, A;   Villano, I;   Ascione, A;   Moscatelli, F;   Crescenzo, R;   Catizzone, AR;   Panico, A;   Fulgione, E;   Piombino, L;   Dorato, D;   Cavaliere, G;   Trinchese, G;   Cibelli, G;   Bartolettic, E;   Messina, G",,,,"Messina, Antonietta; Russo, Gianluca; Monda, Vincenzo; Valenzano, Anna; Villano, Ines; Ascione, Antonio; Moscatelli, Fiorenzo; Crescenzo, Romoaldo; Catizzone, Anna Rosa; Panico, Annalisa; Fulgione, Elisabetta; Piombino, Laura; Dorato, Dario; Cavaliere, Gina; Trinchese, Giovanna; Cibelli, Giuseppe; Bartolettic, Emanuele; Messina, Giovanni",,,RETRACTED: EFFECT OF RADIOFREQUENCY ON SYMPATHETIC NERVOUS SYSTEM FUNCTIONING (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,radiofrequency devices; sympathetic nervous system; thermogenesis; resting energy expenditure; eating behavior,HYPERTHERMIC REACTIONS; CEREBRAL INJECTION; CHILDREN; ENERGY; INTERFERENCE; POPULATION; MIGRAINE; INCREASE; EXPOSURE; STANDARD,"Radiofrequency devices for aesthetic applications such as body and face skin tightening, cellulite reduction, rhytids and body contouring treatments are becoming increasingly popular in clinics worldwide due to their demonstrated efficacy and safety combined with a relative lack of complications and down-time. Heating of body tissues by radiofrequency (RF) energy is a mechanism for therapeutic. Such effects may be produced by local changes in tissue temperature (for example, thermally induced changes in regional blood flow) and others may be systemic effects due to the additional thermal load on the body. An elevated core temperature increases metabolism and certain other functions such as heart rate, respiration rate, and nerve conduction velocity The aim of this study was to determine whether healthy subjects, non-obese, undergoing treatment with radiofrequency could see changes in REE and SNA, GSR. Twenty healthy adult female, took part in the study. The study protocol consisted of the treatment of twenty minutes of radiofrequency in the abdominal region. Participants in the study were presented in the morning at 8 am fasting for at least 12 h, underwent measurement of REE, HRV and GSR 60 minutes prior to treatment, immediately after treatment, and 120 minutes after treatment. Radiofrequency induced significant increases of REE, sympathetic activity, and GSR. This result is also useful in the interpretation of the relationship between the sympathetic nervous system and food intake in young subjects. It has demonstrated a significant influence of sympathetic activity on eating behavior, also through an increase in thermogenesis.","[Messina, Antonietta; Monda, Vincenzo; Villano, Ines] Univ Campania Luigi Vanvitelli, Dept Expt Med, Caserta, Italy; [Russo, Gianluca] Univ Foggia, Italian Soc Nonablat Radiofrequency, Foggia, Italy; [Valenzano, Anna; Moscatelli, Fiorenzo; Cibelli, Giuseppe; Messina, Giovanni] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Ascione, Antonio] Univ Naples Parthenope, Dept Motor Sci & Wellness, Naples, Italy; [Crescenzo, Romoaldo; Catizzone, Anna Rosa; Panico, Annalisa; Fulgione, Elisabetta; Piombino, Laura; Dorato, Dario] Univ Naples Federico II, Italian Soc Aesthet Med, Naples, Italy; [Cavaliere, Gina; Trinchese, Giovanna] Univ Naples Federico II, Dept Biol, Naples, Italy","Messina, A (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Caserta, Italy.",antonietta.messina@unicampania.it,"Cibelli, Giuseppe/AAC-2635-2019; Messina, Antonietta/AHH-2383-2022; Ascione, Antonio/I-9473-2018; Moscatelli, Fiorenzo/ABC-9536-2020; MESSINA, ANTONIETTA/K-9366-2016; Giovanna, Trinchese/AAC-5995-2022","Messina, Antonietta/0000-0001-8343-432X; Ascione, Antonio/0000-0003-4466-1807; Giovanna, Trinchese/0000-0002-4096-6876; Monda, Vincenzo/0000-0002-6083-5814; CIBELLI, GIUSEPPE/0000-0002-5371-2584; VILLANO, INES/0000-0002-1755-358X; Moscatelli, Fiorenzo/0000-0003-1274-0332",,,"Acar YA, 2016, ACTA MEDICA MEDITERR, V32, P7; Adair ER, 2003, BIOELECTROMAGNETICS, V24, P489, DOI 10.1002/bem.1012; Adair ER, 2001, BIOELECTROMAGNETICS, V22, P429, DOI 10.1002/bem.7; Antonino A, 2016, ACTA MEDICA MEDITERR, V32, P38; Aurilio C, 2015, AFRICAN J PSYCHIAT, V18, DOI 10.4172/2378-5756.1000307; Behnamipour S, 2016, ACTA MEDICA MEDITERR, V32, P154; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Chieffi S., 2015, J PSYCHIAT, V18, DOI [10.4172/1994-8220.1000228, DOI 10.4172/1994-8220.1000228; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; De Fusco C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/404523; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Di Serio F, 2016, ACTA MEDICA MEDITERR, V32, P1911, DOI 10.19193/0393-6384_2016_6_18; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, CHEMOSPHERE, V94, P62, DOI 10.1016/j.chemosphere.2013.09.01; Esposito T, 2006, J THERM BIOL, V31, P527, DOI 10.1016/j.jtherbio.2006.07.00; Fahrenberg J., 2000, ENG PSYCHOPHYSIOLOGY, P11; Fariba F, 2016, ACTA MEDICA MEDITERR, V32, P210; Fiorelli A, 2017, ANN THORAC SURG, V103, P216, DOI 10.1016/j.athoracsur.2016.10.05; Hirsch J, 2003, OBES RES, V11, P2, DOI 10.1038/oby.2003.; Li HC, 2016, ACTA MEDICA MEDITERR, V32, P51; Licata M, 2016, ACTA MEDICA MEDITERR, V32, P1569, DOI 10.19193/0393-6384_2016_5_13; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/63928; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G, 2014, AFRICAN J PSYCHIAT, V17, DOI 10.4172/Psychiatry.1000172; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Asian J Sports Med, V7, pe26841, DOI 10.5812/asjsm.2684; Messina G, 2016, NEUROPSYCH DIS TREAT, V12, P319; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Mohammadnejad E, 2016, ACTA MEDICA MEDITERR, V32, P129; Monda M, 2008, CLIN NUTR, V27, P657, DOI 10.1016/j.clnu.2008.04.00; Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.01; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V., 2016, BIOL MED, V8, DOI [10.4172/0974-8369.1000306, DOI 10.4172/0974-8369.1000306; Moscatelli F, 2015, BIOL ME; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Nankaly A, 2016, ACTA MEDICA MEDITERR, V32, P95; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Pirsaheb M, 2016, ACTA MEDICA MEDITERR, V32, P96; Refahi S, 2016, ACTA MEDICA MEDITERR, V32, P120; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Santamaria S., 2016, BIOL MED, V8, DOI 10.4172/0974-8369.100026; Senol S, 2016, ACTA MEDICA MEDITERR, V32, P1773, DOI 10.19193/0393-6384_2016_6_16; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Wang GP, 2016, ACTA MEDICA MEDITERR, V32, P59; Wang H, 2016, ACTA MEDICA MEDITERR, V32, P54; Yoon H., 2016, ACTA MEDICA MEDITERR, V32, P1697, DOI DOI 10.19193/0393-6384_5_15",69,23,23,1,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,833.0,840,,10.19193/0393-6384_2017_5_124,,8,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000018,,,,,2022-07-14,0.006921487603305785,0.055612330229965985,0.005558340566858072,0.11134755852073389,0.005383140264764072
J,"Mohamadizadeh, L1;  Makvandi, B;  Pasha, R;  Bakhtiarpour, S;  Hafezi, F",,,,"Mohamadizadeh, Ladan; Makvandi, Behnam; Pasha, Reza; Bakhtiarpour, Saeid; Hafezi, Fariba",,,COMPARING OF THE EFFECT OF DIALECTICAL BEHAVIOR THERAPY (DBT) AND SCHEMA THERAPY (ST) ON REDUCING MOOD ACTIVITY AND SUICIDAL THOUGHTS IN PATIENTS WITH BORDERLINE PERSONALITY DISORDER,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,dialectical behavior therapy; schema therapy; mood activity; suicidal thoughts; borderline personality disorder,DEPRESSION,"Introduction: Borderline personality disorder is known as the most common personality disorder in the field of psychiatry. The aim of this study was to compare the effect of dialectical behavior therapy and schema therapy on mood activity and suicidal thoughts in patients with borderline personality disorder in the city of Qazvin. Materials and methods: This study in terms of purpose is an applied one and in terms of the method of data collection, can be regarded as pre-experimental and post-experimental semi-experimental study with the control group. The study population included all patients with borderline personality disorder and mood activity and suicidal thoughts who referred to Bou-Ali Hospital in the city of Ghazvin. The sample consisted of 36 students, who were selected by convenience sampling. Of these, 24 patients were randomly divided into two groups, two experimental group including12 people, and a control group consisting 12 patients. In this study, The Millon Clinical Multiaxial Inventory, The beck Depression Inventory and Scale suicide imagination Mach (SSIM) were used. Patients with the borderline personality disorder who belonged to the experimental group were under intervention for 16 section which takes long 90 minutes sessions in eight consecutive weeks under the controls. Research data was analyzed using multivariate and single factor analysis of covariance, and T-experimental was analyzed for the independent groups. Results: The results showed that there was a significant difference between dialectical behavior therapy and schema therapy with regard to their effect on mood activity and suicidal thoughts at (0.05>P). The results of the Independent t-experimental also showed that there was no significant difference between dialectical behavior therapy and schema therapy in patients with the borderline personality disorder in terms of the Suicidal thoughts variable at (0.05>P), but there was a significant difference between schema therapy and dialectical behavior therapy in patients with the borderline personality disorder in terms of the mood activity variable at (0.01>P). Discussion and conclusion: So, we could conclude that dialectical behavior therapy and schema therapy should be effective in reducing mood activity and suicidal thoughts in patients with borderline personality disorder.","[Mohamadizadeh, Ladan] Islamic Azad Univ, Khuzestan Sci & Res Branch, Dept Psychol, Ahvaz, Iran; [Makvandi, Behnam; Pasha, Reza; Bakhtiarpour, Saeid; Hafezi, Fariba] Islamic Azad Univ, Ahvaz Branch, Dept Psychol, Ahvaz, Iran","Makvandi, B (corresponding author), Islamic Azad Univ, Ahvaz Branch, Dept Psychol, Ahvaz, Iran.",,"makvandi, behnam/AAN-4246-2021","mohamadizadeh, ladan/0000-0001-6250-2709",,,"Abolghasemi A, 2012, J CLIN PSYCHOL, V42, P2; Aghayusefi A, 2015, Q J RES ADDICT, V9, P7; Alizadeh A, 2013, J PSYCHONURSE, V1, P6; American Psychiatric Association, 2000, DIAGNOSTIC STAT MAN; [Anonymous], 2001, PRACT GUID TREATM P; Arntz A, 2015, BEHAV RES THER, V74, P60, DOI 10.1016/j.brat.2015.09.00; Barlow DH, 2002, ABNORMAL PSYCHOL IN; Barnicot K, 2016, J BEHAV THER EXP PSY, V52, P147, DOI 10.1016/j.jbtep.2016.04.00; Beck A.T., 1996, BECK DEPRESSION INV; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_1; Dickhaut V, 2014, J BEHAV THER EXP PSY, V45, P242, DOI 10.1016/j.jbtep.2013.11.00; Khajeh Mogehi N., THESI; Kianpoor M, 2016, ACTA MEDICA MEDITERR, V32, P149; Kiehn B, 2002, OVERVIEW DIALECTICA; Kroger C, 2010, J BEHAV THER EXP PSY, V41, P381, DOI 10.1016/j.jbtep.2010.04.00; Lynch TR, 2007, INT J GERIATR PSYCH, V22, P131, DOI 10.1002/gps.170; Miller PA, 2007, DIALECTICAL BEHAV T; Millon T, 1977, J PERSO ASSESSMENT, V68, P6; Millon T., 1994, MILLON CLINICALMULT; Mohan MR, 2009, INT J BUS PERFORM MA, V11, P1, DOI 10.1504/IJBPM.2009.02379; Moosaviasl SA, 2014, YASUJ UNI MED SCI J, V19, P8; Sempertegui GA, 2013, CLIN PSYCHOL REV, V33, P426, DOI 10.1016/j.cpr.2012.11.00; Soloff PH, 2000, PSYCHIAT CLIN N AM, V23, P169, DOI 10.1016/S0193-953X(05)70150-; Stepp SD, 2008, J PERS DISORD, V22, P549, DOI 10.1521/pedi.2008.22.6.54; Zamani N, 2014, SCI J ILAM U MED SCI, V20, P4; Zamani N, 2012, J HAMEDAN ISLAMIC AZ, V5, P12",26,4,4,0,25,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,1025.0,1031,,10.19193/0393-6384_2017_6_162,,7,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500021,,,,,2022-07-14,0.0026859504132231405,7.200916108002324e-15,0.011936210198615217,0.06223439478979819,0.011936210198615217
J,"Monda, V1;  Nigro, E;  Ruberto, M;  Monda, G;  Valenzano, A;  Triggiani, AI;  Moscatelli, F;  Monda, E;  Villano, I;  Roccella, M;  Parisi, L;  Messina, A",,,,"Monda, Vincenzo; Nigro, Ersilia; Ruberto, Maria; Monda, Giuseppe; Valenzano, Anna; Triggiani, Antonio I.; Moscatelli, Fiorenzo; Monda, Emanuele; Villano, Ines; Roccella, Michele; Parisi, Lucia; Messina, Antonietta",,,SYNERGISM OR COMPETITION BETWEEN ZINC AND CHROMIUM DIETARY LEVELS ON INSULIN ACTION MECHANISM. A METHOD TO INVESTIGATE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,zinc; chromium; dietary supplementation; glucose,HYPERTHERMIC REACTIONS; CEREBRAL INJECTION; NOCTURNAL ENURESIS; CHILDREN; MIGRAINE; INTERFERENCE; ADOLESCENTS; POPULATION; STRESS; SLEEP,"Introduction: The action of zinc and chromium on the metabolism of carbohydrates and, consequently, on lipids and protein metabolism improves, on the one hand, the receptor membrane efficiency and, on the other hand, plays an important role in the regulation of secretion and insulin activity. Aim of the study is to gather preliminary data on the efficacy of treatment with zinc or chromium on impairment glucose tolerance. Materials and methods: Subjects: All patients from a dietician examination had levels of blood sugar limits (35 men and 58 women; age 39-61 years). Diet food: intake of all nutrients was measured in weekly diary. The supplementation of chromium or zinc has been carried out - in a random way. Statistical analysis: Data are expressed as mean +/- SD or percentage changes from baseline. Results: Blood glucose trigger levels of our patients (especially the elderly) was closely linked to the intake of chromium with diet rather than to zinc intake. The effect of dietary supplementation of chromium based on the contribution of some foods has a beneficial effect on the glucose tolerance test (0.5 g glucose / kg body weight) (Fig. 1-A) and on the basal blood glucose levels (Fig. 1-B). In particular, the basal level of glucose in the serum decreases after 1 month of treatment, and this is still true after 6 months. Discussion: The effect of dietary chromium supplementation has a beneficial effect on the glucose tolerance test and fasting plasma glucose. The presence of zinc was less than chromium, but competes with the same chromium to the glucose tolerance test. The baseline serum glucose level decreases although it is still less than the amount detected in subjects treated with chromium. We can speculate that zinc and chromium may present a competitive effect on the absorption of insulin secretion and insulin receptor.","[Monda, Vincenzo; Monda, Giuseppe; Monda, Emanuele; Villano, Ines; Messina, Antonietta] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy; [Nigro, Ersilia] CEINGE Biotecnol Avanzate Scarl, Naples, Italy; [Ruberto, Maria] Univ Campania Luigi Vanvitelli, Dept Med Surg & Dent Specialties, Naples, Italy; Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Valenzano, Anna; Triggiani, Antonio I.; Moscatelli, Fiorenzo] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy","Messina, A (corresponding author), Univ Naples 2, Dept Expt Med, Sect Human Physiol, Via Costantinopoli 16, I-80138 Naples, Italy.;Messina, A (corresponding author), Univ Naples 2, Clin Dietet Serv, Via Costantinopoli 16, I-80138 Naples, Italy.",,"Monda, Emanuele/AAQ-6457-2020; Triggiani, Antonio Ivano/M-6252-2015; MESSINA, ANTONIETTA/K-9366-2016; Messina, Antonietta/AHH-2383-2022; triggiani, antonio ivano/Q-4701-2019; Moscatelli, Fiorenzo/ABC-9536-2020","Monda, Emanuele/0000-0001-9304-988X; Messina, Antonietta/0000-0001-8343-432X; triggiani, antonio ivano/0000-0003-3291-9452; Moscatelli, Fiorenzo/0000-0003-1274-0332; Nigro, Ersilia/0000-0001-5637-1685; VILLANO, INES/0000-0002-1755-358X; Monda, Vincenzo/0000-0002-6083-5814",,,"Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Chieffi S., 2015, J PSYCHIAT, V18, DOI [10.4172/1994-8220.1000228, DOI 10.4172/1994-8220.1000228; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2014, CHEMOSPHERE, V94, P62, DOI 10.1016/j.chemosphere.2013.09.01; Esposito T, 2006, J THERM BIOL, V31, P527, DOI 10.1016/j.jtherbio.2006.07.00; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/63928; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2008, CLIN NUTR, V27, P657, DOI 10.1016/j.clnu.2008.04.00; Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.01; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Moscatelli F, 2015, BIOL ME; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707",47,21,21,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,581.0,585,,10.19193/0393-6384_2017_4_085,,5,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700006,,,,,2022-07-14,0.004442148760330579,0.05743288622765123,0.0010625445422582762,0.11120684703314378,0.0009859052447408834
J,"Monda, V21;   Anna, V;   Ruberto, M;   Villano, I;   Russo, V;   La Marra, M;   Pastore, B;   Giuseppe, C;   Salerno, M;   Albano, GD;   Sessa, F;   Marsala, G;   Messina, A",,,,"Monda, Vincenzo; Anna, Valenzano; Ruberto, Maria; Villano, Ines; Russo, Vincenzo; La Marra, Marco; Pastore, Bianca; Giuseppe, Cibelli; Salerno, Monica; Albano, Giseppe D.; Sessa, Francesco; Marsala, Gabriella; Messina, Antonietta",,,PHYSIOLOGICAL POSTURAL STABILIZATION WITH RUGRAN PLANTAR IN ATHLETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Plantar; posture; foot; static pedobarographic,LASER-SCANNING MICROSCOPY; TESTOSTERONE BIOSYNTHESIS; MICROVASCULAR RESPONSES; PRESSURE DISTRIBUTION; LINE BISECTION; PES CAVUS; CHILDREN; MIGRAINE; STABILITY; AURA,"The foot is a complex structure with many articulations and multiple degrees of freedom that play an important role in static posture and dynamic activities. The evolutionary development of the arch of the foot was coincident with the greater demands placed on the foot as humans began to run. The movement and stability of the arch is controlled by intrinsic and extrinsic muscles. The aim of the present study was to investigate if a medical device (plantar), called RUGRAN, can enhance muscle rehabilitation in pain syndromes muscle-tendon for the correction and stabilization postural. The static pedobarographic evaluation revealed significantly higher values in terms of forefoot peak pressure, total plantar force and total contact area in subject without RUGARN plantar, compared to subjects with RUGARN plantar. To the best of our knowledge this is the first study that analyzed the pedobarographic improvements in subjects with the RUGARN plantar. The static pedobarographic results observed while the subjects were standing revealed no difference of force distribution and contact area between forefoot and rearfoot and this finding did not support the hypothesis that the centre of the body shifts to forward because of excessive adipose tissue causing excessive forefoot loading.","[Monda, Vincenzo; Villano, Ines; La Marra, Marco; Pastore, Bianca; Messina, Antonietta] Univ Naples 2, Dept Expt Med, Naples, Italy; [Anna, Valenzano; Giuseppe, Cibelli; Salerno, Monica; Albano, Giseppe D.; Sessa, Francesco] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Ruberto, Maria] Univ Campania Luigi Vanvitelli, Dept Med Surg & Dent Specialties, Caserta, Italy; [Russo, Vincenzo] FMSI, Via Campi Sportivi, Rome, Italy; [Marsala, Gabriella] Azienda Osped Univ, Osped Riuniti Foggia, Struttura Complessa Farm, Foggia, Italy","Messina, A (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.",antonietta.messina@unicampania.it,"Sessa, Francesco/G-1754-2018; SALERNO, MONICA/AAC-1321-2019; MESSINA, ANTONIETTA/K-9366-2016; Messina, Antonietta/AHH-2383-2022","Sessa, Francesco/0000-0003-0357-8791; SALERNO, MONICA/0000-0002-6410-3960; Messina, Antonietta/0000-0001-8343-432X; VILLANO, INES/0000-0002-1755-358X; Monda, Vincenzo/0000-0002-6083-5814; la marra, marco/0000-0001-7488-8493",,,"Barone R, 2017, J CELL MOL MED, V21, P1636, DOI 10.1111/jcmm.1309; Barone R, 2017, J CELL PHYSIOL, V232, P1086, DOI 10.1002/jcp.2551; Bergmann A., 2017, J MANIPULATIVE PHYS; Brunelli M, 2012, ARCH ITAL BIOL, V150, P231, DOI 10.4449/aib.v150i4.142; Burns J, 2005, CLIN BIOMECH, V20, P877, DOI 10.1016/j.clinbiomech.2005.03.00; Busardo FP, 2015, INT J MOL SCI, V16, P6557, DOI 10.3390/ijms1603655; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Cerretani D, 2011, PHARMACOL RES, V64, P517, DOI 10.1016/j.phrs.2011.08.00; Chieffi S., 2015, J PSYCHIAT, V18, DOI [10.4172/1994-8220.1000228, DOI 10.4172/1994-8220.1000228; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Femery V, 2002, CLIN BIOMECH, V17, P406, DOI 10.1016/S0021-9290(02)00063-; FRANCO AH, 1987, PHYS THER, V67, P688, DOI 10.1093/ptj/67.5.68; Franettovich MM, 2007, J AM PODIAT MED ASSN, V97, P115, DOI 10.7547/097011; FRANK JS, 1990, PHYS THER, V70, P855, DOI 10.1093/ptj/70.12.85; Frati P, 2013, CURR PHARM BIOTECHNO, V14, P1157, DOI 10.2174/138920101566614043010163; Frati P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt33; Gao S, 2011, ENTROPY-SWITZ, V13, P936, DOI 10.3390/e1305093; Gravante G, 2003, CLIN BIOMECH, V18, P780, DOI 10.1016/S0268-0033(03)00123-; HENNIG EM, 1994, FOOT ANKLE, V15, P35, DOI 10.1177/10711007940150010; Hillman SJ, 2016, MED ENG PHYS, V38, P485, DOI 10.1016/j.medengphy.2016.01.00; Hong YL, 2012, J SCI MED SPORT, V15, P554, DOI 10.1016/j.jsams.2012.01.00; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.00; Khoury M, 2013, FOOT ANKLE INT, V34, P593, DOI 10.1177/107110071347761; Lapi D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.0009; Lapi D, 2013, CLIN HEMORHEOL MICRO, V53, P303, DOI 10.3233/CH-2012-155; Lapi D, 2011, J PINEAL RES, V51, P136, DOI 10.1111/j.1600-079X.2011.00870.; Lee J.-W., 2010, GRAVITY QUANTUM ENTA, V; Massion J., 2004, PROGR BRAIN RE; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; McKeon PO, 2015, CLIN SPORT MED, V34, P347, DOI 10.1016/j.csm.2014.12.00; Mei Z., 2016, MED BIOL ENG COMPUT; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2014, J ANESTH CLIN RES, V5, P; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, J PSYCHIAT, V18, P1, DOI [10.4172/2378-5756.100028, DOI 10.4172/2378-5756.100028; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Moscatelli F, 2015, BIOL ME; Moscatelli F, 2016, NEUROL SCI, V37, P1947, DOI 10.1007/s10072-016-2693-; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Pastorelli F, 2013, CLIN CASES MINER BON, V10, P96, DOI 10.11138/ccmbm/2013.10.2.09; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/036354651037605; Carpes FP, 2008, J BODYW MOV THER, V12, P22, DOI 10.1016/j.jbmt.2007.05.00; Pomara C, 2016, J CELL PHYSIOL, V231, P1385, DOI 10.1002/jcp.2527; Pomara C, 2015, LEGAL MED-TOKYO, V17, P192, DOI 10.1016/j.legalmed.2014.12.00; Puttaswamaiah R., 2007, FOOT, V17, P3, DOI DOI 10.1016/J.FOOT.2006.07.00; Ribeiro AP, 2011, CLIN BIOMECH, V26, P194, DOI 10.1016/j.clinbiomech.2010.08.00; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Salomone F, 2013, STEM CELL RES, V11, P1037, DOI 10.1016/j.scr.2013.07.00; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shimba T, 1984, J BIOMECHANICS, V1; Statler TK, 2005, J AM PODIAT MED ASSN, V95, P42, DOI 10.7547/095004; Tasseel-Ponche S, 2015, NEUROPHYSIOL CLIN, V45, P327, DOI 10.1016/j.neucli.2015.09.00; Taylor NF, 2007, AUST J PHYSIOTHER, V53, P7, DOI 10.1016/S0004-9514(07)70057-; Tibullo D, 2013, CURR PHARM DESIGN, V19, P2765, DOI 10.2174/138161281131915001; Triggiani A. I., 2015, CLIN PHYSL FUNCTION; Turillazzi E, 2008, FORENSIC SCI INT, V179, pE5, DOI 10.1016/j.forsciint.2008.03.02; Turillazzi E, 2008, PATHOL RES PRACT, V204, P259, DOI 10.1016/j.prp.2007.12.01; Turillazzi E, 2008, INT J LEGAL MED, V122, P173, DOI 10.1007/s00414-007-0208-; Turillazzi E, 2008, VIRCHOWS ARCH, V453, P209, DOI 10.1007/s00428-008-0632-; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Varrassi G, 2016, J PSYCHIAT, V1; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Volti GL, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-6",77,0,0,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1271.0,1278,,10.19193/0393-6384_2017_2s_196,,8,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700013,,,,,2022-07-14,0.00743801652892562,0.036715150888858086,0.008278212433896903,0.11128099601089818,0.008056817020997293
J,"Monda, V31;   Ruberto, M;   Villano, I;   Valenzano, A;   Ricciardi, A;   Gallai, B;   Marotta, R;   Lavano, F;   Lavano, SM;   Maltese, A;   Tripi, G;   Romano, P;   Salerno, M",,,,"Monda, Vincenzo; Ruberto, Maria; Villano, Ines; Valenzano, Anna; Ricciardi, Annaclaudia; Gallai, Beatrice; Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Salerno, Margherita",,,A MINIREVIEW ABOUT SPORTING PRACTICE IN EPILEPTIC CHILDREN,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,exercise; synaptic-plasticity; hippocampus; epilepsy,SLEEP-APNEA SYNDROME; CHILDHOOD ABSENCE EPILEPSY; PRIMARY NOCTURNAL ENURESIS; PRIMARY CILIARY DYSKINESIA; PRADER-WILLI-SYNDROME; WEIGHT-LOSS PROGRAM; QUALITY-OF-LIFE; PARENTAL STRESS; MATERNAL STRESS; NERVOUS-SYSTEM,"Movement is important for neuropsycho-physical development, ensuring the correct growth and giving many benefits from childhood to adulthood. Motor activity plays a pivotal role in psychological, educational and social terms: sport practice induces harmonious physical development with common important benefits independently from sport type and each sport imposes rules respect that children learns to know and respect step by step improving the social skills and cognitive abilities. Sport has a very important role in the growth of children and adolescents. Sport and physical activity work as a moral laboratory to practice decision-making and problem-solving skills, as well as teamwork and cooperation. In many pathological conditions, the sport practice is strongly discouraged, as in epileptic patients for the negative consequences on their physical condition and psychic. In general, several studies reported that physical activity has positive influence on seizure frequency and severity. As a result, attitudes regarding sports and epilepsy have changed considerably in the last decades and presently, the risk of convulsive seizures during sports practice is minimal in case of well-managed epilepsy. Evaluating the control of convulsive disease is therefore a key point to allow sports in the children and adolescents.","[Monda, Vincenzo; Villano, Ines] Univ Campania Luigi Vanvitelli, Sect Human Physiol, Dept Expt Med, Caserta, Italy; [Monda, Vincenzo; Villano, Ines] Univ Campania Luigi Vanvitelli, Unit Dietet & Sport Med, Caserta, Italy; [Ruberto, Maria] Univ Campania Luigi Vanvitelli, Dept Med Surg & Dent Specialties, Caserta, Italy; [Valenzano, Anna] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Ricciardi, Annaclaudia; Romano, Palmira] Univ Campania Luigi Vanvitelli, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Ricciardi, Annaclaudia; Romano, Palmira] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Caserta, Italy; [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy; [Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,"Marotta, Rosa/AAG-1453-2020","Marotta, Rosa/0000-0003-0515-5952; Monda, Vincenzo/0000-0002-6083-5814; VILLANO, INES/0000-0002-1755-358X; TRIPI, Gabriele/0000-0001-7088-9325",,,"Capovilla G, 2003, EPILEPSIA, V44, P1085, DOI 10.1046/j.1528-1157.2003.55402.; Carotenuto M, 2006, SLEEP MED, V7, P357, DOI 10.1016/j.sleep.2006.01.00; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto Marco, 2005, J Headache Pain, V6, P26; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2015, CURRENT TOPICS PEPTI, V16, P4; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0035; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0023; Chieffi S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.0098; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.0018; Chieffi S, 2017, EXP BRAIN RES, V235, P1511, DOI 10.1007/s00221-017-4919-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Coaccioli S., 2016, THE J, V19, DOI [10.4172/2378-5756.1000369, DOI 10.4172/2378-5756.1000369; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.; Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-; D'Agostino D, 2016, ACTA MEDICA MEDITERR, V32, P1905, DOI 10.19193/0393-6384_2016_6_18; De Fusco C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/404523; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Elia M, 2008, NEUROLOGY, V71, P997, DOI 10.1212/01.wnl.0000326592.37105.8; Elia M, 2012, BRAIN DEV-JPN, V34, P873, DOI 10.1016/j.braindev.2012.03.00; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2011, NEUROL SCI, V32, P79, DOI 10.1007/s10072-010-0411-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Esposito T, 2016, DRUG DES DEV THER, V10, P2939, DOI 10.2147/DDDT.S10644; Fiorelli A, 2017, ANN THORAC SURG, V103, P216, DOI 10.1016/j.athoracsur.2016.10.05; Gallelli L, 2014, HEADACHE, V54, P313, DOI 10.1111/head.1216; Guzzetta A, 2011, DEV MED CHILD NEUROL, V53, P46, DOI 10.1111/j.1469-8749.2011.04065.; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Hashemian K, 2016, ACTA MEDICA MEDITERR, V32, P105; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Mazzeo F, 2016, BIOL MED PARIS, V8, P1, DOI [10.4172/0974-8369.1000294, DOI 10.4172/0974-8369.1000294; Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_12; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina Giovanni, 2016, Asian J Sports Med, V7, pe26841, DOI 10.5812/asjsm.2684; Messina G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0013; Messina G, 2016, NEUROPSYCH DIS TREAT, V12, P319; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Monda V., 2016, BIOL MED, V8, DOI [10.4172/0974-8369.1000306, DOI 10.4172/0974-8369.1000306; Monda V, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/383197; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2016, NEUROL SCI, V37, P1947, DOI 10.1007/s10072-016-2693-; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P485, DOI 10.19193/0393-6384_2017_3_07; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Parisi P, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Piombino L., 2016, BIOL MED, V8, DOI [10.4172/0974-8369.1000298, DOI 10.4172/0974-8369.1000298; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_05; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_14; Salehi N, 2016, ACTA MEDICA MEDITERR, V32, P92; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Santamaria S., 2016, BIOL MED, V8, DOI 10.4172/0974-8369.100026; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Verrotti A, 2013, EUR J NEUROL, V20, P394, DOI 10.1111/j.1468-1331.2012.03771.; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001; Yilmaz M, 2016, ACTA MEDICA MEDITERR, V32, P785, DOI 10.19193/0393-6384_2016_3_9",98,10,10,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,2.0,,1279.0,1287,,10.19193/0393-6384_2017_2s_197,,9,"Medicine, General & Internal",General & Internal Medicine,FV8ZY,WOS:000424877700014,,,,,2022-07-14,0.008677685950413223,0.11990463469490353,0.021534219073094468,0.11467699707384109,0.022930856797846528
J,"Moscatelli, F1;  Valenzano, A;  Monda, V;  Ruberto, M;  Monda, G;  Triggiani, AI;  Monda, E;  Chieffi, S;  Villano, I;  Parisi, L;  Roccella, M;  Messina, A",,,,"Moscatelli, Fiorenzo; Valenzano, Anna; Monda, Vincenzo; Ruberto, Maria; Monda, Giuseppe; Triggiani, Antonio I.; Monda, Emanuele; Chieffi, Sergio; Villano, Ines; Parisi, Lucia; Roccella, Michele; Messina, Antonietta",,,TRANSCRANIAL MAGNETIC STIMULATION (TMS) APPLICATION IN SPORT MEDICINE: A BRIEF REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,TMS; transcrania magnetic stimulation; motor cerebral cortex; atlethes,HYPERTHERMIC REACTIONS; NOCTURNAL ENURESIS; CEREBRAL INJECTION; PARENTAL STRESS; CHILDREN; MIGRAINE; SLEEP; AURA; INTERFERENCE; ADOLESCENTS,"Since 1985, transcranial magnetic stimulation (TMS) has been used for non-invasive exploration of motor control in humans and for a wide range of applications in all ages of life. This brief review examined briefly the potential interest in sport medicine.","[Moscatelli, Fiorenzo; Valenzano, Anna; Monda, Giuseppe; Triggiani, Antonio I.; Monda, Emanuele] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Monda, Vincenzo; Chieffi, Sergio; Villano, Ines; Messina, Antonietta] Univ Campania Luigi Vanvitelli, Dept Expt Med, Caserta, CE, Italy; [Ruberto, Maria] Univ Naples 2, Dept Med Surg & Dent Specialties, Naples, Italy; [Parisi, Lucia; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy","Messina, A (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Sect Human Physiol, Via Costantinopoli 16, I-80138 Naples, Italy.;Messina, A (corresponding author), Univ Campania Luigi Vanvitelli, Clin Dietet Serv, Via Costantinopoli 16, I-80138 Naples, Italy.",,"Moscatelli, Fiorenzo/ABC-9536-2020; triggiani, antonio ivano/Q-4701-2019; Messina, Antonietta/AHH-2383-2022; Triggiani, Antonio Ivano/M-6252-2015; MESSINA, ANTONIETTA/K-9366-2016; Monda, Emanuele/AAQ-6457-2020","triggiani, antonio ivano/0000-0003-3291-9452; Messina, Antonietta/0000-0001-8343-432X; Monda, Emanuele/0000-0001-9304-988X; Chieffi, Sergio/0000-0002-1478-784X; Moscatelli, Fiorenzo/0000-0003-1274-0332; VILLANO, INES/0000-0002-1755-358X; Monda, Vincenzo/0000-0002-6083-5814",,,"Aurilio C, 2015, AFRICAN J PSYCHIAT, V18, DOI 10.4172/2378-5756.1000307; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Chieffi S., 2015, J PSYCHIAT, V18, DOI [10.4172/1994-8220.1000228, DOI 10.4172/1994-8220.1000228; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Chieffi S, 2014, EXP BRAIN RES, V232, P1327, DOI 10.1007/s00221-014-3851-; De Fusco C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/404523; De Luca V, 2008, PSYCHIAT INVEST, V5, P203, DOI 10.4306/pi.2008.5.4.20; Di Bernardo G, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt39; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2016, EUR J PHYS REHABIL ; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2014, CHEMOSPHERE, V94, P62, DOI 10.1016/j.chemosphere.2013.09.01; Esposito T, 2006, J THERM BIOL, V31, P527, DOI 10.1016/j.jtherbio.2006.07.00; Fiorelli A, 2017, ANN THORAC SURG, V103, P216, DOI 10.1016/j.athoracsur.2016.10.05; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Iavarone A, 2007, J AUTISM DEV DISORD, V37, P775, DOI 10.1007/s10803-006-0190-; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Mazzeo F., 2013, CURR TOP TOXICOL, V9, P2; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/63928; Messina G, 2012, AUTON NEUROSCI-BASIC, V169, P102, DOI 10.1016/j.autneu.2012.05.00; Messina G., 2015, J PSYCHIAT, V18, DOI [10.4172/2378-5756.1000280, DOI 10.4172/2378-5756.1000280; Messina G, 2014, AFRICAN J PSYCHIAT, V17, DOI 10.4172/Psychiatry.1000172; Messina G., 2014, J ANESTH CLIN RES, V5, P395, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395; Messina G., 2015, BIOL MED, V1, P7, DOI [DOI 10.4172/0974-8369.1000S3007, 10.4172/0974-8369.1000S3007; Messina G., 2015, BIOL MED, V7, P1, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000240; Messina Giovanni, 2016, Asian J Sports Med, V7, pe26841, DOI 10.5812/asjsm.2684; Messina G, 2016, NEUROPSYCH DIS TREAT, V12, P319; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Monda M, 2008, CLIN NUTR, V27, P657, DOI 10.1016/j.clnu.2008.04.00; Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.01; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.00; Monda M, 2006, NEUROPEPTIDES, V40, P357, DOI 10.1016/j.npep.2006.07.00; Monda M, 2006, NUTR NEUROSCI, V9, P141, DOI 10.1080/1028415060090355; Monda M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/13102; Monda V., 2016, BIOL MED, V8, DOI [10.4172/0974-8369.1000306, DOI 10.4172/0974-8369.1000306; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2015, BIOL ME; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Moscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015599; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/26596; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria S., 2016, BIOL MED, V8, DOI 10.4172/0974-8369.100026; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.1228; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-003; Verrotti A, 2017, EUR J PAEDIATR NEURO, V21, P570, DOI 10.1016/j.ejpn.2017.02.00; Viggiano A, 2010, NEUROSCIENCE, V166, P416, DOI 10.1016/j.neuroscience.2009.12.07; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.80523; Viggiano A, 2009, J DIABETES COMPLICAT, V23, P119, DOI 10.1016/j.jdiacomp.2007.11.00; Viggiano E, 2016, NEUROPSYCH DIS TREAT, V12, P1705, DOI 10.2147/NDT.S10707; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",76,32,33,3,18,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,423.0,430,,10.19193/0393-6384_2017_3_062,,8,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200010,,,,,2022-07-14,0.006921487603305785,0.08935552942635087,0.0020712421135362412,0.11126820465073509,0.0021367652830190887
J,"Nayir, T1;  Aydin, CG;  Eroglu, A;  Tas, SK",,,,"Nayir, Tufan; Aydin, Canan Gonen; Eroglu, Ali; Tas, Suleyman Kasim",,,DOES THE REGULAR SPORTS ACTIVITIES AFFECT VITAMIN D LEVELS AT YOUNG ATHLETES: A CROSS SECTIONAL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Vitamin D; Sports; Athletes; Sports Medicine,HIGH PREVALENCE; D INSUFFICIENCY; CHILDREN; MUSCLE,"Objectives: The aim of this paper is to evaluate whether making regular sports activities cause vitamin D increase status at the Turkish athletes of 17 different sport modalities. Methods: A total of 1126 athletes were included in the study who applied to the Baltalimani Bone Diseases Hospital Sports Medicine Polyclinic between April 2015 and 2016. There were 17 different group of athletes. Vitamin D levels of the athletes were evaluated. Results: 39.7% of the participants were women while 60.3% were men. There was a significant difference in height and weight between the men and women in the study group (p=0.03 and p=0.00). Athletes were classified according to years of sport start. There was no statistically significant difference between groups in terms of vitamin D levels Although beginners had low levels of vitamin D, there was no significant difference (p=0.577) when compared to other groups. There was no statistically significant difference between ALP, P, Ca and PTH values according to years of sport start in females and males. Conclusion: In this study, even those who are engaged in long-lasting sports have not found enough vitamin D levels.","[Nayir, Tufan] Minist Hlth Turkey Republ, TR-06420 Ankara, Turkey; [Aydin, Canan Gonen] Baltalimani Bone Dis Training & Res Hosp, Sports Med Clin, Istanbul, Turkey; [Eroglu, Ali] Erenkoy Phys Therapy & Rehabil Hosp, Sports Med Clin, Istanbul, Turkey; [Tas, Suleyman Kasim] Baltalimani Bone Dis Training & Res Hosp, Orthoped & Traumatol Clin, Istanbul, Turkey","Nayir, T (corresponding author), Minist Hlth Turkey Republ, TR-06420 Ankara, Turkey.",,,,,,"Abboud M, 2014, J STEROID BIOCHEM, V144, P232, DOI 10.1016/j.jsbmb.2013.10.02; Al-Othman A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-9; Association of Endocrinology and Metabolism in Turkey, 2015, GUID DIAGN TREATM M; Cashman Kevin D, 2007, Novartis Found Symp, V282, P12; Close GL, 2013, BRIT J SPORT MED, V47, P692, DOI 10.1136/bjsports-2012-09173; Constantini NW, 2010, CLIN J SPORT MED, V20, P368, DOI 10.1097/JSM.0b013e3181f207f; De Ronne N, 2013, J Pharm Belg, P1; Dong J, 2014, PERITON DIALYSIS INT, V34, P447, DOI 10.3747/pdi.2013.0000; Foo LH, 2009, J NUTR, V139, P1002, DOI 10.3945/jn.108.10205; Glerup H, 2000, CALCIFIED TISSUE INT, V66, P419, DOI 10.1007/s00223001008; Ha CD, 2013, MED SCI SPORT EXER, V45, P102, DOI 10.1249/MSS.0b013e31826c695; Halliday TM, 2011, MED SCI SPORT EXER, V43, P335, DOI 10.1249/MSS.0b013e3181eb9d4; Hamilton B, 2010, SCAND J MED SCI SPOR, V20, P182, DOI 10.1111/j.1600-0838.2009.01016.; Henderson A, 2005, JOGNN-J OBST GYN NEO, V34, P367, DOI 10.1177/088421750527615; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra07055; Koenig J, 2000, INT J VITAM NUTR RES, V70, P214, DOI 10.1024/0300-9831.70.5.21; Lovell G, 2008, CLIN J SPORT MED, V18, P159, DOI 10.1097/JSM.0b013e3181650ee; Moreno LA, 2011, ANN NUTR METAB, V59, P22, DOI 10.1159/00033207; Morton JP, 2012, APPL PHYSIOL NUTR ME, V37, P798, DOI [10.1139/h2012-037, 10.1139/H2012-037; Muhairi SJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-3; Ogan D, 2013, NUTRIENTS, V5, P1856, DOI 10.3390/nu506185; Ruohola JP, 2006, J BONE MINER RES, V21, P1483, DOI 10.1359/JBMR.06060; Shady Mones M Abu, 2015, Open Access Maced J Med Sci, V3, P80, DOI 10.3889/oamjms.2015.00; Valtuena J, 2014, NUTR HOSP, V30, P124, DOI 10.3305/nh.2014.30.1.753; Whiting SJ, 2011, AM J CLIN NUTR, V94, P128, DOI 10.3945/ajcn.111.01326; Willis KS, 2008, INT J SPORT NUTR EXE, V18, P204, DOI 10.1123/ijsnem.18.2.20",26,1,1,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,913.0,919,,10.19193/0393-6384_2017_6_145,,7,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500004,,,,,2022-07-14,0.0026859504132231405,1.1427453980394002e-20,0.005158885343493069,0.07211234029872984,0.005158885343493069
J,"Parisi, L1;  Faraldo, MA;  Ruberto, M;  Salerno, M;  Maltese, A;  Di Folco, A;  Messina, G;  Di Filippo, T;  Roccella, M",,,,"Parisi, Lucia; Faraldo, Maria Antonietta; Ruberto, Maria; Salerno, Margherita; Maltese, Agata; Di Folco, Annabella; Messina, Giovanni; Di Filippo, Teresa; Roccella, Michele",,,RETRACTED: LIFE EVENTS AND PRIMARY MONOSYMPTOMATIC NOCTURNAL ENURESIS: A PEDIATRIC PILOT STUDY (Retracted Article),ACTA MEDICA MEDITERRANEA,,,English,Article; Retracted Publication,,,,,,primary monosymptomatic nocturnal enuresis; PMNE; Coddington Life Events Scales; life adverse events,SLEEP-APNEA SYNDROME; CHILDHOOD MIGRAINE; MATERNAL STRESS; CHILDREN; DISORDERS; SYMPTOMS; EPILEPSY; AURA; ADOLESCENTS,"Introduction: The association between primary monosymptomatic nocturnal enuresis (PMNE) and behavioral disorders was highlighted frequently, suggesting psychiatric origin. On the other hand, there is no difference between the incidence of mental disorders in children with PMNE and controls, although the psychological genesis could provide additional secondary forms, in which the child might react to stressful events with the resumption of involuntary urination at night, with a possible alteration of bowel control due to a high vulnerability to stressors. The purpose of this study is assessing the stressful events of life in a sample of children with PMNE. Materials and methods: 56 subjects with PMNE, (37 males and 19 females) (mean 10.87 years; SD +/- 1.68) were recruited consecutively. All subjects were evaluated for the presence of stressful events (ICU) with test Coddington Life Events Scales (CLES). The control group consists of 98 typically developing children (65 males, 33 females) (p = 0.855) (mean 11.3 years; SD +/- 1.85; p = 0.594). Results: Individuals with enuresis do not show a significant difference in the prevalence of stressful events than the control group (42.85% vs 41.83%; Chi-square = 0.002; p = 0,963) (table 1). Conclusions: These results for the first time show that PMNE can be regarded as an independent state by stress factors, suggesting that it itself represents a stress factor that can affect the proper psychological and neuropsychological development in children.","[Parisi, Lucia; Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Faraldo, Maria Antonietta] Univ Naples 2, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Naples, Italy; [Ruberto, Maria] Univ Naples 2, Dept Med Surg & Dent Specialties, Naples, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, I-90133 Palermo, Italy; [Messina, Giovanni] Univ Foggia, Dept Expt Med, Sect Human Physiol, Foggia, Italy; [Messina, Giovanni] Univ Foggia, Unit Dietet & Sports Med, Dept Clin & Expt Med, Foggia, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,,,,,"Amjad RN, 2016, ACTA MEDICA MEDITERR, V32, P130; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2016, EUR J PHYS REHABIL ; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Foumany GHE, 2015, ACTA MEDICA MEDITERR, V31, P135; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shams S, 2016, ACTA MEDICA MEDITERR, V32, P155; Zou YL, 2016, ACTA MEDICA MEDITERR, V32, P117",50,15,15,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,1.0,,,,,23.0,27,,10.19193/0393-6384_2017_1_003,,5,"Medicine, General & Internal",General & Internal Medicine,EP2PY,WOS:000397226800003,,,,,2022-07-14,0.004132231404958678,0.07659668990968926,0.0005801894997387627,0.11067790215067287,0.0006721573365268797
J,"Parisi, L21;   Fortunato, MR;   Salerno, M;   Maltese, A;   Di Folco, A;   Di Filippo, T;   Roccella, M",,,,"Parisi, Lucia; Fortunato, Maria Rosaria; Salerno, Margherita; Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele",,,SENSORY PERCEPTION IN PRESCHOOL CHILDREN AFFECTED BY AUTISM SPECTRUM DISORDER: A PILOT STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Autism Spectrum Disorders; Preschool children; Perception; SPCR,SLEEP-APNEA SYNDROME; PRIMARY NOCTURNAL ENURESIS; PRIMARY CILIARY DYSKINESIA; CHILDHOOD MIGRAINE; MATERNAL STRESS; SELF-CONCEPT; AURA; SYMPTOMS; MULTICENTER; ADOLESCENTS,"Introduction: Autism spectrum disorder (ASD) is a behavioral syndrome caused by a developmental disorder, biologically determined, with onset in the first three years of life. The areas concerned are mainly those related to social communication, social interaction and mutual functional and symbolic play. In the last decades, different conceptions of autism have taken, also emphasizing different sensory-perceptual abnormalities as the basis of the central features of disorder. This pilot study intends to address the issue of sensory perception in preschool children affected by ASD. Material and methods: 11 ASD children were enrolled (7 males, 4 female) aged between 2.3 years and 4.6 years, (mean age 3.29 +/- 0.72). The control group consisted of 24 typical developing children (15 males, 9 females) (mean age 3.08 +/- 0.87). All subjects underwent assessment of sensory perceptual abilities according to the Bogdashina's Sensory Profile Checklist Revised (SPCR) evaluation (43). Results: The two groups are comparable for age (p = 0.491) and sex distribution (p = 0.755). Table 1 shows the comparison between the two groups results in the SPCR, specifically, individuals with ASD, showed significantly higher scores on near all perception areas evaluated than healthy controls, suggesting a clear perceptual impairment in ASD subjects. Only for olfactory perception two groups were comparable. Conclusions: no significant differences in behavioral reaction to smell stimulation between ASD and typical developing children, and this result could be explained according to the early age of our sample that could cause high reactivity to smell stimulation also in typical developing examined children.","[Parisi, Lucia; Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Fortunato, Maria Rosaria] Univ Naples 2, Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, I-90133 Palermo, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,,,,,"Amjad RN, 2016, ACTA MEDICA MEDITERR, V32, P130; Bogdashina O., 2003, SENSORY PERCEPTUAL ; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Foumany GHE, 2015, ACTA MEDICA MEDITERR, V31, P135; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Montalbano R, 2009, Minerva Pediatr, V61, P36; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Narzisi A, 2011, GIOR NEUROPSICH ETA, V31, P21; Parisi L, 2015, MINERVA PEDIATR, V67, P36; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2015, MENT ILLN, V7, P32, DOI 10.4081/mi.2015.598; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shams S, 2016, ACTA MEDICA MEDITERR, V32, P155; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Yongli Z, 2016, ACTA MEDICA MEDITERR, V32, P117",50,16,16,0,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,1.0,,,,,49.0,53,,10.19193/0393-6384_2017_1_007,,5,"Medicine, General & Internal",General & Internal Medicine,EP2PY,WOS:000397226800007,,,,,2022-07-14,0.004235537190082644,0.07088746582436863,0.0007792902327700867,0.11066524905397217,0.0007915768557056947
J,"Parisi, L31;   Salerno, M;   Maltese, A;   Tripi, G;   Romano, P;   Di Folco, A;   Di Filippo, T;   Roccella, M",,,,"Parisi, Lucia; Salerno, Margherita; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele",,,PATERNAL SHIFT-WORKING AND SLEEP DISORDERS IN CHILDREN AFFECTED BY PRIMARY NOCTURNAL ENURESIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Primary nocturnal enuresis; paternal shift-working; SDSC,QUALITY-OF-LIFE; AUTISM SPECTRUM DISORDERS; CHILDHOOD MIGRAINE; PARENTAL STRESS; MULTICENTER; AURA; ABNORMALITIES; ADOLESCENTS; DEPRESSION; EFFICACY,"Objectives: Primary monosymptomatic nocturnal enuresis (PMNE) is a common problem in childhood and studies about the sleep habits of affected children are not conclusive. Work-family conflict (WFC) results from the incompatibility between family demands and business/workplace needs. WFC can impact parental quality with many consequences on children health. Aim of study is assessing the prevalence of sleep disturbances in enuretic children, sons of work-shifters. Materials and methods: 80 children (67 males) aged 5-13 years (mean 10,43; SD +/- 1,99), were consecutively referred for PMNE. Sleep habits were investigated with Sleep Disturbances Scale for Children (SDSC) and the results were compared with a control group of 255 (190 males) typical developing children (TDC) sons of no shift-workers, matched for age (mean 10.57 SD +/- 1,89; p = 0.569) and sex distribution (Chi-square= 2.416; p = 0.120). Results: To evaluate statically differences among mean values of two samples, the Chi-square test was performed. Logistic regression was assessed to verify the role of paternal shift-working as risk factor for sleep disorders. p <= 0.05. All sleep disturbances categories were more prevalent in PMNE children sons of shift-workers than control group (Chi-square= 43.926; p<0.001); particularly 82.5% of PMNE vs. 11.76% of TDC show pathological scores for SBD category (Chi-square = 145.592; p<0.001; OR = 35,35; IC95% = 17.71-70.57); 61.25% vs 9.41% for SWTD (Chi-square = 93; p <0.001; OR = 15.213; IC95% = 8.21-28.15); 57.5% vs 9.41% for DA (Chi-square = 82.31; p < 0.001; OR = 13.02; IC95% = 7.06-23.98); 37.5% vs 6.67% for DIMS (Chi-square = 45.476; p < 0.001; OR = 8,4; IC95% = 4.3-16.39); 26.25% vs 5.88% for SHY (Chi-square = 24.257; p < 0.001; OR = 5.69; IC95% = 2,76-11,71) and 25%c vs 5.49% for DOES (Chi-square = 23.323; p < 0.001; OR = 5,73; IC95% = 2,73-12,01). Conclusions: Our findings suggest that paternal shif-working plus PMNE children may be a relevant factor affecting sleep quality in affected children.","[Parisi, Lucia; Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Maltese A, 2014, MINERVA PEDIATR, V66, P; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",48,9,9,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,481.0,484,,10.19193/0393-6384_2017_3_071,,4,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200019,,,,,2022-07-14,0.004442148760330579,0.08539989981052079,0.00016913492607642893,0.11067030994546515,0.0001781184378189846
J,"Parisi, L41;   Salerno, M;   Maltese, A;   Tripi, G;   Romano, P;   Di Folco, A;   Di Filippo, T;   Messina, G;   Roccella, M",,,,"Parisi, Lucia; Salerno, Margherita; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Di Folco, Annabella; Di Filippo, Teresa; Messina, Giovanni; Roccella, Michele",,,EMOTIONAL INTELLIGENCE AND OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN: PRELIMINARY CASE-CONTROL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,emotional intelligence; OSAS; sleep apnea; Bar-On emotional quotient inventory; EQ-i: YV,QUALITY-OF-LIFE; PRIMARY NOCTURNAL ENURESIS; AUTISM SPECTRUM DISORDERS; CHILDHOOD MIGRAINE; PARENTAL STRESS; MULTICENTER; ABNORMALITIES; ADOLESCENTS; DEPRESSION; THERAPY,"Introduction: Obstructive sleep apnea syndrome (OSAS) affects up to 4% of pediatric population, with many co-morbidities in the medium-long term. Functional alterations in prefrontal cortex (PFC) may explain why OSAS impacts aspects such as: executive functions, memory, motor control, attention, visual-spatial skills, learning and mood regulation. Emotional intelligence (EI) is a complex neuropsychological function that could be impaired in many clinical conditions. Aim of the study is to evaluate the difference in emotional intelligence skills among children with OSAS and healthy subjects Materials and methods: 29 children (16 males) mean age 9.5 +/- 1.54 years, affected by OSAS were compared with 60 typical developing children similar for gender (p = 0,871), age (p = 0,934) and socio-economic status (p = 0.714). Bar-On emotional quotient inventory, youth version (EQ-i: YV) was used in order to assess the Emotional Quotient. Results: Apnea/hypopnea index (AHI) results to be 8.76 +/- 3.45 with medium desaturation index (ODI) amounting to 2: 52 +/- 21.5, average saturation 92.7 +/- 4.8 %, average desaturation 4.9 %. OSAS children have significant differences in Interpersonal scales (84.95 +/- 07.03 vs. 99.61 +/- 8.96; p <0.001), Adaptability (7: 36 +/- 79.61 vs. 101.32 +/- 9.4; p <0.001), Stress Management (72.48 +/- 8.14 vs. 98.44 +/- 5.19, p <0.001), QE Total (81.28 +/- 11.03 vs. 102.14 +/- 9.62; p <0.001). Pearson correlation analysis shows an inverse relationship between QE total and ODI (p <0.01). Conclusion: Our findings tend to highlight the role of intermittent hypoxia in OSAS effects genesis, involving also aspects different from physical impairments.","[Parisi, Lucia; Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy; [Messina, Giovanni] Univ Foggia, Dept Expt Med, Sect Human Physiol, Foggia, Italy; [Messina, Giovanni] Univ Foggia, Unit Dietet & Sports Med, Dept Clin & Expt Med, Foggia, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy.",,"Messina, Giovanni/AAE-8668-2022","Messina, Giovanni/0000-0002-0011-867X; TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Maltese A, 2014, MINERVA PEDIATR, V66, P; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",48,18,18,0,9,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,485.0,489,,10.19193/0393-6384_2017_3_072,,5,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200020,,,,,2022-07-14,0.004442148760330579,0.08539989981052079,0.00016913492607642893,0.11067030994546515,0.0001781184378189846
J,"Parisi, L51;   Salerno, M;   Maltese, A;   Tripi, G;   Romano, P;   Di Folco, A;   Di Filippo, T;   Roccella, M",,,,"Parisi, Lucia; Salerno, Margherita; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele",,,AUTONOMIC REGULATION IN AUTISM SPECTRUM DISORDERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,autonomic regulation; autism spectrum disorders; SenseWear Armband,QUALITY-OF-LIFE; PRIMARY NOCTURNAL ENURESIS; CHILDHOOD MIGRAINE; PARENTAL STRESS; CHILDREN; MULTICENTER; SLEEP; AURA; ABNORMALITIES; ADOLESCENTS,"Introduction: The sinactive developmental model provides suggests a different way for the brain study by observing the children behavior. In all neurodevelopmental disorders, we can observe autonomic alteration comprising sleep disorders, meal behaviour alteration and self-regulatory impairment. These alterations/impairment are very frequent in autism spectrum disorders (ASD) (1-12). Aim of the present preliminary study is the assessment of metabolic rate in children affected by ASD. Material s and methods: 5 males affected by ASD aged 7-10 years (mean age 6.73 +/- 3:39), were recruited. The average score at the ADOS scale was 12.24 (SD +/- 3.29). The control group consisted of 5 males typically developing children (TDC) aged 7 to 11 years (mean age 7.92 +/- 3.23). Autonomic/Metabolic evaluation: Free-living daily physical activity was measured using either the SenseWear Armband in order to calculate the total energy expenditure (TEE), baseline (REE) and the metabolic physical activity for prolonged periods of time. In general, the SenseWear Armband allows objective monitoring of the lifestyle including duration and sleep efficiency. Results: ASD subjects show values of total energy expenditure (p = 0.0047) and active energy expenditure (p = 0.044) significantly higher compared to control subjects (Table 1). In addition, ASD children have a metabolic intermediate significantly higher than healthy subjects (p=0.015). (Table 1). Finally, the ASD children show a significant reduction of sleep time (p = 0.027) (Table 1). Conclusion: ASD can represents a very significant risk factor for developing sleep disorders and to high energy expenditure, although further studies are needed in this respect.","[Parisi, Lucia; Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Maltese A, 2014, MINERVA PEDIATR, V66, P; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",48,11,11,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,491.0,494,,10.19193/0393-6384_2017_3_073,,4,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200021,,,,,2022-07-14,0.004442148760330579,0.08539989981052079,0.00016913492607642893,0.11067030994546515,0.0001781184378189846
J,"Parisi, L61;   Salerno, M;   Maltese, A;   Tripi, G;   Romano, P;   Di Folco, A;   Di Filippo, T;   Roccella, M",,,,"Parisi, Lucia; Salerno, Margherita; Maltese, Agata; Tripi, Gabriele; Romano, Palmira; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele",,,ANXIETY LEVELS IN MOTHERS OF CHILDREN AFFECTED BY X-FRAGILE SYNDROME,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,anxiety disorder; X-fragile; scale state-trait anxiety inventory for adults,QUALITY-OF-LIFE; PRIMARY NOCTURNAL ENURESIS; AUTISM SPECTRUM DISORDERS; CHILDHOOD MIGRAINE; PARENTAL STRESS; MULTICENTER; SLEEP; AURA; ABNORMALITIES; ADOLESCENTS,"Introduction: Anxiety is the psychological process by which the individual reacts to dangerous external stimuli, triggering responses (mediated by norepinephrine, GABA and serotonin) involving physiological reactions and cognitive strategies. Anxiety can be differentiated in state anxiety and trait anxiety. Fragile X Syndrome (FXS) is a disorder most commonly caused by a triplet repeat expansion of >200 cytosine-guanine-guanine (CGG) repeats in the 50 untranslated region of the Fragile X mental retardation 1 (FMR1) gene. Aim of the present study is investigating the state or trait anxiety in a sample of mothers of children affected by X-fragile. Materials and methods: 84 mothers (mean age 48.36 +/- 7.11) of children affected by FXS were recruited and compared with mother of 171 typical developing children (mean age 46.18 +/- 9.53). The Scale State-Trait Anxiety Inventory for Adults (STAI) was used in order to assess the anxiety levels. Results: All mothers of children affected by FXS showed high score of anxiety levels at the STAI evaluation (Table 1), with no differences were found between mothers of males and females children affected. Conclusions: Mothers of children with FXS appear to be in a state of anxiety effects and suddenly even higher than those found later in mothers of children with other chronic diseases.","[Parisi, Lucia; Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Maltese A, 2014, MINERVA PEDIATR, V66, P; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",48,15,15,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,495.0,499,,10.19193/0393-6384_2017_3_074,,5,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200022,,,,,2022-07-14,0.004442148760330579,0.08539989981052079,0.00016913492607642893,0.11067030994546515,0.0001781184378189846
J,"Pasalar, P1",,,,"Pasalar, Parvin",,,WOUND HEALING POTENTIAL OF AQUEOUS EXTRACT OF ELAEAGNUS ANGUSTIFOLIA FRUIT WITH DOWN REGULATION OF TNF-ALPHA IN RAT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Wound healing; Elaeagnus angustifolia; TNF-alpha; Antioxidant; Anti-inflammatory,MICE; MYELOPEROXIDASE; FIBROBLASTS; FLAVONOIDS; HOSPITALS; MODEL,"Wound healing properties of Elaeagnus angustifolia (EA) fruit has been used for a long time in traditional Iranian medicine. The present study was performed to investigate the biochemical mechanism of wound healing activity of this plant in rats. After creating full-thickness skin wounds on the back of the rats, they were randomly divided into three groups. Two groups as the treated and positive control received the extract of EA and mupirocin ointment, respectively and other group as the control group, was not subjected to any treatments. Isolated tissues from wounds were harvested for 5, 10, and 15 days and were then underwent biochemical analysis. Healing activity was assessed by the rate of wound contraction and collagen content. The in vivo antioxidant and anti-inflammatory activity was investigated to understand the mechanism of wound healing potency. The concentration levels of transforming growth factor beta 1 (TGF-beta 1) and tumor necrosis factor alpha (TNF-alpha) were determined in wound tissues by an enzyme-linked immunosorbent assay (ELISA) and a real-time RT-PCR. The results indicated a significant increase in the percentage of wound contraction and collagen content in the treated group, when compared with the control and positive control groups. Both mRNA and protein levels of the TNF-alpha were significantly reduced in the EA treated group. A significant decrease was also observed in Malondialdehyde and Myeloperoxidase content in the treated group compared to the control group. This study revealed that the EA extract accelerates cutaneous wound healing. This effect may confer its antioxidant and anti inflammatory activities. Therefore, EA extract may be useful in the current management of wound healing. ns.","[Pasalar, Parvin] Univ Tehran Med Sci, Fac Med, Keshavarz Blvd, Tehran, Iran","Pasalar, P (corresponding author), Univ Tehran Med Sci, Fac Med, Keshavarz Blvd, Tehran, Iran.",ppasalar@yahoo.com,"Dehpour, Ahmad Reza/I-6422-2019; Mehrabani Natanzi, Mahboobeh/O-3489-2017; Khodaii, Zohreh/S-4983-2017","Dehpour, Ahmad Reza/0000-0002-8001-5565; Kamalinejad, Mohammad/0000-0002-5946-4913; Mehrabani Natanzi, Mahboobeh/0000-0001-8879-5984; Tavangar, Seyed Mohammad/0000-0002-4253-2385; Khodaii, Zohreh/0000-0002-8858-1983",Tehran University of Medical Sciences [89-01-30-10456],The present study was financially supported by the Tehran University of Medical Sciences (Grant No. 89-01-30-10456).,"Abedi G, 2012, HEALTHMED, V6, P12; Abedi G, 2012, HEALTHMED, V6, P2; Ahmad SF, 2013, PHARM BIOL, V51, P411, DOI 10.3109/13880209.2012.73431; Al-Henhena N, HISTOLOGICAL STUDY ; [Anonymous], 2012, ASIAN PAC J TROP BIO, DOI DOI 10.1016/S2221-1691(12)60520-; Avecina A, 1991, GHANOON OF MED, V; Beigom Taheri Jamileh, 2010, J Dent Res Dent Clin Dent Prospects, V4, P2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-; Burgess C, 2008, J DRUGS DERMATOL, V7, pS; Charles CA, 2009, J AM ACAD DERMATOL, V60, P951, DOI 10.1016/j.jaad.2008.09.01; DEMBINSK.W, 1973, POL J PHARMACOL PHAR, V25, P59; Ehrlich HP, 2012, ADV WOUND CARE, V1, P3, DOI 10.1089/wound.2011.031; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.570089; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/002203450935912; Kokane DD, 2009, J ETHNOPHARMACOL, V124, P311, DOI 10.1016/j.jep.2009.04.03; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.00; Lim JS, 2010, J KOREAN MED SCI, V25, P746, DOI 10.3346/jkms.2010.25.5.74; Liu X, 2008, BIOCHEM J, V409, P289, DOI 10.1042/BJ2007054; Liza MS, 2010, FOOD BIOPROD PROCESS, V88, P319, DOI 10.1016/j.fbp.2009.02.00; Mori R, 2004, AM J PATHOL, V164, P1303, DOI 10.1016/S0002-9440(10)63217-; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776co; Natanzi M, 2012, ACTA MED IRANICA, V5; Nayak S, 2006, J BIOL SCI, V6, P5; Pandian C, EVALUATION WOUND HE; Rasekh H. R., 1999, Journal of Pharmacy and Pharmacology, V51, P12; Ruchi Tiwari, 2013, Pharma Science Monitor, V4, P21; Sen CK, 2003, WOUND REPAIR REGEN, V11, P431, DOI 10.1046/j.1524-475X.2003.11607.; Shiba Y, 2008, CHEM RES TOXICOL, V21, P1600, DOI 10.1021/tx800083; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM19990902341100; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-; SOLISHERRUZO JA, 1988, J BIOL CHEM, V263, P584; Song HS, 2008, KOREAN J PHYSIOL PHA, V12, P343, DOI 10.4196/kjpp.2008.12.6.34; Wallace HJ, 1998, J INVEST DERMATOL, V110, P292, DOI 10.1046/j.1523-1747.1998.00113.; Zargari A., 1990, MED PLANTS, V4, P57; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M20912420",36,0,1,3,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,305.0,311,,10.19193/0393-6384_2017_2_046,,7,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700021,,,,,2022-07-14,0.00371900826446281,1.1825794977168612e-11,0.007218703865145552,0.10687275738338393,0.007218703865145552
J,"Precenzano, F1;  Ruberto, M;  Parisi, L;  Salerno, M;  Maltese, A;  Vagliano, C;  Messina, G;  Di Folco, A;  Di Filippo, T;  Roccella, M",,,,"Precenzano, Francesco; Ruberto, Maria; Parisi, Lucia; Salerno, Margherita; Maltese, Agata; Vagliano, Clara; Messina, Giovanni; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele",,,EXECUTIVE FUNCTIONING IN PRESCHOOL CHILDREN AFFECTED BY AUTISM SPECTRUM DISORDER: A PILOT STUDY (RETRACTION ARTICLE),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Autism Spectrum Disorders; Preschool children; BRIEF-P; executive functions,SLEEP-APNEA SYNDROME; NOCTURNAL ENURESIS; CHILDHOOD MIGRAINE; MATERNAL STRESS; SYMPTOMS; EPILEPSY; AURA; QUESTIONNAIRE; ADOLESCENTS,"Introduction: Autism spectrum disorders (ASD) are a complex set of neurological dysfunction and development characterized by deficits in social and non-verbal interaction. Few studies have explored the executive functioning in ASD preschoolers. The aim of this pilot study is the assessment of executive functioning in preschool children with ASD. Material and methods: 8 ASD children (7 males, 1 female) mean age 3.09 (SD +/- 0.83 years) were enrolled in the study and compared with a control group of 15 typically developing children (12 males, 3 females) (mean age 24.3 +/- 0.61). All subjects underwent assessment of executive functioning with the BRIEF-P test. Results: The two groups were matched for age (p = 0.625) and gender (p = 0.900). Table 1 shows the comparison between the two groups at the BRIEF-P, with significantly higher scores on all subscales of ASD children compared with controls. Conclusions: Despite the small sample examined the results of this study agree with what is already known in the literature confirm the presence of a significant deficit in executive functions of subjects with ASD emphasizing for the first time the emergence of such problems at an early stage of development, but demanding further studies to confirm this.","[Precenzano, Francesco; Vagliano, Clara; Di Filippo, Teresa] Univ Naples 2, Clin Child & Adolescent Neuropsychiat, Dept Mental Hlth & Phys & Prevent Med, Naples, Italy; [Ruberto, Maria] Univ Naples 2, Dept Med Surg & Dent Specialties, Naples, Italy; [Parisi, Lucia; Maltese, Agata; Di Folco, Annabella; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, I-90133 Palermo, Italy; [Messina, Giovanni] Univ Foggia, Dept Expt Med, Sect Human Physiol, Foggia, Italy; [Messina, Giovanni] Univ Foggia, Unit Dietet & Sports Med, Dept Clin & Expt Med, Foggia, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,,,,,"Amjad RN, 2016, ACTA MEDICA MEDITERR, V32, P130; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2016, EUR J PHYS REHABIL ; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Foumany GHE, 2015, ACTA MEDICA MEDITERR, V31, P135; Garon NM, 2016, APPL NEUROPSYCH-CHIL, V5, P110, DOI 10.1080/21622965.2014.100292; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Miano S, 2007, SLEEP MED, V9, P64, DOI 10.1016/j.sleep.2007.01.01; Montalbano R, 2009, Minerva Pediatr, V61, P36; Parisi L, 2015, MINERVA PEDIATR, V67, P36; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2015, MENT ILLN, V7, P32, DOI 10.4081/mi.2015.598; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1755, DOI 10.19193/0393-6384_2016_6_15; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1749, DOI 10.19193/0393-6384_2016_6_15; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shams S, 2016, ACTA MEDICA MEDITERR, V32, P155; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Zou YL, 2016, ACTA MEDICA MEDITERR, V32, P117",50,33,33,3,37,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,1.0,,,,,35.0,39,,10.19193/0393-6384_2017_1_005,,5,"Medicine, General & Internal",General & Internal Medicine,EP2PY,WOS:000397226800005,,,,,2022-07-14,0.004235537190082644,0.06939449901242789,0.0009062861237623751,0.11068043311723208,0.0009906562687341611
J,"Precenzano, F21;   Ruberto, M;   Parisi, L;   Salerno, M;   Maltese, A;   Verde, D;   Tripi, G;   Romano, P;   Di Folco, A;   Di Filippo, T;   Messina, G;   Roccella, M",,,,"Precenzano, Francesco; Ruberto, Maria; Parisi, Lucia; Salerno, Margherita; Maltese, Agata; Verde, Domenico; Tripi, Gabriele; Romano, Palmira; Di Folco, Annabella; Di Filippo, Teresa; Messina, Giovanni; Roccella, Michele",,,SLEEP HABITS IN CHILDREN AFFECTED BY AUTISM SPECTRUM DISORDERS: A PRELIMINARY CASE-CONTROL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Autism Spectrum Disorders; sleep problems; DIMS; SDSC,MONOSYMPTOMATIC NOCTURNAL ENURESIS; PRIMARY CILIARY DYSKINESIA; CHILDHOOD MIGRAINE; MATERNAL STRESS; APNEA SYNDROME; SELF-CONCEPT; AURA; MULTICENTER; ADOLESCENTS; EFFICACY,"Introduction: The core of autism spectrum disorders (ASD) consists of alterations of neurological functions that affect the typical developmental trajectory leading to deficits in social interaction and non-verbal behaviors. In general, ASD is diagnosed at age three and many other frequent neurological signs may be present, such as sleep disorders. The aim of study is evaluating sleep habits in a sample of ASD children. Material and methods: The study population consists of 65 ASD children (43 males and 22 females), aged between 2 and 11 years (mean 5.73 +/- 2.39 years). The control group consists of 114 children with typical development (68 males and 46 females), aged between 3 and 10 years (mean 5.91 +/- 2.23 years). The diagnosis of ASD was confirmed by the evaluation ADOS -2, while the evaluation of sleep habits with the SDSC tests. Results: The two groups were matched for age (p = 0.633) and sex distribution (p = 0.483). The ASD subjects show a significantly higher rate of sleep disorders in all categories explored by SDSC tests (Table 1). Discussion: The sleep of people with ASD is compromised at any age and regardless of the severity of social impairment and communication, but not the level of development. Still, ASD is a very important risk factor for the development of sleep disorders, although the report could also be interpreted in the opposite manner.","[Precenzano, Francesco; Verde, Domenico; Romano, Palmira] Univ Naples 2, Clin Child & Adolescent Neuropsychiat, Naples, Italy; [Precenzano, Francesco; Verde, Domenico; Romano, Palmira] Univ Naples 2, Dept Mental Hlth & Phys & Prevent Med, Headache Ctr Children & Adolescents, Naples, Italy; [Ruberto, Maria] Univ Naples 2, Dept Med Surg & Dent Specialties, Naples, Italy; [Parisi, Lucia; Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy; [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Messina, Giovanni] Univ Foggia, Dept Expt Med, Sect Human Physiol, Foggia, Italy; [Messina, Giovanni] Univ Foggia, Unit Dietet & Sports Med, Dept Clin & Expt Med, Foggia, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy.",,,"TRIPI, Gabriele/0000-0001-7088-9325",,,"Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Garon NM, 2016, APPL NEUROPSYCH-CHIL, V5, P110, DOI 10.1080/21622965.2014.100292; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2016, J BASIC CLIN PHYSL ; Miano S, 2007, SLEEP MED, V9, P64, DOI 10.1016/j.sleep.2007.01.01; Parisi L, 2015, MINERVA PEDIATR, V67, P36; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_00; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2015, MENT ILLN, V7, P32, DOI 10.4081/mi.2015.598; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Toldo I, 2017, EUR J PAEDIATR NEURO, V21, P507, DOI 10.1016/j.ejpn.2016.12.00; Vecchio D, 2011, MINERVA PEDIATR, V63, P34",47,33,33,3,26,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,405.0,409,,10.19193/0393-6384_2017_3_059,,5,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200007,,,,,2022-07-14,0.004132231404958678,0.0735511712464479,0.0007737493640508228,0.11066271878179552,0.0007819634430983962
J,"Rinella, S1;  Romeo, R;  Di Corrado, D;  Massimino, S",,,,"Rinella, Sergio; Romeo, Rossella; Di Corrado, Donatella; Massimino, Simona",,,ATTENTIONAL PROCESSES AND AFFECTIVE REGULATION ABILITY OF WOMEN PRACTICING HATHA YOGA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Hatha Yoga; anxiety; stress; attention; age,BLOOD LACTATE LEVELS; MOOD STATES; IN-VITRO; STRESS; CELLS; PERFORMANCE; EXCITABILITY; PLAYERS; PROFILE; VIVO,"Introduction: The present study aims to evaluate the attentional processes and affective regulation ability of women practicing Hatha Yoga in comparison with peoples not practicing any physical activity. We hypothesized in the Hatha Yoga practitioners, reduced anxiety and a better tone of mood, superior performances in attentional tasks and, finally, more efficient attentive functions. Materials and methods: The research sample includes 26 women, of whom 13 (average age 39.07 years +/- 10.53 SD) practice Hatha Yoga (Yoga group) and 13 (average age 39.23 years +/- 13.45 SD) do not practicing any sport activities (Nsport group). The following psychological assessment tests were used: Profile of Mood States (POMS), State-Trait Anxiety Inventory Form Y (STAI-Y) and Attention And Concentration Test (ACT). Results: Yoga group shows better control of internal tension states. None significant differences between the Yoga group and the Nsport group was observed by evaluating the anxiety, although in the Nsport group, State anxiety is associated with a lower sense of perceived energy, while in the Yoga group the State anxiety is related to a decrease of Depression. The Trait anxiety in Nsport group is associated with feelings of tension, fatigue, depression and aggression, with a consequent decrease in mood, whereas in the Yoga group none relationship between Trait anxiety and mood states was detected. Finally, concerning the sense of perceived energy, only the Yoga group showing performance improvement in the Attention and Concentration test. Conclusion. The practice of Hatha Yoga can be seen as a factor that can prevent and improve the quality of people's life, and although its effectiveness in treatment is still under investigation, it could be understood as a valid helper of classical treatments.","[Rinella, Sergio; Romeo, Rossella; Massimino, Simona] Univ Catania, Sect Physiol, Dept Biomed & Biotechnol Sci, Catania, Italy; [Di Corrado, Donatella] Kore Univ, Dept Human & Social Sci, Sch Sport Sci, Enna, Italy","Massimino, S (corresponding author), Univ Catania, Sect Physiol, Dept Biomed & Biotechnol Sci, Catania, Italy.",,"Di Corrado, Donatella/K-3757-2019; Rinella, Sergio/ADM-1130-2022; Di Corrado, Donatella/H-3726-2019; Rinella, Sergio/AAB-5946-2021","Rinella, Sergio/0000-0002-9368-7088; Di Corrado, Donatella/0000-0001-8223-6671; ",,,"Borella E, 2013, DETERIORAMENTO COGN; Bussing A, 2012, J EVID BASED COMPLE; Coco M, 2016, MEDICINE, V95, DOI 10.1097/MD.000000000000297; Coco M, 2015, MOL MED REP, V11, P2135, DOI 10.3892/mmr.2014.289; Coco M, 2014, SOMATOSENS MOT RES, V31, P35, DOI 10.3109/08990220.2013.83481; Coco M, 2013, SOMATOSENS MOT RES, V30, P90, DOI 10.3109/08990220.2013.76994; Coco M, 2011, MOL MED REP, V4, P471, DOI 10.3892/mmr.2011.45; Coco M, 2009, BRAIN RES, V1302, P205, DOI 10.1016/j.brainres.2009.09.03; Di Corrado D, 2014, MOL MED REP, V9, P2441, DOI 10.3892/mmr.2014.211; Di Nuovo S., 2013, ATTENZIONE CONCENTR; Donia M, 2012, ONCOL REP, V28, P682, DOI 10.3892/or.2012.184; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.33; Eysenck MW, 2011, PERS INDIV DIFFER, V50, P955, DOI 10.1016/j.paid.2010.08.01; Fagone P, 2013, J NEUROIMMUNOL, V261, P82, DOI 10.1016/j.jneuroim.2013.04.01; Fagone P, 2013, BASIC CLIN PHARMACOL, V112, P63, DOI 10.1111/j.1742-7843.2012.00923.; Kabat-Zinn J, 1994, WHEREVER YOU GO THE; Kabat-Zinn J., 2013, FULL CATASTROPHE LI; Khalsa SBS, 2009, APPL PSYCHOPHYS BIOF, V34, P279, DOI 10.1007/s10484-009-9103-; Kozasa EH, 2012, NEUROIMAGE, V59, P745, DOI 10.1016/j.neuroimage.2011.06.08; Marchand WR, 2014, WORLD J RADIOL, V6, P471, DOI 10.4329/wjr.v6.i7.47; McCall Marcy C, 2014, Int J Yoga, V7, P4, DOI 10.4103/0973-6131.12347; McNair D.M., 1991, PROFILE MOOD STATE; Michalsen A, 2005, MED SCI MONITOR, V11, pCR55; Mijatovic S, 2010, FREE RADICAL BIO MED, V48, P1090, DOI 10.1016/j.freeradbiomed.2010.01.02; Perciavalle V, 2017, NEUROL SCI, V38, P451, DOI 10.1007/s10072-016-2790-; Perciavalle V, 2015, NEUROL SCI, V36, P2129, DOI 10.1007/s10072-015-2329-; Perciavalle V, 2015, NEUROL SCI, V36, P1597, DOI 10.1007/s10072-015-2210-; Perciavalle V, 2014, PERCEPT MOTOR SKILL, V118, P940, DOI 10.2466/19.50.PMS.118k27w; Perciavalle V, 2014, PERCEPT MOTOR SKILL, V118, P733, DOI 10.2466/29.30.PMS.118k22w; Perciavalle V, 2014, SOMATOSENS MOT RES, V31, P1, DOI 10.3109/08990220.2013.79692; Perciavalle V, 2013, MOL MED REP, V7, P1733, DOI 10.3892/mmr.2013.142; Sethi Jaspal Kaur, 2013, J Educ Health Promot, V2, P55, DOI 10.4103/2277-9531.11904; Sheela, 2013, Ayu, V34, P270, DOI 10.4103/0974-8520.12311; Spielberger CD., 1996, MANUAL STATE TRAIT ; Taneja Davendra Kumar, 2014, Indian J Community Med, V39, P68, DOI 10.4103/0970-0218.13271; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.070767810; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.101104310; Yoshihara K, 2014, BIOPSYCHOSOC MED, V8, DOI 10.1186/1751-0759-8-; Yoshihara K, 2011, BIOPSYCHOSOC MED, V5, DOI 10.1186/1751-0759-5-",39,0,0,1,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,1067.0,1072,,10.19193/0393-6384_2017_6_169,,6,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500028,,,,,2022-07-14,0.003822314049586777,7.312913851745544e-15,0.01728900147771377,0.062406116830955496,0.01736491642230858
J,"Sahin, L1;  Sarihan, ME;  Parlakpinar, H;  Polat, A;  Vardi, N",,,,"Sahin, Levent; Sarihan, M. Ediz; Parlakpinar, Hakan; Polat, Alaadin; Vardi, Nigar",,,THE EFFECTS OF VINPOCETINE ON THE PREVENTION AND TREATMENT OF THE ISCHEMIA/REPERFUSION INJURY: AN EXPERIMENTAL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Animal study; kidney; rat; reperfusion injury; vinpocetine,ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; OXIDATIVE STRESS; RAT MODEL; PATHOPHYSIOLOGY; ACID,"Object: Histopathological and biochemical effects of vinpocetine, which is an anti-inflammatory and antioxidant agent, on ischemia / reperfusion (I/R) injury were studied in an animal model. Material and methods: Forty Sprague Dawley rats were divided into five groups. Group1 underwent only a right nephrectomy. Group 2 was administrated vinpocetine after right nephrectomy. Group 3 initially underwent a right nephrectomy. Them, left kidney of this group was applied ischemia for 60 minutes, which was followed by reperfusion for 24 hours. Group 4 underwent same steps as group 3; but was administrated vinpocetine 10 mg/kg i.p. before I/R to the left kidney. Similarly, group 5 underwent same steps as group 3 but was administrated vinpocetine 10 mg/kg i.p. after I/R to the left kidney. Results: Plasma BUN and creatinine showed no significant differences between control ( Sham) group and groups that were administrated vinpocetine. Decrease in plasma urea and creatinine was detected group 5, but this finding was not present in group 4. Superoxide dismutase and glutathione reductase levels in groups 4 and 5 were significantly higher than the group 3. Parallel to this, oxidative stress index was higher in the group 3compared to groups 2, 4, and 5 (p<0.05). No significant difference was found between levels of malondialdehite in sham and vinpocetine administrated only group (p<0.005). All groups showed no differences in catalase levels and Total Antioxidant Capacity. Decreased tubular injury was present in the groups administrated vinpocetine before and after I/R. In control and vinpocetine given groups, there were some apoptosis in tubules after tested with caspase 3. Caspase 3 positivity was significantly higher in I/R group compared to control group. Vinpocetine if given after I/R was more effective to prevent apoptosis then to be administrated before I/R. Conclusion: This experimental study showed that vinpocetine promotes achieving better renal functions. The results of this study suggest that vinpocetine may be used in the treatment of renal I/R","[Sahin, Levent; Sarihan, M. Ediz] Inonu Univ, Med Fac, Dept Emergency Med, Malatya, Turkey; [Parlakpinar, Hakan] Inonu Univ, Med Fac, Dept Med Pharmacol, Malatya, Turkey; [Polat, Alaadin] Inonu Univ, Med Fac, Dept Physiol, Malatya, Turkey; [Vardi, Nigar] Inonu Univ, Med Fac, Dept Histol & Embryol, Malatya, Turkey","Sarihan, ME (corresponding author), Inonu Univ, Med Fac, Dept Emergency Med, Malatya, Turkey.",,"Sahin, Levent/AAR-9222-2021; Polat, Alaadin/Q-4052-2018; ParlakpÄ±nar, Hakan/T-6517-2018; Parlakpinar, Hakan/V-6637-2019; Polat, Alaadin/AAA-7171-2021; vardÄ±, nigar/C-9549-2018","Sahin, Levent/0000-0003-0193-4393; Polat, Alaadin/0000-0002-6920-3856; ParlakpÄ±nar, Hakan/0000-0001-9497-3468; Parlakpinar, Hakan/0000-0001-9497-3468; Polat, Alaadin/0000-0002-6920-3856; vardÄ±, nigar/0000-0003-0576-1696",,,"[Anonymous], 2015, BAZI SALVIA TURLERI; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.bi.59.070190.00403; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.; Bozkurt Y, 2012, KAFKAS UNIV VET FAK, V18, P82; Cakar N, 2010, TURK YOGUN BAKIM D S, V8, P; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-; Chukanova EI, 2010, ZH NEVROL PSIKHIATR, V110, P4; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-0003; Cotran R, 1994, NOBEL TIP KITABEVLER, V1, P; Heyman Samuel N, 2002, Curr Opin Crit Care, V8, P526, DOI 10.1097/00075198-200212000-0000; Kalman S, 2002, J TURK SOCNEPHROL, V11, P14; Lameire N, 2005, LANCET, V365, P41; Nyakas C, 2009, CNS NEUROSCI THER, V15, P89, DOI 10.1111/j.1755-5949.2009.00078.; Ozkan G, 2012, KIDNEY BLOOD PRESS R, V35, P445, DOI 10.1159/00033792; PALLER MS, 1994, J INVEST MED, V42, P63; Sheridan AM, 2001, CONTRIB NEPHROL, V132, P; SIES H, 1991, AM J MED, V91, pS31, DOI 10.1016/0002-9343(91)90281-; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM19960530334220; UDASSIN R, 1994, J SURG RES, V56, P221, DOI 10.1006/jsre.1994.103; Walker LM, 2001, TOXICOL SCI, V63, P143, DOI 10.1093/toxsci/63.1.14; Welbourn CR, 2004, BRIT J SURG, V10, P16; WELBOURN CRB, 1991, BRIT J SURG, V78, P651, DOI 10.1002/bjs.180078060; Yamamoto S, 2011, AM J NEPHROL, V33, P485, DOI 10.1159/00032782; Yildiz F, 2010, RENAL FAILURE, V32, P126, DOI 10.3109/0886022090336757; Yun Y, 2009, TRANSPL P, V41, P3597, DOI 10.1016/j.transproceed.2009.06.20",25,2,2,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,857.0,862,,10.19193/0393-6384_2017_5_127,,6,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000021,,,,,2022-07-14,0.0026859504132231405,1.871637692385814e-08,0.005158885343493069,0.12776347917904046,0.005158885343493069
J,"Salerno, M1;  Maltese, A;  GabrieleTripi;  Romano, P;  Di Folco, A;  Di Filippo, T;  Parisi, L",,,,"Salerno, Margherita; Maltese, Agata; GabrieleTripi; Romano, Palmira; Di Folco, Annabella; Di Filippo, Teresa; Parisi, Lucia",,,SEPARAXION ANXIETY IN PEDIATRIC MIGRAINE WITHOUT AURA: A PILOT STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Migraine without aura; Mw; separation anxiety; SCARED,QUALITY-OF-LIFE; PRIMARY NOCTURNAL ENURESIS; AUTISM SPECTRUM DISORDERS; CHILDHOOD MIGRAINE; PARENTAL STRESS; CHILDREN; MULTICENTER; SLEEP; ABNORMALITIES; ADOLESCENTS,Background: Separation anxiety (SA) can be defined as the fear reaction and protest manifested by children when the main caregivers move away from him/her or in front of unfamiliar person. SA near eight months may be considered as an important and normal phase of the correct and typical social neurodevelopment. Aims of the present pilot study is assessing the prevalence of separation anxiety in a population of patients with migraine without aura (MwA). Materials and methods: 119 children (69 males) suffering from MwA (mean age 1.78 +/- 7: 59) were consecutively recruited. The control population consisted of 231 (114 males) healthy subjects similar for age (7.64 +/- 1: 34; p = 0.768) and gender (p = 0.987) The Screen for child anxiety related emotional disorders (SCARED) test was used to assess the prevalence of separation anxiety among MwA children. Results: Healthy individuals are on average less affected (mean 4.72 +/- 0: 32) of the Separation Anxiety Disorder respect of MwA children (mean 6.83 +/- 0.97; p < 0.001) (Figure 1). Conclusion. MwA presents many psychiatric comorbidities and among ones separation anxiety may be considered in the clinical and therapeutic management of pediatric primary headache.,"[Maltese, Agata; Di Folco, Annabella; Di Filippo, Teresa; Parisi, Lucia] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy; [GabrieleTripi] Univ Palermo, Dept PROSAMI, Palermo, Italy; [GabrieleTripi] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, Chinon, France; [Romano, Palmira] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Phys & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, CE, Italy","Salerno, M (corresponding author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.",,,,,,"Alesi M, 2014, NEUROPSYCH DIS TREAT, V10, P479, DOI 10.2147/NDT.S5845; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.0008; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e; Epifanio M. F., 2013, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V172, P70; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.587; Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e1; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.011; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Maltese A, 2014, MINERVA PEDIATR, V66, P; Matricardi S, 2016, AM J MED GENET C, V172, P288, DOI 10.1002/ajmg.c.3151; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Morandi A, 2015, AM J MED GENET A, V167, P2720, DOI 10.1002/ajmg.a.3722; Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.120330; Panico A, 2017, PATIENT PREFER ADHER, V11, P423, DOI 10.2147/PPA.S11918; Parisi L, 2012, MINERVA PEDIATR, V64, P6; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Parisi L, 2013, MENT ILLN, V5, P26, DOI 10.4081/mi.2013.e; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P35, DOI 10.19193/0393-6384_2017_1_00; Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S11964; Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_16; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Vecchio D, 2011, MINERVA PEDIATR, V63, P34; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Villano I, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.0001",48,20,20,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,621.0,625,,10.19193/0393-6384_2017_4_092,,5,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700013,,,,,2022-07-14,0.004442148760330579,0.08539989981052079,0.00016913492607642893,0.11067030994546515,0.0001781184378189846
J,"Sanal, L1;  Yilmaz, N;  Sen, S;  Cesur, S",,,,"Sanal, Laser; Yilmaz, Neziha; Sen, Suha; Cesur, Salih",,,"DETECTION OF SYNERGISTIC ANTIMICROBIAL ACTIVITIES BETWEEN DORIPENEM, TIGECYCLINE AND COLISTIN AGAINST MULTI-DRUG-RESISTANT ACINETOBACTER BAUMANNII STRAINS OBTAINED FROM PATIENTS IN INTENSIVE CARE UNITS",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Acinetobacter baumannii; epsilometer test; synergy; intensive care unit,IN-VITRO ACTIVITY; COMBINATIONS; EFFICACY; SUSCEPTIBILITY; EPIDEMIOLOGY; INFECTIONS; PREVALENCE; IMIPENEM; SEPSIS,"Introduction: Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen leading to nosocomial epidemics and multidrug-resistant (MDR) isolates are making the treatment of these infections more complicated. Combinations of antibiotics acting by different mechanisms are used for the treatment of MDR bacterial infections. In this study we evaluated the minimum inhibitory concentrations (MICs) of colistin (CO), doripenem (DOR), tigecycline (TIG) alone and in vitro synergistic activity of CODOR, CO-TIG and DOR-TIG combinations against MDR A. baumannii strains isolated from patients in intensive care units (ICUs). Materials and methods: Thirty A. baumannii strains isolated from various clinical specimens of patients in ICUs were included in the study. The epsilometer test (E-test) method was used for determining the synergistic activity of different antibiotic combinations. Synergistic, additive, indifferent and antagonist effects of A. baumannii strains were evaluated by Fractional Inhibitory Concentration (FIC) index. Results: Of the 30 MDR A. baumannii strains tested, 90% were susceptible to TIG, 93.3% to CO and 50% to DOR. CO-DOR, CO-TIG and DOR-TIG combinations were found to have synergistic or additive effects against 3 (9.9%), 5 (16.6%) and 4 strains (13.3%), respectively. The synergistic or additive effect of DOR-TIG combination was 19.9% for DOR resistant strains and 6.6% for DOR susceptible strains. The synergistic or additive effect of CO-DOR combination was 19.9% for DOR resistant strains and 0% for DOR susceptible strains. Conclusion: Among the tested antimicrobial combinations, the combination of CO with TIG was most effective against MDR A. baumannii strains isolated from patients in ICUs. The synergistic or additive effects both for CO-DOR and DOR-TIG combinations were higher in DOR resistant strains. This study suggested that combination therapy with DOR for treating MDR A. baumannii infections should be used especially in DOR resistant strains.","[Sanal, Laser] YuksekIhtisas Training & Res Hosp, Microbiol Lab, TR-06420 Ankara, Turkey; [Yilmaz, Neziha] Bozok Univ, Microbiol Dept, Yozgat, Turkey; [Sen, Suha] Yuksek Ihtisas Training & Res Hosp, Infect Dis Dept, Ankara, Turkey; [Cesur, Salih] Ankara Numune Training & Res Hosp, Infect Dis Dept, Ankara, Turkey","Sanal, L (corresponding author), YuksekIhtisas Training & Res Hosp, Microbiol Lab, TR-06420 Ankara, Turkey.",,"yÄ±lmaz, neziha/AAH-3524-2020",,Yuksek Ihtisas Training and Research Hospital [322-1],"This study was presented as a poster presentation in the 7th Eurasia Congress of Infectious Diseases between 30 September and 3 October 2015 in Tbilisi, Georgia and 30th National Congress of Antibiotic and Chemotherapy at 6-10 May 2015 in TRNC (Turkish Republic of Northern Cyprus) and was supported by a grant from Yuksek Ihtisas Training and Research Hospital, Project no: 322-1.","Ahmed Nahid H, 2012, BMC Res Notes, V5, P215, DOI 10.1186/1756-0500-5-21; Aygencel G, 2010, YOGUN BAKIM DERGISI, V9, P16; Baadani AM, 2013, SAUDI MED J, V34, P24; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks08; Cekin Y, 2013, EUR J THER, V19, P185, DOI 10.5455/GMJ-30-2013-16; Cikman A, 2013, MIKROBIYOL BUL, V47, P14; CLSI Institute) LS, 2014, M100S24 CLS; Dent LL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-19; Dinc G, 2015, NEW MICROBIOL, V38, P6; Dizbay M, 2008, INT J ANTIMICROB AG, V32, P29, DOI 10.1016/j.ijantimicag.2008.02.01; Dizbay M, 2010, J ANTIBIOT, V63, P51, DOI 10.1038/ja.2009.11; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/42932; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/50020; Karabay O, 2014, ACTA MEDICA MEDITERR, V30, P113; Karageorgopoulos DE, 2008, J ANTIMICROB CHEMOTH, V62, P45, DOI 10.1093/jac/dkn16; Karaoglan I, 2013, J INT MED RES, V41, P1830, DOI 10.1177/030006051349617; Lopez-Cortes LE, 2014, J ANTIMICROB CHEMOTH, V69, P3119, DOI 10.1093/jac/dku23; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/52919; Pachon-Ibanez ME, 2004, ANTIMICROB AGENTS CH, V48, P4479, DOI 10.1128/AAC.48.11.4479-4481.200; Principe L, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-1; Rossi F, 2016, BJID, V10, P20; Taskin G, 2016, ACTA MEDICA MEDITERR, V32, P1891, DOI 10.19193/0393-6384_2016_6_17; Tunyapanit W, 2014, SCIENCEASIA, V40, P28, DOI 10.2306/scienceasia1513-1874.2014.40.02; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.175; Zhang YJ, 2013, EXP THER MED, V5, P1737, DOI 10.3892/etm.2013.103",25,3,3,1,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,691.0,697,,10.19193/0393-6384_2017_4_103,,7,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700024,,,,,2022-07-14,0.0025826446280991736,1.0752393700144941e-23,0.014591283079411078,0.06499217811079555,0.014591283079411078
J,"Scoppa, F21;   Gallamini, M;   Belloni, G;   Messina, G",,,,"Scoppa, Fabio; Gallamini, Michele; Belloni, Gabriele; Messina, Giuseppe",,,CLINICAL STABILOMETRY STANDARDIZATION: FEET POSITION IN THE STATIC STABILOMETRIC ASSESSMENT OF POSTURAL STABILITY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,stabilometry standardization; postural stability; Balance,RE-CALIBRATION; SWAY-DENSITY; REHABILITATION; STABILIZATION; PARAMETERS; PRESSURE; BALANCE,"Introduction: We address the topic of feet position during the quiet upright stance balance test over a force platform. Such position is widely discussed and three among the most accepted criteria were submitted to comparison. Materials and methods: 55 subjects devoid of any evident motor dysfunction were receiving the test in the three selected feet positions configurations: Joined Parallel [JP], 30 degrees degrees with 5 cm heels apart [30 degrees], Parallel Apart [PA] at about 15 cm distance from each other. Six sequences have been selected and applied in a random way to the subjects in order to avoid learning effects or fatigue bias in the test results. Results: The data have demonstrated that: 1) The Romberg quotients (the ratio between homologous parameters calculated in the Closed Eyes Test vs. the Open Eyes Test), although affected by the feet position, keep their standard meaning independently by the feet position; 2) A significantly greater variability of Sway Parameters is afforded by the Joined Parallel Feet [JP] while the Parallel Apart Feet position [PA] seems to afford the lowest sensitivity in quantifying balance performances; 3) The [30 degrees] test seems to be the most comfortable one and therefore likely to be the most convenient for unstable or dysfunctional subjects that cannot keep the [JP] position; 4) The [PA] and the [30 degrees] test are showing very similar results. Conclusion: We can therefore conclude that the first choice for feet positioning to perform balance tests on force platform should be towards the Joined Parallel Feet, the others, however, might represent a valid choice for impaired patients.","[Scoppa, Fabio] Sapienza Univ Rome, Fac Med & Dent Surg, Masters Degree Course Posturol, Rome, Italy; [Scoppa, Fabio; Belloni, Gabriele] Chinesis IFOP, Osteopathy Sch, Rome, Italy; [Gallamini, Michele] Univ Palermo, Sport & Exercise Sci Res Unit, Palermo, Italy; [Messina, Giuseppe] Univ Palermo, Sport & Exercise Sci Res Unit, Dept Psychol Pedag & Educ Sci, Palermo, Italy","Scoppa, F (corresponding author), Via Giovanni Pascoli 6, I-90144 Palermo, Italy.",,"Messina, Giuseppe/N-7298-2019","Messina, Giuseppe/0000-0003-2774-4950; Gallamini, Michele/0000-0002-4550-526X",,,"[Anonymous], NORM 85, V8; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.24; Baratto M, 2004, IMEKO IEEE SICE 2 I; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.01; Battaglia G, 2016, ACTA MEDICA MEDITERR, V32, P1589, DOI 10.19193/0393-6384_2016_5_13; Bianco A, 2014, AGING CLIN EXP RES, V26, P147, DOI 10.1007/s40520-013-0144-; BIZZO G, 1985, MED BIOL ENG COMPUT, V23, P474, DOI 10.1007/BF0244893; Cakrt O, 2012, NEUROREHABILITATION, V31, P429, DOI 10.3233/NRE-2012-0081; Cappello A, 2004, MED BIOL ENG COMPUT, V42, P350, DOI 10.1007/BF0234471; Cappello A, 2011, GAIT POSTURE, V33, P724, DOI 10.1016/j.gaitpost.2011.02.00; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-; de Oliveira J. M., 2016, BEHAV RES METHOD; Demura S, 2008, PERCEPT MOTOR SKILL, V106, P307, DOI 10.2466/PMS.106.1.307-31; GAGEY PM, 1991, ANN OTO RHINOL LARYN, V100, P971, DOI 10.1177/00034894911000120; Jacono M, 2004, MOTOR CONTROL, V8, P292, DOI 10.1123/mcj.8.3.29; Kapteyn T S, 1983, Agressologie, V24, P32; Khasnis A, 2003, J Postgrad Med, V49, P16; KOLLEGGER H, 1989, EUR NEUROL, V29, P241, DOI 10.1159/00011642; Martines F, 2015, ACTA MEDICA MEDITERR, V31, P90; Messina G, 2017, EUR J TRANSL MYOL, V27, P74, DOI DOI 10.4081/EJTM.2017.636; Morasso Pietro G, 2004, Technol Health Care, V12, P29; Ondo W, 2000, ARCH NEUROL-CHICAGO, V57, P1464, DOI 10.1001/archneur.57.10.146; Paolucci T, 2012, INT J REHABIL RES, V35, P360, DOI 10.1097/MRR.0b013e328356427; Patti A, 2016, J PHYS THER SCI, V28, P72, DOI 10.1589/jpts.28.7; Patti A, 2016, MEDICINE, V95, DOI 10.1097/MD.000000000000241; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.01; Sahin N, 2015, J PHYS THER SCI, V27, P437, DOI 10.1589/jpts.27.43; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.00; Uimonen S, 1992, J Vestib Res, V2, P34",29,24,25,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,707.0,713,,10.19193/0393-6384_2017_4_105,,7,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700026,,,,,2022-07-14,0.002995867768595041,1.2245288877130043e-11,0.016157859276068883,0.10363027117301331,0.015284609049722855
J,"Serra, A1;  Gulino, A;  Di Luca, M;  Conti, A;  Maniaci, A;  Campione, G;  Migliore, F;  Castro, V;  Maiolino, L",,,,"Serra, Agostino; Gulino, Alessandro; Di Luca, Milena; Conti, Angelo; Maniaci, Antonino; Campione, Gianluca; Migliore, Francesca; Castro, Veronica; Maiolino, Luigi",,,SINONASAL ANEURYSMAL BONE CYST: ARTICLE REVIEW,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,aneurysmal bone cyst; paranasal sinuses; orbit; CT and MRI; Fess,USP6; OSTEOBLASTOMA; EXPRESSION; RECURRENT; SINUS; CELL,"Aneurysmal Bone Cyst (ABC) are extremely rare in the head and neck region and even rare in sinuses. It's a benign multicystic mass that is locally-destructive and rapidly expandable. The etiopathogenesis, even today, is not entirely clear. However, hemorragic fluid content and septated appearance are the characteristic feature of ABC. The clinical presentation produces symptoms due to the compression of adjacent structures or as a result of a pathological fracture and depends on localization. Most common location in this area are the mandible and maxillary bones. The complete surgical excision is the treatment of choice. There are limited reports in literature on these tumors at the sinonasal level. We present a complete review of the literature as well as an unusual localization of ABC in this district.","[Serra, Agostino; Gulino, Alessandro; Di Luca, Milena; Conti, Angelo; Maniaci, Antonino; Campione, Gianluca; Migliore, Francesca; Castro, Veronica; Maiolino, Luigi] Univ Catania, ENT Sect, Dept GF Ingrassia, Catania, Italy","Maiolino, L (corresponding author), Univ Catania, ENT Sect, Dept GF Ingrassia, Catania, Italy.",,"Maniaci, Antonino/AAB-6004-2021","Maniaci, Antonino/0000-0002-1251-0185",,,"Bathla G, 2009, EUR J RADIOL EXTRA, V70, pe4; Bhalodiya NH, 2005, INDIAN J OTOLARYNGOL, V57, P325, DOI 10.1007/BF0290770; BIESECKE.JL, 1970, CANCER, V26, P615, DOI 10.1002/1097-0142(197009)26:3<615::AID-CNCR2820260319>3.0.CO;2-; Boscolo-Rizzo P, 2015, EUR ARCH OTO-RHINO-L, V272, P3491, DOI 10.1007/s00405-014-3369-; Caltabiano R, 2012, EUR REV MED PHARMACO, V16, P189; Caltabiano R, 2008, PATHOLOGICA, V100, P18; Campidelli C, 2003, Pathologica, V95, P10; Dani RD, 2006, IND J RADIOL IMAG, V16, P49, DOI DOI 10.4103/0971-3026.2904; DEDIOS AMV, 1992, CANCER, V69, P2921, DOI 10.1002/1097-0142(19920615)69:12<2921::AID-CNCR2820691210>3.0.CO;2-; Guida F, 2001, CHILD NERV SYST, V17, P297, DOI 10.1007/s00381000041; Guilemany JM, 2004, RHINOLOGY, V42, P16; Guseva NV, 2017, GENE CHROMOSOME CANC, V56, P266, DOI 10.1002/gcc.2243; Hashemi Seyyed Mostafa, 2015, Iran J Otorhinolaryngol, V27, P39; Hnenny L, 2015, J NEUROL SURG REP, V76, pE216, DOI 10.1055/s-0035-155501; Jaffe HL, 1942, ARCH SURG-CHICAGO, V44, P1004, DOI 10.1001/archsurg.1942.0121024004300; Janjua N, 2014, BMJ CASE RE; Leithner A, 2001, MODERN PATHOL, V14, P1100, DOI 10.1038/modpathol.388044; Mankin HJ, 2005, J CLIN ONCOL, V23, P6756, DOI 10.1200/JCO.2005.15.25; Matin N, 2015, HUM VACC IMMUNOTHER, V11, P2021, DOI 10.1080/21645515.2015.103492; Morris LGT, 2009, HEAD NECK PATHOL, V3, P169, DOI 10.1007/s12105-009-0121-; Murphey MD, 2003, RADIOLOGY, V229, P545, DOI 10.1148/radiol.229202113; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.120850; Oliveira AM, 2004, AM J PATHOL, V165, P1773, DOI 10.1016/S0002-9440(10)63432-; Panoutsakopoulos G, 1999, GENE CHROMOSOME CANC, V26, P265, DOI 10.1002/(SICI)1098-2264(199911)26:3<265::AID-GCC12>3.0.CO;2-; Park YK, 2007, SKELETAL RADIOL, V36, P463, DOI 10.1007/s00256-006-0269-; Rapisarda V, 2016, TOXICOL IND HEALTH, V32, P1729, DOI 10.1177/074823371557661; Riccioni L, 1996, TUMORI, V82, P485, DOI 10.1177/03008916960820051; de la Cuesta FR, 2007, ACTA OTORRINOLAR ESP, V58, P11; Serra A, 2015, ACTA OTORHINOLARYNGO, V35, P21; Serra A, 2003, INT J PEDIATR OTORHI, V67, P841, DOI 10.1016/S0165-5876(03)00069-; Serra A, 2017, ONCOTARGET, DOI DOI 10.18632/ONCOTARGET1716; Serra A, 2007, INT J PEDIATR OTORHI, V71, P1693, DOI 10.1016/j.ijporl.2007.07.00; Sinha NR, 2010, POL J RADIOL, V75, P6; Terkawi AS, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-1; Tirelli G, 2013, AM J RHINOL ALLERGY, V27, pE202, DOI 10.2500/ajra.2013.27.396; Vitaliti G, 2017, INT J IMMUNOPATH PH, V30, P94, DOI 10.1177/039463201668157; Vitaliti G, 2015, HUM VACC IMMUNOTHER, V11, P2749, DOI 10.1080/21645515.2015.106116",37,3,3,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,869.0,873,,10.19193/0393-6384_2017_5_129,,5,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000023,,,,,2022-07-14,0.003925619834710744,1.885829104260216e-08,0.03544009538129894,0.12826798468204645,0.035444002479595
J,"Serra, A21;   Maiolino, L;   Campione, G;   Conti, A;   Di Mauro, P",,,,"Serra, Agostino; Maiolino, Luigi; Campione, Gianluca; Conti, Angelo; Di Mauro, Paola",,,CELLULAR OXIDATION AND IMMUNE SYSTEM IN THE PATHOGENESIS OF SURGICAL STRESS IN OTORHINOLARYNGOLOGY: A BIO-PROTECTIVE ROLE OF A SUBSTANCE TO IMMUNOMODULATORY ACTION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,oxidative stress; surgical intervention; immunostimolatory activity; lymphocyte; plasma,,"Introduction: Oxidative stress is a biological condition characterized by the breakdown of the physiological cellular balance between production and elimination of chemical elements for oxidizing activity. Many causes may cause an increase in the production of free radicals of oxygen and the present study aims to assess the extent of oxidative stress, in patients undergoing surgical interventions in the ent district Materials and methods: The study was performed on 50 patients, of both sexes, aged between 20 and 60 years, divided into two groups, A and B The subjects in both groups had undergone surgery of various types within the ENT. Group A consisted of 25 patients who, in the post-operative period for a total temporal space of 3 months, were treated with a compound with immunostimulatory activity, Pidotimod, while the B group, the control group, was composed of 25 patients who, in the post-operative period, were not treated with Pidotimod or other substances having immunostimulatory and/or bioprotective. Each patient, either in group A and group B, was submitted to blood sampling for dosage of plasma levels and lymphocyte of specific markers of cellular oxidative stress, Results: The analysis of the results has allowed us to notice Group A patients treated with Pidotimod, the presence of a whole set of variations lymphocyte and plasma between the two different phases, pre-and post-treatment Conclusions: It is possible to state that patients undergoing surgery for otolaryngologic pathologies may be in systemic oxidative stress conditions.","[Serra, Agostino; Maiolino, Luigi; Campione, Gianluca; Conti, Angelo; Di Mauro, Paola] Univ Catania, ENT Dept, Catania, Italy","Maiolino, L (corresponding author), Univ Catania, ENT Dept, Azienda Osped Univ Policlin Vittorio Emanuele, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Di Mauro, Paola/AAC-1502-2019",,,,"Andersen BL, 1998, JNCI-J NATL CANCER I, V90, P30, DOI 10.1093/jnci/90.1.3; Bellia F, 2009, ANTIOXID REDOX SIGN, V11, P2759, DOI [10.1089/ars.2009.2738, 10.1089/ARS.2009.2738; Calabrese V, 2015, FREE RADICAL RES, V49, P511, DOI 10.3109/10715762.2015.102079; Calabrese V, 2010, NEUROCHEM RES, V35, P2208, DOI 10.1007/s11064-010-0304-; Dattilo S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0046-; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-; Kamogashira T., 2015, REACTIVE OXYGEN SPE; Labbe D, 2005, HEARING RES, V202, P21, DOI 10.1016/j.heares.2004.10.00; Melki SJ, 2010, LARYNGOSCOPE, V120, P1637, DOI 10.1002/lary.2101; Serra Agostino, 2016, Acta Biomed, V87, P25; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-; Trovato A, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0078-; Van Wijk R, 2008, INDIAN J EXP BIOL, V46, P27; Yoo TJ, 2002, ACTA OTO-LARYNGOL, V122, P3, DOI 10.1080/0001648026009489",14,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,1039.0,1044,,10.19193/0393-6384_2017_6_164,,6,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500023,,,,,2022-07-14,0.001446280991735537,6.580828015491676e-14,0.002271585241628165,0.08505926908780964,0.002271585241628165
J,"Serra, A31;   Maiolino, L;   Campione, G;   Conti, A;   Di Mauro, P",,,,"Serra, Agostino; Maiolino, Luigi; Campione, Gianluca; Conti, Angelo; Di Mauro, Paola",,,CLINICAL POSTOPERATIVE RECOVERY AFTER ADENOTONSILLECTOMY IN PEDIATRIC AGE: ROLE OF PIDOTIMOD,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,adeno-tonsillectomy surgery; immune system; physical performance; dysphagia; odinophagia and asthenia,RESPIRATORY-TRACT INFECTIONS; RECURRENT INFECTIONS; BACTERIAL EXTRACT; T-CELLS; CHILDREN; PREVENTION; IMMUNITY; DISEASE,"Introduction: There are numerous relationships between behaviour and immune system. Is particularly useful to identify the possible role played by a specific molecule to immunostimulant, Pidotimod, on restoring and optimizing physical performance in pediatric patients undergoing adeno-tonsillectomy surgery. Materials and methods: The study was performed on 600 patients, 275 males and 325 females, aged between 5 and 12 years, all subjected to adeno-tonsillectomy surgery. Group A: 300 patients treated with immunostimulant therapy (Pidotimod). Group B: 300 untreated patients with no therapy. The treatment of patients in the A group with Pidotimod provided for the administration of the drug, which started soon after hospitalization Parents of all patients provided a specific questionnaire The patient follow-up was divided into three phases: Phase T0: one week after the adeno-tonsillectomy intervention Phase T1: three months after the adeno-tonsillectomy intervention Phase T2: six months after the adeno-tonsillectomy operation. Results: The analysis of the obtained data revealed in its absolute evaluation the presence of a difference, somewhat evident, expressed in mean values, between the total score obtained in group A and that in group B. PHASE T0: The analysis of relative values, related to each single symptom, identified as the most prevalent phenomena, in descending order of frequency, dysphagia, odinophagia and asthenia PHASE T1: Reduction in the mean value of the mean score for the reference symptoms PHASE T2: Further decrease in the mean score for the reference symptoms in the two different groups Conclusions: The results of the study carried out, highlight the role that immunostimulants, specifically Pidotimod, can be used to optimize healing processes in pediatric patients undergoing adeno-tonsillectomy surgery.","[Serra, Agostino; Maiolino, Luigi; Campione, Gianluca; Conti, Angelo; Di Mauro, Paola] Univ Catania, ENT Dept, Catania, Italy","Maiolino, L (corresponding author), Univ Catania, ENT Dept, Azienda Osped Univ Policlin Vittorio Emanuele, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Di Mauro, Paola/AAC-1502-2019",,,,"Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.17; Bousquet Jean, 2006, Paediatr Drugs, V8, P235, DOI 10.2165/00148581-200608040-0000; Bowman LM, 2001, INFECT IMMUN, V69, P3719, DOI 10.1128/IAI.69.6.3719-3727.200; Boyle P, 2000, BIODRUGS, V14, P389, DOI 10.2165/00063030-200014060-0000; COLLET JP, 1993, PEDIATR INFECT DIS J, V12, P648, DOI 10.1097/00006454-199308000-0000; GREGORY RL, 1986, REV INFECT DIS, V8, P20; Jara-Perez JV, 2000, CLIN THER, V22, P748, DOI 10.1016/S0149-2918(00)90008-; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.5; Ogawa K, 2000, SURGERY, V127, P329, DOI 10.1067/msy.2000.10349; Ogden NS, 2005, CURR OPIN ALLERGY CL, V5, P179, DOI 10.1097/01.all.0000162312.64308.f; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-; Pavone P, 2014, INT J IMMUNOPATH PH, V27, P371, DOI 10.1177/03946320140270030; Rozy Adriana, 2008, Pneumonol Alergol Pol, V76, P35; Schaad UB, 2002, CHEST, V122, P2042, DOI 10.1378/chest.122.6.204; Slapak I, 1999, PEDIATR RES, V45, P757, DOI 10.1203/00006450-199905010-0011; TRINCHIERI G, 1994, IMMUNOL TODAY, V15, P460, DOI 10.1016/0167-5699(94)90189-; Vitaliti G, 2015, HUM VACC IMMUNOTHER, V11, P2749, DOI 10.1080/21645515.2015.106116; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-; Zelle-Rieser C, CLINICALLY APPROVE",19,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,1045.0,1050,,10.19193/0393-6384_2017_6_165,,6,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500024,,,,,2022-07-14,0.001962809917355372,1.1781706785030298e-11,0.003715742268983118,0.10222076728935446,0.003715742268983118
J,"Shahdadi, H1;  Balouchi, A;  Shaykh, A",,,,"Shahdadi, Hosien; Balouchi, Abbas; Shaykh, Ameneh",,,THE EFFECT OF VITAMIN D AND CALCIUM SUPPLEMENT ON HBA1C AND BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETES: A QUASI-EXPERIMENTAL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Type 2 diabetes; Vitamin D; Calcium; HbA1c,RANDOMIZED CONTROLLED-TRIAL; BONE; ADULTS; HEALTH,"Introduction: To assess the effect of vitamin D and calcium supplement on HbA1c and blood pressure in patients with Type 2 diabetes. Methods: This quasi-experimental study was conducted on 48 patients with type 2 diabetes visiting the Diabetes Clinic of Imam Khomeini Hospital in Zabol in Southeast of Iran from March to August 2016. They were divided into three groups, one of which received vitamin D supplement and routine treatments (A). The second group received vitamin D and calcium supplement and routine treatments (B). The third group received placebos and routine treatments (C). For a month, they were orally treated with 50000 units of vitamin D supplement and 150-250 milligrams of calcium on a daily basis. The HbA1c level and blood pressure were recorded before and after the intervention. Results: Blood pressure decreased after the intervention in the first and second groups; however, no significant decrease was observed in the third group (p=0.001) The HbA1c levels decreased by 1.76 and 1.85 in the first and second groups, respectively. An intragroup comparison, drawn after the intervention, indicated that HbA1c decreased in patients (28.08 -/+ 2 to 20.50 -/+ 2, p=0.122). Conclusion: Vitamin D and calcium supplements can decrease blood pressure and HbA1c in patients with type 2 diabetes.","[Shahdadi, Hosien] Zabol Univ Med Sci, Fac Nursing & Midwifery, Zabol, Iran; [Balouchi, Abbas] Zabol Univ Med Sci, Nursing & Midwifery Sch, Student Res Comm, Zabol, Iran; [Balouchi, Abbas] Iran Univ Med Sci, Sch Nursing & Midwifery, Student Res Comm, Zabol, Iran; [Shaykh, Ameneh] Zabol Univ Med Sci, Student Res Comm, Zabol, Iran","Shaykh, A (corresponding author), Zabol Univ Med Sci, Student Res Comm, Zabol, Iran.",,"Balouchi, Abbas/K-7590-2019","Balouchi, Abbas/0000-0002-4490-4904",Zabol University of Medical Science,This work was supported by Zabol University of Medical Science.,"[Anonymous], [No title captured; Anyanwu Anthony Chinedu, 2016, Indian J Endocrinol Metab, V20, P189, DOI 10.4103/2230-8210.17634; Aulinas A, 2015, DIABETIC ME; Bouillon R, 2014, BONEKEY REPORTS, V; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-225; Fadini GP, 2017, STEM CELLS, V35, P106, DOI 10.1002/stem.244; Farvid MS, 2004, J AM COLL NUTR, V23, P272, DOI 10.1080/07315724.2004.1071937; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.122; Foroughi Mehdi, 2016, Iran J Nurs Midwifery Res, V21, P100, DOI 10.4103/1735-9066.17475; Ganz T, 2016, DIABETES METABOLIS; Hartmann K, 2016, PHYSIOL REV, V96, P409, DOI 10.1152/physrev.00011.201; Holick MF., 2002, CURR OPIN ENDOCRINOL, V9, P87, DOI [10.1097/00060793-200202000-00011, DOI 10.1097/00060793-200202000-00011; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.112393; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.01168; Mohammedi K, 2016, DIABETES CAR; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-196; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.281; Smith-Palmer J, 2014, DIABETES RES CLIN PR, V105, P273, DOI 10.1016/j.diabres.2014.06.00; Talaei A, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-; Tikkanen I, 2015, DIABETES CARE, V38, P420, DOI 10.2337/dc14-109; Witham MD, 2013, JAMA INTERN MED, V173, P1672, DOI 10.1001/jamainternmed.2013.904; Zghebi SS, 2017, DIABETES OBESITY ME",23,0,0,1,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,6.0,,,,,991.0,996,,10.19193/0393-6384_2017_6_157,,6,"Medicine, General & Internal",General & Internal Medicine,FI4NW,WOS:000411949500016,,,,,2022-07-14,0.0023760330578512395,7.08949745479038e-08,0.008449514540724188,0.09276562305340731,0.008449514540724188
J,"Shari, S1;  Tabibi, SJ;  Nasiripour, A;  Ghaffari, F",,,,"Shari, Somayeh; Tabibi, Seyed Jamalledin; Nasiripour, Amirashkan; Ghaffari, Farhad",,,HEALTH SYSTEM PERFORMANCE EVALUATION FRAMEWORK WITH AN EMPHASIS ON HEALTH PROMOTION OF VULNERABLE GROUPS IN IRAN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Performance; Evaluation; Health System; Health promotion; Vulnerable Groups,PHYSICIAN DISTRIBUTION; PAYMENTS,"Introduction: The aim of this article was to identify the factors influencing the health system performance evaluation, In order to protect and promote health of vulnerable groups. Materials and methods: The current research is a descriptive-analytical comparative study. The statistical society includes 419 scholars in health system. After reviewing the theoretical literature, 6 variables have been assessed in the form of the research model. This study's tool is a questionnaire to evaluate the health system performance with an emphasis on health promotion with the reliability coefficient of 0.94. Data analysis was done through the statistical technique of finding the model of structural equations using LISREL software Results: The study's findings indicated that there are significant relationships between the stewardship variables on financial supply (0.553), stewardship on health service delivery (0.270), the variable of financial resources on resource generation (0.270), the financial resources on health service delivery (0.248), resource generation on health service delivery (0.132), the variable of health service delivery on access (0.132) and the financial resources on protecting from financial risks (0.612) in the confidence level of 99% with the mentioned standard coefficients. Conclusion: Health system Performance evaluation model was approved with six factors. The model can provide an opportunity for the policymakers to improve the performance, As well as to maintain and improve the health of vulnerable groups through identifying strengths and weaknesses.","[Shari, Somayeh] Islamic Azad Univ, Sci & Res Branch, Dept Hlth Serv Management, Tehran, Iran; [Tabibi, Seyed Jamalledin; Nasiripour, Amirashkan] Islamic Azad Univ, Sci & Res Branch, Fac Med Sci, Dept Hlth Serv Management, Tehran, Iran; [Ghaffari, Farhad] Islamic Azad Univ, Fac Econ & Management, Sci & Res Branch, Dept Econ, Tehran, Iran","Tabibi, SJ (corresponding author), Islamic Azad Univ, Sci & Res Branch, Fac Med Sci, Dept Hlth Serv Management, Tehran, Iran.",,"Ghaffari, Farhad/AFZ-2397-2022; Nasiripour, Amir Ashkan/L-7251-2017","Ghaffari, Farhad/0000-0002-9945-5720; Nasiripour, Amir Ashkan/0000-0002-2569-6118",,,"[Anonymous], 2008, REPORT ACTIONS TAKE; Atun R, 2008, EUROPEAN OBSERVATOR; Bakhshiyan F, 2007, MED J TABRIZ U MED S, V29, P; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-; CARTER RG, 1987, CAN MED ASSOC J, V136, P36; Central Bank of Islamic Republic of Iran, 2012, MAIN EC IN; CIHI, 2012, PERF MEAS FRAM CAN ; Damari B., 2007, POLICY DOCUMENT RE; Dastjerdi V. M., 2011, FAMILY PHY; Eastaugh Steven R, 2002, J Health Care Finance, V29, P1; Ebrahimi H, 2008, THESI; Haghdoost A, 2013, HAKIM RES J, V16, P17; Hatt L., 2006, THESI; Hurst J., 2001, PERFORMANCE MEASUREM, DOI [10.1787/788224073713, DOI 10.1787/788224073713; Inoue K, 2009, RURAL REMOTE HEALTH, V; Islam M., 2007, HLTH SYSTEMS ASSESS; Karimi E, 2005, SOCIAL SECUR J, V26, P1; Karimi I, 2009, J ARAK UNI MED SCI, V12, P9; Khayatan M., 2011, PAYAVARD, V4, P1; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.04940; Machado M. C., 2010, PORTUGAL HLTH SYSTE; Meng QY, 2011, HEALTH POLICY PLANN, V26, P93, DOI 10.1093/heapol/czq03; Ministry of Health, 2004, TREATM MED ED NAT H; Mistretta MJ, 2007, J RURAL HEALTH, V23, P215, DOI 10.1111/j.1748-0361.2007.00093.; MITKA M, 2011, JAMA J AM MED ASSOC, V306, P244; Peters D., 2002, BETTER HLTH SYSTEM; Pileh Roodi S, 2007, J PAYESH, V5, P13; Roberts M, 2003, GETTING HLTH REFOR; Skarbinski J, 2002, JAMA-J AM MED ASSOC, V287, P1043, DOI 10.1001/jama.287.8.104; Smith P. C, 2003, EUR J HEALTH ECON, V3, P14; Sun XY, 2009, HEALTH ECON, V18, P103, DOI 10.1002/hec.134; UNESCAP, 2008, WHAT IS GOOD GO; Vatankhah M. A., 2012, HEALTH INFO MANAG, V8, P28; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-; WHO, 2010, WOR HEALT REP, P; Wickramasinghe N., 2004, International Journal of Mobile Communications, V2, P140, DOI 10.1504/IJMC.2004.00466; Wickramasinghe N., 2000, International Journal of Healthcare Technology and Management, V2, P163, DOI 10.1504/IJHTM.2000.00108; Wickramasinghe Nilmini, 2004, Int J Electron Healthc, V1, P60, DOI 10.1504/IJEH.2004.00465; World Health Organization, 2000, WORLD HLTH REPORT 2; World Health Organization, 2009, GEORG HLTH SYST PER; World Health Organization, 2008, P WHO EUR MIN C HLT; World Health Organization (WHO), 2007, EV BUS STRENGTH HLT; Zarei H, 2011, J MED TAZKIYE, V20, P",43,1,1,2,9,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,259.0,265,,10.19193/0393-6384_2017_2_038,,7,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700013,,,,,2022-07-14,0.004442148760330579,1.475941597526224e-14,0.008659306720949077,0.08899267281402554,0.008659306720949077
J,"Sofulu, F1;  Avdal, EU;  Arkan, B",,,,"Sofulu, Funda; Avdal, Elif Unsal; Arkan, Burcu",,,VALIDITY AND RELIABILITY OF THE DIABETES FAMILY SUPPORT AND CONFLICT SCALE IN TURKISH,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Type 2 diabetes; diabetes mellitus; family; validity; reliability; scale,SELF-MANAGEMENT EDUCATION,"Objectives: This research was achieved methodologically for testing if The Diabetes Family Support and Conflict Scale is a reliable and validated instrument for the Turkish society. Materials and methods: The research was achieved in the Endocrinology and Diabetes policlinics of the university hospital in Izmir. The universe of the research was created by the sample of the individuals with the type 2 diabetes that has been consulted to the endocrinology and diabetes polyclinics. In assessing the data of the research; language and content validity, structure validity and reliability analysis were made. For testing the internal consistency of the scale the Cronbach Alpha coefficient was determined. Results: The Cronbach Alpha value that was determined for the whole scale was 0.735. By the outcome of the material analysis that has been made; the correlation coefficient of the correlation of the total score of the family support sub format of the scale and total scores of the scale as 0.79; family conflict as 0.64 were found out. Conclusions: it was deduced that the Diabetes Family Support and Conflict Scale is an instrument with high level of reliability and validity on the purpose of being used in Turkish Society.","[Sofulu, Funda] Izmir Katip Celebi Univ, Ataturk Res & Educ Hosp, Izmir, Turkey; [Avdal, Elif Unsal] Izmir Katip Celebi Univ, Fac Hlth Sci Izmir, Izmir, Turkey; [Arkan, Burcu] Uludag Univ, Sch Hlth, Psychiat Nursing Dept, Bursa, Turkey","Arkan, B (corresponding author), Uludag Univ, Sch Hlth, Psychiat Nursing Dept, Bursa, Turkey.",,"AVDAL, ELÄ°F UNSAL/ABE-9593-2021",,,,"ADA (The American Diabetes Association), 2014, STAND MED CAR DIA; Akgul A., 1997, STAT METHODS MED RE; Alpar R., 2002, APPL STAT RELIABILI; American Association of Clinical Endocrinologists, 2004, AM COLL END GUI; Aydemir O, 2006, CLIN SCALES USED PS; Carlson ED, 2000, PUBLIC HEALTH NURS, V17, P61, DOI 10.1046/j.1525-1446.2000.00061.; Duzoz TG, 2009, MUGLA U YENI TIP DER, V26, P21; Ercan I, 2004, ULUDAG U TIP FAKULTE, V30, P21; Erefe I., 2002, PRINCIPLES PROCESS ; Erkus A., 2003, WRITINGS PSYCHOMETR; Funnell MM, 2002, AM J PREV MED, V22, P3, DOI 10.1016/S0749-3797(02)00431-; GOZUM S, 2003, HEMSIRELIKTE ARASTIR, V5, P; Karakurt P, 2013, J A MENDERES U MED F, V14, P; Karasar N, 1997, SCI RES METHO; Norris SL, 2002, AM J PREV MED, V22, P39, DOI 10.1016/S0749-3797(02)00424-; oner N, 2009, PSYCHOL TESTS USED ; Oner N, 1997, PSYCHOGICAL TESTS U; Ozguven IE, 2011, PSYCHOL TEST; Ozguven IE, 2000, PSYCHOL TEST; Sarac ZF, 2007, TURK J ENDOCRINOL ME, V11, P4; Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.155; Tezbasaran A, 1997, GUIDE SCALE DEV LIK; Turgay M, 1997, J CINAR, V3, P7; Waltz C.F., 1981, NURSING RES DESIGN ; Yurdugul H., 2005, USING CONTENT VALID",25,3,3,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,1.0,,,,,107.0,114,,10.19193/0393-6384_2017_1_017,,8,"Medicine, General & Internal",General & Internal Medicine,EP2PY,WOS:000397226800017,,,,,2022-07-14,0.0025826446280991736,6.367232644540099e-12,0.027364228512097844,0.08230942561965902,0.027364228512097844
J,"Taravati, F1;  Irandoust, K;  Rahimi, A",,,,"Taravati, Fatemeh; Irandoust, Khadijeh; Rahimi, Alireza",,,THE EFFECTS OF 8 WEEKS HIGH INTENSITY INTERVAL TRAINING (HIIT) WITH GARLIC COMPLEMENT ON SOME LIPID PROFILES IN OBESE INACTIVE WOMEN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,HIIT; garlic complement; lipid profiles,RISK-FACTORS; WEIGHT-LOSS; EXERCISE; CHOLESTEROL; PLASMA; METABOLISM; RESISTANCE; DEPEND; DIET,"Background: regular exercise and garlic complement can independently improve lipid profiles. However, combining these lifestyle modifications may be more effective than either intervention alone. Therefore, We examined the effects of 8 weeks High Intensity Interval Training (HIIT) with and without garlic supplement on some lipid profiles in obese inactive women. Method: The study used a 3-experimental group, pretest and posttest design with 40 obese women of mean age 35.9 +/- 1.7 years (BMI, more than 30) whom were purposefully selected and randomly divided into three experimental groups and control group. The first experimental group followed a 8-week training program on 3 days/week; the second one underwent on the same training program with garlic supplement intake simultaneously; the third group has just garlic supplement and a control group with no training and supplement. before taking primary and final blood samples, the 24-hour diet recall questionnaire was used to control the subject's diet the day before taking blood samples. Total cholesterol and high-density lipoprotein (HDL) cholesterol and triglycerides were assessed by the enzymatic colorimetric method on an Architect C8000 system using the respective reagent kits. Low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald formula. Results: Improved lipid profiles were detected in the HIIT exercise and garlic complement in obese inactive women (p=0.05). The results indicated that garlic supplementation and exercise training improved all lipid profiles including TG, HDL, LDL, Chol/HDL and VLDL, while the combination of HIIT and garlic supplement may have more significant effect on lipid profiles (p=0.05). Conclusion: HIIT exercise and garlic complement improves the lipid profiles such including LDL, HDL, Cholesterol and Triglyceride in obese inactive women. It appears that HIIT exercise and garlic supplement may represent an effective approach for improving lipid profiles in obese inactive women individuals","[Taravati, Fatemeh] Islamic Azad Univ, Karaj Branch, Karaj, Iran; [Irandoust, Khadijeh] Imam Khomeini Int Univ, Karaj, Iran; [Rahimi, Alireza] Islamic Azad Univ, Karaj Branch, Dept Sport Physiol, Karaj, Iran","Irandoust, K (corresponding author), Imam Khomeini Int Univ, Karaj, Iran.",parirandoust@gmail.com,"irandoust, khadijeh/ABH-3519-2021; Taheri, Morteza/N-5170-2016","Taheri, Morteza/0000-0001-8031-3792",,,"Chhatwal S, 2012, INT J BASIC CLIN PHA, V1, P2; CHI MS, 1982, J NUTR, V112, P241, DOI 10.1093/jn/112.2.24; Christian DJ, 2010, SURG OBES RELAT DIS, V6, P448, DOI 10.1016/j.soard.2010.04.00; Couillard C, 2001, ARTERIOSCL THROM VAS, V21, P1226, DOI 10.1161/hq0701.09213; Finelli C, 2016, EXCLI J, V15, P166, DOI 10.17179/excli2015-64; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P49; Guessogo WR, 2016, J EXERC REHABIL, V12, P90, DOI 10.12965/jer.1630502.25; Ho SS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-70; Lira FS, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-3; Mathunjwa ML, 2013, ETHNIC DIS, V23, P14; Paoli A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-23; Rashidy-Pour A, 2009, OBES REV, V10, P2, DOI 10.1111/j.1467-789X.2008.00536.; Seip RL, 1998, EXERCISE SPORT SCI R, V26, P19; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.; Yeh YY, 2001, J NUTR, V131, p989S, DOI 10.1093/jn/131.3.989; Zorba E, 2011, J SPORT MED PHYS FIT, V51, P66",16,3,3,1,13,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,271.0,274,,10.19193/0393-6384_2017_2_040,,4,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700015,,,,,2022-07-14,0.001652892561983471,1.36045021918225e-11,0.003096932184272161,0.08370154519278161,0.003096932184272161
J,"Temizi, A1;  Ozdemir, Y;  Aslan, A;  Bostanci, MT;  Atasoy, G;  Caparlar, MA;  Albayrak, Y",,,,"Temizi, Ayetullah; Ozdemir, Yilmaz; Aslan, Adem; Bostanci, Mustafa Taner; Atasoy, Gussen; Caparlar, Mehmet Ali; Albayrak, Yavuz",,,ROLE OF COMPLETE BLOOD COUNTS PARAMETERS IN DIAGNOSIS OF ACUTE CHOLECYSTITIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,cholecystitis; complete blood count; neutrophil-leukocytes rate,MEAN PLATELET VOLUME; CELL DISTRIBUTION WIDTH; IN-HOSPITAL MORTALITY; LYMPHOCYTE RATIO NLR; NEUTROPHIL-LYMPHOCYTE; INDICATOR; SEVERITY; FAILURE; MARKER,"Introduction: The aim of this study is to determine the effectiveness of complete blood count parameters in the diagnosis of acute cholecystitis. Materials and methods: 58 patients diagnosed with acute cholecystitis and 60 patients underwent surgery elective cholecystectomy have been included retrospectively this to case-control study. Groups compared according to age, gender, white blood cell count, mean platelet volume, platelet count, red blood cell distribution width, neutrophil / lymphocyte ratio and platelet / lymphocyte ratio. Results: Any significative difference hasn't been detected between the two groups in terms of age (p = 0.144; p> 0.05). In the control group, more male patients have been observed than acute cholecystitis group (p <0.05). Red blood cell distribution width, neutrophil / lymphocyte ratio, platelet / lymphocyte ratio values and leukocyte levels of the patients in the study group have been observed significantly higher than the control group (p <0.05). The parameter with the highest sensitivity and specificity was found as NLR. Conclusion: The highest sensitivity and specificity parameter is neutrofil-leukocyte ratio. We suggest that neutrophil / lymphocyte ratio aids in the diagnosis of acute cholecystitis since neutrofil-leukocyte ratio is cheap, ease of use and rapid assessment method.","[Temizi, Ayetullah; Ozdemir, Yilmaz; Aslan, Adem; Atasoy, Gussen; Albayrak, Yavuz] Erzurum Area Training & Res Hosp, Dept Gen Surg, TR-25100 Erzurum, Turkey; [Bostanci, Mustafa Taner; Caparlar, Mehmet Ali] Diskapi Yildirim Beyazit Area Training & Res Hosp, Dept Gen Surg, Ankara, Turkey","Temizi, A (corresponding author), Erzurum Area Training & Res Hosp, Dept Gen Surg, TR-25100 Erzurum, Turkey.",,"bostancÄ±, mustafa taner/AAD-6014-2022; aslan, adem/AAI-4239-2020","aslan, adem/0000-0002-9083-9306",,,"Albayrak Y, 2011, CLIN APPL THROMB-HEM, V17, P362, DOI 10.1177/107602961036452; Barbosa Aldo Benjamim Rodrigues, 2011, Radiol Bras, V44, P381, DOI 10.1590/S0100-3984201100060001; Becchi C, 2006, MINERVA ANESTESIOL, V72, P74; Beyazit Y, 2012, CLIN RES HEPATOL GAS, V36, P162, DOI 10.1016/j.clinre.2011.10.00; Bilgic I, 2015, PERFUSION-UK, V30, P161, DOI 10.1177/026765911453428; Budak YU, 2016, BIOCHEM MEDICA, V26, P178, DOI 10.11613/BM.2016.02; Canpolat FE, 2009, PEDIATR INT, V51, P314, DOI 10.1111/j.1442-200X.2009.02820.; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-; Charalel RA, 2011, ULTRASOUND Q, V27, P161, DOI 10.1097/RUQ.0b013e31822a33e; Chua TC, 2012, ANN SURG, V256, P342, DOI 10.1097/SLA.0b013e3182602ad; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.06; Ghaffari S, 2014, J CARDIOVASC THORAC, V6, P35, DOI 10.5681/jcvtr.2014.00; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-; Hong N, 2012, CLIN CHIM ACTA, V413, P992, DOI 10.1016/j.cca.2012.02.02; Khode Vitthal, 2012, J Cardiovasc Dis Res, V3, P272, DOI 10.4103/0975-3583.10269; Kisacik B, 2008, JOINT BONE SPINE, V75, P291, DOI 10.1016/j.jbspin.2007.06.01; Kostrubiec M, 2010, HEART, V96, P460, DOI 10.1136/hrt.2009.18048; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.65670; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.62; Markar SR, 2010, ACTA CHIR BELG, V110, P543, DOI 10.1080/00015458.2010.1168067; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.01; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp16; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.02; Riall TS, 2010, J AM COLL SURGEONS, V210, P668, DOI 10.1016/j.jamcollsurg.2009.12.03; Russo MW, 2004, GASTROENTEROLOGY, V126, P1448, DOI 10.1053/j.gastro.2004.01.02; Sayid AT, 2015, J CLIN DIAGN RES, V9, P; Seker A, 2013, ACTA MEDICA MEDITERR, V29, P51; Sunbul M, 2014, CLIN EXP HYPERTENS, V36, P217, DOI 10.3109/10641963.2013.80454; Suppiah A, 2013, J GASTROINTEST SURG, V17, P675, DOI 10.1007/s11605-012-2121-; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.00; Temiz A, 2014, MED SCI MONITOR, V20, P660, DOI 10.12659/MSM.89015; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.72754; Uyanik B, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/82309",33,5,5,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,411.0,416,,10.19193/0393-6384_2017_3_060,,6,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200008,,,,,2022-07-14,0.003409090909090909,4.342652046737962e-14,0.13519228422537188,0.10141329058888854,0.1313079690041895
J,"Vural, M1;  Mert, M;  Erhan, B;  Gunduz, B;  Keles, BY;  Erdem, AE;  Bozan, A;  Arslan, H",,,,"Vural, Meltem; Mert, Meral; Erhan, Belgin; Gunduz, Berrin; Keles, Betul Yavuz; Erdem, Abdullah Eslem; Bozan, Ahmet; Arslan, Hulya",,,"IS THERE ANY RELATIONSHIP BETWEEN MEAN PLATELET VOLUME, BONE MINERAL DENSITY AND VITAMIN D IN POSTMENOPAUSAL WOMEN?",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Postmenopausal osteoporosis; platelet; mean platelet volume; vitamin D,D DEFICIENCY; IN-VITRO; SUPPLEMENTATION; OSTEOPOROSIS; CLOPIDOGREL; RECEPTOR; MARROW; ALPHA,"Introduction: Platelets have many functions notably atherogenesis, inflamation and atherothrombosis. Platelets precursors megakaryocytes are shown to contribute to bone formation with osteoblasts. It was indicated that vitamin D, which also played an important role in bone remodeling, had receptors in many tissues as well as receptors in platelets, and these receptors decreased in osteoporosis. In this study we aimed to evaluate the relationship between the mean platelet volume (MPV), which shows platelets and platelet functions, and bone mineral density (BMD) and serum 25-hydroxyvitamin D levels in postmenopausal women. Material and methods: Three hundred sixty two postmenopausal women were included in this study. Their demographics, laboratory values and BMD were recorded. The subjects were divided into three groups as control, osteopenia and osteoporosis according to the results of BMD. MPV and platelet counts were investigated in these groups. Also correlation tests were performed to evaluate the relationship between platelet functions, vitamin D and BMD measurements. Results: There was no difference in MPV and platelet counts between groups. No significant correlation was determined between MPV and serum 25-hydroxyvitamin D levels. However, based on the findings of our study, we established that there was a significant correlation between the platelet count and lumbar spine (L1-4) T score. Conclusion: This study showed that there was no relationship between MPV and osteoporosis. MPV might be considered a less important indicator in serum 25-hydroxyvitamin D levels and osteoporosis.","[Vural, Meltem; Mert, Meral] Bakirkoy Dr Sadi Konuk Training Hosp, Istanbul, Turkey; [Erhan, Belgin; Gunduz, Berrin; Keles, Betul Yavuz; Erdem, Abdullah Eslem; Bozan, Ahmet] Istanbul Phys Med Rehabil Training Hosp, Istanbul, Turkey; [Arslan, Hulya] Yozgat Publ Hosp, Yozgat, Turkey","Vural, M (corresponding author), Bakirkoy Dr Sadi Konuk Training Hosp, Istanbul, Turkey.",,,,,,"Akbal A, 2014, OSTEOPOROSIS INT, V25, P2291, DOI 10.1007/s00198-014-2764-; Bath PMW, 1996, BLOOD COAGUL FIBRIN, V7, P157, DOI 10.1097/00001721-199603000-0001; Beeton CA, 2006, BONE, V39, P985, DOI 10.1016/j.bone.2006.06.00; Beilfuss J, 2012, CYTOKINE, V60, P870, DOI 10.1016/j.cyto.2012.07.03; Bonucci E, 2014, TOXICOL PATHOL, V42, P957, DOI 10.1177/019262331351242; Bord S, 2005, BONE, V36, P812, DOI 10.1016/j.bone.2004.12.00; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature0204; Chappard D., 1999, Morphologie, V83, P1; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.; Cure MC, 2014, ANN LAB MED, V34, P98, DOI 10.3343/alm.2014.34.2.9; D'Amelio P, 2012, PANMINERVA MED, V54, P22; Ferdous F, 2015, IMMUNOL LETT, V163, P32, DOI 10.1016/j.imlet.2014.11.01; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P4; Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/1354378090324160; Gur EB, 2015, ARCH ENDOCRIN METAB, V59, P448, DOI 10.1590/2359-399700000006; Jorgensen NR, 2012, J INTERN MED, V272, P385, DOI 10.1111/j.1365-2796.2012.02535.; Kebapcilar AG, 2013, ARCH GYNECOL OBSTET, V288, P207, DOI 10.1007/s00404-013-2735-; Kim HL, 2011, YONSEI MED J, V52, P739, DOI 10.3349/ymj.2011.52.5.73; Kiskac M, 2014, ANN ENDOCRINOL-PARIS, V75, P200, DOI 10.1016/j.ando.2014.07.11; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-; Li XS, 2012, J BONE MINER METAB, V30, P660, DOI 10.1007/s00774-012-0362-; Linden MD, 2010, INT J BIOCHEM CELL B, V42, P1762, DOI 10.1016/j.biocel.2010.07.01; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM19950202332050; Muscari A, 2009, THROMB RES, V123, P587, DOI 10.1016/j.thromres.2008.03.02; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.0004; PFEILSCHIFTER J, 1990, ENDOCRINOLOGY, V127, P69, DOI 10.1210/endo-127-1-6; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI2707; Seida JC, 2014, J CLIN ENDOCR METAB, V99, P3551, DOI 10.1210/jc.2014-213; Sharif Pooneh Salari, 2010, Inflammation & Allergy Drug Targets, V9, P39; Shih TTF, 2004, SPINE, V29, P2844, DOI 10.1097/01.brs.0000147803.01224.5; Syberg S, 2012, J BONE MINER RES, V27, P2373, DOI 10.1002/jbmr.169; Vestergaard P, 2012, INT J CARDIOL, V160, P36, DOI 10.1016/j.ijcard.2011.03.02; Wang RT, 2011, PLATELETS, V22, P447, DOI 10.3109/09537104.2011.56543",33,5,5,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,443.0,448,,10.19193/0393-6384_2017_3_065,,6,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200013,,,,,2022-07-14,0.003409090909090909,1.714227197430297e-20,0.04119056421886354,0.0739422364471061,0.04119056421886354
J,"Wang, H1;  Ge, ZQ;  Wu, JW;  Yang, J",,,,"Wang, Hui; Ge, Zhiqiang; Wu, Jiwei; Yang, Jie",,,BIOMECHANICAL ANALYSIS OF KNEE JOINT INJURIES CAUSED BY TORNADO KICK TURN 720 degrees TO HORSE STEP LANDING,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Tornado; Horse Step; Landing; Knee Joint Injury; Sports; Biomechanics,,"Objective: Injury caused by tornado kick turn 720 degrees to horse step landing in Wushu jump is studied with detailed analysis of the biomechanical principles of the injuries. Methods: The author selected 3450 cases of athlete injured in Wushu routine movements between January 2014 and January 2016. Documentary analysis, logical analysis and expert interviews were used to analyze the biomechanical principles of the knee joint injury in athletes. Then based on the results, future rehabilitation measures are proposed. Results: Wushu athletes' landing in tornado kick turn 720 degrees to horse step can cause serious damage to the knee, as huge impact will be created by the moment during landing. At the same time, the weight of Wushu athletes as well as height of the arch will exert huge impact on athletes' knee joint. Conclusion: During tornado kick turn 720 degrees to horse step landing, Wushu athletes should pay more attention to the serious force generated by the movement and try to slow down landing time in order to reduce the impact. This will effectively protect the athletes' knee joint and keep the athletes healthy, which is important in the Wushu athletes' career.","[Wang, Hui; Ge, Zhiqiang; Wu, Jiwei; Yang, Jie] Jizhong Energy Grp, Fengfeng Gen Hosp, Dept Orthoped, Handan 056002, Peoples R China","Yang, J (corresponding author), Jizhong Energy Grp, Fengfeng Gen Hosp, Dept Orthoped, Handan 056002, Peoples R China.",opq007007@126.com,,,,,"Chen GM, 2016, SAUDI PHARM J, V24, P250, DOI 10.1016/j.jsps.2016.04.00; Deng Xiaofeng, 2014, ZHEJIANG SPORT SCI, V23, P12; Gao W, 2017, SAUDI J BIOL SCI, V24, P132, DOI 10.1016/j.sjbs.2016.09.00; Hu Pingxiu, 2010, WUSHU SCI, V21, P5; Kumar R, 2016, SAUDI J BIOL SCI, V23, P243, DOI 10.1016/j.sjbs.2015.03.00; Li Zhonghua, 2011, WUSHU SCI, V1; Peng Liming, 2010, WUSHU SCI, V26, P4; Peng WX, 2017, SAUDI J BIOL SCI, V24, P103, DOI 10.1016/j.sjbs.2016.08.01; Sheng Yancha, 2013, WUSHU SCI, V; Wang Dongmei, 2015, J BEIJING SPORT U, V14, P13; Wang Sen, 2014, J TIANJIN U SPORT, V16, P17; Xu Man, 2012, ZHEJIANG SPORT SCI, V13, P12; Yang Jiapeng, 2012, SPORT SCI TECHNOLOGY, V5, P6; Zhang Yanhua, 2014, WUSHU SCI, V05, P6",14,0,0,4,17,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,,,,3.0,,1297.0,1300,,10.19193/0393-6384_2017_3s_199,,4,"Medicine, General & Internal",General & Internal Medicine,FV9AC,WOS:000424878100001,,,,,2022-07-14,0.001446280991735537,1.1351005055601526e-06,0.0022805219820586694,0.08464276033332459,0.002279399231117796
J,"Wang, Y21;   Fang, NY",,,,"Wang, Yakun; Fang, Ningyuan",,,RELATIONSHIP OF SELF-MANAGEMENT WITH BLOOD GLUCOSE CONTROL AND SEVERAL RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Type 2 diabetes mellitus; self-management; A1c; UACR,COMPLICATIONS; ASSOCIATION,"Introduction: previous studies have shown that to normalize blood glucose is able to delay the occurrence of complications. This study aimed to investigate the role of self-management in the blood glucose control of type 2 diabetes mellitus (T2DM) patients and explore the relationship of self-management with risk factors of chronic complications of T2DM. Materials and methods: a survey was conducted in 900 DM patients in the Huamu Community Health Center in Shanghai in Deptember 2014, and the individual background, past medical history, self-management of DM were collected. Moreover, these patients received physical examination and laboratory examination. Results: excise and medication in self-management were negatively related to glycated hemoglobin (P<0.05), special diet and excise in self-management were negatively associated with systolic blood pressure (P<0.05), and general diet and excise in selfmanagement were negatively related to urinary microalbumin to creatinine ratio (P<0.05). The self-management has no relationship with total cholesterol and low-density lipoprotein cholesterin. Logistic regression analysis showed good excise (OR 0.929, 95% CI 0.877-0.983) and medication (OR 0.932, 95% CI 0.886-0.981) in self-management were helpful for the normalization of blood glucose, and good excise was able to reduce the risk for microalbuminuria (OR 0.918, 95% CI 0.861-0.979). Conclusion: the effective self-management of DM desires to be generalized in clinical practice. To improve the self-management in T2DM patients is helpful to control blood glucose and blood pressure and delay the microalbuminuria progression.","[Wang, Yakun] Huamu Community Hlth Ctr Shanghai Pudong New Area, Shanghai 201204, Peoples R China; [Fang, Ningyuan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Geriatr, Shanghai 200127, Peoples R China","Fang, NY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Geriatr, Shanghai 200127, Peoples R China.",,,,Outstanding Young Medical Talent Project of Health System in Shanghai Pudong New Area [PWRq2014-25],This study was supported by Outstanding Young Medical Talent Project of Health System in Shanghai Pudong New Area (PWRq2014-25).,"Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-262; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S01; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.1857; Gay HC, 2016, HYPERTENSION, V67, P733, DOI 10.1161/HYPERTENSIONAHA.115.0685; Heisler M, 2005, DIABETES CARE, V28, P816, DOI 10.2337/diacare.28.4.81; Houle J, 2015, DIABETIC MED, V32, P1247, DOI 10.1111/dme.1268; Litwak L, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-5; Nicoll Katie G, 2014, Diabetes Spectr, V27, P207, DOI 10.2337/diaspect.27.3.20; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa080298; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.40; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.94; Wang YK, 2013, INT J CLIN EXP MED, V6, P97; Wong ND, 2016, DIABETES CARE, V39, P668, DOI 10.2337/dc15-243; Yang SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015075",14,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,5.0,,,,,751.0,756,,10.19193/0393-6384_2017_5_110,,6,"Medicine, General & Internal",General & Internal Medicine,FA9PC,WOS:000405777000004,,,,,2022-07-14,0.001446280991735537,7.051009219729465e-08,0.014614756324203835,0.11320181029341254,0.013816858522944018
J,"Yildirim, N1;  Simsek, M;  Turkeli, M;  Bilici, M;  Ozmen, HK",,,,"Yildirim, Nilgun; Simsek, Melih; Turkeli, Mehmet; Bilici, Mehmet; Ozmen, Hilal Kiziltunc",,,EARLY ONSET OF RADIATION INDUCED SARCOMA: A CASE REPORT AND REVIEW OF THE LITERATURE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Radiation induced sarcoma; radiotherapy; synchronous tumors; treatment,BREAST-CANCER-TREATMENT; SOFT-TISSUE; BONE; RADIOTHERAPY; ANGIOSARCOMA; MUTATIONS; THERAPY; RISK; BRCA,"Introduction: Radiation induced sarcoma (RIS) is a long-term complication of radiation therapy. Its incidence, 5 years after treatment, is 0.03-0.2%. This risk is related to radiation dose, concomitant alkylating agents and genetic factors. Case presentation: We report the case of a 33-year-old woman with synchronous gastric (adenocarcinoma, intestinal type, T3N2M0, Stage 3A) and right-sided breast cancer (invasive ductal carcinoma (IDC), T2N1M0, Cerb2 (+++), Stage 2B) who received postoperative adjuvant chemotherapy (CT) and radiotherapy (RT) to stomach and breast. At the 22nd month after RT, pleomorphic undifferentiated sarcoma was diagnosed at the right thoracic wall including axillary region (field of RT) synchronously with the left sided breast cancer. After adjuvant CT, first she received chemo-radiotherapy (CRT) for gastric cancer. After that she received complex RT to breast region (right supraclavicular fossa single front plan, tangential fields bolus), a total of 5000 cGy as 200 cGy/day X 25 fractions to right chest wall and a total dose as 5000 cGy to posterior axillary region. During follow-up, a 3 cm lesion at right axilla and a BIRADS 4A lesion in her left breast were determined. Sarcoma in right axilla and IDC in left breast were reported after biopsy. Patient underwent surgery at the same session. Conclusion: Although post-radiation sarcomas are rare complications with poor prognosis, enhanced awareness and early detection by clinicians are essential to improve outcomes via curative surgical resection. Latent period is expressed with years, but in our case RIS was developed after a short time with 22 months.","[Yildirim, Nilgun] Dr Ersin Arslan Training & Res Hosp, Dept Med Oncol, Gaziantep, Turkey; [Simsek, Melih; Turkeli, Mehmet; Bilici, Mehmet] Ataturk Univ, Fac Med, Dept Med Oncol, Erzurum, Turkey; [Ozmen, Hilal Kiziltunc] Ataturk Univ, Fac Med, Dept Radiat Oncol, Erzurum, Turkey","Yildirim, N (corresponding author), Dr Ersin Arslan Training & Res Hosp, Dept Med Oncol, Gaziantep, Turkey.",,"yÄ±ldÄ±rÄ±m, NilgÃ¼n/W-1484-2018; Kiziltunc Ozmen, Hilal/AAZ-7566-2021; Kiziltunc Ozmen, Hilal/AAZ-8355-2021","Kiziltunc Ozmen, Hilal/0000-0003-0695-0931; ",,,"Beck A., 1992, MUNCHEN MED WOCHEN, V69, P62; Cahan WG, 1998, CANCER-AM CANCER SOC, V82, P8, DOI 10.1002/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO;2-; Fletcher CDM, 2006, HISTOPATHOLOGY, V48, P3, DOI 10.1111/j.1365-2559.2005.02284.; Gonin-Laurent N, 2007, ONCOGENE, V26, P6106, DOI 10.1038/sj.onc.121040; Henderson TO, 2007, JNCI-J NATL CANCER I, V99, P300, DOI 10.1093/jnci/djk05; Jallali N, 2012, AM J SURG, V203, P156, DOI 10.1016/j.amjsurg.2010.12.01; Kadouri L, 2013, BREAST CANCER RES TR, V140, P207, DOI 10.1007/s10549-013-2621-; Lagrange JL, 2000, RADIOLOGY, V216, P197, DOI 10.1148/radiology.216.1.r00jl0219; MARK RJ, 1994, CANCER, V73, P2653, DOI 10.1002/1097-0142(19940515)73:10<2653::AID-CNCR2820731030>3.0.CO;2-; Patel S R, 2000, Curr Treat Options Oncol, V1, P258, DOI 10.1007/s11864-000-0037-; Riad S, 2012, CANCER-AM CANCER SOC, V118, P2682, DOI 10.1002/cncr.2654; Rubino C, 2005, BREAST CANCER RES TR, V89, P277, DOI 10.1007/s10549-004-2472-; Sheth GR, 2012, ONCOLOGIST, V17, P405, DOI 10.1634/theoncologist.2011-028; Torres KE, 2013, ANN SURG ONCOL, V20, P1267, DOI 10.1245/s10434-012-2755-; TUCKER MA, 1987, NEW ENGL J MED, V317, P588, DOI 10.1056/NEJM19870903317100; Warren S, 1936, ARCH SURG-CHICAGO, V33, P425, DOI 10.1001/archsurg.1936.0119003007800; West JG, 2008, CLIN BREAST CANCER, V8, P533, DOI 10.3816/CBC.2008.n.06; Yap J, 2002, INT J RADIAT ONCOL, V52, P1231, DOI 10.1016/S0360-3016(01)02799-",18,3,3,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,565.0,568,,10.19193/0393-6384_2017_4_082,,4,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700003,,,,,2022-07-14,0.001962809917355372,1.8634729387996942e-08,0.003715742268983118,0.12773987516330382,0.003715742268983118
J,"Yilmaz, B1;  Cevik, H;  Bildaci, TB;  Ozdogan, S",,,,"Yilmaz, Birnur; Cevik, Halime; Bildaci, Tevfik Berk; Ozdogan, Serdinc",,,RENAL STIFFNESS ON PATIENTS WITH GESTATIONAL DIABETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Renal Stiffness; Gestational Diabetes; Acoustic Radiation Force Imaging; Ultrasound,ALLOGRAFT FIBROSIS; ELASTOGRAPHY; RECOMMENDATIONS; QUANTIFICATION; MELLITUS,"Introduction: Gestational diabetes is defined as glucose intolerance first recognized in pregnancy. Oral glucose tolerance testing is the cornerstone in diagnosing gestational diabetes. In this study, we aimed to find a new method of diagnosis in addition to conventional diagnosed by 75 gr oral glucose tolerance testing. Material and methods: 121 pregnant woman were included part in this study, forming two groups as gestational diabetic patients (51 patients) and control group (70 pregnant woman). Both kidneys are evaluated with B Mode Ultrasound and Colour Doppler Ultrasound mode by measuring resistive index for depiction of other renal pathologies. Stiffness of renal tissue determined by Acoustic Radiation Force Impulse (ARFI) technology utilized by two blinded radiology specialists. Results: We were not able to find any correlation between gestational diabetes mellitus and resistivity index measurements (p > 0.05). But a correlation between second hour glucose levels in oral glucose tolerance test and bilateral renal stiffness was found (p < 0,05). Conclusion: ARFI ultrasound may be a non-invasive technique in determining the course of the disease.","[Yilmaz, Birnur; Cevik, Halime] Okan Univ, Dept Radiol, Fac Med, Istanbul, Turkey; [Bildaci, Tevfik Berk; Ozdogan, Serdinc] Baskent Univ, Dept Jinecol & Obstet, Fac Med, Istanbul, Turkey","Yilmaz, B (corresponding author), Okan Univ Med Hosp Icmeler, Aydinli Yolu Cad,Aydemir Sk 2, Istanbul, Turkey.",,,,,,"[Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S00; [Anonymous], 2014, AM FAM PHYSICIAN, V90, P41; Arndt R, 2010, TRANSPL INT, V23, P871, DOI 10.1111/j.1432-2277.2010.01057.; Cimsit C, 2015, J ULTRAS MED, V34, P151, DOI 10.7863/ultra.34.1.15; Getahun D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.01; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P176, DOI 10.1016/j.diabres.2013.11.00; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s22; Shahbazian H, 2016, DIABETES METAB SYND, V10, P242, DOI 10.1016/j.dsx.2016.06.01; Shiina T, 2015, ULTRASOUND MED BIOL, V41, P1126, DOI 10.1016/j.ultrasmedbio.2015.03.00; Stock KF, 2010, CLIN HEMORHEOL MICRO, V46, P139, DOI 10.3233/CH-2010-134; Sugitani M, 2013, PLACENTA, V34, P1009, DOI 10.1016/j.placenta.2013.08.01; Syversveen T, 2012, EUR RADIOL, V22, P2130, DOI 10.1007/s00330-012-2476-; Syversveen T, 2011, TRANSPL INT, V24, P100, DOI 10.1111/j.1432-2277.2010.01165.; Wahabi Hayfaa A, 2012, BMC Res Notes, V5, P496, DOI 10.1186/1756-0500-5-49",14,2,2,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,4.0,,,,,663.0,666,,10.19193/0393-6384_2017_4_099,,4,"Medicine, General & Internal",General & Internal Medicine,EX2TM,WOS:000403079700020,,,,,2022-07-14,0.001446280991735537,8.023718344284889e-27,0.002684285395919768,0.05599291990351633,0.002684285395919768
J,"Yilmazel, G1",,,,"Yilmazel, Guelay",,,PREHYPERTENSION PREVALENCE AND ITS ASSOCIATION WITH NECK AND ABDOMINAL OBESITY IN DISEASE-FREE YOUNG ADULTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Prehypertension; prevalence; neck; abdominal obesity; young adults,BODY-MASS INDEX; CARDIOVASCULAR RISK; FATTY-ACIDS; CIRCUMFERENCE; HYPERTENSION; OVERWEIGHT; CHILDREN,"Introduction: Hypertension and obesity are threatening facts of public health in the Turkish community; hence it is lifesaving to carry out blood pressure and upper body measurements for early determination of cardiovascular risks. The aim of this study was to determine prevalence of prehypertension and its association with neck and abdominal obesity in disease-free young adults. Materials and methods: This cross-sectional survey was conducted in an urban public university of Turkey. The anthropometric and blood pressure measurements were obtained from 704 healthy disease-free young adults. Comparisons among blood pressure groups were done with the Chi-square test. Multivariate regression analysis was carried out to determine risk factors for prehypertension. The Pearson correlation was employed to determine correlation between the prehypertension and anthropometric measurements. P<0.05 values were considered as statistically significant. Results: The overall prevalence of prehypertension was 49.0%, 53.1% in males and 44.9% in females. Prevalence of prehypertension was significantly higher in males comparison to females (p<0.001). The overall prevalence of neck obesity, abdominal obesity and overweight/obesity was 18.2%, 6.1% and 23.0% respectively. Multivariate logistic regression analysis showed that neck circumference was the strongest predictor of prehypertension among other obesity indicators. Prehypertension was positively correlated with neck circumference, waist circumference and Body Mass Index for both sexes (p<0.05). Conclusion: Public health interventions are needed to prevent prehypertension and obesity in young adults. Further research should focus on determining prehypertension, neck and abdominal obesity which will decrease probable cardiovascular risks in young populations.","[Yilmazel, Guelay] Hitit Univ, Sch Hlth, Dept Publ Hlth, TR-19000 Corum, Turkey","Yilmazel, G (corresponding author), Hitit Univ, Sch Hlth, Dept Publ Hlth, TR-19000 Corum, Turkey.",,"YILMAZEL, GÃLAY/AAF-1762-2020; YILMAZEL, GÃLAY/AAC-5444-2021; YILMAZEL, Gulay/H-9788-2014","YILMAZEL, GÃLAY/0000-0002-2487-5464; ",,,"Al-Majed HT, 2012, J FAM COMMUNITY MED, V19, P105, DOI 10.4103/2230-8229.9829; Ben-Noun L, 2001, OBES RES, V9, P470, DOI 10.1038/oby.2001.6; Ben-Noun Liubov Louba, 2006, Exp Clin Cardiol, V11, P1; Celik MM, 2012, M KEMAL U MED J, V3, P; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c; Erem C, 2009, J PUBLIC HEALTH-UK, V31, P47, DOI 10.1093/pubmed/fdn07; Grotto I, 2006, HYPERTENSION, V48, P254, DOI 10.1161/01.HYP.0000227507.69230.f; Gupta AK, 2010, HYPERTENS RES, V33, P905, DOI 10.1038/hr.2010.9; Hu YH, 2011, J INT MED RES, V39, P23, DOI 10.1177/14732300110390010; Kawamoto R, 2008, TOHOKU J EXP MED, V216, P353, DOI 10.1620/tjem.216.35; Kini S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.015453; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-; Lu X, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-2; Mendis S., 2011, GLOBAL ATLAS CARDIO; Piro S, 2008, NUTR METAB CARDIOVAS, V18, P96, DOI 10.1016/j.numecd.2007.01.00; Satman I, TURK DIYAB HIP OB E; Stojiljkovic MP, 2002, J HYPERTENS, V20, P1215, DOI 10.1097/00004872-200206000-0003; Stojiljkovic MP, 2001, AM J PHYSIOL-REG I, V280, pR1674, DOI 10.1152/ajpregu.2001.280.6.R167; T. C. Ministry of Health, 2013, SAGL BAK YAYIN, V90; Turkish Statistical Institute, 2015, CAUS DEATH STA; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P; WHO, 2008, WAIST CIRCUMFERENC; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.186; World Health Organization, 2000, REPORT WHO CONSULTAT, V894, P253, DOI DOI 10.1007/978-0-387-71799-9_45; Zen V, 2012, AM J CARDIOVASC DIS, V2, P32; Zhou JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-7",27,4,4,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,2.0,,,,,329.0,334,,10.19193/0393-6384_2017_2_049,,6,"Medicine, General & Internal",General & Internal Medicine,EP2RK,WOS:000397230700024,,,,,2022-07-14,0.0027892561983471073,7.125139514015773e-08,0.011199924381070939,0.10512711910424744,0.011200684328338852
J,"Yilmazel, G21",,,,"Yilmazel, Gulay",,,CO-EXISTENCE OF LIPITENSION AND CENTRAL OBESITY: AN EPIDEMILOGIC STUDY OF PRIMARY CARE PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Dyslipidemia; hypertension; central obesity; primary care; patients,BLOOD-PRESSURE; WAIST CIRCUMFERENCE; HYPERTENSION; DYSLIPIDEMIA; CHOLESTEROL; PREVALENCE; MORTALITY; RISK,"Introduction: The burden of cardiovascular disease an increasing public health problem worldwide as such in Turkey. This epidemiologic study was performed to determine co-existence of lipitension and central obesity among primary care patients. Materials and methods: A single-center retrospective case-control study was conducted in a population recruited from a family health center in year 2016. A total of 204 individuals with central obesity were matched on gender and age (+/- 2 years) with controls without central obesity. Chi-square and logistic regression analyses were performed to determine the association between lipitension and central obesity. Results: The prevalence of dyslipidemia, hypertension and lipitension in all participants was 60.8%, 40.4% and 23.3% respectively. Among cases, the prevalence of central obesity was 36% among women and 24.4% among men. The prevalence of lipitension in central obesity was 37.3% in this study. Lipitension risk was 1.75 fold higher in men than women. In particular, central obesity was strongly associated with lipitension (OR, 4.75; 95% CI, 2.87-7.87). Conclusions: The considerably high prevalence of lipitension and central obesity among the primary care population aged and over 30 invites to us for effective preventive measures and public health framework urgently.","[Yilmazel, Gulay] Hitit Univ, Sch Hlth, Dept Publ Hlth, Corum, Turkey","Yilmazel, G (corresponding author), Hitit Univ, Sch Hlth, Dept Publ Hlth, Corum, Turkey.",,"YILMAZEL, GÃLAY/AAF-1762-2020; YILMAZEL, Gulay/H-9788-2014; YILMAZEL, GÃLAY/AAC-5444-2021","YILMAZEL, GÃLAY/0000-0002-2487-5464",,,"Borghi C, 2004, AM HEART J, V148, P285, DOI 10.1016/j.ahj.2004.02.00; Chhatriwalla AK, 2009, J AM COLL CARDIOL, V53, P1110, DOI 10.1016/j.jacc.2008.09.06; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.248; DALAL JJ, 2012, J ENDOCRINOL METABOL, V16, P240, DOI DOI 10.4103/2230-8210.9374; Feng RN, 2012, J EPIDEMIOL, V22, P317, DOI 10.2188/jea.JE2011012; Gu QP, 2008, ANN EPIDEMIOL, V18, P302, DOI 10.1016/j.annepidem.2007.11.01; Johnson ML, 2004, AM J MANAG CARE, V10, P92; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/93140; Liao D, 2004, EUR HEART J, V25, P23; Mendis S., 2011, GLOBAL ATLAS CARDIO; Nickenig G, 2002, CIRCULATION, V105, P393, DOI 10.1161/hc0302.10261; Nickenig G, 2002, J HUM HYPERTENS, V16, pS26, DOI 10.1038/sj.jhh.100143; Okaka E., 2013, AFR J MED HLTH SCI, V12, P8; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-0001; Paoli A, 2015, CLIN PHYSIOL FUNCT I, V35, P1, DOI 10.1111/cpf.1213; Park SH, 2009, CIRC J, V73, P1643, DOI 10.1253/circj.CJ-09-016; T.C. Ministry of Health, 2013, OB HE MUC LI; T.C. Ministry of Health, 2014, TURK BES SAGL AR 20; Thomas F, 2002, EUR HEART J, V23, P528, DOI 10.1053/euhj.2001.288; Turkish Statistical Institute, 2015, CAUS DEATH STA; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P; WHO, 2011, WORLD REPORT ON DISABILITY, P; Wong ND, 2006, AM J CARDIOL, V98, P204, DOI 10.1016/j.amjcard.2006.01.07; Yao XG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-9",25,2,2,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,437.0,441,,10.19193/0393-6384_2017_3_064,,5,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200012,,,,,2022-07-14,0.0025826446280991736,7.126212700785234e-08,0.08659158739372955,0.12301905016076353,0.08309558300050446
J,"Yuzbasioglu, Y1;  Ucoz, D;  Icme, F;  Haydar, GE;  Uzunosmanoglu, H;  Pekcici, R",,,,"Yuzbasioglu, Yucel; Ucoz, Dilber; Icme, Ferhat; Haydar, Gullu Ercan; Uzunosmanoglu, Huseyin; Pekcici, Recep",,,THE ROLE OF C-REACTIVE PROTEIN IN THE EVALUATION OF THE SEVERITY OF ACUTE CHOLECYSTITIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,reactive protein; Acute Cholecystitis; Severity of Illness Index,SUSPECTED ACUTE CHOLECYSTITIS; ACUTE CALCULOUS CHOLECYSTITIS; TOKYO GUIDELINES; ACUTE CHOLANGITIS; LAPAROSCOPIC CHOLECYSTECTOMY; PREDICTIVE FACTORS; DIAGNOSIS; MANAGEMENT; SURGERY,"Introduction: Acute cholecystitis (AC) is the acute inflammation of the gallbladder wall. Tokyo guidelines provide criteria for the diagnosis and classification of AC. We aimed this study to identify the role of C-reactive protein (CRP) in determining the severity of AC and determine cut-off levels for each group. Materials and methods: A retrospective analysis was made of 236 patients diagnosed with AC between January 2009 and January 2015. The patients were divided into three groups according to the Tokyo classification. CRP values of the patients were analyzed and compared among the groups. Results: Disease severity was determined as mild in 57.6%, moderate in 28.8% and severe in 13.6% of the patients. The mean age was 53.7 +/- 18.3 years and the clinical picture was seen to become more severe with increasing age (p<0.05). CRP values of the patients were determined to rise with increasing grade (p<0.05). There was no relationship between CRP and white blood cell (WBC) (p>0.05). The CRP cut-off values were determined as 0.815 mg/dl (sensitivity 44.9%, specificity 34%) for the Grade 1 patient group, 1.095 mg/dl (sensitivity 57.4%, specificity 57.7%) for the Grade 2 patient group and 2.095 mg/dl (sensitivity 71.9%, specificity 69.6%) for the Grade 3 patient group. Conclusion: CRP values may be useful in assessing the severity of AC, and may be considered to be a parameter that could be added to the Tokyo classification.","[Yuzbasioglu, Yucel; Ucoz, Dilber; Icme, Ferhat] Ankara Ataturk Training & Res Hosp, Dept Emergency Med, Ankara, Turkey; [Haydar, Gullu Ercan; Pekcici, Recep] Ankara Ataturk Training & Res Hosp, Dept Gen Surg, Ankara, Turkey; [Uzunosmanoglu, Huseyin] Ankara Kecioren Training & Res Hosp, Dept Emergency Med, Ankara, Turkey","Icme, F (corresponding author), Ankara Ataturk Training & Res Hosp, Clin Emergency Med, Ataturk Egitim & Arastirma Hastanesi Acil, Serv Bilkent, Eskisehir Yolu 2 Km, TR-06800 Ankara, Turkey.",,"Ä°ÃME, DoÃ§. Dr. Ferhat/F-7739-2013","Ä°ÃME, DoÃ§. Dr. Ferhat/0000-0001-5180-7152",,,"Asai K, 2014, SURG TODAY, V44, P2300, DOI 10.1007/s00595-014-0838-; Asai K, 2012, J HEPATO-BIL-PAN SCI, V19, P476, DOI 10.1007/s00534-011-0463-; Aydin C, 2006, J HEPATO-BILIARY-PAN, V13, P155, DOI 10.1007/s00534-005-1042-; Beliaev AM, 2015, J SURG RES, V198, P93, DOI 10.1016/j.jss.2015.05.04; Beliaev AM, 2015, J SURG RES, V198, P66, DOI 10.1016/j.jss.2015.05.00; ESKELINEN M, 1993, THEOR SURG, V8, P1; Gilbert DN, 2011, CLIN INFECT DIS, V52, pS346, DOI 10.1093/cid/cir05; Gurbulak EK, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.17(4)2015.2809; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-; Indar AA, 2002, BRIT MED J, V325, P639, DOI 10.1136/bmj.325.7365.63; Kimura Y, 2007, J HEPATO-BILIARY-PAN, V14, P15, DOI 10.1007/s00534-006-1152-; Lee SW, 2010, J HEPATO-BIL-PAN SCI, V17, P879, DOI 10.1007/s00534-010-0289-; Lee SW, 2009, J GASTROEN HEPATOL, V24, P1857, DOI 10.1111/j.1440-1746.2009.05923.; MARTINEZ A, 1986, GASTROINTEST RADIOL, V11, P334, DOI 10.1007/BF0203510; Mayumi T, 2007, J HEPATO-BILIARY-PAN, V14, P114, DOI 10.1007/s00534-006-1163-; Miura F, 2007, J HEPATO-BILIARY-PAN, V14, P27, DOI 10.1007/s00534-006-1153-; Mok KWJ, 2014, INT J SURG, V12, P649, DOI 10.1016/j.ijsu.2014.05.04; Nikfarjam M, 2011, HPB, V13, P551, DOI 10.1111/j.1477-2574.2011.00327.; Posther KE, 2004, CURRENT SURG THERAPY, P38; RALLS PW, 1985, RADIOLOGY, V155, P767, DOI 10.1148/radiology.155.3.389000; Rosalki SB, 2001, INT J CLIN PRACT, V55, P26; Schafer M, 2001, AM J SURG, V182, P291, DOI 10.1016/S0002-9610(01)00702-; Sekimoto M, 2007, J HEPATO-BILIARY-PAN, V14, P11, DOI 10.1007/s00534-006-1151-; Singer AJ, 1996, ANN EMERG MED, V28, P267, DOI 10.1016/S0196-0644(96)70024-; Teckchandani N, 2010, INT J SURG, V8, P623, DOI 10.1016/j.ijsu.2010.05.01; Weigand K, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-2; Yazici P, 2015, TURK J SURG, V31, P1, DOI 10.5152/UCD.2015.280; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-; Yokoe M, 2012, J HEPATO-BIL-PAN SCI, V19, P578, DOI 10.1007/s00534-012-0548-",29,1,1,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2017,33,3.0,,,,,475.0,480,,10.19193/0393-6384_2017_3_070,,6,"Medicine, General & Internal",General & Internal Medicine,EV3BF,WOS:000401631200018,,,,,2022-07-14,0.002892561983471074,2.7232860299537013e-17,0.00557101981882904,0.08439480727818029,0.00557101981882904
J,"Aein, A1;  Lamyian, M;  Maasoumi, R",,,,"Aein, Afsaneh; Lamyian, Minoor; Maasoumi, Raziyeh",,,THE COMPARISON OF BSE PERFORMANCE IN GRADUATE STUDENTS (HUMANITARIAN SCIENCES AND ENGINEERING) USING SMS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,breast cancer; breast self-examination (BSE); SMS; female students,,"SMS is the simplest and most cost-effective method of promoting knowledge of how to prevent diseases and face them in a healthy manner used by the public in educational programs regarding health. In this study, the performance of Breast Self-Examination (BSE) using SMS is investigated in female students majoring in engineering and humanitarian sciences of Tarbiat Modarres University (2013). For this purpose, 108 individuals aged 22-30 were selected into two groups using random cluster sampling. The educational program was compiled using information from pre-test and after determining public educational requirements regarding research. The two groups were then tested simultaneously and the posttest (3 months after training) was taken. The data were then analyzed on a significant level (P<0.005) using SPSS20 software and statistical parametrical (t-pair) and non-parametrical test (chi-square). The t-test results indicated that compared with pre-education phase, both groups had significant differences in average score of knowledge, attitude, and performance regarding BSE (P <= 0.001). The results also showed that knowledge, attitude, and performance of breast cancer and how BSE was performed through SMS was higher in student of humanitarian sciences compared to engineering students (P <= 0.001).","[Aein, Afsaneh] Tarbiat Modares Univ, Fac Med Sci, Dept Hlth Educ & Hlth Promot, Tehran, Iran; [Lamyian, Minoor] Tarbiat Modares Univ, Fac Med Sci, Dept Reprod Hlth & Midwifery, Tehran, Iran; [Maasoumi, Raziyeh] Univ Tehran Med Sci, Fac Nursing & Midwifery, Dept Reprod Hlth, Tehran, Iran","Aein, A (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Hlth Educ & Hlth Promot, Tehran, Iran.",a.aein@modares.ac.ir,"Maasoumi, Raziyeh/I-9512-2017","Lamyian, minoor/0000-0001-7033-5605",,,"Abedi G., 2014, J MAZANDARAN U MED S, V24, P18; Abedi G, 2012, HEALTHMED, V6, P12; Aein A, 2014, HLTH ED HLTH PROMOT, V1, P5; Aein A, 2013, CURRENT RES J BIOL S, V6, P13; Asadi A. H, 2011, DIGITAL HLTH MEDI; Asgarabard A Ashrafi, 2012, J HLTH DEV KERMAN ; FARZIANPOUR F, 2014, AM J AGR BIOL SCI, V9, P147, DOI DOI 10.3844/AJAB-SSP.2014.147.15; Fayazi S, 2013, JENTASHAPIER ; Firoozeh F, 2010, QOM U MED SCI PUBLIC, V4, P2; Hashemian M, 2012, WOMEN MIDWIFERY  FEB, V15, P1; Izadi K, 1988, RES METHODOLOG; Karimi M, 2008, ZAHEDAN TABIB SHARG, V10, P28; Kashfi SM, 2012, JAHROM U MED SCI SP; Mashfegi K, 2010, DANESHVAR 2 MONT JAN, P9; Nezhad F Sadegh, 2001, THESIS, P7; Shahvari Z, 2006, IRANIAN NURSERY PUBL, V19, P4",16,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1187.0,1194,,,,8,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200001,,,,,2022-07-14,0.001652892561983471,1.167875277713683e-11,0.03769453307933996,0.10738255033557047,0.036320520608671726
J,"Aksoy, A1;  Durak, S;  Ozturk, T;  Avci, N;  Cirak, Y;  Deger, AN;  Bilgic, Y;  Koca, SS;  Ozcan, M;  Goktas, S;  Bozdag, A",,,,"Aksoy, Asude; Durak, Serdar; Ozturk, Turkan; Avci, Nilufer; Cirak, Yalcin; Deger, Ayse Nur; Bilgic, Yilmaz; Koca, Suleyman Serdar; Ozcan, Mete; Goktas, Sevil; Bozdag, Ahmet",,,THE ALBUMIN-GLOBULIN RATIO PREDICTING MORTALITY IN GASTRIC CARCINOMA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Albumin-globulin ratio; albumin; gastric carcinoma; predictive; survival,GLASGOW PROGNOSTIC SCORE; LONG-TERM MORTALITY; CARCINOEMBRYONIC ANTIGEN; HEPATOCELLULAR-CARCINOMA; CURATIVE RESECTION; NUTRITIONAL-STATUS; CA 72-4; SURVIVAL; CANCER; INFLAMMATION,"Introduction: The potential effects of serum albumin and albumin-globulin rate on survival were investigated in patients with gastric carcinoma. Materials and methods: The biochemical values of 204 patients under chemotherapy evaluation were obtained retrospectively from archive data. Albumin-globulin ratio values were calculated using albumin/total protein-albumin formula. The values of albumin-globulin ratio and albumin were categorized as 3 groups using receiver operating characteristic analysis and a descending order. Results: The calculated cut-off value for albumin-globulin ratio was 1.14: 34.4-79.7 by receiver operating characteristic. The median survival was 20.7 months (15.9-25.5), 20.1 months (15.1-25.1), 16 months (11.8-20.1), respectively in 1st, 2nd, 3rd groups for albumin-globulin ratio (p=0.46). The median overall survival was 18.3 months (123-24.2), 21.6 months (16.8-26.3), 18.01 months (13.5-22.4) in 1st, 2nd, 3rd groups for albumin, respectively (p=0.52). There were no statistical significant differences by Kaplan-Meier method for albumin-globulin ratio, albumin p>0.05. The effects of clinicopathological and biochemical characteristics on mortality were assessed by Cox-proportional hazard regression analysis. The independent predictors of mortality were observed high grade, the presence of perineural invasion of the tumor, high nodal involvement (p:0.01, p:0.001, p:0.01), respectively. Conclusion: Albumin-globulin ratio and albumin values alone may not be useful parameters to predict mortality and survival in patients with gastric carcinoma.","[Aksoy, Asude] Firat Univ, Fac Med, Med Oncol, Elazig, Turkey; [Durak, Serdar; Koca, Suleyman Serdar] Firat Univ, Med Fac Internal Med, Elazig, Turkey; [Ozturk, Turkan] Karadeniz Tech Univ, Fac Med, Med Oncol, Trabzon, Turkey; [Avci, Nilufer] Bursa Ali Osman Sonmez Oncol Hosp, Med Oncol, Bursa, Turkey; [Cirak, Yalcin] Istanbul Bahcesehir Univ, Fac Med, Med Oncol, Istanbul, Turkey; [Deger, Ayse Nur] Dumlupinar Univ, Fac Med, Pathol, Kutahya, Turkey; [Bilgic, Yilmaz] Inonu Univ, Fac Med, Gastroenterol, Malatya, Turkey; [Ozcan, Mete] Firat Univ, Fac Med, Biophys, Malatya, Turkey; [Goktas, Sevil] Denizli State Hosp, Med Oncol, Denizli, Turkey; [Bozdag, Ahmet] Elazig Educ & Res Hosp, Gen Surg, Elazig, Turkey","Aksoy, A (corresponding author), Firat Univ, Fac Med, Med Oncol, Elazig, Turkey.",,"Bozdag, Ahmet/C-6418-2018; bilgic, yÄ±lmaz/ABI-6432-2020; Ozcan, Mete/V-8758-2018","Bozdag, Ahmet/0000-0003-1973-2511; bilgic, yÄ±lmaz/0000-0002-2169-5548; Ozcan, Mete/0000-0002-5551-4880; aksoy, asude/0000-0002-5609-9658; Durak, Serdar/0000-0002-8175-9611",,,"Alici S, 2006, MED SCI MONITOR, V12, pCR22; Azab B, 2014, CANCER BIOMARK, V14, P303, DOI 10.3233/CBM-14041; Azab BN, 2013, AM J SURG, V206, P764, DOI 10.1016/j.amjsurg.2013.03.00; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_; Chen K, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-18; Das Undurti N., 2014, AM J SURG, V208, P15; Di Fiore F, 2007, AM J GASTROENTEROL, V102, P2557, DOI 10.1111/j.1572-0241.2007.01437.; Dixon MR, 2003, ARCH SURG-CHICAGO, V138, P962, DOI 10.1001/archsurg.138.9.96; Du XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.009447; Duran AO, 2014, ASIAN PAC J CANCER P, V15, P6449, DOI 10.7314/APJCP.2014.15.15.644; Farhan-Alanie OM, 2015, BRIT J ORAL MAX SURG, V53, P126, DOI 10.1016/j.bjoms.2014.10.00; Forones NM, 2001, HEPATO-GASTROENTEROL, V48, P119; Gao YY, 2014, J CANCER RES THER, V10, P799, DOI 10.4103/0973-1482.14605; Gaspar MJ, 2001, TUMOR BIOL, V22, P318, DOI 10.1159/00005063; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-; Gospodarowicz M, 2001, CANCER, V91, P186; Kanat O, 2013, TUMORI J, V99, P229, DOI 10.1700/1283.1419; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.161; Koike Y, 2003, HEPATO-GASTROENTEROL, V50, P203; Li QQ, 2014, ASIAN PAC J CANCER P, V15, P945, DOI 10.7314/APJCP.2014.15.2.94; Liu XC, 2015, TRANSL ONCOL, V8, P339, DOI 10.1016/j.tranon.2015.06.00; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a790; Okamura T, 2004, J CLIN EPIDEMIOL, V57, P1188, DOI 10.1016/j.jclinepi.2004.02.01; Onate-Ocana L F, 1999, Rev Gastroenterol Mex, V64, P11; Ray P, 1998, CANCER DETECT PREV, V22, P293, DOI 10.1046/j.1525-1500.1998.CDOA43.; Ryu JW, 2003, J KOREAN MED SCI, V18, P505, DOI 10.3346/jkms.2003.18.4.50; Shimada H, 2003, J SURG ONCOL, V83, P248, DOI 10.1002/jso.1027; Tateishi R, 2005, GUT, V54, P419, DOI 10.1136/gut.2003.03505; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.2126; WOBBES T, 1992, CANCER, V69, P2036, DOI 10.1002/1097-0142(19920415)69:8<2036::AID-CNCR2820690805>3.0.CO;2-",30,3,3,2,14,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,707.0,712,,10.19193/0393-6384_2016_3_78,,6,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400007,,,,,2022-07-14,0.003202479338842975,1.877520223674976e-08,0.10059064250867845,0.1325137921121439,0.10272763988628984
J,"Alavci, O1;  Balci, UG;  Korkmaz, H;  Kilicaslan, B;  Ongel, K",,,,"Alavci, Ozgur; Balci, Umut Gok; Korkmaz, Hasret; Kilicaslan, Baris; Ongel, Kurtulus",,,LEVELS OF ANXIETY SYMPTOMS AND RELATED FACTORS AMONG CARDIOLOGY CLINIC PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Anxiety levels; cardiovascular disease; hamilton anxiety scale,CHRONIC HEART-FAILURE; DEPRESSION; DISORDER; COMORBIDITY; ASSOCIATION; MORTALITY; DISEASE; WOMEN,"Background: The aim of this study is to determine level of anxiety symptoms of patients who were admitted to cardiology clinics and to understand the distribution of symptoms and to research the related factors. Methods: This is a basic, sectional and descriptive study. Stationary population of this study was patients who were admitted to cardiology inpatient and outpatient clinics of Tepecik Educational and Research Hospital between 01.06.2013 and 31.07.2013. A socio-demographic questionnaire and the Turkish version of Hamilton Anxiety Scale (HAS) were given to patients by interviewer. Results: In the study, there were 101 participants aged between 18-65.61 participants (60.4%) were admitted to outpatient clinic and 40 participants (39.6%) were admitted to inpatient clinic. 79.2% of participants in the study had ischemic heart disease. The mean of HAS scores of the participants was 10.28 +/- 6.21 (min:0, max:26). 27 participants (26.7%) had no anxiety. 49 (485%) participants had mild anxiety and 25 (24.8%) participants had severe anxiety. As for gender, the anxiety average score of the male patients was statistically lower than those of the female patients (p<0.05). When it comes to family history of the psychiatric disease, the anxiety levels of the patients showed a statistical significance (p<0.05). As to drug use, the difference was statistically significant between the groups (p<0.05). The anxiety average score of the patients who have a healthy nutritional status was statistically lower (p<0.05). Conclusion: For the patients diagnosed with anxiety, doctors must be aware of the risk factors like gender, family history of psychiatric disease, drug use and nutritional status.","[Alavci, Ozgur; Balci, Umut Gok] Izmir Tepecik Res & Training Hosp, Dept Family Med, Izmir, Turkey; [Korkmaz, Hasret] Bayram Dist Govt Hosp, Family Med Polyclin, Canakkale, Turkey; [Kilicaslan, Baris] Izmir Tepecik Res & Training Hosp, Dept Cardiol, Izmir, Turkey; [Ongel, Kurtulus] Izmir Katip Celebi Univ, Dept Family Med, Izmir, Turkey","Ongel, K (corresponding author), Katip Celebi Univ, Family Med, Izmir, Turkey.",,,,,,"Australian Bureau of Statistics, 2007, NAT SURV MENT HLTH ; Carney RM, 1999, PSYCHOSOM MED, V61, P666, DOI 10.1097/00006842-199909000-0000; Ekman I, 2000, SCAND J CARING SCI, V14, P130, DOI 10.1080/0283931005016236; Franklin JE, 1996, TXB CONSULTATION LIA, P42; Jespersen L, 2013, CLIN RES CARDIOL, V102, P571, DOI 10.1007/s00392-013-0568-; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P27; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-3540; LEWINSOHN PM, 1993, J ABNORM PSYCHOL, V102, P133, DOI 10.1037/0021-843X.102.1.13; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.135; Mergen H, 2012, SMYRNA TIP DERGISI, V2, P2; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-; Nguyen Sun B, 2009, Congest Heart Fail, V15, P31, DOI 10.1111/j.1751-7133.2008.00046.; Nordgren L, 2007, QUAL HEALTH RES, V17, P4, DOI 10.1177/104973230629638; Ozmen E, 2005, ANADOLU PSIKIYATRI D, V6, P8; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P251; Somberg TC, 2008, CARDIOLOGY, V111, P75, DOI 10.1159/00011969; Vidovich MI, 2009, CARDIOVASC PSYCHIAT, V200; Vural Mutlu, 2006, Anadolu Kardiyol Derg, V6, P5; Wang GF, 2013, PSYCHOSOM MED, V75, P530, DOI 10.1097/PSY.0b013e318298431; YANOVSKI SZ, 1993, AM J PSYCHIAT, V150, P147; Yonkers KA, 1998, AM J PSYCHIAT, V155, P596, DOI 10.1176/ajp.155.5.59; Zambroski Cheryl Hoyt, 2005, Eur J Cardiovasc Nurs, V4, P198, DOI 10.1016/j.ejcnurse.2005.03.01",22,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,213.0,216,,,,4,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700033,,,,,2022-07-14,0.0022727272727272726,1.1693072805911943e-11,0.004334360236312917,0.10198598746246641,0.004334360236312917
J,"Alidadi, A1;  Ameryoun, A;  Zarbizadeh, A;  Moghim, N",,,,"Alidadi, Abuozar; Ameryoun, Ahmad; Zarbizadeh, Arman; Moghim, Navid",,,HEALTH FACTORS AND CHALLENGES AND PREVENTION IN IRAN'S HEALTH TRANSFORMATION PLAN AND PROPOSAL OF SOLUTION FROM THE PERSPECTIVE OF CRITICS: A QUALITATIVE STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,challenges and threats; health transformation plan; health and prevention; self-care; qualitative study,,"Introduction and objectives: Due to its extensive and effective functions, the role of self-care and special attention to non-medical expectations cause an increase in people's expectation of security provision and enhancement, quality and justice, and pressure to establish a responsive health system. With a focus on health and spending abundant resources in treatment and equipping hospitals, in practice health transformation plan has minimized attention in the field of health and prevention. Therefore, the present study was aimed at identifying health and prevention challenges and threats in the health transformation plan. Materials and methods: The present study was a qualitative one in which a non-random purposive sampling was employed in order to select scholars in the field of health in the academic year of 2014-2015. The required data were collected through semi-structured interviews and then analyzed by a content analysis method using MAXQDA 11.0. Results: After the collected data were analyzed, 296 themes were obtained which were encoded through 2 categories of challenges and solutions, and the items led to the formation of 87 primary coded, 8 categories, and 2 themes of factors and challenges and improvement solutions. Discussion and conclusion: The results of the study can be used as an appropriate solution for policymakers and planners in order to enhance the quality of health services according to the country's twenty-year outlook aimed at specifying the features of the Iranian healthy society, an important part of which is the possession of healthy life with appropriate quality and healthy environment which is aimed to be achieved in the second phase of the health system transformation plan and provide necessary requirements to obtain the first place in economy, science, and technology in the region.","[Alidadi, Abuozar; Moghim, Navid] Baqiyatalla Univ Med Sci, Hlth Sch, Dept Hlth Serv Management, Tehran, Iran; [Ameryoun, Ahmad] Baqiyatallah Univ Med Sci, Hlth Management Res Ctr, Hlth Serv Management, Tehran, Iran; [Zarbizadeh, Arman] Baqiyatallah Univ Med Sci, Sch Nursing, Dept Hlth, Community Hlth Nursing, Tehran, Iran","Ameryoun, A (corresponding author), Baqiyatallah Univ Med Sci, Hlth Management Res Ctr, Hlth Serv Management, Tehran, Iran.",ad_amer_heli@yahoo.com,,"ameryoun, ahmad/0000-0003-1261-1493",,,"Abedi G, 2012, INT J COLLAB RES INT, V4, P180; Abedi G, 2012, INT J COLLAB RES INT, V4, P10; Abedi G, 2012, HEALTHMED, V6, P12; Aghazadeh S, 2012, J BASIC APPL SCI RES, V2, P303; Akhondzade, 2014, J ANESTHESIOLOGY PAI, V5, P; [Anonymous], 2011, SHORAYE ALIYEH ENGH; Asgar M, 2015, INT C SUST DEV HLT; Atella V, 2015, CHINA EC RE; Farazi S, 2015, INT C SUST DEV HLTH, P2; Haghdoost A, 2013, HAKIM RES J, V16, P17; Hashemi B, 2015, J EMERG MED, V2, P; Jabbari A, 2015, INT C SUST DEV HLT; Mahdian S, 2015, INT C SUST DEV HLT; Mpofu E, 2014, PRACTICES DISCIPLINE, P11; Pourabbasi A, 2015, IJME, V15, P6; Raeisi AR, 2015, INT C SUST DEV HLT; Shahri S, 2015, INT C SUST DEV HLT; Sharifi V., 2004, NEW TITLES COGNITIVE, V5, P10; Shojaeizadeh N, 2015, INT C SUST DEV HLT; Taherian H, 2015, INT C SUST DEV HLT; Zarei Ehsan, 2014, Glob J Health Sci, V7, P1, DOI 10.5539/gjhs.v7n1p",21,1,1,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1195.0,1202,,,,8,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200002,,,,,2022-07-14,0.0021694214876033058,2.3314516222401034e-11,0.03788497195347125,0.10805380365016465,0.039614498706924614
J,"Antonino, A1;  Giorgio, R;  Juliana, DL;  Giuseppe, A;  Roberto, C;  Laura, V;  Giuseppe, D;  Vincenzo, S;  Leonardo, G;  Massimo, G;  Pasquale, M;  Gaspare, G",,,,"Antonino, Agrusa; Giorgio, Romano; Juliana, Dominguez Ligia; Giuseppe, Amato; Roberto, Citarrella; Laura, Vernuccio; Giuseppe, Di Buono; Vincenzo, Sorce; Leonardo, Gulotta; Massimo, Galia; Pasquale, Mansueto; Gaspare, Gulotta",,,ADRENAL CAVERNOUS HEMANGIOMA: WHICH CORRECT DECISION MAKING PROCESS?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,adrenal hemangioma; adrenal cavernous hemangioma; laparoscopic adrenalectomy; laparoscopy; laparoscopic surgery; adrenal surgery,LAPAROSCOPIC ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; GLAND; HEMANGIOENDOTHELIOMA,"Introduction: Cavernous hemangioma of the adrenal gland is a rare benign tumor characterized by the presence of blood-filled, dilated vascular spaces. These adrenal masses are usually non-functioning and the patients have no symptoms so the diagnosis is incidental. Methods: We performed a systematic literature review for all articles published until April 2015. The initial search identified 98 publications. We considered some characteristics: the mean age of the patients at diagnosis was 59 years (range 19 - 84); there were approximately 1.7 times more female patients than male patients; mean diameter of the lesions was 10.3 cm (range 2 - 25). Surgical treatment was more often open with midline or subcostal Results: From literature analysis we know that small adrenal hemangiomas are usually asymptomatic. Only four patients in our literature review show endocrinologic disturbances with three cases of subclinical Cushing's syndrome and a case of hyperaldosteronism. The pre-operative radiologic features play a fundamental role for correct surgical approach. On enhanced Computed Tomography (CT) scan adrenal hemangiomas tend to be heterogeneous, hypodense lesions with high-density rim of tissue at the periphery. On Magnetic Resonance Imaging (MRI) common findings associated with adrenal hemangiomas are hypointense inhomogeneous masses with central hyperintensity on T1 images and a high intensity peripheral rim on T2 images due to hemorrhage or necrosis. Conclusion: Laparoscopic adrenalectomy is considered the standard treatment in case of benign lesions. Some authors suggest that the main limitation during laparoscopic dissection for large and potentially malign adrenal tumors is incomplete resection and capsular disruption with increased risk of local recurrence and intra-abdominal neoplastic dissemination. We recommend for these patients an integrated multidisciplinary approach that considers endocrine studies, preoperative radiologic findings and the experience of surgical team.","[Antonino, Agrusa; Giorgio, Romano; Giuseppe, Amato; Giuseppe, Di Buono; Vincenzo, Sorce; Leonardo, Gulotta; Gaspare, Gulotta] Univ Palermo, Dept Gen Surg Urgency & Organ Transplantat, I-90133 Palermo, Italy; [Juliana, Dominguez Ligia; Laura, Vernuccio; Pasquale, Mansueto] Univ Palermo, Geriatr Unit, Dept Clin Med & Emerging Dis, I-90133 Palermo, Italy; [Roberto, Citarrella] Univ Palermo, Dept Expt Biomed & Clin Neurosci, I-90133 Palermo, Italy; [Massimo, Galia] Univ Palermo, Sect Radiol DiBiMeF, I-90133 Palermo, Italy","Antonino, A (corresponding author), Univ Palermo, Dept Gen Surg Urgency & Organ Transplantat, I-90133 Palermo, Italy.",,"Di Buono, Giuseppe/AAJ-6311-2020","Amato, Giuseppe/0000-0002-1352-9291; Sorce, Vincenzo/0000-0002-4948-9383",,,"AFTALION B, 1988, J REPROD MED, V33, P32; Agrusa A, 2015, INT J SURG CASE REP, V16, P150, DOI 10.1016/j.ijscr.2015.09.04; Agrusa A, 2014, INT J SURG, V12, pS72, DOI 10.1016/j.ijsu.2014.05.05; Agrusa A, 2012, G CHIR, V33, P40; Agrusa A, 2015, SURG ENDOS; Agrusa A, 2016, INT J SURG, V28, pS114, DOI 10.1016/j.ijsu.2015.12.05; Agrusa A, 2014, INT J SURG, V12, pS37, DOI 10.1016/j.ijsu.2014.08.38; Agrusa A, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-3; Agrusa A, 2014, INT J SURG CASE REP, V5, P70, DOI 10.1016/j.ijscr.2013.12.02; [Anonymous], 2002, NIH CONSENS STATE SC, V19, P; Benassai G, 2014, INT J SURG, V12, pS22, DOI 10.1016/j.ijsu.2014.05.03; Bozkurt O, 2015, UROLOGY, V85, pE15, DOI 10.1016/j.urology.2014.12.01; Conzo G, 2013, INT J SURG, V11, P152, DOI 10.1016/j.ijsu.2012.12.00; Conzo G, 2012, ANN ITAL CHIR, V83, P43; Edwards JP, 2014, INT J SURG CASE REP, V5, P52, DOI 10.1016/j.ijscr.2013.11.00; Fernandez Ruiz M, 1995, ARCH ESP UROL, V48, P8; Forbes TL, 2005, CAN J SURG, V48, P7; Rebollo CG, 2013, ARCH ESP UROL, V66, P31; HAMRICKTURNER JE, 1994, MAGN RESON IMAGING, V12, P1263, DOI 10.1016/0730-725X(94)90091-; Hazzan D, 2001, SURG ENDOSC-ULTRAS, V15, P1356, DOI 10.1007/s00464008005; JOHNSON C C, 1955, J Urol, V74, P57; Kieger AJ, 2011, J UROLOGY, V186, P2415, DOI 10.1016/j.juro.2011.09.06; Lombardi CP, 2012, SURGERY, V152, P1158, DOI 10.1016/j.surg.2012.08.01; Lorenzon L, 2013, ANN ITAL CHIR, V84, P69; NAKAGAWA N, 1986, CLIN RADIOL, V37, P97, DOI 10.1016/S0009-9260(86)80185-; Ng Alvin Choong Meng, 2008, Endocr Pract, V14, P10; Noh JJ, 2014, J PANCREAS, V15, P254, DOI 10.6092/1590-8577/240; Novo G, 2011, INT ANGIOL, V30, P24; Oishi M, 2012, SURG TODAY, V42, P973, DOI 10.1007/s00595-012-0203-; Paluszkiewicz P, 2010, ARCH MED SCI, V6, P122, DOI 10.5114/aoms.2010.1351; Pisano G, 2013, ANN ITAL CHIR, V8; Quildrian SD, 2013, INT J SURG CASE REP, V4, P219, DOI 10.1016/j.ijscr.2012.11.02; Romano G, 2013, G CHIR, V34, P180, DOI 10.11138/gchir/2013.34.5.18; Romano G., 2014, MINERVA CHIR, V69, P12; Romano G, 2006, G CHIR, V27, P22; Stumvoll M, 1996, J UROLOGY, V155, P638, DOI 10.1016/S0022-5347(01)66473-; Telem DA, 2009, JSLS-J SOC LAPAROEND, V13, P26; Terzolo M, 2011, EUR J ENDOCRINOL, V164, P851, DOI 10.1530/EJE-10-114; Todorov G, 2007, Khirurgiia (Sofiia), P5; Yagisawa T, 2001, INT J UROL, V8, P457, DOI 10.1046/j.1442-2042.2001.00352.",40,18,18,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,2.0,,,,,385.0,389,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QQ,WOS:000375338000018,,,,,2022-07-14,0.0040289256198347105,3.201841901629723e-05,0.007836233167315455,0.09086215797625194,0.007836233167315455
J,"Aras, D1;  Ewert, AW",,,,"Aras, Dicle; Ewert, Alan W.",,,THE EFFECTS OF EIGHT WEEKS SPORT ROCK CLIMBING TRAINING ON ANXIETY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Sport rock climbing; cognitive anxiety; somatic anxiety; self-confidence,QUALITY-OF-LIFE; PLASMA-CORTISOL CONCENTRATIONS; ON-SIGHT LEAD; PHYSICAL-ACTIVITY; PERCEIVED ANXIETY; PSYCHOLOGICAL RESPONSES; PSYCHIATRIC-DISORDERS; BODY-COMPOSITION; SEDENTARY WOMEN; CANCER-PATIENTS,"Regular physical activity can be an efficient method for prevention for anxiety. The purpose of the study is to examine the effects of 8 weeks of sport rock climbing (SRC) training on anxiety in healthy sedentary adults. A total number of nineteen students participated in this study voluntarily composing of a control group (CG, n=10, age 21.90 +/- 1.66 years, height 168.50 +/- 4.40 cm, weight 61.18 +/- 7.08 kg) and an experimental group (EG, n=9, age 21.11 +/- 2.31 years, height 167.33 +/- 6.44 cm, weight 59.31 +/- 8.39 kg). After the EG had been taught basic climbing and rope techniques, body composition and aerobic power measurements were taken for both groups. The EG engaged in climbing training by using a top-rope method for 60 minutes a day with an intensity level of 70 % of HR reserve, three days a week for eight weeks. The CG did not engage in any systematic physical activity program during the study. The Competitive Sport Anxiety Inventory-2 (CSAI-2) was given to participants twice. The EG completed the Inventory 20 minutes before the first and the last climbing trial. The CG completed the Inventories on first and last day of 8 weeks period. The results indicated significant changes in all CSAI-2 results for EG, including cognitive (p_=_0.002) and somatic anxiety (p_=_0.032) reduced, self-confidence (p_=_0.001) increased. This current study is one of the first research efforts examining the psychological effects of eight weeks SRC training. Results demonstrated that eight weeks of SRC training significantly reduces cognitive and somatic anxiety and increases self-confidence. In addition to the psychological effects, eight weeks of SRC training also improved the VO2max of participants. This study suggests that SRC can be useful as a regular physical activity in controlling and improving anxiety in the study sample.","[Aras, Dicle] Ankara Univ, Fac Sport Sci, TR-06100 Ankara, Turkey; [Ewert, Alan W.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA","Aras, D (corresponding author), Ankara Univ, Fac Sport Sci, TR-06100 Ankara, Turkey.",,"Aras, Dicle/A-7301-2018","Aras, Dicle/0000-0002-9443-9860",,,"Aidar FJ, 2012, STROKE RES TREAT, V2012, P; Fernandez EMA, 2007, PSICOTHEMA, V19, P15; [Anonymous], 1989, OUTDOOR ADVENTURE P; Aras D, 2014, J SPORT MED PHYS FIT, V54, P; Arazi H, 2012, ACTA KINESIOL, V6, P; Asmundson GJG, 2013, DEPRESS ANXIETY, V30, P362, DOI 10.1002/da.2204; Camacho TC, 1996, AM J EPIDEMIOL, V13, P22; Carraro A, 2012, RES DEV DISABIL, V33, P1221, DOI 10.1016/j.ridd.2012.02.01; de Lima C, 2012, INT J SPORTS MED, V33, P723, DOI 10.1055/s-0032-130632; Dickson T, 2012, SPORTS TECHNOL, V5, P; Draper N, 2012, INT J SPORTS MED, V33, P13, DOI 10.1055/s-0031-128434; Draper N, 2008, J SPORT SCI MED, V7, P49; Draper N, 2010, EUR J SPORT SCI, V10, P13, DOI 10.1080/1746139090310812; DuPont RL, 1996, ANXIETY, V2, P167, DOI 10.1002/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-; Ehrman JK, 2010, ACSMS RESOURCE MANU; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.230; Fourie M, 2013, W INDIAN MED J, V62, P524, DOI 10.7727/wimj.2012.10; Freitas P. Duarte, 2011, Annals of Physical and Rehabilitation Medicine, V54, P132, DOI 10.1016/j.rehab.2011.02.00; Fryer S, 2013, SCAND J MED SCI SPOR, V23, P645, DOI 10.1111/j.1600-0838.2011.01432.; Goodin BR, 2009, PSYCHOSOM MED, V71, P1018, DOI 10.1097/PSY.0b013e3181bc62b; Gould D., 1982, J SPORT BEHAV, V5, P15; Guszkowska M., 2009, HUMAN MOVEMENT, V10, P163, DOI DOI 10.2478/V10038-009-0014-; Hardy L, 2007, ANXIETY STRESS COPIN, V20, P147, DOI 10.1080/1061580070121703; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649; Hazelrigs J, 2009, ROCK CLIMBING OUTDO; Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.53; Hodgson CI, 2009, BRIT J SPORT MED, V43, P531, DOI 10.1136/bjsm.2007.04601; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-09128; Jayakody R, 1998, SOC SCI RES, V27, P371, DOI 10.1006/ssre.1997.061; Judd LL, 1997, ARCH GEN PSYCHIAT, V54, P98; KESSLER RC, 1995, AM J PSYCHIAT, V152, P102; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.59; KHADEMI AR, 2012, ADV ENVIRON BIOL, V6, P222; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM19990909341110; Llewellyn DJ, 2008, PERS INDIV DIFFER, V45, P75, DOI 10.1016/j.paid.2008.03.00; Lokos D., 2013, COGN BRAIN BEHAV, V17, P27; Lundqvist C, 2005, J SPORT SCI, V23, P727, DOI 10.1080/0264041040002148; Martens R, 1990, COMPETITIVE ANXIET; Martines F, 2015, EUR ARCH OTO-RHINO-L, V272, P2719, DOI 10.1007/s00405-014-3275-; McWilliams LA, 2001, J ANXIETY DISORD, V15, P161, DOI 10.1016/S0887-6185(01)00056-; Mehnert A, 2011, ONKOLOGIE, V34, P248, DOI 10.1159/00032781; Morrison AB, 2007, BRIT J SPORT MED, V41, P852, DOI [10.1136/bjsm.2007.034827, 10.1136/bjsm.2006.034827; Mystakidou K, 2005, QUAL LIFE RES, V14, P1825, DOI 10.1007/s11136-005-4324-; Nieuwenhuys A, 2008, J SPORT EXERCISE PSY, V30, P171, DOI 10.1123/jsep.30.2.17; Nikseresht M, 2014, J STRENGTH COND RES, V28, P2560, DOI 10.1519/JSC.000000000000044; O'Connor PJ, 2000, INT J SPORT PSYCHOL, V31, P13; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.; Paoli A, 2015, IRAN J PUBLIC HEALTH, V44, P60; Perpina-Galvan J, 2009, AM J CRIT CARE, V18, P571, DOI 10.4037/ajcc200968; PETRUZZELLO SJ, 1991, SPORTS MED, V11, P143, DOI 10.2165/00007256-199111030-0000; Schoffl V, 2010, SPORTS MED, V40, P657, DOI 10.2165/11533690-000000000-0000; Sekendiz B, 2010, J STRENGTH COND RES, V24, P3032, DOI 10.1519/JSC.0b013e3181d82e7; Shaw W. D., 1996, Agricultural and Resource Economics Review, V25, P13; Smith MM, 2013, J STRENGTH COND RES, V27, P3159, DOI 10.1519/JSC.0b013e318289e59; SMITH RE, 1991, BEHAV THER, V22, P329, DOI 10.1016/S0005-7894(05)80370-; Smits JAJ, 2006, DEPRESS ANXIETY, V23, P102, DOI 10.1002/da.2014; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.151; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-; Tekur P, 2012, COMPLEMENT THER MED, V20, P107, DOI 10.1016/j.ctim.2011.12.00; Thompson W., 2010, ACSMS RESOURCES PER; van Wijk CH, 2014, INT J OCCUP MED ENV, V27, P959, DOI 10.2478/s13382-014-0321-; Vancampfort D, 2011, SCHIZOPHR RES, V129, P122, DOI 10.1016/j.schres.2011.03.01; Vogelsang TW, 2008, SCAND J MED SCI SPOR, V18, P354, DOI 10.1111/j.1600-0838.2007.00706.; Wenger N K, 1995, Clin Pract Guidel Quick Ref Guide Clin, P; Wipfli B, 2011, SCAND J MED SCI SPOR, V21, P474, DOI 10.1111/j.1600-0838.2009.01049.; Wipfli BM, 2008, J SPORT EXERCISE PSY, V30, P392, DOI 10.1123/jsep.30.4.39; Woodman T, 2003, J SPORT SCI, V21, P443, DOI 10.1080/026404103100010180; Zintl F, 1979, FELSKLETTERN ALPIN ",68,13,13,0,24,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,223.0,230,,,,8,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700035,,,,,2022-07-14,0.007128099173553719,4.1597193944e-08,0.05561085028810371,0.1303615918119992,0.054687980201884825
J,"Arslan, A1;  Tuzun, FA;  Tamer, S;  Demir, H;  Aycan, A;  Demir, C;  Tasin, M;  Gonullu, E",,,,"Arslan, Ayse; Tuzun, Fatma Aykan; Tamer, Sibel; Demir, Halit; Aycan, Abdurrahman; Demir, Canan; Tasin, Muhterem; Gonullu, Edip",,,"CHANGE OF ANTIOXIDANT ENZYME ACTIVITIES, SOME METALS AND LIPID PEROXIDATION IN ALZHEIMER'S DISEASE",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Alzheimer's Disease; Antioxidants; Serum Metals; Heavy Metals; Lipid peroxidation,MILD COGNITIVE IMPAIRMENT; GLUTATHIONE S-TRANSFERASES; OXIDATIVE STRESS MARKERS; SUPEROXIDE-DISMUTASE; CEREBROSPINAL-FLUID; DNA-DAMAGE; PLASMA; ZINC; METALLOBIOLOGY; PROTECTION,"Introduction: Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive regression and memory loss. It has been claimed that oxidative stress and factors such as metal accumulation in the brain play important roles in the etiopathogenesis of the disease. Material and methods: The subjects of this study consisted of 24 individuals with Alzheimer's disease and 15 healthy agematched controls. Blood samples were withdrawn from the patients and healthy controls, and the activities of antioxidant enzymes SOD (Superoxide Dismutase), GSH (Glutathion), GSHPx (Glutathion peroxidase), GST (Glutathion S-Transferase) and MDA (Malondialdehyde) levels were determined by Spectrometer. Some metals and heavy metals were measured by atomic absorption spectrometry (AAS). Results: Biochemical analyses showed a significant decrease of the main enzymatic antioxidant defences (SOD, GSH, GST and GSHPx) and increased production of lipid peroxidation marker (MDA) in the serum of AD patients, compared to age-matched control group (p< 0.001). Also the levels of Zn, Mg, and Mn was lower and Fe, Pb, and Cd was higher in the patient group, compared to the control group. Serum Cu and Co levels did not differ significantly between the patient and control groups (p> 0.001). Conclusion: These results supports the theory that in AD there is a defect in the antioxidant defense system, which may lead to oxidative damage. Also alterations in some trace metals and their related enzymes may play a role of etiopathogenesis in AD.","[Arslan, Ayse; Demir, Halit] Yuzuncu Yil Univ, Dept Biochem, Fac Sci, Van, Turkey; [Tuzun, Fatma Aykan] Private Kocaeli Hosp Ctr, Dept Neurol, Kocaeli, Turkey; [Tamer, Sibel] Private Sincan Koru Hosp, Dept Neurol, Ankara, Turkey; [Aycan, Abdurrahman] Yuzuncu Yil Univ, Dursun Odabasi Res Hosp, Deparment Brain Surg, Van, Turkey; [Demir, Canan] Yuzuncu Yil Univ, Vocat Sch Hlth Serv, Van, Turkey; [Tasin, Muhterem] Dicle Univ, Dept Neurol, Diyarbakir, Turkey; [Gonullu, Edip] Training & Res Hosp, Dept Anesthesia, Van, Turkey","Arslan, A (corresponding author), Yuzuncu Yil Univ, Dept Biochem, Fac Sci, Tusba, Van, Turkey.",,"GÃ¶nÃ¼llÃ¼, Edip/AAV-7377-2021","GÃ¶nÃ¼llÃ¼, Edip/0000-0002-7751-3758",,,"Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-; AMBROSIO G, 1991, J CLIN INVEST, V87, P2056, DOI 10.1172/JCI11523; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af; Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P65; Barbagallo M, 2011, MAGNESIUM RES, V24, pS115, DOI 10.1684/mrh.2011.028; BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P23; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.54; Bocca Beatrice, 2005, Ann Ist Super Sanita, V41, P19; Bourdel-Marchasson I, 2001, AGE AGEING, V30, P235, DOI 10.1093/ageing/30.3.23; BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-; Bush AI, 2003, ALZ DIS ASSOC DIS, V17, P147, DOI 10.1097/00002093-200307000-0000; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-; Casado A, 2008, NEUROCHEM RES, V33, P450, DOI 10.1007/s11064-007-9453-; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.02; DRAPER HH, 1988, CELLULAR ANTIOXIDANT, P9; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-; Frausto da Silva JJR., 2001, BIOL CHEM ELEMENT; Gerhardsson L, 2008, DEMENT GERIATR COGN, V25, P508, DOI 10.1159/00012936; Gonzalez-Dominguez R, 2014, BIOMETALS, V27, P539, DOI 10.1007/s10534-014-9728-; HABIG WH, 1974, J BIOL CHEM, V249, P713; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-; Kelley BJ, 2007, NEUROL CLIN, V25, P577, DOI 10.1016/j.ncl.2007.03.00; Khalil N, 2009, NEUROPSYCHOLOGY, V23, P10, DOI 10.1037/a001375; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-; Lovell MA, 1999, BRAIN RES, V823, P88, DOI 10.1016/S0006-8993(99)01114-; Mangialasche F, 2009, AGEING RES REV, V8, P30; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.36; MCCORD JM, 1969, J BIOL CHEM, V244, P604; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.93; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.b; Cristalli DO, 2012, J NEUROL SCI, V314, P48, DOI 10.1016/j.jns.2011.11.00; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.03; PAGLIA DE, 1967, J LAB CLIN MED, V70, P15; Patra RC, 1999, VET HUM TOXICOL, V41, P6; Perry G, 2002, DRUG DEVELOP RES, V56, P293, DOI 10.1002/ddr.1009; Pocernich CB, 2012, BBA-MOL BASIS DIS, V1822, P625, DOI 10.1016/j.bbadis.2011.10.00; Polidori MC, 2001, FREE RADICAL BIO MED, V30, P456, DOI 10.1016/S0891-5849(00)00345-; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.773746; Rinaldi P, 2003, NEUROBIOL AGING, V24, P915, DOI 10.1016/S0197-4580(03)00031-; Rivera-Mancia S, 2011, BIOMETALS, V24, P811, DOI 10.1007/s10534-011-9454-; Saharan S, 2014, J ALZHEIMERS DIS, V40, P519, DOI 10.3233/JAD-13248; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-311; Serra JA, 2001, J NEURAL TRANSM, V108, P1135, DOI 10.1007/s00702017000; Sharma R, 2004, ANTIOXID REDOX SIGN, V6, P289, DOI 10.1089/15230860432289935; SLATER TF, 1984, METHOD ENZYMOL, V105, P28; Sultana R, 2004, NEUROCHEM RES, V29, P2215, DOI 10.1007/s11064-004-7028-; Sultana R, 2008, NEUROCHEM RES, V33, P2540, DOI 10.1007/s11064-008-9593-; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-; Torres LL, 2011, J ALZHEIMERS DIS, V26, P59, DOI 10.3233/JAD-2011-11028; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.213; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.01",53,4,4,0,14,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_144,,7,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000015,,,,,2022-07-14,0.005475206611570247,9.618258407970553e-18,0.028634327192123357,0.07388128620602805,0.028634327192123357
J,"Atik, D1;  Karatepe, H",,,,"Atik, Derya; Karatepe, Hilal",,,SCALE DEVELOPMENT STUDY: ADAPTATION TO CHRONIC ILLNESS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Scale Development; Adaptation; Chronic Illness; Validity; Reliability,MANAGEMENT; MEDICATION; ADJUSTMENT; VALIDITY; DISEASE,"Aim: The study was performed in order to develop the Adaptation to Chronic Illness Scale (ACIS) for the determination of the adaptation levels of individuals with chronic illnesss to their condition. Methods: The study was performed with a methodological design. Context, structural, criterion validity and internal consistency reliability and test-retest validity-reliability analysis were performed. The statistical meaningfulness level in all tests was determined as p<0.05. Results: As a result of context validity, factor analysis and item analysis, a 25 item scale with 3 sub components was obtained. In the scale, the variance amount explained by the three sub components was on a very good level (88.64%). The fact that all of the Cronbach alpha, Spearman-Brown and Guttman internal consistency coefficients of the scale and all of its sub components are above 0.70. When the test retest reliability coefficients of the whole scale and its sub components were examined, the scale was found to present consistent results in different applications and the scale was found to be reliable with regard to the constancy coefficient. The ACIS shows highly meaningful correlation with a scale of proven validity and reliability. Conclusion: The Adaptation to Chronic Illness Scale (ACIS), which was just added to literature, is a valid and reliable tool that can be used to evaluate adaptation to illness in individuals with chronic diseases.","[Atik, Derya; Karatepe, Hilal] Osmaniye Korkut Ata Univ, Sch Hlth, Nursing Div, Osmaniye, Turkey","Atik, D (corresponding author), Osmaniye Korkut Ata Univ, Sch Hlth, Nursing Div, Osmaniye, Turkey.",,,,,,"Adaylar Aygun M, 1995, THESIS ISTANBUL ; Akdemir N, 2011, INTERNAL MED NURSIN; Akgul A, 2005, SPSS STAT ANAL TECH; Aksayan S, 2004, RES NURSING POLICY ; Beck CM, 1994, MENTAL HLTH PSYCHIA; Bennett SJ, 1997, HEART LUNG, V26, P273, DOI 10.1016/S0147-9563(97)90084-; Birol L, 2002, NURSING PROCES; Buyukozturk S, 2008, DATA ANAL HD; Demirag SA, 2009, J HLTH LIFESTYLE, V2, P5; DEROGATIS LR, 1986, J PSYCHOSOM RES, V30, P77, DOI 10.1016/0022-3999(86)90069-; Ercan I, 2004, ULUDAG U TIP FAKULTE, V30, P21; Erdogan A, 2008, ANADOLU PSIKIYATR DE, V9, P24; Eti Asian F, 2010, INTERNAL SURG ILLNE; HURNY C, 1993, SUPPORT CARE CANCER, V1, P200, DOI 10.1007/BF0036644; Kacmaz N, 2003, THESIS ISTANBUL ; Mete HE., 2008, CLIN PSYCHIATR, V11, P; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-0000; Polit D, 2020, ESSENTIALS NURSING ; Roojien AJ, 2004, Q J MED, V97, P34; Sanden-Eriksson B, 2000, J ADV NURS, V31, P1393, DOI 10.1046/j.1365-2648.2000.01410.; Secer I, 2013, PRACTICAL DATA ANA; Taysancil E, 2006, MEASUREMENT ANAL DA; VATANSEVER O, 2014, TURK SOC CARDIOL TUR, V5, P66, DOI DOI 10.5543/KHD.2014.00; Veneziano L, 1997, AM J HEALTH BEHAV, V21, P6; Williams B, 2009, PATIENT EDUC COUNS, V77, P14, DOI 10.1016/j.pec.2009.03.00; Yaman S, 2012, ASSESSMENT EVALUATI; YESILBALKAN OU, 2005, J EGE U NURSING SCH, V21, P1; Yurdugul H., 2005, MEASUREMENT THEORY ",28,7,7,0,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,135.0,142,,,,8,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700021,,,,,2022-07-14,0.002892561983471074,3.9954086455191054e-15,0.008348450125047069,0.07083220523777815,0.008348450125047069
J,"Atik, D21;   Erdogan, Z;   Karatepe, H;   Atik, C;   Cinar, S",,,,"Atik, Derya; Erdogan, Zeynep; Karatepe, Hilal; Atik, Cem; Cinar, Sezgi",,,"SLEEP QUALITY, OBSTRUCTIVE SLEEP APNEA SYNDROME, AND SYMPTOMS IN PATIENTS WITH VARICOSE VEIN: THE EFFECT OF REGULAR PRESSURED VARICOSE VEIN STOCKING USAGE",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Sleep Quality; Obstructive Sleep Apnea Syndrome; Symptoms; Varicose Vein; Varicose Vein Stocking,CHRONIC VENOUS INSUFFICIENCY; COMPRESSION STOCKINGS; OF-LIFE; CLINICAL CLASSIFICATION; DISEASE; RISK,"Introduction: Lower extremity varicosity is an important health problem frequently seen in society that decreases the quality of life and can cause serious complications under certain circumstances. This study was aimed to determine the effect of pressured varicose vein stockings on sleep quality, obstructive sleep apnea syndrome symptoms, and symptoms of patients with varicose veins who were suggested for conservative treatment. Materials and methods: The study was designed according to a pretest posttest single study group pattern from experimental research methods. In gathering data for the study, a questionnaire on sociodemographic and clinical characteristics, The Berlin Sleep Questionnaire, and the Sleep Quality Scale were used. Results: One month of varicose vein stocking use was seen to decrease Obstructive Sleep Apnea Syndrome (OSAS) risk (p<0.05). When the sleep quality of patients for the last month was evaluated using the The Pittsburgh Sleep Quality Scale (PSQS), a statistically significant difference between the mean scores of the first inventory application and the last inventory application was found (p<0.01), and statistically meaningful decreases in pain, cramps, edema, itching, weight feeling and leg fatigue perceptions were seen in patients (p<0.05). Conclusion: Regular varicose vein stocking use was found to increase sleep quality and improve OSAS symptoms. In addition, regular varicose vein stocking use was found to decrease symptoms of patients with varicose veins.","[Atik, Derya; Karatepe, Hilal] Osmaniye Korkut Ata Univ, Sch Hlth, Nursing Div, Osmaniye, Turkey; [Erdogan, Zeynep] Bulent Ecevit Univ, Vocat Sch Hlth Serv, Zonguldak, Turkey; [Atik, Cem] Private New Life Hosp, Osmaniye, Turkey; [Cinar, Sezgi] Celal Bayar Univ, Sch Hlth, Nursing Div, Manisa, Turkey","Atik, D (corresponding author), Osmaniye Korkut Ata Univ, Sch Hlth, Nursing Div, Osmaniye, Turkey.",,"erdoÄan, zeynep/AAB-7372-2022; ERDOGAN, ZEYNEP/T-8947-2018","erdoÄan, zeynep/0000-0002-7298-7559; ERDOGAN, ZEYNEP/0000-0002-7298-7559",,,"Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-; Agargun MY., 1996, TURK PSIKIYATR DERG, V7, P10; Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.01; Bozkurt K., 2007, KRON VEN YET IU CERR, V56, P8; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-; Ceviker K, 2015, QUAL LIFE RE; Col C., 2000, NURS FORUM, V3, P3; Duman E. U., 2011, THESI; Edwards H, 2014, J PAIN SYMPTOM MANAG, V47, P867, DOI 10.1016/j.jpainsymman.2013.06.00; Fan Chieh-Min, 2005, Semin Intervent Radiol, V22, P157, DOI 10.1055/s-2005-92194; Franz A, 2016, J CLIN NURS, V25, P733, DOI 10.1111/jocn.1302; Hareendran A, 2005, J Wound Care, V14, P5; Hirai M, 2006, SKIN RES TECHNOL, V12, P32, DOI 10.1111/j.0909-725X.2006.00129.; Jantet G, 2002, ANGIOLOGY, V53, P245, DOI 10.1177/00033197020530030; Jeanneret C, 2011, VASA, V40, P344, DOI 10.1024/0301-1526/a00013; Kahn SR, 2004, J VASC SURG, V39, P823, DOI 10.1016/j.jvs.2003.12.00; Kelleher D, 2012, PHLEBOLOGY, V27, P16, DOI [10.1258/phleb.2012.012s22, 10.1258/phleb.2012.012S22; Kurz X, 2001, J VASC SURG, V34, P641, DOI 10.1067/mva.2001.11733; Kutlu A., 2010, DAMAR CERRAHI DERGIS, V19, P2; Labas P, 2007, INT ANGIOL, V26, P6; Marchiori A, 2006, SEMIN THROMB HEMOST, V32, P737, DOI 10.1055/s-2006-95145; Marmarali A, 2009, ELECT J TEXTILE TECH, V3, P8; Motykie GD, 1999, DERMATOL SURG, V25, P116, DOI 10.1046/j.1524-4725.1999.08095.; Moura RMF, 2010, BRAZ J PHYS THER, V14, P99, DOI 10.1590/S1413-3555201000500000; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-0000; Onat SS, 2013, TURK OSTEOPOROZ DERG, V19, P32, DOI 10.4274/tod.5272; Ozturk M., 2003, HASTANEDE YATAN YET; Palfreyman SJ, 2004, J CLIN NURS, V13, P332, DOI 10.1046/j.1365-2702.2003.00840.; Potter PA, 2005, FUNDEMENTALS NURSING, P119; Redolfi S, 2011, AM J RESP CRIT CARE, V184, P1062, DOI 10.1164/rccm.201102-0350O; Redolfi S, 2011, RESP PHYSIOL NEUROBI, V175, P390, DOI 10.1016/j.resp.2011.01.00; Ruggiero M, 2016, INT WOUND J, V13, P967, DOI 10.1111/iwj.1249; Sayin OA, 2007, IU CERR TIP FAK SUR, V56, P3; Staffa R, 2002, Bratisl Lek Listy, V103, P16; Uran G., 2001, KIRSAL KESIMDE EVD; White LH, 2015, SLEEP MED, V16, P258, DOI 10.1016/j.sleep.2014.12.00",36,4,4,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,933.0,940,,10.19193/0393-6384_2016_4_112,,8,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000012,,,,,2022-07-14,0.00371900826446281,1.3823727941739752e-11,0.008370620711241962,0.0837565867460393,0.008252047588990468
J,"Ayar, Y1;  Ersoy, A;  Can, FE;  Gullulu, M;  Bayrakci, I;  Demirayak, D;  Duger, H;  Ocak, T;  Oruc, A;  Yildiz, A;  Korkut, B;  Sahin, AB;  Camci, NY;  Vuruskan, BA",,,,"Ayar, Yavuz; Ersoy, Alparslan; Can, Fatma Ezgi; Gullulu, Mustafa; Bayrakci, Ismail; Demirayak, Dilay; Duger, Hakan; Ocak, Tugba; Oruc, Aysegul; Yildiz, Abdulmecit; Korkut, Bayram; Sahin, Ahmet Bilgehan; Camci, Nihal Yucel; Vuruskan, Berna Aytac",,,PRIMARY GLOMERULONEPHRITIS: A SINGLE-CENTER RETROSPECTIVE EXPERIENCE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Primary glomerular disease; proteinuria; renal biopsy,PROGNOSIS,"Aim: Primary glomerular diseases (PGD) are seen frequently. Age, gender, geographical characteristics and genetic affect the distribution of the disease. Despite the treatment, a part of the disease may progress to end-stage renal disease. We evaluated the PGD patients and retrospectively regarding to their clinical and histopathological characteristics. Materials and methods: In this study PGD patients, who have had renal biopsy between 1st January 2009 and 31st December 2014 were evaluated. Clinical and laboratory characteristics, response of the treatment, biopsy evidences, and the risk factors associated with mortality were analyzed. We also compared the cases of primary glomerulonephritis retrospectively. The mean value of the follow-up periods was 22 months (range: 8 - 76 months). Results: The median age was 42 years (18 - 80) in 264 patients. When five groups were compared, there was statistically important difference between the groups (p < 0.001). The distributions of PGD subgroups were 40.5% for membranous glomerulonephritis (MGN), 20.4% for IgA nephropathy (IgAN), 25.7% for focal segmental glomerulosclerosis (FSGS), 7.9% for minimal change disease (MCD) and 5.3% for membranoproliferative glomerulonephritis (MPGN). The distrubition of gender was not significantly in the five PGD groups (p=0.269). Nephrotic syndrome was the most biopsy indication in MGN patients (76.6%). Nephritic syndrome was more seen in immunoglobulin A nephropathy (IgAN) patients (63%). Chronic kidney disease was more detected in focal segmental glomerulosclerosis (FSGS) patients as biopsy indication (p<0.001). Minimal change disease (MCD) and IgAN patients were more received with steroid treatment (85.7% and 55.5% respectively). Cyclophosphamide was more received in MGN patients. Serum IgG levels were more higher in FSGS and IgAN patients (p<0.001). Partial remission was more seen in MCD patients. Complete remission was more detected in MGN and FSGS patients. 29.1% of IgAN patients were not received treatment response. Six year renal survival rates were 84.1% (MGN), 87.1% (IgAN), 95.3% (MCD), 64.3% (MPGN) and 76.5% (FSGS) respectively. Conclusion: Biopsy maintains its diagnostic importance in glomerular diseases. Renal functions at diagnosis are important in response to treatment. Early diagnosis, follow-up and appropriate immunosuppressive medications affect mortality and clinical progress in PGD.","[Ayar, Yavuz; Ersoy, Alparslan; Gullulu, Mustafa; Oruc, Aysegul; Yildiz, Abdulmecit] Uludag Univ, Fac Med, Dept Nephrol, Internal Med, Bursa, Turkey; [Can, Fatma Ezgi] Uludag Univ, Fac Med, Dept Biostat, Bursa, Turkey; [Bayrakci, Ismail; Demirayak, Dilay; Duger, Hakan; Ocak, Tugba; Korkut, Bayram; Sahin, Ahmet Bilgehan; Camci, Nihal Yucel] Uludag Univ, Fac Med, Internal Med, Bursa, Turkey; [Vuruskan, Berna Aytac] Uludag Univ, Dept Pathol, Bursa, Turkey","Ayar, Y (corresponding author), Uludag Univ, Fac Med, Dept Nephrol, TR-16059 Gorukle, Turkey.",,"Oruc, Aysegul/AAH-4002-2021; Vuruskan, Berna Aytac/AAH-9746-2021; Ersoy, Alparslan/AAH-5054-2021; Åahin, Ahmet Bilgehan/AAM-4927-2020; Ayar, Yavuz/O-9948-2015","Ersoy, Alparslan/0000-0002-0710-0923; Åahin, Ahmet Bilgehan/0000-0002-7846-0870; ",,,"Briganti EM, 2001, NEPHROL DIAL TRANSPL, V16, P1364, DOI 10.1093/ndt/16.7.136; Chou YH, 2012, CLIN J AM SOC NEPHRO, V7, P1401, DOI 10.2215/CJN.0450051; Choy BY, 2006, AM J TRANSPLANT, V6, P2535, DOI 10.1111/j.1600-6143.2006.01502.; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.; Franklin KA, 2014, OBSTRUCTIVE SLEEP AP, P; Malafronte P, 2006, NEPHROL DIAL TRANSPL, V21, P3098, DOI 10.1093/ndt/gfl23; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq66; Mitwalli A H, 2000, Saudi J Kidney Dis Transpl, V11, P56; Moranne O, 2008, QJM-INT J MED, V101, P215, DOI 10.1093/qjmed/hcm14; Rivera F, 2002, NEPHROL DIAL TRANSPL, V17, P1594, DOI 10.1093/ndt/17.9.159; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.; Simon P, 2004, KIDNEY INT, V66, P905, DOI 10.1111/j.1523-1755.2004.00834.; Swarnalatha G, 2015, SAUDI J KIDNEY DIS T, V26, P173, DOI 10.4103/1319-2442.14877",13,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,,,5,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000027,,,,,2022-07-14,0.0013429752066115702,4.402262488531609e-27,0.0024779299821800454,0.056040247086543975,0.0024779299821800454
J,"Balkan, A21;   Barutcu, S;   Erdem, R;   Konduk, BT;   Yildirim, AE;   Gulsen, MT",,,,"Balkan, Ayhan; Barutcu, Sezgin; Erdem, Ramazan; Konduk, Bugra Tolga; Yildirim, Abdullah Emre; Gulsen, Murat Taner",,,THE EFFICACY OF LAMIVUDINE TREATMENT IN NAIVE CHRONIC HEPATITIS B PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Efficacy; lamivudine; chronic hepatitis B,VIRUS; MUTATIONS; TELBIVUDINE; MONOTHERAPY; POLYMERASE; RESISTANT; THERAPY,"Introduction: According to our national health care system previous guidelines, lamivudine (LAM) or telbivudine treatment should be initiated in the naive chronic hepatitis B (CHB) patients with low viral load. We aimed to investigate the success of LAM treatment in one year period. Materials and methods: We retrospectively recruited 125 naive CHB patients on LAM therapy. We recorded biopsy results, demographic, biochemical, serological and virological values at baseline and 3th, 6th and 12th months of treatment. Virological response was defined as undetectable hepatitis B virus (HBV) DNA (<20 IU/mL). Results: Of patients, 81 were male (65%), and the mean age was 42 +/- 13. Mean histological activity index (HAI) was 4.55 +/- 2.16, and fibrosis was 2.65 +/- 0.90 in 114 patients who had biopsy results. The initial mean HBV DNA level was 5.52 x 106 IU/mL. Seroconversion was observed in only 3 (18.75%) of 16 HBeAg (+) patients. While baseline median ALT value was 36 U/L, following values were 28 U/L, 25 U/L and 24 U/L, respectively. HBV DNA significantly and gradually decreased with LAM treatment and it was finally determined to be negative in 80% of the patients in the 12th month. Conclusion: LAM treatment for naive CHB patients continues to be effective for the first 6th months, and if continued to be treated until 12th month, this efficiency can increase. However, it should be kept in mind that any patient with positive HBV DNA are under risk of HBV related complications.","[Balkan, Ayhan; Barutcu, Sezgin; Erdem, Ramazan; Konduk, Bugra Tolga; Yildirim, Abdullah Emre; Gulsen, Murat Taner] Gaziantep Univ, Fac Med, Dept Gastroenterol, Univ Bulvari Sehitkamil, TR-27310 Gaziantep, Turkey","Balkan, A (corresponding author), Gaziantep Univ, Fac Med, Dept Gastroenterol, Univ Bulvari Sehitkamil, TR-27310 Gaziantep, Turkey.",,"BarutÃ§u, Sezgin/AAD-4552-2019; YILDIRIM, Abdullah Emre/AAG-6561-2020; GÃ¼lÅen, Murat Taner/AAH-1097-2020","YILDIRIM, Abdullah Emre/0000-0002-4386-9297; GÃ¼lÅen, Murat Taner/0000-0002-8531-9402",,,"Akuta N, 2003, J HEPATOL, V38, P91, DOI 10.1016/S0168-8278(02)00335-; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.51027062; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.2051; Balik I, 2010, UL VIR HEP K 2010 A; Clements CJ, 2010, B WORLD HEALTH ORGAN, V88, P66, DOI 10.2471/BLT.08.06572; EASL Jury, 2003, J Hepatol, V38, P53; Fournier Claire, 2007, Clin Liver Dis, V11, P869, DOI 10.1016/j.cld.2007.08.01; Hadziyannis SJ, 2000, HEPATOLOGY, V32, P847, DOI 10.1053/jhep.2000.1791; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.02; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa06642; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.02; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.2151; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.01; Ryu SH, 2003, J HEPATOL, V39, P614, DOI 10.1016/S0168-8278(03)00394-; Sayan M, 2011, INT J INFECT DIS, V15, pE722, DOI 10.1016/j.ijid.2011.05.01; Suzuki F, 2002, J HEPATOL, V37, P824, DOI 10.1016/S0168-8278(02)00281-; Teo CG, 2010, ANTIVIR THER, V15, P445, DOI 10.3851/IMP155; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-",20,0,0,1,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,663.0,667,,10.19193/0393-6384_2016_3_72,,5,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400001,,,,,2022-07-14,0.002066115702479339,1.478881608687625e-14,0.003910839248414035,0.08655763504511191,0.003889074839539288
J,"Balkarli, A1;  Semiz, M;  Uslu, AU;  Yalcinkaya, S;  Can, B;  Sahin, M;  Kucuk, A;  Solak, Y;  Tunc, R",,,,"Balkarli, Ayse; Semiz, Murat; Uslu, Ali Ugur; Yalcinkaya, Soner; Can, Beray; Sahin, Muhammed; Kucuk, Adem; Solak, Yalcin; Tunc, Recep",,,AN ASSESSMENT OF SLEEP DISTURBANCES AND QUALITY OF LIFE IN PRIMARY SJOGREN'S SYNDROME AND ITS RELATIONSHIP WITH URINARY INCONTINENCE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Primary Sjogren Syndrome; Life quality; Sleep disturbances; Urinary Incontinence,RESTLESS LEGS SYNDROME; SEVERITY; IMPACT; PREVALENCE; INSTRUMENT; PARAMETERS; ARTHRITIS; SYMPTOMS; FATIGUE; WOMEN,"Introduction: It was aimed to evaluate sleep disturbances and quality of life in primary Sjogren's syndrome (pSS) patients and to evaluate any relationship with urinary incontinence. Methods: The study included 77 voluntary patients admitted to the rheumatology clinic. The control group consisted of 80 healthy individuals. All participants were requested to complete the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepines Scale (ESS), International Restless Leg Syndrome (RLS) study group (IRLSSG) rating scale, and SF-36 quality of life questionnaire. The age of pSS onset, age at diagnosis, and age at the beginning of therapy were recorded. Patients with urinary incontinence were evaluated with the incontinence severity index(ISI). Results: The mean scores of the mental health, general health, vitality, physical function, physical role function and emotional role function parameters of the patients were statistically significantly lower than those of healthy volunteers. In the ESS scale, the average score was found to be 7.9 +/- 2.8 in the patient group and 4.5 +/- 2.1 in the control group. The average IRLSSG rating scale score was 13.4 +/- 7.6 in the patient group and 5.4 +/- 5.2 in the control group. The total PSQI score was 7.8 +/- 3.5 in the patient group and 4.11 +/- 1.64 in the control group. There was a statistically significant difference in terms of ESS, IRLSSG rating scale and sleep quality scores. Patients with urinary incontinence (n=26) had significantly higher PSQI and SF-36 scores than patients without urinary incontinence (n=51). Conclusion: Patients diagnosed with pSS have a significantly decreased sleep quality and HRQOL compared with the normal population. Urinary incontinence had a negative impact on sleep and HRQOL. RLS, sleepiness and urinary incontinence are common in patients with pSS.","[Balkarli, Ayse] Antalya Training & Res Hosp, Div Rheumatol, Dept Internal Med, Antalya, Turkey; [Semiz, Murat] Gulhane Mil Med Fac, Dept Psychiat, Ankara, Turkey; [Uslu, Ali Ugur] Eskisehir Mil Hosp, Dept Internal Med, Eskisehir, Turkey; [Yalcinkaya, Soner] Antalya Training & Res Hosp, Dept Urol, Antalya, Turkey; [Can, Beray] Pamukkale Univ, Dept Internal Med, Denizli, Turkey; [Sahin, Muhammed] Necmettin Erbakan Univ, Div Phys Med & Rehabil, Konya, Turkey; [Kucuk, Adem; Tunc, Recep] Necmettin Erbakan Univ, Div Rheumatol, Dept Internal Med, Konya, Turkey; [Solak, Yalcin] Necmettin Erbakan Univ, Div Nephrol, Dept Internal Med, Konya, Turkey","Balkarli, A (corresponding author), Antalya Training & Res Hosp, Div Rheumatol, Dept Internal Med, Antalya, Turkey.",,"Solak, Yalcin/AAD-1393-2020",,,,"Altaweel W, 2012, NEUROUROL URODYNAM, V31, P642, DOI 10.1002/nau.2220; Araujo AB, 2014, J UROLOGY, V191, P100, DOI 10.1016/j.juro.2013.07.01; Bayetto K, 2010, AUST DENT J, V55, P39, DOI 10.1111/j.1834-7819.2010.01197.; Belenguer R, 2005, CLIN EXP RHEUMATOL, V23, P35; Bowman SJ, 2000, ARTHRITIS RHEUM, V43, pS30; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-; Chen YM, 2009, RHEUMATOLOGY, V48, P1261, DOI 10.1093/rheumatology/kep19; Epstein LC, 2014, CLIN RHEUMATOL, V33, P511, DOI 10.1007/s10067-013-2453-; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-; Gandia Myriam, 2014, Oral Health Dent Manag, V13, P40; Godaert GLR, 2002, ANN NY ACAD SCI, V966, P320, DOI 10.1111/j.1749-6632.2002.tb04232.; Goodchild CE, 2010, MUSCULOSKELET CARE, V8, P107, DOI 10.1002/msc.17; GUDBJORNSSON B, 1993, BRIT J RHEUMATOL, V32, P107; Hening WA, 2001, NEUROLOGY, V56, pA; Iacopino Anthony M, 2010, J Can Dent Assoc, V76, pa9; Inal V, 2010, MOD RHEUMATOL, V20, P588, DOI 10.1007/s10165-010-0329-; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.54; Kitapcioglu G, 2008, TURKIYE KLIN J IMMUN, V1, P; Mallah Fatemeh, 2014, J Family Reprod Health, V8, P1; McMillan AS, 2004, J ORAL REHABIL, V31, P653, DOI 10.1111/j.1365-2842.2004.01384.; Moore Courtenay K, 2010, Curr Urol Rep, V11, P299, DOI 10.1007/s11934-010-0124-; Mulherin DM, 1997, BRIT J OBSTET GYNAEC, V104, P1019, DOI 10.1111/j.1471-0528.1997.tb12060.; Ng W-F, 2011, ANN RHEUM DIS, V70, P51; Priori R, 2010, CLIN EXP RHEUMATOL, V28, pS8; Rostron Jocelyne, 2002, Gerodontology, V19, P53, DOI 10.1111/j.1741-2358.2002.00053.; Sahin S, 2013, EUR REV MED PHARMACO, V17, P95; Sandvik H, 2006, INT UROGYNECOL J, V17, P520, DOI 10.1007/s00192-005-0060-; Simsek I, 2012, TURKIYE KLIN J IMMUN, V5, P1; Sinclair AJ, 2011, OBSTET GYNAECOL, V13, P143, DOI 10.1576/toag.13.3.143.2766; Sumardi R, 2014, ACTA MED INDONES, V46, P17; Thanou-Stavraki A, 2008, SEMIN ARTHRITIS RHEU, V37, P273, DOI 10.1016/j.semarthrit.2007.06.00; Theander L, 2010, RHEUMATOLOGY, V49, P1177, DOI 10.1093/rheumatology/keq02; Thomas E, 1998, BRIT J RHEUMATOL, V37, P106; Trotti LM, 2012, BRAIN BEHAV IMMUN, V26, P1239, DOI 10.1016/j.bbi.2012.06.00; Tufik SB, 2013, SLEEP MED, V14, P222, DOI 10.1016/j.sleep.2012.09.00; TURNERSTOKES L, 1992, J ROY SOC MED, V85, P38; Usmani ZA, 2012, SLEEP MED, V13, P1066, DOI 10.1016/j.sleep.2012.06.01; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.55; Walker J, 2003, J RHEUMATOL, V30, P240; Wang F, 2004, ARTHRITIS RHEUM-US, V50, P3637, DOI 10.1002/art.2062; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-0000; Weinstock LB, 2012, SLEEP MED REV, V16, P341, DOI 10.1016/j.smrv.2011.09.00",43,2,2,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,917.0,923,,10.19193/0393-6384_2016_4_110,,7,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000010,,,,,2022-07-14,0.004442148760330579,2.18992878313688e-08,0.02933403146156692,0.09901091370298772,0.029393822415246997
J,"Barghamadi, Z1;  Moosa-Kazemi, SH;  Oshaghi, MA;  Vatandoost, H;  Shahraki, G",,,,"Barghamadi, Zeynab; Moosa-Kazemi, Seyed Hasan; Oshaghi, Mohammad Ali; Vatandoost, Hasan; Shahraki, Gholamhossein",,,SPECIES IDENTIFICATION OF THE ANOPHELES FLUVIATILIS COMPLEX USING PHYLOGENETIC ANALYSIS PCR-SEQUENCING IN SOUTHWESTERN IRAN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Malaria; Anopheles fluviatilis; Kohgiluye and Boyer-Ahmad province,MOSQUITOS DIPTERA-CULICIDAE; SOUTHERN IRAN; MALARIOUS AREA; MOLECULAR VARIATION; STEPHENSI; PROVINCE; VECTOR; MEMBERS,"Introduction: Anopheles fluviatilis is one of the most important malaria vector in Iran. The aim of this study was to identify Anopheles fluviatilis complex species using proliferation and sequence analysis of ITS2 and also 28. S-D3parts of rDNA gene in southwestern Iran. Method: In this research Anopheles fluviatilis was caught from different areas of Kohgiluye and Boyer-Ahmad province at southwestern Iran at 1392. DNA was taken from 4 Anopheles fluviatilis selected samples and PCR tests of 28S-D3 part was done on sample's DNA and then after sequence of obtained results were identified and were compared with similar samples of Anopheles fluviatilis based on data's of gene word bank. Phylogenetic tree and individual sequences of samples were calculated. Results: PCR Phylogenetic analysis of r DNA 28S-D3 part of Anopheles fluviatilis confirmed that U genotype in Kohgiluye and Boyer-Ahmad province was identified. Gene length of r DNA 28S-D3 part between populations of this species was same (333bp). Conclusion: This study showed that Anopheles fluviatilis has species separate branch in southwestern Iran which is different with branch of southeastern Iran (Hormozgan, Kerman and Sistaan & Baluchestaan provinces).","[Barghamadi, Zeynab; Moosa-Kazemi, Seyed Hasan; Oshaghi, Mohammad Ali; Vatandoost, Hasan] Univ Tehran Med Sci, Dept Med Entomol & Vector Control, Tehran, Iran; [Shahraki, Gholamhossein] Yasuj Univ Med Sci, Fac Hlth, Yasuj, Iran","Shahraki, G (corresponding author), Fac Hlth, Dept Common Hlth, 14 Golestan St Ostandari Sq, Yasuj 75918, Iran.",shahraki.gh@gmail.com,"Oshaghi, Mohammad A/H-8373-2016; Vatandoost, Hassan/AAY-2459-2021; Shahraki, Gholamhossein/M-6090-2017","Shahraki, Gholamhossein/0000-0002-5227-1887; Vatandoost, Hassan/0000-0002-5983-9420",research deputy of Tehran's school of medicine,"Authors of this paper appreciate sincere cooperation of molecular biology division of health faculty, medical entomology group, Mrs. Mohtarami. This study was funded by research deputy of Tehran's school of medicine.","Abai M. R., 2008, Journal of Vector Borne Diseases, V45, P30; Azari-Hamidian S., 2011, Journal of Entomology, V8, P204, DOI 10.3923/je.2011.204.21; Azari-Hamidian S, 2007, IRAN J ARTHROPOD-BOR, V1, P; Azari-Hamidian S, 2009, ZOOTAXA, P; Barghamadi Z, 2014, J MED SCI, V19, P6; Chen B, 2006, MED VET ENTOMOL, V20, P33, DOI 10.1111/j.1365-2915.2006.00604.; Chen B, 2002, MED VET ENTOMOL, V16, P253, DOI 10.1046/j.1365-2915.2002.00373.; Djadid ND, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-; Edalat H, 1997, THESI; ESHGHI N, 1976, TROP GEOGR MED, V28, P4; Hanari-Bojd AA, 2012, J VECTOR DIS, V49, P9; Kazemi SHM, 2010, J VECTOR DIS, V47, P10; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;; LITVAITIS MK, 1994, MAR BIOL, V120, P437, DOI 10.1007/BF0068021; Manonmani A, 2001, ACTA TROP, V78, P3, DOI 10.1016/S0001-706X(00)00154-; MANOUCHEHRI AV, 1976, TROP GEOGR MED, V28, P22; Mehravaran A, 2011, ACTA TROP, V117, P76, DOI 10.1016/j.actatropica.2010.09.01; Mehravaran A., 2013, HORMOZGAN MED ; Naddaf S R, 2003, East Mediterr Health J, V9, P25; Naddaf SR, 2010, KOREAN J PARASITOL, V48, P231, DOI 10.3347/kjp.2010.48.3.23; Sedaghat MM, 2005, J VECTOR ECOL, V30, P27; Shahgoudian ER., 1986, ACTA MED IRAN, V3, P3; Shahi M, 2006, HORMOZGAN MED J, P32; Singh OP, 2010, ACTA TROP, V113, P241, DOI 10.1016/j.actatropica.2009.11.00; Singh OP, 2004, AM J TROP MED HYG, V70, P27, DOI 10.4269/ajtmh.2004.70.2; Soleimani-Ahmadi M., 2012, Eastern Mediterranean Health Journal, V18, P103; SUBBARAO SK, 1994, ANN ENTOMOL SOC AM, V87, P116, DOI 10.1093/aesa/87.1.11; Vatandoost H, 2006, ACTA TROP, V97, P196, DOI 10.1016/j.actatropica.2005.11.00; Vatandoost H, 2012, ASIAN PAC J TROP MED, V5, P722, DOI 10.1016/S1995-7645(12)60114-; WHO, 2013, TEST PROC INS RES M",30,3,3,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,5.0,,2069.0,2073,,,,5,"Medicine, General & Internal",General & Internal Medicine,EI1YW,WOS:000392283800030,,,,,2022-07-14,0.003202479338842975,2.86119672200895e-05,0.006189061434015364,0.11578531870865878,0.006189061434015364
J,"Battaglia, G1;  Giustino, V;  Iovane, A;  Bellafiore, M;  Martines, F;  Patti, A;  Traina, M;  Messina, G;  Palma, A",,,,"Battaglia, Giuseppe; Giustino, Valerio; Iovane, Angelo; Bellafiore, Marianna; Martines, Francesco; Patti, Antonino; Traina, Marcello; Messina, Giuseppe; Palma, Antonio",,,INFLUENCE OF OCCLUSAL VERTICAL DIMENSION ON CERVICAL SPINE MOBILITY IN SPORTS SUBJECTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,sport; the stomatognathic system; cervical spine mobility; exercise,TEMPOROMANDIBULAR DISORDERS; DENTAL OCCLUSION; POSTURAL CONTROL; MOUTHGUARDS; DYSFUNCTION; PREVENTION; SYMPTOMS; TINNITUS; POSITION; MUSCLES,"Introduction: In the scientific literature, a number of studies have reported conflicting results regarding the effects of occlusal vertical dimension (OVD) on sports-related skills. The purpose of this study was to increase OVD in sports subjects so as to specifically investigate the influence on cervical spine mobility. In particular, we measured cervical range of motion (ROM) before and after increasing OVD in individuals, either with or without malocclusion, analyzing both sports and sedentary subjects. Materials and methods: Participants were divided into two groups: a sports group (SG) and a control group (CG), each including 18 subjects. The SG was composed of sports subjects (age: 20.11 +/- 3.45 yrs; BMI: 25.39 +/- 2.32 kg/m(2)), whereas the CG consisted of age-matched sedentary subjects (age: 25.78 +/- 2.26 yrs; BMI: 24.88 +/- 2.87 kg/m(2)). Cervical range of motion (ROM) was evaluated, by way of an accelerometer (Moover r, Sensor Medica r), before (pre-test) and after (post-test) increasing OVD. Results: The main finding of this study was that sports subjects showed no significant difference, compared to control subjects, in cervical ROM in response to increased OVD. Moreover, we found that sports and sedentary subjects alike showed no significant change in cervical spine mobility as a result of increased OVD, regardless of whether they were affected by malocclusion (class II) or represented subjects with normocclusion (class I). Conclusion: In accord with several studies reported in the literature, the findings of our study indicate that occlusal splints failed to significantly improve the physical-performance endpoint measured, i. e. cervical ROM, in sports subjects as compared to sedentary individuals. Due to the paucity of studies, characterized by conflicting results, there is as yet no compelling scientific evidence as to whether OVD positively impacts sports performance or not. Accordingly, we suggest that further scientific investigation, regarding the relationship between sports performance and OVD, be conducted in the field of sport and exercise sciences.","[Battaglia, Giuseppe; Iovane, Angelo; Bellafiore, Marianna; Patti, Antonino; Traina, Marcello; Palma, Antonio] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Battaglia, Giuseppe; Iovane, Angelo; Bellafiore, Marianna; Patti, Antonino; Traina, Marcello; Messina, Giuseppe; Palma, Antonio] Univ Palermo, Sport & Exercise Sci Res Unit, I-90133 Palermo, Italy; [Martines, Francesco] Univ Palermo, ENT Sect, BioNeC Dept, I-90133 Palermo, Italy; [Giustino, Valerio; Messina, Giuseppe] Posturalab Italy, Pavia, PV, Italy","Battaglia, G (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,"Bellafiore, Marianna/AAN-5526-2021; Giustino, Valerio/AAR-6788-2021; Battaglia, Giuseppe/AAV-3916-2020; Messina, Giuseppe/N-7298-2019","Bellafiore, Marianna/0000-0002-3092-1666; Giustino, Valerio/0000-0002-4575-8021; Battaglia, Giuseppe/0000-0002-7758-7175; Messina, Giuseppe/0000-0003-2774-4950; Traina, Marcello/0000-0003-2373-3621; MARTINES, Francesco/0000-0002-8616-4481; Patti, Antonino/0000-0003-3753-5191",,,"Angle E.H., 1899, TAL COSM, V41, P24; Armijo-Olivo S, 2012, CLIN J PAIN, V28, P55, DOI 10.1097/AJP.0b013e31822019f; Badel Tomislav, 2007, Acta Medica Croatica, V61, P; Baldini A, 2011, MONDO ORTODONTICO, V36, P131, DOI DOI 10.1016/J.M0R.2010.09.00; Battaglia G, 2014, J SPORT MED PHYS FIT, V54, P58; Battaglia G, 2010, AGING CLIN EXP RES, V22, P406, DOI [10.3275/6713, 10.1007/BF03337736; Bellafiore M, 2011, AGING CLIN EXP RES, V23, P378, DOI [10.3275/7354, 10.1007/BF03337762; Bevilaqua-Grossi D, 2007, J APPL ORAL SCI, V15, P259, DOI 10.1590/S1678-7757200700040000; Bjorney A, 2007, PROG BRAIN RES, V166, P215, DOI 10.1016/S0079-6123(07)66019-; Chaves TC, 2014, BRAZ J PHYS THER, V18, P481, DOI 10.1590/bjpt-rbf.2014.006; Dawson EP, 1989, EVALUATION DIAGNOSIS, P5; DeWijer A, 1996, J ORAL REHABIL, V23, P742, DOI 10.1046/j.1365-2842.1996.d01-187.; Fernandez-de-las-Penas C, 2009, J PAIN, V10, P1170, DOI 10.1016/j.jpain.2009.04.01; Fujimoto Mariko, 2001, Journal of Medical and Dental Sciences, V48, P13; GREENBERG MS, 1981, J AM DENT ASSOC, V103, P576, DOI 10.14219/jada.archive.1981.030; Hoerzer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.013863; Hu JW, 2005, BRAIN RES, V1044, P93, DOI 10.1016/j.brainres.2005.03.00; Kim Hee-Sun, 2009, J Adv Prosthodont, V1, P118, DOI 10.4047/jap.2009.1.3.11; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-0000; Lai V, 2004, Minerva Stomatol, V53, P4; Manfredi Massimo, 2009, Prog Orthod, V10, P5; Martines F, 2015, ACTA MEDICA MEDITERR, V31, P90; Ohlendorf D, 2014, SPINE J, V14, P2384, DOI 10.1016/j.spinee.2014.01.04; Orthlieb JD, 2000, J ORAL REHABIL, V27, P802, DOI 10.1046/j.1365-2842.2000.00592.; Packer AC, 2014, J BACK MUSCULOSKELET, V27, P493, DOI 10.3233/BMR-14047; PASSERO PL, 1985, PHYS THER, V65, P1203, DOI 10.1093/ptj/65.8.120; Perinetti G, 2006, GAIT POSTURE, V24, P165, DOI 10.1016/j.gaitpost.2005.07.01; Seifeldin SA, 2015, SAUDI DENT J, V27, P208, DOI 10.1016/j.sdentj.2014.12.00; Sforza C, 2006, CRANIO, V24, P43, DOI 10.1179/crn.2006.00; Smith S D, 1978, N Y State Dent J, V44, P27; Solow B, 1998, EUR J ORTHODONT, V20, P685, DOI 10.1093/ejo/20.6.68; Svensson P, 2005, J OROFAC PAIN, V19, P10; Tecco Simona, 2010, BMC Res Notes, V3, P141, DOI 10.1186/1756-0500-3-14; von Piekartz H, 2013, MANUAL THER, V18, P345, DOI 10.1016/j.math.2012.12.00; Weber Priscila, 2012, J. Soc. Bras. Fonoaudiol., V24, P134, DOI 10.1590/S2179-6491201200020000; Wiesinger B, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-2",36,12,12,0,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,1589.0,1595,,10.19193/0393-6384_2016_5_135,,7,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000006,,,,,2022-07-14,0.00371900826446281,1.223455076936066e-11,0.00955780304989946,0.10339560568675832,0.009859625981123188
J,"Bayhan, Z1;  Zeren, S;  Kocak, FE;  Ekici, MF;  Kahraman, C;  Kocak, C;  Duzgun, SA",,,,"Bayhan, Zulfu; Zeren, Sezgin; Kocak, Fatma Emel; Ekici, Mehmet Fatih; Kahraman, Cuneyt; Kocak, Cengiz; Duzgun, Sukru Aydin",,,DIAGNOSTIC VALUE OF THE NEUTROPHIL TO LYMPHOCYTE RATIO AND THE PLATELET TO LYMPHOCYTE RATIO IN PATIENTS WITH GASTRIC ADENOCARCINOMA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Adenocarcinoma; platelets; lymphocytes; neutrophils; gastric neoplasm,METASTATIC COLORECTAL-CANCER; NEUTROPHIL/LYMPHOCYTE RATIO; PROGNOSTIC VALUE; PLATELET/LYMPHOCYTE RATIO; PREDICTIVE FACTOR; LUNG-CANCER; VOLUME; INFLAMMATION; CARCINOMA; SUPERIOR,"Background: Gastric adenocarcinoma is the second commonest cause of cancer-related deaths worldwide. Improving this, will depend on earlier diagnosis and treatment. Recently it has been reported that inflammatory markers, particularly the neutrophil / lymphocyte ratio (NLR) and platelet 1 lymphocyte ratio (PLR), and to a lesser extent the mean platelet volume (MPV), may be useful in the early diagnosis and prognostication of various malignancies. Objective: To investigate whether the NLR, PLR and MPV may be useful markers for the early diagnosis of gastric adenocarcinoma. Materials and methods: We retrospectively studied a group of 36 patients with gastric adenocarcinoma, comparing them to healthy age and sex matched controls. Full blood counts were used to obtain various hematological indices, including the MPVs and to calculate the NLRs and the PLRs. Unpaired t-tests were used to determine if these differed between patients and controls. Results: Hemoglobin concentrations and lymphocyte counts were both significantly lower in patients compared to controls (P < 0.001). Neutrophil counts, NLRs, and PLRs were significantly higher in patients than in controls (P = 0.012, <0.001, and <0.001, respectively). MPVs did not differ significantly between patients and controls (P = 0.320) Conclusions: Both NLRs and PLRs may be usefid markers for the early diagnosis of gastric adenocarcinoma. They are almost universally available and easily obtained.","[Bayhan, Zulfu; Zeren, Sezgin; Duzgun, Sukru Aydin] Dumlupinar Univ, Fac Med, Dept Gen Surg, Evliya Celebi Campus, TR-43100 Kutahya, Turkey; [Kocak, Fatma Emel] Dumlupinar Univ, Fac Med, Dept Biochem, Kutahya, Turkey; [Ekici, Mehmet Fatih] Evliya Celebi Training & Res Hosp, Dept Gen Surg, Kutahya, Turkey; [Kahraman, Cuneyt] Dumlupinar Univ, Fac Med, Dept Internal Med, Kutahya, Turkey; [Kocak, Cengiz] Dumlupinar Univ, Fac Med, Dept Pathol, Kutahya, Turkey","Bayhan, Z (corresponding author), Dumlupinar Univ, Fac Med, Dept Gen Surg, Evliya Celebi Campus, TR-43100 Kutahya, Turkey.",,"duzgun, sukru/A-9700-2013; Bayhan, Zulfu/AAB-8502-2020; Kocak, Emel Fatma/F-6055-2011","duzgun, sukru/0000-0003-2095-2167; Bayhan, Zulfu/0000-0002-7587-7267; Kocak, Emel Fatma/0000-0001-5549-3883",,,"Alexandrakis MG, 2003, AM J CLIN ONCOL-CANC, V26, P135, DOI 10.1097/00000421-200304000-0000; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-; Bayhan Z, 2016, INT SURG, V101, P50, DOI 10.9738/INTSURG-D-15-00123.; Bozkus F, 2015, ACTA MEDICA MEDITERR, V31, P10; Cannon NA, 2015, J THORAC ONCOL, V10, P280, DOI 10.1097/JTO.000000000000039; Chai EZP, 2015, BIOCHEM J, V468, P1, DOI 10.1042/BJ2014133; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature0132; Demirin H, 2011, THROMB RES, V128, P358, DOI 10.1016/j.thromres.2011.05.00; Feng JF, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-5; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc109; Graziosi L, 2015, AM J SURG, V209, P333, DOI 10.1016/j.amjsurg.2014.06.01; He WZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0439-; Inagaki N, 2014, LUNG CANCER, V83, P97, DOI 10.1016/j.lungcan.2013.08.02; Kemal Y, 2014, ASIAN PAC J CANCER P, V15, P2651, DOI 10.7314/APJCP.2014.15.6.265; Kilincalp S, 2015, EUR J CANCER PREV, V24, P328, DOI 10.1097/CEJ.000000000000009; Kurt M, 2012, HEPATO-GASTROENTEROL, V59, P1580, DOI 10.5754/hge1044; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.65670; Lai Q, 2014, TRANSPL INT, V27, P32, DOI 10.1111/tri.1219; Li Shumei, 2014, Zhonghua Zhong Liu Za Zhi, V36, P91; Li XB, 2015, HEPATO-GASTROENTEROL, V62, P507, DOI 10.5754/hge1492; Nash GF, 2002, LANCET ONCOL, V3, P425, DOI 10.1016/S1470-2045(02)00789-; Paliogiannis P, 2015, ACTA MEDICA MEDITERR, V31, P37; Peng W, 2015, J SURG RES, V194, P464, DOI 10.1016/j.jss.2014.12.02; PETRIE HT, 1985, J IMMUNOL, V134, P23; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.120348; Seretis C, 2013, AM J SURG, V205, P691, DOI 10.1016/j.amjsurg.2012.08.00; Tuncel T, 2014, ASIAN PAC J CANCER P, V15, P6421, DOI 10.7314/APJCP.2014.15.15.642; Vural V, 2013, TURK J SURG, V29, P1, DOI 10.5152/UCD.2013.0; Xie X, 2016, DIS ESOPHAGUS, V29, P79, DOI 10.1111/dote.1229; Zhang W, 2012, BLOOD, V120, P2889, DOI 10.1182/blood-2012-04-42520; Zhang Y, 2014, INT J GYNECOL CANCER, V24, P1319, DOI 10.1097/IGC.000000000000021; Zu HL, 2015, HEPATO-GASTROENTEROL, V62, P225, DOI 10.5754/hge1380",33,1,1,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,111.0,115,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700017,,,,,2022-07-14,0.003409090909090909,2.9640590296817645e-14,0.008789253828015039,0.09596795780582351,0.009035477960663769
J,"Bayrak, M1",,,,"Bayrak, Metin",,,DETERMINATION OF VARIABLES THAT PREDICT THE LEVEL OF SOCIAL SUPPORT RECEIVED BY RETIRED ATHLETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,retired professional athlete; social support; stress management strategies,,"In this study, we have aimed to determine the relationship between social support and stress management strategies, variables that explain level of social support received via identification of social support and stress management strategies of retired athletes. Research has been conducted on 135 individuals (age (X-=37,78 +/- 11,28). Participants have been given Social Support Scale, Stress Management Strategy Scale and Personal Data Form. Unrelated samples t test, Kruskall-Wallis Test, Mann-Whitney Test, Multivariate Analysis of Variance (MANOVA), Pearson Coefficient of Correlation and Stepwise Linear Regression Analysis have been utilized in data analyses. At the end of the research, it is determined that retired athletes participated in the research receive a social support of 65% and social support has a meaningful relationship with search for social support and optimistic approaches together with psychological preparation to retirement.","[Bayrak, Metin] Siirt Univ, Dept Phys Educ & Sport, Siirt, Turkey","Bayrak, M (corresponding author), Siirt Univ, Dept Phys Educ & Sport, Siirt, Turkey.",,,,,,"Aksullu N., 2004, ANADOLU PSIKIYATR DE, V5, P7; Arvinen-Barow M, 2013, PSYCHOL SPORT INJUR; Ates B., 2012, AKAD BAKIS DERGISI, V30, P; Baille P., 1992, HUMAN KINETICS J, V6, P7; Bayrak M., 2012, Selcuk Universitesi Beden Egitimi ve Spor Bilim Dergisi, V14, P15; Bernes K.B., 2009, J EXCELL, P6; Blinde E. M, 1985, SOCIOLOGY SPORT J, V2, P10; Buyukozturk S., 2010, BILIMSEL ARASTIRMA Y, V5t; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.31; ERIKSON E., 1984, INSANIN SEKIZ CAG; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/213661; Gilmore O., 2008, THESIS U STERLING, P3; Grove JR, 1997, J APPL SPORT PSYCHOL, V9, P191, DOI 10.1080/1041320970840648; Inoue Y, 2015, GROUP DYN-THEOR RES, V19, P31, DOI 10.1037/gdn000001; Ivarsson A, 2013, J SPORT REHABIL, V22, P19, DOI 10.1123/jsr.22.1.1; Kalayci S., 2009, SPSS UYGULAMALI CO; Krespi M., 1993, THESIS BOGAZICI U I; Lagimodiere C., 2015, ATHLETIC INSIGHT, V7, P; Lewis LE., 1997, THESIS U MINNESOTA ; Lu Lee, 2016, PSYCHOL SPORT EXERC, V22, P20; Marthinus J.M., 2007, THESIS STELLANBASC; Martines F, 2015, EUR ARCH OTO-RHINO-L, V272, P2719, DOI 10.1007/s00405-014-3275-; McCormack HM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.0185; McPearson B.P., 1980, PROC PROBL OCC PSYCH, V30, P12; Mitchell I, 2014, BRIT J HEALTH PSYCH, V19, P486, DOI 10.1111/bjhp.1204; Ogilvie B. C, 1986, APPL SPORT PSYCHOL P, P36; OZGUR G, 1991, THESIS EGE U IZMI; Ozmete E., 2008, AILE TOPLUM DERGISI, V4, P; Paoli A, 2015, IRAN J PUBLIC HEALTH, V44, P60; SAHIN NH, 1995, TURK PSIKOL DERG, V10, P5; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.12; Taylor J., 2001, APPL SPORTS PSYCHOL, P48; Tezer N, 2013, ANADOLU PSIKIYATR DE, V14, P46, DOI 10.5455/apd.3446; Torregrosa M, 2015, PSYCHOL SPORT EXERC, V21, P50, DOI 10.1016/j.psychsport.2015.03.00; Torun A., 1995, THESIS MARMARA U IS; Tunckol H. M., 2013, PERFORMANS ARASTIRMU, V5, P4; Yildirim I, 1997, HACET U EGITIM FAK, V13, P8; Yildirim I., 2010, ANNE BABA DESTEGI B",38,0,0,2,17,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,675.0,683,,10.19193/0393-6384_2016_3_74,,9,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400003,,,,,2022-07-14,0.003925619834710744,2.1908756743607332e-08,0.00875694007137255,0.11207465468733718,0.008626475794467415
J,"Boyuk, B1;  Altay, M;  Atalay, H;  Guzel, S;  Celebi, A;  Ekizoglu, I",,,,"Boyuk, Banu; Altay, Murat; Atalay, Hande; Guzel, Savas; Celebi, Aslan; Ekizoglu, Ismail",,,NO RELATIONSHIP BETWEEN 25 OH VITAMIN D AND AUTOIMMUNITY IN WOMEN PATIENTS WITH HYPOTHYROIDISM,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,vitamin D; hypothyroidism Hashimoto's thyroiditis,"HASHIMOTOS-THYROIDITIS; D DEFICIENCY; DISEASE; 1,25-DIHYDROXYVITAMIN-D3; RECEPTORS; INDUCTION; RISK; BONE","Introduction: Hypothyroidism is a common disease in the society. Based on the effects of vitamin D on immune system and endocrine system, the relationship between hypothyroidism and vitamin D gained importance. The relationship between vitamin D deficiency and thyroid was suggested for the first time by Kivity and his colleagues. In their study, they found a significant relationship between thyroid autoantibodies and vitamin D levels. In this study we want to show the relationship between autoimmunity and vitamin D deficiency in female patients with hypothyroidism. Materials and methods: This study was performed at the GOP Taksim Education and Research Hospital outpatient department of internal medicine between January and June in 2015. It included 80 females patients, and 18 control females subjects Results: A total of 98 participants were included in this study. The mean durations of hypothyroidism are 5,86 +/- 5,91 vs. 5,43 +/- 5,62 years. Anti-thyroid autoantibodies (Anti TPO) and anti-thyroglobulin antibodies (anti TG) levels were significantly higher in the group 1 patients compared to the group 2 patients and control subjects (p<0,01). There were no significant differences at other variables between the patients and control subjects. The serum 25-OH vitamin D levels were significantly lower in the Hashimoto thyroiditis and Non-Hashimoto thyroiditis patients compared to the healthy controls (10,88 +/- 9,19 ng/ml vs. 10,53 +/- 6,87 ng/ml, p<0.01). Conclusion: It was thought that the study's being conducted during the winter months might have affected vitamin D levels. The vitamin D value of the control group cases was found to be higher as compared to the case of hypothyroidism associated with Hashimoto's thyroiditis and of hypothyroidism associated with other reasons. No significant difference was observed in vitamin D levels between the groups of hypothyroidism associated with Hashimoto's thyroiditis and hypothyroidism associated with other reasons","[Boyuk, Banu; Altay, Murat; Celebi, Aslan; Ekizoglu, Ismail] Gaziosmanpasa Taksim Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey; [Atalay, Hande] Gebze Fatih Devlet Hastanesi, Ic Hastaliklari Anabilim Dali, Kocaeli, Turkey; [Guzel, Savas] Namik Kemal Univ, Dept Biochem, Tekirdag, Turkey","Boyuk, B (corresponding author), Gaziosmanpasa Taksim Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey.",,"BOYUK, BANU/ABA-7026-2021; Boyuk, Banu/GLN-8251-2022; erman, hande/AAZ-7697-2021; erman, hande/AAP-6507-2021","Boyuk, Banu/0000-0001-7794-4411; erman, hande/0000-0001-7213-9624; erman, hande/0000-0001-7213-9624",,,"BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-130; Bizzaro G, 2015, IMMUNOL RES, V61, P46, DOI 10.1007/s12026-014-8579-; Bozkurt Nujen, 2013, ENDOCR PRACT, V19, P47; Effraimidis G, 2012, EUR J ENDOCRINOL, V167, P43, DOI 10.1530/EJE-12-004; Ergur AT, 2009, VITAMIN DEFICIENCY T, V1, P26; Erkal MZ, 2006, OSTEOPOROSIS INT, V17, P1133, DOI 10.1007/s00198-006-0069-; FOURNIER C, 1990, CLIN IMMUNOL IMMUNOP, V54, P53, DOI 10.1016/0090-1229(90)90005-; Hahn HJ, 1997, TRANSPLANT P, V29, P215; Heaney RP, 2003, AM J CLIN NUTR, V78, P912, DOI 10.1093/ajcn/78.5.91; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739; Holick MF, 2005, SOUTH MED J, V98, P1024, DOI 10.1097/01.SMJ.0000140865.32054.D; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-038; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.48; Kivity S, 2011, CELL MOL IMMUNOL, V8, P243, DOI 10.1038/cmi.2010.7; Lin WY, 2006, J CLIN LAB ANAL, V20, P109, DOI 10.1002/jcla.2011; Monaco Fabrizio, 2012, THYROID DIS, P78, DOI [10.1201/b12117, DOI 10.1201/B12117; Pani MA, 2002, EUR J ENDOCRINOL, V146, P777, DOI 10.1530/eje.0.146077; POLS HAP, 1990, J STEROID BIOCHEM, V37, P873, DOI 10.1016/0960-0760(90)90435-; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.631074; Tamer G, 2011, THYROID, V21, P891, DOI 10.1089/thy.2009.020; van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fj",21,1,1,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,779.0,784,,10.19193/0393-6384_2016_3_89,,6,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400018,,,,,2022-07-14,0.0021694214876033058,1.1377470027913221e-20,0.004128175593578668,0.07200505820656823,0.004128175593578668
J,"Buscemi, A1;  Rapisarda, A;  Platania, S;  Maida, F;  Brancat, D;  Petralia, MC;  Di Nuovo, S;  Salvatore, G;  Caldarella, L;  Blandino, MG;  Grillo, G;  Barbagallo, G;  Coco, O;  Perciavalle, V;  Perciavalle, V;  Armenia, G;  Coco, M",,,,"Buscemi, Andrea; Rapisarda, Alessandro; Platania, Silvia; Maida, Felice; Brancat, Demetrio; Petralia, Maria Cristina; Di Nuovo, Santo; Salvatore, Giustiniani; Caldarella, Lucia; Blandino, Maria Grazia; Grillo, Giovanna; Barbagallo, Giuseppe; Coco, Ornella; Perciavalle, Valentina; Perciavalle, Vincenzo; Armenia, Giuseppe; Coco, Marinella",,,THE WOMAN IN PREGNANCY: BODY CARE BY KNOWING OF ALTERNATIVE MEDICINE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,woman in pregnancy; body; alternative medicine,BLOOD LACTATE LEVELS; LOW-BACK-PAIN; PELVIC PAIN; EXCITABILITY; RESPONSES; NERVE; MICROSTIMULATION; ORGANIZATION; PERFORMANCE; EXPRESSION,"Introduction: In 1907 Louisa Burns took into account the pregnant woman as a target of choice for Osteopathic Manipulative Treatment (OMT) and over the years various studies have shown the efficacy of OMT and identified fields of application for the problems that may be encountered by pregnant women. Firstly Osteopathy in Italy is not recognized today, despite it being recognized as a profession, it is not considered a medical practice and thus cannot be taught in university faculties of medicine and surgery and the professional figure of an osteopath cannot take part of the hospital staff. This study aims to examine the state of knowledge of the osteopathic profession in the population of pregnant women in relation to the level of study. Materials and methods: The study was performed at the 2nd Family Counseling - Modica Alta USL No. 7 - Ragusa, the counseling Family (ex CT3) - Via G. D'Annunzio 60 - Catania and the hospital of Lentini - District hospital SR2. 288 pregnant women aged between 15 and 42 participated in the research. The gestational average period is 7 months. To Pregnant women was asked to fill out a self-reported, for evaluate their knowledge of the osteopathy Results: The results obtained show that there is a knowledge default of osteopathy as alternative medicine and the benefits that you could have from a manual processing. Conclusion: Complementary and Alternative therapies in Medicine should be considered as treatment options for to ensure a physiological development of the body of woman nine months of pregnancy is continually changing. For this aim, we suggest to encourage projects in osteopathy during pregnancies in family counseling using childbirth courses to inform medical, obstetrician and nurse staff and women. We hope for a successful collaboration among the professional figures that with their passion are dedicated to the prevention and care of the pregnant woman.","[Buscemi, Andrea; Rapisarda, Alessandro] Ctr Studies Osteopathy, Dept Res, Catania, Italy; [Platania, Silvia; Petralia, Maria Cristina; Di Nuovo, Santo; Perciavalle, Valentina] Univ Catania, Dept Educ Sci, Catania, Italy; [Salvatore, Giustiniani; Barbagallo, Giuseppe; Coco, Ornella] Univ Catania, Catania, Italy; [Caldarella, Lucia; Blandino, Maria Grazia; Grillo, Giovanna; Armenia, Giuseppe] Mod Alta USL 7, Family Counseling, Ragusa, Italy; [Perciavalle, Vincenzo; Coco, Marinella] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy","Coco, M (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy.",marinella.coco@unict.it,"Di Nuovo, Santo/K-7760-2019; Petralia, Maria/AAE-6337-2019; Platania, silvia/F-4869-2017; Coco, Marinella/AAC-8750-2020","Di Nuovo, Santo/0000-0001-6086-7624; BARBAGALLO, Giuseppe Maria Vincenzo/0000-0002-7760-6700; Platania, Silvia/0000-0002-7324-4466; Petralia, Maria Cristina/0000-0002-9643-1045",,,"Alagona G, 2009, NEUROSCI LETT, V450, P111, DOI 10.1016/j.neulet.2008.11.06; Ashton-Miller JA, 2009, ANNU REV BIOMED ENG, V11, P163, DOI 10.1146/annurev-bioeng-061008-12482; Aukee Pauliina, 2010, Duodecim, V126, P238; Baytur YB, 2007, J REPROD MED, V52, P60; BERRETTA S, 1993, J COMP NEUROL, V338, P50, DOI 10.1002/cne.90338010; Borggren CL, 2007, J CHIROPR MED, V6, P70, DOI 10.1016/j.jcme.2007.04.00; Cardile V, 2001, NEUROREPORT, V12, P1705, DOI 10.1097/00001756-200106130-0003; Casabona A, 2004, CEREBELLUM, V3, P172, DOI 10.1080/1473422041001673; Casabona A, 2010, CEREBELLUM, V9, P103, DOI 10.1007/s12311-009-0149-; Chang JL, 2008, ORTHOPEDICS, V31, P49; Coco M, 2016, MEDICINE, V95, DOI 10.1097/MD.000000000000297; Coco M, 2015, ACTA MEDICA MEDITERR, V31, P44; Coco M, 2015, NEUROL SCI, V36, P541, DOI 10.1007/s10072-014-2015-; Coco M, 2015, MOL MED REP, V11, P2135, DOI 10.3892/mmr.2014.289; Coco M, 2014, SOMATOSENS MOT RES, V31, P35, DOI 10.3109/08990220.2013.83481; Coco M, 2013, SOMATOSENS MOT RES, V30, P90, DOI 10.3109/08990220.2013.76994; Coco M, 2011, SOMATOSENS MOT RES, V28, P19, DOI 10.3109/08990220.2011.59826; Coco M, 2011, MOL MED REP, V4, P471, DOI 10.3892/mmr.2011.45; Coco M, 2009, BRAIN RES, V1302, P205, DOI 10.1016/j.brainres.2009.09.03; Donia M, 2012, ONCOL REP, V28, P682, DOI 10.3892/or.2012.184; Dumoulin C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005654.pub; El-Khawand D, 2012, FEMALE PELVIC MED RE, V18, P127, DOI 10.1097/SPV.0b013e3182436ae; Fagone P, 2013, J NEUROIMMUNOL, V261, P82, DOI 10.1016/j.jneuroim.2013.04.01; Fagone P, 2013, BASIC CLIN PHARMACOL, V112, P63, DOI 10.1111/j.1742-7843.2012.00923.; FAST A, 1987, SPINE, V12, P368, DOI 10.1097/00007632-198705000-0001; Franke H, 2013, J BODYW MOV THER, V17, P11, DOI 10.1016/j.jbmt.2012.05.00; Frinchi M, 2014, INT J SPORTS MED, V35, P19, DOI 10.1055/s-0033-134340; Garifoli A, 2010, ARCH ITAL BIOL, V148, P339, DOI 10.4449/aib.v148i4.102; GIUFFRIDA R, 1980, EXP BRAIN RES, V39, P261, DOI 10.1007/BF0023711; GRAY C, 1993, BRAIN RES, V622, P280, DOI 10.1016/0006-8993(93)90829-; Hay-Smith J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001407.pub; Heit M, 2001, Curr Womens Health Rep, V1, P7; Howard FM, 2003, OBSTET GYNECOL, V101, P594, DOI 10.1016/S0029-7844(02)02723-; Jessen MR, 1996, J OSTEOPATH MED, V96, P5; Jiang HH, 2009, NEUROUROL URODYNAM, V28, P229, DOI 10.1002/nau.2063; JONASSON A, 1989, ACTA OBSTET GYN SCAN, V68, P301, DOI 10.3109/0001634890902866; Kristiansson P, 1996, SPINE, V21, P702, DOI 10.1097/00007632-199603150-0000; Kwong KF, 2009, GEN THORACIC SURG, P65; Laslett M, 2008, J MAN MANIP THER, V16, P142, DOI 10.1179/jmt.2008.16.3.14; Lavelle JM, 2012, J AM OSTEOPATH ASSOC, V112, P343, DOI 10.7556/jaoa.2012.112.6.34; Licciardone JC, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.05; MacEvilly M, 1996, PAIN, V64, P405, DOI 10.1016/0304-3959(95)00184-; Mangano K, 2014, J CELL PHYSIOL, V229, P1918, DOI 10.1002/jcp.2464; Pannuzzo G, 2010, MOL GENET METAB, V100, P234, DOI 10.1016/j.ymgme.2010.03.02; Pennick VE, 2007, COCHRANE DB SYST REV, V1; Perciavalle V, 1998, EUR J NEUROSCI, V10, P1975, DOI 10.1046/j.1460-9568.1998.00212.; PERCIAVALLE V, 1978, EXP BRAIN RES, V33, P24; PERCIAVALLE V, 1977, BRAIN RES, V126, P557, DOI 10.1016/0006-8993(77)90608-; PERCIAVALLE V, 1987, NEUROSCIENCE, V23, P243, DOI 10.1016/0306-4522(87)90286-; Perciavalle Va, 2015, ACTA MEDICA MEDITERR, V31, P127; Perciavalle V, 2015, NEUROL SCI, V36, P2129, DOI 10.1007/s10072-015-2329-; Perciavalle V, 2015, NEUROL SCI, V36, P1597, DOI 10.1007/s10072-015-2210-; Perciavalle V, 2014, PERCEPT MOTOR SKILL, V118, P940, DOI 10.2466/19.50.PMS.118k27w; Perciavalle V, 2014, PERCEPT MOTOR SKILL, V118, P733, DOI 10.2466/29.30.PMS.118k22w; Perciavalle V, 2013, MOL MED REP, V7, P1733, DOI 10.3892/mmr.2013.142; Perciavalle V, 2013, CEREBELLUM, V12, P738, DOI 10.1007/s12311-013-0464-; Peterson CD, 2012, CHIROPRACTIC MANUAL, V20, P; Sergueef Nicette, 2006, Complement Ther Clin Pract, V12, P101, DOI 10.1016/j.ctcp.2005.11.00; Skaggs CD, 2007, J MANIP PHYSIOL THER, V30, P130, DOI 10.1016/j.jmpt.2006.12.00; Spaeth DG, 1997, J OSTEOPATH MED, V97, P15; Sullivan C, 1997, Complement Ther Nurs Midwifery, V3, P72, DOI 10.1016/S1353-6117(97)80037-; Terry RR, 2006, J AM OSTEOPATH ASSOC, V106, P19; Tettambel MA, 2005, J AM OSTEOPATHIC S4, V105, P2; To WWK, 2003, ACTA OBSTET GYN SCAN, V82, P1086, DOI 10.1046/j.1600-0412.2003.00235.; Tu FF, 2005, OBSTET GYNECOL SURV, V60, P474, DOI 10.1097/01.ogx.0000162246.06900.9; Wang SM, 2005, J ALTERN COMPLEM MED, V11, P459, DOI 10.1089/acm.2005.11.45; Wang SM, 2004, OBSTET GYNECOL, V104, P65, DOI 10.1097/01.AOG.0000129403.54061.0; Whiting L., 1911, J AM OSTEOPATH ASSOC, V11, P91",68,11,11,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,953.0,958,,10.19193/0393-6384_2016_4_115,,6,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000015,,,,,2022-07-14,0.006818181818181818,1.0984595969983548e-16,0.009909216057733256,0.05561460457901238,0.009911841243920099
J,"Cataldo, A1;  Zangla, D;  Cerasola, D;  Bellavia, D;  Traina, M",,,,"Cataldo, Angelo; Zangla, Daniele; Cerasola, Dario; Bellavia, Diego; Traina, Marcello",,,ASSOCIATION OF CARDIO-PULMONARY STRESS TEST PARAMETERS AND HEART RATE RECOVERY IN OBESE SUBJECTS WITH OR WITHOUT TYPE II DIABETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Cardio-Pulmonary Stress Test; Heart Rate Recovery; Autonomic Nervous System; maximal oxygen uptake (VO(2)max),CARDIOVASCULAR-DISEASE; NEURAL REGULATION; RATE-VARIABILITY; EXERCISE; MORTALITY; PREDICTOR; CAPACITY; MEN,"Background and objectives: Heart rate recovery at first (HRR-I) and second (HRR-II) minute after exercise is accurate in estimating autonomic nervous system balance, and has been related to risk of cardiovascular events. Our aim was to determine independent predictors of HRR collected during standard cardio-pulmonary stress test (CPT) in a group of overweight/obese subjects without (N = 14) and with type 2 diabetes (N = 19), as compared to a sample (N = 15) of healthy sedentary subjects. Methods: A graded exercise test on treadmill was performed. Oxygen uptake at rest and at peak exercise (VO(2)max), as well as respiratory exchange ratio at peak exercise was collected. Linear and logistic regression was used to assess association between variables collected at CPT and HRR-I and HRR-II. Results: Age, gender, as well as VO2 and HR at rest were all comparable among groups. VO(2)max and HRmax were both lower in diabetic patients as compared to healthy and overweight/obese groups (20 +/- 4.3 vs. 28 +/- 7 vs. 25.1 +/- 5 ml/Kg/min respectively, p < 0.01). VO(2)max had the highest association to HRR-I (R2=0.47) and HRR-II (R2=0.44); VO(2)max < 28 and VO(2)max < 29 were the most accurate cut-off values to identify subjects with abnormally low HRR-I and HRR-II. Conclusions: VO(2)max is an independent predictor of HRR-I or HRR-II, and it is able to discriminate between patients with normal or abnormally low HRR values. Further studies are warranted to test usefulness of a customized exercise program to ameliorate autonomic nervous system balance, therefore reducing global cardiovascular risk.","[Cataldo, Angelo; Zangla, Daniele; Cerasola, Dario; Traina, Marcello] Univ Palermo, Sport & Exercise Sci DISMOT Res Unit, Via Pascoli 6, I-90144 Palermo, Italy; [Bellavia, Diego] Mediterranean Inst Transplantat & Adv Specialized, Div Cardiovasc Dis, Palermo, Italy","Cataldo, A (corresponding author), Univ Palermo, Sport & Exercise Sci DISMOT Res Unit, Via Pascoli 6, I-90144 Palermo, Italy.",,"Zangla, Daniele/AAG-8419-2021; Cataldo, Angelo/AAS-4410-2020; Bellavia, Diego/K-3072-2018","Zangla, Daniele/0000-0003-1643-6960; Cataldo, Angelo/0000-0003-3038-4917; Bellavia, Diego/0000-0003-3808-2868; Traina, Marcello/0000-0003-2373-3621",,,"[Anonymous], 2006, BMI CLASSIFICATIO; Arena R, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.09.01; Cataldo A, 2014, EJSS J, V2, P8; Cheng YLJ, 2003, DIABETES CARE, V26, P2052, DOI 10.2337/diacare.26.7.205; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM19991028341180; DARR KC, 1988, AM J PHYSIOL, V254, pH340, DOI 10.1152/ajpheart.1988.254.2.H34; Dimkpa U, 2009, J EXE PHYSL, V12, P1; DIXON EM, 1992, CARDIOVASC RES, V26, P713, DOI 10.1093/cvr/26.7.71; Du N, 2005, J SPORT SCI MED, V4, P; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.54545; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-; Kannankeril PJ, 2004, J INVEST MED, V52, P394, DOI 10.1136/jim-52-06-3; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.03; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa01185; Paoli A, 2015, IRAN J PUBLIC HEALTH, V44, P60; Ribisl PM, 2012, J OBES, V2012, DOI 10.1155/2012/30919; Rosenblueth A, 1934, AM J PHYSIOL, V110, P42, DOI 10.1152/ajplegacy.1934.110.1.4; Sacre JW, 2012, DIABETIC MED, V29, pE312, DOI 10.1111/j.1464-5491.2012.03719.; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-",19,0,0,1,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,889.0,896,,10.19193/0393-6384_2016_4_106,,8,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000006,,,,,2022-07-14,0.001962809917355372,2.1611304812116646e-08,0.003715742268983118,0.11099517262730618,0.003715742268983118
J,"Cavallaro, A1;  Martines, F;  Cannizzaro, C;  Lavanco, G;  Brancato, A;  Carollo, G;  Plescia, F;  Salvago, P;  Cannizzaro, E;  Mucia, M;  Rizzo, S;  Martini, A;  Plescia, F",,,,"Cavallaro, Angela; Martines, Francesco; Cannizzaro, Carla; Lavanco, Gianluca; Brancato, Anna; Carollo, Gaetano; Plescia, Fabiana; Salvago, Pietro; Cannizzaro, Emanuele; Mucia, Marianna; Rizzo, Serena; Martini, Alessandro; Plescia, Fulvio",,,ROLE OF CANNABINOIDS IN THE TREATMENT OF TINNITUS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,cannabinoids; tinnitus; dorsal cochlear nucleus,DORSAL COCHLEAR NUCLEUS; TEMPORAL-LOBE EPILEPSY; INTENSE SOUND EXPOSURE; INFERIOR COLLICULUS; ENDOGENOUS CANNABINOIDS; AUDITORY-CORTEX; ENDOCANNABINOID SYSTEM; RECEPTOR AGONISTS; ACOUSTIC TRAUMA; NEURAL ACTIVITY,"Tinnitus is a frequent symptom in audiological clinical practice characterized by an abnormal noise perceived in one or both ears or in the head, in which a patient has a conscious hearing percept in absence of external sound. Tinnitus might be caused by a homeostatic response of central dorsal cochlear nucleus auditory neurons that makes them hyperactive in compensation to auditory input loss. One hypothesis suggests that tinnitus is a sensory form of epilepsy that involves the cochlear nucleus and the inferior colliculus, which display impairment in the electrical activity in the auditory system. This alteration determines a synaptic plasticity in the dorsal cochlear nucleus that becomes a target for pharmacological compounds able to treat tinnitus. There is no effective drug treatment for tinnitus, but different studies propose the use of cannabinoid receptors agonist for their anti-epileptic activity, although their practical effects are still unclear. In this review, we want to analyze the emerging pharmacological approaches of cannabinoid receptor agonists to the therapy of tinnitus.","[Cavallaro, Angela; Cannizzaro, Carla; Lavanco, Gianluca; Brancato, Anna; Carollo, Gaetano; Cannizzaro, Emanuele; Plescia, Fulvio] Univ Palermo, Dept Sci Hlth Promot & Mother & Child Care Giusep, Via Vespro 129, I-90127 Palermo, Italy; [Martines, Francesco; Salvago, Pietro; Mucia, Marianna; Rizzo, Serena] Univ Palermo, BioNeC Dept, ENT Sect, Palermo, Italy; [Plescia, Fabiana] Univ Palermo, DIBIMED Dept Biotecnol & Biopathol Med, Palermo, Italy; [Martini, Alessandro] Univ Padua, Dept Neurosci, ENT Surg, Padua, Italy","Plescia, F (corresponding author), Univ Palermo, Dept Sci Hlth Promot & Mother & Child Care Giusep, Via Vespro 129, I-90127 Palermo, Italy.",,"Plescia, Fulvio/AAZ-2591-2020; Brancato, Anna/P-7418-2017; Martini, Alessandro/K-2513-2018","Brancato, Anna/0000-0002-8635-4146; Martini, Alessandro/0000-0002-2003-6348; CANNIZZARO, Emanuele/0000-0001-7070-209X; PLESCIA, Fulvio/0000-0002-4786-8435; Lavanco, Gianluca/0000-0002-4962-379X; MARTINES, Francesco/0000-0002-8616-4481",,,"ADAMS JC, 1979, J COMP NEUROL, V183, P519, DOI 10.1002/cne.90183030; Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.00; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-; Ballacchino A, 2015, ACTA MEDICA MEDITERR, V31, P60; Basta D, 2004, NEUROSCI RES, V50, P237, DOI 10.1016/j.neures.2004.07.00; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-; Bauer CA, 2003, OTOLARYNG CLIN N AM, V36, P267, DOI 10.1016/S0030-6665(02)00171-; Biegon A, 2001, NEUROIMAGE, V14, P1463, DOI 10.1006/nimg.2001.093; Brozoski T, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.0000; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.200; BRUNSOBECHTOLD JK, 1981, J COMP NEUROL, V197, P705, DOI 10.1002/cne.90197041; Cannizzaro E, 2014, HEARING BALANC COMMU, V12, P166, DOI 10.3109/21695717.2014.96493; Carletti F, 2015, NEUROSCIENCE, V303, P149, DOI 10.1016/j.neuroscience.2015.06.04; Carletti F, 2016, EPILEPSY RES, V122, P56, DOI 10.1016/j.eplepsyres.2016.02.00; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.02; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.01; Eggermont JJ, 1998, HEARING RES, V117, P149, DOI 10.1016/S0378-5955(98)00008-; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.00; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.200; GERKEN GM, 1985, HEARING RES, V20, P221, DOI 10.1016/0378-5955(85)90027-; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-; Guo J, 2004, MOL PHARMACOL, V65, P665, DOI 10.1124/mol.65.3.66; Hajos M, 2008, BIOL PSYCHIAT, V63, P1075, DOI 10.1016/j.biopsych.2007.12.00; Heffner HE, 2002, HEARING RES, V170, P83, DOI 10.1016/S0378-5955(02)00343-; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.193; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-; Irvine DRF, 1997, ACTA OTO-LARYNGOL, P3; JASTREBOFF PJ, 1991, ARCH OTOLARYNGOL, V117, P116; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.81; JASTREBOFF PJ, 1994, HEARING RES, V80, P216, DOI 10.1016/0378-5955(94)90113-; Kaltenbach JA, 1996, AUDIT NEUROSCI, V3, P5; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.03; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-; Kaltenbach JA, 2006, HEARING RES, V216, P224, DOI 10.1016/j.heares.2006.01.00; Kanold PO, 2001, J NEUROSCI, V21, P7848, DOI 10.1523/JNEUROSCI.21-19-07848.200; Katona I, 1999, J NEUROSCI, V19, P454; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-15042; Kempel P, 2003, NEUROPSYCHOBIOLOGY, V48, P95, DOI 10.1159/00007288; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.060183210; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.200; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.00; Martines F, 2015, ACTA MEDICA MEDITERR, V31, P90; Martines F, 2015, EUR ARCH OTO-RHINO-L, V272, P2719, DOI 10.1007/s00405-014-3275-; McFadden SL, 1998, HEARING RES, V120, P121, DOI 10.1016/S0378-5955(98)00052-; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-; Ochi K, 1997, HEARING RES, V105, P105, DOI 10.1016/S0378-5955(96)00201-; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-; OLIVER DL, 1984, J COMP NEUROL, V224, P155, DOI 10.1002/cne.90224020; OSEN KK, 1972, J COMP NEUROL, V144, P355, DOI 10.1002/cne.90144030; Penzo MA, 2009, J NEUROSCI, V29, P4131, DOI 10.1523/JNEUROSCI.5466-08.200; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn124; PITLER TA, 1992, J NEUROSCI, V12, P412; PLESCIA F, 2016, EMERGING PHARMACOLOG, P4; Raby WN, 2006, J OCUL PHARMACOL TH, V22, P68, DOI 10.1089/jop.2006.22.6; Rizzo V, 2014, EPILEPSY RES, V108, P1711, DOI 10.1016/j.eplepsyres.2014.10.00; Ryberg E, 2005, FEBS LETT, V579, P259, DOI 10.1016/j.febslet.2004.11.08; RYUGO DK, 1981, BRAIN RES, V210, P342, DOI 10.1016/0006-8993(81)90907-; SHIRE D, 1995, J BIOL CHEM, V270, P3726, DOI 10.1074/jbc.270.8.372; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.; Smith Paul F, 2005, Curr Opin Investig Drugs, V6, P68; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.02; Ueda N, 2011, BIOFACTORS, V37, P1, DOI 10.1002/biof.13; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.05192; WallhausserFranke E, 1997, NEUROREPORT, V8, P725, DOI 10.1097/00001756-199702100-0002; Wang J, 1996, J NEUROPHYSIOL, V75, P171, DOI 10.1152/jn.1996.75.1.17; Wang JA, 2002, HEARING RES, V168, P238, DOI 10.1016/S0378-5955(02)00360-; Wilson RI, 2001, NATURE, V411, P974, DOI 10.1038/3508212; Wright DD, 1996, J COMP NEUROL, V365, P159, DOI 10.1002/(SICI)1096-9861(19960129)365:1<159::AID-CNE12>3.0.CO;2-; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-; Zhao Y, 2010, J NEUROPHYSIOL, V103, P2931, DOI 10.1152/jn.z9k-0103-corr.201; Zheng Y, 2008, ACTA OTO-LARYNGOL, V128, P48, DOI 10.1080/0001648070136193; Zheng Y, 2007, HEARING RES, V228, P105, DOI 10.1016/j.heares.2007.01.02; Zheng YW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.0006; Zheng YW, 2010, HEARING RES, V268, P145, DOI 10.1016/j.heares.2010.05.01; [No title captured",77,4,5,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,903.0,909,,10.19193/0393-6384_2016_4_108,,7,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000008,,,,,2022-07-14,0.008057851239669421,1.9387237324241082e-08,0.08966214527260793,0.12950006020147425,0.08920999987248056
J,"Celik, M1;  Koklu, M;  Gusoy, E;  Gungor, M;  Yasar, S;  Gormel, S;  Yildirim, E;  Gokoglan, Y;  Yuksel, UC;  Kabul, HK;  Barcin, C",,,,"Celik, Murat; Koklu, Mustafa; Gusoy, Erol; Gungor, Mutlu; Yasar, Salim; Gormel, Suat; Yildirim, Erkan; Gokoglan, Yalcin; Yuksel, Uygar Cagdas; Kabul, Hasan Kutsi; Barcin, Cem",,,THE SERUM CALCIUM TO MAGNESIUM RATIO IN PATIENTS WITH ACUTE CORONARY SYNDROME,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Serum CalMg ratio; acute coronary syndrome; ST-segment elevation myocardial infarction; and non-ST-segment elevation myocardial infarction,ACUTE MYOCARDIAL-INFARCTION; IONIZED MAGNESIUM; DEFICIENCY; ATHEROSCLEROSIS; HYPOMAGNESEMIA; INFLAMMATION; DYSFUNCTION; POTASSIUM; DIAGNOSIS; PROMOTES,"Introduction: There is still uncertainty about the pathophysiological role of magnesium (Mg) in the course of acute coronary syndrome. Since Mg is considered to be natural physiologic 'calcium (Ca) antagonist', the balance between Ca and Mg seems to be more important to reflect its homoeostasis rather than the measurement of serum Mg level. Material and methods: A total of 92 patients (67 male, mean age 61.19 +/- 13.64 years) with the diagnosis of acute coronary syndrome were enrolled into this study. Patients were divided into 2 groups by non-ST-segment elevation myocardial infarction to ST segment elevation myocardial infarction. Clinical and demographic characteristics, and the results of blood samples within 24 hour of admission were evaluated. Results: The mean Ca/Mg ratio for the entire subject cohort on admission was 4.28 +/- 0.53. Although serum Ca level was not statistically significantly different between two groups, the patients with ST-segment elevation myocardial infarction were found to have significantly low levels of serum Mg as compared to the non-ST-segment elevation myocardial infarction group (p = 0.004). Consistently, ST-segment elevation myocardial infarction was associated with higher Ca/Mg ratio as compared those with non-ST segment elevation myocardial infarction. In multivariate linear regression analysis, acute coronary syndrome presentation (ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction) (Unstandardized Coefficients B = 0.262; 95%CI=0.048 - 0.476; p=0.017) and serum triglyceride (Unstandardized Coefficients B = -0.002; 95%CI=-0.001 -0.000; p=0.027) were found as independent predictors of serum Ca/Mg ratio. Conclusion: The serum Ca/Mg ratio is higher in ST-segment elevation myocardial infarction patients compared those with non-ST-segment elevation myocardial infarction. This could be because of a greater decrease in the levels of Mg than in those of Ca.","[Celik, Murat; Koklu, Mustafa; Gusoy, Erol; Yasar, Salim; Gormel, Suat; Yildirim, Erkan; Gokoglan, Yalcin; Yuksel, Uygar Cagdas; Kabul, Hasan Kutsi; Barcin, Cem] Gulhane Mil Med Acad, Dept Cardiol, Ankara, Turkey; [Gungor, Mutlu] Mem Sisli Hosp, Serv Cardiol, Istanbul, Turkey","Celik, M (corresponding author), Gulhane Mil Med Acad, Dept Cardiol, Cardiol, TR-06018 Etlik, Turkey.",,"yuksel, uygar cagdas/AAA-5958-2021",,,,"AGUS ZS, 1991, ANNU REV PHYSIOL, V53, P299, DOI 10.1146/annurev.physiol.53.1.29; Barbagallo M, 2007, ARCH BIOCHEM BIOPHYS, V458, P40, DOI 10.1016/j.abb.2006.05.00; Dong JF, 2008, THROMB HAEMOSTASIS, V99, P586, DOI 10.1160/TH07-11-069; Elin RJ, 2010, MAGNESIUM RES, V23, pS194, DOI 10.1684/mrh.2010.021; Ferre S, 2010, BBA-MOL BASIS DIS, V1802, P952, DOI 10.1016/j.bbadis.2010.06.01; FLETCHER GF, 1991, AM HEART J, V121, P105, DOI 10.1016/0002-8703(91)90962-; FLINK EB, 1981, ARCH INTERN MED, V141, P441, DOI 10.1001/archinte.141.4.44; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr16; King DE, 2009, MAGNESIUM RES, V22, P57, DOI 10.1684/mrh.2009.016; Kumar A, 2009, MAYO CLIN PROC, V84, P917, DOI 10.1016/S0025-6196(11)60509-; Liao FZ, 1998, AM HEART J, V136, P480, DOI 10.1016/S0002-8703(98)70224-; Maier JAM, 2004, BBA-MOL BASIS DIS, V1689, P13, DOI 10.1016/j.bbadis.2004.01.00; Maier JAM, 2004, BBA-MOL BASIS DIS, V1689, P6, DOI 10.1016/j.bbadis.2004.02.00; Mazur A, 2007, ARCH BIOCHEM BIOPHYS, V458, P48, DOI 10.1016/j.abb.2006.03.03; Niemela JE, 1997, J LAB CLIN MED, V129, P89, DOI 10.1016/S0022-2143(97)90165-; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm115; Pearson PJ, 1998, ANN THORAC SURG, V65, P967, DOI 10.1016/S0003-4975(98)00020-; Ramasamy R, 2013, J CLIN DIAGN RES, V7, P817, DOI 10.7860/JCDR/2013/5524.294; Ravn HB, 2001, BLOOD COAGUL FIBRIN, V12, P223, DOI 10.1097/00001721-200106000-0000; Rosanoff A, 2004, J AM COLL NUTR, V23, p501S, DOI 10.1080/07315724.2004.1071938; RUBEIZ GJ, 1993, CRIT CARE MED, V21, P203, DOI 10.1097/00003246-199302000-0001; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-; Shechter M, 2010, MAGNESIUM RES, V23, P60, DOI 10.1684/mrh.2010.020; Shimosawa Tatsuo, 2005, Clin Calcium, V15, P23; Shivakumar K, 2001, MED HYPOTHESES, V56, P110, DOI 10.1054/mehy.2000.112; SPEICH M, 1980, CLIN CHEM, V26, P166; Tong Garrison M, 2005, J Intensive Care Med, V20, P3, DOI 10.1177/088506660427153; Ueshima K, 2004, HEART VESSELS, V19, P267, DOI 10.1007/s00380-004-0782-; WEISMAN HF, 1988, CIRCULATION, V78, P186, DOI 10.1161/01.CIR.78.1.18; Wolf FI, 2008, MAGNESIUM RES, V21, P5",30,4,4,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,691.0,697,,10.19193/0393-6384_2016_3_76,,7,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400005,,,,,2022-07-14,0.002995867768595041,5.578926958536077e-13,0.005777055036933499,0.07774038886256496,0.005777055036933499
J,"Chisari, G31;   Rampello, L;   Chisari, EM;   Catania, VE;   Greco, C;   Stagni, E;   Chisari, CG",,,,"Chisari, Giuseppe; Rampello, Liborio; Chisari, Eleonora Margherita; Catania, Vito Emanuele; Greco, Carmen; Stagni, Edoardo; Chisari, Clara Grazia",,,MICROBIOLOGY SYNERGISM BETWEEN TEAR SUBSTITUTES AND SYMBIOTIC TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Dry eye; tear; ecosystem eye; Lactobacillus and Bifidobacterium,OCULAR SURFACE; GUT MICROBIOTA; RISK-FACTORS; PROBIOTICS; DISEASE; HEALTH,"The tear film consists of a set of heterogeneous substances (lipids, proteins, mucin and water) combined in order to form a highly organic tropism structure specialized in the defense of the ocular surface. Dry Eye Disease (DED) is characterized by discomfort, visual disturbance, constant irritation, foreign body sensation, and blurred vision. We evaluate in this preliminary report the effect of supplementation with symbiotic Maxiflor on tear film in DED patients. We recruited 40 patients (27 females and 13 males, age 51.5 +/- 11. 1) showing signs of discomfort and / or dry eyes (burning, foreign body sensation, dryness or itching). Following the run-in period subjects were randomized in two groups: group A (N degrees 20 subjects) and group B (N degrees 20 subjects). Group A (control) treated only with substitute tear and group B treated with substitute tear + mixture (symbiotic). The data obtained in the two study groups A and B were, respectively the following: Schirmer 10.1 +/- 0.2 vs 12.7 +/- 0.4 (p < 0.001); Schirmer II 3.6 +/- 0.1 VS 4.6 +/- 0.2 (p<0.001); Fluorescein in break-up time (TF BUT) 4.1 +/- 0.3 vs 6.5 +/- 0.2 (p<0.001). Culture test showed initial bacterial growth in 18 out of 40 samples tested in group A (control), corresponding to 45.0%; whereas bacterial culture was found positive after treatment in 14 out of 40 tests, equal to 35.0%, in group B (symbiotic). A reduction of 16 to 12 strains of aerobic and anaerobic isolates from 10 to 6 has been found. The present study shows that the administration of Bifidobacteria and Lactobacillus may represent a successful treatment in ameliorating DED.","[Chisari, Giuseppe] Univ Catania, Dept Biomed & Biotechnol Sci, Ctr Ocular Microbiol, I-95124 Catania, Italy; [Rampello, Liborio; Chisari, Clara Grazia] Univ Catania, Dept Neurosci, I-95124 Catania, Italy; [Chisari, Eleonora Margherita] Univ Catania, Dept Educ, I-95124 Catania, Italy; [Catania, Vito Emanuele; Stagni, Edoardo] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, I-95124 Catania, Italy; [Greco, Carmen] Univ Catania, Res Ctr Great Senescence, Hosp Cannizzaro, I-95124 Catania, Italy","Chisari, G (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, Ctr Ocular Microbiol, I-95124 Catania, Italy.",,,"chisari, clara grazia/0000-0003-1607-543X; CATANIA, Vito Emanuele/0000-0001-5184-5220; CHISARI, Giuseppe/0000-0002-0492-2171",,,"Chisari CG, 2015, ACTA MEDICA MEDITERR, V31, P121; Chisari CG, 2014, ACTA MEDICA MEDITERR, V30, P24; Chisari G, 2015, ACTA MEDICA MEDITERR, V31, P105; Chisari G, 2013, ACTA MEDICA MEDITERR, V29, P36; Chisari G, 2011, ACTA MEDICA MEDITERR, V27, P7; Chisari G, 2008, CURR CLIN PHARMACOL, V3, P153, DOI 10.2174/15748840878574769; Ferreira CM, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/68949; Frazzetto P, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-S1-S1; Galvano Fabio, 2010, Front Biosci (Schol Ed), V2, P86; Gill HS, 2001, J CLIN IMMUNOL, V21, P264, DOI 10.1023/A:101097922501; Goldsmith JR, 2014, J GASTROENTEROL, V49, P785, DOI 10.1007/s00535-014-0953-; Ibrahim F, 2010, FEMS IMMUNOL MED MIC, V59, P53, DOI 10.1111/j.1574-695X.2010.00658.; Kaido M, 2012, CORNEA, V31, P1009, DOI 10.1097/ICO.0b013e31823f8cf; Leahy SC, 2005, J APPL MICROBIOL, V98, P1303, DOI 10.1111/j.1365-2672.2005.02600.; Magnano M, 2012, ACTA MEDICA MEDITERR, V28, P23; Malaguarnera G, 2015, CLIN OPHTHALMOL, V9, P1437, DOI 10.2147/OPTH.S7753; Malaguarnera G, 2014, WORLD J GASTROENTERO, V20, P16639, DOI 10.3748/wjg.v20.i44.1663; Malaguarnera G, 2013, ANTI-CANCER AGENT ME, V13, P1406, DOI 10.2174/1871520611313666034; Malaguarnera G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/94350; Malaguarnera M, 2013, ACTA MEDICA MEDITERR, V29, P79; Malaguarnera M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/65098; Malaguarnera M, 2012, J CANCER RES THER, V8, P520, DOI 10.4103/0973-1482.10652; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.06; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.35; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P126; Schiffman RM, 2003, OPHTHALMOLOGY, V110, P1412, DOI 10.1016/S0161-6420(03)00462-; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.200; Shanahan F, 2012, GASTROENTEROL CLIN N, V41, P869, DOI 10.1016/j.gtc.2012.08.00; Sheppard John D, 2003, Manag Care, V12, P2; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.124116; Uccello M, 2012, BMC SURG, V35, P147; Vinci M, 2001, ANN RHEUM DIS, V60, P42; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-; Wopereis H, 2014, PEDIAT ALLERG IMM-UK, V25, P428, DOI 10.1111/pai.1223; Yoon Kyung-Chul, 2004, Korean J Ophthalmol, V18, P16",35,13,14,1,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,865.0,870,,10.19193/0393-6384_2016_4_102,,6,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000002,,,,,2022-07-14,0.003615702479338843,3.849180522212054e-06,0.0028534634346118267,0.09707861562684905,0.0027973187177814094
J,"Cocuzza, S1;  Serra, A;  Gulino, A;  Di Luca, M;  Follari, S;  Campione, G;  Licciardello, L;  Maiolino, L;  Di Mauro, P",,,,"Cocuzza, Salvatore; Serra, Agostino; Gulino, Alessandro; Di Luca, Milena; Follari, Stefania; Campione, Gianluca; Licciardello, Luisa; Maiolino, Luigi; Di Mauro, Paola",,,CLINICAL EXPERIENCE WITH THIRD GENERATION OF VOCAL PROSTHESIS IN LARYNGECTOMIZED PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,tracheoesophageal voice; vocal prosthesis; lifetime,TRACHEOESOPHAGEAL VOICE PROSTHESIS; SPEECH REHABILITATION; BLOM-SINGER; PROVOX; RESTORATION; PUNCTURE; SUCCESS; REFLUX,"Introduction: Technological advancements have been such that today the indwelling vocal prostheses, in laryngectomyzed patients, are designed to meet the criteria of low airflow resistance, optimal retention in the tracheoesophageal party wall, prolonged device lifetime, simple maintenance by patient and comfortable outpatient replacement. The aim of this study was to assess the initial clinical experience using third generation of vocal prosthesis (Provox Vega). Materials and method: A retrospective study was carried out with 54 laryngectomized patients during the period 2011-2015. Patients were rehabilitated with indwelling Provox Vega 17 and 20 Fr. Fourteen patients were considered normal patients (Group A); thirteen patients received postoperative radiotherapy (Group B); sixteen patients were categorized as GERD patients (Group C) and eleven subject as elderly patients (Group D). Results: The mean in situ Vega lifetime was 193 days (range: 144-243) in group A, 168 days: (range 125-182) in group B, 123 days (range: 97-134) in group C and 240 days in group D (range: 205-328). Overall, the prosthetic lifetime average was 187.5 days. The Harrison-Robillard-Schultz score, did not show statistically significant differences with the reference groups. Conclusion: The study in question showed an overall better results in terms of lifetime and use, quality and care of the rehabilitation level, but nonetheless comparable with those present in the literature and previously registered, in terms of statistical significance.","[Cocuzza, Salvatore; Serra, Agostino; Gulino, Alessandro; Di Luca, Milena; Follari, Stefania; Campione, Gianluca; Licciardello, Luisa; Maiolino, Luigi; Di Mauro, Paola] Univ Catania, ENT Dept, Via Santa Sofia 78, I-95125 Catania, Italy","Cocuzza, S (corresponding author), Univ Catania, ENT Dept, Via Santa Sofia 78, I-95125 Catania, Italy.",,"Di Mauro, Paola/AAC-1502-2019","Cocuzza, Salvatore/0000-0002-6135-0958",,,"Ackerstaff AH, 1999, ARCH OTOLARYNGOL, V125, P167, DOI 10.1001/archotol.125.2.16; Bozec A, 2010, EUR ARCH OTO-RHINO-L, V267, P751, DOI 10.1007/s00405-009-1138-; Cantu E, 1998, AM J OTOLARYNG, V19, P12, DOI 10.1016/S0196-0709(98)90059-; Chone CT, 2005, OTOLARYNG HEAD NECK, V133, P89, DOI 10.1016/j.otohns.2005.02.01; Cocuzza S, 2014, J VOICE, V28, P245, DOI 10.1016/j.jvoice.2013.08.00; Cocuzza S, 2013, EUR ARCH OTO-RHINO-L, V270, P1879, DOI 10.1007/s00405-013-2430-; Cocuzza S, 2012, EUR ARCH OTO-RHINO-L, V269, P1483, DOI 10.1007/s00405-012-1938-; Cornu AS, 2003, J LARYNGOL OTOL, V117, P56, DOI 10.1258/00222150332104665; Cornu AS, 2003, LARYNGOSCOPE, V120, P113; Delsupehe K, 1998, LARYNGOSCOPE, V108, P1561, DOI 10.1097/00005537-199810000-0002; Free RH, 2003, ACTA OTO-LARYNGOL, V123, P547, DOI 10.1080/003655402100002811; Hancock KL, 2013, EUR ARCH OTO-RHINO-L, V270, P1447, DOI 10.1007/s00405-012-2154-; Herranz Gonzalez-Botas J, 2001, Acta Otorrinolaringol Esp, V52, P22; Hilgers FJM, 2003, ACTA OTO-LARYNGOL, V123, P972, DOI 10.1080/0001648031001537; Hilgers FJM, 2010, LARYNGOSCOPE, V120, P1135, DOI 10.1002/lary.2092; HILGERS JM, 1990, LARYNGOSCOPE, V100, P120; Leder SB, 1997, HEAD NECK-J SCI SPEC, V19, P48; Lequeux T, 2003, J LARYNGOL OTOL, V117, P875, DOI 10.1258/00222150332254288; Lorenz KJ, 2010, HNO, V58, P1174, DOI 10.1007/s00106-010-2169-; Lorenz KJ, 2010, ANN OTO RHINOL LARYN, V119, P719, DOI 10.1177/00034894101190111; Makitie AA, 2003, ANN OTO RHINOL LARYN, V112, P100; Op de Coul BMR, 2000, ARCH OTOLARYNGOL, V126, P1320, DOI 10.1001/archotol.126.11.132; Serra A, 2015, ACTA OTORHINOLARYNGO, V35, P412, DOI 10.14639/0392-100X-68; Serra A, 2016, EUR ARCH OTORHINOLA; Serra A, 2010, ACTA MEDICA MEDITERR, V26, P9; Serra A, 2009, ACTA MEDICA MEDITERR, V25, P12; SHULTZ JR, 1992, ARCH OTOLARYNGOL, V118, P81; SINGER MI, 1986, ANN OTO RHINOL LARYN, V112, P44",28,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_134,,4,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000005,,,,,2022-07-14,0.002892561983471074,1.1960372213662285e-11,0.005282000565252028,0.10239593801237637,0.0052275779804442325
J,"Colak, A1;  Kaya, U;  Becit, N;  Sevil, MCF;  Kocak, H",,,,"Colak, Abdurrahim; Kaya, Ugur; Becit, Necip; Sevil, Munacettin Ceviz Fehimcan; Kocak, Hikmet",,,HOLT-ORAM SYNDROME: A RARE CASE REPORT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Holt-Oram; Atrial Septal Defect; Surgery,MUTATIONS; DISEASE; LIMB,"Holt-Oram syndrome (HOS) is a heart-upper limb malformation complex with an autosomal dominant inheritance and near-complete penetrance but variable expression. Holt and Oram first described this syndrome in 1960. Approximately 40% of cases represent new mutations. The syndrome is associated with defective development of cardiac structures that results in atrial septal defect (ASD), most commonly the secundum type; heart block of varying degree; or both. The syndrome is characterized by cardiac malformations and aplasia or hypoplasia of the thumb. The incidence of HOS is estimated at 1: 100,000 live births. In the literature, it is also known as atriodigital syndrome, heart-hand syndrome, upper limb-cardiovascular syndrome, cardiac-limb syndrome, or cardiomelic syndrome. Herein, we report a 22-year-old female case of HOS presenting with the absence of the right radius of the upper limb and ulnar dysplasia, hypoplasia, and kyphoscoliosis along with a large secundum type ASD and carotid artery abnormalities. We present this case of holt-oram syndrome with cardiac surgery and postoperative neurological complication and its successful treatment.","[Colak, Abdurrahim; Kaya, Ugur; Becit, Necip; Sevil, Munacettin Ceviz Fehimcan; Kocak, Hikmet] Ataturk Univ, Fac Med, Dept Cardiovasc Surg, TR-25240 Erzurum, Turkey","Colak, A (corresponding author), Ataturk Univ, Fac Med, Dept Cardiovasc Surg, TR-25240 Erzurum, Turkey.",,"Sevil, Fehim Can/AAA-5289-2021; Kaya, Ugur/AAO-1605-2021; Ãolak, Abdurrahim/AAO-1201-2021","Sevil, Fehim Can/0000-0003-3902-9831; ",,,"Al-Qattan MM, 2015, GENE, V560, P129, DOI 10.1016/j.gene.2015.02.01; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-3; Bostan Ozlem M, 1999, TURK KARDIYAL DERN A, V27, P12; Brockhoff CJ, 1999, CIRCULATION, V99, P1395, DOI 10.1161/01.CIR.99.10.139; HOLT M, 1960, BRIT HEART J, V22, P23; HURST JA, 1991, J MED GENET, V28, P406, DOI 10.1136/jmg.28.6.40; Isik O, 2015, EGE TIP DERGISI, V54, P8; James MA, 1996, J HAND SURG-AM, V21A, P104, DOI 10.1016/S0363-5023(96)80162-; SEALY WC, 1969, J THORAC CARDIOV SUR, V57, P245, DOI 10.1016/S0022-5223(19)42747-; Sletten LJ, 1996, AM J MED GENET, V65, P128, DOI 10.1002/(SICI)1096-8628(19961016)65:2<128::AID-AJMG9>3.0.CO;2-; STARKE H, 1967, AM J CARDIOL, V19, P588, DOI 10.1016/0002-9149(67)90436-; ZHANG KZ, 1986, AM HEART J, V111, P572, DOI 10.1016/0002-8703(86)90066-",12,0,0,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1899.0,1903,,10.19193/0393-6384_2016_6_180,,5,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300024,,,,,2022-07-14,0.0013429752066115702,1.8565310647407575e-08,0.0024779299821800454,0.12771965009038014,0.0024779299821800454
J,"Dahaz, S1;  Saberi, A;  Orazizadeh, M;  Mackvandi, M;  Teimorri, A;  Neysi, N",,,,"Dahaz, Shapour; Saberi, Alihossein; Orazizadeh, Mahmod; Mackvandi, Manochehr; Teimorri, Ali; Neysi, Nilofar",,,EVALUATION OF TARDBP GENE KNOCK EFFECT ON EXPRESSION RATE OF SMN1 GENE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,neurodegenerative; TD-P43 gene; knockdown; Tardbp gene,,"Introduction: Neurodegenerative diseases are among significant agent of mortality in human societies. The major cause of this disease is the elimination of SMN1 gene exogenous 7 located on telomeric terminal of chromosome 5. The patients at least posses one copy of SMN2 gene which is located on centromeric terminal and is slightly different from the main gene. Methods: In the present study, TDP-43 gene was knocked down in Hela cell line, using siRNA technic and the expression level of mRNA was evaluated in SMN1 gene by semi-quantitative index method and using real-time PCR. Results: After statistical analyses the most important result was significant decrease in level of mRNA expression in SMN1 gene approximately by 6.14 fold. Sanger sequencing method was applied for exact evaluation of total TDP-43 gene length in the patients and carriers. Conclusion: In accordance with involvement of motor neurons in the anterior horn of the spinal cord and brain in ALS and SMA diseases in this survey, it is suggested that the mentioned gene mutation in SMA disease can be effective in regulation of the disease main gene expression.","[Dahaz, Shapour; Orazizadeh, Mahmod] Jundi Shapour Univ, Departement Anat, Ahvaz, Iran; [Saberi, Alihossein] Jundi Shapour Univ, Dept Genet, Ahvaz, Iran; [Mackvandi, Manochehr; Teimorri, Ali; Neysi, Nilofar] Jundi Shapour Univ, Departement Virol, Ahvaz, Iran","Dahaz, S (corresponding author), Jundi Shapour Univ, Departement Anat, Ahvaz, Iran.",shapour1348@gmail.com,"Orazizadeh, Mahmoud/ABG-8317-2020","Orazizadeh, Mahmoud/0000-0002-0485-149X; dahaz, shapour/0000-0001-7701-1072; saberi, Alihossein/0000-0003-4360-9118",,,"[Anonymous], HER MOT SYNDR SMA A; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.05; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb88; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/33862; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-; Imlach Wendy L., 2012, SMN IS REQUIRED SENS, V151, P42; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng120; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.01; Macare I. j, 2006, STRUCTURE DICER MEC; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.3347; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.19088; Setola Veronica, 2006, AXONAL SMN A SMN PRO, V10; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.3.CO;2-",13,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,2.0,,1039.0,1044,,,,6,"Medicine, General & Internal",General & Internal Medicine,EF2SU,WOS:000390175400034,,,,,2022-07-14,0.001446280991735537,1.8576844498372542e-08,0.002684285395919768,0.1277230204911003,0.002684285395919768
J,"Daniela, G1;  Giovanni, A;  Gaspare, B;  Riccardo, M;  Mario, C;  Angelo, T;  Gaglio, RM;  Rosa, A;  Giacomo, G",,,,"Daniela, Graci; Giovanni, Alba; Gaspare, Borsellino; Riccardo, Mandracchia; Mario, Cutro; Angelo, Trigona; Gaglio, Rosa Maria; Rosa, Avarello; Giacomo, Gurgone",,,CREUTZFELDT-JAKOB DISEASE: RECENT OBSERVATION AND DISCUSSION OF TWO CLINICAL CASES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Transmissible Spongiform Encephalopathies; protein 14-3-3; periodic sharp wave complexes; prion protein,14-3-3 PROTEIN; MRI; DIAGNOSIS; ACCURACY; VARIANT; PATTERN; TESTS,"Introduction: Creutzfeldt-Jakob Disease (CJD) is a prion disease that has a wide range of clinical presentations. The diagnosis of CJD is a highly challenging issue, as clinical manifestations should be considered along with electroencephalography (EEG), cerebrospinal fluid examination (CSF), Magnetic Resonance Imaging (MRI) and serum analysis. Cases presentation: we describe two cases of CJD, come to our observation in the same period. In first patient clinical features suggested the diagnosis of Heidenhain's dementia, a rare variant of sporadic CJD, occurring in a 71-year-old woman. She succumbed to the disease within 8 weeks of onset of symptoms and diagnosis was pathologically confirmed. Second patient, a 56-year-old housewife, referred with mood disorders and presenting dementia, ataxia, myoclonic jerks, carried point mutation V2101 at codon 210 of the Prion Protein (PRNP) gene. In both patients protein 14-3-3 in CSF was detected, EEG showed bilaterally periodic sharp and slow-wave discharges, and MRI findings revealed cortex hyper-intensity (ribbon-sign) in DWI and T2W sequences. Conclusions: Our two cases are interesting because the beginning was atypical, namely with visual disturbance previous for several months the definite clinical picture in one case, and in the other with misleading psychiatric disorders.","[Daniela, Graci; Giovanni, Alba; Mario, Cutro; Gaglio, Rosa Maria; Rosa, Avarello; Giacomo, Gurgone] ASP 1 Agrigento, Dept Med, Operat Unit Neurol, Agrigento, Italy; [Gaspare, Borsellino; Riccardo, Mandracchia; Angelo, Trigona] ASP 1 Agrigento, Dept Radiol, Agrigento, Italy","Daniela, G (corresponding author), Osped S Giovanni di Dio, I-92100 Agrigento, Italy.",,,,,,"Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.15432; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P36; Castellani RJ, 2004, NEUROLOGY, V63, P436, DOI 10.1212/01.WNL.0000135153.96325.3; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl15; Demaerel P, 2003, J NEUROL, V250, P222, DOI 10.1007/s00415-003-0983-; Fukushima R, 2004, J NEUROL NEUROSUR PS, V75, P485, DOI 10.1136/jnnp.2002.00801; GERTZ HJ, 1988, NEUROLOGY, V38, P1481, DOI 10.1212/WNL.38.9.148; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.38; HARRIESJONES R, 1988, J NEUROL NEUROSUR PS, V51, P1113, DOI 10.1136/jnnp.51.9.111; Kallenberg K, 2006, AM J NEURORADIOL, V27, P145; Keyrouz SG, 2006, NEUROLOGY, V67, P333, DOI 10.1212/01.wnl.0000208487.18608.4; Krasnianski A, 2006, BRAIN, V129, P2288, DOI 10.1093/brain/awl12; Kropp S, 1999, ARCH NEUROL-CHICAGO, V56, P55, DOI 10.1001/archneur.56.1.5; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.110019; Manners DN, 2009, NEUROLOGY, V72, P1425, DOI 10.1212/WNL.0b013e3181a1884; Meissner B, 2008, AM J NEURORADIOL, V29, P1519, DOI 10.3174/ajnr.A112; Murata T, 2002, AM J NEURORADIOL, V23, P116; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.41039061; Sanchez-Juan P, 2007, J NEUROL, V254, P901, DOI 10.1007/s00415-006-0472-; Steinhoff BJ, 1996, ARCH NEUROL-CHICAGO, V53, P162, DOI 10.1001/archneur.1996.0055002007401; Stone J, 2003, AM J PSYCHIAT, V160, P391, DOI 10.1176/appi.ajp.160.2.39; Tschampa HJ, 2007, AM J NEURORADIOL, V28, P1114, DOI 10.3174/ajnr.A049; Ukisu R, 2005, AM J ROENTGENOL, V184, P560, DOI 10.2214/ajr.184.2.0184056; Wall CA, 2005, J NEUROPSYCH CLIN N, V17, P489, DOI 10.1176/appi.neuropsych.17.4.48; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-; Zerr I, 2000, ANN NEUROL, V48, P323, DOI 10.1002/1531-8249(200009)48:3<323::AID-ANA6>3.3.CO;2-; Zerr I, 2000, NEUROLOGY, V55, P811, DOI 10.1212/WNL.55.6.81; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp19",29,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,729.0,734,,10.19193/0393-6384_2016_3_81,,6,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400010,,,,,2022-07-14,0.0030991735537190084,1.876335469756682e-08,0.005983068908662273,0.1277769711049804,0.005983068908662273
J,"Degirmen, E1;  Yildirim, M;  Akin, S;  Dayanan, R;  Efe, SC",,,,"Degirmen, Elif; Yildirim, Mustafa; Akin, Selcuk; Dayanan, Ramazan; Efe, Savas Cumali",,,THE ROLE OF THE SYSTEMIC INFLAMMATORY RESPONSE IN THE DIFFERENTIAL DIAGNOSIS OF GASTRIC PATHOLOGIES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Gastric; Malignant; Benign; Neutrophil/lymphocyte ratio; Thrombocyte/lymphocyte ratio,NEUTROPHIL-LYMPHOCYTE RATIO; PREOPERATIVE NEUTROPHIL; CANCER; PROGNOSIS; SURVIVAL,"Introduction: Gastric cancer continues to be one of the most common cancers in the world, even though its incidence has decreased in some countries. Despite developments in diagnosis and treatment techniques, the disease may progress after operation despite adjuvant treatment combinations((2)). Thus, early diagnosis is important. In this study, the role of the systemic immune response (SIR) was assessed by the neutrophil/lymphocyte ratio (NLR) and the thrombocyte/lymphocyte ratio (TLR) in relation to the diagnosis of gastric malignant-benign pathologies performed using upper gastrointestinal system endoscopy. Material and methods: In total, 1916 patients were included in this study, of whom 964 (50.3%) were male and 952 (49.7%) were female. All subject had undergone upper gastrointestinal system endoscopy in the Batman Regional State Hospital Endoscopy Unit between 2010 and 2012. Results: When SIR was evaluated with the NLR, it was positive in 1415 (73.9%) patients. When the patients were grouped based on their pathological diagnosis, there was no relationship between the pathological diagnosis and the SIR determined by the NLR (p=0.629). When SIR was evaluated with the TLR, it was positive in 1450 (75.7%) patients. When the patients were grouped based on their pathological diagnosis, there was no relationship between the pathological diagnosis and the SIR determined by the TLR (p=0.944). Endoscopy is a standard method for the differential diagnosis of gastric pathologies. Conclusion: We have demonstrated that NLR and TLR, which are indicators of the systemic inflammatory response, do not play a role in increasing the diagnostic strength of endoscopy. Additionally, we believe that easily accessible, cheap, and easy-to-use laboratory methods can be developed with further studies on this topic.","[Degirmen, Elif; Akin, Selcuk] Batman Reg Goverment Hosp, Minist Hlth, Dept Biochem, Batman, Turkey; [Yildirim, Mustafa] Medicalpk Gaziantep Hosp, Dept Med Oncol, Mucahitler Mh 52063 Sk 2 Sehitkamil, TR-27090 Gaziantep, Turkey; [Dayanan, Ramazan] Batman Reg Govt Hosp, Minist Hlth, Dept Internal Med, Batman, Turkey; [Efe, Savas Cumali] Batman Reg Goverment Hosp, Minist Hlth, Dept Gastroenterol, Batman, Turkey","Yildirim, M (corresponding author), Medicalpk Gaziantep Hosp, Dept Med Oncol, Mucahitler Mh 52063 Sk 2 Sehitkamil, TR-27090 Gaziantep, Turkey.",,,,,,"Aliustaoglu M, 2010, MED ONCOL, V27, P1060, DOI 10.1007/s12032-009-9335-; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.5; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.660124; GRAHAM DY, 1982, GASTROENTEROLOGY, V82, P22; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.01; Haruma T, 2015, ANTICANCER RES, V35, P33; Hussein MR, 2005, CANCER BIOL THER, V4, P819, DOI 10.4161/cbt.4.8.186; Liu H, 2014, J VIRAL HEPATITIS, V21, P499, DOI 10.1111/jvh.1216; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa01018; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a790; Olt S, 2015, ACTA MEDICA MEDITERR, V31, P72; Ozyalvacli G, 2014, ASIAN PAC J CANCER P, V15, P10363, DOI 10.7314/APJCP.2014.15.23.1036; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.7; Sharma R, 2008, CLIN COLORECTAL CANC, V7, P331, DOI 10.3816/CCC.2008.n.04; Sharma R, 2008, EUR J CANCER, V44, P251, DOI 10.1016/j.ejca.2007.11.01; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-; Wiesner T, 2010, CLIN EXP METASTAS, V27, P141, DOI 10.1007/s10585-010-9311-; Xu AM, 2014, AM J CANCER RES, V4, P18; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/00012741; Yilmaz B, 2014, EUR J GASTROEN HEPAT, V26, P1325, DOI 10.1097/MEG.000000000000020",22,0,0,2,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,2.0,,,,,373.0,376,,,,4,"Medicine, General & Internal",General & Internal Medicine,DL0QQ,WOS:000375338000016,,,,,2022-07-14,0.0022727272727272726,1.1729856198783984e-11,0.009575315190115388,0.10857495373226403,0.008866746603171983
J,"Demirbas, B1;  Gursoy, G;  Simsek, M;  Bahsi, R;  Kosar, P;  Usta, BM",,,,"Demirbas, Berrin; Gursoy, Gul; Simsek, Meltem; Bahsi, Remzi; Kosar, Pinar; Usta, Behice Merve",,,"VISCERAL OBESITY,MAY HAVE DIFFERENT EFFECTS ON METABOLIC SYNDROME PARAMETERS IN WOMEN AND MEN",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Visceral obesity; metabolic syndrome; women; men,BODY-FAT DISTRIBUTION; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; RISK-FACTORS; ULTRASONOGRAPHY; THICKNESS; PREVALENCE; ULTRASOUND,"Introduction: This study aims to assess whether female and male individuals have different parameters of metabolic syndrome when they are classified as being viscerally obese or non-obese. Material and methods: We enrolled 288 subjects (169 women, 119 men) who were admitted to Clinic of Internal Medicine, Ankara Education and Research Hospital. They underwent physical examinations and anthropometric evaluation. They also underwent ultrasonography and blood samples were collected for further investigation. After cut-off values for visceral fat were determined, female and male subjects were classified as they were viscerally obese or not obese and all their parameters were compared. Results: Female viscerally obese subjects had statistically higher values of blood glucose, blood pressure, insulin, cholesterol, triglyceride and homeostasis model assessment - insulin resistance index than female Who were not obese. Men with visceral obesity had higher values of blood pressure, insulin, triglyceride and homeostasis model assessment - insulin resistance index than men who were not obese. Conclusions: Visceral obesity was linked to high blood pressure, triglyceride, insulin resistance in all subjects, but high blood glucose, total cholesterol levels were elevated only in females. We think that visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular diseases and metabolic syndrome both in females and males.","[Demirbas, Berrin] TOBB ETU Univ, Dept Endocrinol & Metab, Ankara, Turkey; [Gursoy, Gul] Kafkas Univ, Dept Internal Med, Kars, Turkey; [Simsek, Meltem; Bahsi, Remzi] Minist Hlth, Dept Internal Med, Ankara, Turkey; [Simsek, Meltem; Bahsi, Remzi] Educ & Res Hosp, Ankara, Turkey; [Kosar, Pinar; Usta, Behice Merve] Minist Hlth, Ankara Educ & Res Hosp, Dept Radiol, Ankara, Turkey","Demirbas, B (corresponding author), Tobb Etu Hosp, Dept Endocrinol, Yasam 5, TR-06510 Ankara, Turkey.",,"BahÅi, Remzi/AAO-9073-2021","bahsi, remzi/0000-0003-1715-6856",,,"Abe Takashi, 1995, Applied Human Science, V14, P13; ARMELLINI F, 1993, INT J OBESITY, V17, P20; ARMELLINI F, 1990, J CLIN ULTRASOUND, V18, P563, DOI 10.1002/jcu.187018070; Berker D, 2010, DIAGN INTERV RADIOL, V16, P99, DOI 10.4261/1305-3825.DIR.2749-09.; BUSETTO L, 1992, INT J OBESITY, V16, P73; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM19991007341150; Coppini LZ, 2005, CURR OPIN CLIN NUTR, V8, P329, DOI 10.1097/01.mco.0000165013.54696.6; DERIDDER CM, 1992, INT J OBESITY, V16, P44; Diaz AA, 2015, CHRON OBSTR PULM DIS, V2, P8, DOI 10.15326/jcopdf.2.1.2015.012; Erem C, 2015, IJC METAB ENDOCR, V8, P38, DOI 10.1016/j.ijcme.2015.07.00; Frayn KN, 2000, BRIT J NUTR, V83, pS71, DOI 10.1017/S000711450000098; Gomi Tatsuya, 2005, Radiat Med, V23, P58; Gong WK, 2007, ASIA PAC J CLIN NUTR, V16, P33; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.37; Hirooka M, 2005, INTERNAL MED, V44, P794, DOI 10.2169/internalmedicine.44.79; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.96; KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.151; Kim SK, 2004, AM J CLIN NUTR, V79, P59; Kosus N, 2014, ARCH MED SCI, V10, P739, DOI 10.5114/aoms.2014.4486; Kranendonk MEG, 2015, ATHEROSCLEROSIS, V239, P419, DOI 10.1016/j.atherosclerosis.2015.01.03; Leite CC, 2002, METABOLISM, V51, P1034, DOI 10.1053/meta.2002.3403; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.73; Ohman MK, 2009, CURR VASC PHARMACOL, V7, P169, DOI 10.2174/15701610978745568; REAVEN GM, 1994, J INTERN MED, V236, P1; Ribeiro FF, 2003, OBES RES, V11, P1488, DOI 10.1038/oby.2003.19; Ross R, 2002, J CLIN ENDOCR METAB, V87, P5044, DOI 10.1210/jc.2002-02057; ROSSNER S, 1990, INT J OBESITY, V14, P89; Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-; Shah Ravi V, 2014, JACC Cardiovasc Imaging, V7, P1221, DOI 10.1016/j.jcmg.2014.07.01; Spoto B, 2014, NUTR METAB CARDIOVAS, V24, P1137, DOI 10.1016/j.numecd.2014.04.01; Staten MA, 1998, J PEDIAT CHILD HLTH, V34, P2; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.080173; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.2; VANDERKOOY K, 1993, INT J OBESITY, V17, P18; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.69; WHO Consultation, 2000, WHO TECH REP SER, V894, P; Zamboni M, 1998, INT J OBESITY, V22, P655, DOI 10.1038/sj.ijo.080064; ZAMBONI M, 1992, J INTERN MED, V232, P341, DOI 10.1111/j.1365-2796.1992.tb00595.",40,1,1,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,45.0,50,,,,6,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700006,,,,,2022-07-14,0.0040289256198347105,1.6170645465263e-05,0.025447554645822604,0.10471317460489166,0.026052132266479934
J,"Demircan, F1;  Gozel, N;  Kilinc, F;  Yilmaz, M;  Donder, E;  Atmaca, M",,,,"Demircan, Fatih; Gozel, Nevzat; Kilinc, Faruk; Yilmaz, Musa; Donder, Emir; Atmaca, Murad",,,THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT ON MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER (MDD) PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Depression; mean platelet volume; coronary artery disease; SSRI,REACTIVITY; INFARCTION,"Introduction: Patients with depression are at an increased risk for cardiovascular disease. Mean platelet volume (MPV) provides a measurement of activated platelets; increasing platelet activation is one of the mechanisms that may link depression and ischemic cardiac disease. Material and method: 100 newly diagnosed patients with major depressive disorder (MDD) and 100 healthy controls admitted to our outpatient clinics. We started selective serotonin reuptake inhibitor (SSRI) treatment in the MDD patients and followed them for 3 months. Patients' laboratory tests and physical, neurological, and psychiatric examinations were performed both at diagnosis and after 3 months of treatment. Results: The MDD group consisted of 90 people and the control group consisted of 88 people met the inclusion/exclusion criteria. There was no significant difference between the ages of the groups (p = 0.28). There were more males within the MDD group (55.6%). MPV was significantly greater in MDD group (p<0.001); MPV levels showed significantly decline after treatment with SSRIs (p<0.001). The platelet counts were also significantly low in MDD patients when compared with the control group, with the difference being statistically significant (p<0.001). No significant difference was observed in platelet counts after treatment. Severity of depression also declined after treatment. The average Montgomery-Asberg Depression Rating Scale (MADRS) score decreased 9.23 points; the difference was statistically significant (p<0.001). Conclusion: We conclude that MPV can be an indicator of platelet activity in patients with MDD and SSRIs can be used along with MPV to help identifying and treating coronary artery disease in MDD patients. According to our findings, SSRIs may have an antiplatelet action in addition to their antidepressant effects, which may be beneficial for MDD patients with coronary artery disease.","[Demircan, Fatih] Private Cagri Med Ctr, Dept Internal Med, Elazig, Turkey; [Gozel, Nevzat] Firat Med Fac, Dept Internal Med, Elazig, Turkey; [Kilinc, Faruk] Dicle Univ, Fac Med, Dept Internal Med, Diyarbakir, Turkey; [Yilmaz, Musa] Firat Med Fac, Dept Biochem, Elazig, Turkey; [Donder, Emir; Atmaca, Murad] Firat Med Dept Psychiat, Ankara, Turkey","Demircan, F (corresponding author), Private Cagri Med Ctr, Dept Internal Med, Elazig, Turkey.",,"Atmaca, Murad/V-9377-2018; Donder, Emir/V-8352-2018; faruk, kilinc/W-7108-2018","Gozel, Nevzat/0000-0001-7326-6860; kilinc, faruk/0000-0002-0198-2558; donder, emir/0000-0003-2537-6023",,,"Atar D, 2007, NEUROPSYCHOPHARMACOL, V32, P2369, DOI 10.1038/sj.npp.130135; BATH PMW, 1994, CLIN SCI, V87, P253, DOI 10.1042/cs087025; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-9; Chu H, 2011, EMERG MED J, V28, P569, DOI 10.1136/emj.2010.09309; de Abajo Francisco J., 2011, DRUGS AGING, V28, P34; De Luca G, 2013, BLOOD COAGUL FIBRIN, V24, P619, DOI 10.1097/MBC.0b013e328360c75; Endler G, 2002, BRIT J HAEMATOL, V117, P399, DOI 10.1046/j.1365-2141.2002.03441.; Erem C, 2002, J ENDOCRINOL INVEST, V25, P345, DOI 10.1007/BF0334401; Galan A.M., THROMB HAEMOST, V102, P51; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.; Hrdina PD, 1997, PSYCHIAT RES, V66, P73, DOI 10.1016/S0165-1781(96)03046-; KARIO K, 1992, CLIN LAB HAEMATOL, V14, P28; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P; Khawaja Imran Shuja, 2009, Psychiatry (Edgmont), V6, P3; Laine-Cessac P, 1998, PHARMACOEPIDEM DR S, V7, pS54, DOI 10.1002/(SICI)1099-1557(199808)7:1+<S54::AID-PDS345>3.3.CO;2-; Mendoza-Sotelo J, 2010, PSYCHIAT RES, V176, P179, DOI 10.1016/j.psychres.2009.07.02; Mirzaie Ali Zare, 2012, Med J Islam Repub Iran, V26, P1; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.38; Musselman DL, 1996, AM J PSYCHIAT, V153, P131; Nusair Maen, 2012, Mo Med, V109, P19; O'Kearney R, 2009, DEPRESS ANXIETY, V26, P65, DOI 10.1002/da.2050; Pizzi C, 2012, J BIOL REG HOMEOS AG, V26, P77; Schins A, 2004, LIFE SCI, V76, P637, DOI 10.1016/j.lfs.2004.04.06; Serebruany VL, 2001, PHARMACOL RES, V43, P453, DOI 10.1006/phrs.2001.081; WEDZICHA JA, 1988, THORAX, V43, P61, DOI 10.1136/thx.43.1.6; Wozniak G, 2011, MED SCI MONITOR, V17, pRA205, DOI 10.12659/MSM.88192; Zuberi BF, 2008, SINGAP MED J, V49, P11",27,1,1,1,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,93.0,96,,,,4,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700014,,,,,2022-07-14,0.002892561983471074,1.873984370214686e-08,0.07212783130036776,0.13192504258943782,0.06670073648565067
J,"Di Mauro, P1;  Cocuzza, S;  Licciardello, L;  Maiolino, L;  Spinato, G;  Gulino, A;  Di Luca, M;  Campione, G;  Serra, A",,,,"Di Mauro, Paola; Cocuzza, Salvatore; Licciardello, Luisa; Maiolino, Luigi; Spinato, Giacomo; Gulino, Alessandro; Di Luca, Milena; Campione, Gianluca; Serra, Agostino",,,AUDITORY FUNCTION IN PATIENTS WITH CHARCOT-MARIE-TOOTH SYNDROME,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Charcot-Marie-Tooth syndrome; hearing loss; otofunctional evaluation; sound distorsion,SENSORINEURAL HEARING-LOSS; DISEASE; NEUROPATHY; INFANTS; GENE,"The Charcot-Marie-Tooth (CMT) disease is a neurological syndrome, which has seldom been associated with hearing dysfunction, particularly sudden sensorineural hearing loss (SNHL). The disease of Charcot-Marie-Tooth is due to the alteration of one or more geniuses that give way to the formation of the assone and the genesis of the myelin, whose synthetic deficit involves the reduction of the speed of nervous management. The aim of the study was to detect in individuals suffering from Charcot-Marie-Tooth syndrome with audiological signs and symptoms qualitative and quantitative type of hearing impairment and of these finds some assumptions on the location of the damage along the auditory nerve pathways.","[Di Mauro, Paola; Cocuzza, Salvatore; Licciardello, Luisa; Maiolino, Luigi; Gulino, Alessandro; Di Luca, Milena; Campione, Gianluca; Serra, Agostino] Univ Catania, ENT Dept, I-95124 Catania, Italy; [Spinato, Giacomo] Rovigo Prov Hosp, ENT Dept, Rovigo, Italy","Maiolino, L (corresponding author), Azienda Policlin Vittorio Emanuele, Clin Otorinolaringoiatr, Via Santa Sofia 78, I-95123 Catania, Italy.",,"Di Mauro, Paola/AAC-1502-2019","Cocuzza, Salvatore/0000-0002-6135-0958; Spinato, Giacomo/0000-0001-5295-5077",,,"Butinar D, 2008, CLIN NEUROPHYSIOL, V119, P367, DOI 10.1016/j.clinph.2007.10.00; Calabrese V, 2010, NEUROCHEM RES, V35, P2208, DOI 10.1007/s11064-010-0304-; Dattilo S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0046-; Fukushima E, 2011, BRAZ J OTORHINOLAR, V77, P135, DOI 10.1590/S1808-8694201100010002; Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.151; Martines F, 2013, INT J PEDIATR OTORHI, V77, P513, DOI 10.1016/j.ijporl.2012.12.02; Martines F, 2012, INT J PEDIATR OTORHI, V76, P1285, DOI 10.1016/j.ijporl.2012.05.02; Matin N, 2015, HUM VACC IMMUNOTHER, V11, P2021, DOI 10.1080/21645515.2015.103492; Murphy SM, 2011, J PERIPHER NERV SYST, V16, P191, DOI 10.1111/j.1529-8027.2011.00350.; Papadakis CE, 2003, J LARYNGOL OTOL, V117, P399, DOI 10.1258/00222150332162646; Rance G, 2012, BRAIN, V135, P1412, DOI 10.1093/brain/aws08; Salvago P, 2013, EUR ARCH OTO-RHINO-L, V270, P3049, DOI 10.1007/s00405-013-2379-; Serra A, 2015, ACTA OTORHINOLARYNGO, V35, P21; Serra A., 2016, EUROPEAN ARCH OTORHI, P; Starr A, 2003, BRAIN, V126, P1604, DOI 10.1093/brain/awg15; Trovato A, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0078-; Vitaliti G, 2015, HUM VACC IMMUNOTHER, V11, P2749, DOI 10.1080/21645515.2015.106116",17,0,0,1,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_155,,4,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000026,,,,,2022-07-14,0.001756198347107438,3.528720647483985e-11,0.005377850061349486,0.10243928250171967,0.005373950078511969
J,"Di Serio, F1;  Lovero, R;  D'Agostino, D;  Nisi, L;  Miragliotta, G;  Contino, R;  Man, A;  Ciccone, MM;  Santacroce, L",,,,"Di Serio, Francesca; Lovero, Roberto; D'Agostino, Donato; Nisi, Lucia; Miragliotta, Giuseppe; Contino, Renato; Man, Adrian; Ciccone, Marco Matteo; Santacroce, Luigi",,,"EVALUATION OF PROCALCITONIN, VITAMIN D AND C-REACTIVE PROTEIN LEVELS IN SEPTIC PATIENTS WITH POSITIVE EMOCOLTURES. OUR PRELIMINARY EXPERIENCE",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,sepsis; emocoltures; vitamin D; procalcitonin; C-reactive protein,SERUM PROCALCITONIN; SEPSIS; MARKERS,"Sepsis, the systemic inflammatory response to infection, is the most common cause of death in people hospitalized in intensive care units (ICU). Early diagnosis of infection is crucial to the appropriate management of sepsis, with early antibiotic administration consistently resulting in improved outcomes. The purpose of this study, although preliminary, was to determine whether vitamin D levels correlate with procalcitonin (PCT) and C-reactive protein (CRP) levels in 59 septic patients, with positive emocoltures. This study is also aimed to point out new possible diagnostic protocols identifying potential biomarkers for the diagnosis of sepsis, defined according to literature data.","[Di Serio, Francesca; Lovero, Roberto; Nisi, Lucia; Contino, Renato] Univ Hosp Policlin, Clin Pathol Serv, Bari, Italy; [D'Agostino, Donato] Univ Bari, Sect Cardiac Surg, Dept Emergency & Organ Transplantat, I-70121 Bari, Italy; [Miragliotta, Giuseppe] Univ Bari, Sect Microbiol & Virol, Interdisciplinary Dept Med, I-70121 Bari, Italy; [Man, Adrian] Univ Med & Pharm Tirgu Mures, Microbiol Lab, Targu Mures, Romania; [Ciccone, Marco Matteo] Univ Bar, Cardiol Sect, Dept Emergency & Organ Transplantat, Bologna, Italy; [Santacroce, Luigi] Univ Bari, Ionian Dept & Microbiol & Virol Serv, I-70121 Bari, Italy","D'Agostino, D (corresponding author), Corso Vittorio Emanuele 143, I-70122 Bari, Italy.",d.dagostino@live.it,"Ciccone, Marco M/C-5271-2013; Santacroce, Luigi/B-5466-2016; Man, Adrian/M-3475-2016","Ciccone, Marco M/0000-0002-5710-4228; Santacroce, Luigi/0000-0001-5671-8124; Man, Adrian/0000-0001-5281-0601; D'AGOSTINO, DONATO/0000-0001-5887-7655",,,"ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-145; Bochud PY, 2001, INTENS CARE MED, V27, pS33, DOI 10.1007/PL0000379; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f; Cecchi A, 2011, MINERVA ANESTESIOL, V77, P118; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8; Fan SL, 2016, CLIN CHIM ACTA, V460, P203, DOI 10.1016/j.cca.2016.07.00; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra07055; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra02133; Linscheid P, 2003, ENDOCRINOLOGY, V144, P5578, DOI 10.1210/en.2003-085; Mitaka C, 2005, CLIN CHIM ACTA, V351, P17, DOI 10.1016/j.cccn.2004.08.01; Moromizato T, 2014, CRIT CARE MED, V42, P97, DOI 10.1097/CCM.0b013e31829eb7a; Muller B, 2000, CRIT CARE MED, V28, P977, DOI 10.1097/00003246-200004000-0001; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc887; Povoa P, 2002, INTENS CARE MED, V28, P235, DOI 10.1007/s00134-002-1209-; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.631074; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/42199",18,24,24,1,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1911.0,1914,,10.19193/0393-6384_2016_6_182,,4,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300026,,,,,2022-07-14,0.001859504132231405,1.8211253421947004e-17,0.049833525812342086,0.08403872031948605,0.0507690546063091
J,"Dogan, L1;  Gulcelik, MA;  Karaman, N;  Baskan, E;  Kahraman, YS;  Aksel, B;  Ozaslan, C",,,,"Dogan, Lutfi; Gulcelik, Mehmet Ali; Karaman, Niyazi; Baskan, Emel; Kahraman, Yavuz Selim; Aksel, Bulent; Ozaslan, Cihangir",,,THE CONTRIBUTION OF CLINICAL AND RADIOLOGICAL FEATURES TO THE DIAGNOSIS IN AUS/FLUS AND FN/SFN THYROID NODULES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Bethesda; Fine needle; Thyroid; Ultrasound,FINE-NEEDLE-ASPIRATION; INCREASING INCIDENCE; BETHESDA SYSTEM; UNDETERMINED SIGNIFICANCE; FOLLICULAR NEOPLASM; CANCER; MALIGNANCY; MANAGEMENT; CYTOLOGY; RISK,"Aims: Atypical cytologies were categorized as Bethesda category III (atipia with unknown significance, follicular lesions with unknown significance, AUS/FLUS) and Bethesda category IV (follicular neoplasm or suspicious for follicular neoplasm, FN/SFN) in Bethesda system for reporting thyroid cytopathology (BSRTC). Tins study was planned to define the contribution of clinical and radiological features in the course of action for AUS/FLUS and FN/SFN thyroid nodules. Materials and methods: The age, gender, nodule size and definitive pathological results of 124 patients treated with total thyroidectomy after preoperative diagnosis of AUS/FLUS and FN/SFN lesions were recorded. Radiological features were grouped as increased vascularity, irregular borders, microcalcification, cystic component, presence of hypoechoic halo, hypoechogenicity and extraglandular involvement. Results: The malignancy rates in AUS/FLUS and FN/SFN lesions were 8% and 163%, respectively. Fine needle aspiration cytology (FNAC) was repeated only in 8 patients among 75 patients diagnosed as AUS/FLUS, but the diagnosis was not changed in direction to follow-up. The presence of irregular borders at ultrasonography, increased vascularity, microcalcification, presence of hypoechoic halo and hypoechoic nodules were found to be related to the malignancy in AUS/FLUS group. On the other hand, age less than 50, presence of irregular borders, increased vascularity and presence of microcalcifications were found to be related to the malignancy in FN/SFN group. Conclusions: The success of BSRTC in prevention of unnecessary thyroidectomies shows differences between clinics. Radiological criteria apart from patient's related factors play an important role in clinical judgement. Microcalcifications seem to be the most sensitive criteria both in AUS/FLUS and FN/SFN lesions. Irregular border was the criteria with the highest specificity in both categories.","[Dogan, Lutfi; Gulcelik, Mehmet Ali; Karaman, Niyazi; Baskan, Emel; Kahraman, Yavuz Selim; Aksel, Bulent; Ozaslan, Cihangir] Ankara Oncol Training & Res Hosp, Dept Gen Surg, Angora Evleri Ressamlar Caddesi F6 Blok 8 Beysuke, Ankara, Turkey","Karaman, N (corresponding author), Ankara Oncol Training & Res Hosp, Dept Gen Surg, Angora Evleri Ressamlar Caddesi F6 Blok 8 Beysuke, Ankara, Turkey.",,"Baskan, Emel Bulbul/AAH-1388-2021; Dogan, Lutfi/ABI-5044-2020; Ozaslan, Cihangir/ABH-1340-2021","Baskan, Emel Bulbul/0000-0002-0144-3263; Dogan, Lutfi/0000-0002-3834-0911; Ozaslan, Cihangir/0000-0002-2611-4837",,,"Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-024; Baloch ZW, 2002, DIAGN CYTOPATHOL, V26, P41, DOI 10.1002/dc.1004; Bongiovanni M, 2012, ACTA CYTOL, V56, P333, DOI 10.1159/00033995; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.2441; Chen JC, 2012, SURGERY, V152, P1037, DOI 10.1016/j.surg.2012.08.05; Cibas ES, 2010, OTOLARYNG CLIN N AM, V43, P257, DOI 10.1016/j.otc.2010.01.00; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.027; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.2107; Faquin WC, 2010, DIAGN CYTOPATHOL, V38, P731, DOI 10.1002/dc.2129; Gulcelik NE, 2008, ARCH OTOLARYNGOL, V134, P1312, DOI 10.1001/archotol.134.12.131; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp03143; Ito Y, 2013, NAT REV ENDOCRINOL, V9, P178, DOI 10.1038/nrendo.2012.25; Koike E, 2001, ARCH SURG-CHICAGO, V136, P334, DOI 10.1001/archsurg.136.3.33; Layfield LJ, 2010, CYTOPATHOLOGY, V21, P75, DOI 10.1111/j.1365-2303.2010.00750.; Layfield LJ, 2009, DIAGN CYTOPATHOL, V37, P710, DOI 10.1002/dc.2109; Leenhardt L, 1999, J CLIN ENDOCR METAB, V84, P24, DOI 10.1210/jc.84.1.2; Luo J, 2012, J SURG RES, V174, P207, DOI 10.1016/j.jss.2011.11.103; Nagarkatti SS, 2013, ANN SURG ONCOL, V20, P60, DOI 10.1245/s10434-012-2601-; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/96521; Raber W, 2000, THYROID, V10, P709, DOI 10.1089/1050725005013780; Rago T, 1998, EUR J ENDOCRINOL, V138, P41, DOI 10.1530/eje.0.138004; Rosen JE, 2006, J SURG ONCOL, V94, P649, DOI 10.1002/jso.2070; Sahin M, 2006, CLIN ENDOCRINOL, V65, P514, DOI 10.1111/j.1365-2265.2006.02625.; Schlinkert RT, 1997, MAYO CLIN PROC, V72, P913, DOI 10.1016/S0025-6196(11)63360-; Smith JJ, 2013, J AM COLL SURGEONS, V216, P571, DOI 10.1016/j.jamcollsurg.2012.12.02; Wang D, 2011, ENDOCR-RELAT CANCER, V18, P773, DOI 10.1530/ERC-11-023; Yoder BJ, 2006, THYROID, V16, P781, DOI 10.1089/thy.2006.16.78",28,1,1,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,151.0,155,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700023,,,,,2022-07-14,0.002892561983471074,1.8287396103270625e-08,0.00557101981882904,0.10816730173983977,0.00557101981882904
J,"Eraslan, A1;  Selcuk, OT;  Eyigor, H;  Erkal, Z;  Osma, U",,,,"Eraslan, Ali; Selcuk, Omer Tarik; Eyigor, Hulya; Erkal, Zehra; Osma, Ustun",,,SUCCESS RATE OF OUTPATIENT WEIGHT MANAGEMENT IN OBESE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Obstructive sleep apnea; obesity; weight loss; exercise; diet,PHYSICAL-ACTIVITY; DAYTIME SLEEPINESS; METABOLIC SYNDROME; VISCERAL OBESITY; RISK-FACTOR; EXERCISE; HEALTH; EPIDEMIOLOGY; POPULATION; PREVALENCE,"Introduction: Obesity is a modifiable risk factor for obstructive sleep apnea (OSA). The purpose of this study was to examine the success rate and the effects of an outpatient weight loss program on obese OSA patients. Materials and methods: This prospective study included 34 apneic obese patients (body mass index 33.7 +/- 5.8 kg/m(2), age 47.1 +/- 8.7 years). Intervention program consisted of 12-week program of moderate intensity exercise (40-60% of HRR) and individualized diet. A weight loss of >= 3% from baseline was considered as clinically significant weight loss according with the guidelines of American College of Sports Medicine (ACSM). Polysomnographic, anthropometric and metabolic measurements were taken before and after the significant weight loss. Data were analyzed using the Chi square test, Wilcoxon signed ranks test and Mann Whitney U test. Results: Clinically significant weight loss was achieved by 18 patients (53%), and 16 patients (47%) were unsuccessful. It was significant that mild /moderate OSA patients were mostly successful (68%), while the majority of severe patients (75%) were unsuccessful (P = 0.016). There were significant improvements in anthropometric, metabolic and sleep parameters (apnea-hypopnea index, O-2 desaturation index, Epworth sleepiness score) of successful patients after 12 weeks program. Conclusion: Outpatient weight loss programs are more convenient for patients with mild /moderate OSA. However, obese patients with severe OSA have more barriers to perform exercise. Inpatient weight loss program seems like a better option for obtaining effective weight loss in severe apneic patients.","[Eraslan, Ali] Antalya Educ & Res Hosp, Dept Sports Med, TR-07100 Antalya, Turkey; [Selcuk, Omer Tarik; Eyigor, Hulya; Osma, Ustun] Antalya Educ & Res Hosp, Dept Otorhinolaryngol, Antalya, Turkey; [Erkal, Zehra] Antalya Educ & Res Hosp, Dept Cardiol, Antalya, Turkey","Eraslan, A (corresponding author), Antalya Educ & Res Hosp, Dept Sports Med, TR-07100 Antalya, Turkey.",,"Selcuk, Omer/AAJ-3450-2021","Selcuk, Omer/0000-0002-7364-7599; Eraslan, Ali/0000-0001-6909-8198",,,"Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.19264; Ancoli-Israel S, 2007, AASM MANUAL SCORIN; Awad KM, 2012, AM J MED, V125, P485, DOI 10.1016/j.amjmed.2011.11.02; Basta M, 2008, J CLIN SLEEP MED, V4, P1; Beitler JR, 2014, J CLIN SLEEP MED, V10, P1199, DOI 10.5664/jcsm.420; Bonsignore MR, 2013, EUR RESPIR REV, V22, P353, DOI 10.1183/09059180.0000341; Borel AL, 2012, THORAX, V67, P735, DOI 10.1136/thoraxjnl-2011-20100; Chennaoui M, 2015, SLEEP MED REV, V20, P59, DOI 10.1016/j.smrv.2014.06.00; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e318194933; Frankenfield DC, 1998, J AM DIET ASSOC, V98, P439, DOI 10.1016/S0002-8223(98)00100-; Franklin KA, 2015, J THORAC DIS, V7, P1311, DOI 10.3978/j.issn.2072-1439.2015.06.1; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.11; Greenburg DL, 2009, AM J MED, V122, P535, DOI 10.1016/j.amjmed.2008.10.03; Hora F, 2007, RESPIRATION, V74, P517, DOI 10.1159/00009779; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.54; Jonas S, 2009, ACSMS EXERCISE IS ME, P9; Jonas S, 2009, ACSMS EXERCISE IS ME, P21; Jones SF, 2013, SLEEP MED CLIN, V8, P517, DOI 10.1016/j.jsmc.2013.07.00; Kim TH, 2010, CLIN EXP OTORHINOLAR, V3, P147, DOI 10.3342/ceo.2010.3.3.14; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195O; Mansukhani MP, 2013, AM J CARDIOL, V111, P1650, DOI 10.1016/j.amjcard.2013.02.00; Marshall NS, 2008, SLEEP, V31, P107; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-0000; Netzer NC, 2003, CHEST, V124, P1406, DOI 10.1378/chest.124.4.140; Paoli A, 2015, IRAN J PUBLIC HEALTH, V44, P60; Paoli A, 2012, AM J CARDIOL, V109, P305, DOI 10.1016/j.amjcard.2011.10.01; Papandreou C, 2012, EUR RESPIR J, V39, P1398, DOI 10.1183/09031936.0010341; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws34; Peppard PE, 2009, AM J RESP CRIT CARE, V180, P788, DOI 10.1164/rccm.200905-0773O; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.301; Potteiger JA, 2012, EUR J APPL PHYSIOL, V112, P2035, DOI 10.1007/s00421-011-2174-; Quercioli A, 2010, SLEEP BREATH, V14, P261, DOI 10.1007/s11325-010-0338-; Shah NA, 2010, SLEEP BREATH, V14, P131, DOI 10.1007/s11325-009-0298-; Smith Simon S, 2007, J Clin Sleep Med, V3, P68; Svatikova Anna, 2005, Curr Diab Rep, V5, P53, DOI 10.1007/s11892-005-0068-; Vgontzas AN, 2003, J INTERN MED, V254, P32, DOI 10.1046/j.1365-2796.2003.01177.; Webster AL, 2008, ACSMS HEALTH FIT J, V12, P13, DOI 10.1249/FIT.0b013e31817047b; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.210908",38,2,2,1,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_153,,8,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000024,,,,,2022-07-14,0.003822314049586777,3.4571062482147235e-05,0.09247743254310495,0.12151797034861095,0.09051457668537724
J,"Erfani, N1;  Barooti, M;  Hekmat, HR",,,,"Erfani, Nasrolah; Barooti, Mahshid; Hekmat, Hamid Reza",,,THE RELATION BETWEEN LOVE MAKING STYLES AND SOLVING FAMILY PROBLEMS SKILL AMONG MARRIED FEMALE STUDENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,love making styles; problem solving skill; family; student,INTIMACY,"The aim of this study was to find the relation between love making styles and solving family problems skill. The statistical population was the female married students of Hamedan Payam Noor University. Since that the minimum number of sample in correlational studies is 100, 120 participants were selected in this study using a random sampling method. The selected participants answered the love triangle of Sternberg and the family problem solving questionnaires. Data were analyzed through frequency distribution and chi-square test using SPSS Software. Results showed that there is a significant relation between love making styles and the levels of family problem solving skill.","[Erfani, Nasrolah] PNU, Dept Psychol, Tehran, Iran; [Barooti, Mahshid; Hekmat, Hamid Reza] Islamic Azad Univ, Borujerd Branch, Dept Psychol, Borujerd, Iran","Erfani, N (corresponding author), PNU, Dept Psychol, Tehran, Iran.",erfani@pnu.ac.ir,"Erfani, Nasrolah/AAD-9041-2022",,,,"Abedi G., 2014, J MAZANDARAN U MED S, V24, P18; Ahmetoglu G., 2009, SPRINGER SCI BUSINE; ARON A, 1995, J SOC PERS RELAT, V12, P139, DOI 10.1177/026540759512101; BEACH SRH, 1993, J SOC PERS RELAT, V10, P405, DOI 10.1177/026540759310300; Brown N. M., 2000, LOVE INTIMATE RELAT; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.; Corcoran M., 1988, DYNAMICA SIGNS, V10, P23; Delavar A., 1993, RES METHODS PSYCHO; DIENER E, 2000, HDB EMOTION; DOHERTY WJ, 1989, J FAM ISSUES, V10, P72, DOI 10.1177/01925138901000100; DORNBUSCH SM, 1989, ANNU REV SOCIOL, V15, P233, DOI 10.1146/annurev.so.15.080189.00131; Drigotas M., 1999, J PERS SOC PSYCHOL, V77, P29; Duncan G. J., 1985, HORIZONTAL EGUITY U; Dwyer D., 2000, INTERPERSONAL RELAT; FURSTENBERG FF, 1990, ANNU REV SOCIOL, V16, P379, DOI 10.1146/annurev.so.16.080190.00211; GLENN ND, 1981, J MARRIAGE FAM, V43, P161, DOI 10.2307/35142; Hafezi F., 2010, NEW FINDINGS PSYCHOL, V4, P3; Hafezi Taraghfeh M., 2007, J MED SCI MAZANDARAN, V54, P9; Hatfield E., 1981, J SOC CLIN PSYCHOL, V2, P10; Heterington E. M., 1987, REMARRIAGE STEPPAREN, P18; Hutson T. L., 2001, J PERS SOC PSYCHOL, V80, P23; Kim JS, 2004, SOC BEHAV PERSONAL, V32, P173, DOI 10.2224/sbp.2004.32.2.17; KITSON GC, 1990, J MARRIAGE FAM, V52, P913, DOI 10.2307/35331; Lee J.A., 1988, PSYCHOL LOVE, P3; Mahmoodi G. R., 2001, PSYCHOL RES, V2, P10; Montgomery MJ, 1997, FAM RELAT, V46, P55, DOI 10.2307/58560; MOSS BF, 1993, FAM RELAT, V42, P31, DOI 10.2307/58491; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, V2n; Pato M., 2003, THESI; Riehl-Emde A, 2003, FAM PROCESS, V42, P253, DOI 10.1111/j.1545-5300.2003.42205.; Shaban Zadeh A., 2008, THESI; Sterenberg R., 1998, LOVE IS STORY NEW T; Sternberg R., 1985, PSYCHOL LOV; Taii S., 2012, NEW FINDINGS PSYCHOL, V23, P3; TRAUPMANN J, 1982, GERONTOLOGIST, V22, P493, DOI 10.1093/geront/22.6.49",35,0,0,1,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1317.0,1323,,,,7,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200019,,,,,2022-07-14,0.003615702479338843,7.411863837140869e-15,0.007012818071670883,0.0892387967512653,0.007012818071670883
J,"Fariba, F1;  Mahboobian, F",,,,"Fariba, Farnaz; Mahboobian, Farzaneh",,,COMPARING THE MEAN PLATELET VOLUME (MPV) BETWEEN PATIENTS WITH MYOCARDIAL INFARCTION (MI) AND HEALTHY INDIVIDUALS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,acute myocardial infarction (AMI); mean platelet volume (MPV); coronary artery disease (CAD); prognostic factor,CORONARY-ARTERY-DISEASE; HETEROGENEITY; COUNT; RISK,"Purpose and background: Ischemic heart diseases (IHDs) occurring as a result of the lack of adequate supply of blood and oxygen to part of the myocardium, are the most common causes of death and disability in developed countries. Since platelets play a fundamental role in the onset of atherosclerosis and coronary clots, assessment of platelet volume indices (PVI) can be important in the prediction and detection of coronary facts. This research was conducted to compare the Mean Platelet Volume (MPV) between patients with myocardial infarction (MI) and healthy individuals. Materials and methods: The study population in this cross-sectional survey included 36 patients with acute myocardial infarction (AMI) and 36 healthy individuals whose PVIs were compared with each other. After questioning and recording the demographic data of both groups, their blood samples were taken for testing the platelet indices and the results for the MPV were registered in a questionnaire and analyzed using the SPSS software. Findings: the mean and standard deviation for the platelet volume (PV) in patients with AMI and healthy individuals (control group) were +/- 0.95, 10.01 and +/- 0.29, 9.07, respectively. The mean difference in the PV between the two groups was statistically significant (P.value = 0.000). No significant difference was observed between the MPV and the variables of age and gender. Also, no significant differences were observed between the MPV and risk factors for high blood pressure, diabetes, cigarette smoking and body mass index (BMI). Conclusion: This study showed that the MPV is clinically important and a high level of this index can independently be considered as a prognostic factor for cardiovascular disease and myocardial infarction.","[Fariba, Farnaz] Univ Hamedan, Farshchian Hosp, Dept Cardiol, Hamadan, Iran; [Fariba, Farnaz; Mahboobian, Farzaneh] Univ Hamedan, Farshchian Hosp, Dept Cardiol, Hamadan, Iran","Fariba, F (corresponding author), Univ Hamedan, Farshchian Hosp, Dept Cardiol, Hamadan, Iran.",farnaz.Fariba@gmail.com,"fariba, farnaz/P-5771-2017","fariba, farnaz/0000-0001-7641-2691",,,"American Heart Association, 2004, HEART DIS STROK STA; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-280; CORASH L, 1977, BLOOD, V49, P7; Dow RB, 1994, AUSTR J MED SCI, V1; Endler G, 2002, BRIT J HAEMATOL, V117, P399, DOI 10.1046/j.1365-2141.2002.03441.; ERUSALIMSKY JD, 1993, EUR J CLIN INVEST, V23, P1, DOI 10.1111/j.1365-2362.1993.tb00711.; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI2719; Gebaiska J, 1993, INT J CARDIOL, V38, P192; KARPATKI.S, 1969, J CLIN INVEST, V48, P1083, DOI 10.1172/JCI10606; KARPATKIN S, 1972, ANN NY ACAD SCI, V201, P262, DOI 10.1111/j.1749-6632.1972.tb16304.; Khandekar MM, 2006, J CLIN PATHOL, V59, P146, DOI 10.1136/jcp.2004.02538; Khode Vitthal, 2012, J Cardiovasc Dis Res, V3, P272, DOI 10.4103/0975-3583.10269; Kilicli-Camur N, 2005, MED SCI MONITOR, V11, pCR38; Longo Dan L, 2012, HARRISONS PRINCIPLES, p[368, 405; Mayda-Domac F, 2010, J STROKE CEREBROVASC, V19, P66, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.00; Neelam B, 2012, J CARDIOVASC DIS RES, V3, P27; Nurcan K C, 2005, MED SCI MONITOR, V11, P38; Schull MJ, 2006, ANN EMERG MED, V48, P647, DOI 10.1016/j.annemergmed.2006.03.02; SELWYN AP, 2001, HARRISONS PRINCIPLES, P139; Shafai, 2005, J BABOL U MED SCI, V2, P4; THAULOW E, 1991, CIRCULATION, V84, P613, DOI 10.1161/01.CIR.84.2.61",21,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,2.0,,863.0,866,,,,4,"Medicine, General & Internal",General & Internal Medicine,EF2SU,WOS:000390175400001,,,,,2022-07-14,0.0021694214876033058,1.1700533408307554e-11,0.06853843246133891,0.11210580564466628,0.0631600353310238
J,"Faridi, M1;  Rahnama, M;  Eskandani, MA",,,,"Faridi, Mehrdad; Rahnama, Mohammad; Eskandani, Majid Alipour",,,EVALUATING THE EFFECT OF THE CHEMICAL COMPOUNDS AND ANTIMICROBIAL ACTIVITY OF CUMINUM CYMINUM SEED EXTRACT ON THE INHIBITION OF STAPHYLOCOCCUS AUREUS BACTERIA IN SILVER CARP MINCE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,fish; extract; Cuminum cyminum; Staphylococcus aureus; silver carp; mince,ESSENTIAL OIL,"Staphylococcus aureus is a pathogen in food products that poses a great danger for the human food industry. This study was performed for evaluating the effect of the chemical compound and antimicrobial activity of Cuminum cyminum seed extract on the inhibition of Staphylococcus aureus bacteria in silver carp mince. The extract was extracted from the plant via steam distillation using a Clevenger apparatus. Next, its chemical compound was analyzed using a gas chromatography-mass spectrometry (GC-MS) instrument. The major compound constituting the Cuminum cyminum extract, was cumin aldehyde (20.27%). The effect of different concentrations of Cuminum cyminum (0%, 0.015%, 0.03%, 09.06%, 0.0% and 0.1%) on the growth behavior of the said bacterium was investigated at 4 degrees C for 21 days. The results showed that the bacteria growth stopped up to 6 days in different concentrations of Cuminum cyminum extract. Also, the effect of Cuminum cyminum extract in controlling the bacterium possessed significant differences (p<0.05). Different concentrations of Cuminum cyminum extract for controlling the growth of the bacterium at the above temperature possessed significant statistical differences compared to the control samples (p<0.05). But low concentrations of the Cuminum cyminum extract (0.015% and 0.03%) did not possess significant differences in inhibiting the growth of the bacterium (p>0.05). Whereas high concentrations of the extract used for inhibiting the growth of the bacteria showed significant statistical differences (p<0.05). Suitable inhibitory effects on the growth of the Staphylococcus aureus in silver carp mince were observed at concentrations of 0.09% and 0.1% of Cuminum cyminum extract. Based on the findings of this research it can be said that the extract of the Cuminum cyminum has strong bactericidal properties and is introduced as a natural food preservative instead of its chemical and industrial variations.","[Faridi, Mehrdad] Univ Zabol, Dept Fisheries, Zabol, Iran; [Rahnama, Mohammad; Eskandani, Majid Alipour] Univ Zabol, Fac Vet Med, Dept Food Hyg, Zabol, Iran","Rahnama, M (corresponding author), Univ Zabol, Fac Vet Med, Dept Food Hyg, Zabol, Iran.",dr_m_rahnama@yahoo.com,,"Saadati, Dariush/0000-0001-9002-1507",,,"Adams R.P, 1995, IDENTIFICATION ESSE; Azimzadeh M., 2009, GENETIC ASSESSMENT ; Bagamboula CF, 2004, FOOD MICROBIOL, V21, P33, DOI 10.1016/S0740-0020(03)00046-; Basti AA, 2007, LWT-FOOD SCI TECHNOL, V40, P973, DOI 10.1016/j.lwt.2006.07.00; Bishop C. D., 1995, Journal of Essential Oil Research, V7, P64; Boukhatem MN, 2013, FOOD CONTROL, V34, P208, DOI 10.1016/j.foodcont.2013.03.04; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.02; Chen HQ, 2003, INT J FOOD MICROBIOL, V87, P161, DOI [10.1016/S0168-1605(03)00064-3, 10.1111/j.1541-4337.2003.tb00016.x; Dussault D, 2014, MEAT SCI, V96, P514, DOI 10.1016/j.meatsci.2013.08.01; Essawi T, 2000, J ETHNOPHARMACOL, V70, P343, DOI 10.1016/S0378-8741(99)00187-; Iacobellis NS, 2005, J AGR FOOD CHEM, V53, P57, DOI 10.1021/jf048735; Karpouhtsis I, 1998, J AGR FOOD CHEM, V46, P1111, DOI 10.1021/jf970822; Kim J.M., 1994, FOOD SCI, V60, P136; Lis-Balchin M, 1998, FLAVOUR FRAG J, V13, P98, DOI 10.1002/(SICI)1099-1026(199803/04)13:2&lt;98::AID-FFJ705&gt;3.0.CO;2-; Mari M, 2003, J APPL MICROBIOL, V94, P761, DOI 10.1046/j.1365-2672.2003.01920.; Martin R.E., 2000, MARINE FRESH WATER P, P98; Moreira M.R., 2001, LEBENSMITTEL WISSENS, V38, P56; Oroojalian F, 2010, FOOD CHEM, V120, P765, DOI 10.1016/j.foodchem.2009.11.00; Oussalah M, 2007, FOOD CONTROL, V18, P414, DOI 10.1016/j.foodcont.2005.11.00; Singh N., 2002, LEBEN SMITTEL WISSEN, V33, P72; Skandamis P, 2001, ITAL J FOOD SCI, V13, P6",21,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,5.0,,1991.0,1994,,,,4,"Medicine, General & Internal",General & Internal Medicine,EI1YW,WOS:000392283800014,,,,,2022-07-14,0.0024793388429752063,1.872836121970851e-08,0.00458789114031485,0.1277567342844699,0.00458789114031485
J,"Feng, Y1;  Yang, HX",,,,"Feng, Yong; Yang, Hongxing",,,REHABILITATION EFFECT OF MASSAGE WITH THERMAL MAGNETIC THERAPY IN TREATING LUMBAR MUSCLE STRAIN OF ATHLETES,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Massage; Thermal Magnetic Field; Lumbar Muscle Strain of Athlete; Treatment; Rehabilitation Effect,,"Purpose: to discuss the rehabilitation effect Of massage with thermal magnetic therapy in treating lumbar muscle strain (LMS) of athletes. Method: analyse the pathomechanism of lumbar muscle strain; applying massage with thermal magnetic therapy, and discuss the clinical effect and post-treatment indexes such as symptom integral, lumbar muscle force and spinal mobility. Results: after 2-4 weeks of treatment, the symptom integral, lumbar muscle force and spinal mobility all improved significantly. Compared to the control group, the clinical effect in the treatment group was P<0.05 and statistically significant. Conclusion: Applying massage with thermal magnetic therapy for lumbar muscle strain of athletes achieved significant effects and should be promoted for clinical application.","[Feng, Yong] Sichuan Tourism Univ, Chengdu 610199, Peoples R China; [Yang, Hongxing] WenZhou Med Univ, Wenzhou 325015, Peoples R China","Yang, HX (corresponding author), WenZhou Med Univ, Wenzhou 325015, Peoples R China.",,,,,,"Cahill G., 2015, ASIAN PAC J SURG ONC, V1, P2; Gao Liping, 2008, COMMERCIAL CULTURE A, V09, P27; Liu Jizhi, 2009, J WINTER SPORTS, V06, P4; Mu Zhiyou, 2014, J BEIJING SPORT U, V12, P6; Song Fengjun, 2014, J TRADITIONAL CHINES, V12, P5; Yao Shenglei, P 13 ANN C TRAD CHI; Yung K. W., 2015, ASIAN PAC J SURG ONC, V1, P; Zheng Y. F., 2015, ASIAN PAC J SURG ONC, V1, P1; Zhou Mei, 2014, HEILONGJIANG SCI TEC, V11, P3",9,2,3,2,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,1.0,,505.0,509,,,,5,"Medicine, General & Internal",General & Internal Medicine,DN9SI,WOS:000377420600007,,,,,2022-07-14,0.0009297520661157025,1.823823409575742e-09,0.0015398019529746752,0.07359929441998737,0.0014335191613907515
J,"Gao, W1;  Yu, XM;  Wu, DW",,,,"Gao, Wei; Yu, Xiaoming; Wu, Dawei",,,CLINICAL VALUE OF CYTOKINES COMBINED WITH THE BISAP SCORING SYSTEM IN EARLY PREDICTION OF ACUTE PANCREATITIS SEVERITY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,BISAP scoring system; cytokine; acute pancreatitis; predictive value,,"Acute pancreatitis, a common disease, has recently shown increasing incidence. The overall mortality rate of acute pancreatitis is about 5%-10%, but if acute pancreatitis continues to deteriorate, severity of the condition will rise. Therefore, early prediction of severity of the disease is necessary. To fully demonstrate the value of cytokines combined with the BISAP scoring system for early prediction of acute pancreatitis severity, BISAP scoring, traditional Ranson scoring and CT scoring were carried out for 2380 patients with acute pancreatitis admitted in January 2012 to October 2015. Receiver operating curve (ROC) was adopted for accuracy analysis of the three scoring systems. The results show that ROC curve area of BISAP scoring for severity of acute pancreatitis, concurrent symptoms, organ failure and death, etc. enjoys the highest similarity with the actual situation. This fully proves the high clinical value of the BISAP scoring system in early prediction of acute pancreatitis severity, which can provide scientific treatment evidence for medical personnel and improve treatment efficiency.","[Gao, Wei] Shandong Univ, Hosp 2, Dept Intens Care Med, 247 Beiyuan St, Jinan 250033, Peoples R China; [Yu, Xiaoming] Shandong Univ, Hosp 2, Jinan 250033, Peoples R China; [Wu, Dawei] Shandong Univ, Qilu Hosp, Dept Intens Care Med, Jinan 250012, Peoples R China","Gao, W (corresponding author), Shandong Univ, Hosp 2, Dept Intens Care Med, 247 Beiyuan St, Jinan 250033, Peoples R China.",,,,,,"Chen Chenyang, 2015, CHINESE J BASES CLIN, V9, P11; Guo Xiaoyan, 2012, CHINESE J GASTROENTE, V15, P109; Lee R., 2015, ASIAN PAC J SURG ONC, V1, P3; Wang LC, 2011, IEEE WIREL COMMUN, V18, P18, DOI 10.1109/MWC.2011.610833; Yu Xianen, 2014, WORLD CHINESE J DIGE, V18, P434; Yung K. W., 2015, ASIAN PAC J SURG ONC, V1, P; Zhang Jia, 2014, CHINESE J GEN SURG, V35, P117; Zheng Y. F., 2015, ASIAN PAC J SURG ONC, V1, P1; Zhou Huihui, 2012, WORLD CHINESE J DIGE, V34, P163; Zhou Y, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-1",10,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,1.0,,497.0,500,,,,4,"Medicine, General & Internal",General & Internal Medicine,DN9SI,WOS:000377420600005,,,,,2022-07-14,0.0010330578512396695,4.785047145013168e-09,0.0018253193723106438,0.07371250599675604,0.001944479571191464
J,"Gerardo, B1",,,,"Gerardo, Bosco",,,KETOGENIC DIET AND SPORT: FACTS AND FALLACIES,ACTA MEDICA MEDITERRANEA,,,English,Letter,,,,,,,HUMAN METABOLIC RESPONSE; CALORIC RESTRICTION; CHRONIC KETOSIS; RISK-FACTORS; PERFORMANCE; EXERCISE; PHYTOEXTRACTS; RESISTANCE; WEIGHT,,"[Gerardo, Bosco] Univ Padua, Dept Biomed Sci, Nutr Sci, I-35100 Padua, Italy","Gerardo, B (corresponding author), DSB Univ Padova, Via Marzolo 3, I-35131 Padua, Italy.",,,"BOSCO, GERARDO/0000-0001-6595-7944",,,"Burke LM, 2015, SPORTS MED, V45, pS33, DOI 10.1007/s40279-015-0393-; Helms ER, 2015, J SPORT MED PHYS FIT, V55, P16; Kiens B, 2015, EXERC SPORT SCI REV, V43, P109, DOI 10.1249/JES.000000000000005; Millet GY, 2012, J APPL PHYSIOL, V113, P507, DOI 10.1152/japplphysiol.00016.201; Paoli A, 2015, EXERC SPORT SCI REV, V43, P153, DOI 10.1249/JES.000000000000005; Paoli A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/47429; Paoli A, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-3; Paoli A, 2012, AM J CARDIOL, V109, P305, DOI 10.1016/j.amjcard.2011.10.01; Paoli A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-11; Paoli A, 2010, AGRO FOOD IND HI TEC, V21, P2; PHINNEY SD, 1983, METABOLISM, V32, P769, DOI 10.1016/0026-0495(83)90106-; PHINNEY SD, 1983, METABOLISM, V32, P757, DOI 10.1016/0026-0495(83)90105-; Reale R, 2016, INT J SPORTS PH 072; Rhyu HS, 2014, J EXERC REHABIL, V10, P326, DOI 10.12965/jer.14016; Tinsley GM, 2016, INT J SPORT NUTR EXE, V26, P78, DOI 10.1123/ijsnem.2015-007; Volek JS, 2016, METABOLISM, V65, P100, DOI 10.1016/j.metabol.2015.10.02; White AM, 2007, J AM DIET ASSOC, V107, P1792, DOI 10.1016/j.jada.2007.07.00; Zajac A, 2014, NUTRIENTS, V6, P2493, DOI 10.3390/nu607249",18,1,1,0,22,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_137,,2,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000008,,,,,2022-07-14,0.001756198347107438,2.1585394988097736e-08,0.003303223558884831,0.10038890329271455,0.003303223558884831
J,"Guclu, A1;  Dursun, B;  Rota, S;  Sabir, N;  Kaya, C;  Yaman, F",,,,"Guclu, Aydin; Dursun, Belda; Rota, Simin; Sabir, Nuran; Kaya, Cihan; Yaman, Fatih",,,THE RELATIONSHIP BETWEEN VISCERAL ADIPOSE TISSUE AND INTIMA-MEDIA THICKNESS IN PATIENTS WITH KIDNEY DISEASE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,visceral adipose tissue; intima media thickness; adiponectin; leptin; Pentraxin-3; Chronic Kidney Disease,CHRONIC-RENAL-FAILURE; OBESITY-ASSOCIATED HYPERTENSION; C-REACTIVE PROTEIN; BODY-FAT CONTENT; HEMODIALYSIS-PATIENTS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; RISK-FACTORS; INSULIN CONCENTRATIONS; CAROTID-ARTERY,"Introduction: Increase in visceral adipose tissue (VAT) is associated with cardiovascular risk. However, the relationship between atherosclerosis and VAT has not yet been adequately studied in chronic kidney disease (CKD). The aim of this study was to assess the relationship among VAT, adipokines, and atherosclerosis in patients with CKD. Materials and methods: 45 healthy control, 53 predialysis patients, and 52 hemodialysis patients have been enrolled in the study. Intima media thickness (IMT) of the carotid artery, and VAT measurements were evaluated via ultrasonography. Results: IMT (p:0.002), VAT (p:0.021), adiponectin (p<0.001) and pentraxin-3 (p:0.003) were higher in predialysis patients than healthy controls. The values of IMT (p<0.001), VAT (p:0.0014), adiponectin (p:0.005), pentraxin-3 (p: <0.001), C reactive protein (CRP) (p:0.009), triglyceride (p: <0.001) and parathyroid hormone (PTH) (p<0.001), were higher in hemodialysis patients than healthy controls. VAT was positively correlated with CRP(r: 0, 23 p: 0.005), IMT (r: 0.347 p<0.001), body mass index (BMI) (r: 0.33 p<0.001), and negatively correlated with creatinine clearance (R: -0.245 p: 0.003). VAT is independently related with adiponectin (beta:-0.213 p: 0.008), BMI (beta:0.369, P<0.001), and CRP (beta:0.164, P:0.032) in multiple regression analysis. IMT was positively correlated with VAT (r: 0.347 p<0.001), CRP (r: 0.186 p:0.022), age (r: 0.333 p<0.001), BMI (r: 0.444 p<0.001) in all participants. Conclusion: These findings show that VAT is a strong risk factor for atherosclerosis in patients with CKD. However IMT was not correlated with adiponectin, pentraxin-3, and leptin in patients with CKD. Also sonographic measurement of VAT could be useful to stratify the risk of cardiovascular disease in patients with CKD.","[Guclu, Aydin] Ahi EvranUniv, Dept Nephrol, Sch Med, Kirsehir, Turkey; [Dursun, Belda] PamukkaleUniv, Dept Nephrol, Sch Med, Denizli, Turkey; [Rota, Simin; Yaman, Fatih] PamukkaleUniv, Dept Biochem, Sch Med, Denizli, Turkey; [Rota, Simin; Yaman, Fatih] PamukkaleUniv, Dept Radiol, Sch Med, Denizli, Turkey","Guclu, A (corresponding author), Ahi EvranUniv, Dept Nephrol, Sch Med, Kirsehir, Turkey.",,"Rota, Simin/AAK-4032-2021; GÃ¼Ã§lÃ¼, AydÄ±n/AAK-4817-2020","Rota, Simin/0000-0003-3406-3483; ",Pamukkale University Scientific Research Projects Unit [2011TPF019],This study was supported by the Pamukkale University Scientific Research Projects Unit (Project Number 2011TPF019).,"Alexopoulos N, 2014, ATHEROSCLEROSIS, V233, P104, DOI 10.1016/j.atherosclerosis.2013.12.02; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.025; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P191; Boehme M, 2007, NEPHROL DIAL TRANSPL, V22, P2224, DOI 10.1093/ndt/gfl74; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6; Carrero JJ, 2010, CURR OPIN NEPHROL HY, V19, P37, DOI 10.1097/MNH.0b013e328332fc2; Cianciolo G, 2010, MINERVA UROL NEFROL, V62, P5; Ciccone M, 2001, INT J OBESITY, V25, P805, DOI 10.1038/sj.ijo.080162; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp49; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-0001; Folsom AR, 2001, AM J CARDIOL, V88, P112, DOI 10.1016/S0002-9149(01)01603-; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa04103; Guebre-Egziabher F, 2005, NEPHROL DIAL TRANSPL, V20, P129, DOI 10.1093/ndt/gfh56; Hall JE, 2003, CURR OPIN NEPHROL HY, V12, P195, DOI 10.1097/00041552-200303000-0001; Heimburger O, 1997, J AM SOC NEPHROL, V8, P142; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.17894; Kato A, 2011, NEPHROL DIAL TRANSPL, V26, P1967, DOI 10.1093/ndt/gfq65; KAWAGISHI T, 1995, KIDNEY INT, V48, P820, DOI 10.1038/ki.1995.35; Lee MJ, 2012, OBESITY, V20, P1301, DOI 10.1038/oby.2011.24; Malaponte G, 2007, INT J MOL MED, V20, P47; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF0028088; Nakanishi-Minami T, 2012, DIABETES RES CLIN PR, V95, pE23, DOI 10.1016/j.diabres.2011.10.02; Nasri H, 2006, Minerva Urol Nefrol, V58, P18; Noori N, 2009, J RENAL NUTR, V19, P228, DOI 10.1053/j.jrn.2008.11.00; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM19990107340010; Odamaki M, 2006, NEPHRON CLIN PRACT, V102, pC8, DOI 10.1159/00008829; Odamaki M, 1999, NEPHROL DIAL TRANSPL, V14, P2427, DOI 10.1093/ndt/14.10.242; Okamoto T, 2014, AM J NEPHROL, V39, P122, DOI 10.1159/00035833; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M20719820; Pausova Z, 2006, CURR OPIN NEPHROL HY, V15, P173, DOI 10.1097/01.mnh.0000214775.42103.a; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.173; Rondinone CM, 2006, ENDOCRINE, V29, P81, DOI 10.1385/ENDO:29:1:8; Rubio-Guerra AF, 2013, CARDIOLOGY, V125, P150, DOI 10.1159/00034865; St-Pierre AC, 2005, ARTERIOSCL THROM VAS, V25, P553, DOI 10.1161/01.ATV.0000154144.73236.f; Stenvinkel P, 1997, NEPHROL DIAL TRANSPL, V12, P1321, DOI 10.1093/ndt/12.7.132; Sugerman H, 1997, J INTERN MED, V241, P71, DOI 10.1046/j.1365-2796.1997.89104000.; Tong M, 2007, CLIN J AM SOC NEPHRO, V2, P889, DOI 10.2215/CJN.0087020; Witasp A, 2011, J INTERN MED, V269, P410, DOI 10.1111/j.1365-2796.2010.02293.; Yamauchi T, 2003, NEPHROL DIAL TRANSPL, V18, P1842, DOI 10.1093/ndt/gfg26; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P454, DOI 10.1093/ndt/15.4.45; Zoccali C, 2003, KIDNEY INT, V63, pS98, DOI 10.1046/j.1523-1755.63.s84.49.; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V13113",44,1,1,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1843.0,1849,,10.19193/0393-6384_2016_6_172,,7,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300016,,,,,2022-07-14,0.004545454545454545,9.091539569648665e-14,0.008865021743418272,0.09131127901821509,0.008865021743418272
J,"Gunduz, O1;  Ayanoglu, BT;  Gurler, A;  Erdogan, FG;  Alhan, A",,,,"Gunduz, Ozge; Ayanoglu, Burcu T.; Gurler, Aysel; Erdogan, Fatma G.; Alhan, Aslihan",,,DOES MEAN PLATELET VOLUME SHOW DISEASE ACTIVITY IN BEHCET'S DISEASE?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Behcet's disease; Mean platelet volume; disease activity,RECURRENT APHTHOUS STOMATITIS; THROMBOSIS; STATE,"Introduction: The mean platelet volume (MPV) shows the average size of platelets in blood and indicates platelet function and activation, which are correlated with thrombosis and inflammation. Platelet activation might be related with the pathophysiology of Behcet's disease (BD) since this disease is also prone to inflammation and thrombosis. We aimed to determine whether MPV can be used as a marker for BD in disease activation and severity. Materials and methods: The data of 33 BD patients during the active and the inactive periods of the disease were collected retrospectively, and the results were then compared with 35 recurrent aphthous stomatitis (RAS) patients and 60 healthy controls who were age- and gender-matched. If at least two clinical findings were present, BD was considered to be active. Results: In the active period of BD, the MPV levels (8,6 fL) were slightly higher than those in RAS (8,4 fL) and control groups (8,4 fL) (p=0,148), however, the MPV levels of active period (8.66 fL) were significantly higher than the inactive period (83 fL), (p=0.007). Moreover, 8 BD patients with vascular event history had significantly higher levels of MPV during active (9,3 fL) than inactive period (7,3 fL) of the disease (p=0,012). Conclusion: In conclusion, elevation of MPV levels should be considered for each patient individually, and during follow-ups MPV measurements can be valuable to determine disease activity. Additionally, an elevation in MPV could alarm clinician as BD is getting activated and that there might be an increased risk of vascular involvement with BD.","[Gunduz, Ozge; Gurler, Aysel; Erdogan, Fatma G.] Ufuk Univ, Fac Med, Dept Dermatol, Dermatol, TR-06520 Ankara, Turkey; [Ayanoglu, Burcu T.] Aksaray State Hosp, Dept Dermatol, Aksaray, Turkey; [Alhan, Aslihan] Ufuk Univ, Fac Arts & Sci, Dept Stat, Stat, TR-06520 Ankara, Turkey","Gunduz, O (corresponding author), Ufuk Univ, Fac Med, Dept Dermatol, TR-06520 Ankara, Turkey.",,,"Gunduz, Ozge/0000-0001-8541-9246",,,"Acikgoz N, 2010, TOHOKU J EXP MED, V221, P119, DOI 10.1620/tjem.221.11; Adam B, 2004, J EUR ACAD DERMATOL, V18, P318, DOI 10.1111/j.1468-3083.2004.00907.; Akar S, 2006, CLIN APPL THROMB-HEM, V12, P451, DOI 10.1177/107602960629343; Balta I, 2014, J EUR ACAD DERMATOL, V28, P1388, DOI 10.1111/jdv.1229; Beyan C, 2012, CLIN APPL THROMB-HEM, V18, P670, DOI 10.1177/107602961245278; Buttarello M, 2008, AM J CLIN PATHOL, V130, P104, DOI 10.1309/EK3C7CTDKNVPXVT; Chavan M, 2012, J ORAL PATHOL MED, V41, P577, DOI 10.1111/j.1600-0714.2012.01134.; Colkesen Y, 2012, CLIN CHEM LAB MED, V50, P631, DOI 10.1515/CCLM.2011.80; Ekiz O, 2014, ANGIOLOGY, V65, P161, DOI 10.1177/000331971349237; Emmi G, 2014, INTERN EMERG MED, V9, P257, DOI 10.1007/s11739-013-1036-; Gaffo AL, 2013, BEST PRACT RES CL RH, V27, P57, DOI 10.1016/j.berh.2012.12.00; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P4; Kiraz S, 2002, THROMB RES, V105, P125, DOI 10.1016/S0049-3848(02)00006-; Kurzrock R, 2005, CLIN CANCER RES, V11, P1361, DOI 10.1158/1078-0432.CCR-04-109; Lance Marcus D, 2010, Lab Hematol, V16, P28, DOI 10.1532/LH96.1001; Lee WS, 2010, TOHOKU J EXP MED, V222, P225, DOI 10.1620/tjem.222.22; Mat C, 2013, CLIN DERMATOL, V31, P352, DOI 10.1016/j.clindermatol.2013.01.00; SILMAN AJ, 1990, LANCET, V335, P107; Turkcu FM, 2013, SCI WORLD J, DOI 10.1155/2013/21591; vanderLoo B, 1997, BAILLIERE CLIN HAEM, V10, P109, DOI 10.1016/S0950-3536(97)80053-; Yazici S, 2010, PLATELETS, V21, P122, DOI 10.3109/0953710090347437",21,2,2,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,805.0,809,,10.19193/0393-6384_2016_3_94,,5,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400023,,,,,2022-07-14,0.0021694214876033058,1.7013916428774255e-20,0.009474546154706576,0.07376530744435215,0.009474546154706576
J,"Guzel, M1;  Soylu, AI;  Salt, O;  Erenler, AK;  Tomak, L;  Aksu, EA;  Atay, E;  Baydin, A",,,,"Guzel, Murat; Soylu, Aysegul Idil; Salt, Omer; Erenler, Ali Kemal; Tomak, Leman; Aksu, Esra Arslan; Atay, Erdi; Baydin, Ahmet",,,VALUE OF PULMONARY VASCULAR OBSTRUCTION INDEX FOR DETERMINING THROMBOLYTIC THERAPY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,computed tomography pulmonary angiography; pulmonary artery obstruction index; pulmonary embolism; thrombolysis,PROGNOSTIC VALUE; EMBOLISM; CT; ANGIOGRAPHY; SEVERITY; QUANTIFICATION; FIBRINOLYSIS; METAANALYSIS,"Introduction: An index for Pulmonaty Artery Computed Tomography Index Ratio (PACTOIR) may have important prognostic and therapeutic implications and as well as providing a standard to evaluate thrombolytic therapy response. The aim of this study was to determine whether PACTOIR predict the thrombolytic therapy in the treatment of pulmonary embolism (PE). Materials and methods: This retrospective study was conducted by reviewing charts of 52 patients (aged >= 18 years) who were admitted to our emergency department (ED) with initial diagnosis of pulmonary embolism and confirmed diagnosis of PE by Computed Tomography Pulmonary Angiography (CPTA). The patients were divided into two groups as follows: Group 1 (n=14) consisted of the patients who received thrombolytic therapy and Group 2 (n=38) consisted of the patients who did not receive thrombolytic therapy. PACTOIR was calculated in both groups to estimate thrombus load. We evaluated the effectiveness of thrombolytic therapy by comparing the levels of D-dieter and Troponin I. Results: Mean value for PACTOIR, D-dimer and Troponin I levels were 56.4 (%), 6.21 (mg/L) and 0.35 (mu g-IL) in Group 1 whereas they were 20.46 (%), 220 (mg/L) and 0.11 (mu g/L) in Group 2, respectively. Significant difference was detected between Group 1 and Group 2 (p<0.001). The sensitivity and specificity values were calculated as 92.9% and 89.5% for PACTOIR, whereas they were 85.7% and 78.9% for D-dimer, respectively. These values were found to be 78.6% and 65.8% for Troponin I, respectively. Conclusion: Based on our results, sensitivity to show PE severity and to determine thrombolytic therapy was significant when compared to D-dimer and Troponin I. In addition, we concluded that PACTOIR is the parameter with greatest sensitivity in determining the effectiveness of thrombolytic therapy.","[Guzel, Murat; Atay, Erdi] Samsun Training & Res Hosp, Dept Emergency Med, Samsun, Turkey; [Soylu, Aysegul Idil] Ondokuz Mayis Univ, Dept Radiol, Samsun, Turkey; [Salt, Omer] Trakya Univ, Dept Emergency Med, Edirne, Turkey; [Erenler, Ali Kemal] Hitit Univ, Dept Emergency Med, Corum, Turkey; [Tomak, Leman] Ondokuz Mayis Univ, Dept Med Biostat, Samsun, Turkey; [Aksu, Esra Arslan] Samsun Training & Res Hosp, Dept Chest Dis, Samsun, Turkey; [Baydin, Ahmet] Ondokuz Mayis Univ, Dept Emergency Med, Samsun, Turkey","Guzel, M (corresponding author), Samsun Training & Res Hosp, Baris Bulvari Kadikoy Mahallesi 199, Ilkadim Samsun, Turkey.",,"gÃ¼zel, murat/Q-3326-2016; Erenler, Ali Kemal/AAA-2995-2020; BAYDIN, AHMET/AAG-4188-2019","BAYDIN, AHMET/0000-0003-4987-0878",,,"Barclay L., MEDSCAP; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.68042; Bloomer Tyler L, 2015, Crit Pathw Cardiol, V14, P90, DOI 10.1097/HPC.000000000000004; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM19920507326190; Chaosuwannakit Narumol, 2012, Journal of the Medical Association of Thailand, V95, P145; Collomb D, 2003, EUR RADIOL, V13, P1508, DOI 10.1007/s00330-002-1804-; Elliott CG, 2014, NEW ENGL J MED, V370, P1457, DOI 10.1056/NEJMe140102; Jeebun V, 2010, QJM-INT J MED, V103, P91, DOI 10.1093/qjmed/hcp16; Ji YQ, 2014, CHINESE MED J-PEKING, V127, P2025, DOI 10.3760/cma.j.issn.0366-6999.2013302; Kearon C, 2012, AM COLL CHEST PHYS S, V141, P41; Kline JA, 2006, ROSENS EMERGENCY MED, P136; Lankeit M, 2011, CIRCULATION, V124, P2716, DOI 10.1161/CIRCULATIONAHA.111.05117; Matsuoka S, 2006, AM J ROENTGENOL, V186, P1272, DOI 10.2214/AJR.05.004; Metafratzi ZM, 2006, AM J ROENTGENOL, V186, P213, DOI 10.2214/AJR.04.132; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa130209; Ozsu S, 2011, AM J EMERG MED, V29, P26, DOI 10.1016/j.ajem.2009.07.00; Patel S, 2003, RADIOLOGY, V227, P455, DOI 10.1148/radiol.227201113; Qanadli SD, 2001, AM J ROENTGENOL, V176, P1415, DOI 10.2214/ajr.176.6.176141; Vedovati MC, 2013, J THROMB HAEMOST, V11, P2092, DOI 10.1111/jth.1242; Wu AS, 2004, RADIOLOGY, V230, P831, DOI 10.1148/radiol.230303008; Yasui T, 2007, CIRC J, V71, P1948, DOI 10.1253/circj.71.194",21,0,0,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,811.0,815,,10.19193/0393-6384_2016_3_95,,5,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400024,,,,,2022-07-14,0.0021694214876033058,2.027455664935047e-20,0.004128175593578668,0.07162041181736795,0.004128175593578668
J,"Habib, V1;  Farzad, A",,,,"Habib, Vahedi; Farzad, Abdollazadeh",,,MODELING THE EFFECT OF ADDING HYDROCOLLOIDS ON BAGUETTE BREAD STALING USING NEURAL NETWORKS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Baguette bread; Hydrocolloids; Neural network; Stale,QUALITY; CLASSIFICATION; PREDICTION; DOUGHS,"Wheat bread as an integral part of the food basket is of paramount importance to meet the nutritional requirements and nutrient supply. Recently, there has been an increased attention to bulky breads because modern methods of processing and baking dough are in a way through which bread waste is reduced and they result in longer lasting of bread and preserve bread vitamins and proteins. Moreover, having additives in baking industry has also become more common. So that, they are generally used to improve the quality, to enhance efficiency and ease of working with dough, to delay staling, and hence to reduce waste. Neural Networks are a branch of artificial intelligence with computer algorithms on different classification and pattern recognition, parameter estimation, and so on. The aim of this research study was to use artificial network in order to predict appropriate models for the effect of adding hydrocolloids on baguette bread staling. The results showed that adding hydrocolloids would delay staling and adding guar in a long time has the greatest impact on baguette bread sustainability.","[Habib, Vahedi] Mazandaran Univ Med Sci, Fac Hlth, Dept Basic Sci, Hlth Sci Res Ctr, Sari, Iran; [Farzad, Abdollazadeh] Islamic Azad Univ, Boukan Branch, Young Researchers & Elite Club, Boukan, Iran","Farzad, A (corresponding author), Tabriz Univ, Dept Nutr, Anim Sci, Tabriz, Iran.",f.abdolahzadeh@gmail.com,,,,,"Alimoradi A, 2008, TUNN UNDERGR SP TECH, V23, P711, DOI 10.1016/j.tust.2008.01.00; Armero E, 1996, J FOOD SCI, V61, P299, DOI 10.1111/j.1365-2621.1996.tb14180.; Azizi MH, 2003, LEBENSM-WISS TECHNOL, V36, P189, DOI 10.1016/S0023-6438(02)00201-; Barzegar H., 2009, FOOD SCI TECHNOLOGY, V; Bechtel W. G., 2000, CEREAL CHEM, V39, P16; Castellani M, 2009, ENG APPL ARTIF INTEL, V22, P732, DOI 10.1016/j.engappai.2009.01.01; HERZ KO, 1965, FOOD TECHNOL-CHICAGO, V19, P182; Kamrunnahar M, 2010, CORROS SCI, V52, P669, DOI 10.1016/j.corsci.2009.10.02; Monjezi M, 2010, INT J ROCK MECH MIN, V47, P476, DOI 10.1016/j.ijrmms.2009.09.00; Monjezi M., 2010, J TUNNELLING UNDERG; NAVICKIS LL, 1982, J TEXTURE STUD, V13, P249, DOI 10.1111/j.1745-4603.1982.tb01399.; Oh H.J., 2010, NAT RESOUR RES, V19, P10; Rocha M, 2007, NEUROCOMPUTING, V70, P2809, DOI 10.1016/j.neucom.2006.05.02; Rojas JA, 1999, FOOD HYDROCOLLOID, V13, P27, DOI 10.1016/S0268-005X(98)00066-; Rosell CM, 2001, FOOD HYDROCOLLOID, V15, P75, DOI 10.1016/S0268-005X(00)00054-; Vahedi H., 2013, ACRYLAMIDE ITS CHAL; Vahedi H, 2012, IRANIAN J NUTR SCI F, V7, P; Vahedi H, 2012, FOOD SCI NUTR J, V9, P; Vahedi H., 2012, GMUHS J, V18, P3; Vahedi H, 2015, ACTA MEDICA MEDITERR, V31, P135; Zadeh N. Rajab, 1989, BREAD TECHNOLOGY, P37; [No title captured",22,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1325.0,1328,,,,4,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200020,,,,,2022-07-14,0.0022727272727272726,1.2142560134702463e-11,0.004334360236312917,0.10339781454619254,0.004334360236312917
J,"Hassaniazad, M1;  Bojdi, A;  Chinikar, S;  Bazaz, SMM;  Abedi, F",,,,"Hassaniazad, Mehdi; Bojdi, Amin; Chinikar, Sadegh; Bazaz, Seyed Mojtaba Mousavi; Abedi, Farshid",,,PREVENTIVE MEASURES FOR CRIMEAN-CONGO HEMORRHAGIC FEVER IN HEALTHCARE WORKERS; HOW HIGH IS THE CHANCE OF TRANSMISSION?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Crimean-Congo hemorrhagic fever; Healthcare workers (HCW); Antibody; Prevention,NOSOCOMIAL OUTBREAK; VIRUS,"Introduction: Crimean-Congo hemorrhagic fever (CCHF) is a fatal viral infection which can lead to nosocomial epidemics with high mortality rates. Two nosocomial transmissions were reported from two hospitals of Mashhad in the last 4 years. The aim of this study was to assess the role of preventive measures on disease prevention among Health Care Workers (HCWs) who are in contact with confirmed CCHF cases. Methodology: This descriptive cross-sectional study was conducted in the infectious ward of a referral hospital in North-East of Iran. During 2009 to 2012 about 45 confirmed cases of CCHF were admitted to this hospital. 44 HCWs who had contact with these cases were included in this study. Participants were questioned regarding taking preventive measures including the use of gloves, gown, shield, mask, and shoe cover. Sera samples were also collected 2 months after the last CCHF case admission and were checked for anti-CCHF IgM and IgG. Results: All study participants had a history of close contact with confirmed CCHF patients. The contacts were due to daily visits and examination, suction of secretions, intubation, taking blood samples, administering drugs, contact with the patients' clothes, and performing cardiopulmonary resuscitation. The adherence rate to universal precautions was fairly good and anti-CCHF IgM and IgG results were negative in all subjects. Conclusion: The findings of our study further prove that protective measures are highly effective in preventing CCHF transmission in HCWs.","[Hassaniazad, Mehdi] Hormozgan Univ Med Sci, Infect Dis Res Ctr Infect & Trop, Bandar Abbas, Iran; [Bojdi, Amin; Abedi, Farshid] Mashhad Univ Med Sci, Infect Dis, Mashhad, Iran; [Chinikar, Sadegh] Inst Iran, VHFs Lab, Natl Ref Lab, Mashhad, Iran; [Bazaz, Seyed Mojtaba Mousavi] Univ Med Sci, Sch Med, Dept Med Educ, Mashhad, Iran","Abedi, F (corresponding author), Mashhad Univ Med Sci, Infect Dis, Mashhad, Iran.",AbediF@mums.ac.ir,"CHINIKAR, Sadegh/AAH-8155-2019; abedi, farshid/O-3402-2017; Hassaniazad, Mehdi/H-3409-2017","Hassaniazad, Mehdi/0000-0003-3924-2069",,,"Athar MN, 2005, AM J TROP MED HYG, V72, P471, DOI 10.4269/ajtmh.2005.72.47; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.94; Chinikar S, 2012, NOSOCOMIAL INFECT C; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-; Ergonul Onder, 2007, P207, DOI 10.1007/978-1-4020-6106-6_1; Ergonul O, 2007, INT J INFECT DIS, V11, P48, DOI 10.1016/j.ijid.2005.10.00; Ergonul O, 2012, CURR OPIN VIROL, V2, P215, DOI 10.1016/j.coviro.2012.03.00; GOLDFARB LG, 1980, AM J TROP MED HYG, V29, P260, DOI 10.4269/ajtmh.1980.29.26; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.30; Izadi S, 2008, JPN J INFECT DIS, V61, P49; mostafavi ehsan, 2013, AM J TROPICAL MED HY, V1; Naderi HR, 2011, EPIDEMIOL INFECT, V139, P862, DOI 10.1017/S095026881000200; Naderi H, 2013, AM J TROP MED HYG, V88, P469, DOI 10.4269/ajtmh.2012.12-033; Papa A, 2002, EUR J CLIN MICROBIOL, V21, P603, DOI 10.1007/s10096-002-0770-; Tarantola Arnaud, 2007, P281, DOI 10.1007/978-1-4020-6106-6_2; Watts DM, 1988, ARBOVIRUSES EPIDEMI",16,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,5.0,,2017.0,2020,,,,4,"Medicine, General & Internal",General & Internal Medicine,EI1YW,WOS:000392283800019,,,,,2022-07-14,0.001652892561983471,1.7135301454905964e-20,0.0029926956082251288,0.07470230975220132,0.002992428511699389
J,"Inci, A21;   Demiraran, Y;   Erus, S;   Ocak, T;   Yaprak, U;   Akman, C;   Basturk, M;   Kalafat, UM",,,,"Inci, A.; Demiraran, Y.; Erus, S.; Ocak, T.; Yaprak, U.; Akman, C.; Basturk, M.; Kalafat, U. M.",,,COMPARISON OF PROCALCITONIN VALUES OF PATIENTS IN INTENSIVE CARE UNIT WITH SYSTEMIC AND LOCALIZED BACTERIAL INFECTIONS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Intensive care unit; mean platelet volume; procalcitonin; crp.,MEAN PLATELET VOLUME; C-REACTIVE PROTEIN; EMERGENCY-DEPARTMENT; SERUM PROCALCITONIN; SEPSIS; MARKER; CHILDREN; BACTEREMIA; DIAGNOSIS; GUIDE,"Introduction: Intensive care unit (ICU) hospital infections are a global problem concerning the whole world. Sensitivity and specificity of parameters such as CRP (C-reactive protein), erythrocyte sedimentation rate and WBC (white blood cell), which are among the classical markers of systemic inflammation, were reported to have limited benefit in patients with these types of bacterial infections. PCT (procalcitonin) has been a focus of interest as a specific and early marker in systemic inflammation, sepsis and infections especially in recent years. In this study, we aimed to evaluate potential usability of PCT in distinction of systemic and localized bacterial infections in patients who are followed up in ICU and to compare CRP, WBC and MPV (mean platelet volume) values in patients with systemic and localized bacterial infections. Materials and methods: Totally 52 patients who were followed in Adult ICU of our hospital were included in the study. The patients were divided into two groups. Group 1 consisted of patients with growth in blood culture and systemic bacterial infection clinic. Group 2 consisted of patients with growth in phlegm, tracheal aspirate, wound and urine culture without growth in blood culture. Age, gender growth region and growing microorganisms, simultaneously checked CRP, PCT, WBC, MPV values were recorded in follow-up form. Results: The study showed that PCT value was significantly high in systemic infections, while other parameters did not show a significant difference between the two groups. Furthermore, Acinetobacter baumannii was found to be the most common agent. Conclusion: Our study suggests that PCT value has a more valuable potential than other standard infection parameters in distinction of systemic infection and localized bacterial infection in patients who are followed in ICU. However, we believe that more comprehensive studies with a larger sampling can guide the clinicians for early diagnosis and treatment.","[Inci, A.] Kanuni Sultan Suleyman Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey; [Demiraran, Y.] Kanuni Sultan Suleyman Training & Res Hosp, Dept Anesthesiol & Intens Care, Istanbul, Turkey; [Erus, S.; Yaprak, U.] Koc Univ, Fac Med, Dept Thorac Surg, Istanbul, Turkey; [Ocak, T.; Akman, C.; Basturk, M.; Kalafat, U. M.] Kanuni Sultan Suleyman Training & Res Hosp, Dept Emergency Med, Istanbul, Turkey","Ocak, T (corresponding author), Kanuni Sultan Suleyman Training & Res Hosp, Dept Emergency Med, Istanbul, Turkey.",,"Kalafat, Utku Murat/AAF-1888-2020; Erus, Suat/AAX-9849-2020","Kalafat, Utku Murat/0000-0003-1749-8098; ",,,"Aikawa Naoki, 2005, Journal of Infection and Chemotherapy, V11, P152, DOI 10.1007/s10156-005-0388-; Akin A, 2011, ERCIYES MED J, V33, P; Aslan O, 2014, INFECT DIS CLIN PRAC, V22, P267, DOI [10.1097/IPC.0000000000000132, DOI 10.1097/IPC.0000000000000132; Aydemir H, 2015, PLATELETS, V26, P331, DOI 10.3109/09537104.2012.70102; Becchi C, 2006, MINERVA ANESTESIOL, V72, P74; Celebi S, 2013, J PEDIATR INFECT, V7, P147, DOI 10.5152/ced.2013.156; Christ-Crain M, 2005, SWISS MED WKLY, V135, P45; Deis JN, 2010, PEDIATR EMERG CARE, V26, P51, DOI 10.1097/PEC.0b013e3181c399d; Endo Shigeatsu, 2008, Journal of Infection and Chemotherapy, V14, P244, DOI 10.1007/s10156-008-0608-; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-; Gao Yanxia, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P28, DOI 10.3760/cma.j.issn.2095-4352.2014.01.00; Gunal O, 2011, KLIMIK J, V24, P31, DOI 10.5152/kd.2011.0; Gurler MY, 2014, TURK ONCOL DERG, V29, P1, DOI 10.5505/tjoncol.2014.65; Inci A, 2015, J CLIN ANAL MED, V6, P1, DOI 10.4328/JCAM.227; Karadag-Oncel E, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-1; Kim MH, 2011, YONSEI MED J, V52, P276, DOI 10.3349/ymj.2011.52.2.27; Kitazawa T, 2013, INTERNAL MED, V52, P1487, DOI 10.2169/internalmedicine.52.955; Kucukbayrak A, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.00; Luna CM, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/48046; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.E; Mahajan P, 2014, ACAD EMERG MED, V21, P171, DOI 10.1111/acem.1231; Mehanic Snjezana, 2013, Mater Sociomed, V25, P277, DOI 10.5455/msm.2013.25.277-28; Muller B, 2000, CRIT CARE MED, V28, P977, DOI 10.1097/00003246-200004000-0001; Nargis Waheeda, 2014, Int J Crit Illn Inj Sci, V4, P195, DOI 10.4103/2229-5151.14135; Pavic M, 2010, BIOCHEM MEDICA, V20, P23; Pourakbari B, 2010, BRAZ J INFECT DIS, V14, P252, DOI 10.1590/S1413-8670201000030000; Qadri S, 2013, HIV MED, V14, P549, DOI 10.1111/hiv.1204; Riedel S, 2011, AM J CLIN PATHOL, V135, P182, DOI 10.1309/AJCP1MFYINQLECV; Saeed K, 2014, EXPERT REV MOL DIAGN, V14, P47, DOI 10.1586/14737159.2014.86423; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-10; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/42199; Sumer S, 2012, NOBEL MED, V8, P6; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.06071; Tozkoparan E, 2007, CLIN CHEM LAB MED, V45, P1009, DOI 10.1515/CCLM.2007.19; Ulu-Kilic A., 2013, OA CRIT CARE, V; VANDERLELIE J, 1983, J CLIN PATHOL, V36, P693, DOI 10.1136/jcp.36.6.69; Venkatesh B, 2009, ANAESTH INTENS CARE, V37, P20, DOI 10.1177/0310057X090370010",37,1,1,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,249.0,253,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700039,,,,,2022-07-14,0.003822314049586777,2.742764260323953e-17,0.05528366456803726,0.08728505604097347,0.05419325372142117
J,"Jahdi, F1;  Kalati, M;  Kashanian, M;  Naseri, M;  Haghani, H",,,,"Jahdi, Fereshteh; Kalati, Mahnaz; Kashanian, Maryam; Naseri, Mohsen; Haghani, Hamid",,,EFFECT OF ORAL EVENING PRIMROSE CAPSULES ON RIPENING OF THE CERVIX IN NULLIPAROUS IRANIAN PREGNANT WOMEN (A RANDOMIZED TRIAL),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Ripening of the Cervix; Evening primrose; Pregnancy,LABOR INDUCTION; OIL; LENGTH; DELIVERY; TERM,"Introduction: Ripening of the cervix and uterine contractions are two basic factors of a successful delivery. Lack of ripening of the cervix is considered to be one of the problems of delivery. Thus, the present research was designed to determine the effect of oral evening primrose capsules on the ripening of cervix in nulliparous women. Materials and methods: This research has been conducted with the triple-blind randomized trial method on 80 nulliparous women in the 40th week of pregnancy (6th day + 40 weeks) visiting the prenatal clinic Prenatal clinic Shahid Akbarabadi educational and medical center of Iran University of Medical Sciences in 2015. Samples were divided into two equal groups of medicine and placebo with the randomized allocation method. Each of the participants took a bottle containing 14 1000mg oral evening primrose capsules (2 capsules per day, each 12 twelve hours for a week) or the placebo containing 14 1000mg oral capsules of paraffin in similar bottles. Data collecting tools include: demographic specifications questionnaire and the form of the records of the examinations. Data was analyzed through statistical tests and SPSS software version 16 using descriptive inferential statistic. Findings: Similarity of the two groups in terms of individual specifications and Bishop Score before the intervention were reviewed in the two groups and no significant statistical difference was seen between the two groups. The mean of the Bishop score for those who had taken 10 or more capsules after the intervention did not show a statistically significant difference (p=0.110). Conclusion: Consumption of evening primrose did not show a considerable improvement in the score. It is recommended to do more comparative studies in this field in later weeks of pregnancy due to the conflicts of the studies.","[Kalati, Mahnaz] Iran Univ Med Sci, Sch Nursing & Midwifery Fac, Int Campus, Tehran, Iran; [Kashanian, Maryam] Iran Univ Med Sci, Dept Obstet & Midwifery, Tehran, Iran; [Naseri, Mohsen] Shahed Univ, Tradit Med, Tehran, Iran; [Naseri, Mohsen] Shahed Univ, Res Ctr Randomized Trial Tradit Med, Tehran, Iran; [Haghani, Hamid] Univ Med Sci, Fac Management, Biostat, Tehran, Iran","Kalati, M (corresponding author), Iran Univ Med Sci, Sch Nursing & Midwifery Fac, Int Campus, Tehran, Iran.",mahnazkalati77@yahoo.com,"jahdi, fereshteh/I-3132-2017","jahdi, fereshteh/0000-0002-7018-4744",Iran University of Medical Sciences of International Pardis,"Authors sincerely thank the respected deputy of research unit of Iran University of Medical Sciences of International Pardis for their financial support. Also, we thank the friendly cooperation of the respected authorities of Iran University of Medical Sciences, doctors and midwives of the prenatal clinic Shahid Akbarabadi educational and medical center and all of the dear mothers who participated in this research and made it possible.","Abedi G., 2014, J MAZANDARAN U MED S, V24, P18; ACOG committee on obstetric practice, 2006, OBSTET GYNECOL, V108, P46; Bayles B, 2009, AM FAM PHYSICIAN, V80, P140; Cohen S M, 2000, Holist Nurs Pract, V14, P5; Dashe, 2014, WILLIAMS OBSTE; Esmaeelzadeh SH, 2008, EFFECT SEXUAL RELATI, V1; Fan YY, 1998, J NUTR, V128, P1411, DOI 10.1093/jn/128.9.141; FARZIANPOUR F, 2014, AM J AGR BIOL SCI, V9, P147, DOI DOI 10.3844/AJAB-SSP.2014.147.15; Ghasemnezhad A, 2008, IND CROP PROD, V28, P17, DOI 10.1016/j.indcrop.2007.12.00; Grobman WA, 2007, EUR J OBSTET GYN R B, V132, P163, DOI 10.1016/j.ejogrb.2006.09.00; Harman J., 1999, AM FAM PHYSICIAN, V60, P4; Jessica Hudson, 2006, NATURAL LABOR INDUC; Khan IA, 2011, ENCY COMMON NATURA; KLEIJNEN J, 1994, BMJ-BRIT MED J, V309, P824, DOI 10.1136/bmj.309.6958.82; McFarlin BL, 1999, J NURSE-MIDWIFERY, V44, P205, DOI 10.1016/S0091-2182(99)00037-; Meroitz L, 2005, CAN J CLIMPHARMACOL, V12, P; Modaress Nejad V., 2006, COMPARAISON EFFICACI, V12, P42; Moriarty KA, 2007, THESI; Pevzner L, 2009, OBSTET GYNECOL, V114, P261, DOI 10.1097/AOG.0b013e3181ad937; Pillitterl A., 2007, MATERNAL CHILD HLT; Stager L., 2009, MIDWIFERY TODAY INT, V92, P1; Stonemetz Diane, 2008, Holist Nurs Pract, V22, P171, DOI 10.1097/01.HNP.0000318026.45527.0; Tan PC, 2006, AUST NZ J OBSTET GYN, V46, P505, DOI 10.1111/j.1479-828X.2006.00650.; Ty-Torredes KA, 2006, AM J OBSTET GYNECOL, V195, pS30, DOI 10.1016/j.ajog.2006.10.07; Wang W., 2009, EVENING PRIMROSE OI; Yanik A, 2007, ADV THER, V24, P748, DOI 10.1007/BF0284996; Ziai A., 2005, MED PLANT EVIDENCE B, P9",27,5,5,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1273.0,1279,,,,7,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200013,,,,,2022-07-14,0.0027892561983471073,1.469855823425075e-14,0.005472559660985404,0.0893425752443538,0.005461122078835824
J,"Jalilian, N1;  Veisi, F;  Rezavand, N",,,,"Jalilian, Nasrin; Veisi, Firoozeh; Rezavand, Negin",,,CERVICAL CYTOLOGIC ABNORMALITIES IN INFERTILE WOMEN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Screening; cervical cancer; infertility,POPULATION; INFECTION; WORLDWIDE; LESIONS; CANCER,"Background: Global estimates indicate that cervical cancer is the second most common cancer among women following breast cancer. Therefore, screening for cervical cancer is considered an effective method in early diagnosis and treatment of this condition. Here, we studied screening tests results to determine the frequency of abnormal cervical cytologic findings. Methods: This study had two phases. The first phase was conducted from March 2007 to March 2008 (400 subjects). The second phase lasted from March 2011 to March 2012 (208 subjects). All infertile women (either primary causes or secondary ones) who presented to our university infertility clinic to receive treatments were included. Results: Cervical cytology reports were unsatisfactory in 10 subjects (1.7%) and abnormal in three patients (0.5%). Most cases whose reports were unsatisfactory were documented in the first phase of the study (i.e., 9 patients, 90%). Conclusion: Cervical screening with Pap smear enables early diagnosis and management of cervical abnormalities and consequently a decrease in the rate of invasive cervical cancers. It is suggested to conduct studies with larger sample sizes to ensure the beneficial effects of cervical screening.","[Jalilian, Nasrin; Veisi, Firoozeh; Rezavand, Negin] Kermanshah Univ Med Sci, Matern Res Ctr, Kermanshah, Iran","Rezavand, N (corresponding author), Kermanshah Univ Med Sci, Matern Res Ctr, Kermanshah, Iran.",nRezavand@kums.ac.ir,"Rezavand, Negin/Q-9181-2017; Jalilian, Nasrin/H-6119-2017","rezavand, negin/0000-0002-7978-106X",,,"Al Jaroudi D, 2010, ANN SAUDI MED, V30, P397, DOI 10.4103/0256-4947.6855; Almasi-Nokiani F, 2009, HAKIM RES J, V11, P2; Anguenot JL, 2001, HUM REPROD, V16, P2206, DOI 10.1093/humrep/16.10.220; [Anonymous], 2008, PRINC PREV SURV NON; Brown DR, 2005, J INFECT DIS, V191, P182, DOI 10.1086/42686; CancerIAfro, CERV CANC INC MORT ; Chism A, 2015, FERTILITY PRESERVAT; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.660068; Cuschieri KS, 2005, J CLIN PATHOL, V58, P946, DOI 10.1136/jcp.2004.02286; Franco EL, 2001, CAN MED ASSOC J, V164, P101; Ghaffari Saeed Reza, 2006, Asian Pac J Cancer Prev, V7, P52; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.169; JALILIAN N, 2013, LIFE SCI J, V10, P22; Mari N, BMC CANC, V1; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-; Plante M, 2014, PATIENT INFORM FERT; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.291061030; Shafaghi B, 2013, HUMAN PAPILLOMA VIR; van Hamont D, 2006, HUM REPROD, V21, P2359, DOI 10.1093/humrep/del13; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM19991125341220",21,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,2.0,,905.0,908,,,,4,"Medicine, General & Internal",General & Internal Medicine,EF2SU,WOS:000390175400008,,,,,2022-07-14,0.0025826446280991736,1.8740069103358054e-08,0.004794033090297731,0.12776010664273366,0.004794033090297731
J,"Jamshidi, F1;  Shayan, A;  Forouhari, S;  Taherkhani, H;  Seyedi, M",,,,"Jamshidi, Farkhondeh; Shayan, Arezoo; Forouhari, Sedigheh; Taherkhani, Hamid; Seyedi, Mahdieh",,,THE EFFECT OF COMMUNITY RE-ENTRY PROGRAM (CRP) ON SOCIAL FUNCTION OF PATIENTS WITH CHRONIC MENTAL DISORDERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Community Re-Entry Program; Social function; Patients with chronic mental disorders; Skills training,SCHIZOPHRENIA; SKILLS; REHABILITATION; ILLNESS; MODULE,"Background and objectives: Community Re-Entry Program is one of the programs related to social and independent living skills that provides patients with chronic mental disorders with some information and skills. The present study aimed to assess the effect of Community Re-Entry Program on social function of patients with chronic mental disorders. Methods: In this study, 40 patients with chronic mental disorders referring to outpatient rehabilitation centers of Hamadan, Iran were randomly divided into an intervention (N=20) and a control (N=20) group. The intervention group received community rehabilitation program in 16 60-90-minute educational sessions held twice a week for two months. The control group, on the other hand, took part in the center's routine occupational therapy. Both groups were evaluated using Assessment of Communication and Interaction Skills (ACIS) questionnaire before and after the intervention. Results: The results showed a significant change in physicality (P<0.02), information exchange (P<0.02), and total score of ACIS questionnaire (P<0.01) in the intervention group compared to the control group after the intervention. However, no significant difference was found between the two groups concerning relations (P<0.09). Conclusion: The results showed that Community Re-Entry Program played an important role in improving social function among patients with chronic mental disorders. Yet, future studies are required to assess the long-term clinical effects of this program","[Jamshidi, Farkhondeh; Seyedi, Mahdieh] Hamadan Univ Med Sci, Sch Rehabil, Dept Occupat Therapy, Occupat Therapy Fac, Hamadan, Iran; [Shayan, Arezoo] Hamadan Univ Med Sci, Sch Nursing & Midwifery, Dept Midwifery, Midwifery Fac, Hamadan, Iran; [Forouhari, Sedigheh] Shahid Sadoughi Univ Med Sci, Social Determinants Hlth Res Ctr, Yazd, Iran; [Taherkhani, Hamid] Psychiat Rehabil Ctr, Tehran, Iran","Seyedi, M (corresponding author), Hamadan Univ Med Sci, Sch Rehabil Sci, Pajohesh Intersect, Hamadan, Iran.",mahdiehseyedi@gmail.com,"jamshidi, farkhondeh/O-3233-2016; Seyedi, Mahdieh/M-9726-2017; jamshidihosseinabadi, F/D-7760-2018; Jamshidi, Farkhondeh/P-4079-2017; jamshidi, farkhondeh/V-7494-2017","Seyedi, Mahdieh/0000-0001-7149-6216; jamshidihosseinabadi, F/0000-0002-7514-4370; Jamshidi, Farkhondeh/0000-0002-7619-1566; jamshidi, farkhondeh/0000-0003-2439-617X",Hamadan University of Medical Sciences [9308204308],"This article was extracted from the researcher's research proposal with the number 9308204308 that financially supported by Hamadan University of Medical Sciences. Hereby, the authors would like to thank of the respected authorities of School of Rehabilitation, Mr. Tahmasebi the director of financial affairs, Mr. Soori the dean of Welfare Organization, personnel of Tabesh and Kowsar rehabilitation centers, and all the study participants for their cooperation.","Abedi G., 2014, J MAZANDARAN U MED S, V24, P18; Abedi G, 2012, INT J COLLAB RES INT, V4, P10; ANTHONY WA, 1980, REHABIL COUNS BULL, V24, P; Blackwell G., 1993, INNOVATIONS RES, V2, P4; Drake RE, 2003, COMMUNITY MENT HLT J, V39, P427, DOI 10.1023/A:102586091927; FALLOON IRH, 1983, SCHIZOPHRENIA BULL, V9, P543, DOI 10.1093/schbul/9.4.54; Gerson LD, 2012, ARCH PSYCHIAT NURS, V26, P261, DOI 10.1016/j.apnu.2012.02.00; Glynn SM, 2004, FOCUS, V2, P6; Gui-hua W, 2013, MED J CHINESE PEOPLE, V1; HAYES RL, 1995, BEHAV THER, V26, P433, DOI 10.1016/S0005-7894(05)80092-; Jamshidi F, 2012, MODERN REHABILITATIO, V6, P; Kopelowicz A, 1998, PSYCHIATR SERV, V49, P1313, DOI 10.1176/ps.49.10.131; Kopelowicz A, 2003, PSYCHIAT SERV, V54, P1491, DOI 10.1176/appi.ps.54.11.149; Kurtz MM, 2008, J CONSULT CLIN PSYCH, V76, P491, DOI 10.1037/0022-006X.76.3.49; LEHMAN AF, 1982, AM J PSYCHIAT, V139, P127; Liberman RP, 2005, PSYCHIATRY, V68, P220, DOI 10.1521/psyc.2005.68.3.22; LIBERMAN RP, 1986, SCHIZOPHRENIA BULL, V12, P631, DOI 10.1093/schbul/12.4.63; Liu G-y, 2009, CHINESE J REHABILITA, V1; Peng L, 2011, CHINESE J REHABILITA, V1; SCHOOLER NR, 1986, J CLIN PSYCHOPHARM, V6, pS1; Xiang YT, 2007, BRIT J PSYCHIAT, V190, P49, DOI 10.1192/bjp.bp.106.02369; Xiang YT, 2006, SOC PSYCH PSYCH EPID, V41, P464, DOI 10.1007/s00127-006-0050-; [é¡¹çæ¶ Xiang Yutao], 2004, [ä¸­åç²¾ç¥ç§æå¿, Chinese Journal of Psychiatry], V37, P3; [é¡¹çæ¶ Xiang Yutao], 2002, [ä¸­å½å¿çå«çæå¿, Chinese Mental Health Journal], V16, P70",24,2,2,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1311.0,1316,,,,6,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200018,,,,,2022-07-14,0.0024793388429752063,2.934342047067814e-14,0.004853208208468905,0.08993357179356157,0.004918286584378704
J,"Janati, A1;  Ghoddoosi-Nejad, D;  Doshmangir, L;  Imani, A",,,,"Janati, Ali; Ghoddoosi-Nejad, Djavad; Doshmangir, Leila; Imani, Ali",,,CHALLENGES OF IMPLEMENTING STRATEGIC PURCHASING OF HEALTH SERVICES IN IRAN: A QUALITATIVE STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,purchasing; health services; Iran; payment system; benefit package,,"Introduction: To understand the challenges of implementing strategic purchasing of health services in Iran from the viewpoints of experts, policy makers, and decision makers. Methods: In a qualitative study in 2014-15, one focus group discussion -FGD- and 21 interviewees carried out with policy makers, decision makers and experts. Experts were selected from purchaser organizations of health services in Iran health system. The content analysis method was used to analyze the data. Results: five important themes emerged after the data were analyzed, i. e., infrastructures of strategic purchasing, stakeholders of purchasing health services, payment system, package of health services, and stewardship of health system. Conclusion: along-term, well-defined plan, developed with the participation of all stakeholders, is needed for proper implementation of strategic purchasing.","[Janati, Ali; Doshmangir, Leila; Imani, Ali] Tabriz Univ Med Sci, Tabriz Hlth Serv, Res Ctr, Iranian Ctr Excellence Hlth Management,Sch Manage, Tabriz, Iran; [Ghoddoosi-Nejad, Djavad] Tabriz Univ Med Sci, Student Res Comm, Sch Management & Med Informat, Iranian Ctr Excellence Hlth Management, Tabriz, Iran","Ghoddoosi-Nejad, D (corresponding author), Tabriz Univ Med Sci, Student Res Comm, Sch Management & Med Informat, Iranian Ctr Excellence Hlth Management, Tabriz, Iran.",javad6463@gmail.com,"Ghoddoosi-Nejad, Djavad/O-1613-2017; Imani, Ali/K-9927-2017; Doshmangir, Leila/AAM-7947-2021; , Leila/L-1446-2017","Ghoddoosi-Nejad, Djavad/0000-0003-2534-5155; Imani, Ali/0000-0002-4606-9631; , Leila/0000-0001-5197-8437",Tabriz University of Medical Sciences,This research was conducted with the approval of the ethics committee at Tabriz University of medical sciences. All interviews were conducted with the free and informed consent of interviewees. We received funding from the Tabriz University of Medical Sciences.,"[Anonymous], 2000, WORLD HLTH REP 200; Bigdeli M, 2009, B WORLD HEALTH ORGAN, V87, P560, DOI 10.2471/BLT.08.05305; Busse Reinhard, 2007, Healthc Pap, V8 Spec No, P6; Carey JW., 1996, CULT ANTHROPOL, V8, P1, DOI DOI 10.1177/1525822X96008003010; Cashin C, 2014, 3 INT C AFR HLTH E; Davari M, 2011, EC CHALLENGES IRAN H, V8, P91; ENTHOVEN AC, 1994, SOC SCI MED, V39, P1413, DOI 10.1016/0277-9536(94)90236-; Figueras J., 2005, PURCHASING IMPROVE ; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.00; HOWDENCHAPMAN P, 1994, HEALTH POLICY, V29, P61, DOI 10.1016/0168-8510(94)90007-; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/104973230527668; McSorley G, 2006, HEALTHCAREPAPERS, V8, P7; Nasiripour A. A., 2011, INT BUSINESS RES, V4, P10; Preker AS, 2007, PUBLIC ENDS, PRIVATE MEANS: STRATEGIC PURCHASING OF HEALTH SERVICES, P1, DOI 10.1596/978-0-8213-6547-; Preker AS., 2005, SPENDING WISELY BUY; president pasco, 2010, 5 DEV PLAN ISLAMIC R, P5; Saravi N, 2012, 2 SEM HLTH EC TEH; Williams A Paul, 2007, Healthc Pap, V8 Spec No, P9",18,5,5,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,2.0,,1033.0,1038,,,,6,"Medicine, General & Internal",General & Internal Medicine,EF2SU,WOS:000390175400033,,,,,2022-07-14,0.001859504132231405,7.407938241013796e-15,0.007105847133409442,0.08825594223247417,0.005550038999828378
J,"Jiang, S1",,,,"Jiang, Shan",,,ANKLE JOINT INJURY IN AEROBICS AND CLINICAL REHABILITATION EFFECT OF RICE TREATMENT PRINCIPLE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Aerobics Exercise; Ankle Joint Injury; Cause; RICE Treatment Principle; Rehabilitation Effect,,"Aerobics have gained wide development in recent years as an important part of current sports events. In the process of aerobics exercise, athletes are prone to ankle joint injury. In order to analyze the causes of ankle joint injury in aerobics exercise and estimate the treatment effect of applying RICE treatment, the author selected 400 patients with ankle joint injury after aerobics from August 2014 to December 2015. Causes of ankle joint injury of aerobics athletes were analyzed, and the effect of applying RICE treatment was observed. Final study results show that ankle joint injury among aerobics athletes is mainly due to inattention, poor psychological attitude; landing instability, training with injury, etc. Application of RICE for patients can provide a_significdnt treatment effect and pro MOO recovery. Having certain clinical value, it is worth being popularized and applied in future clinical treatment.","[Jiang, Shan] Nanjing Sport Inst, Nanjing 210014, Jiangsu, Peoples R China","Jiang, S (corresponding author), Nanjing Sport Inst, Nanjing 210014, Jiangsu, Peoples R China.",,,,,,"Cahill T., 2015, ASIAN PAC J SURG ONC, V1, P4; Chen Guifeng, 2011, J CHIFENG U SCI ED E, V9, P12; Dobson P. R., 2015, ASIAN PAC J SURG ONC, V1, P5; Lee R., 2015, ASIAN PAC J SURG ONC, V1, P3; Su Ling, 2011, SCI TECHNOLOGY INFOR, V1; Sun Tao, 2010, GUIDE SCI TECH MAGAZ, V; Tian Hongwei, 2012, J ED I JILIN PROV, V14, P14; Xia Xiurong, 2013, SHANXI YOUTH, V22, P18; Zeng Bosi, 2010, J GUANGZHOU SPORT U, V13, P9",9,1,1,0,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,1.0,,539.0,542,,,,4,"Medicine, General & Internal",General & Internal Medicine,DN9SI,WOS:000377420600015,,,,,2022-07-14,0.0009297520661157025,6.588702290954681e-09,0.0012575021481569405,0.07374957144489734,0.0012527017188604984
J,"Karabulut, M21;   Alis, H;   Gunaldi, M;   Afsar, CU;   Karabulut, S;   Kones, O;   Seyit, H;   Serilmez, M;   Aykan, NF",,,,"Karabulut, Mehmet; Alis, Halil; Gunaldi, Meral; Afsar, Cigdem Usul; Karabulut, Senem; Kones, Osman; Seyit, Hakan; Serilmez, Murat; Aykan, Nuri Faruk",,,CLINICAL SIGNIFICANCE OF SERUM HEPATOCYTE GROWTH FACTOR (HGF) AND ITS RECEPTOR CMET LEVELS IN COLORECTAL CANCER PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,HGF; cMET; serum; diagnostic; colorectal cancer,C-MET; COLON-CANCER; EXPRESSION; RESISTANCE; INHIBITION; EGFR; METASTASIS,"Objective: The cMET receptor tyrosine kinase and its ligand hepatocyte growth factor (HGF) regulate many signaling pathways involved in proliferation and cell motility, invasion and angiogenesis. Deregulation of HGF/cMET system by different biological mechanisms may contribute to the minor development in many types of cancers. Therefore, the present study was performed to investigate clinical significance of serum patterns of both HGF and cMET in colorectal cancer (CRC) patients. Materials and methods: One hundred and three CRC patients were enrolled in this study. Serum HGF and cMET levels were measured by the solid-phase sandwich enzyme-linked immunosorbent assay (ELISA) method. Age- and sex-matched 30 healthy control patients were included in the analysis. Results: The median age of the patients was 60 years old, range 24 to 84 years. Most of the tumor localization areas were colon (n = 57, 55%). Median follow-up time was 14 months. While thirty-one patients (30 %) experienced disease progression, twenty-three of the remaining patients (22 %) died because of the disease. The estimated 2-year overall (OS) and 1-year progression-free survival (PFS) rates for the whole patient groups were 70.1 % (95% confidence interval (CI) = 57.2-83.0) and 233 % (95% CI = 82-38.4), respectively. The baseline median serum HGF and cMET levels were significantly higher in metastatic CRC patients than in the healthy control group (p<0.001). Furthermore, worse performance status and metastatic disease were associated with higher serum HGF concentrations all patients with CRC (p=0.03 and p=0.03, respectively). Clinical variables including metastatic disease, greater pathologic tumor status, and colonic site were found to be correlated with higher serum cMET concentrations all patients with CRC (p=0.01, p=0.05, and p=0.04, respectively). A correlation was determined between HGF and cMET levels in metastatic CRC patients (rs=0.286, n=47, and p=0.05), (Spearman's correlation). Our study results did not show a statistically significant serum HGF and cMET concentrations regarding PFS and OS. Conclusion: Serum levels of HGF and cMET may be diagnostic markers in CRC patients. However; their predictive and prognostic values were not determined.","[Karabulut, Mehmet; Alis, Halil; Kones, Osman; Seyit, Hakan] Istanbul Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Clin Gen Surg, Istanbul, Turkey; [Gunaldi, Meral] Istanbul Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Clin Med Oncol, Istanbul, Turkey; [Afsar, Cigdem Usul] Istanbul Educ & Res Hosp, Dept Med Oncol, Istanbul, Turkey; [Karabulut, Senem; Aykan, Nuri Faruk] Istanbul Univ, Fac Med, Inst Oncol, Dept Med Oncol, Istanbul, Turkey; [Serilmez, Murat] Istanbul Univ, Fac Med, Inst Oncol, Dept Basic Oncol, Istanbul, Turkey","Karabulut, M (corresponding author), Istanbul Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Clin Gen Surg, Istanbul, Turkey.",,"Afsar, Cigdem Usul/C-3436-2015; Afsar, Cigdem Usul/AAA-6103-2021; Serilmez, Murat/V-6153-2018; karabulut, senem/AAT-3594-2020; Alis, Halil/AAJ-6721-2020; Gunaldi, Meral/Z-1463-2018; Aykan, Nuri Faruk/I-6425-2019; Seyit, Hakan/AAJ-7050-2020","Afsar, Cigdem Usul/0000-0002-3764-7639; Afsar, Cigdem Usul/0000-0002-3764-7639; Serilmez, Murat/0000-0001-8502-2505; Aykan, Nuri Faruk/0000-0002-5472-3218; ",,,"Ajisaka H, 1998, Nihon Shokakibyo Gakkai Zasshi, V95, P75; Corso S, 2013, CANCER DISCOV, V3, P978, DOI 10.1158/2159-8290.CD-13-004; Dang H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1166-; Elliott VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.009743; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.114147; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-337; Garouniatis A, 2013, INT J COLORECTAL DIS, V28, P9, DOI 10.1007/s00384-012-1520-; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.39; Ho-Yen CM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0547-; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115; Jiang Tao, 2015, Zhongguo Fei Ai Za Zhi, V18, P240, DOI 10.3779/j.issn.1009-3419.2015.04.0; Kirzin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.010315; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.010355; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-056; Liu Y, 2012, TUMORI, V98, P105, DOI 10.1700/1053.1150; Luraghi P, 2014, CANCER RES, V74, P1857, DOI 10.1158/0008-5472.CAN-13-2340-; Matsumoto R, 2015, CANCER SCI, V106, P709, DOI 10.1111/cas.1266; Saigusa S, 2012, INT J ONCOL, V40, P583, DOI 10.3892/ijo.2011.120; Salgia R, 2009, SEMIN ONCOL, V36, pS52, DOI 10.1053/j.seminoncol.2009.02.00; Sun YL, 2013, INT J MED SCI, V10, P548, DOI 10.7150/ijms.519; Sun Yanlai, 2014, Zhonghua Wei Chang Wai Ke Za Zhi, V17, P59; Takeuchi H, 2003, CLIN CANCER RES, V9, P148; Toiyama Y, 2009, INT J CANCER, V125, P1657, DOI 10.1002/ijc.2455; Yonesaka K, 2015, ANTICANCER RES, V35, P168; Zaanan A, 2014, B CANCER, V101, P25, DOI 10.1684/bdc.2013.187; Zaytseva YY, 2012, CANCER RES, V72, P1504, DOI 10.1158/0008-5472.CAN-11-405",26,1,1,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,179.0,187,,,,9,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700028,,,,,2022-07-14,0.0026859504132231405,7.378997206715216e-15,0.02150850140758001,0.08718757036703445,0.02150850140758001
J,"Karabulut, S1;  Afsar, CU;  Karabulut, M;  Alis, H;  Binboga, S;  Ozkara, IO;  Karaca, F;  Bilgin, E;  Tas, F",,,,"Karabulut, Senem; Afsar, Cigdem Usul; Karabulut, Mehmet; Alis, Halil; Binboga, Sinan; Ozkara, Irem Oner; Karaca, Feryal; Bilgin, Elif; Tas, Faruk",,,CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-A) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,MIP1-alpha/CCL3; pancreatic adenocarcinoma; serum; diagnostic; biomarker,MORTALITY-RATES; GASTRIC-CANCER; BONE-DISEASE; SERUM-LEVELS; CCL2; IMMUNOTHERAPY; COMBINATION; EXPRESSION; CHEMOKINES; CYTOKINES,"Introduction: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States among both men and women. Macrophage inflammatory protein-1 alpha [MIP-1 alpha/CC-chemokine ligand 3 (CCL3)] is a small chemotactic protein detected in several kinds of tumor tissue samples and functions as a key regulator of cancer progression. This study aimed to investigate the serum MIP-1 alpha/CCL3 levels in pacreatic adenocarcinoma (PA). Materials and methods: Thirty-three patients with PA were investigated. Serum MIP1-alpha/CCL3 levels were determined using enzyme-linked immunosorbent assay (ELISA). Age and sex matched 30 healthy controls were included in the analysis. Results: The median age at diagnosis was 59 years, range 32-84 years; 20 (61%) patients were men. The tumor was located in the head of the pancreas in 21 (63%) patients. The most common metastatic site was the liver in the 23 patients with metastasis (n= 19, 83%). The median follow-up time was 26.0 weeks (range: 1.0-184.0 weeks). At the end of the observation period, thirty-two patients (97%) were dead. Thirty-nine percent of 23 metastatic patients who received palliative chemotherapy (CTx) were CTx-responsive. The median overall survival of all the patients was 41.3 +/- 8.3 weeks (95% confidence interval [CI]= 5-58 weeks). The baseline serum MIP1-alpha/CCL3 levels were significantly higher in patients with PA than in the control group (p< 0.001). Serum MIP1-alpha/CCL3 levels were significantly higher in the older patients(p= 0.03). Conversely, serum MIP1-alpha/CCL3 concentration had no prognostic role on survival (p= 0.68). Conclusion: Serum levels of MIP1-alpha/CCL3 may have a good diagnostic role in PA. However, serum MIP1-alpha/CCL3 concentrations were not associated with prognosis and survival.","[Karabulut, Senem; Tas, Faruk] Istanbul Univ, Inst Oncol, Dept Med Oncol, Istanbul, Turkey; [Afsar, Cigdem Usul] Istanbul Educ & Res Hosp, Dept Med Oncol, Kasap Ilyas Mah Org Abdurrahman Nafiz Gurman Cd, TR-34098 Istanbul, Turkey; [Karabulut, Mehmet; Alis, Halil; Binboga, Sinan] Istanbul Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Clin Gen Surg, Istanbul, Turkey; [Bilgin, Elif] Istanbul Univ, Inst Oncol, Dept Basic Oncol, Istanbul, Turkey; [Ozkara, Irem Oner] Medicana Int Hosp, Dept Internal Med, Istanbul, Turkey; [Karaca, Feryal] Adana Numune Training & Res Hosp, Dept Radiat Oncol, Adana, Turkey","Afsar, CU (corresponding author), Istanbul Educ & Res Hosp, Dept Med Oncol, Kasap Ilyas Mah Org Abdurrahman Nafiz Gurman Cd, TR-34098 Istanbul, Turkey.",,"karabulut, senem/AAT-3594-2020; Alis, Halil/AAJ-6721-2020; Afsar, Cigdem Usul/AAA-6103-2021; Tas, Faruk/AAF-8751-2019; Afsar, Cigdem Usul/C-3436-2015; DoÄru, Elif Bilgin/A-6543-2018","Afsar, Cigdem Usul/0000-0002-3764-7639; Afsar, Cigdem Usul/0000-0002-3764-7639; DoÄru, Elif Bilgin/0000-0003-0077-7939",,,"Falcao JOA, 2013, TUMORI, V99, P540, DOI 10.1700/1361.1510; Baba T, 2013, J EXP MED, V210, P2661, DOI 10.1084/jem.2013011; Baschuk N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.7; Ben-Baruch A, 2006, SEMIN CANCER BIOL, V16, P38, DOI 10.1016/j.semcancer.2005.07.00; Bodelon C, 2013, INT J MOL EPIDEMIOL, V4, P21; BOYLE P, 1989, INT J PANCREATOL, V5, P327, DOI 10.1007/BF0292429; Cao Q, 2010, CANCER LETT, V295, P17, DOI 10.1016/j.canlet.2010.02.00; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.002; Ding L, 2014, TUMOR BIOL, V35, P10539, DOI 10.1007/s13277-014-2306-; Drake CG, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds26; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-; Hariharan D, 2008, HPB, V10, P58, DOI 10.1080/1365182070188314; Hsu CJ, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115; Jeong KY, 2015, J RADIAT RES, V56, P37, DOI 10.1093/jrr/rru07; Li Y, 2015, ONCOTARGET, V6, P24218, DOI 10.18632/oncotarget.452; Lunardi S, 2014, CANCER LETT, V343, P147, DOI 10.1016/j.canlet.2013.09.03; Ma JM, 2013, JNCI-J NATL CANCER I, V105, P1694, DOI 10.1093/jnci/djt29; McCawley LJ, 2001, CURR BIOL, V11, pR25, DOI 10.1016/S0960-9822(00)00038-; Pandol S, 2009, CLIN GASTROENTEROL H, V7, pS44, DOI 10.1016/j.cgh.2009.07.03; Paniccia A, 2015, CHINESE J CANCER RES, V27, P376, DOI 10.3978/j.issn.1000-9604.2015.05.0; Shiraishi K, 2008, CLIN CANCER RES, V14, P1159, DOI 10.1158/1078-0432.CCR-07-448; Takai E, 2015, WORLD J GASTRO ONCOL, V7, P250, DOI 10.4251/wjgo.v7.i10.25; Tao LL, 2014, WORLD J GASTROENTERO, V20, P4421, DOI 10.3748/wjg.v20.i15.442; Tonouchi H, 2002, SCAND J GASTROENTERO, V37, P830, DOI 10.1080/71378653; Tsirakis G, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0778-; Wang XT, 2014, LEUKEMIA RES, V38, P525, DOI 10.1016/j.leukres.2014.02.01; Wu HH, 2015, J EXP MED, V212, P333, DOI 10.1084/jem.2014170; Wu JH, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-1; Zhang JJ, 2008, EUR J CANCER PREV, V17, P18, DOI 10.1097/CEJ.0b013e32809b4cc; Zhang Y, 2015, REV RECENT CLIN TRIA, V10, P317, DOI 10.2174/157488711066615091614253",31,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,1035.0,1040,,10.19193/0393-6384_2016_4_128,,6,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000028,,,,,2022-07-14,0.003202479338842975,7.43032890918585e-15,0.009704753474976497,0.08712165531145091,0.010536981955481707
J,"Kardes, S1;  Karagulle, M;  Karagulle, MZ;  Erdogan, N",,,,"Kardes, Sinan; Karagulle, Mine; Karagulle, Mufit Zeki; Erdogan, Nergis",,,COEXISTENCE OF BEHCET'S DISEASE AND ANKYLOSING SPONDYLITIS: CASE REPORT AND REVIEW OF THE LITERATURE,ACTA MEDICA MEDITERRANEA,,,English,Review,,,,,,Behcet's Syndrome; Ankylosing Spondylitis; Sponyloarthritis,COMPUTED-TOMOGRAPHY; SACROILIITIS; MANIFESTATIONS,"Objective: To review the clinical characteristics, genetic features and treatments of the previously reported cases of Behcet's disease and ankylosing spondylitis with additional one case presentation. Method: Pubmed, Web of Science and Google Scholar databases were interrogated. Results: A total of 23 cases with coexistence of Behcet's disease and ankylosing spondylitis were found and afterwards reviewed. The majority of them involved male subjects (82.6%). All patients had mucocutaneous lesions and sacroiliitis, 54.5% of all patients had eye involvement, 68.4% had positive pathergy test, 75% had peripheral arthritis and 55.6% of patients developed ankylosing spondylitis after Behcet's disease. Tumor necrosis factor inhibitors were used in six cases. HLA-B51 was positive in 57.1% and HLA-B27 in 59.1% of all cases. Conclusion: Even though Behcet's disease has some clinical and genetic features in common with spondyloarthritis, there remains no sufficient evidence that phenotypes of these shared features are identical or these features are traced to a similar pathogenesis. By taking into account all previously reported cases and our presented case, we suggest that ankylosing spondylitis should be considered in differential diagnosis as a coexisting condition when a Behcet's disease patient with low back pain is being examined.","[Kardes, Sinan; Karagulle, Mine; Karagulle, Mufit Zeki; Erdogan, Nergis] Istanbul Univ, Dept Med Ecol & Hydroclimatol, Istanbul Fac Med, Istanbul, Turkey","Kardes, S (corresponding author), Istanbul Tip Fak Fatih Cap, Tibbi Ekol & Hidroklimatol ABD, TR-34093 Istanbul, Turkey.",,"KaragÃ¼lle, MÃ¼fit Zeki/AAD-6090-2020; Erdogan, Nergis/A-9030-2016; Kardes, Sinan/L-6731-2015; KaragÃ¼lle, Mine/J-4418-2016","Erdogan, Nergis/0000-0001-9674-8547; Kardes, Sinan/0000-0002-6311-8634; KaragÃ¼lle, Mine/0000-0002-8060-970X",,,"Badi MAA, 2008, REV MED INTERNE, V29, P277, DOI 10.1016/j.revmed.2007.09.03; Benamour S, 1998, REV RHUM, V65, P29; Borman P, 2000, RHEUMATOL INT, V19, P195, DOI 10.1007/s00296000005; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-; Celik C, 2011, TURK J RHEUMATOL, V26, P271, DOI 10.5606/tjr.2011.04; CHAMBERLAIN MA, 1993, BRIT J RHEUMATOL, V32, P69; Chang HK, 2002, J KOREAN MED SCI, V17, P524, DOI 10.3346/jkms.2002.17.4.52; Chang Hyun Kyu, 2000, Korean Journal of Internal Medicine, V15, P9; Chung SH, 2013, WORLD J GASTROENTERO, V19, P5389, DOI 10.3748/wjg.v19.i32.538; Cimen OB, 2002, Z RHEUMATOL, V61, P440, DOI 10.1007/s00393-002-0319-; Davatchi F, 2014, J EUR ACAD DERMATOL, V28, P338, DOI 10.1111/jdv.1210; Dilsen N, 1986, RECENT ADV BEHCETS D, V103, P28; El Maghraoui A, 2001, CLIN RHEUMATOL, V20, P189, DOI 10.1007/s10067017006; Eser F, 2008, ROMATIZMA, V23, P6; Etaouil N, 2002, JOINT BONE SPINE, V69, P96, DOI 10.1016/S1297-319X(01)00353-; Fatemi A, 2017, INT J RHEUM DIS, V20, P97, DOI 10.1111/1756-185X.1263; Hatemi I, 2008, CLIN EXP RHEUMATOL, V26, pS9; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.252; Kocyigit H, 2010, TURK J RHEUMATOL, V25, P217, DOI 10.5152/tjr.2010.3; Kotevoglu N, 2004, JCR-J CLIN RHEUMATOL, V10, P42, DOI 10.1097/01.rhu.0000111298.67743.0; Kotevoglu N, 2003, SCAND J RHEUMATOL, V32, P184, DOI 10.1080/0300974031000255; Kucuksen S, 2013, EUR J GEN MED, V10, P11; Lee SK, 2009, ENDOSCOPY, V41, P9, DOI 10.1055/s-0028-110348; McGonagle D, 2015, NAT REV RHEUMATOL, V11, P731, DOI 10.1038/nrrheum.2015.14; MOLL JMH, 1974, MEDICINE, V53, P343, DOI 10.1097/00005792-197409000-0000; Nacir B, 2013, J PMR SCI, V16, P2; OLIVIERI I, 1988, ANN RHEUM DIS, V47, P780, DOI 10.1136/ard.47.9.78; OLIVIERI I, 1990, BRIT J RHEUMATOL, V29, P26; Ordahan B, 2014, J RHEUMATOL ORTHOP, V1, P2, DOI 10.7243/2055-7000-1-; Ozsahin M, 2012, TURK J RHEUMATOL, V27, P214, DOI 10.5606/tjr.2012.03; Smith EL, CLIN MANIFESTATION; Terzi R, 2012, MED J KOCAELI, V1, P2; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P36; YAZICI H, 1981, ANN RHEUM DIS, V40, P558, DOI 10.1136/ard.40.6.55; Yazici H, 2012, CLIN REV ALLERG IMMU, V43, P275, DOI 10.1007/s12016-012-8319-; YAZICI H, 1987, ANN RHEUM DIS, V46, P139, DOI 10.1136/ard.46.2.13; Yildiz N, 2010, RHEUMATOL INT, V30, P1511, DOI 10.1007/s00296-009-1104-; Yoo WH, 2012, RHEUMATOL INT, V32, P1793, DOI 10.1007/s00296-010-1439-",38,2,3,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,947.0,951,,10.19193/0393-6384_2016_4_114,,5,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000014,,,,,2022-07-14,0.003925619834710744,1.7320115509027565e-20,0.007630411412967837,0.07241010450094627,0.007630411412967837
J,"Kianpoor, M1;  Amouchie, R;  Raghibi, M;  Hesam, S;  Mazidi, M;  Abasian, M;  Saffarian, Z;  Masoumi, S;  Sadeghkhani, A",,,,"Kianpoor, Mohsen; Amouchie, Ramin; Raghibi, Mahvash; Hesam, Saeed; Mazidi, Mahdi; Abasian, Mahboobe; Saffarian, Zahra; Masoumi, Sarah; Sadeghkhani, Ali",,,VALIDITY AND RELIABILITY OF PERSIAN VERSIONS OF PERITRAUMATIC DISTRESS INVENTORY (PDI) AND DISSOCIATIVE EXPERIENCES SCALE (DES),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Reliability; validity; dissociative experience scale; peritraumatic distress inventory,POSTTRAUMATIC-STRESS-DISORDER; INJURED TRAUMA SURVIVORS; PTSD; METAANALYSIS; PROPRANOLOL; VALIDATION; PREDICTORS; SYMPTOMS,"Background: Posttraumatic stress disorder (PTSD) is one of the most commonly observed stress-related conditions following a motor vehicle accident, and its effective prevention is a high health-care priority. Although the reliable and valid Dissociative Experience Scale (DES) as the gold-standard instrument to quantify the frequency of self-reported dissociative experiences, and as much the Peritraumatic Distress Inventory (PDI; as a self-report measure-validated in several languages) are useful for identifying adults at risk of developing acute and chronic posttraumatic stress disorder (PTSD), they have not been validated in Iran and their predictive values remain unknown in this population. Objective: To assess the reliability and validity of the Persian version of Dissociative Experience Scale (DES) and the Peritraumatic Distress Inventory (PDI). Method: We included 43 male survivors of fatal motor vehicle accidents. The participants were assessed by PDI and DES, and were retested by DES, and assessed by Mississippi Scale for PTSD in three intervals of immediately after, one month and three months after the event. Results: The DES was significantly correlated with PTSD. Reliability analysis revealed a Cronbach's alpha coefficient of 0.87. The Intraclass Correlation Coefficient for test-retest analysis was 0.87. The PDI was not significantly correlated with PTSD and was borderline and not significantly correlated with DES. Reliability analysis revealed a Cronbach's alpha coefficient of 0.73. Conclusion: Our results suggest that Persian versions of PDI and DES showed a desirable psychometric applicability, except for predictive criterion validity for PDI. In regard to predictive validity, DES but not PDI, might be good instruments to use as a reliable screening tool for future PTSD at least in the initial week after MVA.","[Kianpoor, Mohsen] Zahedan Univ Med Sci, Zahedan Med Sch, Psychiat, Zahedan, Iran; [Amouchie, Ramin; Mazidi, Mahdi; Abasian, Mahboobe; Saffarian, Zahra] Univ Social Welf & Rehabil Sci, Sch Behav Sci, Dept Clin Psychol, Clin Psychol, Tehran, Iran; [Raghibi, Mahvash] Univ Sistan & Baluchestan, Fac Educ Psychol, Psychol, Univ St, Zahedan, Iran; [Hesam, Saeed] ACECR, Royan Inst Reprod Biomed, Dept Epidemiol, Biostatist, Tehran, Iran; [Hesam, Saeed] ACECR, Royan Inst Reprod Biomed, Reprod Epidemiol Res Ctr, Tehran, Iran; [Masoumi, Sarah] Shiraz Univ, Dept Educ Psychol, Shiraz, Iran; [Sadeghkhani, Ali] Univ Allameh Tabatabaei, Fac Psychol, Gen Psychol, Tehran, Iran","Amouchie, R (corresponding author), Univ Social Welf & Rehabil Sci, Sch Behav Sci, Dept Clin Psychol, Clin Psychol, Tehran, Iran.",ramin_amouchie@yahoo.com,"hesam, saeed/AAG-3289-2019","Mazidi Sharafabadi, Mahdi/0000-0002-0039-8229",,,"Abedi G., 2014, J MAZANDARAN U MED S, V24, P18; Abedi G, 2012, INT J COLLAB RES INT, V4, P10; Agorastos A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-; Al-Balbissi Adli H, 2003, Traffic Inj Prev, V4, P64, DOI 10.1080/1538958030985; Allenou C, 2010, DEPRESS ANXIETY, V27, P652, DOI 10.1002/da.2065; Apfel BA, 2011, J PSYCHIATR RES, V45, P735, DOI 10.1016/j.jpsychires.2010.11.01; Armour C, 2014, J ANXIETY DISORD, V28, P418, DOI 10.1016/j.janxdis.2013.12.00; Berger W, 2012, SOC PSYCH PSYCH EPID, V47, P1001, DOI 10.1007/s00127-011-0408-; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.148; Bryant RA, 2001, HYPNOTIZABILITY ACU; Bryant RA, 2011, DISSOCIATION AND THE DISSOCIATIVE DISORDERS: DSM-V AND BEYOND, P18; Bryant RA, 2011, BEHAV RES THER, V49, P346, DOI 10.1016/j.brat.2011.03.00; Carlson E.B., 1993, DISSOCIATION PROGR ; Chan AOM, 2003, J CLIN PSYCHIAT, V64, P175, DOI 10.4088/JCP.v64n021; Creamer M, 2004, BEHAV RES THER, V42, P315, DOI 10.1016/S0005-7967(03)00141-; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-; Fiszman Adriana, 2004, Rev. Bras. Psiquiatr., V26, P164, DOI 10.1590/S1516-4446200400030000; Fullerton C. S., 2001, AM J PSYCHIA; Garofalo C, 2015, FACTOR STRUCTURE DI; Gerritsen AAM, 2006, SOC PSYCH PSYCH EPID, V41, P18, DOI 10.1007/s00127-005-0003-; Goudarzi, 2003, IRANIAN J PSYCHOL, V2, P15; Guardia D., 2013, PRIM CARE COMPANION, V1; Kianpoor M., 2012, INT J HIGH RISK BEHA, V1, P7, DOI [10.5812/ijhrba.4624, DOI 10.5812/IJHRBA.4624; King JH, 2013, COUNSELING TODAY, V56, P2; Kunst MJJ, 2011, CLIN PSYCHOL PSYCHOT, V18, P13, DOI 10.1002/cpp.69; Lilly MM, 2009, J ANXIETY DISORD, V23, P767, DOI 10.1016/j.janxdis.2009.02.01; Nishi D, 2013, MOL PSYCHIATR, V18, P743, DOI 10.1038/mp.2012.9; Nishi D, 2009, GEN HOSP PSYCHIAT, V31, P75, DOI 10.1016/j.genhosppsych.2008.09.00; O'Donnell ML, 2010, PSYCHIAT RES, V176, P257, DOI 10.1016/j.psychres.2009.05.01; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.5; Pierce H, 2012, J TRAUMA STRESS, V25, P211, DOI 10.1002/jts.2168; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-; Saadat S, 2015, EMERGENCY, V3, P1; Saberi H., 2013, INT J OCCUP ENV MED, V4, P31; Shalev AY, 1996, AM J PSYCHIAT, V153, P21; Simeon D, 2014, AM J PSYCHIA; Thomas E, 2012, CAN J PSYCHIAT, V57, P122, DOI 10.1177/07067437120570020; Vaiva G, 2003, CAN J PSYCHIAT, V48, P395, DOI 10.1177/07067437030480060; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-; van Ijzendoorn MH, 1996, CLIN PSYCHOL REV, V16, P365, DOI 10.1016/0272-7358(96)00006-; van Wingen GA, 2011, MOL PSYCHIATR, V16, P664, DOI 10.1038/mp.2010.13; vanderKolk BA, 1995, NATO ADV SCI INST SE, V80, P42; VANDERKOLK BA, 1989, AM J PSYCHIAT, V146, P153",43,11,11,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1493.0,1501,,,,9,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200030,,,,,2022-07-14,0.004442148760330579,2.969591922289695e-14,0.008766255027901616,0.08996533360595556,0.008831333403811422
J,"Kirisci, O1;  Paksoy, T;  Caliskan, A;  Analan, A;  Ozkaya, E;  Kirmaci, B;  Tumer, S;  Citil, R;  Cikim, G;  Agirbas, S;  Guzel, Z;  Senol, H",,,,"Kirisci, Ozlem; Paksoy, Tugba; Caliskan, Ahmet; Analan, Asiye; Ozkaya, Esra; Kirmaci, Beyhan; Tumer, Seray; Citil, Rana; Cikim, Gurkan; Agirbas, Sule; Guzel, Zeki; Senol, Hande",,,"THE RELATIONSHIP BETWEEN SERUM DNA LEVELS AND SEROLOGICAL MARKERS, ALT AND AST WITH LIVER HISTOLOGY IN CHRONIC HEPATITIS B PATIENTS",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Hepatitis B virus; fibrosis; histological activity index; alanine aminotransferase,ALANINE AMINOTRANSFERASE; TRANSAMINASE; FIBROSIS; DISEASE; ANTIGEN; HBEAG,"Introduction: Determination of Hepatitis B virus (HBV) by molecular methods is increasingly common. Together with biochemical and serological diagnostic methods and a histopathological assessment is important to detect necrosis, inflammation, and fibrosis in the liver. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) values are tests often used to predict the histological stages of chronic hepatitis. Materials and methods: One hundred seventy-three patients who were referred to the Kahramanmaras Necip Fazil City Hospital Microbiology Laboratory with prediagnosis of HBV infection between September 2012-January 2016, were evaluated with necroinflammatory activity levels/ histological activity index (HAI) and fibrosis scores according to the ISHAK classification criteria, and the results were compared with alanine aminotransferase (ALT), aspartate aminotransferase (AST), and HBV-DNA serum levels of the time of biopsy. Results: The study included 63 female and 109 male patients. The mean age was 39.39 +/- 13.4 years. There was statistically significant difference in age, ALT, AST, and HBV DNA levels between patients in the high fibrosis group and the low fibrosis group (p: 0.034, 0.002, 0.0001, and 0.007, respectively). There was significant difference between patients from severe HAI and mild to moderate HAI groups in terms of AST values (p: 0.045). AST was found to be a risk factor for fibrosis, and ALT and AST were found to be risk factors for HAI. HBV DNA, ALT, and AST levels of HBe-Ag positive patients were significantly higher compared to HBe-Ag negative patients (p: 0,0001, 0,027, 0,008). Conclusions: In our study, advanced age, high HBV DNA, ALT and AST levels were found to be associated with fibrosis, and high AST levels were found to be associated with liver necroinflammation. It is thought that serum ALT and AST levels could be useful parameters for liver necroinflammation and fibrosis. Evaluation of these parameters in chronic hepatitis B patients as indicator parameters for advanced stages of fibrosis and necroinflammation would be a right approach.","[Kirisci, Ozlem; Caliskan, Ahmet; Tumer, Seray] Necip Fazil City Hosp, Dept Med Microbiol, Kahramanmaras, Turkey; [Paksoy, Tugba; Analan, Asiye; Kirmaci, Beyhan; Citil, Rana; Agirbas, Sule; Guzel, Zeki] Necip Fazil City Hosp, Dept Med Pathol, Kahramanmaras, Turkey; [Ozkaya, Esra] Karadeniz Tech Univ, Fac Med, Dept Med Microbiol, Trabzon, Turkey; [Cikim, Gurkan] Necip Fazil City Hosp, Dept Med Biochem, Kahramanmaras, Turkey; [Senol, Hande] Pamukkale Univ, Fac Med, Dept Biostat, Denizli, Turkey","Kirisci, O (corresponding author), Necip Fazil City Hosp, Dept Med Microbiol, Kahramanmaras, Turkey.",,,"Ozkaya, Esra/0000-0003-1673-9101",,,"Aygun C., 2010, Firat Tip Dergisi, V15, P7; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.2; CHU CM, 1993, CLIN INFECT DIS, V16, P709, DOI 10.1093/clind/16.5.70; Demir NA, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.1697; Inci A, 2015, VIRAL HEPAT DERG, V21, P52, DOI 10.4274/vhd.9870; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-; Kaya S, 2006, INONU U TIP FAK DERG, V13, P2; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.184001051; Kose S, VIRAL HEPATIT DERGIS, V17, P5; LJUNGGREN KK, 1993, J MED VIROL, V39, P297, DOI 10.1002/jmv.189039040; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.2483; MCGILL DB, 1990, GASTROENTEROLOGY, V99, P1396, DOI 10.1016/0016-5085(90)91167-; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.; Ortatatli M, 2014, J CLIN ANAL MED, V5, P494, DOI 10.4328/JCAM.153; Ozbilge H, 2005, ERCIYES MED J, V27, P1; Ozkara S, 2011, TURK KLIN TIP BILIM, V31, P68, DOI 10.5336/medsci.2009-1651; Sakugawa H, 2001, HEPATOL RES, V21, P159, DOI 10.1016/S1386-6346(01)00085-; Solter PF, 2005, TOXICOL PATHOL, V33, P9, DOI 10.1080/0192623059052208; TASYARAN MA, 2003, VIRAL HEPATIT 2003, P12; ter Borg F, 1998, LANCET, V351, P1914, DOI 10.1016/S0140-6736(97)09391-; Thapa BR, 2007, INDIAN J PEDIATR, V74, P663, DOI 10.1007/s12098-007-0118-; Tsai JF, 2000, J GASTROENTEROL, V35, P690, DOI 10.1007/s00535007004; Ustundag Y, 2000, NEPHROL DIAL TRANSPL, V15, P1716, DOI 10.1093/ndt/15.10.171; Yalcin K, 2003, T KLIN GASTROENTEROH, V14, P15; Zavaglia C, 1997, LIVER, V17, P8; Zechini B, 2004, EUR J GASTROEN HEPAT, V16, P891, DOI 10.1097/00042737-200409000-0001",26,2,2,0,9,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1805.0,1811,,10.19193/0393-6384_2016_6_167,,7,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300011,,,,,2022-07-14,0.0026859504132231405,7.538925236848294e-15,0.005158885343493069,0.08587117549477942,0.005158885343493069
J,"Kohan, S1;  Yarmohammadian, MH;  Bahmanjanbeh, F;  Haghshenas, A",,,,"Kohan, Shahnaz; Yarmohammadian, Mohammad Hossein; Bahmanjanbeh, Farideh; Haghshenas, Abbas",,,CONSEQUENCES OF EARTHQUAKE (AUGUST 2012) ON IRANIAN WOMEN'S REPRODUCTIVE HEALTH: A QUALITATIVE STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,disasters; earthquakes; Iran; reproductive health; women's health,MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; 2008 WENCHUAN; HURRICANE; DISASTERS; CHINA; AFTERMATH; SURVIVORS; DISORDER; PARENTS,"Aim: Natural disasters have numerous effects on vulnerable groups, particularly pregnant women and women in labor. There is little information available about the aftermath of earthquakes on women's reproductive health in Iran and other Middle East countries. Hence, this study aimed to investigate the status of women's reproductive health following East Azerbaijan province earthquakes of August 12, 2012 in Iran. Methods: In this qualitative study, 16 earthquake-affected women and 14 health providers from the three struck towns and their villages, and health center and deputy for healthcare of Red Crescent Society of East Azerbaijan province in Iran, participated in semi-structured interviews and data were analyzed by means of qualitative content analysis. Results: Four main categories were extracted including psychological complications, reproductive system physical damages, sexual health damages, and fertility regulation. The first category had two subcategories (short term and long term effects). Conclusion: Results showed that the earthquake had severe effects on some aspects of women's reproductive health, particularly on pregnant women and women in labor. Providing such cares, must therefore be prioritized in services for earthquake-affected women. This issue shows a demand for decision-makers' and service providers' greater attention to women needs during natural disasters.","[Kohan, Shahnaz] Isfahan Univ Med Sci, Nursing & Midwifery Care Res Ctr, Sch Nursing & Midwifery, Esfahan, Iran; [Yarmohammadian, Mohammad Hossein; Haghshenas, Abbas] Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran; [Bahmanjanbeh, Farideh] Isfahan Univ Med Sci, Res Ctr, Sch Nursing & Midwifery, Esfahan, Iran; [Bahmanjanbeh, Farideh] Islamic Azad Univ, Dept Midwifery, Tabriz Branch, Tabriz, Iran; [Haghshenas, Abbas] Univ Technol Sydney, Fac Hlth, Sydney, NSW, Australia; [Haghshenas, Abbas] Benchmark Med, Martin Pl, Sydney, NSW, Australia","Bahmanjanbeh, F (corresponding author), Isfahan Univ Med Sci, Res Ctr, Sch Nursing & Midwifery, Esfahan, Iran.;Bahmanjanbeh, F (corresponding author), Islamic Azad Univ, Dept Midwifery, Tabriz Branch, Tabriz, Iran.",farideh_obs@yahoo.com,"kohan, shahnaz/E-7974-2012; Yarmohammadian, Mohammad H/E-7436-2012; Yarmohammadian, Mohammad H/ABD-6806-2020","Yarmohammadian, Mohammad H/0000-0002-4711-3163; kohan, shahnaz/0000-0003-1479-2160","Isfahan University of Medical Sciences, Isfahan, Iran [39634]","This article is part of the PhD dissertation in reproductive health submitted and supported financially by Isfahan University of Medical Sciences (Code 39634), Isfahan, Iran. Authors would like to thank all the participants in this research and health deputy of Tabriz University of Medical Sciences and health managers of earthquake struck towns.","Abbasi M, 2013, IRAN RED CRESCENT ME, V15, P829, DOI 10.5812/ircmj.807; Abedi G, 2012, INT J COLLAB RES INT, V4, P180; Abedi G., 2014, J MAZANDARAN U MED S, V24, P18; Abedi Gh, 2011, WORLD APPL SCI J, V12, P93; Abeid M, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-2; Anear M., 2010, PRACTICAL GUIDE GEN; Anwar J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-52; Bayer AM, 2014, DISASTERS, V38, P351, DOI 10.1111/disa.1204; Bloem CM, 2013, PREHOSP DISASTER MED, V28, P150, DOI 10.1017/S1049023X1200167; Carlsen HK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-00185; Casey SE, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S; Dong XH, 2013, J AFFECT DISORDERS, V151, P566, DOI 10.1016/j.jad.2013.06.04; Eftekhari Monir Baradaran, 2014, Iran J Psychiatry, V9, P24; Ellington SR, 2013, J WOMENS HEALTH, V22, P189, DOI 10.1089/jwh.2012.417; Enarson Elaine., 2001, ENVIRON HAZARDS-UK, V3, P133, DOI [DOI 10.3763/EHAZ.2001.0314, 10.1016/S1464-2867(02)00006-2, DOI 10.1016/S1464-2867(02)00006-2; Flores EC, 2014, SOC SCI MED, V101, P9, DOI 10.1016/j.socscimed.2013.11.01; Forbes D, 2015, AUST NZ J PSYCHIAT, V49, P706, DOI 10.1177/000486741456547; Gerdin M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.100163; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.00; Haffman Sh, 2009, PREPARING DISASTER P, V42, P149; Hapsari ED, 2009, CONTRACEPTION, V79, P316, DOI 10.1016/j.contraception.2008.10.01; He Huan, 2008, Arrows for Change, V14, P; Hirth JM, 2013, J ADOLESCENT HEALTH, V52, P765, DOI 10.1016/j.jadohealth.2012.12.01; Holloway I., 2007, NARRATIVE RES NURSI; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/104973230527668; Jouhari Zahra, 2015, J Adv Med Educ Prof, V3, P5; Liang Y, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-1; Liu SJ, 2010, INT J GYNECOL OBSTET, V108, P161, DOI 10.1016/j.ijgo.2009.08.03; Liu WM, 2013, J TRAUMA STRESS, V26, P274, DOI 10.1002/jts.2179; Lowe SR, 2014, HEALTH PSYCHOL, V33, P774, DOI 10.1037/hea000001; Lowe SR, 2012, PSYCHOL WOMEN QUART, V36, P286, DOI 10.1177/036168431143430; McFarlane A C, 2012, Depress Res Treat, V2012, P970194, DOI 10.1155/2012/97019; Navrud Stale, 2012, Glob Health Action, V5, P17609, DOI 10.3402/gha.v5i0.1760; Ni CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.012103; Oyarzo C, 2012, J MATERN-FETAL NEO M, V25, P1868, DOI 10.3109/14767058.2012.67843; Paul LA, 2014, J CLIN PSYCHOL, V70, P322, DOI 10.1002/jclp.2202; Polit DF, 2012, NURSING RES GENERAT; Qu ZY, 2012, J AFFECT DISORDERS, V136, P117, DOI 10.1016/j.jad.2011.08.02; Rezaeian M, 2013, J RES MED SCI, V18, P110; Streubert S, 2007, QUALITATIVE RES NUR; Svendsen ER, 2012, INT J ENV RES PUB HE, V9, P2894, DOI 10.3390/ijerph908289; Teramoto C, 2015, JPN J NURS SCI, V12, P320, DOI 10.1111/jjns.1207; UNFPA, 2010, INT FIELD MAN REPR ; Urrutia RP, 2012, REPROD HEALTH MATTER, V20, P93, DOI 10.1016/S0968-8080(12)39602-; Vu Alexander, 2014, PLoS Curr, V6, DOI 10.1371/currents.dis.835f10778fd80ae031aac12d3b533ca; Women's Refugee Commission, 2012, AD SEX REPR HLTH PR; Yokoyama Yukari, 2014, PLoS One, V9, pe102497, DOI 10.1371/journal.pone.010249; Zotti ME, 2013, MATERN CHILD HLTH J, V17, P783, DOI 10.1007/s10995-012-1068-",48,5,5,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1503.0,1511,,,,9,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200031,,,,,2022-07-14,0.004958677685950413,3.730625334382595e-14,0.02096153255023469,0.09008925164496645,0.022573974862884764
J,"Korkmaz, S1;  Denk, A;  Gundogan, B;  Korucu, T;  Dulkadir, ZE;  Telo, S;  Atmaca, M",,,,"Korkmaz, Sevda; Denk, Affan; Gundogan, Burcu; Korucu, Tuba; Dulkadir, Zehra Emine; Telo, Selda; Atmaca, Murad",,,NEUTROPHIL LYMPHOCYTE RATIO IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Neutrophil; lymphocyte; major depressive disorder; inflammation,,"Introduction: Neutrophil - lymphocyte ratio (NLR) is accepted as an inflammation marker. The objective of the study is to indicate the variations in NLR that occur in patients with major depressive disorder. Materials and methods: Forty prospective patients diagnosed with major depressive disorder based on DSM 4-TR and treated in our clinic were included in the study. The control group included forty healthy individuals that applied to our clinic, however were not diagnosed with active psychopathology in the initial examination, and have matching age and gender demographics with the patient group. Lymphocyte and neutrophil percentages taken during the application before the treatment were recorded in the related forms. NLR was calculated by the division of neutrophil rate by the lymphocyte rate for each patient. Results: There was no significant difference between the groups based on socio-demographic characteristics such as age, gender, marital status, income level, smoking, and employment. Mean NLR value was 1.58 +/- 0.59 in the patient group, and it was 2.05 +/- 0.89 in the control group. The difference between these mean values was statistically significant (p=0.007). In control group, the neutrophil percentage, and in patient group the lymphocyte percentage was significantly high. There was no difference between the groups on white blood cell count. Conclusion: It was determined that the NLR is significantly lower in patients with major depressive disorder when compared to the control group. The changes in NLR could reflect the changes in central nervous system metabolisms. Thus, NLR could be an indicator of the fact that immune system is suppressed in chronic inflammation in psychiatric diseases such as depressive disorder.","[Korkmaz, Sevda; Gundogan, Burcu; Korucu, Tuba; Dulkadir, Zehra Emine; Atmaca, Murad] Firat Univ, Fac Med, Dept Psychiat, TR-23169 Elazig, Turkey; [Denk, Affan] Firat Univ, Fac Med, Dept Infect, TR-23169 Elazig, Turkey; [Telo, Selda] Firat Univ, Fac Med, Dept Biochem, TR-23169 Elazig, Turkey","Korkmaz, S (corresponding author), Firat Univ, Fac Med, Dept Psychiat, TR-23169 Elazig, Turkey.",,"Atmaca, Murad/V-9377-2018; KORKMAZ, SEVDA/O-2867-2015; Telo, Selda/V-6019-2018; Telo, Selda/V-5992-2018","Telo, Selda/0000-0003-3655-0269; ",,,"American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th, DOI [DOI 10.1176/APPI.BOOKS.9780890420249.DSM-IV-TR, 10.1176/appi.books.9780890420249.dsm-iv-tr; Azab B, 2014, CANCER BIOMARK, V14, P303, DOI 10.3233/CBM-14041; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.00; Jilma B, 1999, AM J RESP CRIT CARE, V159, P857, DOI 10.1164/ajrccm.159.3.980508; Kalelioglu T, 2015, PSYCHIAT RES, V228, P925, DOI 10.1016/j.psychres.2015.05.11; Lanquillon S, 2000, NEUROPSYCHOPHARMACOL, V22, P370, DOI 10.1016/S0893-133X(99)00134-; MAES M, 1995, PSYCHONEUROENDOCRINO, V20, P111, DOI 10.1016/0306-4530(94)00066-; MUSSELMAN DL, 1996, BR J PSYCHIAT S, V30, P12; Ozturk C, 2015, ANGIOLOGY, V66, P695, DOI 10.1177/000331971558629; Reichlin T, 2010, CLIN CHEM, V56, P944, DOI 10.1373/clinchem.2009.14225; Sarandol Asli, 2003, Turk Psikiyatri Derg, V14, P11; Semiz M, 2014, PSYCHIAT DANUB, V26, P22; Tuglu C, 2003, B CLIN PSYCHOPHARMAC, V13, P14; Wen Ru-Min, 2015, Asian Pac J Cancer Prev, V16, P370; Yildiz A, 2014, J CLIN EXPT INVESTIG, V5, P2; Yu XY, 2015, ARCH GERONTOL GERIAT, V61, P76, DOI 10.1016/j.archger.2015.03.01; Zahorec R, 2001, Bratisl Lek Listy, V102, P",17,4,4,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,795.0,798,,10.19193/0393-6384_2016_3_92,,4,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400021,,,,,2022-07-14,0.001756198347107438,5.864688231189828e-11,0.049553879205544105,0.11471233039047224,0.05334125407163409
J,"Koylu, O1;  Koylu, R;  Dundar, ZD",,,,"Koylu, Oznur; Koylu, Ramazan; Dundar, Zerrin Defne",,,THE EFFECT OF LACTATE AND LACTATE CLEARANCE ON PROGNOSIS AND THERAPY OUTCOME IN MUSHROOM POISONING,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,mushroom poisoning; lactate; lactate clearance,METABOLIC-ACIDOSIS; LACTIC-ACIDOSIS; BLOOD LACTATE; FAILURE; SEPSIS; SHOCK; COMA,"Introduction: Mushroom poisoning is a serious poisoning that may have a fatal course. Typically, the signs of hepatotoxicity appear 24-36 hours after ingestion. The lactate clearance naturally decreases in impaired hepatic fraction. The purpose of this study was to assess the effect of lactate and lactate clearance on the prognosis and the efficacy of therapy in patients with mushroom poisoning hospitalized in the Toxicology Unit. Materials and methods: This retrospective study included 236 patients who had been diagnosed with mushroom poisoning upon referral to the Emergency Unit, hospitalized, and treated between July 2008 and March 2013. The patients were divided into two groups as those undergone hemoperfusion and those not undergone hemoperfusion. The patients were also divided into two groups as those with abnormal liver fraction tests and those with normal liver function tests. The lactate clearance of each patient was calculated according to the values of lactate upon referral, lactate at hours 6 and 24 in the blood gas analyses. Results: The mean lactate value upon referral in patients with normal liver enzymes was 0.97 +/- 0.48 mmol/L, whereas this was 1.68 +/- 0.63 mmol/L in patients with elevated liver enzymes. The mean lactate clearance values at the 24th hour were 25.76 +/- 14.80% and 36.05 +/- 14.22%, respectively. The mean lactate clearance values at the 24th hour in patients undergoing hemoperfusion and patients not undergoing hemoperfusion were 14.26 +/- 23.52% and 39.48 +/- 14.33%, respectively. The lactate clearance at the 24th hour was significantly higher; particularly in patients with elevated liver enzymes who had received hemoperfusion along with supportive therapy (p<0.001). Conclusion: Mushroom poisoning patients with high blood lactate levels on admission to the hospital should be approached carefully with regard to requirement for hemoperfusion and the prognosis.","[Koylu, Oznur] Konya Training & Res Hosp, Dept Biochem, Konya, Turkey; [Koylu, Ramazan] Konya Training & Res Hosp, Emergency Dept, Konya, Turkey; [Dundar, Zerrin Defne] NecmettinErbakan Univ, Meram Fac Med, Dept Emergency Med, Konya, Turkey","Koylu, O (corresponding author), Konya Training & Res Hosp, Dept Biochem, Konya, Turkey.",,"Dundar, Zerrin Defne/AAR-4130-2020; Koylu, Ramazan/AGQ-8717-2022",,,,"Benaissa ML, 2003, INTENS CARE MED, V29, P1372, DOI 10.1007/s00134-003-1866-; Berger KJ, 2005, J EMERG MED, V28, P53, DOI 10.1016/j.jemermed.2004.08.01; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-; Brent J, 2007, HADDAD WINCHESTERS C, P45; Bronstein AC, 2009, CLIN TOXICOL, V47, P911, DOI 10.3109/1556365090343856; Bustamante J, 1998, FREE RADICAL BIO MED, V24, P1023, DOI 10.1016/S0891-5849(97)00371-; Esen F, 2006, J SURG MED SCI, V2, P2; Goldfrank LR, 2011, GOLDFRANKS TOXICOLOG, P152; Head JM, 2012, BMJ CASE REP, V201; Levy B, 2006, CURR OPIN CRIT CARE, V12, P315, DOI 10.1097/01.ccx.0000235208.77450.1; MacQuillan GC, 2005, LIVER TRANSPLANT, V11, P1073, DOI 10.1002/lt.2042; Mendoza CD, 2006, ANN EMERG MED, V48, P637, DOI 10.1016/j.annemergmed.2006.06.04; Montanini S, 1999, ARZNEIMITTEL-FORSCH, V49, P104; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A; Nilsson UA, 2008, FREE RADICAL BIO MED, V44, P1562, DOI 10.1016/j.freeradbiomed.2008.01.01; Protti A, 2012, CRIT CARE, V16, DOI 10.1186/cc1133; Roth B, 1999, ANN EMERG MED, V33, P452, DOI 10.1016/S0196-0644(99)70312-; Sargin G, 2011, TURKISH J INTENSIVE, V3, P6; Shah AD, 2011, BRIT J CLIN PHARMACO, V71, P20, DOI 10.1111/j.1365-2125.2010.03765.; Shih RD, 2014, ROSENS EMERGENCY MED, P206; SOKAL JA, 1985, ARCH TOXICOL, V57, P196, DOI 10.1007/BF0029088; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.; Zahorec R, 2001, Bratisl Lek Listy, V102, P",23,1,1,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,2.0,,,,,291.0,295,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QQ,WOS:000375338000003,,,,,2022-07-14,0.0023760330578512395,3.6685851008720474e-14,0.004540523532671482,0.09522591561488594,0.004540523532671482
J,"Koyuncuer, A21;   Bayraktar, SG;   Gurkan, E",,,,"Koyuncuer, Ali; Bayraktar, Suphi Gurman; Gurkan, Eren",,,HISTOPATHOLOGIC EXAMINATION OF THYROIDECTOMY SPECIMENS FROM 1149 NODULAR GOITER PATIENT,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Cytology; Carcinoma; Incidental; Nodular hyperplasia; Thyroid; Thyroidectomy,FINE-NEEDLE-ASPIRATION; CANCER DATA REGISTRY; HASHIMOTOS-THYROIDITIS; INSTITUTIONAL EXPERIENCE; INCIDENTAL CARCINOMA; MULTINODULAR GOITER; RISING INCIDENCE; CYTOLOGY; GLAND; EPIDEMIOLOGY,"Introduction: Thyroid nodules are common in clinical pathology practice and are the most common indication for thyroidectomies. In the present study we evaluated patients diagnosed with nodular goiter according to preoperative thyroid fine needle aspiration cytology and who also underwent thyroidectomy. Materials and methods: The case reports, pathologic reports, and stained sections of 1149 patients who were admitted and underwent thyroidectomy specimens were retrospectively evaluated. Results: The cytology and histology records were correlated for 260 cases. The 1149 cases included in this study consisted of 1020 female and 129 male cases with a mean age of 41.4 years (range, 13 to 82 years). The distribution of histological findings are as follows: 999 (72.3%) cases were found to be non-neoplastic and 150 cases (13.1%) were neoplastic. Postoperative histologic evaluation demonstrated 939 (81.7%) cases of nodular hyperplasia, 70 (6.1%) cases of papillary carcinoma, 55 (4.8%) cases of follicular adenoma, 39 (3.4%) cases of Hashimoto's thyroiditis. The correlation of cytology and histopathology showed that 145 of 260 FNA results (55.7%) were concordant, whereas 8 patients (3%) had discordant results. Eighty-five cases were excluded for being non-diagnostic. Histological review revealed incidental papillary thyroid carcinoma in 62 (5.39 %) patients. Mean tumor size was 1.26 cm. Conclusion: Nodular hyperplasia was the most common histopathological finding followed by papillary thyroid carcinoma. Improved imaging techniques combined with the correct use of fine-needle aspiration diagnoses may reduce the number of cases that are not treatable by thyroidectomy. It is likely that the early detection of some thyroid cancers is primarily incidental.","[Koyuncuer, Ali; Bayraktar, Suphi Gurman] Antakya State Hosp, Dept Pathol, Antakya, Turkey; [Gurkan, Eren] Antakya State Hosp, Dept Endocrinol & Metab, Antakya, Turkey","Koyuncuer, A (corresponding author), Antakya State Hosp, Dept Pathol, Antakya, Turkey.",,"Koyuncuer, Ali/I-7999-2014; gÃ¼rkan, eren/A-8172-2019","Koyuncuer, Ali/0000-0002-0994-1275; ",,,"AGRAWAL S, 1995, J SURG ONCOL, V58, P168, DOI 10.1002/jso.293058030; Albasri A, 2014, ASIAN PAC J CANCER P, V15, P5565, DOI 10.7314/APJCP.2014.15.14.556; ALTAVILLA G, 1990, ACTA CYTOL, V34, P25; Amrikachi M, 2001, ARCH PATHOL LAB MED, V125, P48; Bahn RS, 2011, J CLIN ENDOCR METAB, V96, P1202, DOI 10.1210/jc.2010-258; Bakhos R, 2000, DIAGN CYTOPATHOL, V23, P233, DOI 10.1002/1097-0339(200010)23:4<233::AID-DC3>3.3.CO;2-; Baloch ZW, 1998, THYROID, V8, P565, DOI 10.1089/thy.1998.8.56; Bisi H, 1989, CANCER, V1, P188; Bombil I, 2014, S AFR J SURG, V52, DOI 10.7196/SAJS.197; Burch HB, 1996, ACTA CYTOL, V40, P117; Cappel RJDTN, 2001, CYTOPATHOLOGY, V12, P399, DOI 10.1046/j.1365-2303.2001.00363.; Chukudebelu O, 2012, Ir Med J, V105, P16; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4L; CORREA P, 1995, CANCER, V75, P338, DOI 10.1002/1097-0142(19950101)75:1+<338::AID-CNCR2820751316>3.0.CO;2-; Costamagna D, 2013, G CHIR, V34, P2; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.01; Darwish AH, 2006, BAHRAIN MED B, V2; de Benoist B, 2004, IODINE STATUS WORLD; de Benoist B, 2008, FOOD NUTR BULL, V29, P195, DOI 10.1177/15648265080290030; DeLellis R.A., 2004, WHO CLASSIFICATION T, P5; Faquin WC, 2008, ARCH PATHOL LAB MED, V132, P622, DOI 10.1043/1543-2165(2008)132[622:TTGRPI]2.0.CO;; GARDINER GW, 1986, J OTOLARYNGOL, V15, P16; Hofman V, 2009, VIRCHOWS ARCH, V455, P21, DOI 10.1007/s00428-009-0798-; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.013; Jin J, 2013, CURR PROB SURG, V50, P241, DOI 10.1067/j.cpsurg.2013.02.00; Ko HM, 2003, ACTA CYTOL, V47, P727, DOI 10.1159/00032659; Konturek A, 2013, LANGENBECK ARCH SURG, V398, P389, DOI 10.1007/s00423-012-1021-; Lebastchi AH, 2014, CURR PROB CANCER, V38, P48, DOI 10.1016/j.currproblcancer.2014.04.00; Lew JI, 2011, J AM COLL SURGEONS, V213, P188, DOI 10.1016/j.jamcollsurg.2011.04.02; Liu Q, 1998, SURGERY, V123, P2, DOI 10.1067/msy.1998.8330; Liu ZY, 2011, CANCER SCI, V102, P288, DOI 10.1111/j.1349-7006.2010.01769.; Luo J, 2012, J SURG RES, V174, P207, DOI 10.1016/j.jss.2011.11.103; Matesa-Anic D, 2009, ACTA CLIN CROAT, V48, P; Mazokopakis EE, 2010, HORM-INT J ENDOCRINO, V9, P312, DOI 10.14310/horm.2002.128; McHenry CR, 2011, ONCOLOGIST, V16, P585, DOI 10.1634/theoncologist.2010-040; Misiakos EP, 2006, SOUTH MED J, V99, P1224, DOI 10.1097/01.smj.0000232202.82002.c; Nanjappa N, 2013, INDIAN J OTOLARYNGOL, V65, P37, DOI 10.1007/s12070-012-0596-; OTT RA, 1987, AM SURGEON, V53, P44; Pacini F, 2012, BEST PRACT RES CL EN, V26, P381, DOI 10.1016/j.beem.2011.10.00; Pagni F, 2014, ENDOCR PATHOL, V25, P288, DOI 10.1007/s12022-014-9323-; Papotti M, 2005, MODERN PATHOL, V18, P541, DOI 10.1038/modpathol.380032; Parangi S, 2010, SURGERY, V148, P115; Pezzolla A, 2014, INT J SURG, V12, pS98, DOI 10.1016/j.ijsu.2014.05.04; Rago T, 2008, BEST PRACT RES CL EN, V22, P913, DOI 10.1016/j.beem.2008.09.01; Repplinger D, 2008, J SURG RES, V150, P49, DOI 10.1016/j.jss.2007.09.02; Rosai J, 2011, ROSAI ACKERMANS SURG, P48; Rosai J, 1992, ATLAS TUMOR PATHOLO; Rossi ED, 2013, EUR J ENDOCRINOL, V169, P649, DOI 10.1530/EJE-13-043; Sclabas GM, 2003, AM J SURG, V186, P702, DOI 10.1016/j.amjsurg.2003.08.01; Seethala RR, 1996, PROTOCOL EXAMINATIO; Sidawy MK, 1997, CANCER CYTOPATHOL, V81, P253, DOI 10.1002/(SICI)1097-0142(19970825)81:4<253::AID-CNCR7>3.0.CO;2-; Sinna EA, 2012, J EGYPT NATL CANCER, V24, P63, DOI 10.1016/j.jnci.2012.01.00; Theoharis CGA, 2009, THYROID, V19, P1215, DOI 10.1089/thy.2009.015; Tsegaye B, 2003, East Afr Med J, V80, P52; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr03; Vashishta R, 2012, OTOLARYNG HEAD NECK, V147, P1027, DOI 10.1177/019459981245440; Yeung MJ, 2008, ONCOLOGIST, V13, P105, DOI 10.1634/theoncologist.2007-021; Ylagan LR, 2004, THYROID, V14, P35, DOI 10.1089/10507250432278382; Zhang Y, 2014, J CANCER RES CLIN, V140, P1021, DOI 10.1007/s00432-014-1629-",59,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,35.0,43,,,,9,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700005,,,,,2022-07-14,0.006301652892561983,2.9161754308535126e-05,0.2538374713093554,0.1378073259968965,0.253749344256177
J,"Li, Y21;   Li, XH;   Shi, GN;   Wang, P;   Ma, HB",,,,"Li, Yong; Li, Xiaohui; Shi, Gongning; Wang, Pei; Ma, Hongbing",,,"APPLICATION VALUE OF JOINT DETECTION OF SERUM MARKER CYFRA21-1, NSE, CEA, CA19-9, CA125, SCC IN DIAGNOSIS OF LUNG CANCER",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Serum Marker; Diagnosis of Lung Cancer; Chemiluminescence Detection; Application Value,,"Introduction: To further increase diagnosis accuracy of lung cancer and seize the optimal opportunity for treatment, in this paper we conducted in-depth analysis on application value of joint detection of CYFRA21-1, NSE, CEA, CA19-9, CA125 and SCC in diagnosis of lung cancer. Materials and methods: In this research, 1000 patients, who have been clinically diagnosed with lung cancer, were selected into observation group, in which there were 312 patients of small cell carcinoma, 458 with adenocarcinoma, and remaining 330 with squamous carcinoma. In addition, 200 healthy people were selected as research objects in control group. Electrochemistry luminescence method was adopted to test index levels of the two groups, respectively, with test items including CYFRA21-1, NSE, CEA, CA19-9, CA125, SCC. Results: Test results showed the serum indexes of observation group were significantly higher than those of control group. In addition, through comparing 3 different types of lung cancer patients, patients with small cell carcinoma had a significantly higher concentration of serum NSE than those with squamous carcinoma or adenocarcinoma; the concentrations of CA125, CEA, CA19-9 in patients with adenocarcinoma were higher than that of patients with squamous carcinoma or small cell carcinoma; the concentrations of CYFRA21-1 in patients with squamous carcinoma was the highest of the three. Moreover, it finally confirmed 958 lung cancer patients in total by testing 6 serum indexes of all selected patients, with positive rate accounting for 87.09%. Conclusion: As a result, it is of vital significance to test serum indexes such as CYFRA21-1, NSE, CEA, CA19-9, CA125, SCC for suspected lung cancer patients, and the concentrations of different indexes play key roles in confirming type of lung cancer. Finally, it concluded that joint detection of serum markers can further enhance diagnosis efficiency, which should be promoted in clinical practice.","[Li, Yong; Li, Xiaohui; Shi, Gongning; Wang, Pei; Ma, Hongbing] Henan Univ, Huaihe Hosp, Ward Cardiothorac Surg 1, Kaifeng 475000, Peoples R China","Li, Y (corresponding author), Henan Univ, Huaihe Hosp, Ward Cardiothorac Surg 1, Kaifeng 475000, Peoples R China.",,,,,,"Al-Ghanim KA, 2016, SAUDI J BIOL SCI, V23, P72, DOI 10.1016/j.sjbs.2015.03.01; August DA, 2016, ASIAN PAC J SURG ONC, V2, P15; El-Serehy HA, 2016, SAUDI J BIOL SCI, V23, P327, DOI 10.1016/j.sjbs.2016.01.02; Kos M, 2015, ACTA MEDICA MEDITERR, V31, P21; Liu GJ, 2015, J COASTAL RES, P741, DOI 10.2112/SI73-127.; Mellotte G. M. V., 2015, ASIAN PAC J SURG ONC, V1, P10; Plescia F, 2015, ACTA MEDICA MEDITERR, V31, P81; Shen XZ, 2015, J COASTAL RES, P375, DOI 10.2112/SI73-066.; WANG N, 2008, EDFAAO, V1, P1; Zhao Chunming, 2013, LABELED IMMUNOASSAYS, V05, P35",10,2,2,1,15,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_148,,4,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000019,,,,,2022-07-14,0.0010330578512396695,1.8195930489521096e-08,0.06161394039690188,0.08188331627430911,0.05974089662186758
J,"Licata, M1;  Iorio, S;  Badino, P;  Tornali, C;  Vecchio, I",,,,"Licata, Marta; Iorio, Silvia; Badino, Paola; Tornali, Cristina; Vecchio, Ignazio",,,"LEOPOLDO MAGGI: PHYSICAN, ANTHROPOLOGIST AND ARCHAEOLOGIST",ACTA MEDICA MEDITERRANEA,,,English,Letter,,,,,,,,,"[Licata, Marta; Badino, Paola] Univ Insubria, Dept Biotechnol & Life Sci, Varese, VA, Italy; [Iorio, Silvia] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Tornali, Cristina] Univ Catania, Dept Biomed & Biotechnol Sci, I-95124 Catania, Italy; [Vecchio, Ignazio] Univ Catania, Dept Clin & Expt Med, I-95124 Catania, Italy","Licata, M (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, VA, Italy.",marta.licata@uninsubria.it,"Tornali, Cristina/M-5187-2017","Tornali, Cristina/0000-0002-1722-5498; Vecchio, Ignazio/0000-0001-5942-1908; iorio, silvia/0000-0001-9741-7838",,,"Armocida G., 2002, TERRA GENTE, V10, P5; Licata M, 2012, RIV SOC STORICA VARE, VXXXI, P12; Licata M, 2014, ACTA MEDICA MEDITERR, V30, P55; Maggi L, 1872, ATTI SOC ITALIANA SC, VXV, P10; Maggi L., 1878, ATT SETT RIUN STRAOR, P11; Maggi L, 1872, ATTI SOC ITALIANA SC, VXV, P13",6,7,7,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,1569.0,1570,,10.19193/0393-6384_2016_5_131,,2,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000002,,,,,2022-07-14,0.0005165289256198347,4.470137813078722e-08,0.0008263182027376301,0.08079256841911979,0.0008263182027376301
J,"Mahadavi, A1;  Mousavi, T;  Dehkhoda, F;  Charati, JY;  Esmaeili, R",,,,"Mahadavi, Ali; Mousavi, Tahoora; Dehkhoda, Fatemeh; Charati, Jamshid Yazdani; Esmaeili, Ravanbakhsh",,,THE PREVALENCE OF BREAST CANCER IN THE EAST OF MAZANDARAN PROVINCE IN 2012-2013,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Breast Cancer; Prevalence; East of Mazandaran Province,BURDEN,"Introduction: Breast Cancer is one of the most common cancer and cause of death in Iranian women, so that 32% of women suffer this disease. Due to high incidence of this disease and its consequences in the society, this study aimed to determine the prevalence of breast cancer in the east of Mazandaran province in 2010 to 2013. Methodology: This is a correlational study. Samples were selected by simple random sampling and through discovering 103224 file of patients in Behshahr Imam Khomeini Hospital from 2010-2013. Then, data were analysed by descriptive statistical test and SPSS 20 statistical software. Findings: by studying the patients file, it was founded that 159 cases (0.001%) suffered all kinds of Cancer in which 46 cases (28.9%) was related to Breast Cancer. The people who suffered cancer included 4 male (8.7%) and 42 female (91.3%) in the age group 34-83 years old and average age of 11.06 +/- 55.77. Conclusion: The results of the study showed that the average age of Breast Cancer is lower in Iran compared to foreign statistic. The incidence of Breast Cancer in most of western countries was below 40 years old.","[Mahadavi, Ali; Mousavi, Tahoora] Mazandaran Univ Med Sci, Nursing, Sari, Iran; [Dehkhoda, Fatemeh] Mazandaran Univ Med Sci, Biol Res Ctr, Microbiol, Sari, Iran; [Charati, Jamshid Yazdani] Mazandaran Univ Med Sci, Dept Biostat, Sari, Iran; [Esmaeili, Ravanbakhsh] Mazandaran Univ Med Sci, Orthoped Res Ctr, Sari, Iran","Esmaeili, R (corresponding author), Sari Nursing & Midwiferi Sch, Vesal St, Sari, Iran.",r.esmaeili90@gmail.com,"Mousavi, Tahoora/ABG-4372-2020","Mousavi, Tahoora/0000-0003-2505-370X",,,"Almaci F, 2005, IRANIAN J OBSTET GYN, V8, P2; Aryandono Teguh, 2006, Asian Pac J Cancer Prev, V7, P45; Benz CC, 2008, CRIT REV ONCOL HEMAT, V66, P65, DOI 10.1016/j.critrevonc.2007.09.00; Bhurgri Y, 2000, INT J CANCER, V85, P325, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;325::AID-IJC5&gt;3.0.CO;2-; Bouchardy C, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.1387; FasihiHarandy T, 2012, PAYESH, V11, P7; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.2551; Hamadeh Randah R., 2014, SULTAN QABOOS U MED, V14, P17; Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa101396; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.04; Lacey JV, 2002, ENVIRON MOL MUTAGEN, V39, P82, DOI 10.1002/em.1006; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-; Luciani S, 2013, B WORLD HEALTH ORGAN, V91, P640, DOI 10.2471/BLT.12.11669; MohsenMousavi S, 2008, BREAST J, V14, P605, DOI 10.1111/j.1524-4741.2008.00662.; Naderimagham S, 2014, ARCH IRAN MED, V17, P794, DOI 0141712/AIM.00; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.144; Ravichandran K., 2009, Eastern Mediterranean Health Journal, V15, P61; Roue1 T, 2013, EPIDEMIOLOGY BREAST, V17, P471, DOI [10.1186/2193-1801-2-471, DOI 10.1186/2193-1801-2-471; Saadatjoo SA, 2013, J BIRJAND U MED SCI, V20, P6; Shaukat U, 2013, ASIAN PAC J CANCER P, V14, P5625, DOI 10.7314/APJCP.2013.14.10.562; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.88",21,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1521.0,1524,,,,4,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200033,,,,,2022-07-14,0.0024793388429752063,1.8728383149865328e-08,0.09133980028900147,0.12929249756240901,0.09134067193267553
J,"Mohammadlou, M1;  Elahi, T;  Morovati, Z",,,,"Mohammadlou, Maryam; Elahi, Tahereh; Morovati, Zekrollah",,,THE ROLE OF PERSONALITY TRAITS IN PREDICTING DEFENSE MECHANISMS WITH MEDIATING ROLE OF ATTRIBUTION STYLES IN UNIVERSITY STUDENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,personality traits; attribution style; defense mechanism; structural equation modeling,,"The purpose of the present study was examining the role of personality traits in predicting defense mechanisms with mediating Role of Attribution Styles in University Students. The study sample consisted of 300 students of Islamic Azad University of Zanjan who were selected through a random stratified method. The research instruments were, NEO-Personality Inventory-Revised (NEO-FFI-R), Defense Mechanisms Questionnaire (DSQ-40), and Attributional Style Questionnaires (ASQ-48). Data analysis was carried out through Pearson Correlation Coefficient and Structural Equation Modeling (LISREL). The results showed that significant positive relationship among personality dimensions, i.e. extraversion, openness to experience, and conscientiousness with mature defense mechanisms, among personality dimensions, i.e. extraversion, conscientiousness and agreeableness with neurotic defense mechanisms, and among positive attribution style with mature and neurotic defense mechanisms. There was a negative significant relationship among neuroticism with mature defense mechanism and positive attribution style. Modeling and structural equation analysis proved the significant mediation of attribution styles in relationship between personality traits and defense mechanisms. According to the results of the present study, personality traits indirectly determined the type of defense mechanisms employed by the individuals through their attribution styles.","[Mohammadlou, Maryam] Islamic Azad Univ, Dept Psychol, Coll Educ Sci, Zanjan, Iran; [Elahi, Tahereh; Morovati, Zekrollah] Univ Zanjan, Dept Psychol, Coll Humanities, Zanjan, Iran","Elahi, T (corresponding author), Univ Zanjan, Dept Psychol, Coll Humanities, Zanjan, Iran.",telahi@znu.ac.ir,"elahi, tahereh/Y-5273-2019; morovati, zekrollah/R-9836-2019","morovati, zekrollah/0000-0003-1216-462X",,,"azad M. Ardkan, 2012, DERMATOLOGY COSMETIC, V3, P7; Beigdeli I. A., 1993, THESI; Besharat M. A., 2001, PSYCHOL J, V5, P27; Cheng H., 2011, J HAPPINESS STUD, V2, P30; Constantinos M., 2014, J PSYCHOL INTERDISCI, V58, P54; Cramer P., 2010, AM PSYCHOL ASS, V55, P63; Cramer P, 2009, J RES PERS, V43, P464, DOI 10.1016/j.jrp.2009.01.02; DUA JK, 1995, J CLIN PSYCHOL, V51, P507, DOI 10.1002/1097-4679(199507)51:4<507::AID-JCLP2270510407>3.0.CO;2-; Esma'ili N., 2014, INT C HUM BEH STUD ; Furnham A, 2012, PSYCHOL HEALTH MED, V17, P723, DOI 10.1080/13548506.2012.66392; Ganji M., 2013, J LEARNING INABILITI, P5; Heidarinasab L., 2006, THESI; Kachouyi M., 2014, J MED SCI, V24, P18; Kwon P, 2000, J CLIN PSYCHOL, V56, P723, DOI 10.1002/(SICI)1097-4679(200006)56:6<723::AID-JCLP3>3.0.CO;2-; Mahasneh A., 2013, INT J BUSINESS SOCIA, V4, P28; Malouff JM, 2010, J RES PERS, V44, P124, DOI 10.1016/j.jrp.2009.09.00; Mousavinasab S. M. H., 2006, J IRANS PSYCHIAT CLI, V47, P38; Schultz D., 2013, PERSONALITY THEORIE; Schwartz JAJ, 2000, J CLIN CHILD PSYCHOL, V29, P188, DOI 10.1207/S15374424jccp2902_; Shark F. Motamedi, 2007, J IRANS PSYCHIAT CLI, P17; Vaillant GE, 2000, AM PSYCHOL, V55, P89, DOI 10.1037/0003-066X.55.1.8; Wallach HS, 2008, J FAM VIOLENCE, V23, P655, DOI 10.1007/s10896-008-9189-",22,1,1,2,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1265.0,1271,,,,7,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200012,,,,,2022-07-14,0.0023760330578512395,1.868129767807357e-08,0.004540523532671482,0.12775336210423513,0.004540523532671482
J,"Mohammadnejad, E1;  Abbaszadeh, A;  Soori, H;  Afhami, S",,,,"Mohammadnejad, Esmaeil; Abbaszadeh, Abbas; Soori, Hamid; Afhami, Shirin",,,PREVENTION AND CONTROL OF NOSOCOMIAL INFECTIONS PROCEEDING IN INTENSIVE CARE UNITS: A CONTENT ANALYSIS STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Intensive Care Units; Infection Control; nosocomial infections; content analysis,,"Background: ICU nosocomial infection is a major safety concern for both health care providers and the patients and noteworthy that increased morbidity, mortality and hospitalization costs. Objectives: The purpose of this study was to explore the perspectives of healthcare workers about the process of prevention and control of nosocomial infectionsin intensive care units of hospitals. Patients and methods: This qualitative study was conducted through purposeful sampling strategy withparticipating 21 health care workers. The data were collected using semi-structured interviews (34-145 minute), and was continued until achieving data saturation and themes' emergence. Content analysis method was used for data analysis. Results: Thematic analysis led to the identification five main categories The effectiveness of the infection control training process in the intensive care units, Systematic infection control processes, General management of hospitals, Management of resources and Organizational leadership. Conclusion: Qualitative content analysis showed that with enforcement of facilitating factors, it can be improved the quality of medical care and reduced the incidence of infections.","[Mohammadnejad, Esmaeil] Shahid Beheshti Univ Med Sci, Int Branch, Nursing, Tehran, Iran; [Abbaszadeh, Abbas] Shahid Beheshti Univ Med Sci, Nursing & Midwifery Sch, Dept Nursing, Tehran, Iran; [Soori, Hamid] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Afhami, Shirin] Univ Tehran Med Sci, Dept Infect Dis, Tehran, Iran","Abbaszadeh, A (corresponding author), Shahid Beheshti Univ Med Sci, Nursing & Midwifery Sch, Dept Nursing, Tehran, Iran.",aabaszadeh@hotmail.com,"Mohammadnejad, Esmaeil/ABD-8170-2020; Abbaszadeh, Abbas/G-1783-2016","Abbaszadeh, Abbas/0000-0003-0899-0232; Abbaszadeh, Abbas/0000-0001-5708-7838; mohammadnejad, esmaeil/0000-0002-2673-3646",,,"Abbaszadeh A, 2014, J MED ETHICS HIST ME, V; Abedi Gh, 2011, WORLD APPL SCI J, V12, P207; Abedi G, 2012, INT J COLLAB RES INT, V4, P10; ALLEN S, 2006, CURR ANAESTH CRIT CA, V16, P191, DOI DOI 10.1016/J.CACC.2006.01.00; Alp E, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-3; Askarian M, 2003, AM J INFECT CONTROL, V31, P465, DOI 10.1016/S0196-6553(03)00673-; Bagheri P, 2014, IRAN J MED MICROBIOL, V8, P; Birgan A Ghorbani, 2011, MODERN CARE SCI Q BI, V8, P8; Colpan A, 2005, AM J INFECT CONTROL, V33, P42, DOI 10.1016/j.ajic.2004.09.00; de Oliveira AC, 2010, REV LAT-AM ENFERM, V18, P233, DOI 10.1590/S0104-1169201000020001; Doron S, 2011, MAYO CLIN PROC, V86, P1113, DOI 10.4065/mcp.2011.035; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.00; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.00; Jamshidi M, 2008, J ISLAMIC AZAD U TEH, V18, P26; Kalantarzadeh M, 2014, ARCH CLIN INFECT DIS, V9, DOI 10.5812/archcid.1827; Lincoln Y., 1985, NATURALISTIC INQUIRY, DOI DOI 10.1080/10502556.2015.101270; Litvak E, 2011, HEALTH AFFAIR, V30, P76, DOI 10.1377/hlthaff.2010.111; Morrison LG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-25; Reed D, 2009, OCHSNER J, V9, P2; Savas L, 2006, W INDIAN MED J, V55, P18; Sunakawa Mitsuhiro, 2009, Kokubyo Gakkai Zasshi, V76, P2; Wagenlehner FME, 2006, INT J ANTIMICROB AG, V28, pS86, DOI 10.1016/j.ijantimicag.2006.05.01; Wolf R, 2008, J AM MED DIR ASSOC, V9, P342, DOI 10.1016/j.jamda.2008.02.00",23,4,4,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1295.0,1301,,,,7,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200016,,,,,2022-07-14,0.0023760330578512395,3.6724339709185255e-14,0.00663728618224906,0.0899452709043774,0.006984424396529255
J,"Murat, B1;  Beril, D;  Demet, K;  Levent, C",,,,"Murat, Borlu; Beril, Demirel; Demet, Kartal; Levent, Cinar",,,THE EFFECTS OF EPIDEMIOLOGICAL AND CLINICAL FINDINGS IN BEHCET'S DISEASE ON THE COURSE AND PROGNOSIS OF THE DISEASE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Behcet's disease; clinical findings; demographic data,VASCULAR INVOLVEMENT; ARTHRITIS; MORTALITY; FEATURES,"Aim: Behcet's Disease (BD) is s a complex disease which occurs as a result of the involvement of different systems. In this study, we aim to determine the importance of clinical findings and demographic data in its occurence and in understanding the prognostic importance of BD, and to establish the influencing factors of these findings. Materials and methods: We conducted a retrospective statistical analysis on the clinical and demographic data assessed by examining the patient charts of 703 patients with BD who were admitted to the Behcet outpatient clinic in Erciyes University Department of Dermatology between 1998-2010. Results: Seven hundred and three patients were included in this study, of which 297 (42.2%) were male, and 406 (57.8%) were female. The mean age at diagnosis of the disease was 30.1 +/- 19.1 years. Mucocutaneous findings were the most frequent and first seen findings of the disease. The most frequent finding after mucocutaneous ones was ocular involvement. It was observed that vascular involvement was more common in male patients compared to female ones. In contrast, genital ulcer, erythema nodosum and arthralgia were seen more in female patients than in males. Conclusion: There is not a specific laboratory, monitoring or histopathologic examining method for the diagnosis and assessment of the prognosis of the disease. Consequently, it seems that the age, gender, genotype and other existing clinical findings of the patient give a clue to the prognosis of the disease.","[Murat, Borlu; Demet, Kartal; Levent, Cinar] Erciyes Univ, Fac Med, Dept Dermatol, TR-38039 Kayseri, Turkey; [Beril, Demirel] Bulent Ecevit Univ, Fac Med, Dept Dermatol, Zonguldak, Turkey","Demet, K (corresponding author), Erciyes Univ, Sch Med, Dermatol & Venereol Dept, TR-38039 Kayseri, Turkey.",,"cinar, levent/A-6566-2019","cinar, levent/0000-0002-3708-2412","Erciyes University, Scientific Research Unit","The current study was supported by Erciyes University, Scientific Research Unit. The authors declare that they have no conflict of interest.","Alpsoy E, 2007, BRIT J DERMATOL, V157, P901, DOI 10.1111/j.1365-2133.2007.08116.; Alpsoy E, 2007, TURKIYE KLIN J INT M, V3, P; AZIZLERLI G, 1992, ACTA DERM-VENEREOL, V72, P28; Bang Dongsik, 1997, Yonsei Medical Journal, V38, P42; Behcet H, 1937, DERMATOL WOCHENSCHR, V105, P115; Borlu M, 2006, INT J DERMATOL, V45, P713, DOI 10.1111/j.1365-4632.2006.02754.; Can M, 2009, Turkderm-Turk Arch D, V43, P5; DAVIES PG, 1984, ANN RHEUM DIS, V43, P70, DOI 10.1136/ard.43.1.7; Diri E, 2001, ANN RHEUM DIS, V60, P1074, DOI 10.1136/ard.60.11.107; Evereklioglu C, 2005, SURV OPHTHALMOL, V50, P297, DOI 10.1016/j.survophthal.2005.04.00; Filali-Ansary N, 1999, ANN MED INTERNE, V150, P17; Ghate JV, 1999, J AM ACAD DERMATOL, V40, P1, DOI 10.1016/S0190-9622(99)70523-; Gur A, 2006, CLIN RHEUMATOL, V25, P524, DOI 10.1007/s10067-005-0100-; Gurler Aysel, 1997, Yonsei Medical Journal, V38, P42; Hamzaoui Amira, 2014, Acta Med Iran, V52, P74; Jorizzo JL, 2008, FITZPATRICKS DERMAT; Kirimli O, 2007, TURKIYE KLIN J INT M, V3, P3; KOC Y, 1992, J RHEUMATOL, V19, P40; Kural-Seyahi E, 2003, MEDICINE, V82, P60, DOI 10.1097/00005792-200301000-0000; Onder M, 2001, J EUR ACAD DERMATOL, V15, P126, DOI 10.1046/j.1468-3083.2001.00251.; Sarica R, 1996, INT J DERMATOL, V35, P10; Shahram F, 2003, ADV EXP MED BIOL, V528, P14; SILMAN AJ, 1990, LANCET, V335, P107; Tugal-Tutkun I, 2004, AM J OPHTHALMOL, V138, P373, DOI 10.1016/j.ajo.2004.03.02; Tursen U, 2003, INT J DERMATOL, V42, P346, DOI 10.1046/j.1365-4362.2003.01741.; Yazici H, 1996, BRIT J RHEUMATOL, V35, P13",26,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,843.0,849,,10.19193/0393-6384_2016_3_100,,7,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400029,,,,,2022-07-14,0.0026859504132231405,1.0656097063891071e-23,0.005158885343493069,0.06432620295980276,0.005158885343493069
J,"Nazari, M1;  Kamrani, F;  Sahebalzamani, M;  Amin, GR",,,,"Nazari, Mahboubeh; Kamrani, Farhad; Sahebalzamani, Mohammad; Amin, Gholam Reza",,,ON THE INVESTIGATION OF THE EFFECT OF AROMATHERAPY ON PAIN AFTER ORTHOPEDIC SURGERY: CLINICAL TRIAL,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Pain; aromatherapy; orthopedic surgery,LAVENDER ESSENTIAL OIL; QUALITY-OF-LIFE; DISTAL; INHALATION; STATE,"Introduction: Orthopedic surgery is one of the most painful surgeries. This study aimed to investigate the effect of aromatherapy on pain after orthopedic surgery. Methods: This study is a randomized and controlled clinical trial involving 82 patients undergoing orthopedic surgery of wrist fracture in randomly selected hospitals of Tehran in 2015. The patients of the treatment group, 8 and 16 hours after surgery, sniffed 3 drops of essential oil of lemon for 20 minutes and the intensity of pain was measured half an hour after the intervention. For the control group, routine healthcare services continued. Data was analyzed using the SPSS 21 software and descriptive and inferential statistics. Moreover, in order to measure the effects of aromatherapy and change trends, repeated measures ANOVA was used. Chi-square test was also used to determine the success rate of the treatment. Results: Comparison of changes in pain scores between the two groups showed that there is a significant relationship (p=. 049) between the intensity of pain in control and treatment groups during the examined intervals (mean of pain and anxiety reduction 8 and 16 hours after surgery). There was also a significant relationship between the recovery rates of the control and treatment groups and different intervals (p=. 008). Conclusion: The results of the study indicate a positive impact of aromatherapy with essential oils of lemon on the reduction of pain, 8 and 16 hours after orthopedic surgery. Therefore, it can be used as a non-pharmacological, inexpensive, and non-invasive care nursing-method with no complication in the orthopedic surgical sections.","[Nazari, Mahboubeh] Islamic Azad Univ, Dept Nursing, Tehran Med Sci Branch, Tehran, Iran; [Kamrani, Farhad] Shahid Beheshti Univ Med Sci & Hlth Serv, Med Surg Dept, Tehran, Iran; [Sahebalzamani, Mohammad] Islamic Azad Univ, Social Determinants Hlth Res Ctr, Tehran Med Sci Branch, Tehran, Iran; [Amin, Gholam Reza] Univ Tehran Med Sci, Fac Pharm & Pharmaceut Sci, Res Ctr, Dept Pharmacognosy, Tehran, Iran","Nazari, M (corresponding author), Islamic Azad Univ, Dept Nursing, Tehran Med Sci Branch, Tehran, Iran.",mahnazari2010@yahoo.com,"sahebalzamani, mohammad/AAO-6051-2021","sahebalzamani, mohammad/0000-0003-1730-6770",,,"Abedi Gh, INT J COLLABORATIV; Abedi G, 2012, LIFE SCI J, V9, P533; Abedi G, 2012, INT J COLLAB RES INT, V4, P10; Atrian MK, 2013, IRAN RED CRESCENT ME, V15, P848, DOI 10.5812/ircmj.1271; Bagherinesami M, 2012, MAZANDARAN U MED SCI, V22, P5; Bikmoradi A, 2015, COMPLEMENT THER MED, V23, P331, DOI 10.1016/j.ctim.2014.12.00; Buyukyilmaz FE, 2010, PAIN MANAG NURS, V11, P76, DOI 10.1016/j.pmn.2009.01.00; Dorr LD, 2007, CLIN ORTHOP RELAT R, P7, DOI 10.1097/BLO.0b013e318149296; Fayazi Sadigheh, 2011, Iran J Nurs Midwifery Res, V16, P27; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.2054; Huang Su-Hui, 2014, OIL RELIEVING POSTAR, V201; Hur MH, 2012, J EVAL CLIN PRACT, V18, P37, DOI 10.1111/j.1365-2753.2010.01521.; Ikeda H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-1; Iyer, 2013, TRAUMA MANAGEMENT OR, P234, DOI [10.1007/978-1-4471-4462-5, DOI 10.1007/978-1-4471-4462-5; Jafari D, 2013, SHAFA ORTHO J, V1, P2; Jahr JS, 2013, AM J THER, V20, P189, DOI 10.1097/MJT.0b013e31828900c; Jun YS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/50272; Kakar S, 2015, CLIN ORTHOP RELAT R, V473, P3098, DOI 10.1007/s11999-015-4335-; Kim Jung T, 2006, Pain Pract, V6, P273, DOI 10.1111/j.1533-2500.2006.00095.; Ko YL, 2012, J CLIN NURS, V21, P689, DOI 10.1111/j.1365-2702.2011.03818.; Lips P, 2010, OSTEOPOROSIS INT, V21, P61, DOI 10.1007/s00198-009-0946-; Lua PL, 2012, J ALTERN COMPLEM MED, V18, P534, DOI 10.1089/acm.2010.086; Mohseni M, 2012, ANESTH PAIN MED, V2, P8; Morris BJ, 2015, J AM ACAD ORTHOP SUR, V23, P267, DOI 10.5435/JAAOS-D-14-0016; Morshedi A, 2011, JMP, V4, P4; Nellans KW, 2012, HAND CLIN, V28, P113, DOI 10.1016/j.hcl.2012.02.00; Noroozinia H Heydar, 2011, TEHRAN U MED J, V69, P19; Olapour Alireza, 2013, Anesth Pain Med, V3, P203, DOI 10.5812/aapm.957; Pountos I, 2012, SCI WORLD J, DOI 10.1100/2012/60640; Sadeghifar A.R., 2014, J BABOL U MED SCI, V16, P; Sahebalzamin M, 2010, MED SCI J ISLAMIC AZ, V20, P17; Salamati A, 2014, IRAN J PHARM RES, V13, P125; Shahram Maghsoudi, 2012, LEMONTHERAPY, P15; Shauver MJ, 2011, J HAND SURG-AM, V36A, P1282, DOI 10.1016/j.jhsa.2011.05.01; Smeltzer CS, 2014, BRUNNER SUDARTH SUDA, p[231, 2364; Soleimanpour J., 2011, J KERMAN U MED SCI, V18, P4; Vakilian Katayon, 2011, Complement Ther Clin Pract, V17, P50, DOI 10.1016/j.ctcp.2010.05.00; Valipour NS, 2012, COMPLEMENT MED J FAC, V2, P; Van Son MAC, 2013, QUAL LIFE RES, V22, P2399, DOI 10.1007/s11136-013-0391-; Zamanzade Vahid, 2015, MED SURG NURSING J, V3, P20",40,4,4,1,9,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1513.0,1519,,,,7,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200032,,,,,2022-07-14,0.004132231404958678,2.222315053732342e-14,0.008042033575287386,0.08965370330922193,0.008042033575287386
J,"Negargar, S1;  Naghipour, B;  Anvari, S;  Enamzadeh, E;  Shiriza-Deh, M",,,,"Negargar, Sohrab; Naghipour, Bahman; Anvari, Shahriar; Enamzadeh, Elgar; Shiriza-Deh, Maryam",,,EFFECTS OF PRE AND POST-PUMP TRANEXAMIC ACID ON BLEEDING AFTER CORONARY ARTERY BYPASS GRAFT SURGERY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Tranexamic Acid; Bleeding; Cardiopulmonary bypass; Coronary Artery Bypass Graft Surgery,CARDIAC-SURGERY; TRANSFUSION,"Introduction and objective: Bleeding caused by coagulopathy after Cardiopulmonary Bypass (CPB) leads to morbidity and mortality. Research results suggest thatTranexamic Acid (TA) plays a major role in reducing bleeding after heart surgery. The objective of this study was to compare the effect of preoperative TA and post-CPB TA on the decrease in bleeding after heart surgery. Materials and methods: A total of 60 patients, who were candidates for Coronary Artery Bypass Graft (CABG), were randomly categorized into two groups after their written consent was obtained. First, before the surgery, TA was added to the serum of group I and normal saline was added to the serum of group II. After detachment from CPB, normal saline was injected to group I and TA was injected to group II. Postoperative bleeding was measured based on the volume of blood flowing into the chest bottle of patients and the number of blood units transfused to patients after surgery was recorded. Results: Investigation results revealed that although bleeding during surgery in the pre-pump group was higher than the post-pump group, the difference was not significant. The average volume of bleeding in the pre-pump group was higher than the post-pump group, but the difference was not statistically significant either. Moreover, pre-pump TA did not lead to a reduction in the need for transfusion during surgery. The level of bleeding in the first 2 hours after hospitalization in ICU was significant lower in the pre-pump group. However, no significant difference was observed between the duration stay of the groups in ICU. Conclusion: Pre-pump administration of TA did not result in a significant decrease in bleeding during surgery, need for transfusion, duration of stay in ICU, and duration of hospitalization as compared to post-pump TA administration.","[Negargar, Sohrab] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Anesthesiol & Crit Care, Tabriz, Iran; [Naghipour, Bahman] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Anesthesiol, Tabriz, Iran; [Anvari, Shahriar] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Cardiovasc Surg, Tabriz, Iran; [Enamzadeh, Elgar; Shiriza-Deh, Maryam] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran","Negargar, S (corresponding author), Tabriz Univ Med Sci, Cardiovasc Res Ctr, Anesthesiol & Crit Care, Tabriz, Iran.",negargars@yahoo.com,"anvari, shahriar/M-2997-2017; negargar, sohrab/AAD-9329-2022; naghipour, bahman/AAH-7403-2019; Enamzadeh, E/W-4893-2019","anvari, shahriar/0000-0002-4079-3530; ",,,"Abedi Gh, 2011, WORLD APPL SCI J, V12, P207; Abedi G, 2012, HEALTHMED, V6, P12; Braunwald E., 2001, HARRISONS PRINCIPLE; Casati V, 2004, J THORAC CARDIOV SUR, V128, P83, DOI 10.1016/j.jtcvs.2003.10.03; Center of diseases control and prevention (CDC), 2011, ATL HEART DIS STRO; Esfandiari Bakhtiari Rostam, 2013, Asian Cardiovasc Thorac Ann, V21, P669, DOI 10.1177/021849231246639; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e305; Koster A, 2013, BRIT J ANAESTH, V110, P34, DOI 10.1093/bja/aes31; Mangano DT, 1999, CARDIAC ANESTHESI; Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P28; Pleym H, 2003, ANESTH ANALG, V96, P923, DOI 10.1213/01.ANE.0000054001.37346.0; Seth HJ, 2000, HEART J, V84, P39; Takagi Hisato, 2009, Interact Cardiovasc Thorac Surg, V9, P98, DOI 10.1510/icvts.2008.19832; Trudell Jason, 2008, AANA J, V76, P12; World Health Organization (WHO), 2011, CARD DIS CV; Zabeeda D, 2002, ANN THORAC SURG, V74, P733, DOI 10.1016/S0003-4975(02)03784-",17,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1231.0,1235,,,,5,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200007,,,,,2022-07-14,0.001756198347107438,2.3335638941969748e-11,0.0032938609495664836,0.10694832672271878,0.00329528259551526
J,"Nicosia, L1;  Licata, M;  Armocida, G;  Vecchio, I;  Iorio, S;  Ros-Setti, C",,,,"Nicosia, Luca; Licata, Marta; Armocida, Giuseppe; Vecchio, Ignazio; Iorio, Silvia; Ros-Setti, Chiara",,,THE CASE OF AN OSTEOCHONDROMA IN A SKELETON FROM THE SEVENTEEN CENTURY CRYPT OF NORTHERN LOMBARDY,ACTA MEDICA MEDITERRANEA,,,English,Letter,,,,,,,,,"[Nicosia, Luca] Univ Milan, Postgrad Sch Radiodiagnost, Milan, Italy; [Licata, Marta; Armocida, Giuseppe] Insubria Univ, Dept Biotechnol & Life Sci, Varese, Italy; [Vecchio, Ignazio] Univ Catania, Dept Med & Pediat Sci, I-95124 Catania, Italy; [Iorio, Silvia] Sapienza Univ Rome, Dept Mol Med, Unit Hist Med, Rome, Italy; [Ros-Setti, Chiara] Univ Brescia, Dept Med & Surg Special Radiol Sci & Publ Hlth, Spedali Civili, Brescia, Italy","Licata, M (corresponding author), Insubria Univ, Dept Biotechnol & Life Sci, Varese, Italy.",marta.licata@uninsubria.it,"Nicosia, Luca/AAB-7879-2019","Nicosia, Luca/0000-0003-3979-8075; Vecchio, Ignazio/0000-0001-5942-1908; iorio, silvia/0000-0001-9741-7838",,,"Akansu B, 2012, TURK J PATHOL, V28, P172, DOI 10.5146/tjpath.2012.0111; Buzon MR, 2005, INT J OSTEOARCHAEOL, V15, P377, DOI 10.1002/oa.78; Licata M, 2014, ACTA MEDICA MEDITERR, V30, P55; Slaus M, 2000, CROAT MED J, V41, P33; Vyhnanek L, 1999, INT J OSTEOARCHAEOL, V9, P36",5,2,2,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,1567.0,1568,,10.19193/0393-6384_2016_5_130,,2,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000001,,,,,2022-07-14,0.0005165289256198347,4.470137813078723e-08,0.00082631820273763,0.08079256841911979,0.00082631820273763
J,"Noto, D1;  Canino, B;  Vieni, S;  Graceffa, G;  Paterno, V;  Hopps, E;  Fertitta, E;  Tinaglia, M;  Brocato, F;  Giammanco, A;  Urso, C;  Cardella, A;  Averna, MR;  Squatrito, R",,,,"Noto, Davide; Canino, Baldassare; Vieni, Salvatore; Graceffa, Giuseppa; Paterno, Vincenzo; Hopps, Eugenia; Fertitta, Emanuela; Tinaglia, Martino; Brocato, Francesco; Giammanco, Antonina; Urso, Caterina; Cardella, Antonella; Averna, Maurizio R.; Squatrito, Rosario",,,PULMONARY EMBOLISM IN AN EMERGENCY CARE UNIT: EVALUATION OF PREDICTIVE FACTORS FROM CLINICAL HISTORY AND PHYSICAL EXAM,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Pulmonary embolism; diagnostic score; emergency care unit,DEEP-VEIN THROMBOSIS; PROGNOSTIC VALUE; D-DIMER; RISK; PROBABILITY; MANAGEMENT; OUTCOMES; REGISTRY; UTILITY; RATIO,"Objective: An early diagnosis of pulmonary embolism (PE) improves outcome. Therefore, PE should be diagnosed in Emergency Care Units (ECU) at admission. Clinical algorithms support the clinician in this task, although performance is biased by differences in risk factors prevalent in different populations. The clinical conditions predictive of PE were evaluated in subjects from Southern Italy accessing ECU for dyspnea/chest pain. Methods: Retrospective clinical data were obtained by electronic retrieving from a hospital database. Data from 8177 patients (age 18-90 years, 54 with PE) were collected from years 2007-2013. Results: Previous history of PE, thrombosis and/or phlebitis, rheumatic diseases, respiratory failure, low blood pressure, pulse oxymetry rate (SpO(2)) and high heart rate were associated with PE diagnosis. High white blood count with neutrophilia, C reactive protein, D-dimer, NT-pro-BNP determinations, but not troponin T, were associated with PE. Recalibration of the GENEVA score and its modification, by inclusion of novel risk factors, improved the algorithm performance (GENEVA AROC=0.730, modified GENEVA AROC = 0.792, DeLong's test p = <0.001). Conclusions: PE risk factors in a large Sicilian sample are similar to those of other populations. Data from clinical history and clinical features present at admission were used to recalibrate the PE diagnostic algorithm showing that PE predictive power improved by fitting local data into the predictive model.","[Noto, Davide; Canino, Baldassare; Hopps, Eugenia; Giammanco, Antonina; Urso, Caterina; Cardella, Antonella; Averna, Maurizio R.] Univ Palermo, Dept Biomed Internal Med & Med Specialties DIBIMI, Via Vespro 129, I-90123 Palermo, Italy; [Paterno, Vincenzo; Fertitta, Emanuela] Hosp San Raffaele Giglio, Emergency Care Unit, Cefalu, Italy; [Tinaglia, Martino; Squatrito, Rosario] Hosp San Raffaele Giglio, Core Lab Unit, Cefalu, Italy; [Brocato, Francesco] Hosp San Raffaele Giglio, Engn & Informat Unit, Cefalu, Italy; [Vieni, Salvatore; Graceffa, Giuseppa] Univ Palermo, Dept Surg Oncol & Oral Sci, Palermo, Italy","Averna, MR (corresponding author), Univ Palermo, Dept Biomed Internal Med & Med Specialties DIBIMI, Via Vespro 129, I-90123 Palermo, Italy.",,"Averna, Maurizio/U-9527-2017; Noto, Davide/AAA-9208-2019; Giammanco, Antonina/AAA-8904-2019","Giammanco, Antonina/0000-0002-3088-3049; Averna, Maurizio/0000-0003-3558-9209",,,"ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.93; Becattini C, 2007, INTERN EMERG MED, V2, P119, DOI 10.1007/s11739-007-0033-; Bruinstroop E, 2009, EUR J INTERN MED, V20, P441, DOI 10.1016/j.ejim.2008.12.00; Carrier M, 2006, THROMB RES, V117, P469, DOI 10.1016/j.thromres.2005.04.00; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM19920507326190; Cavus UY, 2014, TURK J MED SCI, V44, P50, DOI 10.3906/sag-1302-4; Celik A, 2015, KAOHSIUNG J MED SCI, V31, P145, DOI 10.1016/j.kjms.2014.12.00; Choi HK, 2013, ANN RHEUM DIS, V72, P1182, DOI 10.1136/annrheumdis-2012-20166; Dalen JE, 2002, CHEST, V122, P1801, DOI 10.1378/chest.122.5.180; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-; Guijarro Ricardo, 2005, Eur J Intern Med, V16, P279, DOI 10.1016/j.ejim.2005.02.00; Johannesdottir SA, 2012, J THROMB HAEMOST, V10, P815, DOI 10.1111/j.1538-7836.2012.04666.; Kayrak M, 2014, HEART LUNG CIRC, V23, P56, DOI 10.1016/j.hlc.2013.06.00; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-0000; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.07; R Development Core Team, 2005, R LANG ENV STAT COM; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-7; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa05236; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn31; Vuilleumier N, 2008, THROMB RES, V121, P617, DOI 10.1016/j.thromres.2007.07.00; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P41",22,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1857.0,1863,,10.19193/0393-6384_2016_6_174,,7,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300018,,,,,2022-07-14,0.0022727272727272726,3.2472475485697147e-17,0.04447450132731764,0.08353397019356064,0.04447450132731764
J,"Okyay, R1;  Kocyigit, B;  Gursoy, S",,,,"Okyay, Ramazanazim; Kocyigit, Burhanfatih; Gursoy, Savas",,,"VITAMIN D LEVELS IN WOMEN WITH FIBROMYALGIA AND RELATIONSHIP BETWEEN PAIN, TENDER POINT COUNT AND DISEASE ACTIVITY",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Fibromyalgia; vitamin D; pain; Turkey,BONE-MINERAL DENSITY; D DEFICIENCY; PREVALENCE,"Introduction: Fibromyalgia syndrome (FMS) is a chronic syndrome characterized by widespread musculoskeletal pain, tender points and fatigue. There are several studies suggesting a possible relationship between musculoskeletal pain and vitamin D deficiency. In this study, we aimed to compare serum vitamin D levels between fibromyalgia patients and control groups and investigate the relationship between vitamin D and clinical findings on patients with fibromyalgia syndrome. Materials and methods: This case control study enrolled 79 women with fibromyalgia who fulfilled the American College of Rheumatology 1990 criteria and 80 healthy women. All subjects were evaluated with vitamin D and other biochemical markers. The patients were divided into three groups based on their serum vitamin D levels (normal, insufficient, deficient). Visual analogue scale and fibromyalgia impact questionnaire were used to evaluate the patients with FMS. Results: Mean serum vitamin D levels were lower in the FMS group than in the controls (12.99 +/- 8.37 ng/ml vs.16.05 +/- 9.42 ng/ml, p=0.037). Vitamin D level was significantly negative correlated with visual analogue scale, tender point count and fibromyalgia impact questionnaire (p=0.000, r=-0.578; p=0.001, r=-0.361; p=0.000, r=-0.621). Conclusion: It was concluded that vitamin D deficiency may be related to the clinical findings in patients with FMS.","[Okyay, Ramazanazim] Ceyhan Community Hlth Ctr, Adana, Turkey; [Kocyigit, Burhanfatih; Gursoy, Savas] Gaziantep Univ, Fac Med, Dept Phys Med & Rehabil, Gaziantep, Turkey","Kocyigit, B (corresponding author), Gaziantep Univ, Fac Med, Dept Phys Med & Rehabil, Gaziantep, Turkey.",,"ravegnini, gloria/K-1330-2016; Okyay, Ramazan Azim/AAC-5703-2020; Okyay, Ramazan A./C-9299-2016; Kocyigit, Burhan Fatih/AAX-4980-2021; Gursoy, Savas/AAH-3078-2020","ravegnini, gloria/0000-0002-7774-402X; Kocyigit, Burhan Fatih/0000-0002-6065-8002; Gursoy, Savas/0000-0002-1673-9905",,,"Armstrong DJ, 2007, CLIN RHEUMATOL, V26, P551, DOI 10.1007/s10067-006-0348-; Atherton K, 2009, ANN RHEUM DIS, V68, P817, DOI 10.1136/ard.2008.09045; Bhatty SA, 2010, J PAK MED ASSOC, V60, P94; Binkley N, 2010, ENDOCRIN METAB CLIN, V39, P287, DOI 10.1016/j.ecl.2010.02.00; HICKEY L, 2004, CURR OPIN ENDOCRINOL, V11, P18, DOI DOI 10.1097/00060793-200402000-0000; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra07055; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI2944; Huisman AM, 2001, J RHEUMATOL, V28, P253; Olama SM, 2013, RHEUMATOL INT, V33, P185, DOI 10.1007/s00296-012-2361-; Plotnikoff GA, 2003, MAYO CLIN PROC, V78, P1463, DOI 10.4065/78.12.146; Rooks DS, 2007, CURR OPIN RHEUMATOL, V19, P11; Sarmer S, 2000, RHEUMATOL INT, V20, P9, DOI 10.1007/s00296000007; Sarzi-Puttini P, 2002, CLIN EXP RHEUMATOL, V20, P6; Shipton EE, PAIN RES TREATMENT, V201; Tandeter H, 2009, ISR MED ASSOC J, V11, P33; Thompson Mollie E, 2003, Curr Pain Headache Rep, V7, P342, DOI 10.1007/s11916-003-0032-; Ulusoy H, 2010, BRATISL MED J, V111, P60; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.178033020",18,13,13,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,243.0,247,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700038,,,,,2022-07-14,0.001859504132231405,1.1370521710694386e-20,0.009882688857789592,0.0721370604147881,0.009882688857789592
J,"Olmez, S1;  Aslan, M;  Saritas, B;  Yalcin, MS;  Tas, A;  Balaharoglu, R",,,,"Olmez, Sehmus; Aslan, Mehmet; Saritas, Bunyamin; Yalcin, Mehmet Suat; Tas, Adnan; Balaharoglu, Ragip",,,SERUM FERRITIN LEVELS IN PATIENTS WITH HBV AND HDV-RELATED CIRRHOSIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Liver cirrhosis; hepatitis B; hepatitis D; ferritin; iron; total iron binding capacity,CHRONIC HEPATITIS-C; IRON OVERLOAD; INTERFERON-ALPHA; FIBROSIS; INFECTION; PROGRESSION; DISEASE; PATHOGENESIS; METABOLISM; MECHANISMS,"Aim: Several studies have investigated serum ferritin levels in patients with chronic liver diseases, such as nonalcoholic fatty liver disease, alcoholic liver disease, hepatitis C virus or hepatitis B virus (HBV)-related hepatitis and cirrhosis. However, there is no data on serum ferritin levels in patients with hepatitis D virus (HDV)-related cirrhosis. The aim of the present study was to investigate whether there are differences in serum ferritin levels among patients with HBV-related cirrhosis, HDV-related cirrhosis and healthy subjects. Materials and methods: Thirty-one patients with HBV-related cirrhosis, 33 patients with HDV-related cirrhosis, and 51 healthy controls were included in the study. Serum iron parameters including serum iron (SI), total iron binding capacity (TIBC) and ferritin were measured in these groups. Results: The average serum ferritin levels of patients with HDV-related cirrhosis, HBV-related cirrhosis and controls were 173.7 +/- 161.3, 168.2 +/- 165.1 and 86.3 +/- 58.4; respectively. The HBV-related cirrhosis and HDV-related cirrhosis groups had higher ferritin levels than the control group. However, there were no statistically significant differences between patients with HBV-related cirrhosis and control groups and HDV-related cirrhosis and HBV-related cirrhosis (all, p>0.05). On the contrary, comparison between HDV-related cirrhosis and control group was statistically significant (p=0.004). Conclusions: HBV and HDV-related cirrhosis patients had higher ferritin levels and lower total iron binding capacity (TIBC) than healthy controls. The presence of HDV-related cirrhosis affects serum ferritin levels. Therefore, increased ferritin levels may play a role in the pathogenesis HDV-related cirrhosis.","[Olmez, Sehmus] Yuzuncu Yil Univ, Fac Med, Dept Gastroenterol, TR-65000 Van, Turkey; [Aslan, Mehmet] Yuzuncu Yil Univ, Fac Med, Dept Internal Med, Van, Turkey; [Saritas, Bunyamin] Elazig Med Pk Hosp, Dept Gastroenterol, Elazig, Turkey; [Yalcin, Mehmet Suat; Tas, Adnan] Adana Numune Res & Educ Hosp, Dept Gastroenterol, Adana, Turkey; [Balaharoglu, Ragip] Yuzuncu Yil Univ, Fac Med, Dept Clin Biochem, Van, Turkey","Olmez, S (corresponding author), Yuzuncu Yil Univ, Fac Med, Dept Gastroenterol, TR-65000 Van, Turkey.",,"Olmez, Sehmus/ABG-1212-2020; Tas, Adnan/ABF-7933-2020; SarÄ±taÅ, BÃ¼nyamin/K-9920-2015","Olmez, Sehmus/0000-0002-7288-3936; Tas, Adnan/0000-0002-5706-2136; SarÄ±taÅ, BÃ¼nyamin/0000-0003-0957-7001",,,"Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.51030060; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.00; BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.184011012; Beinker NK, 1996, J HEPATOL, V25, P633, DOI 10.1016/S0168-8278(96)80231-; BELL H, 1994, J INTERN MED, V236, P315, DOI 10.1111/j.1365-2796.1994.tb00802.; BLUMBERG BS, 1981, P NATL ACAD SCI-BIOL, V78, P3222, DOI 10.1073/pnas.78.5.322; Bonkovsky HL, 2002, J HEPATOL, V37, P848, DOI 10.1016/S0168-8278(02)00305-; Bonkovsky HL, 2002, AM J GASTROENTEROL, V97, P; Britton RS, 1996, SEMIN LIVER DIS, V16, P3, DOI 10.1055/s-2007-100721; Buyukasik NS, 2011, TURK J GASTROENTEROL, V22, P606, DOI 10.4318/tjg.2011.032; Cao Z, 2001, Zhonghua Gan Zang Bing Za Zhi, V9, P3; Casaril M, 2000, HEPATO-GASTROENTEROL, V47, P22; Chandok N, 2012, J GASTROINTEST LIVER, V21, P5; COHEN C, 1985, CANCER, V56, P2201, DOI 10.1002/1097-0142(19851101)56:9<2201::AID-CNCR2820560911>3.0.CO;2-; D'Souza RFC, 2005, ALIMENT PHARM THER, V21, P519, DOI 10.1111/j.1365-2036.2005.02382.; DIBISCEGLIE AM, 1992, GASTROENTEROLOGY, V102, P2108, DOI 10.1016/0016-5085(92)90339-; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro193; Fabris C, 2001, CLIN CHIM ACTA, V304, P49, DOI 10.1016/S0009-8981(00)00397-; Fargion S, 2000, Can J Gastroenterol, V14 Suppl D, p89; FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-; FATTOVICH G, 1987, J INFECT DIS, V155, P931, DOI 10.1093/infdis/155.5.93; Ferrara F, 2009, AM J GASTROENTEROL, V104, P605, DOI 10.1038/ajg.2008.12; Franchini M, 2008, HEPATOL INT, V2, P335, DOI 10.1007/s12072-008-9076-; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P182; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM19990211340060; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-; Gerin JL, 2002, HEPATITIS DELTA VIRU, P16; Halliday JW, 1994, CELLULAR IRON PROCES, P9; Haque S, 1996, HUM PATHOL, V27, P1277, DOI 10.1016/S0046-8177(96)90337-; HENGEVELD P, 1982, HEPATO-GASTROENTEROL, V29, P13; HULTCRANTZ R, 1991, J CLIN INVEST, V87, P45, DOI 10.1172/JCI11499; Jurczyk K, 2001, Med Sci Monit, V7, P96; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.2156; KONIJN AM, 1994, BAILLIERE CLIN HAEM, V7, P829, DOI 10.1016/S0950-3536(05)80127-; Lange CM, 2012, HEPATOLOGY, V55, P1038, DOI 10.1002/hep.2478; Metwally MA, 2004, AM J GASTROENTEROL, V99, P286, DOI 10.1111/j.1572-0241.2004.04049.; Mitsuyoshi H, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/68642; Negro F, 2000, J MED VIROL, V60, P21, DOI 10.1002/(SICI)1096-9071(200001)60:1&lt;21::AID-JMV4&gt;3.0.CO;2-; Ohkoshi S, 2008, HEPATOL INT, V2, P382, DOI 10.1007/s12072-008-9084-; OLYNYK JK, 1995, GASTROENTEROLOGY, V108, P1104, DOI 10.1016/0016-5085(95)90209-; Piperno A, 1998, HEPATOLOGY, V28, P1105, DOI 10.1002/hep.51028042; Pippard M, 1994, LAB DETERMINATION IR, P44; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.180060081; Ryder SD, 2004, GUT, V53, P451, DOI 10.1136/gut.2003.02169; SAGNELLI E, 1989, LIVER, V9, P22; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-; Searle SJ, 1994, IRON STORAGE DIS PAT, P21; Sumida Y, 2001, LIVER, V21, P295, DOI 10.1034/j.1600-0676.2001.210501.; Valenti L, 2007, HAEMATOLOGICA, V92, P1037, DOI 10.3324/haematol.1128; Walker NM, 2010, HEPATOLOGY, V51, P1683, DOI 10.1002/hep.2353; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.20; Wojtowicz-Chomicz Katarzyna, 2013, Pol Merkur Lekarski, V35, P7; Yonal O, 2010, DIGEST DIS SCI, V55, P3548, DOI 10.1007/s10620-010-1183-; Younossi ZM, 1999, HEPATOLOGY, V30, P847, DOI 10.1002/hep.51030040; ZHOU XD, 1987, CANCER, V59, P1430, DOI 10.1002/1097-0142(19870415)59:8<1430::AID-CNCR2820590808>3.0.CO;2-",55,1,1,1,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1813.0,1819,,10.19193/0393-6384_2016_6_168,,7,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300012,,,,,2022-07-14,0.005991735537190082,1.9134821935162452e-08,0.05863688768988668,0.12870800037229588,0.05865855248234166
J,"Ozdemir, R1;  Mutlu, NM;  Ozdemir, M;  Akcay, M;  Yel, C;  Turan, IO",,,,"Ozdemir, Rabia; Mutlu, Nevzat Mehmet; Ozdemir, Metin; Akcay, Murat; Yel, Cihat; Turan, Isil Ozkocak",,,THE IMPORTANCE OF RED CELL DISTRIBUTION WIDTH (RDW) IN PATIENT FOLLOW UP IN INTENSIVE CARE UNIT (ICU),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,RDW; intensive care unit; mortalite,CORONARY-ARTERY-DISEASE; OLDER-ADULTS; MORTALITY; RISK; PREDICTOR; SEPSIS; COHORT,"Objective: In this study we aimed to determine the effect of RDW on mortality by comparing the temporal changes in RDW level in deceased and surviving ICU patients. Materials and method: This study was retrospectively conducted in 776 patients admitted to intensive care unit between 01.01.2013 and 31.12.2013. Age, sex, clinical diagnosis, comorbid conditions, RDW levels at intensive care admission and discharge, duration of intensive care stay, and mortality rate were evaluated. Kolmogorov Smirnov, student t-test, Mann Whithey u test, and Chi-square test were used for data analysis. The results were provided at a confidence interval of 95% and a significance level of p<0.05. Results: Conducted on 776 patients in Ankara Numune Hospital's general intensive care clinic 3, this study revealed a mortality rate of 38.2%. The mean age of the study population was 65.4+/-18.3 years, with the deceased patients having a greater mean age (p<0.05). Four hundred and thirteen (53.2%) patients were male, and there was no significant difference between the ratios of both genders (p>0.05). The deceased patients had significantly increasing RDW levels whereas the surviving patients had significantly reducing RDW levels (p<0.05). There was a significant correlation between the magnitude of RDW increment and duration of hospital stay in the deceased patients (p<0.05). Conclusion: The results of this study suggest that RDW, with known association with mortality, can be used as a simple marker for patient follow-up and monitorization of effectiveness of the administered therapies in ICU.","[Ozdemir, Rabia] Medipol Univ Hosp, Dept Anesthesiol & Reanimat, Istanbul, Turkey; [Mutlu, Nevzat Mehmet; Ozdemir, Metin; Akcay, Murat; Turan, Isil Ozkocak] Ankara Numune Training & Res Hosp, Dept Intens Care, Ankara, Turkey; [Yel, Cihat] Antakya State Hosp, Dept Emergency, Antakya, Turkey","Ozdemir, R (corresponding author), Medipol Mega Univ Hosp, Anestesiol & Reanimat Dept, Istanbul, Turkey.",,"Mutlu, Mehmet Nevzat/AIB-3959-2022; TURAN, ISIL OZKOCAK/B-6466-2017",,,,"Akpir K, 2002, YOGUN BAKIN SERUVENI, V1, P; Altun Y, 2011, RELATIONSHIP MEAN PL, V2, P40; Anderson JL, 2007, AM J CARDIOL, V99, P169, DOI 10.1016/j.amjcard.2006.08.01; Ayazoglu TA, 2012, YENI TIP DERGISI, V29, P10; Bekler A, 2014, MED SCI MONITOR, V20, P413, DOI 10.12659/MSM.89015; Braun E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-12; BUENOCAVANILLAS A, 1994, CRIT CARE MED, V22, P55, DOI 10.1097/00003246-199401000-0001; CEYLAN E, 2001, TURKISH THORACIC J, V2, P; Fujita B, 2015, CLIN BIOCHEM, V48, P1048, DOI 10.1016/j.clinbiochem.2015.07.01; Fukuta H, 2009, INT HEART J, V50, P301, DOI 10.1536/ihj.50.30; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-0001; Hunziker S, 2012, CRIT CARE, V16, DOI 10.1186/cc1135; Isik B, 2016, J PAK MED ASSOC, V66, P15; Isik T, 2012, CORONARY ARTERY DIS, V23, P51, DOI 10.1097/MCA.0b013e32834e4f5; Jo YH, 2013, AM J EMERG MED, V31, P545, DOI 10.1016/j.ajem.2012.10.01; Kim CH, 2013, CRIT CARE, V17, DOI 10.1186/cc1314; Ku NS, 2012, SHOCK, V38, P123, DOI 10.1097/SHK.0b013e31825e2a8; Lee JH, 2013, AM J EMERG MED, V31, P72, DOI 10.1016/j.ajem.2012.06.00; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.62; Majercik S, 2013, J TRAUMA ACUTE CARE, V74, P1021, DOI 10.1097/TA.0b013e3182826f0; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI3180; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/cclm.2011.831, 10.1515/CCLM.2011.831; Ozay HY, 2012, J TURK SOC INTENSI, V10, P91, DOI 10.4274/Tybdd.3007; Ozdogan HK, 2015, ULUS TRAVMA ACIL CER, V21, P352, DOI 10.5505/tjtes.2015.2673; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp16; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.1; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.5; Sadaka Farid, 2013, J Intensive Care Med, V28, P307, DOI 10.1177/088506661245283; SPENCER RC, 1994, INTENS CARE MED, V20, pS2, DOI 10.1007/BF0171397; Uysal N, 2010, J MED SURG INTENSIVE, V1, P; Vashistha T, 2016, AM J KIDNEY DI; Wang FL, 2011, ANN MED, V43, P40, DOI 10.3109/07853890.2010.52176; Wonnerth A, 2016, EUR J CLIN INVEST, V46, P198, DOI 10.1111/eci.1258; Zhang ZH, 2013, J THORAC DIS, V5, P730, DOI 10.3978/j.issn.2072-1439.2013.11.1",34,2,2,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,2.0,,,,,349.0,354,,,,6,"Medicine, General & Internal",General & Internal Medicine,DL0QQ,WOS:000375338000012,,,,,2022-07-14,0.003512396694214876,8.52329113202381e-14,0.005742853477580984,0.09036172695449242,0.005740711099281325
J,"Ozer, B1;  Inci, M;  Duran, N;  Kurtgoz, S;  Alagoz, G;  Pasa, O;  Kilinc, C",,,,"Ozer, Burcin; Inci, Melek; Duran, Nizami; Kurtgoz, Seyda; Alagoz, Gulcan; Pasa, Ozgur; Kilinc, Cetin",,,COMPARISON OF ANTIBIOTIC RESISTANCE OF ACINETOBACTER AND PSEUDOMONAS AERUGINOSA STRAINS ISOLATED FROM INTENSIVE CARE UNITS WITH OTHER CLINICS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Acinetobacter; Pseudomonas aeruginosa; intensive care unit; Multidrug resistance,ANTIMICROBIAL RESISTANCE; MICROORGANISMS; INFECTIONS; SURVEILLANCE; BAUMANNII; SPECTRUM; PROFILE,"Introduction: Acinetobacter and Pseudomonas strains lead to serious and nosocomial infections in intensive care units (ICUs) and the other clinics. Resistance of these bacteria against to antibiotics, in particular is emerging as a very significant in intensive care units. The factors which affect the increase in resistance to antimicrobial drugs are the high probability of encountering antimicrobial resistant microorganisms and empiric antimicrobial treatment. Materials and methods: The bacterial culture results of clinical specimens sent to Microbiology Laboratory of Mustafa Kemal University Hospital in five year period were examined retrospectively. Antimicrobial susceptibility of the bacteria of genus Acinetobacter and Pseudomonas aeruginosa isolated from these specimens were analyzed. The antibiotic resistance of P. aeruginosa and Acinetobacter strains isolated from ICUs and those isolated from other clinics was compared. Results: In five-year period, 772 P. aeruginosa and 971 Acinetobacter spp. were isolated from the specimens. Twenty-three percent of P. aeruginosa strains and 49.3% of Acinetobacter spp. were isolated from the patients in intensive care units. 628 (64.7%) of Acinetobacter and 92 (11.9%) of P. aeruginosa strains were found to be Multidrug Resistant (MDR). The ratios of multidrug-resistance in Acinetobacter strains isolated from the patients in ICUs were found to be higher than those in P. aeruginosa strains isolated from the patients in intensive care units. MDR ratio of these bacteria isolated in ICUs was higher than that isolated in the other clinics. Conclusion: Acinetobacter strains isolated from the patients in ICUs were determined to be more resistant than those isolated from the patients in other clinics while Pseudomonas strains isolated from the other clinics, were more resistant than those isolated from the patients hospitalized in ICUs. The ratio of MDR bacteria was higher in ICUs than that in other clinics.","[Ozer, Burcin; Inci, Melek; Duran, Nizami; Kurtgoz, Seyda; Alagoz, Gulcan; Pasa, Ozgur; Kilinc, Cetin] Mustafa Kemal Univ, Sch Med, Dept Med Microbiol, Antakya, Turkey","Ozer, B (corresponding author), Mustafa Kemal Univ, Sch Med, Dept Med Microbiol, Tayfur Sokmen Campus, TR-31034 Alahan Hatay, Turkey.",,,,,,"Cortes JA, 2013, BRAZ J INFECT DIS, V17, P346, DOI 10.1016/j.bjid.2012.10.02; [Anonymous], 2014, J INFECTION, V68, P13; Brusselaers N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-4; Chen Minjun, 2005, DIAGN MICROBIOL INFE, V51, P20; Clark Nina M, 2003, Curr Opin Crit Care, V9, P413, DOI 10.1097/00075198-200310000-0001; Henry DA, 2011, MANUAL CLIN MICROBIO, V10th, P67; Inan A, 2012, JPN J INFECT DIS, V65, P14; Landman D, 2002, ARCH INTERN MED, V162, P1515, DOI 10.1001/archinte.162.13.151; Luna CM, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/48046; Gago MM, 2013, MEDICC REV, V15, P26, DOI 10.37757/MR2013V15.N2.; Oncul O, 2014, BURNS, V40, P835, DOI 10.1016/j.burns.2013.11.00; Ozer B, 2012, J ANTIBIOT, V65, P9, DOI 10.1038/ja.2011.10; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/50447; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.00; Resende MM, 2013, BMC INFECT DIS, P1; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.02; Sharma SK, 2013, INDIAN J CRIT CARE M, V17, P87, DOI 10.4103/0972-5229.11482; Tognim MCB, 2004, INT J INFECT DIS, V8, P284, DOI 10.1016/j.ijid.2003.11.00; Vaneechoutte M, 2011, MANUAL CLIN MICROBIO, V1, P71; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl50; Xu JC, 2012, PROCEDIA ENVIRON SCI, V12, P1375, DOI 10.1016/j.proenv.2012.01.43; Yali G, 2014, BURNS, V40, P",22,0,1,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,117.0,122,,,,6,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700018,,,,,2022-07-14,0.0022727272727272726,1.7135457004389818e-20,0.004334360236312917,0.07436257902944543,0.004334360236312917
J,"Ozkaya, I1;  Bicer, EK;  Yardimci, B;  Tunckale, A",,,,"Ozkaya, Ismail; Bicer, Emine Kir; Yardimci, Bulent; Tunckale, Aydin",,,A PREVENTIVE EFFECT OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE RISK IN TYPE 2 DIABETICS (PREMEDIC TRIAL),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,cardiovascular risk; diabetes mellitus; Mediterranean diet,LOW-CARBOHYDRATE; LIFE-STYLE; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; OLIVE OIL; FAT DIET; ADHERENCE; MELLITUS; GLUCOSE,"Introduction: Changes in lifestyle are recommended to all diabetics and consist of medical nutrition therapy and physical exercise programs. There has been growing evidence that the Mediterranean diet plays a role in medical nutrition therapy. This study aimed to determine the effects of the Mediterranean diet on the estimated 10-year risk of cardiovascular disease in type 2 diabetics. Materials and methods: This trial is an open, nonrandomized clinical trial. Participants consumed a Mediterranean diet for 12 weeks. The cardiovascular disease risk score of each individual was calculated before and after the dietary intervention, without any change in his or her medical treatments throughout the study. Results: A total of 254 patients were screened. Thirty-two patients were excluded from the study before and 20 patients after the dietary intervention. Therefore, 202 patients completed the study. We obtained a significant reduction in cardiovascular disease risk score of 245 +/- 3.6% in men and 20.0 +/- 3.5% in women (p < 0.001). Conclusion: This study demonstrates the efficacy of the Mediterranean diet for reducing cardiovascular diseases risk in type 2 diabetics in 12 weeks.","[Ozkaya, Ismail] Kirklareli Univ, Hlth Sch, Dept Nutr & Dietet, Kirklareli, Turkey; [Bicer, Emine Kir] Beykent Univ, Sch Hlth Sci, Dept Nursing, Istanbul, Turkey; [Yardimci, Bulent] Istanbul Florence Nightingale Hosp, Div Internal Med, Dept Internal Med, Istanbul, Turkey; [Tunckale, Aydin] Istanbul Bilim Univ, Div Gen Internal Med, Dept Internal Med, Istanbul, Turkey","Ozkaya, I (corresponding author), Kirklareli Univ, Hlth Sch, Dept Nutr & Dietet, Kirklareli, Turkey.",,"BICER, Emine KIR/ABG-7528-2020","BICER, Emine KIR/0000-0002-4773-9393",,,"Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.04245; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-; [Anonymous], 1999, CIRCULATION, V100, P1132, DOI DOI 10.1161/01.CIR.100.10.113; Assmann G, 1997, EUR J CANCER PREV, V6, P418, DOI 10.1097/00008469-199710000-0000; Barzi F, 2003, EUR J CLIN NUTR, V57, P604, DOI 10.1038/sj.ejcn.160157; Bedard A, 2012, BRIT J NUTR, V108, P1428, DOI 10.1017/S000711451100696; Brehm BJ, 2009, DIABETES CARE, V32, P215, DOI 10.2337/dc08-068; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S000711451100546; Chomistek AK, 2015, J AM COLL CARDIOL, V65, P43, DOI 10.1016/j.jacc.2014.10.02; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.03; Domenech M, 2014, HYPERTENSION, V64, P69, DOI 10.1161/HYPERTENSIONAHA.113.0335; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.; Esposito K, 2009, DIABETIC MED, V26, P900, DOI 10.1111/j.1464-5491.2009.02798.; Esposito K, 2010, DIABETES RES CLIN PR, V89, P97, DOI 10.1016/j.diabres.2010.04.01; Esposito K, 2009, ANN INTERN MED, V151, P306, DOI 10.7326/0003-4819-151-5-200909010-0000; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa120030; Golf DC, 2013, CIRCULATION S2, V129, P4; Huo R, 2014, EUR J CLIN NUT; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.07; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a11448; Lopez-Legarrea P, 2014, ASIA PAC J CLIN NUTR, V23, P360, DOI 10.6133/apjcn.2014.23.3.1; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.B; Martinez-Gonzalez MA, 2004, EUR J EPIDEMIOL, V19, P9, DOI 10.1023/B:EJEP.0000013351.60227.7; Mayor S, 2007, INT J CLIN PRACT, V61, P1773, DOI 10.1111/j.1742-1241.2007.01547.; Mozaffarian D, 2007, LANCET, V370, P667, DOI 10.1016/S0140-6736(07)61343-; O'Keefe JH, 2008, J AM COLL CARDIOL, V51, P249, DOI 10.1016/j.jacc.2007.10.01; Pronk NP, 2015, ANN INTERN MED, V163, P465, DOI 10.7326/M15-102; Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-; Schwenke DC, 2005, CURR OPIN LIPIDOL, V16, P55, DOI 10.1097/00041433-200502000-0001; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa070868; Soares TS, 2014, ARQ BRAS CARDIOL, V102, P374, DOI 10.5935/abc.2014002; Staimez LR, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0460-; Tobias DK, 2012, ARCH INTERN MED, V172, P1566, DOI 10.1001/archinternmed.2012.374; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-070; Wheeler ML, 2012, DIABETES CARE, V35, P434, DOI 10.2337/dc11-221; WHO, 2014, WHO NONC DIS COUNT; WHO, 1995, PHYS STAT UINT AN; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402; World Health Organization (WHO), CARD DSEAS CONTR HI",39,1,1,1,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,255.0,261,,,,7,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700040,,,,,2022-07-14,0.0040289256198347105,1.0230288177589499e-08,0.007836233167315455,0.09774124822036209,0.007836233167315455
J,"Ozku, F1;  Turkon, H;  Cakir, DU;  Eroglu, M;  Tutunculer, FK;  Faydaci, U;  Ukinc, K;  Asik, M",,,,"Ozku, Faruk; Turkon, Hakan; Cakir, Dilek Ulker; Eroglu, Mustafa; Tutunculer, Funda Kirtay; Faydaci, Umut; Ukinc, Kubilay; Asik, Mehmet",,,SERUM ISCHEMIA MODIFIED ALBUMIN LEVELS IN SUBCLINICAL CUSHING'S SYNDROME,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Ischemia-modified albumin; adrenal incidentaloma; subclinical Cushing's syndrome; oxidative stress,ADRENAL INCIDENTALOMA,"Introduction: Subclinical Cushing's syndrome (SCS) is defined as biochemical overt cortisol excess in the absence of the classical signs and symptoms of Cushing's disease. The prevalence of SCS is reported as between approximately 5% and 24% in patients with adrenal incidentalomas (AI). SCS has increased cardiovascular and metabolic risk factors, and metabolic syndrome. Recently some studies demonstrated oxidative stress enhancement in Cushing's disease. Ischemia-modified albumin (IMA) is a marker of ischemia and oxidative stress and is increased in different clinical conditions such as cardiovascular diseases and metabolic syndrome. However, it has not been investigated in the patients with SCS. We aimed to evaluate serum IMA levels in the patients with SCS. Materials and methods: A total of 128 patients with AI were included in this study (17 patients with SCS and 111 patients with non-functional adenomas (NFA)). All patients were evaluated for the presence of adrenal masses using adrenal computed tomography (CT) scans. Serum IMA levels were measured by using a calorimetric method. Results: Serum IMA levels were significantly higher in SCS patients than in NFA patients (p < 0.05). Serum IMA was significantly correlated with waist circumference, low-density lipoprotein (LDL) levels and SCS. Furthermore, regression analysis revealed that serum IMA levels are independent and positively associated only with SCS. Conclusion: We concluded that elevated serum IMA levels might be accepted as a useful marker in patients with SCS. In order to reveal the pathological role of IMA levels in patients with SCS more studies are required.","[Ozku, Faruk] Canakkale Onsekiz Mart Univ, Fac Med, Dept Gen Surg, TR-17100 Canakkale, Turkey; [Turkon, Hakan; Cakir, Dilek Ulker; Tutunculer, Funda Kirtay] Canakkale Onsekiz Mart Univ, Fac Med, Dept Med Biochem, TR-17100 Canakkale, Turkey; [Eroglu, Mustafa; Ukinc, Kubilay; Asik, Mehmet] Canakkale Onsekiz Mart Univ, Fac Med, Dept Endocrinol, TR-17100 Canakkale, Turkey; [Eroglu, Mustafa; Ukinc, Kubilay; Asik, Mehmet] Canakkale Onsekiz Mart Univ, Fac Med, Dept Metab, TR-17100 Canakkale, Turkey; [Faydaci, Umut] Near East Univ, Fac Med, Dept Gen Surg, Nicosia, Cyprus","Turkon, H (corresponding author), Canakkale Onsekiz Mart Univ, Fac Med, Dept Med Biochem, TR-17100 Canakkale, Turkey.",,"EroÄlu, Mustafa/AAC-1081-2020","EroÄlu, Mustafa/0000-0002-7526-7151",,,"Arnaldi G, 2012, BEST PRACT RES CL EN, V26, P405, DOI 10.1016/j.beem.2011.12.00; Bar-Or D, 2000, J EMERG MED, V19, P311, DOI 10.1016/S0736-4679(00)00255-; Bittner JG, 2012, J SURG ONCOL, V106, P557, DOI 10.1002/jso.2316; Caglar GS, 2011, FERTIL STERIL, V95, P310, DOI 10.1016/j.fertnstert.2010.06.09; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.248; Garrapa GGM, 2001, J CLIN ENDOCR METAB, V86, P5301, DOI 10.1210/jc.86.11.530; Kaefer M, 2010, CLIN BIOCHEM, V43, P450, DOI 10.1016/j.clinbiochem.2009.11.01; Karamouzis I, 2014, CLIN ENDOCRINOL OX; Kazanis K, 2009, CLIN CHIM ACTA, V408, P65, DOI 10.1016/j.cca.2009.07.00; Lippi G, 2009, ANN THORAC CARDIOVAS, V15, P13; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-012; Nieman LK, 2010, J CLIN ENDOCR METAB, V95, P4106, DOI 10.1210/jc.2010-045; Paschou S, 2015, ENDOCRIN; Prazny M, 2008, PHYSIOL RES, V57, P13, DOI 10.33549/physiolres.93112; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P4872, DOI 10.1210/jc.2001-01176; Terzolo M, 2002, J CLIN ENDOCR METAB, V87, P998, DOI 10.1210/jc.87.3.99; Gottlieb MGV, 2010, J CLIN ENDOCR METAB, V95, P586, DOI 10.1210/jc.2009-159",17,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,2.0,,,,,463.0,467,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QQ,WOS:000375338000031,,,,,2022-07-14,0.001756198347107438,1.1658471257965018e-10,0.003303223558884831,0.11132194813409235,0.003303223558884831
J,"Ozlem, B1;  Gokhan, E;  Baris, G;  Asim, K;  Ozcan, Y;  Kamil, K",,,,"Ozlem, Bilir; Gokhan, Ersunan; Baris, Giakoup; Asim, Kalkan; Ozcan, Yavasi; Kamil, Kayayurt",,,THE DIAGNOSIS OF PULMONARY EMBOLISM IN PATIENTS WITH NORMAL D-DIMER LEVELS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,D-Diener; Pulmonary Embolism; Wells Score; Revised Geneva Score; Pulmonary Embolism Severity Index,DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; CLINICAL-ASSESSMENT; EMERGENCY; PROBABILITY; MANAGEMENT; ACCURACY; RULES,"Introduction: The combination of clinical probability assessment and the D-dimer test has been recommended to avoid unnecessary diagnostic testing in pulmonary thromboembolism (PTE). However, in clinical practice, patients are occasionally diagnosed with PTE despite normal D-dieter levels. In the present study, we reviewed the characteristics of cases in an emergency department (ED) in which a diagnosis of PTE was made despite normal D-dimer test results. Materials and methods: The hospital records of 107 patients who were admitted to the ED of a teaching hospital and diagnosed with PTE between January 2011 and December 2013 were reviewed retrospectively. We acquired data for 11 patients (10.2%) in whom D-dimer measurements obtained by an automated latex turbidimetric quantitative method were below 500 ng/ml (0-450). Results: Of the 11 patients, 72.7% (8/11) were female, and mean age was 71. +/- 57.9 (61-84) years. The most common symptom was dyspnea (54.5%, n=6). The mean delay between onset of symptoms and admission to the ED was 10.6 (3-30) days, and follow-ups were performed for patients in other health facilities for various causes of dyspnea. When risk factors were analyzed with the Wells score, 18.2% (2/11) of patients had low probability of PTE, whereas 72.7% (8/11) had intermediate, and 9% (1/11) had high probability. According to the revised Geneva score, 18.2% (2/11) of patients were found to have low probability, and 81.8% (9/11) had intermediate probability. The Pulmonary Embolism Severity Index score classified 18.2% (2/11) of the patients in the low risk group, and the European Society of Cardiology classification classified 81.8% (9/11) in the low risk group. Conclusion: In patients with nonspecific symptoms of PTE, the delay between onset of symptoms and admission to the ED is important. The risk factors of the patients and their pre-test probabilities should be considered along with D-dieter test results.","[Ozlem, Bilir; Gokhan, Ersunan; Asim, Kalkan; Ozcan, Yavasi; Kamil, Kayayurt] Recep Tayyip Erdogan Univ, Fac Med, Dept Emergency Med, TR-53200 Rize, Turkey; [Baris, Giakoup] Rize State Hosp, Dept Emergency Med, Rize, Turkey","Ozlem, B (corresponding author), Recep Tayyip Erdogan Univ, Fac Med, Dept Emergency Med, TR-53200 Rize, Turkey.",,"Kalkan, Asim/AAE-3280-2020; YAVASI, OZCAN/AFP-3972-2022; Kalkan, Asim/AAF-3504-2019; YavaÅi, Ãzcan/AFQ-6296-2022","Kalkan, Asim/0000-0002-5800-0201; YAVASI, OZCAN/0000-0001-8641-7031; ",,,"ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.93; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-; Bruinstroop E, 2009, EUR J INTERN MED, V20, P441, DOI 10.1016/j.ejim.2008.12.00; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.; De Bastos M, 2006, J THROMB HAEMOST, V4, P2079, DOI 10.1111/j.1538-7836.2006.02063.; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-0000; Dunn KL, 2002, J AM COLL CARDIOL, V40, P1475, DOI 10.1016/S0735-1097(02)02172-; Duriseti RS, 2010, ANN EMERG MED, V56, P321, DOI 10.1016/j.annemergmed.2010.03.02; Eftychiou V, 1996, Nurse Pract, V21, P5; Gibson NS, 2008, CHEST, V134, P789, DOI 10.1378/chest.08-034; Guo ZG, 2014, CHINESE MED J-PEKING, V127, P18, DOI 10.3760/cma.j.issn.0366-6999.2013168; Gussoni G, 2013, THROMB RES, V131, P24, DOI 10.1016/j.thromres.2012.10.00; Kabrhel C, 2009, ACAD EMERG MED, V16, P325, DOI 10.1111/j.1553-2712.2009.00368.; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-0000; Keeling DM, 2004, BRIT J HAEMATOL, V124, P15, DOI 10.1046/j.1365-2141.2003.04723.; Koracevic GP, 2009, AM J EMERG MED, V27, P1016, DOI 10.1016/j.ajem.2008.11.01; Ku GH, 2009, BLOOD, V113, P3911, DOI 10.1182/blood-2008-08-17574; Kutinsky I, 1999, ARCH INTERN MED, V159, P1569, DOI 10.1001/archinte.159.14.156; Miniati M, 1999, AM J RESP CRIT CARE, V159, P864, DOI 10.1164/ajrccm.159.3.980613; Pasha SM, 2010, THROMB RES, V125, pE123, DOI 10.1016/j.thromres.2009.11.00; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.07; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.; Rogers MAM, 2012, CIRCULATION, V125, P2092, DOI 10.1161/CIRCULATIONAHA.111.08446; Wood KE, 2002, CHEST, V121, P877, DOI 10.1378/chest.121.3.87",26,1,1,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,171.0,177,,,,7,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700027,,,,,2022-07-14,0.0026859504132231405,6.101414429693568e-20,0.004746697502217888,0.07162889130611731,0.004746697502217888
J,"Ozturk, S1;  Unver, M;  Yoldas, O;  Dizen, H;  Erol, V;  Bozbiyik, O;  Guner, M;  Pehlivanoglu, K;  Kebapci, B;  Aydin, C;  Akbulut, G",,,,"Ozturk, S.; Unver, M.; Yoldas, O.; Dizen, H.; Erol, V; Bozbiyik, O.; Guner, M.; Pehlivanoglu, K.; Kebapci, B.; Aydin, C.; Akbulut, G.",,,RECEIVER OPERATING CHARACTERISTIC ANALYSIS AND DISCRIMINATIVE EFFECT OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN PATIENTS WITH SUSPECTED APPENDICITIS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Appendicitis; Receiver operating characteristic curve; neutrophil to lymphocyte ratio,C-REACTIVE PROTEIN; BLOOD-CELL COUNT; LEUKOCYTE COUNT; DIAGNOSTIC-VALUE; COMPUTED-TOMOGRAPHY; CHILDREN; PREDICTOR; ULTRASONOGRAPHY; APPENDECTOMY; METAANALYSIS,"Introduction: Acute appendicitis (AA) is one of the most common causes of abdominal pain and emergent abdominal surgery. The incidence is approximately 10% during the lifetime. Although appendectomy is a most common surgical procedure worldwide, it's complication rate is 5-28% A delay in diagnosis of AA is associated with prolonged hospitalization, an increased rate of perforation (34%-75%), wound infection (0%-11%), pelvic abscess (1%-5%) and late intro-abdominal adhesions. Appendectomy is first described by McBurney in 1894 and still remains the standart procedure for AA. Although patients with AA often present with a characteristic symptom complex and physical findings, atypical presentations are common. The aim of this study was to assess the diagnostic value of neutrophil-to-lymphocyte ratio (NLR) in patients who were operated for suspected acute appendicitis and to assess the discriminative effect of this ratio between wzinflamed, uncomplicated and complicated appendicitis. Materials and methods: The medical records of 3212 patients who underwent appendectomy for suspected acute appendicitis during a 10-year period were reviewed retrospectively. Patients were divided into 3 groups; group 1, 208 consecutive patients who had uninflamed appendix at appendectomy; group 2, 2111 consecutive patients who had uncomplicated acute appendicitis at appendectomy; group 3, 893 patients who had complicated appendicitis (perforated appendix or peri-appendicular abscess) at appendectomy. Data for three groups of patients were analyzed to calculate the sensitivity and specificity of the NLR in the diagnosis of acute appendicitis. Receivers operating characteristic (ROC) curves were used to evaluate this ratio in a relation with true diagnosis and severity of acute appendicitis. Results: 1792 (55.8%) of the patients were male and 1420 (44.2%) of them were female. The mean age of the groups were 30.28 +/- 14.18, 29.98 +/- 12.63 and 33.81 +/- 16.27 respectively. The discriminative effect of NLR was higher between uninflamed and complicated appendicitis groups with a cut-off value of 3,94. The recommended cut-off value of the preoperative NLR was decided using ROC curve analyses. The recommended cut-off value of the NLR was based on the most prominent point on the ROC curve for sensitivity (82.2%) and specificity (56.5%). The area under the ROC curve was 0.74. Conclusion: AA is one of the most common surgical emergencies and the most common source of infection in community acquired intra-abdominal infections. However the diagnosis is often challenging and the decision to operate, observe or further work-up on a patient is often unclear. Initial management of patients with suspected AA is based on the history of the patient, physical examination, basic laboratory tests reflecting the inflammatory response and radiologic imaging. NLR is a helpful biochemical parameter for the diagnosis of acute appendicitis but it has limited value on differentiating patients with complicated appendicitis from patients with uninflamed and uncomplicated appendicitis.","[Ozturk, S.; Unver, M.; Yoldas, O.] Izmir Univ, Fac Med, Dept Gen Surg, Izmir, Turkey; [Dizen, H.] Eskisehir Yunus Emre State Hosp, Dept Gen Surg, Eskisehir, Turkey; [Erol, V] Baskent Univ, Fac Med, Dept Gen Surg, Ankara, Turkey; [Bozbiyik, O.] Ege Univ, Fac Med, Dept Gen Surg, Izmir, Turkey; [Guner, M.; Pehlivanoglu, K.; Kebapci, B.; Aydin, C.; Akbulut, G.] Tepecik Educ & Res Hosp, Dept Gen Surg, Izmir, Turkey","Ozturk, S (corresponding author), Yeni Girne Bulvari 1825 Sokak 12, Karsiyaka Izmir, Turkey.",,"Aydin, Cengiz/AAL-6664-2020; Ãnver, Mutlu/AAA-1673-2021","Aydin, Cengiz/0000-0003-4713-2871; Guner, Murat/0000-0002-3463-8550",,,"Acarturk G, 2015, BRATISL MED J, V116, P213, DOI 10.4149/BLL_2015_04; Al-Khayal KA, 2007, SAUDI MED J, V28, P17; Albayrak Y, 2011, CLIN APPL THROMB-HEM, V17, P362, DOI 10.1177/107602961036452; BECK JR, 1986, ARCH PATHOL LAB MED, V110, P1; Blackmore C, 2015, CAN J SURG, V58, P431, DOI 10.1503/cjs.01271; BOLTON JP, 1975, BRIT J SURG, V62, P906, DOI 10.1002/bjs.180062111; Brigand C, 2009, J CHIR-PARIS, V146, pS2, DOI 10.1016/j.jchir.2009.08.00; Caglayan F, 2003, J INVEST SURG, V16, P233, DOI 10.1080/0894193039021503; Chong CF, 2010, SINGAP MED J, V51, P22; Coleman C, 1998, AM SURGEON, V64, P98; CURRAN TJ, 1993, J PEDIATR SURG, V28, P204, DOI 10.1016/S0022-3468(05)80276-; DUEHOLM S, 1989, DIS COLON RECTUM, V32, P855, DOI 10.1007/BF0255455; ERIKSSON S, 1994, SCAND J GASTROENTERO, V29, P1145, DOI 10.3109/0036552940909490; GILBERT SR, 1985, SURG GYNECOL OBSTET, V161, P26; GOODMAN DA, 1995, AM SURGEON, V61, P25; GRAHAM JM, 1980, AM J SURG, V139, P247, DOI 10.1016/0002-9610(80)90265-; GRONROOS JM, 1994, CLIN CHEM, V40, P175; Hallan S, 1997, EUR J SURG, V163, P53; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.706374; JAHANGIRI M, 1990, BRIT MED J, V301, P215, DOI 10.1136/bmj.301.6745.21; Jang Sung Ouk, 2008, Korean J Gastroenterol, V52, P2; Keskek M, 2008, AM J EMERG MED, V26, P769, DOI 10.1016/j.ajem.2007.10.03; Kozar RA, 1999, PRINCIPLES SURG, P138; Markar SR, 2010, ACTA CHIR BELG, V110, P543, DOI 10.1080/00015458.2010.1168067; Pal K M, 1998, J Pak Med Assoc, V48, P18; Parks NA, 2011, SURG CLIN N AM, V91, P141, DOI 10.1016/j.suc.2010.10.01; PEARL RH, 1995, J PEDIATR SURG, V30, P173, DOI 10.1016/0022-3468(95)90556-; Rodriguez-Sanjuan JC, 1999, DIS COLON RECTUM, V42, P1325, DOI 10.1007/BF0223422; Sallinen V, 2016, BRIT J SURG, V103, P656, DOI 10.1002/bjs.1014; Sartelli M, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-1; SASSO RD, 1970, AM J SURG, V120, P563, DOI 10.1016/S0002-9610(70)80168-; Shafi Sheikh Muzamil, 2009, Saudi J Gastroenterol, V15, P117, DOI 10.4103/1319-3767.4896; STONE HH, 1971, SURGERY, V69, P67; SURANA R, 1995, PEDIATR SURG INT, V10, P7; Tan TP, 2015, ANZ J SURG, V85, P414, DOI 10.1111/ans.1303; Tanrikulu Y, 2015, ULUS TRAVMA ACIL CER, V21, P440, DOI 10.5505/tjtes.2015.7750; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-0001; Terlinder J, 2016, SCAND J GASTROENTERO, V51, P; Yang HR, 2005, AM SURGEON, V71, P34; Yang JJ, 2015, WORLD J GASTROENTERO, V21, P2807, DOI 10.3748/wjg.v21.i9.280; Yildirim M, 2015, GYNECOL OBSTET INVES, V80, P234, DOI 10.1159/00037176; Zahorec R, 2001, Bratisl Lek Listy, V102, P",42,0,0,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,799.0,804,,10.19193/0393-6384_2016_3_93,,6,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400022,,,,,2022-07-14,0.0043388429752066115,3.7154010134935436e-14,0.0096270113307795,0.09779259483760165,0.009505447044065904
J,"Parisi, L71;   Ruberto, M;   Precenzano, F;   Di Filippo, T;   Russotto, C;   Maltese, A;   Salerno, M;   Roccella, M",,,,"Parisi, Lucia; Ruberto, Maria; Precenzano, Francesco; Di Filippo, Teresa; Russotto, Carmen; Maltese, Agata; Salerno, Margherita; Roccella, Michele",,,THE QUALITY OF LIFE IN CHILDREN WITH CEREBRAL PALSY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,cerebral palsy; quality of life; pediatric disability; parenting,PRIMARY CILIARY DYSKINESIA; CHILDHOOD MIGRAINE; MATERNAL STRESS; MOTHERS; SLEEP; AURA; REHABILITATION; MULTICENTER; DEPRESSION; HEADACHE,"Background: Cerebral palsy (CP) is the most common pediatric disability causing long-term functional limitations. CP remarkably influences the life of those affected and their families. For this reason it is important and necessary to direct attention not only type of the CP, but also the impact the disorder has on the child, parents, siblings and the entire family as a whole. The aim of this study was to assess the impact of CP on the child's quality of life, considering parents' perceptions about their child's illness, in order to underline the impact the illness has not only on the child but also his/her family. Methods: The study included both parents of the 36 subjects enrolled (19 males and 17 females), with established CP diagnosis. The effect of CP on the families was assessed using the Impact of Childhood Illness Scale. This questionnaire assesses the quality of life in children with epilepsy and other chronic pathologies and in their families. All questions refer to effect to the illness family. The scale comprises 30 questions divided into four sections: impact of illness and its treatment; impact on development and child s adjustment; impact on parents and impact on the family. Descriptive analyses were used for data analysis and it is also calculated the rank correlation coefficient Spearman's rho. Results and conclusion: The mothers' group presents little higher average scores than the group of fathers in two four subscales or in the basement Impact on the child and Family impact on the organization. This could be due to the fact that mothers are concerned most of the child's caregiver, living most of all the difficulties that entails; mothers show greater concerns than fathers. In subscale Impact on parents the average score of the answers of the group of mothers coincide with that of the fathers; the experience and the experience of his son's illness is analogous for both parents. No significant differences were found from the correlational analysis between the individual items of the subscales and the different forms of CP. In families of children with CP, strategies for optimizing caregiver physical and psychological health include supports for behavioral management and daily functional activities as well as stress management and self-efficacy techniques.","[Parisi, Lucia; Di Filippo, Teresa; Russotto, Carmen; Maltese, Agata; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Ruberto, Maria] Univ Naples 2, Dept Med Surg & Dent Specialties, Caserta, CE, Italy; [Precenzano, Francesco] Univ Naples 2, Dept Mental & Phys Hlth & Prevent Med, Clin Child & Adolescent Neuropsychiat, Caserta, CE, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, I-90133 Palermo, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,,"Precenzano, Francesco/0000-0002-3812-1786",,,"Aisen ML, 2011, LANCET NEUROL, V10, P844, DOI 10.1016/S1474-4422(11)70176-; Basaran A, 2013, EUR J PHYS REHAB MED, V49, P81; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-7; Berker AN, 2008, PEDIATR CLIN N AM, V55, P1209, DOI 10.1016/j.pcl.2008.07.01; Boling S, 2016, DISABIL REHABIL, V38, P683, DOI 10.3109/09638288.2015.106160; Byrne MB, 2010, CHILD CARE HLTH DEV, V36, P696, DOI 10.1111/j.1365-2214.2009.01047.; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, SLEEP BREATH, V17, P877, DOI 10.1007/s11325-012-0697-; Dambi JM, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0219-; Dambi JM, 2015, INT J SCI RES PUBLIC, V5, P1; Davis E, 2010, CHILD CARE HLTH DEV, V36, P63, DOI 10.1111/j.1365-2214.2009.00989.; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Eker L, 2004, DISABIL REHABIL, V26, P1354, DOI 10.1080/0963828040000018; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Gagliardi C, 2008, PEDIATR NEUROL, V39, P335, DOI 10.1016/j.pediatrneurol.2008.07.02; Garip Y, 2017, DISABIL REHABIL, V39, P757, DOI 10.3109/09638288.2016.116183; HOARE P, 1995, DEV MED CHILD NEUROL, V37, P68; Montalbano R, 2009, Minerva Pediatr, V61, P36; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/0963828050015842; Oh H, 2009, INT J DISABIL DEV ED, V56, P149, DOI 10.1080/1034912090286862; Parisi L, 2016, MENT ILLN, V8, P5, DOI 10.4081/mi.2016.630; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-168; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24; Yilmaz H, 2013, EUR J PHYS REHAB MED, V49, P82",39,11,11,0,17,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_147,,6,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000018,,,,,2022-07-14,0.003409090909090909,0.03352350885569376,0.0035857514356981974,0.1106121376252671,0.00356388876668009
J,"Perciavalle, V1;  Buscemi, A;  Borbone, C;  Catania, A;  Buscemi, B;  Petralia, MC;  Puglisi, ML;  Coco, LSG;  Coco, M",,,,"Perciavalle, Valentina; Buscemi, Andrea; Borbone, Carlo; Catania, Andrea; Buscemi, Barbara; Petralia, Maria Cristina; Puglisi, Maria Luisa; Coco, Lucio S. G.; Coco, Marinella",,,EXHAUSTIVE EXERCISE AND SHORT TERM MEMORY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,exhaustive exercise; brain; lactate; short term memory,BLOOD LACTATE LEVELS; MOTOR CORTEX EXCITABILITY; MULTIPLE-SCLEROSIS; IN-VITRO; CELLS; RATIO; CAT; MICROSTIMULATION; PERFORMANCE; RESPONSES,"Introduction: The brain needs a continuous supply of O-2 and its deficiency may interfere with cognitive function. It has been observed that, during the performance of a maximal exercise, in the central nervous system (CNS) increases the use of lactate and glucose. Moreover; it has been described that during a maximal exercise the increase of blood lactate is associated with a worsening of attentive processes. The aim of this study was to investigate whether high levels of Lactate are capable of influencing other cognitive domains as Short-term memory. Materials and methods: Fifteen male and healthy athletes participated in the research. Short-term memory span was carried through the Italian computerized version of Wechsler's Digit Span. The subjects were asked to perform an incremental cycling test on a mechanically braked cycloergometer. The measurement of values of blood lactate and the assessment of Short-term memory through the Italian computerized version of Wechsler's Digit Span were performed in three specific moments: 1) at rest (before); 2) immediately after performing an exhaustive exercise (end); 3) 10 minutes after the end of the exercise (10 min). Results: Blood lactate levels increased ftom 1.5 mmol/l (+/- 0.21) at rest (pre), to 12.0 mmol/l (+/- 2.14) immediately after the exercise (end), and decreased to 1.6 mmol/l (+/- 0.21) 10 min after its conclusion (post). In parallel, we observed that the digit span shows a worsening of short term memory at the end of exercised and returned to the pre-exercise values within 10 min after the conclusion of exercise. Conclusion: The present results show that high levels of blood lactate, as those induced with an exhaustive exercise, influence the cognitive domain of the memory in the same way observed for the cognitive domain of attention.","[Perciavalle, Valentina] Univ Catania, Dept Format Proc, I-95124 Catania, Italy; [Buscemi, Andrea; Borbone, Carlo; Catania, Andrea; Petralia, Maria Cristina; Puglisi, Maria Luisa; Coco, Lucio S. G.] Univ Catania, I-95124 Catania, Italy; [Coco, Marinella] Univ Catania, Dept Biomed Sci, I-95124 Catania, Italy","Buscemi, A (corresponding author), Univ Catania, I-95124 Catania, Italy.",andreabuscemi78@gmail.com,"Coco, Marinella/AAC-8750-2020; Petralia, Maria/AAE-6337-2019","Petralia, Maria Cristina/0000-0002-9643-1045",,,"Alagona G, 2009, NEUROSCI LETT, V450, P111, DOI 10.1016/j.neulet.2008.11.06; Alesi Marianha, 2014, MUSCLES LIGAMENTS TE, V1144, P11; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, P47, DOI DOI 10.1016/S0079-7421(08)60452-; BERRETTA S, 1991, BRAIN RES, V556, P297, DOI 10.1016/0006-8993(91)90319-; BERRETTA S, 1993, J COMP NEUROL, V338, P50, DOI 10.1002/cne.90338010; Buckley JD, 2003, J SCI MED SPORT, V6, P408, DOI 10.1016/S1440-2440(03)80267-; Chomitz VR, 2009, J SCHOOL HEALTH, V79, P30, DOI 10.1111/j.1746-1561.2008.00371.; Coco M, 2015, ACTA MEDICA MEDITERR, V31, P44; Coco M, 2015, NEUROL SCI, V36, P541, DOI 10.1007/s10072-014-2015-; Coco M, 2015, MOL MED REP, V11, P2135, DOI 10.3892/mmr.2014.289; Coco M, 2014, SOMATOSENS MOT RES, V31, P35, DOI 10.3109/08990220.2013.83481; Coco M, 2013, SOMATOSENS MOT RES, V30, P90, DOI 10.3109/08990220.2013.76994; Coco M, 2011, SOMATOSENS MOT RES, V28, P19, DOI 10.3109/08990220.2011.59826; Coco M, 2011, MOL MED REP, V4, P471, DOI 10.3892/mmr.2011.45; Coco M, 2010, SOMATOSENS MOT RES, V27, P1, DOI 10.3109/0899022090347176; Coco M, 2009, BRAIN RES, V1302, P205, DOI 10.1016/j.brainres.2009.09.03; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.05505; Dalsgaard MK, 2002, J PHYSIOL-LONDON, V540, P681, DOI 10.1113/jphysiol.2001.01306; Di Nuovo S., 2002, ATTENZIONE CONCENTR; Donia M, 2012, ONCOL REP, V28, P682, DOI 10.3892/or.2012.184; Donia M, 2009, J AUTOIMMUN, V33, P135, DOI 10.1016/j.jaut.2009.06.00; Fagone P, 2014, LUPUS, V23, P407, DOI 10.1177/096120331452233; Fagone P, 2012, CLIN EXP IMMUNOL, V167, P179, DOI 10.1111/j.1365-2249.2011.04491.; Fagone P, 2015, INT J MOL MED, V36, P747, DOI 10.3892/ijmm.2015.226; Fagone P, 2013, J NEUROIMMUNOL, V261, P82, DOI 10.1016/j.jneuroim.2013.04.01; Fagone P, 2013, BASIC CLIN PHARMACOL, V112, P63, DOI 10.1111/j.1742-7843.2012.00923.; Frinchi M, 2013, INT J SPORTS ME; GRAY C, 1993, BRAIN RES, V622, P280, DOI 10.1016/0006-8993(93)90829-; Humstone HJ, 1919, PSYCHOL CLIN, V12, P19; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-; Mangano K, 2014, J CELL PHYSIOL, V229, P1918, DOI 10.1002/jcp.2464; Mijatovic S, 2010, FREE RADICAL BIO MED, V48, P1090, DOI 10.1016/j.freeradbiomed.2010.01.02; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.34; PERCIAVALLE V, 1978, EXP BRAIN RES, V33, P24; PERCIAVALLE V, 1977, BRAIN RES, V126, P557, DOI 10.1016/0006-8993(77)90608-; Perciavalle V, 2013, SOMATOSENS MOT RE; Perciavalle Va, 2015, NEUROL SCI, DOI [10.1007/sI0072-015-2329-4, DOI 10.1007/SI0072-015-2329-4; Perciavalle V, 2015, NEUROL SCI, V36, P1597, DOI 10.1007/s10072-015-2210-; Perciavalle V, 2014, PERCEPT MOTOR SKILL, V118, P940, DOI 10.2466/19.50.PMS.118k27w; Perciavalle V, 2014, PERCEPT MOTOR SKILL, V118, P733, DOI 10.2466/29.30.PMS.118k22w; Perciavalle V, 2010, SOMATOSENS MOT RES, V27, P106, DOI 10.3109/08990220.2010.50710; Perciavalle V, 2013, CEREBELLUM, V12, P738, DOI 10.1007/s12311-013-0464-; Petralia MC, 2013, MOL MED REPORTS, DOI 10.3892/mmr.2013.142; Podolec Piotr, 2002, Przegl Lek, V59, P58; Wechsler D., 1991, WECHSLER INTELLIGEN; Weiss LG, 2010, PRACT RESOUR MENT, P; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.28105",47,7,7,1,17,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,23.0,27,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700003,,,,,2022-07-14,0.004752066115702479,1.0382263963122676e-16,0.005760837356170617,0.05560182658893133,0.005758511346308668
J,"Precenzano, F31;   Lombardi, P;   Ruberto, M;   Parisi, L;   Salerno, M;   Maltese, A;   D'Alessandro, I;   Della Valle, I;   Magliulo, RM;   Messina, G;   Roccella, M",,,,"Precenzano, Francesco; Lombardi, Paola; Ruberto, Maria; Parisi, Lucia; Salerno, Margherita; Maltese, Agata; D'Alessandro, Ilaria; Della Valle, Immacolata; Magliulo, Rosaria Martina; Messina, Giovanni; Roccella, Michele",,,INTERNALIZING SYMPTOMS IN CHILDREN AFFECTED BY CHILDHOOD ABSENCE EPILEPSY: A PRELIMINARY STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Childhood Absence Epilepsy; CAE; SAFA-A; Children Depression Inventory; Internalizing symptoms,PRIMARY CILIARY DYSKINESIA; SLEEP-APNEA SYNDROME; NOCTURNAL ENURESIS; MATERNAL STRESS; SELF-CONCEPT; MIGRAINE; AURA; MULTICENTER; ADOLESCENTS; DEPRESSION,"Introduction: Childhood absence epilepsy (CAE) is a common type of pediatric idiopathic generalized epilepsy, characterized by multiple seizures of typical absence, with typical EEG pattern consisting in bilateral synchronous and symmetrical discharges of generalized 3 Hz spike-wave (SWDs). Recently, some researchers have suggested that the underlying epileptogenic mechanism of absence seizures selectively involves the frontal cortical circuits, also supported by video-electroencephalography data(3). These data may be considered as a new window in CAE comprehension and management, particularly about symptoms different from seizure that children affected may present. In this light, aim of the present study is evaluating the presence of internalizing problems in prepubertal children affected by CAE. Material and methods: 18 patients (10 females, 8 males) ranging age from 8-11 years (mean age 9.36 +/- 1.32) affected by typical CAE were recruited. Control group was composed by 43 subjects (32 females, 11 males) (mean age 8.54 +/- 2.01). All subjects were screened for internalizing symptoms with SAFA-A scale and CDI test. Results: The two groups were comparable for age (p= 0.117) and sex distribution (p= 0.251). CAE children showed significantly higher score than controls for anxiety (p< 0.001) and depressive symptoms screening tests (p< 0.001) (Table 1). Conclusions: Results of present study suggest the importance of screening for anxiety and depressive signs in CAE children, in order to optimize their management beyond the exclusive idea to control and stop epileptic seizure only.","[Precenzano, Francesco; Lombardi, Paola; D'Alessandro, Ilaria; Della Valle, Immacolata; Magliulo, Rosaria Martina] Univ Naples 2, Clin Child & Adolescent Neuropsychiat, Caserta Ce, Italy; [Precenzano, Francesco; Lombardi, Paola; D'Alessandro, Ilaria; Della Valle, Immacolata; Magliulo, Rosaria Martina] Univ Naples 2, Dept Mental Hlth & Phys & Prevent Med, Headache Ctr Children & Adolescents, Caserta Ce, Italy; [Ruberto, Maria] Univ Naples 2, Dept Med Surg & Dent Specialties, Caserta Ce, Italy; [Parisi, Lucia; Maltese, Agata; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Parisi, Lucia; Maltese, Agata; Roccella, Michele] Univ Palermo, Sci Mother & Child Hlth Promot, I-90133 Palermo, Italy; [Salerno, Margherita] Univ Foggia, Sect Human Physiol, Dept Expt Med, Foggia, Italy; [Salerno, Margherita] Univ Foggia, Dept Clin & Expt Med, Unit Dietet & Sports Med, Foggia, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,"Messina, Giovanni/AAE-8668-2022","Messina, Giovanni/0000-0002-0011-867X",,,"Amjad RN, 2016, ACTA MEDICA MEDITERR, V32, P130; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2013, NEUROPSYCH DIS TREAT, V9, P157, DOI 10.2147/NDT.S4189; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Cheng D, 2016, J CHILD NEURO; Di Filippo T, 2013, MINERVA PEDIATR, V65, P59; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1803, DOI 10.2147/NDT.S5385; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Foumany GHE, 2015, ACTA MEDICA MEDITERR, V31, P135; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Jalili Z, 2016, ACTA MEDICA MEDITERR, V32, P91; Katirci Y, 2013, ACTA MEDICA MEDITERR, V29, P71; Makovac E, 2016, SOC COGN AFFECT NEU; Matricardi S, 2014, PEDIATR NEUROL, V50, P205, DOI 10.1016/j.pediatrneurol.2013.10.00; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Mirzaei-Alavijeh M, 2016, ACTA MEDICA MEDITERR, V32, P101; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Perillo L, 2013, NEUROPSYCH DIS TREAT, V9, P1231, DOI 10.2147/NDT.S4998; Rotondi F, 2016, CLIN NEUROPHYSIOL, V127, P1130, DOI 10.1016/j.clinph.2015.09.00; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shams S, 2016, ACTA MEDICA MEDITERR, V32, P155; Takeuchi H., 2016, BRAIN STRUCT FUNC; Vega C, 2011, EPILEPSIA, V52, pE70, DOI 10.1111/j.1528-1167.2011.03119.; Yongli Z, 2016, ACTA MEDICA MEDITERR, V32, P117",50,13,13,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1749.0,1753,,10.19193/0393-6384_2016_6_158,,5,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300002,,,,,2022-07-14,0.004545454545454545,0.06847718152371698,0.0015355444660700502,0.11067284056479734,0.0015189524062805323
J,"Precenzano, F41;   Ruberto, M;   Parisi, L;   Salerno, M;   Maltese, A;   D'Alessandro, I;   Della Valle, I;   Visco, G;   Magliulo, RM;   Messina, G;   Roccella, M",,,,"Precenzano, Francesco; Ruberto, Maria; Parisi, Lucia; Salerno, Margherita; Maltese, Agata; D'Alessandro, Ilaria; Della Valle, Immacolata; Visco, Gennaro; Magliulo, Rosaria Martina; Messina, Giovanni; Roccella, Michele",,,ADHD-LIKE SYMPTOMS IN CHILDREN AFFECTED BY OBSTRUCTIVE SLEEP APNEA SYNDROME: A CASE-CONTROL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,ADHD; ADHD-like symptoms; obstructive sleep apnea syndrome; OSA,ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PRIMARY NOCTURNAL ENURESIS; MIGRAINE; AURA; EPILEPSY,"Introduction: ADHD is characterized by inattention, hyperactivity, impulsivity, or a combination of these symptoms. Sleep disorders may be considered as a not secondary underlying cause of ADHD and growing evidence evidenced that obstructive sleep apnea syndrome (OSA) symptoms may overlap ADHD's ones. Aim of the present study is verifying the presence of ADHD-like symptoms in other frequent condition such as sleep-related breathing disorders in pediatric age. Materials and methods: 34 children (19 males and 15 females) aged 6-10 years (mean age 9.706 +/- 3.434) with polysomnographic diagnosis of OSA, according to ICSD-3 criteria, were recruited. Control group was composed by 89 typical developing children (47 males, 42 females) (mean age 9,528 +/- 3,351). The Conners' Rating Scale-Revised (CRS-R) test was administered to mothers to assess their children's behavior. Results: The two groups are comparable for age (p = 0.794) and sex distribution (p = 0.918). Subjects affected by OSA present higher scores in pathological range in all scales of CRS-R than controls (Table 1). Conclusions: Scientific and clinical evidences tend to stress the similarities between ADHD and OSA effects/comorbidities in pediatric age, suggesting sleep screening as mandatory before starting stimulant drugs treatment.","[Precenzano, Francesco; D'Alessandro, Ilaria; Della Valle, Immacolata; Visco, Gennaro; Magliulo, Rosaria Martina] Univ Naples 2, Clin Child & Adolescent Neuropsychiat, Caserta Ce, Italy; [Precenzano, Francesco; D'Alessandro, Ilaria; Della Valle, Immacolata; Visco, Gennaro; Magliulo, Rosaria Martina] Univ Naples 2, Dept Mental Hlth & Phys & Prevent Med, Headache Ctr Children & Adolescents, Caserta Ce, Italy; [Ruberto, Maria] Univ Naples 2, Dept Med Surg & Dent Specialties, Caserta Ce, Italy; [Parisi, Lucia; Maltese, Agata; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, I-90133 Palermo, Italy; [Messina, Giovanni] Univ Foggia, Dept Expt Med, Sect Human Physiol, Foggia, Italy; [Messina, Giovanni] Univ Foggia, Dept Clin & Expt Med, Unit Dietet & Sports Med, Foggia, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,"Messina, Giovanni/AAE-8668-2022","Messina, Giovanni/0000-0002-0011-867X",,,"American Academy of Sleep Medicine, 2014, AM ACAD SLEEP ME; American Psychiatric Pub, 2000, DIAGN STAT MAN MENT, V; Amjad RN, 2016, ACTA MEDICA MEDITERR, V32, P130; Ancoli-Israel S, 2007, AASM MANUAL SCORIN; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Conners C.K, 2000, CONNERS RATING SCAL; Cortese S, 2015, CNS DRUGS, V29, P865, DOI 10.1007/s40263-015-0266-; Craig F, 2016, NEUROPSYCH DIS TREAT, V12, P1191, DOI 10.2147/NDT.S10462; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Foumany GHE, 2015, ACTA MEDICA MEDITERR, V31, P135; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Gelade K, 2016, J CLIN PSYCHIAT, V77, pE1270, DOI 10.4088/JCP.15m1014; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Jalili Z, 2016, ACTA MEDICA MEDITERR, V32, P91; Katirci Y, 2013, ACTA MEDICA MEDITERR, V29, P71; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina Giovanni, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P611, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Miano S, 2016, CNS NEUROSCI THER, V22, P906, DOI 10.1111/cns.1257; Mirzaei-Alavijeh M, 2016, ACTA MEDICA MEDITERR, V32, P101; Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_; Parisi L, 2015, ACTA MEDICA MEDITERR, V31, P118; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, P1659, DOI [10.19193/0393-6384_2016_5_146, DOI 10.19193/0393-6384_; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Shams S, 2016, ACTA MEDICA MEDITERR, V32, P155; Verrotti A, 2015, J NEUROL, V262, P124, DOI 10.1007/s00415-014-7579-; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Visser SN, 2015, J PEDIATR-US, V166, P1423, DOI 10.1016/j.jpeds.2015.02.01; Youssef NA, 2011, ANN CLIN PSYCHIATRY, V23, P21; Zou YL, 2016, ACTA MEDICA MEDITERR, V32, P117",50,16,16,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1755.0,1759,,10.19193/0393-6384_2016_6_159,,5,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300003,,,,,2022-07-14,0.004545454545454545,0.054816826059226734,0.058906059814556495,0.11323359107232679,0.060848140337763625
J,"Precenzano, F51;   Ruberto, M;   Parisi, L;   Salerno, M;   Maltese, A;   D'Alessandro, I;   Grappa, MF;   Magliulo, RM;   Messina, G;   Roccella, M",,,,"Precenzano, Francesco; Ruberto, Maria; Parisi, Lucia; Salerno, Margherita; Maltese, Agata; D'Alessandro, Ilaria; Grappa, Maria Francesca; Magliulo, Rosaria Martina; Messina, Giovanni; Roccella, Michele",,,BORDERLINE INTELLECTUAL FUNCTIONING AND PARENTAL STRESS: AN ITALIAN CASE-CONTROL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,borderline intellectual functioning; BIF; parental stress index; PSI,PRIMARY NOCTURNAL ENURESIS; SLEEP-APNEA SYNDROME; CHILDHOOD MIGRAINE; MATERNAL STRESS; SELF-CONCEPT; CHILDREN; MULTICENTER; ADOLESCENTS; PERSPECTIVE; AURA,"Introduction: Borderline intellectual functioning (BIF) children comprises a group of subjects whit intelligence quotient (IQ) ranging 71-85, with a prevalence about 13.6%. Several studies pinpointed the role of parenting on BIF management. Aim of present study was evaluating with objective and validated tool the parental stress rate in mothers of an Italian sample of BIF children. Materials and methods: 26 BIF children (20 males and 6 females) aged 6-10 years (mean age 10.36 +/- 2.03), according to DSM-5 criteria, and 53 (42 males and 11 females) typical developing children (mean age 10.58 +/- 1.97) were recruited for present study. Mothers of all enrolled children underwent an evaluation with Parental Stress Index (PSI) test. Results: The two studied groups were comparable for age (p = 0.646) and gender (p = 0.956). Table 1 shows comparison between BIF and Control groups among PSI-SF scale results (Table 1), specifically mothers of BIF children have a significantly higher levels of global parental stress (p < 0.001), stress related to parenting (p < 0.001), stress linked to difficult child (p < 0.001) and stress related to parent-child interaction (p < 0.001) than mothers of control children. (Table 1) Conclusion: Several reports showed the key role of BIF as risk factor for psychiatric troubles and poor long-term adjustment. Our findings emphasize the need to approach this condition also from a family point of view, stressing that care should not be limited to child rehabilitative treatment but must also involve a family centered intervention.","[Precenzano, Francesco; D'Alessandro, Ilaria; Grappa, Maria Francesca; Magliulo, Rosaria Martina] Univ Naples 2, Clin Child & Adolescent Neuropsychiat, Headache Ctr Children & Adolescents, Caserta Ce, Italy; [Precenzano, Francesco; D'Alessandro, Ilaria; Grappa, Maria Francesca; Magliulo, Rosaria Martina] Univ Naples 2, Dept Mental Hlth & Phys & Prevent Med, Caserta Ce, Italy; [Ruberto, Maria] Univ Naples 2, Dept Med Surg & Dent Specialties, Caserta Ce, Italy; [Parisi, Lucia; Maltese, Agata; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, I-90133 Palermo, Italy; [Messina, Giovanni] Univ Foggia, Dept Expt Med, Sect Human Physiol, Foggia, Italy; [Messina, Giovanni] Univ Foggia, Dept Clin & Expt Med, Unit Dietet & Sports Med, Foggia, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,"Messina, Giovanni/AAE-8668-2022","Messina, Giovanni/0000-0002-0011-867X",,,"ABDIN R, 1990, PARENTING STRESS IN; Abidin R.R., 2012, PARENTING STRESS IND, VFourt; Amjad RN, 2016, ACTA MEDICA MEDITERR, V32, P130; [Anonymous], 2013, DIAGN STAT MAN MEN; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2013, WORLD J PEDIATR, V9, P312, DOI 10.1007/s12519-013-0441-; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-; Emerson E, 2010, SOC PSYCH PSYCH EPID, V45, P579, DOI 10.1007/s00127-009-0100-; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S6979; Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P141, DOI 10.2147/NDT.S5551; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P351, DOI 10.2147/NDT.S4281; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROL SCI, V33, P1365, DOI 10.1007/s10072-012-1019-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Esposito T, 2016, DRUG DES DEV THER, V10, P2939, DOI 10.2147/DDDT.S10644; Fantauzzo G, 2010, ACTA MEDICA MEDITERR, V26, P5; Fenning RM, 2007, AM J MENT RETARD, V112, P107, DOI 10.1352/0895-8017(2007)112[107:PCWBIF]2.0.CO;; Fenning RM, 2014, J FAM PSYCHOL, V28, P326, DOI 10.1037/a003653; Fernell E, 2010, ACTA PAEDIATR, V99, P748, DOI 10.1111/j.1651-2227.2010.01707.; Franzoni E, 2015, EUR J PAEDIATR NEURO, V19, P660, DOI 10.1016/j.ejpn.2015.07.00; Guzzetta A, 2010, DEV MED CHILD NEUROL, V52, P767, DOI 10.1111/j.1469-8749.2009.03497.; Hamissi JH, 2016, ACTA MEDICA MEDITERR, V32, P133; Hassiotis A, 2008, J INTELL DISABIL RES, V52, P95, DOI 10.1111/j.1365-2788.2007.01001.; Jalili Z, 2016, ACTA MEDICA MEDITERR, V32, P91; Katirci Y, 2013, ACTA MEDICA MEDITERR, V29, P71; Messina A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.0006; Messina G, 2016, J BASIC CLIN PH 0926, DOI 10.1515/jbcpp-2015-013; Messina G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.0099; Mirzaei-Alavijeh M, 2016, ACTA MEDICA MEDITERR, V32, P101; Moscatelli F, 2016, NEUROL SCI      082; Pasquali D, 2015, ENDOCRINE, V50, P797, DOI 10.1007/s12020-015-0564-; Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S5897; Shams S, 2016, ACTA MEDICA MEDITERR, V32, P155; Verrotti A, 2015, J NEUROL, V262, P116, DOI 10.1007/s00415-014-7542-; Yongli Z, 2016, ACTA MEDICA MEDITERR, V32, P117",48,47,47,2,10,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1761.0,1765,,10.19193/0393-6384_2016_6_160,,5,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300004,,,,,2022-07-14,0.0043388429752066115,0.045367814346014015,0.22998729276404398,0.12645164661467517,0.23270656235842654
J,"Raluca, P1;  Aurelia, R;  Marian, P;  Bacarea, A",,,,"Raluca, Pop; Aurelia, Romila; Marian, Pop; Bacarea, Anca",,,METABOLIC DISTURBANCES IN ABDOMINAL OBESITY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,waist circumference; metabolic disturbance; metabolically healthy obese,PROVISIONAL REPORT; PARAMETERS; MORTALITY,"Introduction: Increased waist circumference is an independent risk factor for cardio-vascular complications and mortality and current studies focus on describing the factors involved in its etiology and pathogeny. The objective of this study was to analyze all components of the metabolic syndrome in subjects with increased waist circumference, with the hypothesis that even in normal weighted apparently healthy subjects the metabolic profile is already modified. Materials and methods: A cross-sectional study was conducted between February 2013 and April 2014. The sample consisted of 266 consecutive patients presenting to the Endocrinology Outpatient Clinic of the Emergency Mures County Hospital for consultation who signed the informed consent. Inclusion criteria - waist circumference above 80cm for females and >94cm for males. Exclusion criteria - secondary causes of increased abdominal circumference: pregnancy, generalized edema, endocrine causes: untreated hypo-or hyperthyroidism, Cushing syndrome, medications that could lead to weight gain/loss, weight losing diet and refusal to participate. For all patients, height, weight, waist circumference and blood pressure were measured by the same person. Venous blood samples were taken for determination of fasting blood glucose, triglycerides and HDL cholesterol. Microsoft Office Excel was used for data collection and GraphPad Prism v. 5 for statistical analysis, with a level of significance alpha=0.05. Results: Mean age of the sample was 51 +/- 12.7 years with a median of 53 years and a sex ratio F:M of 8.1:1. The normal weighted subjects had a high prevalence of associated disturbances (34.41% hypertriglyceridemia, 37.63% low HDL cholesterol, 29.03% increased blood glucose and 44.09% hypertension). Metabolically healthy obese represented 17.29% (n=46) of the sample. When comparing the metabolically healthy subjects with abdominal obesity to the metabolically unhealthy subjects, the former are younger (41.4 vs. 53.1 years, p<0.0001), thinner (BMI 28.7 vs. 32.5 kg/sqm, p<0.0001) and with significantly smaller differences of the waist compared to the IDF cut-offs (11 vs. 20.2cm, p<0.0001). Conclusions: Waist circumference is an important clinical parameter which correlates with all the elements of the metabolic syndrome. Increased waist circumference should elicit metabolical evaluation and lifestyle modifications.","[Raluca, Pop] Univ Med & Pharm Tirgu Mures, Med Res Methodol Dept, Targu Mures, Romania; [Raluca, Pop] Univ Dunarea De Jos, Endocrinol Outpatient Clin, Emergency Mures Cty Hosp, Fac Med,Clin Med Dept 3, Galati, Romania; [Aurelia, Romila] Univ Med & Pharm Tirgu Mures, Clin Geriatr Dept, Galati Cty Hosp Emergency, Targu Mures, Romania; [Marian, Pop] Univ Med & Pharm Tirgu Mures, Targu Mures, Romania; [Bacarea, Anca] Univ Med & Pharm Tirgu Mures, Dept Pathophysiol, Targu Mures, Romania","Aurelia, R (corresponding author), Univ Dunarea De Jos, Dept Clin Med, Fac Med, Galati 1,Vadu Sacalelor St,Bl Pescarus,Ap 8, Galati, Romania.",,"Pop, Raluca/AAS-7928-2020; Pop, Marian/S-5302-2019; Bacarea, Anca/AAW-9459-2020","Pop, Marian/0000-0001-5324-9780; Pop, Raluca/0000-0003-1243-1855; Pop, Raluca-Monica/0000-0003-1775-4469",University of Medicine and Pharmacy of Tirgu Mures [5/23.12.2014],This project was supported in part by University of Medicine and Pharmacy of Tirgu Mures through Internal Research Grant 5/23.12.2014,"Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.19264; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-; Balkau B, 1999, DIABETIC MED, V16, P44; Berezina A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/54873; Carey DGP, 1996, INT J OBESITY, V20, P72; Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.6; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.248; Demirbas B, 2016, ACTA MEDICA MEDITERR, V32, P4; Grundy SM, 2015, EUR J CLIN INVEST, V45, P1209, DOI 10.1111/eci.1251; Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu12; Hwang YC, 2015, INT J OBESITY, V39, P1365, DOI 10.1038/ijo.2015.7; Janssen I, 2004, AM J CLIN NUTR, V79, P37; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-048; Munoz-Garach A, 2016, NUTRIENTS, V8, DOI 10.3390/nu806032; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.007618; Premanath M, 2014, Indian J Endocrinol Metab, V18, P676, DOI 10.4103/2230-8210.13923; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.159; Rocha FL, 2013, REV ASSOC MED BRAS, V59, P48, DOI 10.1590/S0104-4230201300010001; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp32; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.69; World Health Organization, 2011, WAIST CIRC WAIST HI; Yu Y, 2012, OBESITY, V20, P904, DOI 10.1038/oby.2011.30; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt17",23,0,0,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1821.0,1825,,10.19193/0393-6384_2016_6_169,,5,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300013,,,,,2022-07-14,0.0024793388429752063,4.0408519452906773e-08,0.08337888427798203,0.13183161507347432,0.08018072919418888
J,"Refahi, S1;  Kachooei, AR;  Farsadpour, M;  Shahrayeni, R;  Goudarzian, M;  Taleghani, YM;  Foji, S;  Amiri, P;  Malekkahi, A;  Salari, M;  Vejdani, M",,,,"Refahi, Soheila; Kachooei, Amir Reza; Farsadpour, Majid; Shahrayeni, Ramin; Goudarzian, Maryam; Taleghani, Yasamin Molavi; Foji, Samira; Amiri, Parastoo; Malekkahi, Akram; Salari, Mozhdeh; Vejdani, Marjan",,,IS PRESCRIPTION OF KNEE MRI ACCORDING TO STANDARD CLINICAL GUIDELINE?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,appropriateness; MRI; knee; hospital,APPROPRIATENESS; DIFFUSION; QUALITY; COST,"Introduction: Knee pain is one of the most common complaints that caused patients visit their physician. Among all medical imaging technologies; using Magnetic Resonance Imaging (MRI) is significant. The aim of this study was to determine the appropriateness of knee MRI prescription in Sabzevar Vasei hospital in 2014. Materials and methods: This study is descriptive and analytic, while the statistical population included 115 patients referred to MRI Unit in Sabzevar Vasei hospital, while they were selected randomly. A questionnaire was used for data collection and to determine the appropriateness of prescription; a local clinical guideline was used as well. Data analysis was done by using SPSS16, descriptive statistics, Spearman test, Pearson chi-square and Fisher exact tests. Results: Among 115 prescribed knee MRI patients, 52 prescriptions (45.2%) were inappropriate, 2 prescriptions (1.7%) were uncertain and 61 prescriptions (53%) were considered appropriate. The financial burden arising from inappropriate prescriptions was 39204000 Rials. Besides, there is a significant difference between the appropriate prescriptions and patients' gender, occupation, education, the specialty of a prescriber physician as well as referral institution (P < 0.05). Conclusion: Considering the high rate of inappropriate prescriptions, it is essential to find some reasons and to do continuous monitoring. The use of local clinical guidelines can improve the quality of the health system and avoid additional costs.","[Refahi, Soheila] Ardabil Univ Med Sci, Ardebil, Iran; [Kachooei, Amir Reza] Mashhad Univ Med Sci, Mashhad, Iran; [Farsadpour, Majid; Shahrayeni, Ramin; Foji, Samira; Malekkahi, Akram; Salari, Mozhdeh] Sabzevar Univ Med Sci, Sabzevar, Iran; [Goudarzian, Maryam; Amiri, Parastoo] Sabzevar Univ Med Sci, Iranian Res Ctr Hlth Aging, Sabzevar, Iran; [Taleghani, Yasamin Molavi] Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran; [Vejdani, Marjan] Sabzevar Univ Med Sci, Sch Med, Sabzevar, Iran","Vejdani, M (corresponding author), Sabzevar Univ Med Sci, Sch Med, Sabzevar, Iran.",marjan_vejdani@yahoo.com,"Kachooei, Amir/H-3186-2019; refahi, soheila/R-6915-2017","Kachooei, Amir/0000-0001-7795-1830; Refahi, Soheila/0000-0002-7973-647X; Vejdani, Marjan/0000-0002-8683-4916; Amiri, Parastoo/0000-0002-3085-8652; Shahraini, Ramin/0000-0002-3854-7429",,,"Abedi G, 2012, INT J COLLAB RES INT, V4, P180; Abedi G, 2012, INT J COLLAB RES INT, V4, P10; Alam NR, 2004, J MAZANDARAN U MED S, V1; Barzin M, 2012, J GORGAN U MED SCI, V1; Borowitz M, 1993, Health Econ, V2, P201, DOI 10.1002/hec.473002030; Chevalier Xavier, 2009, Rev Prat, V59, P124; Ebrahimipour H, 2015, HAKIM RES J, V1; Ebrahimipour H, 2014, ARCH BONE JT SURG-AB, V2, P4; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-0000; Fuchs VR, 2001, HEALTH AFFAIR, V20, P30, DOI 10.1377/hlthaff.20.5.3; Greenberg D, 2005, INT J TECHNOL ASSESS, V21, P219, DOI 10.1017/S026646230505029; Hamedi M, 2008, WHY IS DETERIORATIN; HICKS NR, 1994, BRIT MED J, V309, P730, DOI 10.1136/bmj.309.6956.73; HILLMAN AL, 1986, AM J ROENTGENOL, V146, P963, DOI 10.2214/ajr.146.5.96; Karami I., 2005, HEALTH ECON, P1; Keshtkaran A, 2011, EVALUATION APPROPRI; Kistka HM, 2015, J NEUROL SURG PART B, V76, P344, DOI 10.1055/s-0035-154930; Lee JY, 2014, J KOREAN MED SCI, V29, P1590, DOI 10.3346/jkms.2014.29.12.159; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.01; Marzban Sima, 2015, Electron Physician, V7, P1183, DOI 10.14661/2015.1183-118; Neisi K, 2006, J SCI MED, V; News IR., 2013, ADM UNNECESSARY ME; Nicollier-Fahrni A, 2003, INT J QUAL HEALTH C, V15, P15, DOI 10.1093/intqhc/15.1.1; Noureddine Y, 2015, MAGMA NEW YORK N; OC S, 2015, J SCI MED SPOR; Oh EH, 2005, INT J TECHNOL ASSESS, V21, P73, DOI 10.1017/S026646230505009; Palesh M, 2008, INT J TECHNOL ASSESS, V24, P452, DOI 10.1017/S026646230808059; Passariello R, 1997, Eur Radiol, V7 Suppl 5, P25; PHELPS CE, 1993, NEW ENGL J MED, V329, P1241, DOI 10.1056/NEJM19931021329170; Rezaei Y, 2007, TUMJ, V65, P4; Salari H, 2013, INT J HEALTH POLICY, V1, P17, DOI 10.15171/ijhpm.2013.0; Shukla J, 2015, INDIAN J NUCL MED, V30, P295, DOI 10.4103/0972-3919.16401; Vincenzino J V, 1991, Stat Bull Metrop Insur Co, V72, P; Xie L, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0716-; Yazdani S, 2002, J OPHTHALMOLOGY BINA, V",35,4,4,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1207.0,1211,,,,5,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200004,,,,,2022-07-14,0.003615702479338843,1.1723589096944107e-11,0.01576582026152442,0.10620439958308191,0.016971597783594347
J,"Ruberto, M31;   Precenzano, F;   Parisi, L;   Salerno, M;   Maltese, A;   Messina, G;   Roccella, M",,,,"Ruberto, Maria; Precenzano, Francesco; Parisi, Lucia; Salerno, Margherita; Maltese, Agata; Messina, Giovanni; Roccella, Michele",,,VISUOMOTOR INTEGRATION SKILLS IN CHILDREN AFFECTED BY OBSTRUCTIVE SLEEP APNEA SYNDROME: A CASE-CONTROL STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,obstructive sleep apnea syndrome; OSA; visual-motor integration; visual-motor training skills,PRIMARY NOCTURNAL ENURESIS; IDIOPATHIC EPILEPSY; CHILDHOOD MIGRAINE; AURA; MULTICENTER; ADOLESCENTS; DISORDERS; SYMPTOMS; HEADACHE; DISEASE,"Introduction: Sleep related breathing disorders (SRBD) consist of frequent and repetitive episodes of pharyngeal obstruction during sleep, with consequent intermittent hypoxia, sleep architecture fragmentation, daytime sleepiness and/or behavioural problems and executive impairment in children. When untreated, SRBD and obstructive sleep apnea syndrome (OSA) mainly, may impact school performance, cognition, metabolism, and cardiovascular function. Aim of the present study is assessing the visuomotor integration skills in children affected by OSA. Materials and methods: 57 subjects affected by mild-to severe OSA, PSG diagnosed according to international diagnostic criteria, (31 males and 26 females) (mean age 10.8; SD +/- 2.49) and 83 healthy children (45 males and 38 females) (mean age 9.95; SD +/- 1.87; p = 0.725). All subjects underwent assessment of motor coordination skills with Movement-ABC tests and visual-motor integration ability with Visual Motor Integration (VMI) test. Results: The subjects with OSA show a worse average performances in all items of Movement ABC (p < 0.001) respect of controls. Specifically, children with OSAS show significantly higher values of total points (p < 0.001), manual dexterity (p < 0.001), ball skills (p < 0.001) and balance (p < 0.001). Accordingly, the average centile in OSA children at the MABC-test is significantly reduced compared with controls (p < 0.001). (Table 1) On the other hand, the VMI test evaluation among children with OSAS shows worst result in total Visuo-Motor Integration (p < 0.001), and in Motor Coordination sub-item (p < 0.001) than controls. (Table 1). Conclusion: Our results also support for children and adolescents the hypothesis that executive functioning deficits might be linked primarily to the degree of severity nocturnal hypoxemia rather than daytime sleepiness, although several other studies are needed.","[Ruberto, Maria] Univ Naples 2, Dept Mental Hlth & Phys Med & Prevented, Headache Ctr Children & Adolescents, Clin Child & Adolescent Neuropsychiat, Naples, Italy; [Precenzano, Francesco] Univ Naples 2, Dept Med Surg & Dent Specialties, Naples, Italy; [Parisi, Lucia; Maltese, Agata; Roccella, Michele] Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy; [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, I-90133 Palermo, Italy; [Messina, Giovanni] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Messina, Giovanni] Univ Naples 2, Dept Expt Med, Naples, Italy","Roccella, M (corresponding author), Univ Palermo, Dept Psychol Pedag & Educ Sci, I-90133 Palermo, Italy.",,"Messina, Giovanni/AAE-8668-2022","Messina, Giovanni/0000-0002-0011-867X; Precenzano, Francesco/0000-0002-3812-1786",,,"Balottin U, 2007, EXPERT OPIN PHARMACO, V8, P731, DOI 10.1517/14656566.8.6.73; Balottin U, 2013, CEPHALALGIA, V33, P112, DOI 10.1177/033310241246838; Balottin U, 2011, MED HYPOTHESES, V76, P778, DOI 10.1016/j.mehy.2011.02.01; Beery KE, 2004, BEERY BUKTENICA DEV, V; Blechner M, 2016, CURR PROB PEDIATR AD, V46, P19, DOI 10.1016/j.cppeds.2015.10.00; Borgatti R, 2004, J CHILD NEUROL, V19, P509, DOI 10.1177/0883073804019007060; Calderoni S, 2013, J CLIN EXP NEUROPSYC, V35, P167, DOI 10.1080/13803395.2012.76053; Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.1347; Carotenuto M, 2011, MINERVA PEDIATR, V63, P10; Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.00; Carotenuto M, 2009, J ENDOCRINOL INVEST, V32, P752, DOI [10.1007/BF03346531, 10.3275/6398; Carotenuto M, 2014, EPILEPSY BEHAV, V35, P50, DOI 10.1016/j.yebeh.2014.03.00; Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.02; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-; Carotenuto M, 2012, NEUROPSYCH DIS TREAT, V8, P369, DOI [10.2147/NDT.S35974, 10.2147/NDT.535974; Carotenuto M, 2011, SLEEP BREATH, V15, P221, DOI 10.1007/s11325-010-0388-; Cavanna AE, 2013, BEHAV NEUROL, V27, P83, DOI [10.3233/BEN-120296, 10.1155/2013/732038; Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.1203; Esposito M, 2011, MINERVA PEDIATR, V63, P9; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S5271; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1433, DOI 10.2147/NDT.S5125; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S5155; Esposito Maria, 2013, Neuropsychiatr Dis Treat, V9, P1087, DOI 10.2147/NDT.S4728; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S5045; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S4936; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S4677; Esposito M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-5; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P437, DOI [10.2147/NDT.543673, 10.2147/NDT.S43673; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S4218; Esposito M, 2012, NEUROPSYCH DIS TREAT, V8, P509, DOI 10.2147/NDT.S3686; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-; Esposito M, 2010, NEUROSCI LETT, V485, P89, DOI 10.1016/j.neulet.2010.08.06; Gozal David, 2012, Front Biosci (Elite Ed), V4, P241; Henderson S. E., 1992, MOVEMENT ASSESSMEN; Piccinelli P, 2010, SEIZURE-EUR J EPILEP, V19, P540, DOI 10.1016/j.seizure.2010.07.01; Salorio CF, 2002, J CLIN EXP NEUROPSYC, V24, P93, DOI 10.1076/jcen.24.1.93.97; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.1227; Tummala S, 2016, J NEUROSCI RES, V94, P915, DOI 10.1002/jnr.2378; Verrotti A, 2015, PEDIATR OBES, V10, P220, DOI 10.1111/ijpo.24",39,20,20,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_146,,5,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000017,,,,,2022-07-14,0.003305785123966942,0.042727406037756134,0.002588716055677234,0.11062225015713388,0.0025752116488220373
J,"Sadeghi, E1;  Shabani, M;  Mahmoodi, M;  Asadi, F;  Sharafi, K;  Mirzaei, N;  Mohammadi, G",,,,"Sadeghi, Ehsan; Shabani, Maryam; Mahmoodi, Majid; Asadi, Fateme; Sharafi, Kiomars; Mirzaei, Nezam; Mohammadi, Ghobad",,,EVALUATION OF ZEARALENONE MYCOTOXIN IN EDIBLE OILS DISTRIBUTED IN KERMAN-SHAH CITY BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Edible Oil; Zearalenone mycotoxin; HPLC,ESTROGENIC MYCOTOXIN; FUSARIUM-WILT; TOXICITY; RISK,"Introduction: Zearalenone as mycoestrogen find in human food and animal food. Estrogenic properties depending on the Biotransformation level, in this regard, there are some reports of food contamination by mycotoxins such as ZEA. This study has investigated ZEA mycotoxin in edible oils. Materials and methods: 104 random samples of 8 different brands edible oil (corn, sunflower, mix) collected and evaluated from Kermanshah stores in 2013. Determination of ZEA levels was done by using high performance liquid chromatography and fluorescence detector. Detection and quantification was limits of the method and order of micrograms per kilogram. Results: Zearalenone levels in all samples was positive and samples levels was less than the limit specified by the Standards and Industrial Research Institute of Iran. The minimum and maximum ZEA mycotoxin, respectively, with a sunflower oil average 2.67 mu g/kg Bw and E brand of corn oil with average was 70.78 mu g/kg Bw. results of ANOVA significant contamination of corn oil, sunflower and blend oil (P 0.001). Conclusion: Due to the increased levels of ZEA in corn oil liquid than other oils tested and on the other hand, the consumption of food contaminated with mycotoxins Fungal toxins receive provisional tolerable daily intake is much higher than Expert Committee on Food Additives of the FAO /WHO determined therefore, prevention of mycotoxin contamination ours to control pre-and post-harvest And consideration of relevant experiences and practices is essential to a great extent.","[Sadeghi, Ehsan] Kermanshah Univ Med Sci, Res Ctr Environm Determinants Hlth RCEDH, Kermanshah, Iran; [Shabani, Maryam] Kermanshah Univ Med Sci, Food & Drug, Food Chem, Kermanshah, Iran; [Mahmoodi, Majid] Kermanshah Univ Med Sci, Food & Drug, Kermanshah, Iran; [Sharafi, Kiomars] Kermanshah Univ Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Kermanshah, Iran; [Sharafi, Kiomars; Mirzaei, Nezam] Univ Tehran Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Tehran, Iran; [Mirzaei, Nezam] Hormozgan Univ Med Sci, Social Determinants Hlth Promot Res Ctr, Bandar Abbas, Iran; [Mohammadi, Ghobad] Kermanshah Univ Med Sci, Sch Pharm, Kermanshah, Iran",,f_asadi56@yahoo.com,"Mirzaei, Nezam/G-3232-2017; Sadeghi, Ehsan/S-2246-2017; Asadi, Fateme/Q-8256-2019; Sharafi, Kiomars/CAF-0682-2022; Mohammadi, Ghobad/S-2374-2017","Mirzaei, Nezam/0000-0003-4779-1519; Sadeghi, Ehsan/0000-0002-1096-2380",,,"Abadie C, 1998, SOIL BIOL BIOCHEM, V30, P643, DOI 10.1016/S0038-0717(97)00154-; ABBAS HK, 1988, CEREAL CHEM, V65, P1; Alstrom S, 2000, J PHYTOPATHOL, V148, P417, DOI 10.1046/j.1439-0434.2000.00511.; Altomare D.F., 2007, NUTR THERAPY METABOL, V25, P8, DOI DOI 10.3390/IJERPH1406063; ETIENNE M, 1982, J ANIM SCI, V55, P; FAO/WHO, 2000, WHO FOOD ADDITIVES S, V4; Gromadzka K, 2008, WORLD MYCOTOXIN J, V1, P209, DOI 10.3920/WMJ2008.x01; Institute of Medicine, 2005, DIET REF INT EN CAR; Jakobsen MU, 2004, AM J EPIDEMIOL, V160, P141, DOI 10.1093/aje/kwh19; JIMENEZ M, 1991, MYCOPATHOLOGIA, V115, P121, DOI 10.1007/BF0043680; Kappenstein O, 2005, Mycotoxin Res, V21, P3, DOI 10.1007/BF0295480; Koppen R, 2012, J AGR FOOD CHEM, V60, P11733, DOI 10.1021/jf303777; Kroes GMLW, 1999, PLANT PATHOL, V48, P491, DOI 10.1046/j.1365-3059.1999.00359.; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-; Lauren DR, 1997, FOOD ADDIT CONTAM, V14, P435, DOI 10.1080/0265203970937454; Majerus Paul, 2009, Mycotoxin Res, V25, P117, DOI 10.1007/s12550-009-0018-; Marasas WFO, 1984, TOXIGENIC FUSARIUM ; Massart F, 2010, INT J ANDROL, V33, P369, DOI 10.1111/j.1365-2605.2009.01009.; Oskoii S Bohlouli, 2013, IRAN OCCUPATIONAL HL, V10, P9; Pacin AM, 2003, MYCOPATHOLOGIA, V156, P87, DOI 10.1023/A:102294130444; PRELUSKY DB, 1994, TOXICOLOGY MYCOTOXIN, P35; Rafai P, 2000, FOOD ADDIT CONTAM A, V17, P799, DOI 10.1080/02652030041535; Sadeghi E, 2015, BULG CHEM COMMUN, V47, P22; Sadeghi E., 2014, IRAN OCCUP HLTH, V11, P9; Sastry RK, 2003, EUR J PLANT PATHOL, V109, P147, DOI 10.1023/A:102250261888; Schollen berger M, 2005, INT J FOOD MICROBIOL, V97, P31; Schollenberger M, 2006, MYCOPATHOLOGIA, V161, P43, DOI 10.1007/s11046-005-0199-; Schollenberger M, 2008, FOOD CONTROL, V19, P475, DOI 10.1016/j.foodcont.2007.05.01; Scott PM, 1997, FOOD ADDIT CONTAM, V14, P333, DOI 10.1080/0265203970937453; Siegel D, 2010, J CHROMATOGR A, V1217, P2206, DOI 10.1016/j.chroma.2010.02.01; Torres villa L M, 2003, GRASAS A CEITES, V54, P28; Tournas VH, 2005, INT J FOOD MICROBIOL, V105, P11, DOI 10.1016/j.ijfoodmicro.2005.05.00; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.03",33,1,1,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1457.0,1462,,,,6,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200025,,,,,2022-07-14,0.003409090909090909,1.523911561662806e-14,0.006395043286180613,0.08582092860372541,0.006395043286180613
J,"Sadeghi, E21;   Barkhordar, S;   Mohammadi, G;   Moradi, M;   Asadi, F;   Nesari, S;   Sharafi, K",,,,"Sadeghi, Ehsan; Barkhordar, Sodabeh; Mohammadi, Ghobad; Moradi, Masoud; Asadi, Fateme; Nesari, Shiva; Sharafi, Kiomars",,,DETERMINATION OF ZEARALENONE LEVELS IN CONSUMED RICE SAMPLES IN IRAN BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (2015),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Zearalenone; Rice; HPLC,OCHRATOXIN; METABOLISM; MYCOTOXINS; TOXICITY; FOOD,"Aflatoxin, Fumonisin, Zearalenone and Ochratoxins as mycotoxins afford the carcinogenic, nephrotoxicity, estrogenic problems especially kidney and liver cancer in human and animal. Rice and wheat is important foodstuff that used as feed for world's population. Considering the high rate consumption of rice and its derivatives in human diet, this study was to evaluate the Zearalenone levels in consumed rice samples in Kermanshah city by High Performance Liquid Chromatography. For this aim, 42 samples rice randomly selected from 10 Iranian and 4 imported brands from different parts of city. Results revealed that all samples were contaminated to zearalenone and the zearalenone average in Iranian and imported rice were 4.43 and 3.88 mu g/kg respectively. Given the zearalenone risks for human health, it is recommended the control of zearalenone production during harvesting, preserving, and storage of rice. Therefore, implementing health regulation and monitoring their enforcement, determine the maximum allowable amount of mycotoxins in food and attention of public health andnourishment specialists to this issues is most important.","[Sadeghi, Ehsan; Moradi, Masoud; Sharafi, Kiomars] Kermanshah Univ Med Sci, RCEDH, Sch Publ Hlth, Kermanshah, Iran; [Barkhordar, Sodabeh; Mohammadi, Ghobad] Kermanshah Univ Med Sci, Food & Drugs Affairs, Kermanshah, Iran; [Asadi, Fateme; Nesari, Shiva] Kermanshah Univ Med Sci, Sch Publ Hlth, Dept Environm Engn, Kermanshah, Iran; [Sharafi, Kiomars] Univ Tehran Med Sci, Sch Publ Hlth, Dept Environm Engn, Tehran, Iran","Asadi, F (corresponding author), Kermanshah Univ Med Sci, Publ HealthSchool, Dolat Abad,Isar Sq, Kermanshah, Iran.",f_asadi56@yahoo.com,"Asadmasjedi, Nooshin/D-7677-2018; Sharafi, Kiomars/CAF-0682-2022; Asadi, Fateme/Q-8256-2019; Moradi, Masoud/AAF-2174-2020; Mohammadi, Ghobad/S-2374-2017; Sadeghi, Ehsan/S-2246-2017","Moradi, Masoud/0000-0003-2036-5333; Sadeghi, Ehsan/0000-0002-1096-2380",,,"Azizi J, 2002, AGR DEV, V10, P10; Azizi J, 2004, AGR SCI ISLAMIC AZAD, V12, P71; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-; Ibanez-Vea M, 2011, FOOD CONTROL, V22, P1949, DOI 10.1016/j.foodcont.2011.05.00; Marasas WFO, 1984, TOXIGENIC FUSARIUM ; Musaiger AO, 2008, FOOD CONTROL, V19, P854, DOI 10.1016/j.foodcont.2007.08.01; Nguyen MT, 2007, FOOD CHEM, V105, P42, DOI 10.1016/j.foodchem.2007.03.04; Nori K, 2006, PAJOUHESH SAZANDEGI, P1; Nuryono N, 2005, FOOD CONTROL, V16, P65, DOI 10.1016/j.foodcont.2003.11.00; Pitt JI, 2000, MED MYCOL, V38, P17, DOI 10.1080/mmy.38.s1.17.2; Reddy KRN, 2009, PESTIC BIOCHEM PHYS, V93, P53, DOI 10.1016/j.pestbp.2008.11.00; Rezazadeh A, 2013, J PARAMEDICAL SCI, V; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.04; Sharafi K, 2015, J SEP SCI, V38, P1010, DOI 10.1002/jssc.20140120; Sifou A, 2011, FOOD CONTROL, V22, P1826, DOI 10.1016/j.foodcont.2011.04.01; SOARES LMV, 1989, J ASSOC OFF ANA CHEM, V72, P2; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.03; [No title captured",18,3,3,0,6,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,5.0,,1945.0,1949,,,,5,"Medicine, General & Internal",General & Internal Medicine,EI1YW,WOS:000392283800005,,,,,2022-07-14,0.001859504132231405,1.2112329286029793e-11,0.010086898960773047,0.10345970095016192,0.010086898960773047
J,"Salehi, N21;   Azam, H;   Bahremand, M",,,,"Salehi, Nahid; Azam, Hossein; Bahremand, Mostafa",,,"RELATIONSHIP BETWEEN NEUTROPHIL-TO-LYMPHOCYTE RATIO AND NUMBER OF DISEASED CORONARY ARTERIES IN PATIENTS UNDERWENT CORONARY ANGIOGRAPHY IN IMAM ALI HOSPITAL, KERMANSHAH, IRAN, 2012-14",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Neutrophil-to-lymphocyte ratio (NLR); coronary artery disease; angiography,BLOOD-CELL COUNT; EOSINOPHIL COUNT; SEVERITY; OUTCOMES; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATION,"Neutrophil-to-lymphocyte ratio (NLR) has been noted recently as a prognostic factor in patients with cardiovascular diseases. The present study was done to find any relationship between NLR and number of diseased coronary arteries in patients underwent coronary angiography in Imam Ali University Hospital of Kermanshah, Iran between 2012 and 2014. In this retrospective study, medical records of 1,498 patients who underwent coronary angiography were reviewed. The data extracted were entered into a checklist. NLR was calculated using complete blood count (CBC) reports and the number of diseased coronary arteries was determined using coronary angiography reports. The data were analyzed using SPSS software (ver. 20.0) by analysis of variance (ANOVA), t test, Kruskal-Wallis, and Pearson correlation tests. There were significant (P<0.05) relationships between NLR, history of cardiovascular diseases, diabetes mellitus, hypertension, left ventricular ejection fraction (LVEF), fasting blood sugar, serum creatinine and urea, white blood cell (WBC) count, hemoglobin, platelet count, MCV (mean corpuscular volume), and with the number of diseased coronary arteries detected on coronary angiography. However, there was no significant relationship (P>0.05) between history of hyperlipidemia, cigarette smoking, alcohol drinking, type of cardiac chest pain (acute or chronic), serum total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein), and triglyceride with the number of diseased coronary arteries. NLR was effective on the number of diseased coronary arteries (i.e., the severity of disease). Application of this laboratory factor can be helpful in patients with ischemic heart disease.","[Salehi, Nahid; Bahremand, Mostafa] Kermanshah Univ Med Sci, Cardiol Dept, Sch Med, Kermanshah, Iran; [Azam, Hossein] Kermanshah Univ Med Sci, Kermanshah, Iran","Bahremand, M (corresponding author), Kermanshah Univ Med Sci, Cardiol Dept, Sch Med, Kermanshah, Iran.",dr-bahremand@kums.ac.ir,"Salehi, Nahid/S-5521-2017","Salehi, Nahid/0000-0002-4757-6336; Bahremand, Mostafa/0000-0002-3076-7398",,,"Abel p wakai, 2011, BMJ CLIN EVID, V201; An X, INTUROL NEPHROL, V25, P12; Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.00; Ates AH, 2011, CARDIOL J, V18, P37; Cho KH, 2011, AM J CARDIOL, V107, P849, DOI 10.1016/j.amjcard.2010.10.06; Demir Mehmet, 2014, EVALUATION PLASMA EO, V69, P32; Dogan M, 2015, CLIN APPL THROMB-HEM, V21, P25, DOI 10.1177/107602961348893; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-009; Home BD, 2008, AM J CARDIOL, V102, P814, DOI 10.1016/j.amjcard.2008.05.02; Karagoz A, 2015, EUR REV MED PHARMACO, V19, P43; Kaya H, 2014, CLIN APPL THROMB-HEM, V20, P50, DOI 10.1177/107602961245211; Kuklina Elena V, 1999, PREVALENCE CORONARY, V8, P32; Lee S, 2011, J EPIDEMIOL, V21, P161, DOI 10.2188/jea.JE2010012; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.00; Madjid M, 2013, TEX HEART I J, V40, P1; Nilsson L, 2014, NEUTROPHIL LYMPHOCYT, V; Nunez J, 2005, REV ESP CARDIOL, V58, P631, DOI 10.1016/S1885-5857(06)60249-; Okyay GU, 2013, RENAL FAILURE, V35, P29, DOI 10.3109/0886022X.2012.73442; Ozgehan G, 2014, TURK J MED SCI, V20, P10; Pitsavos Christos, 2007, Rev Diabet Stud, V4, P98, DOI 10.1900/RDS.2007.4.9; Sari I, 2015, KARDIOL POL, V73, P1310, DOI 10.5603/KP.a2015.009; Sonmez O, 2013, ANATOL J CARDIOL, V13, P662, DOI 10.5152/akd.2013.18; Suliman MARM, 2010, ARCH MED RES, V41, P618, DOI 10.1016/j.arcmed.2010.11.00; Sunbul M, 2014, CLIN EXP HYPERTENS, V36, P217, DOI 10.3109/10641963.2013.80454; Swirta JS, 2015, CARDIOL POL, V73, P44; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.00; Tanaka M, 2012, HYPERTENS RES, V35, P325, DOI 10.1038/hr.2011.19; Toor IS, 2012, THROMB RES, V130, P607, DOI 10.1016/j.thromres.2012.05.03; Twig G, 2012, WHITE BLOOD CELL COU, V; Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.03",30,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,2.0,,947.0,952,,,,6,"Medicine, General & Internal",General & Internal Medicine,EF2SU,WOS:000390175400015,,,,,2022-07-14,0.0030991735537190084,2.302253399988036e-16,0.005219329557906278,0.085386399922376,0.005314243731072487
J,"San, I1;  Icme, F;  Yuzbasioglu, Y;  Otal, Y;  Coskun, S;  Sener, A;  Kahraman, AF;  Erol, E",,,,"San, Ishak; Icme, Ferhat; Yuzbasioglu, Yucel; Otal, Yavuz; Coskun, Selcuk; Sener, Alp; Kahraman, Ahmet Fatih; Erol, Erkut",,,"THE PROGNOSTIC RELATIONSHIP BETWEEN COMPLETE BLOOD COUNT PARAMETERS AND INFARCT-POSITIVE TRANSIENT ISCHEMIC ATTACK, INFARCT-NEGATIVE TRANSIENT ISCHEMIC ATTACK, AND ISCHEMIC STROKE",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Cerebral infarction; transient ischemic attack; blood cell count parameters; diagnosis,MEAN PLATELET VOLUME; NEUTROPHIL-LYMPHOCYTE RATIO; CELL COUNT; ELEVATED NEUTROPHIL; PREDICTIVE-VALUE; MORTALITY; RISK; INDEXES; DISEASE,"Introduction: Stroke is an important health problem that may lead to serious disabilities or even to death. In the present study we aimed to investigate whether complete blood count parameters can aid in the detection and the differential diagnosis of infarct positive Transient Ischemic Attack (TIA), infarct-negative TIA, and ischemic stroke (IS) in patient followed up in the emergency department. Materials and methods: This study retrospectively reviewed the medical records of 252 patients meeting the medical history and physical examination criteria for TIA (n=99) and IS (n=153) Neutrophil, lymphocyte, and platelet counts, platelet distribution width (PDW), and mean platelet volume (MPV) levels obtained from the complete blood count taken at the time of emergency department admission were recorded for both patient and control groups; platelet/lymphocyte ratio (PLR) and neutrophil/lymphocyte ratio (NLR) were calculated from these parameters. The ischemic stroke, TIA, and control groups, as well as other subgroups were compared with one another with respect to the complete blood count parameters. Results: Neutrophil count, MPV, and NLR levels were higher in the IS group compared to the control group whereas IS group had a lower lymphocyte count, platelet count, and a PDW level compared to the control group. TIA group had a higher neutrophil count, NLR and PLR than the control group whereas lymphocyte count and PDW level were lower in the TIA group compared to the control group. MPV level was higher in the IS and infarct-positive TIA patient group than both the control group and infarct-negative TIA patient group. Conclusion: Owing to high MPV levels in both infarct-positive TIA and IS, we suggest that MPV can be a good marker for infarction. Furthermore, lower platelet count in the IS group and higher PLR in the TIA group can both be used in the differential diagnosis of both conditions.","[San, Ishak] Golbasi Hasvak State Hosp, Dept Emergency Med, Ankara, Turkey; [Icme, Ferhat; Yuzbasioglu, Yucel; Otal, Yavuz; Coskun, Selcuk; Sener, Alp] Ataturk Educ & Res Hosp, Dept Emergency Med, Ankara, Turkey; [Erol, Erkut] Elazig Educ & Res Hosp, Dept Emergency Med, Elazig, Turkey; [Kahraman, Ahmet Fatih] Bozok Univ, Fak Med, Dept Emergency Med, Zonguldak, Turkey","Icme, F (corresponding author), Ankara Ataturk Training & Res Hosp, Clin Emergency Med, TR-06800 Ankara, Turkey.;Icme, F (corresponding author), Ataturk Egitim & Arasurma Hastanesi, Acil Serv, Eskisehir Yolu 2 Km, Ankara, Turkey.",,"Åan, Ä°shak/AAG-2175-2019; Otal, Yavuz/AAA-1140-2022; DOGAN, NURETTIN OZGUR/G-1461-2018; Ä°ÃME, DoÃ§. Dr. Ferhat/F-7739-2013","Åan, Ä°shak/0000-0002-9658-9010; DOGAN, NURETTIN OZGUR/0000-0002-5209-8076; Ä°ÃME, DoÃ§. Dr. Ferhat/0000-0001-5180-7152; SENER, ALP/0000-0002-0583-2936; Yuzbasioglu, Yucel/0000-0002-4622-2456",,,"Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm134; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.49012; Arevalo-Lorido JC, 2013, J STROKE CEREBROVASC, V22, P297, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.00; Christensen H, 2004, CEREBROVASC DIS, V18, P214, DOI 10.1159/00007994; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.00; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.127; Dogan NO, 2013, J PAK MED ASSOC, V63, P58; Duffy BK, 2006, AM J CARDIOL, V97, P993, DOI 10.1016/j.amjcard.2005.10.03; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.19221; Ghahremanfard F, 2013, NEUROSCIENCES, V18, P14; Gibson PH, 2007, AM HEART J, V154, P995, DOI 10.1016/j.ahj.2007.06.04; Gokhan S, 2013, EUR REV MED PHARMACO, V17, P65; Grau AJ, 2004, STROKE, V35, P1147, DOI 10.1161/01.STR.0000124122.71702.6; Gupta Sudhir, 2006, Immun Ageing, V3, P5, DOI 10.1186/1742-4933-3-; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.05; Icme F, 2014, ACTA MEDICA MEDITERR, V30, P52; Icme F, 2014, TURK J GERIATR, V17, P2; Ihara A, 2006, PATHOPHYSIOL HAEMO T, V35, P376, DOI 10.1159/00009769; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-; Kazmierski R, 2004, CLIN NEUROL NEUROSUR, V107, P38, DOI 10.1016/j.clineuro.2004.03.00; Khandekar MM, 2006, J CLIN PATHOL, V59, P146, DOI 10.1136/jcp.2004.02538; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b; KONSTANTOPOULOS K, 1995, THROMB HAEMOSTASIS, V74, P132; Mayda-Domac F, 2010, J STROKE CEREBROVASC, V19, P66, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.00; McCabe DJH, 2004, BRIT J HAEMATOL, V126, P861, DOI 10.1111/j.1365-2141.2004.05137.; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.2; Nasr N, 2009, ATHEROSCLEROSIS, V207, P519, DOI 10.1016/j.atherosclerosis.2009.05.00; Ommen SR, 1997, AM J CARDIOL, V79, P812, DOI 10.1016/S0002-9149(96)00878-; Ommen SR, 1998, CIRCULATION, V97, P19, DOI 10.1161/01.CIR.97.1.1; Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.01; Ross Amy Miner, 2007, J Stroke Cerebrovasc Dis, V16, P203, DOI 10.1016/j.jstrokecerebrovasdis.2007.05.00; Ruggiero C, 2007, J AM COLL CARDIOL, V49, P1841, DOI 10.1016/j.jacc.2007.01.07; Sabatine MS, 2002, J AM COLL CARDIOL, V40, P1761, DOI 10.1016/S0735-1097(02)02484-; Shah SH, 2007, STROKE, V38, P46; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.232",36,1,1,0,9,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,97.0,102,,,,6,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700015,,,,,2022-07-14,0.00371900826446281,1.4762839696307066e-14,0.010635515799802498,0.0925085293246304,0.009136955683245875
J,"Sanal, L21;   Sen, S;   Cesur, S;   Yilmaz, N",,,,"Sanal, Laser; Sen, Suha; Cesur, Salih; Yilmaz, Neziha",,,IN VITRO SYNERGISTIC EFFICACY OF VARIOUS ANTIBIOTIC COMBINATIONS AGAINST MULTI-DRUG-RESISTANT PSEUDOMONAS AERUGINOSA ISOLATES OBTAINED FROM PATIENTS IN INTENSIVE CARE UNITS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,antibiotic combinations; Pseudomonas aeruginosa; epsilometer test; synergy,CYSTIC-FIBROSIS; COLISTIN; POLYMYXINS; STRAINS; PATHOGENESIS,"Introduction: Pseudomonas aeruginosa (P. aeruginosa) is one of the most common nosocomial pathogens in intensive care units (ICUs), with an increased prevalence of multidrug resistance in nosocomial infections. The treatment options are very limited in infections caused by multi drug resistant (MDR) P. aeruginosa strains. Combinations of antimicrobials are frequently used in the treatment of MDR P. aeruginosa infections. In this study we investigated the minimum inhibitory concentrations (MICs) of imipenem(IMP), doripenem(DOR), colistin(CO) and polymyxin B (PO) alone and in vitro synergistic activity of carbapenem-polymixin combinations (IMP-CO, DOR-CO and DOR-PO) in MDR P. aeruginosa strains obtained from patients in ICUs. Materials and methods: Thirty P. aeruginosa strains isolated from various clinical specimens of patients in ICUs were included in the study. The epsilometer test(E test), which is a gradient diffusion method was used for determining synergistic activities of different antibiotic combinations. Synergistic, additive, indifferent and antagonist effects of P. aeruginosa strains were evaluated by fractional inhibitory concentration (FIC) index. Results: Of the 30 MDR P. aeruginosa strains tested, susceptibility rates for IMP, DOR and PO were 40%, 70% and 96.6%, respectively. Resistance to CO was not detected. IMP-CO, DOR-CO and DOR-PO combinations were found to have synergistic or additive effect in 19.9%, 3.3% and 3.3% of the tested strains, respectively. Conclusion: Combination therapy is recommended for the treatment of MDR P. aeruginosa infections in order to ensure synergistic action and decrease the risk of development of resistance. In this study, combinations of IMP-CO, DOR-CO and DOR-PO exhibited synergistic activity in some MDR P. aeruginosa strains. Among the tested antimicrobial combinations, IMP-CO combination was the most effective against MDR P. aeruginosa strains. The development of new combination therapy protocols will help clinicians in selecting appropriate agents for the treatments of infections caused by MDR bacteria.","[Sanal, Laser] Yuksek Ihtisas Training & Res Hosp, Microbiol Lab, TR-06420 Ankara, Turkey; [Sen, Suha] Yuksek Ihtisas Training & Res Hosp, Dept Infect Dis, Ankara, Turkey; [Cesur, Salih] Ankara Numune Training & Res Hosp, Dept Infect Dis, Ankara, Turkey; [Yilmaz, Neziha] Bozok Univ, Dept Microbiol, Yozgat, Turkey","Sanal, L (corresponding author), Yuksek Ihtisas Training & Res Hosp, Microbiol Lab, TR-06420 Ankara, Turkey.",,"yÄ±lmaz, neziha/AAH-3524-2020",,"Yuksek Ihtisas Training and Research Hospital, Project Ihtisas Training and Research Hospital [322-1]","This study was presented as a poster presentation in the 7th Eurasia Congress of Infectious Diseases between 30 September and 3 October 2015 in Tbilisi, Georgia and 30th National Congress of Antibiotic and Chemotherapy at 6-10 May 2015 in TRNC (Turkish Republic of Northern Cyprus) and was supported by a grant from Yuksek Ihtisas Training and Research Hospital, Project Ihtisas Training and Research Hospital, Project no: 322-1.","Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.200; CLSI Institute) LS, 2014, M100S24 CLS; Dundar D, 2010, YONSEI MED J, V51, P111, DOI 10.3349/ymj.2010.51.1.11; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/42932; Fujimura T, 2009, INT J ANTIMICROB AG, V34, P523, DOI 10.1016/j.ijantimicag.2009.07.00; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.1203; Guzel CB, 2008, CHEMOTHERAPY, V54, P147, DOI 10.1159/00011974; He W, 2012, DIAGN MICR INFEC DIS, V74, P417, DOI 10.1016/j.diagmicrobio.2012.08.01; Jain SN., 2011, INT RES J PHARM, V2, P19; Kose S, 2014, ANKEM DERG, V28, P10; Manno G, 2003, EUR J CLIN MICROBIOL, V22, P28, DOI 10.1007/s10096-002-0852-; Michalopoulos A, 2005, CRIT CARE, V9, pR53, DOI 10.1186/cc302; Michalopoulos A, 2008, CRIT CARE CLIN, V24, P377, DOI 10.1016/j.ccc.2007.12.00; Mitsugui CS, 2011, INT J ANTIMICROB AG, V38, P447, DOI 10.1016/j.ijantimicag.2011.06.01; Nazli E, 2015, J INT MED RES, V43, P217, DOI 10.1177/030006051455349; Ochoa SA, 2013, B MED HOSP INFANT M, V70, P13; Onal S, 2015, ACTA MEDICA MEDITERR, V31, P85; Pankey GA, 2005, ANTIMICROB AGENTS CH, V49, P2959, DOI 10.1128/AAC.49.7.2959-2964.200; Pitt TL, 2003, THORAX, V58, P794, DOI 10.1136/thorax.58.9.79; Sabuda DM, 2008, CAN J INFECT DIS MED, V19, P413, DOI 10.1155/2008/74319; Sueke H, 2010, INVEST OPHTH VIS SCI, V51, P4151, DOI 10.1167/iovs.09-483; TozluKeten D, 2010, ANKEM DERG, V24, P7; Tunyapanit W, 2013, SE ASIAN J TROP MED, V44, P27; Varaiya A, 2008, INDIAN J MED MICROBI, V26, P238, DOI 10.4103/0255-0857.4203; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.191; Yaman G, 2011, SAKARYAMJ, V3, P9; Zusman O, 2013, ANTIMICROB AGENTS CH, V57, P5104, DOI 10.1128/AAC.01230-1",27,1,1,0,4,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,1041.0,1046,,10.19193/0393-6384_2016_4_129,,6,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000029,,,,,2022-07-14,0.0027892561983471073,1.347725007280145e-26,0.00947711839297653,0.05758100302776142,0.00947711839297653
J,"Savik, E1;  Sezen, H;  Altay, N;  Altay, MA;  Erturk, C;  Aksoy, N",,,,"Savik, Emin; Sezen, Hatice; Altay, Nuray; Altay, Mehmet Akif; Erturk, Cemil; Aksoy, Nurten",,,NON-TRAUMATIC ADULT OSTEOARTHRITIS IS ASSOCIATED WITH INCREASED SERUM CYSTATIN-C LEVELS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Osteoarthritis; inflammation; Cystatin-C; serum total free thiol,RHEUMATOID-ARTHRITIS; CATHEPSIN-B; GENE-EXPRESSION; CHONDROCYTES; CARTILAGE; SYNOVIUM; INHIBITORS,"Introduction: Despite the fact that cathepsins (Cat) are known to be associated with the pathogenesis of osteoarthritis (OA), there is no relevant literature regarding (cystatin-C) Cys-C, which is a natural inhibitor of Cat in human OA. The purpose of this study is to investigate the levels of Cys-C and total free thiol (TFT) in the serum and synovial liquid of patients with OA. Materials and methods: Forty OA patients, diagnosed according to the American College of Rheumatology (ACR) criteria, and 40 healthy individuals were included in the study. In serum and fluid samples taken from patients and controls, the serum TFT levels were studied with Elman's method, and the Cys-C levels were studied with colorimetric method using commercially available kits in an autoanalyzer. Results: Cys-C levels were significantly higher in the patient group than in the control group (p<0.05), and serum TFT levels were similar between groups (p>0.05). A correlation analysis showed that the levels of serum Cys-C were positively correlated with the presence of OA (correlation coefficient = 0.300, p = 0.014) and negatively correlated with the TFT levels (correlation coefficient = -0.231, p = 0.024). In the regression analysis, it was observed that only the presence of OA independently affected the levels of Cys-C beta regression coefficient = 0.130, p = 0.024). Conclusion: In patients with OA, the level of serum Cys-C was determined to be higher than in controls. This may be related with the pathogenesis of disease, increased oxidative stress, or chronic inflammation in OA.","[Savik, Emin; Sezen, Hatice; Aksoy, Nurten] Harran Univ, Fac Med, Dept Clin Biochem, TR-63300 Sanliurfa, Turkey; [Altay, Nuray] Harran Univ, Fac Med, Dept Anesthesiol & Reanimat, TR-63300 Sanliurfa, Turkey; [Altay, Mehmet Akif; Erturk, Cemil] Harran Univ, Fac Med, Dept Orthoped Surg, TR-63300 Sanliurfa, Turkey","Sezen, H (corresponding author), Harran Univ, Fac Med, Dept Clin Biochem, Resource & Educ Hosp, Meteorol St, TR-63300 Sanliurfa, Turkey.",,"ALTAY, Mehmet Akif/AAG-2803-2021; ErtÃ¼rk, Cemil/AAI-7366-2020",,,,"ABRAHAMSON M, 1986, J BIOL CHEM, V261, P128; Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar265; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.178029081; Atukorala I, 2014, ANN RHEUM DI; BAICI A, 1995, ANN RHEUM DIS, V54, P281, DOI 10.1136/ard.54.4.28; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.01; Bossard MJ, 1996, J BIOL CHEM, V271, P12517, DOI 10.1074/jbc.271.21.1251; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-; Galasso O, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/83420; Guo H, 2012, JOINT BONE SPINE, V7; HALL A, 1995, J BIOL CHEM, V270, P5115, DOI 10.1074/jbc.270.10.511; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.2156; Hu PF, 2014, INT J CLIN EXP PATHO, V7, P657; Hussein MR, 2008, PATHOL ONCOL RES, V14, P321, DOI 10.1007/s12253-008-9016-; Keyszer G, 1998, ARTHRITIS RHEUM, V41, P1378, DOI 10.1002/1529-0131(199808)41:8<1378::AID-ART6>3.0.CO;2-; Kim HR, 2014, INT J RHEUM DI; Kyostio-Moore S, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0519-; LYNN KR, 1984, CAN J BIOCHEM CELL B, V62, P1301, DOI 10.1139/o84-16; Mehraban F, 1997, ANN RHEUM DIS, V56, P108, DOI 10.1136/ard.56.2.10; Monsouvanh A, 2014, ASIAN PAC J CANCER P, V15, P9511, DOI 10.7314/APJCP.2014.15.21.951; Nepple JJ, 2015, CLIN ORTHOP RELAT R, V473, P1683, DOI 10.1007/s11999-015-4148-; Nishiyama K, 2005, BRAIN RES BULL, V67, P94, DOI 10.1016/j.brainresbull.2005.05.02; Olszewska-Slonina D, 2015, SCAND J CLIN LAB INV, V75, P145, DOI 10.3109/00365513.2014.99294; Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.11077; Satkunananthan PB, 2014, OSTEOARTHR CARTILAGE, V22, P1461, DOI 10.1016/j.joca.2014.07.01; Suantawee T, 2013, J CLIN DIAGN RES, V7, P1855, DOI 10.7860/JCDR/2013/5802.333; Takahashi D, 2009, ARTHRITIS RHEUM-US, V60, P2372, DOI 10.1002/art.2471; Targonska-Stepniak B, 2011, SCAND J RHEUMATOL, V40, P341, DOI 10.3109/03009742.2011.57121; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.01688; Xia Hong, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P1151, DOI 10.11817/j.issn.1672-7347.2014.11.00; Yalcin S, 2013, MEDICINA-LITHUANIA, V49, P11; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.13",32,0,0,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,3.0,,,,,767.0,772,,10.19193/0393-6384_2016_3_87,,6,"Medicine, General & Internal",General & Internal Medicine,DM9NQ,WOS:000376693400016,,,,,2022-07-14,0.003409090909090909,1.8798743081042226e-08,0.006600982445594492,0.12778709191957863,0.006600982445594492
J,"Savran, Y21;   Duran, Y;   Comert, B",,,,"Savran, Yusuf; Duran, Yakup; Comert, Bilgin",,,IMPACT OF TIME TO ANTIBIOTICS ON MORTALITY IN SEVERE SEPSIS AND SEPTIC SHOCK,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,sepsis; severe sepsis; septic shock; antibiotherapy; mortality,RISK-FACTORS; EPIDEMIOLOGY; MANAGEMENT; THERAPY; SURVIVAL,"Introduction: Severe sepsis and septic shock are associated with high mortality. Antibiotherapy must be started as early as possible since it seems to be the most important factor determining survival. In this study, we aimed to evaluate the time intervals between diagnosis and first dose of antibiotherapy and its impact on mortality in severe sepsis and septic shock patients. Materials and methods: Medical records of adult patients (>= 18 years old) admitted to medical ICU of a 1200-bed university hospital in Izmir,Turkey with the diagnosis of severe sepsis and septic shock between January 1,2010 and June 30,2014 were evaluated retrospectively. The patients admitted with other diagnosis than severe sepsis and septic shock and patients having an advanced stage of malignancy were excluded. Results: One hundred and ten patients were identified fullfilling the inclusion criteria. 49(44.5%) patients were female and 61(55.5%) were male. Average age of the patients was 74,3 +/- 11,6. Average time from diagnosis of sepsis or septic shock to first dose of antibiotherapy was identified to be 6,9 4,7 hours. Patients were classified into two groups according to application of first dose of antibiotherapy (early<3 hours vs late>3 hours). The overall mortality rate was 54.5%. Mortality rates in early group were significantly lower than late group [25%(n=5) vs 61%(n=55), p<0,05 J. Chronic renal failure was the only comorbidity significantly affecting mortality (p<0,05). Logistic regression analysis displayed early antibiotherapy (p=0,005), culture positivity (p=0,025) and APACHE II scores (p=0,006) to be important in predicting mortality. Conclusions: Time to antibiotherapy is an extremely important factor predicting mortality in severe sepsis and septic shock. Any delay in diagnosis and intense treatment including appropriate antibiotherapy should be avoided to decrease mortality rates.","[Savran, Yusuf; Duran, Yakup] Dokuz Eylul Univ, Fac Med, Dept Internal Med, Izmir, Turkey; [Comert, Bilgin] Dokuz Eylul Univ, Fac Med, Dept Med Intens Care Unit, Izmir, Turkey","Savran, Y (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Internal Med, Mithatpasa Cad 1606 Inciralti Yerleskesi, TR-35340 Izmir, Turkey.",,"Savran, Yusuf/AAI-1796-2019; CÃ¶mert, Bilgin/P-3030-2019","CÃ¶mert, Bilgin/0000-0002-2148-5356; SAVRAN, YUSUF/0000-0002-0130-4730",,,"Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-; Alberti C, 2003, AM J RESP CRIT CARE, V168, P77, DOI 10.1164/rccm.200208-785O; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-0000; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.220108; Appelboam R, 2010, CRIT CARE, V14, P50, DOI DOI 10.1186/CC828; Boussekey N, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/43642; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.96; Daniels R, 2011, EMERG MED J, V28, P507, DOI 10.1136/emj.2010.09506; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.000000000000033; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc482; Gao F, 2005, CRIT CARE, V9, pR764, DOI 10.1186/cc390; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.1; Gurnani PK, 2010, CLIN THER, V32, P1285, DOI 10.1016/j.clinthera.2010.07.00; Khwannimit B, 2009, EPIDEMIOL INFECT, V137, P1333, DOI 10.1017/S095026880900202; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cd; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3; Matot I, 2001, INTENS CARE MED, V27, pS3, DOI 10.1007/PL0000379; Morrell MR, 2009, INFECT DIS CLIN N AM, V23, P485, DOI 10.1016/j.idc.2009.04.00; Nobre V, 2007, CURR OPIN CRIT CARE, V13, P586, DOI 10.1097/MCC.0b013e3282e7d8e; Rezende E, 2008, CLINICS, V63, P457, DOI 10.1590/S1807-5932200800040000",24,3,3,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,17.0,22,,,,6,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700002,,,,,2022-07-14,0.0024793388429752063,1.457924983758615e-14,0.029198644361296235,0.09401800716790179,0.030597141706883123
J,"Sen Tanrikulu, C1;  Akilli, NB;  Guunaydini, YK;  Koylu, O",,,,"Sen Tanrikulu, Ceren; Akilli, Nazire Belgin; Guunaydini, Yahya Kemal; Koylu, Oznur",,,NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO IN CARDIAC AND NON-CARDIAC ARREST DISTINCTION: A RETROSPECTIVE COHORT STUDY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Cardiac arrest; clinical markers; emergency; NLR; PLR,CELL DISTRIBUTION WIDTH; MYOCARDIAL-INFARCTION; NEUTROPHIL/LYMPHOCYTE RATIO; PLATELET/LYMPHOCYTE RATIO; PROGNOSTIC VALUE; CORONARY; MORTALITY; PREDICTOR; ADMISSION; OUTCOMES,"Introduction: Cardiopulmonary arrest (CPA) is a major cause of death in developed countries. While 80% of the arrests occur due to cardiac pathologies, 20% occur due to non-cardiac pathologies. Determining the underlying pathology is very important. In this retrospective study, we examined the potential utilities of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in cardiac and non-cardiac arrest distinction. Materials and methods: We enrolled the following participants: 136 patients with cardiac arrests and 152 patients with noncardiac arrests between January 2012 and December 2015. The distinction was made primarily on whether cardiac pathology was present. The cardiac pathology was determined by using cardiac enzyme levels, electrocardiographic and echocardiographic findings, angiographic results, and patient history. Results: Cardiac arrests were observed more frequently in male patients, while the number of non-cardiac arrests was greater in female patients (p= 0.018). PLR and NLR were higher in non-cardiac arrests than in cardiac arrests (p< 0.001 for PLR and p= 0.001 for NLR). None of these parameters showed any effect on the 30-day mortality. The sensitivities, specificities, positive predictive values (PPV), and negative predictive values (NPV) of the PLRs and NLRs were 80.1%, 42.2%, 64.0%, and 62.3% and 49.7%, 73.5%, 68.8%, and 55.4%, respectively. The area under the curve (AUC) for the PLR was 61.7%, and the AUC for the NLR was 61.0%. Conclusion: We suggest that the NLR and PLR can be helpful in the differential diagnosis of cardiac and non-cardiac arrest. Thus, the NLR and PLR should be evaluated in addition to the clinical examination.","[Sen Tanrikulu, Ceren; Akilli, Nazire Belgin; Guunaydini, Yahya Kemal] Konya Training & Educ Hosp, Dept Emergency Med, Konya, Turkey; [Koylu, Oznur] Konya Training & Educ Hosp, Dept Biochem, Konya, Turkey","Sen Tanrikulu, C (corresponding author), Sagik Bilimleri Univ, Konya Egitim & Arastirma Hastanesi, Saglik Bakanligi, Acil Tip Anabilim Dali, TR-42100 Meram Konya, Turkey.",,"Akilli, Nazire/AAD-9457-2020","Akilli, Nazire/0000-0001-9329-0964",,,"Alexandrakis MG, 2003, AM J CLIN ONCOL-CANC, V26, P135, DOI 10.1097/00000421-200304000-0000; Azab B, 2012, J THROMB THROMBOLYS, V34, P326, DOI 10.1007/s11239-012-0718-; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.06; Balta S, 2014, INTERNAL MED, V53, P1239, DOI 10.2169/internalmedicine.53.178; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P43; Celik A, 2015, KAOHSIUNG J MED SCI, V31, P145, DOI 10.1016/j.kjms.2014.12.00; CHIEN S, 1970, SCIENCE, V168, P977, DOI 10.1126/science.168.3934.97; Cho KH, 2011, AM J CARDIOL, V107, P849, DOI 10.1016/j.amjcard.2010.10.06; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.68531; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.06; Fowler AJ, 2013, ATHEROSCLEROSIS, V228, P44, DOI 10.1016/j.atherosclerosis.2013.02.00; Furman MI, 1998, J AM COLL CARDIOL, V31, P352, DOI 10.1016/S0735-1097(97)00510-; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI2719; Gursoy OM, 2014, AM J CARDIOL, V113, P860, DOI 10.1016/j.amjcard.2013.11.02; Iijima R, 2007, THROMB HAEMOSTASIS, V98, P852, DOI 10.1160/TH07-04-028; Ilhan M, 2016, J MATERN-FETAL NEO M, V29, P1476, DOI 10.3109/14767058.2015.105102; Jilma B, 1999, AM J RESP CRIT CARE, V159, P857, DOI 10.1164/ajrccm.159.3.980508; Karagoz E, 2014, NETH J MED, V72, P11; Kaya MG, 2013, INT J CARDIOL, V168, P1154, DOI 10.1016/j.ijcard.2012.11.07; Kurtipek E, 2015, J PAK MED ASSOC, V65, P128; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.65670; Leong BSH, 2011, SINGAP MED J, V52, P57; Liu Q, 2014, PLATELETS, V25, P246, DOI 10.3109/09537104.2013.81033; Park JJ, 2013, AM J CARDIOL, V111, P636, DOI 10.1016/j.amjcard.2012.11.01; Peerschke EI, 2010, MOL IMMUNOL, V47, P2170, DOI 10.1016/j.molimm.2010.05.00; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI2638; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.99206; Saygitov RT, 2010, EMERG MED J, V27, P105, DOI 10.1136/emj.2008.06815; Soylu K, 2014, PAK J MED SCI, V30, P936, DOI 10.12669/pjms.305.493; Suliman MARM, 2010, ARCH MED RES, V41, P618, DOI 10.1016/j.arcmed.2010.11.00; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.00; Tanboga IH, 2014, CLIN APPL THROMB-HEM, V20, P716, DOI 10.1177/107602961348316; Temiz A, 2014, MED SCI MONITOR, V20, P660, DOI 10.12659/MSM.89015; Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.03; Wang D, 2013, ONCOTARGETS THER, V6, P211, DOI 10.2147/OTT.S4171; Yildiz A, 2015, CLIN APPL THROMB-HEM, V21, P223, DOI 10.1177/107602961351985; Zaman S, 2014, CIRCULATION, V129, P2426, DOI 10.1161/CIRCULATIONAHA.113.00749; Zhang SZ, 2007, CLIN CARDIOL, V30, P26, DOI 10.1002/clc.; Zheng Z.J., 2002, MMWR-MORBID MORTAL W, V51, P12",39,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_140,,7,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000011,,,,,2022-07-14,0.0040289256198347105,5.197641457632446e-14,0.07202708867087144,0.09938296321393005,0.07604596303852901
J,"Senol, S1;  Bahcivan, M;  Yuksel, A;  Es, MU",,,,"Senol, Sefa; Bahcivan, Muzaffer; Yuksel, Ahmet; Es, Mehmet Ugur",,,ADDUCIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Adducin; methylenetetrahydrofolate reductase; gene polymorphism; peripheral arterial disease,RISK-FACTORS; ATHEROSCLEROSIS; HOMOCYSTEINE; HYPERTENSION; SENSITIVITY; PREVALENCE; ALLELE,"Introduction: The aim of this study was to investigate the effects of Adducin Gly460Trp, and methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C gene polymorphisms that are supposed to play a role in atherothrombotic process in patients with peripheral arterial disease (PAD). Materials and methods: This prospective study was performed on a total of 270 participants between January 2013 and June 2014. The participants were divided into two groups: Group 1 (PAD group) included 180 patients with PAD (mean age: 55 +/- 18 years, 128 males), and Group 2 (control group) included 90 participants (mean age: 53 +/- 15 years, 61 males) with normal physical examination and arterial duplex ultrasonography findings for PAD. Groups were compared with each other according to the clinical and demographic characteristics, levels of some biochemical parameters, allele frequencies, and particularly Adducin Gly460Trp, MTHFR C677T and A1298C gene polymorphisms, which were determined by using real time polymerase chain reaction. Results: The incidences of hypertension, diabetes mellitus, smoking, family history of cardiovascular diseases and fasting glucose levels were significantly higher in PAD group. Both groups were statistically similar according to the levels of total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglyceride, urea and creatinine. Comparison of both groups according to the Adducin Gly460Trp, MTHFR C677T and A1298C gene polymorphisms, and allele frequencies did not yield any statistically significant differences. Conclusion: We concluded that Adducin Gly460Trp, MTHFR C677T and A1298C gene polymorphisms were not predictive factors for PAD. The investigations on different polymorphisms of Adducin and MTHFR may be beneficial.","[Senol, Sefa] Elazig Educ & Res Hosp, Dept Cardiovasc Surg, Elazig, Turkey; [Bahcivan, Muzaffer] Mem Diyarbakir Hosp, Dept Cardiovasc Surg, Diyarbakir, Turkey; [Yuksel, Ahmet] Bingol State Hosp, Dept Cardiovasc Surg, Duzagac St, TR-12030 Bingol, Turkey; [Es, Mehmet Ugur] Medicalpk Tokat Hosp, Dept Cardiovasc Surg, Tokat, Turkey","Yuksel, A (corresponding author), Bingol State Hosp, Dept Cardiovasc Surg, Duzagac St, TR-12030 Bingol, Turkey.",,,,,,"Bartholomew John R, 2006, Cleve Clin J Med, V73 Suppl 4, pS; Beeks E, 2004, J HYPERTENS, V22, P1243, DOI 10.1097/01.hjh.0000125443.28861.0; Bianchi G, 2005, HYPERTENSION, V45, P331, DOI 10.1161/01.HYP.0000156497.39375.3; Chen SF, 2010, HUM GENET, V128, P137, DOI 10.1007/s00439-010-0834-; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.86560; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-; Gerhard T, 2008, AM HEART J, V156, P397, DOI 10.1016/j.ahj.2008.03.00; Glorioso N, 2002, HYPERTENSION, V39, P357, DOI 10.1161/hy0202.10306; Gu Y, 2013, CELL PHYSIOL BIOCHEM, V31, P143, DOI 10.1159/00034335; Haigh K, 2013, AUST FAM PHYSICIAN, V42, P39; Hayoz D, 2005, J INTERN MED, V258, P238, DOI 10.1111/j.1365-2796.2005.01536.; Khandanpour N, 2009, J VASC SURG, V49, P711, DOI 10.1016/j.jvs.2008.10.00; Li Y, 2005, HYPERTENSION, V46, P527, DOI 10.1161/01.HYP.0000174988.81829.7; Liu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.001305; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-; Morrison AC, 2002, HYPERTENSION, V39, P1053, DOI 10.1161/01.HYP.0000019128.94483.3; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.02; Pollex RL, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-1; Rajan S, 2010, INDIAN J MED RES, V132, P37; Sabino A, 2009, J THROMB THROMBOLYS, V27, P82, DOI 10.1007/s11239-007-0172-; Schwahn B, 2001, Am J Pharmacogenomics, V1, P189, DOI 10.2165/00129785-200101030-0000; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F; Seshadri N, 2000, MED CLIN N AM, V84, P215, DOI 10.1016/S0025-7125(05)70215-; Szabo GV, 2013, INTERV MED APPL SCI, V5, P46, DOI 10.1556/IMAS.5.2013.1.1; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.01; van Rijn MJE, 2006, STROKE, V37, P2930, DOI 10.1161/01.STR.0000248760.67039.2; Welten GMJM, 2009, J CARDIOVASC SURG, V50, P10",27,2,2,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1773.0,1778,,10.19193/0393-6384_2016_6_162,,6,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300006,,,,,2022-07-14,0.0027892561983471073,3.8448151699645446e-14,0.004127520971391018,0.08604673902415176,0.004127520971391018
J,"Shahram, S1;  Elham, Y;  Abdolali, B",,,,"Shahram, Soheily; Elham, Yadegari; Abdolali, Banaeifar",,,THE EFFECT OF ENDURANCE AND RESISTANCE TRAINING ON INFLAMMATORY CYTOKINES IN SEDENTARY YOUNG WOMEN,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Endurance training; resistance training; inflammatory cytokines; sedentary young women,WEIGHT-LOSS; EXERCISE; SERUM; OLDER,"Background: that low-grade chronic inflammation is a key principle in pathogenesis in most of the Chronic Non-communicable Diseases. The aim of the present study is to analyze the effects of the endurance and resistance training on IL-6, TNF-alpha, IL-10 in sedentary young women. Materials and methods: Thirty female volunteer students who were overweight were chosen (BMI >= 25), and they were randomly distributed into three groups of resistance training, endurance training and control. The training groups practiced for twelve weeks and three times a week with a definite intensity and distance. IL-6, TNF-alpha, IL-10, weight, fat percentage, BMI and the maximum oxygen consumption were measured before and after the twelve weeks of exercise. Results: The results showed that the endurance and resistance trainings, except for BMI have a significant effect upon the body fat percentage, VO2max, IL-6, TNF-alpha and IL-10. In addition, there was not a significant difference between the effect of the resistance and endurance trainings upon the above mentioned variables. Conclusion: It seems that the endurance and resistance trainings with the significant decrease of the inflammation cytokines will decrease the chronic Non-communicable diseases in sedentary young women.","[Shahram, Soheily] Islamic Azad Univ, Shahr E Qods Branch, Dept Phys Educ & Sport Sci, Tehran, Iran; [Elham, Yadegari; Abdolali, Banaeifar] Islamic Azad Univ, South Tehran Branch, Dept Phys Educ & Sport Sci, Tehran, Iran","Shahram, S (corresponding author), Islamic Azad Univ, Shahr E Qods Branch, Dept Phys Educ & Sport Sci, Tehran, Iran.",shsohaily@gmail.com,,,"Islamic Azad University, Shahr - e - Qods Branch","The researchers hereby extend their appreciation to the Research and Technology vice chancellor of Islamic Azad University, Shahr - e - Qods Branch for sponsoring this project.","Balducci S, 2009, NUTR METAB CARDIOVAS, V20, P; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.00; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.06; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.050524; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494; Das UN, 2004, NUTRITION, V20, P323, DOI 10.1016/j.nut.2003.11.01; Haghighi AH, 2006, OLYMPIC, V14, P1; Huffman KM, 2008, METABOLISM, V57, P577, DOI 10.1016/j.metabol.2007.11.02; Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.00; Kadoglou NPE, 2007, EUR J CARDIOV PREV R, V14, P837, DOI 10.1097/HJR.0b013e3282efaf5; Kadoglou NPE, 2010, METABOLISM, V59, P599, DOI 10.1016/j.metabol.2009.09.00; Kohut ML, 2006, BRAIN BEHAV IMMUN, V20, P201, DOI 10.1016/j.bbi.2005.12.00; Lira FS, 2009, CELL BIOCHEM FUNCT, V27, P458, DOI 10.1002/cbf.159; Mathur N, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/10950; Nicklas BJ, 2004, AM J CLIN NUTR, V79, P54; Nikseresht M, 2014, J STRENGTH COND RES, V28, P2560, DOI 10.1519/JSC.000000000000044; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.04807; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.200; Prestes J, 2009, J SPORT SCI, V27, P1607, DOI 10.1080/0264041090335292; Pretolani M, 1999, CLIN EXP ALLERGY, V29, P1164, DOI 10.1046/j.1365-2222.1999.00456.; Radom-Aizik S, 2007, CYTOKINE, V40, P75, DOI 10.1016/j.cyto.2007.08.00; Rall LC, 2000, J NUTR BIOCHEM, V11, P581, DOI 10.1016/S0955-2863(00)00123-",22,3,4,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,2.0,,999.0,1002,,,,4,"Medicine, General & Internal",General & Internal Medicine,EF2SU,WOS:000390175400025,,,,,2022-07-14,0.0022727272727272726,2.5987903468105105e-11,0.004334360236312917,0.10349952420156747,0.004334360236312917
J,"Shakour, M1;  Yamani, N;  Yousefi, A",,,,"Shakour, Mahsa; Yamani, Nikoo; Yousefi, Alireza",,,PREPARATIONS BEFORE FACULTY DEVELOPMENT PROGRAMS FOR MEDICAL PROFESSIONALISM FOR CLINICAL TEACHERS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,staff development; medical education; professionalism; organization; medical teacher; qualitative research,,"Objectives: The goal of the current study was to gather the opinions of medical education experts in order to determine the necessary preparations for implementation of a successful faculty development program for teaching and learning medical professionalism to do professional. Design: The study was triangulated and it was done in two phases. The first phase was qualitative. Data gathering was done by semi structured interview. Interviews were transcript and analyzed by classic content analysis. And then in second phase by focus group of six experts, experts changed and added some themes. At the end, the themes were confirmed by Delphi. Participants and setting: Participants were 23 experts in medical education from high ranked medical universities in Iran. Main results: After analyzing the content of the interviews, confirming and editing themes in focus group and Delphi, we had two main themes and 18 subthemes. Main themes were 1) Organization preparations included four sub-themes of professional behavior requirements, needs assessment, initial evaluation and removing the barriers; 2) Preparing the audience with three sub-themes of motivating the faculty members, creating understanding regarding professionalism and engaging the faculty members in development program. Conclusions: Before starting the faculty development programs for medical professionalism, we should notice many organizational and personal items. These items are important to lead a successful program.","[Shakour, Mahsa] Isfahan Univ Med Sci, Med Educ Res Ctr, Esfahan, Iran; [Yamani, Nikoo; Yousefi, Alireza] Isfahan Univ Med Sci, Med Educ Res Ctr, Dept Med Educ, Esfahan, Iran","Yamani, N (corresponding author), Isfahan Univ Med Sci, Med Educ Res Ctr, Dept Med Educ, Esfahan, Iran.",jhamissi@gmail.com,"Yamani, Nikoo/W-2249-2017; Mehridehnavi, Alirez/W-2237-2017; shakour, Mahsa/N-2852-2015","shakour, Mahsa/0000-0001-6768-7036; yamani, Nikoo/0000-0002-7990-092X",Isfahan University of Medical Sciences,This work was supported by Isfahan University of Medical Sciences.,"Biabangard E., 2005, RES METHODS PSYCHO; Bland C J, 1997, Fam Med, V29, P29; Bland CJ, 2002, ACAD MED, V77, P368, DOI 10.1097/00001888-200205000-0000; Bligh J, 2005, MED EDUC, V39, P120, DOI 10.1111/j.1365-2929.2004.02098.; Bodily BH, 2008, PERCEPTIONS FACULT; Burns NGCK., 2001, UNDERSTANDING NURSI; Cruess R. L., 2008, TEACHING MED PROFES; Davis DA, 2011, ACAD MED, V86, P468, DOI 10.1097/ACM.0b013e31820dfac; DUFFY FM, 2003, J STAFF DEV, V2; Frantz JM, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0320-; Hafferty FW, 2010, ACAD MED, V85, P288, DOI 10.1097/ACM.0b013e3181c85b4; Hilton SR, 2005, MED EDUC, V39, P58, DOI 10.1111/j.1365-2929.2004.02033.; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/104973230527668; Kalanick K., 2006, ED PATHWAYS FACULT; King P, 2000, PLANNING EFFECTIVE ; Knowles MS., 1995, DESIGNS ADULT LEARNI, V1s; Lichtman M., 2010, QUALITATIVE RES ED U, V2n; Lincoln Y., 1985, NATURALISTIC INQUIRY, DOI DOI 10.1080/10502556.2015.101270; Maleki H., 2009, CURRICULUM DEV PRAC; Pires A. L. de Oliveira, 2009, EURO J VOCA TRAIN, V46, P12; Robson J., 2006, TEACHER PROFESSIONA; Shakour M, 2016, FACTORS AFFECTING F; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-0001; Steinert Y, 2006, J VET MED EDUC, V33, P317, DOI 10.3138/jvme.33.3.31; Thistlethwaite J., 2008, PROFESSIONALISM ME; Wallin D.L., 2003, COMMUNITY COLL J RES, V27, DOI [10.1080/713838142, DOI 10.1080/713838142; Yamani N, 2016, XPECTED RESULTS FAC",27,1,1,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1483.0,1491,,,,9,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200029,,,,,2022-07-14,0.0027892561983471073,5.575390235068451e-17,0.00518821259538628,0.07656228990848908,0.00518169750364099
J,"Shen, H1;  Zhao, J;  Weng, SS;  Fang, XF;  Zhang, YY;  Huang, JJ",,,,"Shen, Hong; Zhao, Jing; Weng, Shan-Shan; Fang, Xue-Feng; Zhang, Yi-Yang; Huang, Jian-Jin",,,CONTINUOUS ADMINISTRATION OF ENDOSTAR PLUS GP CHEMOTHERAPY IN LOCAL ADVANCED OR METASTATIC LUNG SQUAMOUS CELL CARCINOMA,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Endostar; lung squamous cell carcinoma; continuous administration; gemcitabine/cisplatin,RECOMBINANT HUMAN ENDOSTATIN; PHASE-II TRIAL; DOUBLE-BLIND; CANCER; CARBOPLATIN; PACLITAXEL; CISPLATIN; CHEMORADIOTHERAPY; RESISTANCE; CRITERIA,"Introduction: In squamous cell lung cancer (SQCLC), the current first-line therapy is considered platinum-based doublet chemotherapy and the benefit is limited. Aim of our study is to compare the effect of patients with local advanced or metastatic SQCLC, in comparable groups of patients treated with systemic chemotherapy containing gemcitabine/cisplatin (GP) or GP+ Endostar. Materials and methods: All patients with local advanced or metastatic SQCLC who had undergone GP+ continuous administration of Endostar from September 2009 to January 2014 were evaluated. The GP group was constituted by selecting patients with local advanced or metastatic SQCLC treated with GP chemotherapy during the same period. Results: Fifty-two patients were retrospectively included in the GP group and were compared with 98 patients who had undergone continuous administration of Endostar +GP and were evaluated prospectively. All characteristics were comparable. Median follow-up was 60 months in the GP group versus 58 months in the Endostar +GP group. The response rate (RR) was 34.7% in Endostar +GP group and 34.6% in the GP group. The disease control rate (DCR) was 89.7% in Endostar +GP group and 80.8% in the GP group. Both the RR and DCR were not found to be significantly different with each other. Median progression free survival (PFS) was 5.56 months in the GP group versus 7.23 months in the Endostar +GP group. Discussion: The combination of continuous infusion of Endostar with chemotherapy can improve the PFS in local advanced or metastatic SQCLC patients without increasing adverse events.","[Shen, Hong; Zhao, Jing; Weng, Shan-Shan; Fang, Xue-Feng; Huang, Jian-Jin] Zhejiang Univ, Sch Med, Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Yi-Yang] Hangzhou Sanat Peoples Liberat Army, Dept Med Ctr, Hangzhou, Zhejiang, Peoples R China","Huang, JJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.",,,,National Natural Science Foundation of China [81201640]; Department of Education of Zhejiang Province of China [Y201225802]; Zhejiang Provincial Natural Science Foundation of China [Y16H160082]; Medical and Technology Plan of Zhejiang Province of China [2013KYA093],"The present study was supported by National Natural Science Foundation of China (No. 81201640), the Department of Education of Zhejiang Province of China (No. Y201225802), Zhejiang Provincial Natural Science Foundation of China (Y16H160082) and the Medical and Technology Plan of Zhejiang Province of China (No. 2013KYA093)","Bao Y, 2015, RADIOTHER ONCOL, V114, P161, DOI 10.1016/j.radonc.2014.11.03; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/3712; Cirillo M, 2009, ANN ONCOL, V20, P1929, DOI 10.1093/annonc/mdp28; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.02; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.04; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.19; Goss GD, 2010, J CLIN ONCOL, V28, P49, DOI 10.1200/JCO.2009.22.942; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.485; Hainsworth JD, 2011, J THORAC ONCOL, V6, P109, DOI 10.1097/JTO.0b013e3181f94ad; Han BH, 2011, J THORAC ONCOL, V6, P1104, DOI 10.1097/JTO.0b013e3182166b6; Hansma AHG, 2005, ANN ONCOL, V16, P1695, DOI 10.1093/annonc/mdi31; Jia HP, 2006, NAT BIOTECHNOL, V24, P117, DOI 10.1038/nbt0206-11; Jiang X, 2015, CELL BIOCHEM BIOPHYS, V71, P571, DOI 10.1007/s12013-014-0236-; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.02; Kelly K, 2001, J CLIN ONCOL, V19, P3210, DOI 10.1200/JCO.2001.19.13.321; Kisker O, 2001, CANCER RES, V61, P766; Kuroiwa M, 2003, J PEDIATR SURG, V38, P1499, DOI 10.1016/S0022-3468(03)00503-; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.812; Novello Silvia, 2003, Oncology (Williston Park), V17, P35; Rong BX, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-17; Sakurai H, 2010, J THORAC ONCOL, V5, P1594, DOI 10.1097/JTO.0b013e3181f1923; Scagliotti G, 2010, J CLIN ONCOL, V28, P1835, DOI 10.1200/JCO.2009.26.132; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2829, DOI 10.1200/JCO.2011.41.498; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.037; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.06; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa01195; Wang J, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.759; Wang Jinwan, 2005, Zhongguo Fei Ai Za Zhi, V8, P283, DOI 10.3779/j.issn.1009-3419.2005.04.0; Zhao X, 2012, INVEST NEW DRUG, V30, P1144, DOI 10.1007/s10637-011-9631-",29,5,5,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,57.0,62,,,,6,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700008,,,,,2022-07-14,0.002995867768595041,2.9331146541885275e-21,0.005777055036933499,0.0650035255011248,0.005777055036933499
J,"Shirafkan, H1;  Yazdani-Charati, J;  Mozaffarpur, SA;  Khafri, S;  Akbari, R;  Pasha, AA",,,,"Shirafkan, Hoda; Yazdani-Charati, Jamshid; Mozaffarpur, Seyyed Ali; Khafri, Soraya; Akbari, Roghaye; Pasha, Abazar Akbarzadeh",,,APPLICATION OF TOBIT MODEL IN TIME UNTIL CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS APPLICATION OF TOBIT MODEL IN TIME UNTIL CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Kidney transplantation; Cytomegalovirus; Tobit regression,RISK-FACTORS; DISEASE; IMPACT,"Background and purpose: Tobit model is one of regression models that is used for estimating the relationship between an explanatory variable and truncated or censored dependent variable. This study want to survey the potential of Tobit regression as a tool to study risk factors of time to onset of CMV in kidney transplant recipients. Materials and methods: 242 kidney transplant recipients from 2010 to 2015 in Shahid Beheshti hospital, Babol, Iran entered to the retrospective cohort study. All patients' clinical and demographic characteristics were analyzed as risk factors. The response variable was the time to onset of CMV infection and Tobit model was used to evaluate the factors affecting it. Results: Evaluating the time to incidence of CMV infection in recipients of renal transplants with Tobit regression, revealed that age at the time of transplantation (p=0.01), hypertension (p=0.05), etiology of urologic disease (p=0.02) have a significant relationship with the period of time to onset of CMV infection after renal transplantation. Conclusion: As a results in this study, the time to onset of CMV is influenced by the age of patients. So, the more the age is, the less period of time is to onset of CMV infection. This time will be shorter with hypertension and etiology of urologic diseases for ESRD in these patients.","[Shirafkan, Hoda] Mazandaran Univ Med Sci, Dept Biostat, Sari, Iran; [Yazdani-Charati, Jamshid] Mazandaran Univ Med Sci, Dept Biostat, Hlth Sci Res Ctr, Fac Hlth, Sari, Iran; [Mozaffarpur, Seyyed Ali] Babol Univ Med Sci, Res Ctr Tradit Med & Hist Med Sci, Babol Sar, Iran; [Khafri, Soraya] Babol Univ Med Sci, Dept Social Med, Babol Sar, Iran; [Akbari, Roghaye] Babol Univ Med Sci, Dept Internal Med, Babol Sar, Iran; [Pasha, Abazar Akbarzadeh] Babol Univ Med Sci, Dept Kidney & Urinary Tract Surg, Babol Sar, Iran","Yazdani-Charati, J (corresponding author), Mazandaran Univ Med Sci, Dept Biostat, Hlth Sci Res Ctr, Fac Hlth, Sari, Iran.",Jamshid.charati@gmail.com,"Khafri, Soraya/N-5630-2017; Khafri, Abolfazl/H-3772-2017; Shirafkan, Hoda/AAE-8403-2020; Mozaffarpur, Seyyedali/AEF-6020-2022; mozaffarpur, seyyedali/R-3599-2016","Shirafkan, Hoda/0000-0002-5682-1153; khafri, soraya/0000-0002-2398-7560; Mozaffarpur, Seyyed Ali/0000-0002-8138-6229",,,"Abedi G, 2012, INT J COLLAB RES INT, V4, P10; AMEMIYA T, 1984, J ECONOMETRICS, V24, P3, DOI 10.1016/0304-4076(84)90074-; Anastasopoulos PC, 2008, ACCIDENT ANAL PREV, V40, P768, DOI 10.1016/j.aap.2007.09.00; Bal Z, 2013, TRANSPLANTATION ; Brennan DC, 2001, J AM SOC NEPHROL, V12, P848, DOI 10.1681/ASN.V12484; Chiasakul T, 2015, TRANSPLANTATION ; Cordero E, 2012, TRANSPLANTATION ; Diaz J, 2014, TRANSPLANTATION ; Ekstrand C, 1998, PREV VET MED, V37, P219, DOI 10.1016/S0167-5877(98)00090-; Erdbruegger U, 2012, NEPHROL DIAL TRANSPL, V27, P435, DOI 10.1093/ndt/gfr30; Falahi S, 2009, IRANIAN J MED MICROB, V3, P6; FORMAN SJ, 1994, BLOOD, V83, P239; Hartmann A, 2006, TRANSPLANTATION, V82, pS15, DOI 10.1097/01.tp.0000230460.42558.b; Helantera I, 2009, NEPHROL DIAL TRANSPL, V24, P316, DOI 10.1093/ndt/gfn55; Jahromi V. Hemayatkhah, 2011, J MICROBIAL WORLD, V4, P3; Khansarinejad B, 2012, MODARES J MED SCI PA, V1; Kleinbaum DG, 1996, SURVIVAL ANA; Komeijani M, 2012, J ISFAHAN MED SCH, V30, P; Kute V, 2012, TRANSPLANTATION ; Mandel GL, 2000, PRINCIPLES PRACTICES, P4; Martin-Davila P, 2008, NEFROLOGIA, V28, P25; MONTASERI M, 2013, J MAZANDARAN U MED S, V23, P7; Motamedifar M, 2009, RESEARCH, V12, P23; Nafar M, 2014, IRAN J KIDNEY DIS, V8, P23; Oliaei F, 2012, CASP J INTERN MED, V3, P51; Osshr Farahani H.A., 2009, J IRANIANPSYCHOLOGIS, V5, P23; PETERSON PK, 1980, MEDICINE, V59, P283, DOI 10.1097/00005792-198007000-0000; Pour-Reza-Gholi F, 2005, TRANSPLANTATION ; RUBIN RH, 1993, KIDNEY INT, V44, P221, DOI 10.1038/ki.1993.23; Safabakhsh H, 2013, IRAN J EPIDEMIOL, V9, P5; Said T, 2001, TRANSPLANTATION ; Seale H, 2008, VIROLOGY RES TREATME, V1, P6; Tarabadi F, 2005, BLOOD KHOON, V2, P14; Weikert BC, 2008, CLIN J AM SOC NEPHRO, V3, pS76, DOI 10.2215/CJN.0290070",34,0,0,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1237.0,1242,,,,6,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200008,,,,,2022-07-14,0.003512396694214876,1.1701449826514156e-11,0.00680691093182053,0.10545925982416193,0.00680691093182053
J,"Silay, K1;  Akinci, S;  Ulas, A;  Guney, T;  Yalcin, A;  Dilek, I",,,,"Silay, Kamile; Akinci, Sema; Ulas, Arife; Guney, Tekin; Yalcin, Ahmet; Dilek, Imdat",,,PERIPHERAL NEUROPATHY: ASSOCIATION WITH AGE AND SURVIVAL IN MULTIPLE MYELOMA PATIENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Multiple Myeloma; Peripheral Neuropathy; Electromyography; Elderly,PREDNISONE PLUS THALIDOMIDE; STEM-CELL TRANSPLANTATION; BORTEZOMIB THERAPY; DEXAMETHASONE; NEUROTOXICITY; VINCRISTINE; COMBINATION; MELPHALAN,"Objective: Multiple myeloma (MM) accounts for approximately 1% of all cancers and 10% of hematologic malignancies. Peripheral neuropathy (PN) is a common side effect of cancer therapy that can have an impact on quality of life and survivorship. PN may happen in MM due to adverse effect of chemotherapeutics, amyloidosis or as a part of paraneoplastic syndrome. The aim of this study is to evaluate the prevalence of peripheral neuropathy in multiple myeloma patients and its association with age and disease outcome. Materials and methods: We conducted a retrospective review of 92 multiple myeloma patients who presented to hematology clinic between 2009 and 2014. Their age, gender, performance status, chemotherapeutic regimens, stage of disease, diabetes status and electromyography results were noted. An association between clinical parameters and neuropathy was analyzed. Kaplan Meier analysis was used in statistical comparisons between mortality and other parameters. Results: The mean age of patients was 64 +/- 11.6. Patients with neuropathy were enrolled as group 1 (27.2%) and patients without neuropathy were enrolled as group 2 (72.8%). No significant association was found between age and peripheral neuropathy (p=1.00). The estimated median survival time was 27 months in patients with PN, whereas 56 months in patients without PN (p=0.273). In group 1 three year overall survival rate was 41% whereas in group 2 it was 57%. Conclusion: It is important to understand pathophysiology of PN and recognize who is at risk since; it is a common side effect of MM treatment. This study is among the few analyses evaluating prevalence of peripheral neuropathy confirmed with electromyography in MM patients. There was no significant association between increased age, survival and neuropathy. Evaluating other associations and understanding potential risks with further research may guide us in developing better preventive and treatment modalities for PN in older MM patients.","[Silay, Kamile] Yildirim Beyazit Univ, Fac Med, Ataturk Training & Res Hosp, Dept Internal Med & Geriatr, Ankara, Turkey; [Akinci, Sema; Guney, Tekin] Ataturk Training & Res Hosp, Dept Hematol, Ankara, Turkey; [Ulas, Arife] Ataturk Training & Res Hosp, Dept Med Oncol, Ankara, Turkey; [Yalcin, Ahmet] Ataturk Training & Res Hosp, Dept Geriatr, Ankara, Turkey; [Dilek, Imdat] Yildirim Beyazit Univ, Fac Med, Ataturk Training & Res Hosp, Dept Hematol, Ankara, Turkey","Silay, K (corresponding author), Yildirim Beyazit Univ, Fac Med, Ataturk Training & Res Hosp, Dept Internal Med & Geriatr, Ankara, Turkey.",,"Yalcin, Ahmet/AAA-9697-2020","Yalcin, Ahmet/0000-0001-9472-2212",,,"Argyriou AA, 2006, SUPPORT CARE CANCER, V14, P223, DOI 10.1007/s00520-005-0868-; Argyriou AA, 2008, BLOOD, V112, P1593, DOI 10.1182/blood-2008-04-14938; Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.01; Badros A, 2007, CANCER-AM CANCER SOC, V110, P1042, DOI 10.1002/cncr.2292; Blade J, 1998, LEUKEMIA LYMPHOMA, V30, P493, DOI 10.3109/1042819980905756; Broyl A, 2010, LANCET ONCOL, V11, P1057, DOI 10.1016/S1470-2045(10)70206-; Cavo M, 2012, BLOOD, V120, P9, DOI 10.1182/blood-2012-02-40889; Delforge M, 2010, LANCET ONCOL, V11, P1086, DOI 10.1016/S1470-2045(10)70068-; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-; Hulin C, 2009, J CLIN ONCOL, V27, P3664, DOI 10.1200/JCO.2008.21.094; Ja'afer FMH, 2006, EXP BRAIN RES, V173, P334, DOI 10.1007/s00221-006-0499-; Jagannath S, 2005, BRIT J HAEMATOL, V129, P776, DOI 10.1111/j.1365-2141.2005.05540.; Kaufmann H, 2004, BLOOD, V104, P2269, DOI 10.1182/blood-2004-03-109; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.2; Lanzani F, 2008, J PERIPHER NERV SYST, V13, P267, DOI 10.1111/j.1529-8027.2008.00192.; Palumbo A, 2011, BLOOD, V118, P4519, DOI 10.1182/blood-2011-06-35881; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-; Rajkumar SV, 2008, J CLIN ONCOL, V26, P2171, DOI 10.1200/JCO.2007.14.185; Richardson PG, 2012, LEUKEMIA, V26, P595, DOI 10.1038/leu.2011.34; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.777; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-26886; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI [10.3322/caac.21254, 10.1001/jamaoto.2014.2530, 10.3322/caac.21208, 10.1136/bmj.g1502; Velasco R, 2010, J PERIPHER NERV SYST, V15, P17, DOI 10.1111/j.1529-8027.2010.00248.; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.",24,1,1,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,123.0,126,,,,4,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700019,,,,,2022-07-14,0.0024793388429752063,4.688926279131009e-18,0.0047466654826543615,0.07459868527523678,0.0047466654826543615
J,"Tabrez, S1;  Nabilalama, M;  Jabir, NR;  Firoz, CK",,,,"Tabrez, Shams; Nabilalama, Mohammed; Jabir, Nasimudeen R.; Firoz, Chelapram K.",,,NEUTROPHILS TO LYMPHOCYTE RATIO AS A BIOMARKER OF CORONARY ARTERY DISEASE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,WBC; Neutrophils to lymphocyte ratio; Inflammation; CAD; Cardiac markers,CELL DISTRIBUTION WIDTH; C-REACTIVE PROTEIN; HEART-DISEASE; NEUTROPHIL/LYMPHOCYTE RATIO; CARDIOVASCULAR-DISEASE; PLATELET COUNT; LIPID PROFILE; RISK; ASSOCIATION; MORTALITY,"Introduction: Cardiovascular disease is the leading contributor of global death. Because of steadily expanding ascend in death rate, the earnest need is to discover novel prognostic biomarkers. In this attempt, inflammation has been a prominent target because of its importance in the development and behavior of atherosclerotic plaques. The current article came up from the recent suggestions by the scientific community on the role of neutrophils to lymphocyte ratio (NLR) as an inflammatory predictive biomarker of cardiovascular events at an early stage. Materials and methods: Blood samples were collected from 100 chronic coronary artery disease (CAD) patients who have visited the outpatient department (OPD) at King Abdulaziz University Hospital, Jeddah, Saudi Arabia and 100 healthy control individuals. Complete blood examination was done on Cell-Dyn Ruby, USA to calculate NLR. In addition, lipid profile, platelet counts, red cell distribution width (RDW), C-reactive proteins (CRP), fasting glucose, insulin and glycosylated hemoglobin (HbA1c) were also measured by various procedures on different instruments. Results: Total cholesterol and low-density lipoproteins (LDL) showed a significant rise of around 13%. However, non-highdensity lipoprotein cholesterol (Non-HDL) level showed a similar decline (P< 0.05) compared with control. A remarkable rise in fasting glucose, Hb1Ac, and insulin by 58%, 53%, and 44% was recorded in CAD group. Moreover, CRP level also showed a significant rise of 39% in CAD group compared with control individuals. The white blood cell (WBC) analysis revealed a significant enhancement in total WBC, neutrophils and lymphocytes counts. The calculated NLR was found to be significantly (P< 0.001) elevated by 110% in CAD patients compared with control individuals. Conclusions: In view of significant enhancement of NLR level in our samples, we recommend its use as a predictive biomarker of CAD because it is a simple and inexpensive method and could be performed in a routine blood sample.","[Tabrez, Shams; Jabir, Nasimudeen R.; Firoz, Chelapram K.] King Abdulaziz Univ, King Fahd Med Res Ctr, POB 80216, Jeddah 21589, Saudi Arabia; [Nabilalama, Mohammed] King Abdulaziz Univ Hosp, Dept Med, Cardiol Unit, Jeddah 21589, Saudi Arabia","Tabrez, S (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, POB 80216, Jeddah 21589, Saudi Arabia.",,"Tabrez, Shams/H-9476-2012; Rehumathbeevi, Jabir Nasimudeen/H-9483-2012; Tabrez, Shams/H-7315-2019; KANDY, FIROZ CHELAPRAM/H-9487-2012","Tabrez, Shams/0000-0003-4550-415X; Rehumathbeevi, Jabir Nasimudeen/0000-0001-8548-7986; Tabrez, Shams/0000-0003-4550-415X; KANDY, FIROZ CHELAPRAM/0000-0002-8832-9411","Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [141 - 912 - D1435]; DSR","This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (141 - 912 - D1435). The authors, therefore, gratefully acknowledge the DSR technical and financial support.","Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.02; Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.00; Ashraf H, 2013, DIABETES RES CLIN PR, V102, P225, DOI 10.1016/j.diabres.2013.10.01; Banu S, 2014, CNS NEUROL DISORD-DR, V13, P402, DOI 10.2174/1871527311312666015; Baysal E, 2015, BLOOD COAGUL FIBRIN, V26, P274, DOI 10.1097/MBC.000000000000022; Bertoluci MC, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-1; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/ERC.12.159, 10.1586/erc.12.159; Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq23; Cavusoglu E, 2010, INT J CARDIOL, V141, P141, DOI 10.1016/j.ijcard.2008.11.18; Celik T, 2011, CARDIOL J, V18, P720, DOI 10.5603/CJ.2011.004; D'Adamo E, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/91204; Feng JF, 2014, TRANSL ONCOL, V7, P632, DOI 10.1016/j.tranon.2014.07.00; Firoz CK, 2015, SAUDI J BIOL SCI, V22, P19, DOI 10.1016/j.sjbs.2014.09.00; Jabir NR, 2015, CNS NEUROSCI THER, V21, P1, DOI 10.1111/cns.1234; Kabakci G, 2008, INTEGR BLOOD PRESS C, V1, P5, DOI 10.2147/IBPC.S380; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht36; Kounis NG, 2015, CLIN APPL THROMB-HEM, V21, P139, DOI 10.1177/107602961453144; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.75; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.02; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.05; Madjid M, 2013, TEX HEART I J, V40, P1; Matowicka-Karna J, 2013, CLIN DEV IMMUNOL, V201; Meade TW, 1997, THROMB HAEMOSTASIS, V78, P92; Mehraj I, 2014, AJST, V5, P23; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-; Milovanovic A, 2004, CLIN CHIM ACTA, V343, P237, DOI 10.1016/j.cccn.2003.12.03; Mohan Viswanathan, 2010, J Diabetes Sci Technol, V4, P15; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.71; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.5; Rewers M, 2004, DIABETES CARE, V27, P781, DOI 10.2337/diacare.27.3.78; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu20; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3; Safak S., 2013, NAT J MED RES, V3, P30; Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.115; Takeda Y, 2003, JPN HEART J, V44, P201, DOI 10.1536/jhj.44.20; THAULOW E, 1991, CIRCULATION, V84, P613, DOI 10.1161/01.CIR.84.2.61; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.72754; Xie X, 2016, DIS ESOPHAGUS, V29, P79, DOI 10.1111/dote.1229; Yayan J, 2013, VASC HEALTH RISK MAN, V9, P435, DOI 10.2147/VHRM.S4570",39,1,1,3,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_143,,6,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000014,,,,,2022-07-14,0.0040289256198347105,3.593959861227008e-14,0.009531809570563278,0.09839298238481008,0.008977141458341381
J,"Taskin, G1;  Ozturk, K;  Turker, T;  Ocal, N;  Cakar, M;  Ozer, S;  Yamanel, L",,,,"Taskin, Gurhan; Ozturk, Kadir; Turker, Turker; Ocal, Nesrin; Cakar, Mustafa; Ozer, Serhat; Yamanel, Levent",,,ASSESSMENT OF MORTALITY RISK FACTORS FOR CRITICALLY ILL PATIENTS WITH ACINETOBACTER BAUMANNII BACTEREMIA WITH A NEW PERSPECTIVE,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Acinetobacter baumannii; bacteremia; mortality; risk factor; central venous catheterization,RANDOMIZED-CONTROLLED-TRIALS; CLINICAL-OUTCOMES; SEPSIS; METAANALYSIS; INFECTIONS; LENGTH; TIGECYCLINE; RESISTANCE; AMERICA; LATIN,"Introduction: Acinetobacter baumannii (AB) is a gram-negative coccobacillus causing life-threatening nosocomial infections in critically ill patients. Although mortality risk factors have been investigated in previous studies, there is not sufficient data about the prognostic roles of tracheostomy and central venous catheterization (CVC) in patients with AB bacteremia. Therefore, we performed this study to assess the risk factors associated to mortality from AB bacteremia in intensive care unit (ICU) with a new perspective. Materials and methods: Data of 90 adult patients with AB bacteremia hospitalized between 01 January 2010 and 01 December 2014 in ICU were evaluated retrospectively. The results were assessed in terms of 14th and 28th day mortality rates. Results: The 14th day and 28th day mortality rates for patients with AB bacteremia were 31.1 % and 48.9 %, respectively. The 14th day non-survivors were more likely to have chronic kidney disease, insertion of subclavian and femoral CVC compared to survivors. While tracheostomy, jugular CVC, absence of CVC, higher serum albumin and lower procalcitonin (PCT) levels were observed significantly more common in survivors; higher high-sensitivity CRP, higher PCT, and lower albumin levels were significantly more common in mortality group. Risk factors associated with 14th day mortality were high serum PCT (p<0.001), lack of tracheostomy (p=0.004) and CVC location (p=0.007). Whereas, 28th day mortality was associated with chronic kidney disease, malignancy, insertion of subclavian and femoral CVC. High serum PCT (p<0.001), lack of tracheostomy (p=0.001) and CVC location (p=0.006) were determined as independent predictors for 28th day mortality. Conclusion: These data reveal that lack of tracheostomy and presence of subclavian or femoral CVC are independent risk factors for 14th and 28th day mortality, and high PCT level is a good predictor for poor prognosis in ICU patients with AB bacteremia. According to our knowledge, this study contributes to current literature in terms of being the first study focused on the prognostic roles of tracheostomy and CVC in patients with AB bacteremia.","[Taskin, Gurhan; Ocal, Nesrin; Ozer, Serhat; Yamanel, Levent] Gulhane Mil Med Fac, Dept Intens Care, Ankara, Turkey; [Ozturk, Kadir] Gulhane Mil Med Fac, Dept Gastroenterol, Ankara, Turkey; [Turker, Turker] Gulhane Mil Med Fac, Dept Hlth Publ & Epidemiol, Ankara, Turkey; [Cakar, Mustafa] Gulhane Mil Med Fac, Dept Rheumatol, Ankara, Turkey","Taskin, G (corresponding author), Gulhane Mil Med Fac, Dept Intens Care, Ankara, Turkey.;Taskin, G (corresponding author), Gulhane Askeri Tip Akad, TR-06010 Ankara, Turkey.",,"Taskin, Gurhan/AGQ-8182-2022; ocal, nesrin/D-4118-2016",,,,"Arora S, 2015, SHOCK, V43, P212, DOI 10.1097/SHK.000000000000030; Choi JY, 2005, INTERN MED J, V35, P599, DOI 10.1111/j.1445-5994.2005.00925.; Costello SE, 2016, MICROB DRUG RESIST, V22, P253, DOI 10.1089/mdr.2015.016; Ellis D, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0083-; Garcia-Garmendia JL, 1999, CRIT CARE MED, V27, P1794, DOI 10.1097/00003246-199909000-0001; Georgopoulou AP, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.07.01; Huang ST, 2012, J MICROBIOL IMMUNOL, V45, P356, DOI 10.1016/j.jmii.2011.12.00; Jung JY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-; Katsaragakis S, 2010, AM J INFECT CONTROL, V38, P631, DOI 10.1016/j.ajic.2010.01.00; Le Hello S, 2010, SCAND J INFECT DIS, V42, P821, DOI 10.3109/00365548.2010.49608; Liu C, 2014, INTERNATIONAL CONFERENCE ON ELECTRONIC AND ELECTRICAL ENGINEERING (CEEE 2014), P; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/52919; Marik PE, 2012, CRIT CARE MED, V40, P2479, DOI 10.1097/CCM.0b013e318255d9b; Park SY, 2013, INFECT CHEMOTHER, V45, P325, DOI 10.3947/ic.2013.45.3.32; Reinert RR, 2007, J ANTIMICROB CHEMOTH, V60, P1018, DOI 10.1093/jac/dkm31; Routsi C, 2010, INFECTION, V38, P173, DOI 10.1007/s15010-010-0008-; Saravu K, 2015, PATHOG GLOB HEALTH, V109, P228, DOI 10.1179/2047773215Y.000000002; Schroeder S, 2009, LANGENBECK ARCH SURG, V394, P221, DOI 10.1007/s00423-008-0432-; Schuetz P, 2013, CRIT CARE, V17, DOI 10.1186/cc1278; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.31; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.129; Sheng WH, 2010, INT J INFECT DIS, V14, pE764, DOI 10.1016/j.ijid.2010.02.225; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.06071; Szakmany T, 2015, BRIT J ANAESTH, V114, P396, DOI 10.1093/bja/aeu44; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P154",26,1,1,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1891.0,1897,,10.19193/0393-6384_2016_6_179,,7,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300023,,,,,2022-07-14,0.0026859504132231405,1.7178392618532554e-20,0.01988583531356545,0.07453664846884168,0.01988583531356545
J,"Toghiani, S1;  Dashti, GR;  Roudbari, NH;  Roozbehani, S",,,,"Toghiani, Shima; Dashti, Gholam Reza; Roudbari, Nasim Hayati; Roozbehani, Shahla",,,EFFECT OF ASCORBIC ACID AND MENTHONE ON THE CASPASE 3 IN THE SPERM CELLS OF ACYCLOVIR TREATED RATS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Challenges and threats; health transformation plan; health and prevention; self-care; qualitative study,LIPID-PEROXIDATION; VITAMIN-C; APOPTOSIS; ANTIOXIDANT; DEATH; SPERMATOGENESIS; RECEPTOR; TISSUE; DAMAGE,"Background and aim: Acyclovir (ACV) is a common drug used for treatment of Herpes virus infection. In this study, the role of this drug on apoptosis in rat spermatozoa was investigated along with the effectiveness of two herbal antioxidants of vitamin C (VC) and menthone in the prevention of ACV adverse effects was compared. Materials and methods: Albino Wister adult male rats with mean weight of 200-250 g were divided randomly into six groups. Treatment groups consisted of acyclovir (ACV) at the dose of 15mg/kg/d, ACV (15mg/kg/d) and VC at the dose of 20mg/kg/d, ACV (15mg/kg/d) and menthone at the dose of 100 mu l/d, ACV (15mg/kg/d) and menthone at the dose of250 mu l/d, ACV (15mg/kg/d) and menthone at the dose of 400 mu l/d and control group ended the trial period without any treatment. The animals were anesthetized and epididymal sperm cells from each rats were isolated in PBS to evaluate the expression of caspase3 enzyme by flow cytometry method. Results: The present results demonstrated a very strong supportive, protective effect along with impressive anti-apoptotic role of VC. The expression level of caspase 3 in VC receiving group was close to normal levels. Menthone, another antioxidant compound in the high dose level showed to have a strong anti-apoptotic power, against changes induced by ACV.","[Toghiani, Shima; Roudbari, Nasim Hayati] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran; [Dashti, Gholam Reza] Isfahan Univ Med Sci, Sch Med, Dept Anat Sci, Esfahan, Iran; [Roozbehani, Shahla] Islamic Azad Univ, Falavarjan Branch, Dept Biol, Esfahan, Iran","Dashti, GR (corresponding author), Isfahan Univ Med Sci, Sch Med, Dept Anat Sci, Esfahan, Iran.",dashti@med.mui.ac.ir,"dashti, Gholam reza/R-8062-2017; dashti, gholam/AAR-5400-2020","dashti, Gholam reza/0000-0002-2725-6423; ","Islamic Azad University, Tehran, Iran","This work was funded by Islamic Azad University, Tehran, Iran. The authors like to thank them for financially supporting this research project and there is no conflict of interest in this paper.","Agarwal A., 2005, Iranian Journal of Reproductive Medicine, V3, P; ARUOMA A, 1994, RES CHEM INTERMEDIAT, V26, P25; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.130; Bhalla Y, 2013, J SCI FOOD AGR, V93, P3643, DOI 10.1002/jsfa.626; BLOCK G, 1991, ANN INTERN MED, V114, P909, DOI 10.7326/0003-4819-114-10-90; Bohlmann J, 2008, PLANT J, V54, P656, DOI 10.1111/j.1365-313X.2008.03449.; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.483; Brinkworth MH, 1997, INT J ANDROL, V20, P222, DOI 10.1046/j.1365-2605.1997.00056.; Sa RDDE, 2013, MOLECULES, V18, P1227, DOI 10.3390/molecules1801122; Das UB, 2002, ASIAN J ANDROL, V4, P20; FADOK VA, 1992, J IMMUNOL, V148, P220; FARZIANPOUR F, 2014, AM J AGR BIOL SCI, V9, P147, DOI DOI 10.3844/AJAB-SSP.2014.147.15; FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.1100; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.637; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.974; Furuchi T, 1996, DEVELOPMENT, V122, P170; Ghavami S, 2005, J SCI, V15, P; Ghavami S, J LEUKOC BI IN PRES; Hansen TM, 2003, SCI STKE, V31, P; Huang RFS, 2002, J NUTR, V132, P2151, DOI 10.1093/jn/132.8.215; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc77; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.3; Kimura M, 2003, J ANDROL, V24, P18; Kumar R, 2006, J UROLOGY, V176, P1307, DOI 10.1016/j.juro.2006.06.00; Mahmoud SS, 2003, P NATL ACAD SCI USA, V100, P14481, DOI 10.1073/pnas.243632510; Mainardi T, 2009, J ALLERGY CLIN IMMUN, V123, P283, DOI 10.1016/j.jaci.2008.12.02; Margret C. M. Vissers&NASYMP, 2001, J BIOL CHEM, V276, P4683; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.00; Mikaili P, 2013, ANCIENT SCI LIFE, V33, P12; MILLER JK, 1993, J DAIRY SCI, V76, P2812, DOI 10.3168/jds.S0022-0302(93)77620-; Morales E, 2007, J ANDROL, V28, P; Moreno RD, 2006, CELL TISSUE RES, V325, P533, DOI 10.1007/s00441-006-0186-; Movahed E, 2013, IRAN J REPROD MED, V11, P11; Narayana K, 2008, J TOXICOL SCI, V33, P61, DOI 10.2131/jts.33.6; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054; Paasch U, 2003, J ANDROLOGY, V2; RETSKY KL, 1993, J BIOL CHEM, V268, P130; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.103; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.95; Salami S, 2003, CLIN BIOCHEM, V36, P247, DOI 10.1016/S0009-9120(03)00007-; Scavroni Joseane, 2005, Braz. J. Plant Physiol., V17, P345, DOI 10.1590/S1677-0420200500040000; Sebesan M., 2008, CHEM B POLITEHNICA U, V53, P; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.012; Sharafi SM, 2010, PHARMACOGN MAG, V6, P147, DOI 10.4103/0973-1296.6692; Sies H., 1991, OXIDATIVE STRESS OXI, P1; Sonmez M, 2005, THERIOGENOLOGY, V63, P2063, DOI 10.1016/j.theriogenology.2004.10.00; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.787846; Tabatabaie SJ, 2007, TURK J AGRIC FOR, V31, P24; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.040; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/3504267; Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.98; Yang HS, 2006, J KOREAN MED SCI, V21, P445, DOI 10.3346/jkms.2006.21.3.44; Yousef MI, 2006, TOXICOLOGY, V227, P240, DOI 10.1016/j.tox.2006.08.00",53,3,3,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1213.0,1219,,,,7,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200005,,,,,2022-07-14,0.005475206611570247,7.45442733688722e-15,0.010715496358735236,0.08864063000778352,0.010715496358735236
J,"Ucmak, F1;  Solmaz, I;  Ekin, N;  Kaplan, I;  Tuncel, ET;  Senates, E;  Yalcin, K",,,,"Ucmak, Feyzullah; Solmaz, Ihsan; Ekin, Nazim; Kaplan, Ibrahim; Tuncel, Elif Tugba; Senates, Ebubekir; Yalcin, Kendal",,,THE STATUS OF OXIDATIVE STRESS AND ANTIOXIDANT DEFENSE IN PATIENTS WITH CHRONIC HEPATITIS D,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Chronic hepatitis D; oxidative stress; antioxidants,NONALCOHOLIC STEATOHEPATITIS; VIRUS-INFECTION; LIVER-DISEASES; C PATIENTS; THERAPY; PATHOGENESIS; MECHANISMS; SEVERITY; FIBROSIS; UPDATE,"Introduction: Oxidative stress is increasingly recognized as an important factor in the progression of chronic liver disease of varying etiologies and antioxidants are utilized in the treatment of some of them. Chronic viral hepatitis D continues to be a significant health problem in certain regions of the world. Rates of response to currently proposed treatments are rather low. The aim of this study was to investigate oxidative stress in patients with chronic viral hepatitis D. Materials and methods: A total of 91 patients with chronic hepatitis D virus infection were included in this study (mean age: 42.2 +/- 11.7). In addition, 40 healthy volunteers were included in the study to form the control group. Patients were divided into two main sub-groups as cirrhotic (n=30) and non-cirrhotic (n=61) groups. Blood samples were taken from both patients and control subjects and compared for total oxidant status (TOS), total anti-oxidant status (TAS) and oxidative stress index (OSI). Results: TOS levels were significantly higher in the patients compared to the control sub-jects (p<0.001). Moreover, TOS levels were higher in the cirrhotic patients compared to the non-cirrhotic patients (p=0.006). TAS levels were significantly lower in the patients compared to the control subjects (p=0.003). OSI levels were significantly higher in the patients compared to the control subjects (p<0.001). Moreover, OSI levels were higher in the cirrhotic patients compared to the non-cirrhotic patients (p<0.05). Conclusion: These results are supportive of the role of oxidative stress in the pathogenesis of chronic viral hepatitis D. Antioxidant therapies might be considered in patients with chronic viral hepatitis D considering the presence of oxidative stress in these patients.","[Ucmak, Feyzullah; Ekin, Nazim; Tuncel, Elif Tugba; Yalcin, Kendal] Dicle Univ, Sch Med, Dept Gastroenterol, TR-21100 Diyarbakir, Turkey; [Solmaz, Ihsan] Siverek State Hosp, Internal Med Clin, Sanliurfa, Turkey; [Kaplan, Ibrahim] Dicle Univ, Sch Med, Dept Clin Biochem, Diyarbakir, Turkey; [Senates, Ebubekir] Medeniyet Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkey","Ucmak, F (corresponding author), Dicle Univ, Sch Med, Dept Gastroenterol, TR-21100 Diyarbakir, Turkey.",,,,,,"Alves C, 2013, ADV VIROL, V2013, DOI 10.1155/2013/56010; Bolukbas C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-9; Chiou YL, 2012, CLIN BIOCHEM, V45, P1389, DOI 10.1016/j.clinbiochem.2012.06.02; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.808; Dikici I, 2005, CLIN BIOCHEM, V38, P1141, DOI 10.1016/j.clinbiochem.2005.10.00; Duygu F, 2012, ANN LAB MED, V32, P113, DOI 10.3343/alm.2012.32.2.11; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.01; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.00; Ha HL, 2010, WORLD J GASTROENTERO, V16, P6035, DOI 10.3748/wjg.v16.i48.603; Heidrich B, 2012, LIVER INT, V32, P1415, DOI 10.1111/j.1478-3231.2012.02831.; Higgs MR, 2014, J GEN VIROL, V95, P991, DOI 10.1099/vir.0.059485-; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.; Koruk M, 2004, ANN CLIN LAB SCI, V34, P5; Levent G, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-2; Look MP, 1999, ANTIVIR RES, V43, P113, DOI 10.1016/S0166-3542(99)00041-; Muriel P, 2009, HEPATOL INT, V3, P526, DOI 10.1007/s12072-009-9158-; Namiduru ES, 2012, ADV CLIN EXP MED, V21, P4; Pascarella S, 2011, LIVER INT, V31, P7, DOI 10.1111/j.1478-3231.2010.02320.; Pijls KE, 2013, LIVER INT, V33, P1457, DOI 10.1111/liv.1227; Rizzetto M, 2015, HEPATOLOGY, V61, P1109, DOI 10.1002/hep.2758; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/09298671280334152; SMEDILE A, 1982, LANCET, V2, P945, DOI 10.1016/S0140-6736(82)90156-; Takaki A, 2015, WORLD J HEPATOL, V7, P968, DOI 10.4254/wjh.v7.i7.96; Takaki A, 2014, INT J MOL SCI, V15, P7352, DOI 10.3390/ijms1505735; Torres JR, 1996, GUT, V38, pS48, DOI 10.1136/gut.38.Suppl_2.S4; Uhl P, 2014, INT J MOL SCI, V15, P7500, DOI 10.3390/ijms1505750; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.20; Williams V, 2012, J VIRAL HEPATITIS, V19, P744, DOI 10.1111/j.1365-2893.2012.01597.; Yurdaydin C, 2010, J VIRAL HEPATITIS, V17, P749, DOI 10.1111/j.1365-2893.2010.01353.; Zuwala-Jagiello J, 2009, ACTA BIOCHIM POL, V56, P67",31,0,0,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,6.0,,,,,1865.0,1871,,10.19193/0393-6384_2016_6_175,,7,"Medicine, General & Internal",General & Internal Medicine,EF2SJ,WOS:000390174300019,,,,,2022-07-14,0.003202479338842975,1.202213644589806e-11,0.04753723839660826,0.10347739638898094,0.04755797106399165
J,"Ugras, D1;  Mustafa, U;  Oguzhan, O;  Mehmet, Y;  Seckin, A;  Gazi, OO;  Cem, O;  Erol, K;  Akin, A",,,,"Ugras, Daban; Mustafa, Ugur; Oguzhan, Ozcan; Mehmet, Yaldiz; Seckin, Akkucuk; Gazi, Ozbilen Orhan; Cem, Oruc; Erol, Kilic; Akin, Aydogan",,,PROTECTIVE EFFECTS OF ESCIN ON HEPATIC ISCHEMIA/REPERFUSION INJURY IN RATS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Liver; ischemia/reperfusion injury; escin; antioxidant effect,ISCHEMIA-REPERFUSION INJURY; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; SEED EXTRACT; REDUCTION; RADICALS; ASSAY,"Introduction: Hepatic ischemia/reperfusion (I/R) injury is a common pathology that can occur during and after vascular surgeries and organ transplantation. Although multiple agents have been used to minimize this pathology, I/R injury remains a challenging problem. In this study, we investigated the effectivity of escin on hepatic I/R injury. Materials and methods: Hepatic I/R injury was determined in rats by the clamping of the hepatic artery and portal vein for 60 minutes, followed by 60-minute reperfusion. Escin 10 mg/kg (i.p.) was administered 30 minutes prior to ischemia and 30 minutes prior to reperfusion. Liver function tests were evaluated by the assessment of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) levels, the radical oxygen species (ROS) were evaluated by the assessment of malondialdehyde (MDA), and the antioxidant activity was evaluated by the assessment of glutathione (GSH), catalase (CAT), and superoxide dismutase (SOD) levels. Samples of liver tissues were histopathologically evaluated. Results: The results revealed that serum AST, ALT, and LDH and the MDA levels were lower both in the pre-ischemia and pre-reperfusion escin groups. The CAT and SOD levels were higher in the pre-reperfusion escin group. Histopathologic injury was lower in the rats administered with escin. Discussion: In this study, it was demonstrated that escin provides useful outcomes since it reduces ROS formation when administered prior to ischemia and removes ROS when administered prior to reperfusion.","[Ugras, Daban; Mustafa, Ugur; Seckin, Akkucuk; Gazi, Ozbilen Orhan; Cem, Oruc; Erol, Kilic; Akin, Aydogan] Mustafa Kemal Univ, Sch Med, Dept Gen Surg, TR-31100 Serinyol, Hatay, Turkey; [Oguzhan, Ozcan] Mustafa Kemal Univ, Sch Med, Dept Biochem, TR-31100 Serinyol, Hatay, Turkey; [Mehmet, Yaldiz] Mustafa Kemal Univ, Sch Med, Dept Pathol, TR-31100 Serinyol, Hatay, Turkey","Mustafa, U (corresponding author), Mustafa Kemal Univ, Tip Fak, Genel Cerrahi AD, TR-31100 Serinyol, Hatay, Turkey.",,,,Scientific Research Projects Coordination Unit of Mustafa Kemal University,This study was granted by Scientific Research Projects Coordination Unit of Mustafa Kemal University.,"Aebi H., 1974, METHODS ENZYMATIC AN, P67; Atila K, 2002, CLIN NUTR, V21, P309, DOI 10.1054/clnu.2002.054; Bilbao G, 1999, ANN SURG, V230, P185, DOI 10.1097/00000658-199908000-0000; Bougelet C, 1998, EUR J PHARMACOL, V345, P89, DOI 10.1016/S0014-2999(97)01616-; Crockett ET, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-; DAWSON TL, 1993, AM J PHYSIOL, V264, pC961, DOI 10.1152/ajpcell.1993.264.4.C96; DRAPER HH, 1990, METHOD ENZYMOL, V186, P42; Dufour DR, 2000, CLIN CHEM, V46, P202; DURAK I, 1993, CLIN CHIM ACTA, V214, P103, DOI 10.1016/0009-8981(93)90307-; GUILLAUME M, 1994, ARZNEIMITTELFORSCH, V44-1, P2; HORTON JW, 1993, J APPL PHYSIOL, V74, P1515, DOI 10.1152/jappl.1993.74.4.151; JENNINGS RB, 1991, ANNU REV MED, V42, P225, DOI 10.1146/annurev.med.42.1.22; Kahraman A, 2003, J NEPHROL, V16, P21; KNIGHT KR, 1991, CLIN SCI, V80, P235, DOI 10.1042/cs080023; KOBAYASHI S, 1989, J BIOL CHEM, V264, P1799; Kucukkurt I, 2010, J ETHNOPHARMACOL, V129, P18, DOI 10.1016/j.jep.2010.02.01; Mandrekar P, 2011, MOL PATHOL LIB, V5, P411, DOI 10.1007/978-1-4419-7107-4_2; MORRIS SF, 1993, PLAST RECONSTR SURG, V92, P1162, DOI 10.1097/00006534-199311000-0002; Nath KA, 1994, AM J MED, V42, P63; Onody P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.007375; PAGLIA DE, 1967, J LAB CLIN MED, V70, P15; Seeto RK, 2000, AM J MED, V109, P109, DOI 10.1016/S0002-9343(00)00461-; Sehirli O, 2008, PHYTOTHER RES, V22, P43, DOI 10.1002/ptr.225; Serracino-Inglott Ferdinand, 2002, BMC Gastroenterol, V2, P22, DOI 10.1186/1471-230X-2-2; Siemionow M, 2004, MICROSURG, V24, P468, DOI 10.1002/micr.2006; Sirtori CR, 2001, PHARMACOL RES, V44, P183, DOI 10.1006/phrs.2001.084; Sozen S, 2011, HIPPOKRATIA, V15, P16; SUN Y, 1988, CLIN CHEM, V34, P49; Wilhelm J, 1990, Acta Univ Carol Med Monogr, V137, P; Yildirim Sadik, 2002, Asian J Surg, V25, P149, DOI 10.1016/S1015-9584(09)60164-; Yining L, 2015, BIOMEDICAL REPORTS, P1; Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.007442",32,2,2,1,8,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,973.0,979,,10.19193/0393-6384_2016_4_118,,7,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000018,,,,,2022-07-14,0.003305785123966942,6.062013100810895e-21,0.006257320027994382,0.06447272896810331,0.006257320027994382
J,"Uluocak, N1;  Kulu, M;  Acar, O;  Atilgan, D;  Parlaktas, BS;  Kilic, S;  Inanc, L;  Erdemir, F",,,,"Uluocak, N.; Kulu, M.; Acar, O.; Atilgan, D.; Parlaktas, B. S.; Kilic, S.; Inanc, L.; Erdemir, F.",,,IS THERE A RELATIONSHIP BETWEEN ALCOHOL/DRUG ABUSE AND LUTS/ED?,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Alcohol; drug addiction; dysfunction; sexual; urinary,URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; BENIGN PROSTATIC HYPERPLASIA; ERECTILE DYSFUNCTION; STYLE FACTORS; RISK-FACTORS; MEN; PREVALENCE; WOMEN,"Introduction: The aim of the study was to assess the presence and severity of lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) in the drug and alcohol addicted population. Materials and methods: Alcohol and drug abuse groups constituted of male abusers who presented to a local Alcohol and Drug Abuse Research Center. Control groups were composed of age-matched healthy men who denied any drug/alcohol abuse. Each group was composed of 30 men. Beck Depression and Anxiety Scales, International Prostate Symptom Score (IPSS), Overactive Bladder Symptom Score (OAB-V8), International Index of Erectile Function (IIEF-5) and sexual satisfaction scale were the tools applied to the subjects and controls. Additionally, maximum (Qmax) and average urinary flow rates (Qave) were recorded for statistical assessment in all groups. Results: The mean age, number of children, number of siblings, were comparable between the subjects and controls (p> 0.05). LUTS and ED were more prevalent in drug and alcohol abusers when compared with their controls. Higher mean depression and anxiety scores of the drug and alcohol abusers highlighted their worse psychological status. The quality of life and sexual satisfaction assessment of the drug abusers yielded significantly lower results when compared with their controls. Regarding the comparison between alcohol addicts and their controls; quality of life scores were significantly higher whereas sexual satisfaction assessment results were comparable. The Qave values were similar between drug abusers and their controls while mean Qave was significantly higher in the alcohol addicts than their controls. Conclusion: ED and LUTS are more prevalent in alcohol and drug abusers when compared to healthy controls. It can be proposed that alcohol and drug addiction should be considered in the etiology of ED and LUTS especially in young adult population.","[Uluocak, N.; Atilgan, D.; Parlaktas, B. S.; Kilic, S.; Erdemir, F.] Gaziosmanpasa Univ, Fac Med, Dept Urol, TR-60100 Tokat, Turkey; [Kulu, M.; Inanc, L.] Tokat State Hosp Mental Hlth & Neurol Dis, Tokat, Turkey; [Acar, O.] Koc Univ, Sch Med, Dept Urol, Istanbul, Turkey","Uluocak, N (corresponding author), Gaziosmanpasa Univ, Fac Med, Dept Urol, TR-60100 Tokat, Turkey.",,"AtÄ±lgan, Dogan/AAP-6285-2020; Ä°nanÃ§, Leman/ABG-7614-2021",,,,"[Anonymous], 2012, WORLD DRUG REPORT R; Bang-Ping J, 2009, J SEX MED, V6, P1072, DOI 10.1111/j.1743-6109.2007.00707.; Bradley CS, 2005, J WOMENS HEALTH, V14, P128, DOI 10.1089/jwh.2005.14.12; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.10; Cheng JYW, 2007, INT J IMPOT RES, V19, P343, DOI 10.1038/sj.ijir.390155; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P8; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-; Forster JA, 2012, BJU INT, V109, P1277, DOI 10.1111/j.1464-410X.2012.10988.; Grover S, 2014, INDIAN J PSYCHOL MED, V36, P355, DOI 10.4103/0253-7176.14069; Kristal AR, 2008, AM J EPIDEMIOL, V167, P925, DOI 10.1093/aje/kwm38; Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.238; Parsons JK, 2006, J CLIN ENDOCR METAB, V91, P2562, DOI 10.1210/jc.2005-279; Ponizovsky AM, 2008, J SEX MED, V5, P2347, DOI 10.1111/j.1743-6109.2008.00882.; Quaglio G, 2008, DRUG ALCOHOL DEPEN, V94, P12, DOI 10.1016/j.drugalcdep.2007.09.02; Skeldon SC, 2014, NAT REV UROL, V11, P169, DOI 10.1038/nrurol.2014.2; Suh B, 2014, ALCOHOL CLIN EXP RES, V38, P2878, DOI 10.1111/acer.1256; Teleman PM, 2004, BJOG-INT J OBSTET GY, V111, P600, DOI 10.1111/j.1471-0528.2004.00137.; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P; Wong SY, 2010, AGING MALE, V13, P113, DOI 10.3109/1368553090344043",20,2,2,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,4.0,,,,,1029.0,1034,,10.19193/0393-6384_2016_4_127,,6,"Medicine, General & Internal",General & Internal Medicine,DY1XF,WOS:000384887000027,,,,,2022-07-14,0.002066115702479339,8.892440542344516e-11,0.0039219696044687355,0.09891378764190756,0.0039219696044687355
J,"Vezzani, G21;   Socias, S;   Bianco, A;   Paoli, A;   Caberti, L;   Cantadori, L;   Manelli, D;   Mordacci, M;   Mangar, D;   Camporesi, EM;   Bosco, G",,,,"Vezzani, Giuliano; Socias, Stephanie; Bianco, Antonino; Paoli, Antonio; Caberti, Leonardo; Cantadori, Luca; Manelli, Daniele; Mordacci, Marco; Mangar, Devanand; Camporesi, Enrico M.; Bosco, Gerardo",,,INFLAMMATORY MEDIATORS AND OTHER BIOMARKERS IN CO-INTOXICATED PATIENTS AFTER HYPERBARIC OXYGEN THERAPY (HBO2),ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Carbon monoxide; Neurological damage; Inflammatory markers; Hyperbaric oxygen,NEURON-SPECIFIC ENOLASE; S100B PROTEIN; MONOXIDE,"Objective: The present study was conducted in attempt to identify reliable biomarkers in predicting the severity of neurological injury. Materials and methods: A number of 30 patients with confirmed CO poisoning and a number of 7 healthy control volunteers were involved into the study. All participants received at least 60 minutes of hyperbaric oxygen therapy (HBO2) at 2.5 atmospheres absolute (ATA). Standard blood gas analysis was performed on 10 mL venous blood samples obtained immediately before and after HBO2. Seven biomarkers and carboxyhemoglobin (COHb) levels were measured. Results: Following HBO2, all patients recovered fully and were discharged in stable condition. Significant differences between pre and post HBO2 values were found in three of the seven biomarkers analyzed: TNF-alpha, IL-10, and S100B. Additionally, S100B and NSE levels were significantly different from controls for the 10 patients who experienced temporary loss of consciousness (LOC), and IL-6 levels were significantly different from controls for all CO-intoxicated patients. Conclusion: Conclusive evidence of a correlation between a single biomarker and LOC patients was not found. However, the data suggests that the significance of the fall between pre and post HBO2 values for TNF-alpha and IL-10, along with the resolution of IL-6 levels, may herald the severity of the patient's neurological condition.","[Vezzani, Giuliano; Caberti, Leonardo; Cantadori, Luca; Manelli, Daniele; Mordacci, Marco] Vaio Hosp, Parma, Italy; [Socias, Stephanie; Mangar, Devanand; Camporesi, Enrico M.] Florida Gulf To Bay Anesthesiol Associates LLC, Tampa Gen Circle, Tampa, FL USA; [Bianco, Antonino] Univ Palermo, Sport & Exercise Sci Res Unit, Via Giovanni Pascoli 6, I-90144 Palermo, Italy; [Paoli, Antonio; Bosco, Gerardo] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy","Bianco, A (corresponding author), Univ Palermo, Sport & Exercise Sci Res Unit, Via Giovanni Pascoli 6, I-90144 Palermo, Italy.",,"Bianco, Antonino/AAB-8023-2020; Paoli, Antonio/A-6151-2015; Bianco, Antonino/AAI-7451-2020","Paoli, Antonio/0000-0003-0474-4229; Bianco, Antonino/0000-0001-8334-6581; BOSCO, GERARDO/0000-0001-6595-7944",,,"Akelma AZ, 2013, AM J EMERG MED, V31, P524, DOI 10.1016/j.ajem.2012.10.00; Brvar M, 2003, RESUSCITATION, V56, P105, DOI 10.1016/S0300-9572(02)00289-; Cakir Z, 2010, AM J EMERG MED, V28, P61, DOI 10.1016/j.ajem.2008.10.03; Ide T, 2012, AM J EMERG MED, V30, P222, DOI 10.1016/j.ajem.2010.11.02; Lippi G, 2012, CLIN BIOCHEM, V45, P1278, DOI 10.1016/j.clinbiochem.2012.06.00; Martines F, 2015, EUR ARCH OTO-RHINO-L, V272, P2719, DOI 10.1007/s00405-014-3275-; Martines F, 2011, ORL-J OTO-RHIN-LARYN, V73, P137, DOI 10.1159/00032752; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.03; Rabczynski M, 2015, INT J OCCUP MED ENV, V28, P169, DOI 10.2478/s13382-014-0293-; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P469, DOI 10.1111/j.1399-6576.2004.00362.; Thom SR, 2010, CLIN TOXICOL, V48, P47, DOI 10.3109/1556365090346820; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp080889; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.01",13,4,4,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,189.0,193,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700029,,,,,2022-07-14,0.0013429752066115702,5.1498070498101625e-11,0.0024779299821800454,0.10457516339869281,0.0024779299821800454
J,"Wan, L21;   Liu, J;   Haung, CB",,,,Wan Lei; Liu Jian; Haung Chuanbing,,,"RESEARCH OF XINFENG CAPSULE ON PULMONARY FUNCTION BASED ON THE B, T CELL IMMUNITY IN THE RAT MODEL OF ADJUVANT INDUCED ARTHRITIS",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,B; T lymphocyte attenuator; regulatory T cells; adjuvant arthritis; pulmonary function; Xinfeng Capsule,INTERSTITIAL LUNG-DISEASE; RHEUMATOID-ARTHRITIS; TRIPTERYGIUM GLYCOSIDES; BTLA; EXPRESSION; MEDICINE; RISK,"Introduction: To observe the effects of Xinfeng Capsule on adjuvant arthritis rat model of pulmonary function, B, T cell immunity. Materials and methods: 40 rats were randomly divided into normal, model, Tripterygium Glycosides tablet and XFC group. Except the normal group, the other rats right rear paw intradermal injection of Freund's complete adjuvant induced arthritis in 0.1 mL. Inflammation induced 19 d after administration, the normal group, the model group were given physiological saline, rats in the treatment group were given of Xinfeng Capsule (2.4 g/kg), Tripterygium Glycosides tablet (10 mg/kg), once a day, continuous administration of 30D. Joint inflammation in rats was observed performance, flow cytometry detection of peripheral blood B, T lymphocyte attenuator (BTLA), regulatory T cells (Treg) and surface markers of forkhead transcription factor (FoxP3) expression was detected by Western blotting, synovial membrane, lung tissue BTLA, FoxP3. Results: Compared with the normal group, model group of rat paw swelling degree, arthritis index increased; pulmonary function, reduce the expression levels of peripheral blood BTLA, Tregs and BTLA in pulmonary tissue, synovium, FoxP3 (P <0.05 or P <0.01). While the XFC group rat paw swelling and arthritis index lower than the model group, pulmonary function, BTLA, Tregs and FoxP3 increased (P <0.05 or P <0.01); Xinfeng capsule group is better than control group (P <0.05) medicine Tripterygium wilfordii. Discussion: Xinfeng capsule may be through upregulation of BTLA, Tregs, FoxP3 expression, reduce the stimulation of inflammatory mediators in the lung tissue and improve the lung function of rats with adjuvant arthritis.","[Wan Lei; Liu Jian; Haung Chuanbing] Anhui Univ Chinese Med, Affiliated Hosp 1, Dept Rheumatol, Hefei 230031, Peoples R China","Liu, J (corresponding author), Anhui Univ Chinese Med, Affiliated Hosp 1, Dept Rheumatol, Hefei 230031, Peoples R China.",liujianahzy@126.com,,,National Natural Science Foundation of China [81403388]; Provincial Natural Science Foundation of China [1508085QH159]; Anhui Key Lab: Modern Chinese medicine applied basic research and development project [1606c08238]; Anhui University of Traditional Chinese university funds [2014qn025]; Anhui Education Department Natural Science Key Research Program [KJ2008A165],"The authors express their gratitude to Mr Wen Hu, Ke Cheng, Qinglin Li for their excellent technical assistance. The authors thank Lei Liu, Yuanyuan Cheng, Yunxia Feng for assistance. This work was supported by grants from National Natural Science Foundation of China (81403388), Provincial Natural Science Foundation of China (1508085QH159), Anhui Key Lab: Modern Chinese medicine applied basic research and development project (1606c08238), Anhui University of Traditional Chinese university funds (2014qn025), Anhui Education Department Natural Science Key Research Program (KJ2008A165).","Cheng Yuan-yuan, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P113; Dai Ling-juan, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P13; Estrada-Capetillo L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/58430; Gertner-Dardenne J, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.2585; Golab K, 2014, TRANSPL P, V46, P1967, DOI 10.1016/j.transproceed.2014.05.07; Ji W, 2014, BIOMED REP, V2, P517, DOI 10.3892/br.2014.26; Kimura LF, 2013, TOXICON, V76, P239, DOI 10.1016/j.toxicon.2013.10.01; Lei W, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/34845; Leonel D, 2012, RHEUMATOL INT, V32, P2111, DOI 10.1007/s00296-011-1933-; Li Q, 2012, CHINESE MED J-PEKING, V125, P786, DOI 10.3760/cma.j.issn.0366-6999.2012.05.01; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.03; Lin SC, 2006, J BIOMED SCI, V13, P853, DOI 10.1007/s11373-006-9113-; Liu J.-S., 2010, EURASIP J WIREL COMM, V2010, P1, DOI DOI 10.1002/MEET.14504701173/FUL; Liu Jian, 2014, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V30, P63; Liu J, 2013, J INTEGR MED-JIM, V11, P428, DOI 10.3736/jintegrmed201305; Liu J, 2011, CHIN J INTEGR MED, V17, P735, DOI 10.1007/s11655-011-0872-; Ma WN, 2014, ONCOL LETT, V8, P414, DOI 10.3892/ol.2014.213; Ma YC, 2008, MOD PREVEN MED, V35, P198; Mori S, 2012, RESP MED, V106, P1591, DOI 10.1016/j.rmed.2012.07.00; Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.100431; Mythilypriya R, 2008, CHEM-BIOL INTERACT, V176, P243, DOI 10.1016/j.cbi.2008.07.00; Nan XP, 2010, VIRAL IMMUNOL, V23, P63, DOI 10.1089/vim.2009.006; Olson AL, 2011, AM J RESP CRIT CARE, V183, P372, DOI 10.1164/rccm.201004-0622O; Pesenacker AM, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.1; Shang Yong-jun, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P64; Shang YJ, 2012, INFLAMMATION, V35, P1102, DOI 10.1007/s10753-011-9417-; Wan L, 2014, J TRADIT CHIN MED, V34, P76, DOI 10.1016/S0254-6272(14)60058-; Wan L, 2013, J CHIN MED ASSOC, V76, P715, DOI 10.1016/j.jcma.2013.08.00; Wan L, 2012, J TRADIT CHIN MED, V32, P430, DOI 10.1016/S0254-6272(13)60050-; Wang P, 2013, INT J CLIN EXP PATHO, V6, P266; Weyand CM, 2014, CURR OPIN RHEUMATOL, V26, P93, DOI 10.1097/BOR.000000000000001; Yuan BQ, 2014, MOL IMMUNOL, V57, P93, DOI 10.1016/j.molimm.2013.08.00",32,2,2,0,3,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,3.0,,1129.0,1136,,,,8,"Medicine, General & Internal",General & Internal Medicine,EI1YM,WOS:000392282800003,,,,,2022-07-14,0.003305785123966942,1.8887895142461243e-10,0.0059831009282258,0.07449534788865717,0.0059831009282258
J,"Wang, H21;   Xiang, HP",,,,"Wang, Hong; Xiang, Hanping",,,CLINICAL EFFECT OF MENISCUS TEAR REPAIR SURGERY BY ARTHROSCOPY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Arthroscopy; Aid; Meniscus; Tear; Repair Surgery; Therapeutic Effect,,"An analysis of the clinical effect of arthroscopy as guidance in repair surgery for meniscus tear to accelerate physical recovery: Method: 3100 patients who underwent meniscus tear surgery with arthroscopic aid in various hospitals from Feb 2012 to July 2014 were followed up after 1-year to observe the Postoperative clinical effect. Results: there were 3002 patients showing meniscus healing, with healing rate of 96.8%6, indicating that the treatment achieved significant effect. Conclusions: with less wounding during surgery and faster post-operative recovery, arthroscopic-aided meniscus tear repair surgery was very effective in accelerating recovery and rendered meniscus repair effective.","[Wang, Hong; Xiang, Hanping] Wuhan Sports Univ, Wushu Coll, Wuhan 430079, Peoples R China","Xiang, HP (corresponding author), Wuhan Sports Univ, Wushu Coll, Wuhan 430079, Peoples R China.",,,,,,"Aldea M, 2016, ASIAN PAC J SURG ONC, V2, P16; August DA, 2016, ASIAN PAC J SURG ONC, V2, P15; Du Yukang, 2014, CHINA PRACTICAL MED, V28, P; Fu Dong, 2014, CHINESE J BONE JOINT, V15, P42; Gu Jianming, 2010, CHINESE J TISSUE ENG, V12, P702; Liu Yu, 2014, CHINESE J JOINT SURG, V18, P53; Mellotte G. M. V., 2015, ASIAN PAC J SURG ONC, V1, P10; Wu Qiuli, 2012, J PRACTICAL ORTHOPAE, V8, P12; Yan Zhihui, 2014, CHINESE J REPARATIVE, V15, P1; Yang Haibo, 2011, NINGXIA MED J, V8, P76",10,2,2,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,1.0,,547.0,550,,,,4,"Medicine, General & Internal",General & Internal Medicine,DN9SI,WOS:000377420600017,,,,,2022-07-14,0.0010330578512396695,2.6638788307617346e-09,0.0014939320108159993,0.07403838063988129,0.0015044271675054889
J,"Yang, J1",,,,"Yang, Jun",,,ROTATIONAL ATHERECTOMY AND DRUG ELUTING STENT IN TREATMENT OF UNPROTECTED LEFT MAIN CORONARY ARTERY CALCIFIED STENOTIC LESION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Calcification stenosis of left main coronary artery; rotational atherectomy; drug eluting stent,,"Objective: To fully explore clinical effect of rotational atherectomy and drug treatment for left main coronary artery calcification. Method: 1000 patients with left main coronary artery calcified stenotic lesions treated in ten hospitals in 2014 were included in the study. First, coronary rotational atherectomy and drug eluting stent (DES) implantation were adopted for treatment, and all patients were observed on return visits fora period of 12 months postoperative. Results: Of 1000 patients, 984 had a successful operation, which is a 98.4%. success rate. In addition, 16 patients had Various degrees of postoperative adverse reactions and gradually improved after follow-up treatment. During the follow-up period, I patient was lost due to, sudden cardiac death, and 21 patients suffered from angina and were hospitalitezed again. Conclusion: The results demonstrate that coronary artery rotational atherectomy and drug stent implantation surgery offer high safety for serious calcified stenotic lesion of left main coronary artery, with good clinical effects and high clinical application value.","[Yang, Jun] First Peoples Hosp Yunnan Prov, Kunming 650000, Peoples R China","Yang, J (corresponding author), First Peoples Hosp Yunnan Prov, Kunming 650000, Peoples R China.",,,,,,"Feifei Yang, 2010, CHINESE J INTERVENTI, V11, P25; Ghoneum M, 2015, ASIAN PAC J SURG ONC, V1, P7; Mellotte G. M. V., 2015, ASIAN PAC J SURG ONC, V1, P10; Sterling B, 2015, ASIAN PAC J SURG ONC, V1, P8; Tiemin Jiang, 2012, CHINESE J FRONTIERS, V9, P4; Tingting Yu, 2014, CHINESE J GERIATRIC, V12, P116; Wang Kun, 2013, CHINESE J INTERVENTI, V14, P36; Wang Lian, 2015, CHINESE J INTERVENTI, V12, P68; Ye Huiming, 2012, CHINESE CIRCULATION, V04, P25; Zhiyong Wu, 2014, J INTERVENTIONAL RAD, V24, P19",10,1,1,0,0,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,1.0,,543.0,546,,,,4,"Medicine, General & Internal",General & Internal Medicine,DN9SI,WOS:000377420600016,,,,,2022-07-14,0.0010330578512396695,5.881472329472039e-09,0.0017364661293873488,0.07408257758389776,0.0017026513622380324
J,"Yildirim, M1;  Carti, EB;  Ucar, AD;  Erkan, N;  Vardar, E;  Yakan, S;  Sipahi, OE;  Adibelli, Z",,,,"Yildirim, Mehmet; Carti, Erdem Baris; Ucar, Ahmet Deniz; Erkan, Nazif; Vardar, Enver; Yakan, Savas; Sipahi, Ozgur Esen; Adibelli, Zehra",,,"PHYLLODES TUMOR OF THE BREAST: CLINICAL PRESENTATION, MANAGEMENT AND FOLLOW-UP",ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Phyllodes; Fibroadenoma; Breast; Neoplasm,SURGICAL-TREATMENT,"Introduction: Phyllodes tumor of the breast is a rare fibroepithelial breast tumor that usually ocur in adult females. They are composed of a benign epithelial component and a cellular, spindle cell stroma forming a leaf-like structure. No one morphologic finding is reliable in predicting the clinical behavior of the tumor. The rarity of phyllodes tumor and similarity to fibroadenoma necessitate studies and case series presentations delineating differential characteristics. We aimed to present our phylloides tumor experience to make contribution to the knowledge in the literature. Materials and method: This retrospective study includes 414 patients (62 Phyllodes tumor and 352 fibroadenoma)that were diagnosed and treated at Izmir Bozyaka Education and Research Hospital between January 2005 and January 2013. Patients demographic findings, tumor characteristics, diagnostic and treatment modalities and also their follow-up results were examined. Multivariate regression analysis and ROC curve were structured in order to see the significance. Results: The mean age was 42.5 (22-62) and mean tumor diameter was 4.4 (1,2-15) cm in phylloides tumor group. Breast preserving surgery was the preferred treatment of 52 and total mastectomy in 10 patients out of 62 phylloides tumor. The mean follow up time interval was 51 and 66 months for breast preserving and mastectomy patients respectively in phylloides tumor group. Recurrent cases in phylloides tumor group were respectively (12.5%) and 5 (12.5%) in breast preserving and mastectomy patients. Tumor size and patients age were found to be concordant with the type of histopathology (benign, borderline and malignant) of the phylloides tumor. Tumor size was found to be correlated with phylloides tumor diagnosis rather than fibroadenoma. Conclusion: Histopathologically more aggressive phylloides tumor is more likely in bigger tumor size and older age. This is also true in differential diagnosis of fibroadenoma in suspicion of phylloides tumor. The lesions greater than 3 cm should always be surgically excised with clear surgical margins.","[Yildirim, Mehmet; Carti, Erdem Baris; Ucar, Ahmet Deniz; Erkan, Nazif; Yakan, Savas; Sipahi, Ozgur Esen] Izmir Bozyaka Educ & Res Hosp, Dept Gen Surg, Izmir, Turkey; [Vardar, Enver] Izmir Bozyaka Educ & Res Hosp, Dept Pathol, Izmir, Turkey; [Adibelli, Zehra] Izmir Bozyaka Educ & Res Hosp, Dept Radiol, Izmir, Turkey","Erkan, N (corresponding author), Izmir Bozyaka Educ & Res Hosp, Dept Gen Surg, Surg, TR-35350 Izmir, Turkey.",,"Ucar, Ahmet Deniz/O-4435-2014; Yildirim, Mehmet/Y-7939-2018; Adibelli, Zehra Hilal/ABE-8234-2020; vardar, enver/AAB-1508-2020","Ucar, Ahmet Deniz/0000-0002-2678-3133; Adibelli, Zehra Hilal/0000-0001-9265-8114; ",,,"Barrio AV, 2007, ANN SURG ONCOL, V14, P2961, DOI 10.1245/s10434-007-9439-; Benningron J, 1979, PROBLEMS BREAST PATH, V11, P33; Blaker KM, 2010, AM SURGEON, V76, P30; Chaney A W, 1998, Radiat Oncol Investig, V6, P264, DOI 10.1002/(SICI)1520-6823(1998)6:6<264::AID-ROI3>3.0.CO;2-; Chelius M., 1827, NEUEJAHRABUCHER TEU; Chen WH, 2005, J SURG ONCOL, V91, P185, DOI 10.1002/jso.2033; FIKS A, 1981, VIRCHOWS ARCH A, V392, P1, DOI 10.1007/BF0043054; Foxcroft LM, 2007, BREAST, V16, P27, DOI 10.1016/j.breast.2006.05.00; Kapiris I, 2001, EUR J SURG ONCOL, V27, P723, DOI 10.1053/ejso.2001.120; Mishra SP, 2013, ISRN SURG, V2013, DOI DOI 10.1155/2013/36146; Priolo S., 1998, CONTEMP SURG, V53, P16; Ramakant P, 2013, INDIAN J CANCER, V50, P345, DOI 10.4103/0019-509X.12362; Reinfuss M, 1996, CANCER-AM CANCER SOC, V77, P910, DOI 10.1002/(SICI)1097-0142(19960301)77:5<910::AID-CNCR16>3.0.CO;2-; Reinfuss Martin, 1995, Strahlentherapie und Onkologie, V171, P; Richard J., 2009, BREAST ONCOLOGY, V16, P228; Richard J., 2009, ANN SURG ONCOLOGY, V1; Rosen PP., 2001, ROSENS BREAST PATHO; ROWELL MD, 1993, AM J SURG, V165, P376, DOI 10.1016/S0002-9610(05)80849-; Spitaleri G, 2013, CRIT REV ONCOLHEMATO, V1; World Health Organization, 1981, HIST TYP BREAST TUM HIST TYP BREAST TUM, V; Wurdinger S, 2005, AM J ROENTGENOL, V185, P1317, DOI 10.2214/AJR.04.162",21,1,1,0,2,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,1.0,,,,,157.0,161,,,,5,"Medicine, General & Internal",General & Internal Medicine,DL0QN,WOS:000375337700024,,,,,2022-07-14,0.0022727272727272726,1.8669633798976202e-08,0.004334360236312917,0.12774999010201524,0.004334360236312917
J,"Yoon, H1;  Kim, SG;  Kim, GS;  Park, BY",,,,"Yoon, Hyun; Kim, Sung Gil; Kim, Gwang Seok; Park, Bu Yeon",,,RELATIONSHIP BETWEEN METABOLIC SYNDROME AND METABOLIC SYNDROME SCORE AND INSULIN RESISTANCE AND BETA CELL FUNCTION IN KOREAN ADULTS WITH TYPE 2 DIABETES MELLITUS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,metabolic syndrome; metabolic syndrome score; insulin resistance; beta cell function; diabetes mellitus,HOMEOSTASIS MODEL ASSESSMENT; RISK-FACTORS; NATIONAL-HEALTH; GLUCOSE; ASSOCIATION; SECRETION; HYPERGLYCEMIA; DYSFUNCTION; MANAGEMENT; MECHANISM,"Introduction: The present study was conducted to assess the relationship between metabolic syndrome (MetS) and metabolic syndrome score (MSS) and insulin resistance and beta cell function in Korean adults with type 2 diabetes mellitus (T2DM). Material and method: This study included 541 adults with T2DM using 2010 Korean National Health and Nutrition Examination Survey (KNHANES) data. Results: The key study results were as follows: First, after adjusted for the related variables [age, gender, smoking, drinking, exercising, TC, 25(OH)D, and BMI], metabolic syndrome (p = 0.967) and MSS increases (p = 0.131) were not significantly associated with the HOMA-IR levels. Second, after adjusting the related variables (except BMI), MetS (p = 0.264) and MSS increases (p = 0.359) were not significantly associated with HOMA-B levels. However, when further adjusted for BMI, MetS (p = 0.004) and MSS increases (p = 0.010) were inversely associated with HOMA-B levels. Conclusion: Metabolic syndrome and increase of metabolic syndrome score were inversely associated with beta cell function, but were not independently associated with insulin resistance in Korean adults with T2DM.","[Yoon, Hyun] Hanlyo Univ, Dept Biomed Lab Sci, 94-13 Hallyeodae Gil, Gwangyang Si, Jellanam Do, South Korea; [Kim, Sung Gil] Hanlyo Univ, Dept Radiol Sci, 94-13 Hallyeodae Gil, Gwangyang Si, Jellanam Do, South Korea; [Kim, Gwang Seok] Chungbuk Hlth & Sci Univ, Emergency Med Technol, 10 Deogam Gil, Cheongju, Chungcheongbuk, South Korea; [Park, Bu Yeon] Seonam Univ, Dept Hosp Adm, 439 Chunhyang Ro, Namwon Si, Jeollabuk Do, South Korea","Yoon, H (corresponding author), Hanlyo Univ, Dept Biomed Lab Sci, 94-13 Hallyeodae Gil, Gwangyang Si, Jellanam Do, South Korea.",,"yoon, hyun/E-6542-2015","yoon, hyun/0000-0002-4741-9664",,,"Ahmed Shahid, 2010, J Ayub Med Coll Abbottabad, V22, P2; Alarcon C, 2002, DIABETES, V51, P2496, DOI 10.2337/diabetes.51.8.249; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc09-S062, 10.2337/dc11-S011, 10.2337/dc12-S064; Baez-Duarte BG, 2010, DIABET METAB SYND OB, V3, P301, DOI 10.2147/DMSOTT.S1237; Cai XL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/64090; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.248; Cubeddu LX, 2012, METAB SYNDR RELAT D, V10, P344, DOI 10.1089/met.2012.004; Gobato Amanda Oliva, 2014, Rev. paul. pediatr., V32, P55, DOI 10.1590/S0103-0582201400010001; Guo JJ, 2013, PAK J MED SCI, V29, P809, DOI 10.12669/pjms.293.298; Haffner SM, 2000, CIRCULATION, V101, P975, DOI 10.1161/01.CIR.101.9.97; Hanley AJG, 2003, DIABETES, V52, P2740, DOI 10.2337/diabetes.52.11.274; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.51; Heine RJ, 2006, BMJ-BRIT MED J, V333, P1200, DOI 10.1136/bmj.39022.462546.8; Imamura F, 2013, AM J EPIDEMIOL, V177, P1418, DOI 10.1093/aje/kws44; Iozzo P, 1999, J CLIN ENDOCR METAB, V84, P863, DOI 10.1210/jc.84.3.86; Kahn SE, 2001, J NUTR, V131, p354S, DOI 10.1093/jn/131.2.354; Kim KA, 2010, J DIABETES INVEST, V1, P232, DOI 10.1111/j.2040-1124.2010.00054.; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.240; Laws A, 1997, ARTERIOSCL THROM VAS, V17, P64, DOI 10.1161/01.ATV.17.1.6; Lee S, 2006, J KOREAN MED SCI, V21, P69; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M20715720; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF0028088; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-902; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.159; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-; Saely CH, 2005, J CLIN ENDOCR METAB, V90, P5698, DOI 10.1210/jc.2005-079; Schmitz O, 2008, AGEING RES REV, V7, P301, DOI 10.1016/j.arr.2008.04.00; Sowjanya B, 2011, INT J APPL BIOL PHAR, V2, P16; Staten MA, 2010, DIABETES CARE, V33, P205, DOI 10.2337/dc09-120; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.148; World Health Organization, 2000, ASIA PACIFIC PERSPEC, P1; Yamada C, 2012, J DIABETES INVEST, V3, P185, DOI 10.1111/j.2040-1124.2011.00162.; Ying X, 2011, IRAN J PUBLIC HEALTH, V40, P; Yoon H, 2016, ENDOCR J, V63, P785, DOI 10.1507/endocrj.EJ16-010; Yoon H, 2015, METAB SYNDR RELAT D, V13, P329, DOI 10.1089/met.2015.003; Yoon H, 2015, J CLIN BIOCHEM NUTR, V57, P82, DOI 10.3164/jcbn.15-3; Zhou LJ, 2009, MOL PHARMACOL, V76, P596, DOI 10.1124/mol.109.05706",37,0,0,0,1,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,5.0,,,,,,,,10.19193/0393-6384_2016_5_152,,8,"Medicine, General & Internal",General & Internal Medicine,EF2RM,WOS:000390172000023,,,,,2022-07-14,0.003822314049586777,1.435223868775387e-10,0.016255680239553028,0.11148605848411208,0.016248273138654536
J,"Zohreyi, T1;  Erfani, N;  Jadidiyan, AA",,,,"Zohreyi, Tahereh; Erfani, Nasrollah; Jadidiyan, Ahmad Ali",,,PREDICTING ACADEMIC STRESS BASED ON ACADEMIC PROCRASTINATION AMONG FEMALE STUDENTS,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,academic procrastination; academic stress; female student,,"The present study was carried out in order to explain and predict academic stress based on academic procrastination among female students. The study method was correlational. The statistical population consisted of first grade female students of second high school in Kabudrahang in 2014-15. The sample size was estimated to be 210 individuals through Cochran formula. In so doing, multi-stage cluster sampling was employed. Data collection was carried out using Zajacova, Lynch and Espenshade academic stress questionnaire and Savari's procrastination survey. The results of Pearson correlation coefficient indicated that there is a direct significant relationship between female students' academic stress and the dimensions of intentional procrastination, procrastination caused by physical and mental fatigue, and procrastination caused by disorganization. The results of stepwise multiple regression analysis indicated that in the second step, the dimensions of procrastination caused by mental and physical fatigue and also intentional procrastination can predict and explain 49% of changes in female students' academic stress. Therefore, it can be concluded that students' academic stress will decrease with a drop in their procrastination.","[Zohreyi, Tahereh] Islamic Azad Univ, Hamedan Branch, Educ Psychol, Hemedan, Iran; [Erfani, Nasrollah] Payame Noor Univ, Dept Psychol, Tehran, Iran; [Jadidiyan, Ahmad Ali] Islamic Azad Univ, Kangavar Branch, Kangavar, Iran","Erfani, N (corresponding author), Payame Noor Univ, Dept Psychol, Tehran, Iran.",erfani@pnu.ac.ir,,,,,"Abedi G., 2014, J MAZANDARAN U MED S, V24, P18; Abedi Gh, 2011, WORLD APPL SCI J, V12, P93; Akgun S., 2009, ED PSYCHOL, V23, P28; AMES C, 1992, J EDUC PSYCHOL, V84, P261, DOI 10.1037/0022-0663.84.3.26; Amirian S. K., 2013, THESI; Amirkhan, 2008, PERS SOC PSYCHOL B, V24, P10; Chase L., 2012, AGENCY SALES MAGAZIN, V33, P6; Chu AHC, 2005, J SOC PSYCHOL, V145, P24; Covington M. V., 2010, IN J SMART HIGER ED, V9, P5; Felsten G., 2013, PSYCHOL REP, V70, P21; Gadzella B.M., 2001, J INSTRUCTIONAL PSYC, V28, P8; Goetz T., 2009, BRIT J EDUC PSYCHOL, V76, P28; Jansenn T., 2013, J GENETIC PSYCHOL, V16; Kafi M., 1998, COMP MALE FEMALE YO; Karatzias A., 2012, ED PSYCHOL, P3; Kitty K., 2003, J PSYCHOL HLTH, V8, P32; Lai J., 2006, J SOCIAL BEHAV PERSO, V11, P14; Mehrabizadeh Honarmand Verdi M, 2008, POS PERF NEG PER; Moti'i H., 2012, ED PSYCHOL, V70, P2; Oladi F., 1999, THESI; Onwuegbuzie A. J., 2009, J ASSESSMENT EVALUAT, V29, P6; Oweini A., 2014, CARROTS STICK UNPU; Pekrun R., 2009, ED PSYCHOL, V37, P9; Perry R. P., 1991, IN J SMART HIGER ED, V7, P; ROTHBLUM ED, 1986, J COUNS PSYCHOL, V33, P387, DOI 10.1037/0022-0167.33.4.38; Saklofske DH, 2012, LEARN INDIVID DIFFER, V22, P251, DOI 10.1016/j.lindif.2011.02.01; Savari K., 2011, J ED ASSESSMENT, V5, P9; Schnell K., 2015, LEARNING INDIVIDUA; Sepehriyan F., 2011, NEW ED IDEAS, V7, P7; Sepehriyan F., 2011, PSYCHOL STUD, V4, P; Shapiro AL, 2014, TEACH LEARN NURS, V9, P193, DOI 10.1016/j.teln.2014.06.00; Shokri O., 2007, PSYCHOL STUDEIS, V3, P2; Struthera C.W., 2004, REAEARCH HIGHER ED, V41, P58; Tamadoni M., 2010, ED PSYCHOL, V17, P6; Vahedi S, 2011, PROCEDIA SOC BEHAV S, V30, P162; Van Eerde W, 2000, APPL PSYCHOL-INT REV, V49, P372, DOI 10.1111/1464-0597.0002; Van Wyk L., 2004, RELATIONSHIP PROCRA; Wood S. E., 2006, MASTERING WORLD PSY",38,1,1,4,18,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,4.0,,1257.0,1264,,,,8,"Medicine, General & Internal",General & Internal Medicine,EI1YQ,WOS:000392283200011,,,,,2022-07-14,0.003925619834710744,1.4856909185364627e-14,0.007814256184116184,0.08978675645342311,0.0077454173209858335
J,"Zong, Y1;  Zhan, YL;  Peng, J",,,,"Zong, Yang; Zhan, Yulin; Peng, Jun",,,ANALYSIS OF USE INTENSITY OF ANTIMICROBIAL AGENTS FOR SPINAL ORTHOPEDICS BEFORE AND AFTER COMPREHENSIVE INTERVENTION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Comprehensive Intervention; Spinal Orthopedics; Antimicrobial Agents; Clinical Effect,,"In order to thoroughly implement the and of people-oriented medical service, our hospital has adopted comprehensive intervention to replace traditional treatment and ntirsing Methods. In order to fully clarify specific changes in the use intensity of antimicrobial agents for spinal orthopedic disease after comprehensive intervention and improve rationality of use of antimicrobial agents, this study selected 2000: cases of patients admitted to the spinal orthopedics department as research subjects and grouped them based On whether they received comprehensive intervention. 1000 patients admitted from January 2013 to January 2014 didn't receive comprehensive intervention and were classified as the reference group; 1000 patients admitted from May 2014 to May 2016 had comprehensive intervention and were classified as the observation group. Use intensity of antimicrobial drug was calculated with defined daily dose (DDD) as the unit, drug use intensity of the two groups of patients, was judged and analyzed using SPSS19.0 statistical software. The results show that after comprehensive intervention, antimicrobial use density (AUD) of,spinal orthopedics patients decreased from the original 69 23 DDDs/100 people / day to 22.30 DDDs1100 person / day. The difference between the two groups was compared and there is a significant statistical difference. Therefore, the results of this study fully confirm the specific role of comprehensive intervention in improving the use intensity of antimicrobial agents. Implementation' of comprehensive fluffing methods can effectively reduce use intensity' of antimicrobial agents of spinal orthopedics patients, and thus improve the rationality of drug use in treatment.","[Zong, Yang; Zhan, Yulin; Peng, Jun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 201306, Peoples R China","Peng, J (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 201306, Peoples R China.",,,,,,"Aldea M, 2016, ASIAN PAC J SURG ONC, V2, P16; August DA, 2016, ASIAN PAC J SURG ONC, V2, P15; Dobson P. R., 2015, ASIAN PAC J SURG ONC, V1, P5; He Yu, 2012, CHONGQING MED, V41, P377; Li Xiujuan, 2015, CHINESE PHARM AFFAIR, V12, P75; Liu WenYing, 2011, Chinese Journal of Nosocomiology, V21, P268; Ma Li, 2013, WORLD HLTH DIGEST, V21, P22; Wang Shuxin, 2012, J MODERN MED HLTH, V2; Yan Nie, 2015, CHINESE J NOSOCOMIOL, V14, P88; Zhang Hongting, 2012, ACTA CHINESE MED PHA, V40, P8",10,0,0,0,5,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2016,32,,,,1.0,,531.0,534,,,,4,"Medicine, General & Internal",General & Internal Medicine,DN9SI,WOS:000377420600013,,,,,2022-07-14,0.0010330578512396695,2.1871991010312694e-09,0.0015348534817110572,0.07397274929504276,0.0015262834820294951
